{"idB": "1430306_12_item1_p34_s8", "idA": "1430306_11_item1_p10_s0", "sentA": "There has been no bankruptcy, receivership or similar proceeding.", "sentB": "Krele has been issued a state license in New York.", "type": 2, "words": ["<tag1>", "There", "has", "been", "no", "bankruptcy,", "receivership", "or", "similar", "proceeding.", "<tag2>", "Krele", "has", "been", "issued", "a", "state", "license", "in", "New", "York.", "<tag3>"], "wordsA": ["There", "has", "been", "no", "bankruptcy,", "receivership", "or", "similar", "proceeding."], "wordsB": ["Krele", "has", "been", "issued", "a", "state", "license", "in", "New", "York."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p164_s0", "idA": "1430306_11_item1_p11_s0", "sentA": "There have been no material reclassifications, mergers, consolidations, or purchase or sale of a significant amount of assets not in the ordinary course of business.", "sentB": "Based on our intent to file under Section 505(b)(2) with respect to our two lead product candidates, we believe it is unlikely the development process for these product candidates will follow the ordinary course of Phase 1, Phase 2 and Phase 3 studies.", "type": 2, "words": ["<tag1>", "There", "have", "been", "no", "material", "reclassifications,", "mergers,", "consolidations,", "or", "purchase", "or", "sale", "of", "a", "significant", "amount", "of", "assets", "not", "in", "the", "ordinary", "course", "of", "business.", "<tag2>", "Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "two", "lead", "product", "candidates,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "these", "product", "candidates", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies.", "<tag3>"], "wordsA": ["There", "have", "been", "no", "material", "reclassifications,", "mergers,", "consolidations,", "or", "purchase", "or", "sale", "of", "a", "significant", "amount", "of", "assets", "not", "in", "the", "ordinary", "course", "of", "business."], "wordsB": ["Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "two", "lead", "product", "candidates,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "these", "product", "candidates", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p33_s0", "idA": "1430306_11_item1_p11_s0", "sentA": "There have been no material reclassifications, mergers, consolidations, or purchase or sale of a significant amount of assets not in the ordinary course of business.", "sentB": "Because of our size and being in the development stage, we do not currently devote a significant amount of time or resources towards our other pipeline candidates.", "type": 2, "words": ["<tag1>", "There", "have", "been", "no", "material", "reclassifications,", "mergers,", "consolidations,", "or", "purchase", "or", "sale", "of", "a", "significant", "amount", "of", "assets", "not", "in", "the", "ordinary", "course", "of", "business.", "<tag2>", "Because", "of", "our", "size", "and", "being", "in", "the", "development", "stage,", "we", "do", "not", "currently", "devote", "a", "significant", "amount", "of", "time", "or", "resources", "towards", "our", "other", "pipeline", "candidates.", "<tag3>"], "wordsA": ["There", "have", "been", "no", "material", "reclassifications,", "mergers,", "consolidations,", "or", "purchase", "or", "sale", "of", "a", "significant", "amount", "of", "assets", "not", "in", "the", "ordinary", "course", "of", "business."], "wordsB": ["Because", "of", "our", "size", "and", "being", "in", "the", "development", "stage,", "we", "do", "not", "currently", "devote", "a", "significant", "amount", "of", "time", "or", "resources", "towards", "our", "other", "pipeline", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p175_s2", "idA": "1430306_11_item1_p12_s0", "sentA": "Exploration programs in Nevada are subject to state and federal regulations regarding environmental considerations.", "sentB": "In addition, after approval, some types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further FDA review and approval.", "type": 2, "words": ["<tag1>", "Exploration", "programs", "in", "Nevada", "are", "subject", "to", "state", "and", "federal", "regulations", "regarding", "environmental", "considerations.", "<tag2>", "In", "addition,", "after", "approval,", "some", "types", "of", "changes", "to", "the", "approved", "product,", "such", "as", "adding", "new", "indications,", "manufacturing", "changes", "and", "additional", "labeling", "claims,", "are", "subject", "to", "further", "FDA", "review", "and", "approval.", "<tag3>"], "wordsA": ["Exploration", "programs", "in", "Nevada", "are", "subject", "to", "state", "and", "federal", "regulations", "regarding", "environmental", "considerations."], "wordsB": ["In", "addition,", "after", "approval,", "some", "types", "of", "changes", "to", "the", "approved", "product,", "such", "as", "adding", "new", "indications,", "manufacturing", "changes", "and", "additional", "labeling", "claims,", "are", "subject", "to", "further", "FDA", "review", "and", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p175_s4", "idA": "1430306_11_item1_p12_s0", "sentA": "Exploration programs in Nevada are subject to state and federal regulations regarding environmental considerations.", "sentB": "Any drug products manufactured or distributed by us pursuant to FDA approvals are subject to continuing regulation by the FDA, including:", "type": 2, "words": ["<tag1>", "Exploration", "programs", "in", "Nevada", "are", "subject", "to", "state", "and", "federal", "regulations", "regarding", "environmental", "considerations.", "<tag2>", "Any", "drug", "products", "manufactured", "or", "distributed", "by", "us", "pursuant", "to", "FDA", "approvals", "are", "subject", "to", "continuing", "regulation", "by", "the", "FDA,", "including:", "<tag3>"], "wordsA": ["Exploration", "programs", "in", "Nevada", "are", "subject", "to", "state", "and", "federal", "regulations", "regarding", "environmental", "considerations."], "wordsB": ["Any", "drug", "products", "manufactured", "or", "distributed", "by", "us", "pursuant", "to", "FDA", "approvals", "are", "subject", "to", "continuing", "regulation", "by", "the", "FDA,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p180_s4", "idA": "1430306_11_item1_p12_s0", "sentA": "Exploration programs in Nevada are subject to state and federal regulations regarding environmental considerations.", "sentB": "Under the FDAAA, companies that violate these and other provisions of the new law are subject to substantial civil monetary penalties.", "type": 2, "words": ["<tag1>", "Exploration", "programs", "in", "Nevada", "are", "subject", "to", "state", "and", "federal", "regulations", "regarding", "environmental", "considerations.", "<tag2>", "Under", "the", "FDAAA,", "companies", "that", "violate", "these", "and", "other", "provisions", "of", "the", "new", "law", "are", "subject", "to", "substantial", "civil", "monetary", "penalties.", "<tag3>"], "wordsA": ["Exploration", "programs", "in", "Nevada", "are", "subject", "to", "state", "and", "federal", "regulations", "regarding", "environmental", "considerations."], "wordsB": ["Under", "the", "FDAAA,", "companies", "that", "violate", "these", "and", "other", "provisions", "of", "the", "new", "law", "are", "subject", "to", "substantial", "civil", "monetary", "penalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p96_s0", "idA": "1430306_11_item1_p12_s0", "sentA": "Exploration programs in Nevada are subject to state and federal regulations regarding environmental considerations.", "sentB": "In the option agreement, we agreed to make certain sublicense, royalty and milestone payments, which are subject to a request for confidential treatment.", "type": 2, "words": ["<tag1>", "Exploration", "programs", "in", "Nevada", "are", "subject", "to", "state", "and", "federal", "regulations", "regarding", "environmental", "considerations.", "<tag2>", "In", "the", "option", "agreement,", "we", "agreed", "to", "make", "certain", "sublicense,", "royalty", "and", "milestone", "payments,", "which", "are", "subject", "to", "a", "request", "for", "confidential", "treatment.", "<tag3>"], "wordsA": ["Exploration", "programs", "in", "Nevada", "are", "subject", "to", "state", "and", "federal", "regulations", "regarding", "environmental", "considerations."], "wordsB": ["In", "the", "option", "agreement,", "we", "agreed", "to", "make", "certain", "sublicense,", "royalty", "and", "milestone", "payments,", "which", "are", "subject", "to", "a", "request", "for", "confidential", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p175_s0", "idA": "1430306_11_item1_p12_s1", "sentA": "All operations involving the exploration for the production of minerals are subject to existing laws and regulations relating to exploration procedures, safety precautions, employee health and safety, air quality standards, pollution of streams and fresh water sources, odor, noise, dust and other environmental protection controls adopted by federal, state and local governmental authorities as well as the rights of adjoining property owners.", "sentB": "Maintaining substantial compliance with appropriate federal, state and local statutes and regulations requires the expenditure of substantial time and financial resources.", "type": 2, "words": ["<tag1>", "All", "operations", "involving", "the", "exploration", "for", "the", "production", "of", "minerals", "are", "subject", "to", "existing", "laws", "and", "regulations", "relating", "to", "exploration", "procedures,", "safety", "precautions,", "employee", "health", "and", "safety,", "air", "quality", "standards,", "pollution", "of", "streams", "and", "fresh", "water", "sources,", "odor,", "noise,", "dust", "and", "other", "environmental", "protection", "controls", "adopted", "by", "federal,", "state", "and", "local", "governmental", "authorities", "as", "well", "as", "the", "rights", "of", "adjoining", "property", "owners.", "<tag2>", "Maintaining", "substantial", "compliance", "with", "appropriate", "federal,", "state", "and", "local", "statutes", "and", "regulations", "requires", "the", "expenditure", "of", "substantial", "time", "and", "financial", "resources.", "<tag3>"], "wordsA": ["All", "operations", "involving", "the", "exploration", "for", "the", "production", "of", "minerals", "are", "subject", "to", "existing", "laws", "and", "regulations", "relating", "to", "exploration", "procedures,", "safety", "precautions,", "employee", "health", "and", "safety,", "air", "quality", "standards,", "pollution", "of", "streams", "and", "fresh", "water", "sources,", "odor,", "noise,", "dust", "and", "other", "environmental", "protection", "controls", "adopted", "by", "federal,", "state", "and", "local", "governmental", "authorities", "as", "well", "as", "the", "rights", "of", "adjoining", "property", "owners."], "wordsB": ["Maintaining", "substantial", "compliance", "with", "appropriate", "federal,", "state", "and", "local", "statutes", "and", "regulations", "requires", "the", "expenditure", "of", "substantial", "time", "and", "financial", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p135_s0", "idA": "1430306_11_item1_p12_s6", "sentA": "Environmental problems known to exist at this time in the United States may not be in compliance with regulations that may come into existence in the future.", "sentB": "We own numerous patents and have patent applications pending in the United States and abroad.", "type": 2, "words": ["<tag1>", "Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future.", "<tag2>", "We", "own", "numerous", "patents", "and", "have", "patent", "applications", "pending", "in", "the", "United", "States", "and", "abroad.", "<tag3>"], "wordsA": ["Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future."], "wordsB": ["We", "own", "numerous", "patents", "and", "have", "patent", "applications", "pending", "in", "the", "United", "States", "and", "abroad."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p144_s0", "idA": "1430306_11_item1_p12_s6", "sentA": "Environmental problems known to exist at this time in the United States may not be in compliance with regulations that may come into existence in the future.", "sentB": "The FDA regulates, among other things, the research, manufacture, promotion and distribution of drugs in the United States under the FFDCA and other statutes and implementing regulations.", "type": 2, "words": ["<tag1>", "Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future.", "<tag2>", "The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FFDCA", "and", "other", "statutes", "and", "implementing", "regulations.", "<tag3>"], "wordsA": ["Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future."], "wordsB": ["The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FFDCA", "and", "other", "statutes", "and", "implementing", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p144_s1", "idA": "1430306_11_item1_p12_s6", "sentA": "Environmental problems known to exist at this time in the United States may not be in compliance with regulations that may come into existence in the future.", "sentB": "The process required by the FDA before prescription drug product candidates may be marketed in the United States generally involves the following:", "type": 2, "words": ["<tag1>", "Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future.", "<tag2>", "The", "process", "required", "by", "the", "FDA", "before", "prescription", "drug", "product", "candidates", "may", "be", "marketed", "in", "the", "United", "States", "generally", "involves", "the", "following:", "<tag3>"], "wordsA": ["Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future."], "wordsB": ["The", "process", "required", "by", "the", "FDA", "before", "prescription", "drug", "product", "candidates", "may", "be", "marketed", "in", "the", "United", "States", "generally", "involves", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p172_s0", "idA": "1430306_11_item1_p12_s6", "sentA": "Environmental problems known to exist at this time in the United States may not be in compliance with regulations that may come into existence in the future.", "sentB": "Other types of exclusivity in the United States include orphan drug exclusivity and pediatric exclusivity.", "type": 2, "words": ["<tag1>", "Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future.", "<tag2>", "Other", "types", "of", "exclusivity", "in", "the", "United", "States", "include", "orphan", "drug", "exclusivity", "and", "pediatric", "exclusivity.", "<tag3>"], "wordsA": ["Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future."], "wordsB": ["Other", "types", "of", "exclusivity", "in", "the", "United", "States", "include", "orphan", "drug", "exclusivity", "and", "pediatric", "exclusivity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p27_s0", "idA": "1430306_11_item1_p12_s6", "sentA": "Environmental problems known to exist at this time in the United States may not be in compliance with regulations that may come into existence in the future.", "sentB": "According to a study conducted by Frost Sullivan on our behalf relating to the FM market in the United States ( Frost and Sullivan ), the immediate-release dose form of cyclobenzaprine is widely used off-label to treat FM.", "type": 2, "words": ["<tag1>", "Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future.", "<tag2>", "According", "to", "a", "study", "conducted", "by", "Frost", "Sullivan", "on", "our", "behalf", "relating", "to", "the", "FM", "market", "in", "the", "United", "States", "(", "Frost", "and", "Sullivan", "),", "the", "immediate-release", "dose", "form", "of", "cyclobenzaprine", "is", "widely", "used", "off-label", "to", "treat", "FM.", "<tag3>"], "wordsA": ["Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future."], "wordsB": ["According", "to", "a", "study", "conducted", "by", "Frost", "Sullivan", "on", "our", "behalf", "relating", "to", "the", "FM", "market", "in", "the", "United", "States", "(", "Frost", "and", "Sullivan", "),", "the", "immediate-release", "dose", "form", "of", "cyclobenzaprine", "is", "widely", "used", "off-label", "to", "treat", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p91_s3", "idA": "1430306_11_item1_p12_s6", "sentA": "Environmental problems known to exist at this time in the United States may not be in compliance with regulations that may come into existence in the future.", "sentB": "The numbers of patients to be evaluated is unknown at this time.", "type": 2, "words": ["<tag1>", "Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future.", "<tag2>", "The", "numbers", "of", "patients", "to", "be", "evaluated", "is", "unknown", "at", "this", "time.", "<tag3>"], "wordsA": ["Environmental", "problems", "known", "to", "exist", "at", "this", "time", "in", "the", "United", "States", "may", "not", "be", "in", "compliance", "with", "regulations", "that", "may", "come", "into", "existence", "in", "the", "future."], "wordsB": ["The", "numbers", "of", "patients", "to", "be", "evaluated", "is", "unknown", "at", "this", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p163_s2", "idA": "1430306_11_item1_p15_s0", "sentA": "We are not required to apply for or have any government approval for our products or services.", "sentB": "If the FDA determines that Section 505(b)(2) NDAs are not appropriate and that full NDAs are required for our product candidates, the time and financial resources required to obtain FDA approval for our product candidates could substantially and materially increase, and our products might be less likely to be approved.", "type": 2, "words": ["<tag1>", "We", "are", "not", "required", "to", "apply", "for", "or", "have", "any", "government", "approval", "for", "our", "products", "or", "services.", "<tag2>", "If", "the", "FDA", "determines", "that", "Section", "505(b)(2)", "NDAs", "are", "not", "appropriate", "and", "that", "full", "NDAs", "are", "required", "for", "our", "product", "candidates,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "our", "product", "candidates", "could", "substantially", "and", "materially", "increase,", "and", "our", "products", "might", "be", "less", "likely", "to", "be", "approved.", "<tag3>"], "wordsA": ["We", "are", "not", "required", "to", "apply", "for", "or", "have", "any", "government", "approval", "for", "our", "products", "or", "services."], "wordsB": ["If", "the", "FDA", "determines", "that", "Section", "505(b)(2)", "NDAs", "are", "not", "appropriate", "and", "that", "full", "NDAs", "are", "required", "for", "our", "product", "candidates,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "our", "product", "candidates", "could", "substantially", "and", "materially", "increase,", "and", "our", "products", "might", "be", "less", "likely", "to", "be", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p139_s0", "idA": "1430306_11_item1_p16_s0", "sentA": "We have not expended funds for research and development costs since inception.", "sentB": "We have one trademark application that is pending as follows:", "type": 2, "words": ["<tag1>", "We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception.", "<tag2>", "We", "have", "one", "trademark", "application", "that", "is", "pending", "as", "follows:", "<tag3>"], "wordsA": ["We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception."], "wordsB": ["We", "have", "one", "trademark", "application", "that", "is", "pending", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p140_s0", "idA": "1430306_11_item1_p16_s0", "sentA": "We have not expended funds for research and development costs since inception.", "sentB": "We have one employee dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception.", "<tag2>", "We", "have", "one", "employee", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception."], "wordsB": ["We", "have", "one", "employee", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p140_s1", "idA": "1430306_11_item1_p16_s0", "sentA": "We have not expended funds for research and development costs since inception.", "sentB": "We anticipate that our research and development expenditures will increase several fold as we move TNX-102 and TNX-105 into clinical development and investigate other product candidates for incorporation into our portfolio.", "type": 2, "words": ["<tag1>", "We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception.", "<tag2>", "We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "move", "TNX-102", "and", "TNX-105", "into", "clinical", "development", "and", "investigate", "other", "product", "candidates", "for", "incorporation", "into", "our", "portfolio.", "<tag3>"], "wordsA": ["We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception."], "wordsB": ["We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "move", "TNX-102", "and", "TNX-105", "into", "clinical", "development", "and", "investigate", "other", "product", "candidates", "for", "incorporation", "into", "our", "portfolio."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p140_s3", "idA": "1430306_11_item1_p16_s0", "sentA": "We have not expended funds for research and development costs since inception.", "sentB": "Our research and development operations are located in New York, NY.", "type": 2, "words": ["<tag1>", "We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception.", "<tag2>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY.", "<tag3>"], "wordsA": ["We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception."], "wordsB": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p143_s1", "idA": "1430306_11_item1_p16_s0", "sentA": "We have not expended funds for research and development costs since inception.", "sentB": "These agencies regulate, among other things, research and development activities and the testing, approval, manufacture, quality control, safety, effectiveness, labeling, storage, record keeping, advertising and promotion of our product candidates.", "type": 2, "words": ["<tag1>", "We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception.", "<tag2>", "These", "agencies", "regulate,", "among", "other", "things,", "research", "and", "development", "activities", "and", "the", "testing,", "approval,", "manufacture,", "quality", "control,", "safety,", "effectiveness,", "labeling,", "storage,", "record", "keeping,", "advertising", "and", "promotion", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception."], "wordsB": ["These", "agencies", "regulate,", "among", "other", "things,", "research", "and", "development", "activities", "and", "the", "testing,", "approval,", "manufacture,", "quality", "control,", "safety,", "effectiveness,", "labeling,", "storage,", "record", "keeping,", "advertising", "and", "promotion", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p29_s6", "idA": "1430306_11_item1_p16_s0", "sentA": "We have not expended funds for research and development costs since inception.", "sentB": "We have not filed an NDA for either of our lead product candidates.", "type": 2, "words": ["<tag1>", "We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception.", "<tag2>", "We", "have", "not", "filed", "an", "NDA", "for", "either", "of", "our", "lead", "product", "candidates.", "<tag3>"], "wordsA": ["We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception."], "wordsB": ["We", "have", "not", "filed", "an", "NDA", "for", "either", "of", "our", "lead", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p78_s1", "idA": "1430306_11_item1_p16_s0", "sentA": "We have not expended funds for research and development costs since inception.", "sentB": "We have not yet conducted any clinical trials on PTSD patients.", "type": 2, "words": ["<tag1>", "We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception.", "<tag2>", "We", "have", "not", "yet", "conducted", "any", "clinical", "trials", "on", "PTSD", "patients.", "<tag3>"], "wordsA": ["We", "have", "not", "expended", "funds", "for", "research", "and", "development", "costs", "since", "inception."], "wordsB": ["We", "have", "not", "yet", "conducted", "any", "clinical", "trials", "on", "PTSD", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p178_s0", "idA": "1430306_11_item1_p16_s1", "sentA": "We paid $3,500 for the geology report and $3,500 for the staking of the claims.", "sentB": "Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label.", "type": 2, "words": ["<tag1>", "We", "paid", "$3,500", "for", "the", "geology", "report", "and", "$3,500", "for", "the", "staking", "of", "the", "claims.", "<tag2>", "Drugs", "may", "be", "promoted", "only", "for", "the", "approved", "indications", "and", "in", "accordance", "with", "the", "provisions", "of", "the", "approved", "label.", "<tag3>"], "wordsA": ["We", "paid", "$3,500", "for", "the", "geology", "report", "and", "$3,500", "for", "the", "staking", "of", "the", "claims."], "wordsB": ["Drugs", "may", "be", "promoted", "only", "for", "the", "approved", "indications", "and", "in", "accordance", "with", "the", "provisions", "of", "the", "approved", "label."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p24_s1", "idA": "1430306_11_item1_p16_s1", "sentA": "We paid $3,500 for the geology report and $3,500 for the staking of the claims.", "sentB": "TNX-102 is being developed for the management of FM.", "type": 2, "words": ["<tag1>", "We", "paid", "$3,500", "for", "the", "geology", "report", "and", "$3,500", "for", "the", "staking", "of", "the", "claims.", "<tag2>", "TNX-102", "is", "being", "developed", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["We", "paid", "$3,500", "for", "the", "geology", "report", "and", "$3,500", "for", "the", "staking", "of", "the", "claims."], "wordsB": ["TNX-102", "is", "being", "developed", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p135_s1", "idA": "1430306_11_item1_p19_s3", "sentA": "In addition, we will file Form 8K and other proxy and information statements from time to time as required.", "sentB": "In addition, we have one trademark application pending.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "will", "file", "Form", "8K", "and", "other", "proxy", "and", "information", "statements", "from", "time", "to", "time", "as", "required.", "<tag2>", "In", "addition,", "we", "have", "one", "trademark", "application", "pending.", "<tag3>"], "wordsA": ["In", "addition,", "we", "will", "file", "Form", "8K", "and", "other", "proxy", "and", "information", "statements", "from", "time", "to", "time", "as", "required."], "wordsB": ["In", "addition,", "we", "have", "one", "trademark", "application", "pending."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p177_s0", "idA": "1430306_11_item1_p19_s3", "sentA": "In addition, we will file Form 8K and other proxy and information statements from time to time as required.", "sentB": "In addition, the FDA strictly regulates labeling, advertising, promotion and other types of information on products that are placed on the market.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "will", "file", "Form", "8K", "and", "other", "proxy", "and", "information", "statements", "from", "time", "to", "time", "as", "required.", "<tag2>", "In", "addition,", "the", "FDA", "strictly", "regulates", "labeling,", "advertising,", "promotion", "and", "other", "types", "of", "information", "on", "products", "that", "are", "placed", "on", "the", "market.", "<tag3>"], "wordsA": ["In", "addition,", "we", "will", "file", "Form", "8K", "and", "other", "proxy", "and", "information", "statements", "from", "time", "to", "time", "as", "required."], "wordsB": ["In", "addition,", "the", "FDA", "strictly", "regulates", "labeling,", "advertising,", "promotion", "and", "other", "types", "of", "information", "on", "products", "that", "are", "placed", "on", "the", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p40_s3", "idA": "1430306_11_item1_p19_s3", "sentA": "In addition, we will file Form 8K and other proxy and information statements from time to time as required.", "sentB": "In addition, we believe that bedtime treatment with TNX-102 will have fewer day time side-effects than off-label bedtime treatment with immediate release cyclobenzaprine.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "will", "file", "Form", "8K", "and", "other", "proxy", "and", "information", "statements", "from", "time", "to", "time", "as", "required.", "<tag2>", "In", "addition,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate", "release", "cyclobenzaprine.", "<tag3>"], "wordsA": ["In", "addition,", "we", "will", "file", "Form", "8K", "and", "other", "proxy", "and", "information", "statements", "from", "time", "to", "time", "as", "required."], "wordsB": ["In", "addition,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate", "release", "cyclobenzaprine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p19_s3", "idA": "1430306_11_item1_p19_s4", "sentA": "We do not intend to voluntarily file the above reports in the event that our obligation to file such reports is suspended under the Exchange Act.", "sentB": "Our projects are in the development phase, and we currently do not market any products.", "type": 2, "words": ["<tag1>", "We", "do", "not", "intend", "to", "voluntarily", "file", "the", "above", "reports", "in", "the", "event", "that", "our", "obligation", "to", "file", "such", "reports", "is", "suspended", "under", "the", "Exchange", "Act.", "<tag2>", "Our", "projects", "are", "in", "the", "development", "phase,", "and", "we", "currently", "do", "not", "market", "any", "products.", "<tag3>"], "wordsA": ["We", "do", "not", "intend", "to", "voluntarily", "file", "the", "above", "reports", "in", "the", "event", "that", "our", "obligation", "to", "file", "such", "reports", "is", "suspended", "under", "the", "Exchange", "Act."], "wordsB": ["Our", "projects", "are", "in", "the", "development", "phase,", "and", "we", "currently", "do", "not", "market", "any", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p4_s0", "idA": "1430306_11_item1_p1_s0", "sentA": "Tamandare Explorations was incorporated in the State of Nevada on November 16, 2007 to engage in the acquisition, exploration and development of natural resource properties.", "sentB": "We were incorporated on November 16, 2007 under the laws of the State of Nevada as Tamandare Explorations Inc. From inception through October 2011, we were involved in the acquisition, exploration and development of natural resource properties in the State of Nevada.", "type": 2, "words": ["<tag1>", "Tamandare", "Explorations", "was", "incorporated", "in", "the", "State", "of", "Nevada", "on", "November", "16,", "2007", "to", "engage", "in", "the", "acquisition,", "exploration", "and", "development", "of", "natural", "resource", "properties.", "<tag2>", "We", "were", "incorporated", "on", "November", "16,", "2007", "under", "the", "laws", "of", "the", "State", "of", "Nevada", "as", "Tamandare", "Explorations", "Inc.", "From", "inception", "through", "October", "2011,", "we", "were", "involved", "in", "the", "acquisition,", "exploration", "and", "development", "of", "natural", "resource", "properties", "in", "the", "State", "of", "Nevada.", "<tag3>"], "wordsA": ["Tamandare", "Explorations", "was", "incorporated", "in", "the", "State", "of", "Nevada", "on", "November", "16,", "2007", "to", "engage", "in", "the", "acquisition,", "exploration", "and", "development", "of", "natural", "resource", "properties."], "wordsB": ["We", "were", "incorporated", "on", "November", "16,", "2007", "under", "the", "laws", "of", "the", "State", "of", "Nevada", "as", "Tamandare", "Explorations", "Inc.", "From", "inception", "through", "October", "2011,", "we", "were", "involved", "in", "the", "acquisition,", "exploration", "and", "development", "of", "natural", "resource", "properties", "in", "the", "State", "of", "Nevada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p1_s3", "idA": "1430306_11_item1_p20_s0", "sentA": "The public may read and copy any materials that we file with the Securities and Exchange Commission, (\"SEC\"), at the SEC's Public Reference Room at 100 F Street NE, Washington, DC 20549.", "sentB": "You can read and copy any materials we file with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Washington, DC 20549.", "type": 2, "words": ["<tag1>", "The", "public", "may", "read", "and", "copy", "any", "materials", "that", "we", "file", "with", "the", "Securities", "and", "Exchange", "Commission,", "(\"SEC\"),", "at", "the", "SEC's", "Public", "Reference", "Room", "at", "100", "F", "Street", "NE,", "Washington,", "DC", "20549.", "<tag2>", "You", "can", "read", "and", "copy", "any", "materials", "we", "file", "with", "the", "SEC", "at", "the", "SEC's", "Public", "Reference", "Room", "at", "100", "F", "Street,", "NE,", "Washington,", "DC", "20549.", "<tag3>"], "wordsA": ["The", "public", "may", "read", "and", "copy", "any", "materials", "that", "we", "file", "with", "the", "Securities", "and", "Exchange", "Commission,", "(\"SEC\"),", "at", "the", "SEC's", "Public", "Reference", "Room", "at", "100", "F", "Street", "NE,", "Washington,", "DC", "20549."], "wordsB": ["You", "can", "read", "and", "copy", "any", "materials", "we", "file", "with", "the", "SEC", "at", "the", "SEC's", "Public", "Reference", "Room", "at", "100", "F", "Street,", "NE,", "Washington,", "DC", "20549."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p1_s4", "idA": "1430306_11_item1_p20_s1", "sentA": "The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.", "sentB": "You can obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.", "type": 2, "words": ["<tag1>", "The", "public", "may", "obtain", "information", "on", "the", "operation", "of", "the", "Public", "Reference", "Room", "by", "calling", "the", "SEC", "at", "1-800-SEC-0330.", "<tag2>", "You", "can", "obtain", "additional", "information", "about", "the", "operation", "of", "the", "Public", "Reference", "Room", "by", "calling", "the", "SEC", "at", "1-800-SEC-0330.", "<tag3>"], "wordsA": ["The", "public", "may", "obtain", "information", "on", "the", "operation", "of", "the", "Public", "Reference", "Room", "by", "calling", "the", "SEC", "at", "1-800-SEC-0330."], "wordsB": ["You", "can", "obtain", "additional", "information", "about", "the", "operation", "of", "the", "Public", "Reference", "Room", "by", "calling", "the", "SEC", "at", "1-800-SEC-0330."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p1_s5", "idA": "1430306_11_item1_p21_s0", "sentA": "The SEC maintains an Internet site (http://www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.", "sentB": "In addition, the SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us.", "type": 2, "words": ["<tag1>", "The", "SEC", "maintains", "an", "Internet", "site", "(http://www.sec.gov)", "that", "contains", "reports,", "proxy", "and", "information", "statements,", "and", "other", "information", "regarding", "issuers", "that", "file", "electronically", "with", "the", "SEC.", "<tag2>", "In", "addition,", "the", "SEC", "maintains", "an", "Internet", "site", "(www.sec.gov)", "that", "contains", "reports,", "proxy", "and", "information", "statements,", "and", "other", "information", "regarding", "issuers", "that", "file", "electronically", "with", "the", "SEC,", "including", "us.", "<tag3>"], "wordsA": ["The", "SEC", "maintains", "an", "Internet", "site", "(http://www.sec.gov)", "that", "contains", "reports,", "proxy", "and", "information", "statements,", "and", "other", "information", "regarding", "issuers", "that", "file", "electronically", "with", "the", "SEC."], "wordsB": ["In", "addition,", "the", "SEC", "maintains", "an", "Internet", "site", "(www.sec.gov)", "that", "contains", "reports,", "proxy", "and", "information", "statements,", "and", "other", "information", "regarding", "issuers", "that", "file", "electronically", "with", "the", "SEC,", "including", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p6_s2", "idA": "1430306_11_item1_p3_s0", "sentA": "We have a total of 75,000,000 authorized common shares with a par value of $0.001 per share with 5,500,000 common shares issued and outstanding as of December 31, 2010.", "sentB": "The 22,666,667 shares issued to the Tonix Shareholders constituted approximately 85% of our 26,666,667 issued and outstanding shares of Common Stock post-Closing.", "type": 2, "words": ["<tag1>", "We", "have", "a", "total", "of", "75,000,000", "authorized", "common", "shares", "with", "a", "par", "value", "of", "$0.001", "per", "share", "with", "5,500,000", "common", "shares", "issued", "and", "outstanding", "as", "of", "December", "31,", "2010.", "<tag2>", "The", "22,666,667", "shares", "issued", "to", "the", "Tonix", "Shareholders", "constituted", "approximately", "85%", "of", "our", "26,666,667", "issued", "and", "outstanding", "shares", "of", "Common", "Stock", "post-Closing.", "<tag3>"], "wordsA": ["We", "have", "a", "total", "of", "75,000,000", "authorized", "common", "shares", "with", "a", "par", "value", "of", "$0.001", "per", "share", "with", "5,500,000", "common", "shares", "issued", "and", "outstanding", "as", "of", "December", "31,", "2010."], "wordsB": ["The", "22,666,667", "shares", "issued", "to", "the", "Tonix", "Shareholders", "constituted", "approximately", "85%", "of", "our", "26,666,667", "issued", "and", "outstanding", "shares", "of", "Common", "Stock", "post-Closing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p98_s13", "idA": "1430306_11_item1_p6_s3", "sentA": "Based on the findings the company decided to abandon the property and is now investigating other opportunities to best utilize our remaining capital.", "sentB": "Based on the study, we have selected a candidate formulation for cyclobenzaprine to be dosed at bedtime.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "findings", "the", "company", "decided", "to", "abandon", "the", "property", "and", "is", "now", "investigating", "other", "opportunities", "to", "best", "utilize", "our", "remaining", "capital.", "<tag2>", "Based", "on", "the", "study,", "we", "have", "selected", "a", "candidate", "formulation", "for", "cyclobenzaprine", "to", "be", "dosed", "at", "bedtime.", "<tag3>"], "wordsA": ["Based", "on", "the", "findings", "the", "company", "decided", "to", "abandon", "the", "property", "and", "is", "now", "investigating", "other", "opportunities", "to", "best", "utilize", "our", "remaining", "capital."], "wordsB": ["Based", "on", "the", "study,", "we", "have", "selected", "a", "candidate", "formulation", "for", "cyclobenzaprine", "to", "be", "dosed", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p12_s0", "idA": "1430306_11_item1_p7_s0", "sentA": "We do not compete directly with anyone for the exploration or removal of minerals from any of our exploration properties as we will hold all interest and rights to the claims.", "sentB": "Plumbline possessed rights to certain technology for the treatment of alcohol dependence and abuse.", "type": 2, "words": ["<tag1>", "We", "do", "not", "compete", "directly", "with", "anyone", "for", "the", "exploration", "or", "removal", "of", "minerals", "from", "any", "of", "our", "exploration", "properties", "as", "we", "will", "hold", "all", "interest", "and", "rights", "to", "the", "claims.", "<tag2>", "Plumbline", "possessed", "rights", "to", "certain", "technology", "for", "the", "treatment", "of", "alcohol", "dependence", "and", "abuse.", "<tag3>"], "wordsA": ["We", "do", "not", "compete", "directly", "with", "anyone", "for", "the", "exploration", "or", "removal", "of", "minerals", "from", "any", "of", "our", "exploration", "properties", "as", "we", "will", "hold", "all", "interest", "and", "rights", "to", "the", "claims."], "wordsB": ["Plumbline", "possessed", "rights", "to", "certain", "technology", "for", "the", "treatment", "of", "alcohol", "dependence", "and", "abuse."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p106_s0", "idA": "1430306_11_item1_p8_s0", "sentA": "Readily available commodities markets exist in the U.S. and around the world for the sale of gold, silver and other minerals.", "sentB": "Off-label prescription practices in the U.S. are acceptable under a long-standing principle that grants physicians the ability to use their professional judgment beyond the FDA recommended uses.", "type": 2, "words": ["<tag1>", "Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals.", "<tag2>", "Off-label", "prescription", "practices", "in", "the", "U.S.", "are", "acceptable", "under", "a", "long-standing", "principle", "that", "grants", "physicians", "the", "ability", "to", "use", "their", "professional", "judgment", "beyond", "the", "FDA", "recommended", "uses.", "<tag3>"], "wordsA": ["Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals."], "wordsB": ["Off-label", "prescription", "practices", "in", "the", "U.S.", "are", "acceptable", "under", "a", "long-standing", "principle", "that", "grants", "physicians", "the", "ability", "to", "use", "their", "professional", "judgment", "beyond", "the", "FDA", "recommended", "uses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p129_s0", "idA": "1430306_11_item1_p8_s0", "sentA": "Readily available commodities markets exist in the U.S. and around the world for the sale of gold, silver and other minerals.", "sentB": "Clinical trials in the U.S. are registered with the FDA and reported on the website, www.ClinicalTrials.gov.", "type": 2, "words": ["<tag1>", "Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals.", "<tag2>", "Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website,", "www.ClinicalTrials.gov.", "<tag3>"], "wordsA": ["Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals."], "wordsB": ["Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website,", "www.ClinicalTrials.gov."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p134_s0", "idA": "1430306_11_item1_p8_s0", "sentA": "Readily available commodities markets exist in the U.S. and around the world for the sale of gold, silver and other minerals.", "sentB": "Proprietary protection for our product candidates, technology and processes are important to our business and we seek patent protection in the U.S. and internationally when we deem appropriate.", "type": 2, "words": ["<tag1>", "Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals.", "<tag2>", "Proprietary", "protection", "for", "our", "product", "candidates,", "technology", "and", "processes", "are", "important", "to", "our", "business", "and", "we", "seek", "patent", "protection", "in", "the", "U.S.", "and", "internationally", "when", "we", "deem", "appropriate.", "<tag3>"], "wordsA": ["Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals."], "wordsB": ["Proprietary", "protection", "for", "our", "product", "candidates,", "technology", "and", "processes", "are", "important", "to", "our", "business", "and", "we", "seek", "patent", "protection", "in", "the", "U.S.", "and", "internationally", "when", "we", "deem", "appropriate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p34_s5", "idA": "1430306_11_item1_p8_s0", "sentA": "Readily available commodities markets exist in the U.S. and around the world for the sale of gold, silver and other minerals.", "sentB": "For ANDAs, the predicate product is a medicine approved by the U.S. Food and Drug Administration (the FDA ) under an NDA.", "type": 2, "words": ["<tag1>", "Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals.", "<tag2>", "For", "ANDAs,", "the", "predicate", "product", "is", "a", "medicine", "approved", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", ")", "under", "an", "NDA.", "<tag3>"], "wordsA": ["Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals."], "wordsB": ["For", "ANDAs,", "the", "predicate", "product", "is", "a", "medicine", "approved", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", ")", "under", "an", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p40_s2", "idA": "1430306_11_item1_p8_s0", "sentA": "Readily available commodities markets exist in the U.S. and around the world for the sale of gold, silver and other minerals.", "sentB": "We believe TNX-102 might help in the management of FM by reducing pain and other symptoms, such as fatigue.", "type": 2, "words": ["<tag1>", "Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals.", "<tag2>", "We", "believe", "TNX-102", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue.", "<tag3>"], "wordsA": ["Readily", "available", "commodities", "markets", "exist", "in", "the", "U.S.", "and", "around", "the", "world", "for", "the", "sale", "of", "gold,", "silver", "and", "other", "minerals."], "wordsB": ["We", "believe", "TNX-102", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p126_s6", "idA": "1430306_11_item1_p8_s1", "sentA": "Therefore, we will likely be able to sell any minerals that we are able to recover.", "sentB": "We anticipate that we will face intense and increasing competition as new drugs enter the market and advanced technologies become available.", "type": 2, "words": ["<tag1>", "Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover.", "<tag2>", "We", "anticipate", "that", "we", "will", "face", "intense", "and", "increasing", "competition", "as", "new", "drugs", "enter", "the", "market", "and", "advanced", "technologies", "become", "available.", "<tag3>"], "wordsA": ["Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover."], "wordsB": ["We", "anticipate", "that", "we", "will", "face", "intense", "and", "increasing", "competition", "as", "new", "drugs", "enter", "the", "market", "and", "advanced", "technologies", "become", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p140_s2", "idA": "1430306_11_item1_p8_s1", "sentA": "Therefore, we will likely be able to sell any minerals that we are able to recover.", "sentB": "We need to raise additional capital to fund our development plans and there is no certainty that we will be successful in continuing to attract new investments.", "type": 2, "words": ["<tag1>", "Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover.", "<tag2>", "We", "need", "to", "raise", "additional", "capital", "to", "fund", "our", "development", "plans", "and", "there", "is", "no", "certainty", "that", "we", "will", "be", "successful", "in", "continuing", "to", "attract", "new", "investments.", "<tag3>"], "wordsA": ["Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover."], "wordsB": ["We", "need", "to", "raise", "additional", "capital", "to", "fund", "our", "development", "plans", "and", "there", "is", "no", "certainty", "that", "we", "will", "be", "successful", "in", "continuing", "to", "attract", "new", "investments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p30_s0", "idA": "1430306_11_item1_p8_s1", "sentA": "Therefore, we will likely be able to sell any minerals that we are able to recover.", "sentB": "We also have a pipeline of several other product candidates that we are constantly evaluating.", "type": 2, "words": ["<tag1>", "Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover.", "<tag2>", "We", "also", "have", "a", "pipeline", "of", "several", "other", "product", "candidates", "that", "we", "are", "constantly", "evaluating.", "<tag3>"], "wordsA": ["Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover."], "wordsB": ["We", "also", "have", "a", "pipeline", "of", "several", "other", "product", "candidates", "that", "we", "are", "constantly", "evaluating."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p37_s2", "idA": "1430306_11_item1_p8_s1", "sentA": "Therefore, we will likely be able to sell any minerals that we are able to recover.", "sentB": "By focusing on developing new formulations of approved drugs for new uses, we believe that we will be able to use the Section 505(b)(2) pathway for FDA approval.", "type": 2, "words": ["<tag1>", "Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover.", "<tag2>", "By", "focusing", "on", "developing", "new", "formulations", "of", "approved", "drugs", "for", "new", "uses,", "we", "believe", "that", "we", "will", "be", "able", "to", "use", "the", "Section", "505(b)(2)", "pathway", "for", "FDA", "approval.", "<tag3>"], "wordsA": ["Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover."], "wordsB": ["By", "focusing", "on", "developing", "new", "formulations", "of", "approved", "drugs", "for", "new", "uses,", "we", "believe", "that", "we", "will", "be", "able", "to", "use", "the", "Section", "505(b)(2)", "pathway", "for", "FDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p88_s0", "idA": "1430306_11_item1_p8_s1", "sentA": "Therefore, we will likely be able to sell any minerals that we are able to recover.", "sentB": "In our Phase 2a study, we anticipate that we will study TNX-105 in less than 50 subjects with combat-related and/or civilian PTSD.", "type": 2, "words": ["<tag1>", "Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover.", "<tag2>", "In", "our", "Phase", "2a", "study,", "we", "anticipate", "that", "we", "will", "study", "TNX-105", "in", "less", "than", "50", "subjects", "with", "combat-related", "and/or", "civilian", "PTSD.", "<tag3>"], "wordsA": ["Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover."], "wordsB": ["In", "our", "Phase", "2a", "study,", "we", "anticipate", "that", "we", "will", "study", "TNX-105", "in", "less", "than", "50", "subjects", "with", "combat-related", "and/or", "civilian", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_12_item1_p90_s2", "idA": "1430306_11_item1_p8_s1", "sentA": "Therefore, we will likely be able to sell any minerals that we are able to recover.", "sentB": "In our Phase 2b study, we anticipate that we will study the drug in 100 to 150 subjects with combat-related and civilian PTSD.", "type": 2, "words": ["<tag1>", "Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover.", "<tag2>", "In", "our", "Phase", "2b", "study,", "we", "anticipate", "that", "we", "will", "study", "the", "drug", "in", "100", "to", "150", "subjects", "with", "combat-related", "and", "civilian", "PTSD.", "<tag3>"], "wordsA": ["Therefore,", "we", "will", "likely", "be", "able", "to", "sell", "any", "minerals", "that", "we", "are", "able", "to", "recover."], "wordsB": ["In", "our", "Phase", "2b", "study,", "we", "anticipate", "that", "we", "will", "study", "the", "drug", "in", "100", "to", "150", "subjects", "with", "combat-related", "and", "civilian", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p110_s0", "idA": "1430306_12_item1_p102_s0", "sentA": "We believe the market for FDA-approved FM treatments is underserved and that there is a constant need for new treatment options, since many prescription drugs provide relief only to some of the affected patients or provide relief only for limited periods of time.", "sentB": "We believe the market for FDA-approved FM treatments is underserved and that there is a constant need for new treatment options, since many prescription drugs provide relief only to some of the affected patients, only to some of some patients symptoms, or provide relief only for limited periods of time.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "market", "for", "FDA-approved", "FM", "treatments", "is", "underserved", "and", "that", "there", "is", "a", "constant", "need", "for", "new", "treatment", "options,", "since", "many", "prescription", "drugs", "provide", "relief", "only", "to", "some", "of", "the", "affected", "patients", "or", "provide", "relief", "only", "for", "limited", "periods", "of", "time.", "<tag2>", "We", "believe", "the", "market", "for", "FDA-approved", "FM", "treatments", "is", "underserved", "and", "that", "there", "is", "a", "constant", "need", "for", "new", "treatment", "options,", "since", "many", "prescription", "drugs", "provide", "relief", "only", "to", "some", "of", "the", "affected", "patients,", "only", "to", "some", "of", "some", "patients", "symptoms,", "or", "provide", "relief", "only", "for", "limited", "periods", "of", "time.", "<tag3>"], "wordsA": ["We", "believe", "the", "market", "for", "FDA-approved", "FM", "treatments", "is", "underserved", "and", "that", "there", "is", "a", "constant", "need", "for", "new", "treatment", "options,", "since", "many", "prescription", "drugs", "provide", "relief", "only", "to", "some", "of", "the", "affected", "patients", "or", "provide", "relief", "only", "for", "limited", "periods", "of", "time."], "wordsB": ["We", "believe", "the", "market", "for", "FDA-approved", "FM", "treatments", "is", "underserved", "and", "that", "there", "is", "a", "constant", "need", "for", "new", "treatment", "options,", "since", "many", "prescription", "drugs", "provide", "relief", "only", "to", "some", "of", "the", "affected", "patients,", "only", "to", "some", "of", "some", "patients", "symptoms,", "or", "provide", "relief", "only", "for", "limited", "periods", "of", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p117_s0", "idA": "1430306_12_item1_p103_s0", "sentA": "Until 2007, there were no FDA-approved drugs to treat FM.", "sentB": "Prior to 2007, the landscape of prescription drugs used to treat FM was characterized by off-label use of generically-available therapies.", "type": 2, "words": ["<tag1>", "Until", "2007,", "there", "were", "no", "FDA-approved", "drugs", "to", "treat", "FM.", "<tag2>", "Prior", "to", "2007,", "the", "landscape", "of", "prescription", "drugs", "used", "to", "treat", "FM", "was", "characterized", "by", "off-label", "use", "of", "generically-available", "therapies.", "<tag3>"], "wordsA": ["Until", "2007,", "there", "were", "no", "FDA-approved", "drugs", "to", "treat", "FM."], "wordsB": ["Prior", "to", "2007,", "the", "landscape", "of", "prescription", "drugs", "used", "to", "treat", "FM", "was", "characterized", "by", "off-label", "use", "of", "generically-available", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p20_s0", "idA": "1430306_12_item1_p104_s0", "sentA": "A number of effective medicines have been identified by physicians who observe improvements in a patient s condition as an unintended consequence of prescribing a particular medicine for another purpose.", "sentB": "Many CNS drugs have been identified by physicians who observe unexpected improvements in their patients CNS conditions despite being prescribed for a different purpose.", "type": 2, "words": ["<tag1>", "A", "number", "of", "effective", "medicines", "have", "been", "identified", "by", "physicians", "who", "observe", "improvements", "in", "a", "patient", "s", "condition", "as", "an", "unintended", "consequence", "of", "prescribing", "a", "particular", "medicine", "for", "another", "purpose.", "<tag2>", "Many", "CNS", "drugs", "have", "been", "identified", "by", "physicians", "who", "observe", "unexpected", "improvements", "in", "their", "patients", "CNS", "conditions", "despite", "being", "prescribed", "for", "a", "different", "purpose.", "<tag3>"], "wordsA": ["A", "number", "of", "effective", "medicines", "have", "been", "identified", "by", "physicians", "who", "observe", "improvements", "in", "a", "patient", "s", "condition", "as", "an", "unintended", "consequence", "of", "prescribing", "a", "particular", "medicine", "for", "another", "purpose."], "wordsB": ["Many", "CNS", "drugs", "have", "been", "identified", "by", "physicians", "who", "observe", "unexpected", "improvements", "in", "their", "patients", "CNS", "conditions", "despite", "being", "prescribed", "for", "a", "different", "purpose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p91_s2", "idA": "1430306_12_item1_p107_s0", "sentA": "Before 2007, a variety of drugs, often in combination, were utilized off-label to treat symptoms associated with FM.", "sentB": "We believe the sleep disturbances of PTSD bear similarity to those associated with FM.", "type": 2, "words": ["<tag1>", "Before", "2007,", "a", "variety", "of", "drugs,", "often", "in", "combination,", "were", "utilized", "off-label", "to", "treat", "symptoms", "associated", "with", "FM.", "<tag2>", "We", "believe", "the", "sleep", "disturbances", "of", "PTSD", "bear", "similarity", "to", "those", "associated", "with", "FM.", "<tag3>"], "wordsA": ["Before", "2007,", "a", "variety", "of", "drugs,", "often", "in", "combination,", "were", "utilized", "off-label", "to", "treat", "symptoms", "associated", "with", "FM."], "wordsB": ["We", "believe", "the", "sleep", "disturbances", "of", "PTSD", "bear", "similarity", "to", "those", "associated", "with", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p117_s1", "idA": "1430306_12_item1_p107_s1", "sentA": "The following three classes of drugs were prescribed as the primary treatments for FM: (1) pain killers, also referred to as analgesics, (2) antidepressants and (3) muscle relaxants.", "sentB": "Drugs that had been prescribed as the primary treatments for FM were approved for other indications, with analgesics, antidepressants, and muscle relaxants among the categories receiving the greatest use by the FM population.", "type": 2, "words": ["<tag1>", "The", "following", "three", "classes", "of", "drugs", "were", "prescribed", "as", "the", "primary", "treatments", "for", "FM:", "(1)", "pain", "killers,", "also", "referred", "to", "as", "analgesics,", "(2)", "antidepressants", "and", "(3)", "muscle", "relaxants.", "<tag2>", "Drugs", "that", "had", "been", "prescribed", "as", "the", "primary", "treatments", "for", "FM", "were", "approved", "for", "other", "indications,", "with", "analgesics,", "antidepressants,", "and", "muscle", "relaxants", "among", "the", "categories", "receiving", "the", "greatest", "use", "by", "the", "FM", "population.", "<tag3>"], "wordsA": ["The", "following", "three", "classes", "of", "drugs", "were", "prescribed", "as", "the", "primary", "treatments", "for", "FM:", "(1)", "pain", "killers,", "also", "referred", "to", "as", "analgesics,", "(2)", "antidepressants", "and", "(3)", "muscle", "relaxants."], "wordsB": ["Drugs", "that", "had", "been", "prescribed", "as", "the", "primary", "treatments", "for", "FM", "were", "approved", "for", "other", "indications,", "with", "analgesics,", "antidepressants,", "and", "muscle", "relaxants", "among", "the", "categories", "receiving", "the", "greatest", "use", "by", "the", "FM", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p111_s1", "idA": "1430306_12_item1_p108_s1", "sentA": "Lyrica previously had been approved and marketed to treat pain in other conditions.", "sentB": "Lyrica previously had been approved and marketed to treat pain in other conditions as well as epilepsy.", "type": 2, "words": ["<tag1>", "Lyrica", "previously", "had", "been", "approved", "and", "marketed", "to", "treat", "pain", "in", "other", "conditions.", "<tag2>", "Lyrica", "previously", "had", "been", "approved", "and", "marketed", "to", "treat", "pain", "in", "other", "conditions", "as", "well", "as", "epilepsy.", "<tag3>"], "wordsA": ["Lyrica", "previously", "had", "been", "approved", "and", "marketed", "to", "treat", "pain", "in", "other", "conditions."], "wordsB": ["Lyrica", "previously", "had", "been", "approved", "and", "marketed", "to", "treat", "pain", "in", "other", "conditions", "as", "well", "as", "epilepsy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p62_s2", "idA": "1430306_12_item1_p109_s0", "sentA": "FM shares a number of symptoms with depression, and a number of FM patients are believed to experience depression as a co-existing condition.", "sentB": "Current CBP products are believed to be widely used off-label by FM patients.", "type": 2, "words": ["<tag1>", "FM", "shares", "a", "number", "of", "symptoms", "with", "depression,", "and", "a", "number", "of", "FM", "patients", "are", "believed", "to", "experience", "depression", "as", "a", "co-existing", "condition.", "<tag2>", "Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients.", "<tag3>"], "wordsA": ["FM", "shares", "a", "number", "of", "symptoms", "with", "depression,", "and", "a", "number", "of", "FM", "patients", "are", "believed", "to", "experience", "depression", "as", "a", "co-existing", "condition."], "wordsB": ["Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p25_s2", "idA": "1430306_12_item1_p109_s3", "sentA": "Savella (milnacipran) was the third medicine approved by the FDA for the management of FM.", "sentB": "We believe that positive results from two adequate, well-controlled safety and efficacy studies and the completion of long-term open-label safety exposure studies would support the approval of TNX-102 SL by the FDA for the management of FM.", "type": 2, "words": ["<tag1>", "Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "completion", "of", "long-term", "open-label", "safety", "exposure", "studies", "would", "support", "the", "approval", "of", "TNX-102", "SL", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "completion", "of", "long-term", "open-label", "safety", "exposure", "studies", "would", "support", "the", "approval", "of", "TNX-102", "SL", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p41_s4", "idA": "1430306_12_item1_p109_s3", "sentA": "Savella (milnacipran) was the third medicine approved by the FDA for the management of FM.", "sentB": "Assuming our clinical development of TNX-102 SL in FM meets with success, we would submit an NDA to the FDA seeking marketing approval of TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "Assuming", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "meets", "with", "success,", "we", "would", "submit", "an", "NDA", "to", "the", "FDA", "seeking", "marketing", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["Assuming", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "meets", "with", "success,", "we", "would", "submit", "an", "NDA", "to", "the", "FDA", "seeking", "marketing", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p51_s2", "idA": "1430306_12_item1_p109_s3", "sentA": "Savella (milnacipran) was the third medicine approved by the FDA for the management of FM.", "sentB": "The excipients used in TNX-102 SL are approved by the FDA for pharmaceutical uses.", "type": 2, "words": ["<tag1>", "Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "The", "excipients", "used", "in", "TNX-102", "SL", "are", "approved", "by", "the", "FDA", "for", "pharmaceutical", "uses.", "<tag3>"], "wordsA": ["Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["The", "excipients", "used", "in", "TNX-102", "SL", "are", "approved", "by", "the", "FDA", "for", "pharmaceutical", "uses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p10_s0", "idA": "1430306_12_item1_p10_s0", "sentA": "L L was a founder of Janus Pharmaceuticals, Inc., later renamed Vela Pharmaceuticals, Inc., ( Vela ), which developed various therapeutics, including a very low dose, or VLD, version of cyclobenzaprine, under an agreement with L L. Vela decided to focus its resources on other programs and transferred the rights in VLD cyclobenzaprine and certain other technologies to L L in March 2006.", "sentB": "L L was a founder of Janus Pharmaceuticals, Inc., which later became Vela Pharmaceuticals, Inc., or Vela, which developed various therapeutics, including a very low dose, or VLD, version of cyclobenzaprine, or CBP, under an agreement with L L. Vela decided to focus its resources on other programs and transferred the rights to VLD CBP and certain other technologies to L L in March 2006.", "type": 2, "words": ["<tag1>", "L", "L", "was", "a", "founder", "of", "Janus", "Pharmaceuticals,", "Inc.,", "later", "renamed", "Vela", "Pharmaceuticals,", "Inc.,", "(", "Vela", "),", "which", "developed", "various", "therapeutics,", "including", "a", "very", "low", "dose,", "or", "VLD,", "version", "of", "cyclobenzaprine,", "under", "an", "agreement", "with", "L", "L.", "Vela", "decided", "to", "focus", "its", "resources", "on", "other", "programs", "and", "transferred", "the", "rights", "in", "VLD", "cyclobenzaprine", "and", "certain", "other", "technologies", "to", "L", "L", "in", "March", "2006.", "<tag2>", "L", "L", "was", "a", "founder", "of", "Janus", "Pharmaceuticals,", "Inc.,", "which", "later", "became", "Vela", "Pharmaceuticals,", "Inc.,", "or", "Vela,", "which", "developed", "various", "therapeutics,", "including", "a", "very", "low", "dose,", "or", "VLD,", "version", "of", "cyclobenzaprine,", "or", "CBP,", "under", "an", "agreement", "with", "L", "L.", "Vela", "decided", "to", "focus", "its", "resources", "on", "other", "programs", "and", "transferred", "the", "rights", "to", "VLD", "CBP", "and", "certain", "other", "technologies", "to", "L", "L", "in", "March", "2006.", "<tag3>"], "wordsA": ["L", "L", "was", "a", "founder", "of", "Janus", "Pharmaceuticals,", "Inc.,", "later", "renamed", "Vela", "Pharmaceuticals,", "Inc.,", "(", "Vela", "),", "which", "developed", "various", "therapeutics,", "including", "a", "very", "low", "dose,", "or", "VLD,", "version", "of", "cyclobenzaprine,", "under", "an", "agreement", "with", "L", "L.", "Vela", "decided", "to", "focus", "its", "resources", "on", "other", "programs", "and", "transferred", "the", "rights", "in", "VLD", "cyclobenzaprine", "and", "certain", "other", "technologies", "to", "L", "L", "in", "March", "2006."], "wordsB": ["L", "L", "was", "a", "founder", "of", "Janus", "Pharmaceuticals,", "Inc.,", "which", "later", "became", "Vela", "Pharmaceuticals,", "Inc.,", "or", "Vela,", "which", "developed", "various", "therapeutics,", "including", "a", "very", "low", "dose,", "or", "VLD,", "version", "of", "cyclobenzaprine,", "or", "CBP,", "under", "an", "agreement", "with", "L", "L.", "Vela", "decided", "to", "focus", "its", "resources", "on", "other", "programs", "and", "transferred", "the", "rights", "to", "VLD", "CBP", "and", "certain", "other", "technologies", "to", "L", "L", "in", "March", "2006."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p114_s0", "idA": "1430306_12_item1_p110_s0", "sentA": "Savella s active ingredient, milnacipran, is approved in Europe to treat depression.", "sentB": "Savella s active ingredient, milnacipran, is approved for the treatment of depression in Europe.", "type": 2, "words": ["<tag1>", "Savella", "s", "active", "ingredient,", "milnacipran,", "is", "approved", "in", "Europe", "to", "treat", "depression.", "<tag2>", "Savella", "s", "active", "ingredient,", "milnacipran,", "is", "approved", "for", "the", "treatment", "of", "depression", "in", "Europe.", "<tag3>"], "wordsA": ["Savella", "s", "active", "ingredient,", "milnacipran,", "is", "approved", "in", "Europe", "to", "treat", "depression."], "wordsB": ["Savella", "s", "active", "ingredient,", "milnacipran,", "is", "approved", "for", "the", "treatment", "of", "depression", "in", "Europe."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p115_s0", "idA": "1430306_12_item1_p111_s0", "sentA": "Since Lyrica and Cymbalta also are marketed for other conditions beyond FM, the sales of these products related specifically to FM can only be estimated.", "sentB": "As many products used for the treatment of FM are approved and marketed for other conditions, sales of these products related specifically to FM can only be estimated.", "type": 2, "words": ["<tag1>", "Since", "Lyrica", "and", "Cymbalta", "also", "are", "marketed", "for", "other", "conditions", "beyond", "FM,", "the", "sales", "of", "these", "products", "related", "specifically", "to", "FM", "can", "only", "be", "estimated.", "<tag2>", "As", "many", "products", "used", "for", "the", "treatment", "of", "FM", "are", "approved", "and", "marketed", "for", "other", "conditions,", "sales", "of", "these", "products", "related", "specifically", "to", "FM", "can", "only", "be", "estimated.", "<tag3>"], "wordsA": ["Since", "Lyrica", "and", "Cymbalta", "also", "are", "marketed", "for", "other", "conditions", "beyond", "FM,", "the", "sales", "of", "these", "products", "related", "specifically", "to", "FM", "can", "only", "be", "estimated."], "wordsB": ["As", "many", "products", "used", "for", "the", "treatment", "of", "FM", "are", "approved", "and", "marketed", "for", "other", "conditions,", "sales", "of", "these", "products", "related", "specifically", "to", "FM", "can", "only", "be", "estimated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p117_s3", "idA": "1430306_12_item1_p112_s2", "sentA": "These market dynamics are consistent with the interpretation that Lyrica s growth came at the expense of off-label pain killers and Cymbalta s and Savella s growth came at the expense of off-label anti-depressants.", "sentB": "In particular, these market dynamics are consistent with the interpretation that Lyrica s growth in FM was driven by switching from off-label analgesics, and Cymbalta s and Savella s growth in FM was driven by switching from off-label anti-depressants.", "type": 2, "words": ["<tag1>", "These", "market", "dynamics", "are", "consistent", "with", "the", "interpretation", "that", "Lyrica", "s", "growth", "came", "at", "the", "expense", "of", "off-label", "pain", "killers", "and", "Cymbalta", "s", "and", "Savella", "s", "growth", "came", "at", "the", "expense", "of", "off-label", "anti-depressants.", "<tag2>", "In", "particular,", "these", "market", "dynamics", "are", "consistent", "with", "the", "interpretation", "that", "Lyrica", "s", "growth", "in", "FM", "was", "driven", "by", "switching", "from", "off-label", "analgesics,", "and", "Cymbalta", "s", "and", "Savella", "s", "growth", "in", "FM", "was", "driven", "by", "switching", "from", "off-label", "anti-depressants.", "<tag3>"], "wordsA": ["These", "market", "dynamics", "are", "consistent", "with", "the", "interpretation", "that", "Lyrica", "s", "growth", "came", "at", "the", "expense", "of", "off-label", "pain", "killers", "and", "Cymbalta", "s", "and", "Savella", "s", "growth", "came", "at", "the", "expense", "of", "off-label", "anti-depressants."], "wordsB": ["In", "particular,", "these", "market", "dynamics", "are", "consistent", "with", "the", "interpretation", "that", "Lyrica", "s", "growth", "in", "FM", "was", "driven", "by", "switching", "from", "off-label", "analgesics,", "and", "Cymbalta", "s", "and", "Savella", "s", "growth", "in", "FM", "was", "driven", "by", "switching", "from", "off-label", "anti-depressants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p118_s1", "idA": "1430306_12_item1_p114_s0", "sentA": "The FM market for muscle relaxants lacks an FDA-approved product and continues to be satisfied by off-label medicines such as cyclobenzaprine, tizanidine, baclofen, carisoprodol and metaxalone.", "sentB": "Demand continues to be satisfied by off-label medicines such as CBP, tizanidine, baclofen, carisoprodol and metaxalone.", "type": 2, "words": ["<tag1>", "The", "FM", "market", "for", "muscle", "relaxants", "lacks", "an", "FDA-approved", "product", "and", "continues", "to", "be", "satisfied", "by", "off-label", "medicines", "such", "as", "cyclobenzaprine,", "tizanidine,", "baclofen,", "carisoprodol", "and", "metaxalone.", "<tag2>", "Demand", "continues", "to", "be", "satisfied", "by", "off-label", "medicines", "such", "as", "CBP,", "tizanidine,", "baclofen,", "carisoprodol", "and", "metaxalone.", "<tag3>"], "wordsA": ["The", "FM", "market", "for", "muscle", "relaxants", "lacks", "an", "FDA-approved", "product", "and", "continues", "to", "be", "satisfied", "by", "off-label", "medicines", "such", "as", "cyclobenzaprine,", "tizanidine,", "baclofen,", "carisoprodol", "and", "metaxalone."], "wordsB": ["Demand", "continues", "to", "be", "satisfied", "by", "off-label", "medicines", "such", "as", "CBP,", "tizanidine,", "baclofen,", "carisoprodol", "and", "metaxalone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p118_s3", "idA": "1430306_12_item1_p114_s2", "sentA": "According to Frost Sullivan, 48 million doses of the Flexeril brand and its associated immediate-release cyclobenzaprine generic products were prescribed off-label for FM in 2010 and accounted for approximately 35% of the muscle spasm pills prescribed for FM.", "sentB": "According to Adivo Associates, 20 million daily doses of the Flexeril brand and its associated CBP IR generic products were prescribed off-label for FM in 2011 and accounted for approximately 48% of the daily doses of muscle relaxants prescribed for FM that year.", "type": 2, "words": ["<tag1>", "According", "to", "Frost", "Sullivan,", "48", "million", "doses", "of", "the", "Flexeril", "brand", "and", "its", "associated", "immediate-release", "cyclobenzaprine", "generic", "products", "were", "prescribed", "off-label", "for", "FM", "in", "2010", "and", "accounted", "for", "approximately", "35%", "of", "the", "muscle", "spasm", "pills", "prescribed", "for", "FM.", "<tag2>", "According", "to", "Adivo", "Associates,", "20", "million", "daily", "doses", "of", "the", "Flexeril", "brand", "and", "its", "associated", "CBP", "IR", "generic", "products", "were", "prescribed", "off-label", "for", "FM", "in", "2011", "and", "accounted", "for", "approximately", "48%", "of", "the", "daily", "doses", "of", "muscle", "relaxants", "prescribed", "for", "FM", "that", "year.", "<tag3>"], "wordsA": ["According", "to", "Frost", "Sullivan,", "48", "million", "doses", "of", "the", "Flexeril", "brand", "and", "its", "associated", "immediate-release", "cyclobenzaprine", "generic", "products", "were", "prescribed", "off-label", "for", "FM", "in", "2010", "and", "accounted", "for", "approximately", "35%", "of", "the", "muscle", "spasm", "pills", "prescribed", "for", "FM."], "wordsB": ["According", "to", "Adivo", "Associates,", "20", "million", "daily", "doses", "of", "the", "Flexeril", "brand", "and", "its", "associated", "CBP", "IR", "generic", "products", "were", "prescribed", "off-label", "for", "FM", "in", "2011", "and", "accounted", "for", "approximately", "48%", "of", "the", "daily", "doses", "of", "muscle", "relaxants", "prescribed", "for", "FM", "that", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p58_s0", "idA": "1430306_12_item1_p116_s2", "sentA": "Symptoms like pain, fatigue, disturbed sleep or altered mood are characteristics of more than one condition.", "sentB": "Following the ingestion of CBP IR, it takes more than one hour for clinically-meaningful blood levels to be achieved.", "type": 2, "words": ["<tag1>", "Symptoms", "like", "pain,", "fatigue,", "disturbed", "sleep", "or", "altered", "mood", "are", "characteristics", "of", "more", "than", "one", "condition.", "<tag2>", "Following", "the", "ingestion", "of", "CBP", "IR,", "it", "takes", "more", "than", "one", "hour", "for", "clinically-meaningful", "blood", "levels", "to", "be", "achieved.", "<tag3>"], "wordsA": ["Symptoms", "like", "pain,", "fatigue,", "disturbed", "sleep", "or", "altered", "mood", "are", "characteristics", "of", "more", "than", "one", "condition."], "wordsB": ["Following", "the", "ingestion", "of", "CBP", "IR,", "it", "takes", "more", "than", "one", "hour", "for", "clinically-meaningful", "blood", "levels", "to", "be", "achieved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p20_s1", "idA": "1430306_12_item1_p121_s0", "sentA": "A desirable quality for CNS medications is the ability to relieve more than one symptom of a CNS condition.", "sentB": "One of our goals is to establish formal clinical study programs to determine if such anecdotal observations are, in fact, reflections of a compound s ability to treat a particular CNS condition.", "type": 2, "words": ["<tag1>", "A", "desirable", "quality", "for", "CNS", "medications", "is", "the", "ability", "to", "relieve", "more", "than", "one", "symptom", "of", "a", "CNS", "condition.", "<tag2>", "One", "of", "our", "goals", "is", "to", "establish", "formal", "clinical", "study", "programs", "to", "determine", "if", "such", "anecdotal", "observations", "are,", "in", "fact,", "reflections", "of", "a", "compound", "s", "ability", "to", "treat", "a", "particular", "CNS", "condition.", "<tag3>"], "wordsA": ["A", "desirable", "quality", "for", "CNS", "medications", "is", "the", "ability", "to", "relieve", "more", "than", "one", "symptom", "of", "a", "CNS", "condition."], "wordsB": ["One", "of", "our", "goals", "is", "to", "establish", "formal", "clinical", "study", "programs", "to", "determine", "if", "such", "anecdotal", "observations", "are,", "in", "fact,", "reflections", "of", "a", "compound", "s", "ability", "to", "treat", "a", "particular", "CNS", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p126_s0", "idA": "1430306_12_item1_p122_s0", "sentA": "We believe the market for the treatment of FM is underserved which we believe fuels a need for new therapeutic options.", "sentB": "We believe the market for the treatment of FM is underserved, which we believe fuels a need for new therapeutic options.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "market", "for", "the", "treatment", "of", "FM", "is", "underserved", "which", "we", "believe", "fuels", "a", "need", "for", "new", "therapeutic", "options.", "<tag2>", "We", "believe", "the", "market", "for", "the", "treatment", "of", "FM", "is", "underserved,", "which", "we", "believe", "fuels", "a", "need", "for", "new", "therapeutic", "options.", "<tag3>"], "wordsA": ["We", "believe", "the", "market", "for", "the", "treatment", "of", "FM", "is", "underserved", "which", "we", "believe", "fuels", "a", "need", "for", "new", "therapeutic", "options."], "wordsB": ["We", "believe", "the", "market", "for", "the", "treatment", "of", "FM", "is", "underserved,", "which", "we", "believe", "fuels", "a", "need", "for", "new", "therapeutic", "options."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p127_s0", "idA": "1430306_12_item1_p123_s0", "sentA": "We believe that if TNX-102 won FDA approval, it would be an appealing option because it has an entirely different mechanism of action from the currently approved products and we expect TNX-102 will be recommended for use before bedtime.", "sentB": "We believe that if TNX-102 SL won FDA approval, it would be an appealing option because it has an entirely different mechanism of action from the currently approved products and we expect TNX-102 SL will be recommended for use at bedtime.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "if", "TNX-102", "won", "FDA", "approval,", "it", "would", "be", "an", "appealing", "option", "because", "it", "has", "an", "entirely", "different", "mechanism", "of", "action", "from", "the", "currently", "approved", "products", "and", "we", "expect", "TNX-102", "will", "be", "recommended", "for", "use", "before", "bedtime.", "<tag2>", "We", "believe", "that", "if", "TNX-102", "SL", "won", "FDA", "approval,", "it", "would", "be", "an", "appealing", "option", "because", "it", "has", "an", "entirely", "different", "mechanism", "of", "action", "from", "the", "currently", "approved", "products", "and", "we", "expect", "TNX-102", "SL", "will", "be", "recommended", "for", "use", "at", "bedtime.", "<tag3>"], "wordsA": ["We", "believe", "that", "if", "TNX-102", "won", "FDA", "approval,", "it", "would", "be", "an", "appealing", "option", "because", "it", "has", "an", "entirely", "different", "mechanism", "of", "action", "from", "the", "currently", "approved", "products", "and", "we", "expect", "TNX-102", "will", "be", "recommended", "for", "use", "before", "bedtime."], "wordsB": ["We", "believe", "that", "if", "TNX-102", "SL", "won", "FDA", "approval,", "it", "would", "be", "an", "appealing", "option", "because", "it", "has", "an", "entirely", "different", "mechanism", "of", "action", "from", "the", "currently", "approved", "products", "and", "we", "expect", "TNX-102", "SL", "will", "be", "recommended", "for", "use", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p128_s1", "idA": "1430306_12_item1_p124_s1", "sentA": "Cymbalta was found effective at once-daily dosing and is generally restricted to daytime use and not recommended for bedtime use.", "sentB": "Cymbalta was found effective at once-daily or twice-daily dosing and is generally restricted to daytime use and not recommended for bedtime use.", "type": 2, "words": ["<tag1>", "Cymbalta", "was", "found", "effective", "at", "once-daily", "dosing", "and", "is", "generally", "restricted", "to", "daytime", "use", "and", "not", "recommended", "for", "bedtime", "use.", "<tag2>", "Cymbalta", "was", "found", "effective", "at", "once-daily", "or", "twice-daily", "dosing", "and", "is", "generally", "restricted", "to", "daytime", "use", "and", "not", "recommended", "for", "bedtime", "use.", "<tag3>"], "wordsA": ["Cymbalta", "was", "found", "effective", "at", "once-daily", "dosing", "and", "is", "generally", "restricted", "to", "daytime", "use", "and", "not", "recommended", "for", "bedtime", "use."], "wordsB": ["Cymbalta", "was", "found", "effective", "at", "once-daily", "or", "twice-daily", "dosing", "and", "is", "generally", "restricted", "to", "daytime", "use", "and", "not", "recommended", "for", "bedtime", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p128_s2", "idA": "1430306_12_item1_p125_s0", "sentA": "Cymbalta and Savella act on the CNS in ways that are believed to interfere with sleep.", "sentB": "Cymbalta and Savella act on the CNS in ways that are believed to interfere with sleep, while data support the view that CBP, the active ingredient in TNX-102 SL, improves sleep quality.", "type": 2, "words": ["<tag1>", "Cymbalta", "and", "Savella", "act", "on", "the", "CNS", "in", "ways", "that", "are", "believed", "to", "interfere", "with", "sleep.", "<tag2>", "Cymbalta", "and", "Savella", "act", "on", "the", "CNS", "in", "ways", "that", "are", "believed", "to", "interfere", "with", "sleep,", "while", "data", "support", "the", "view", "that", "CBP,", "the", "active", "ingredient", "in", "TNX-102", "SL,", "improves", "sleep", "quality.", "<tag3>"], "wordsA": ["Cymbalta", "and", "Savella", "act", "on", "the", "CNS", "in", "ways", "that", "are", "believed", "to", "interfere", "with", "sleep."], "wordsB": ["Cymbalta", "and", "Savella", "act", "on", "the", "CNS", "in", "ways", "that", "are", "believed", "to", "interfere", "with", "sleep,", "while", "data", "support", "the", "view", "that", "CBP,", "the", "active", "ingredient", "in", "TNX-102", "SL,", "improves", "sleep", "quality."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p91_s1", "idA": "1430306_12_item1_p125_s0", "sentA": "Cymbalta and Savella act on the CNS in ways that are believed to interfere with sleep.", "sentB": "Sleep disturbances are believed to exacerbate daytime symptoms of PTSD, including irritability, poor concentration, and diminished interest in significant activities.", "type": 2, "words": ["<tag1>", "Cymbalta", "and", "Savella", "act", "on", "the", "CNS", "in", "ways", "that", "are", "believed", "to", "interfere", "with", "sleep.", "<tag2>", "Sleep", "disturbances", "are", "believed", "to", "exacerbate", "daytime", "symptoms", "of", "PTSD,", "including", "irritability,", "poor", "concentration,", "and", "diminished", "interest", "in", "significant", "activities.", "<tag3>"], "wordsA": ["Cymbalta", "and", "Savella", "act", "on", "the", "CNS", "in", "ways", "that", "are", "believed", "to", "interfere", "with", "sleep."], "wordsB": ["Sleep", "disturbances", "are", "believed", "to", "exacerbate", "daytime", "symptoms", "of", "PTSD,", "including", "irritability,", "poor", "concentration,", "and", "diminished", "interest", "in", "significant", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p131_s0", "idA": "1430306_12_item1_p128_s0", "sentA": "As of September 15, 2011 several companies are pursuing treatments for FM.", "sentB": "As of February 2013, we are aware of several companies pursuing treatments for FM, including Chelsea Therapeutics, Johnson and Johnson, Meda, Pfizer, Synthetic Biologics, Teva, and Theravance.", "type": 2, "words": ["<tag1>", "As", "of", "September", "15,", "2011", "several", "companies", "are", "pursuing", "treatments", "for", "FM.", "<tag2>", "As", "of", "February", "2013,", "we", "are", "aware", "of", "several", "companies", "pursuing", "treatments", "for", "FM,", "including", "Chelsea", "Therapeutics,", "Johnson", "and", "Johnson,", "Meda,", "Pfizer,", "Synthetic", "Biologics,", "Teva,", "and", "Theravance.", "<tag3>"], "wordsA": ["As", "of", "September", "15,", "2011", "several", "companies", "are", "pursuing", "treatments", "for", "FM."], "wordsB": ["As", "of", "February", "2013,", "we", "are", "aware", "of", "several", "companies", "pursuing", "treatments", "for", "FM,", "including", "Chelsea", "Therapeutics,", "Johnson", "and", "Johnson,", "Meda,", "Pfizer,", "Synthetic", "Biologics,", "Teva,", "and", "Theravance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p28_s0", "idA": "1430306_12_item1_p129_s0", "sentA": "Clinical trials in the U.S. are registered with the FDA and reported on the website, www.ClinicalTrials.gov.", "sentB": "CBP has been approved by the FDA in the U.S. since 1977.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website,", "www.ClinicalTrials.gov.", "<tag2>", "CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977.", "<tag3>"], "wordsA": ["Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website,", "www.ClinicalTrials.gov."], "wordsB": ["CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p132_s0", "idA": "1430306_12_item1_p130_s0", "sentA": "A number of companies are specifically engaged in developing drugs for PTSD.", "sentB": "A number of companies are specifically engaged in developing drugs for PTSD, including AstraZeneca, UCB, GlaxoSmithKline, Ortho-McNeil Janssen Scientific Affairs, and Pfizer.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "specifically", "engaged", "in", "developing", "drugs", "for", "PTSD.", "<tag2>", "A", "number", "of", "companies", "are", "specifically", "engaged", "in", "developing", "drugs", "for", "PTSD,", "including", "AstraZeneca,", "UCB,", "GlaxoSmithKline,", "Ortho-McNeil", "Janssen", "Scientific", "Affairs,", "and", "Pfizer.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "specifically", "engaged", "in", "developing", "drugs", "for", "PTSD."], "wordsB": ["A", "number", "of", "companies", "are", "specifically", "engaged", "in", "developing", "drugs", "for", "PTSD,", "including", "AstraZeneca,", "UCB,", "GlaxoSmithKline,", "Ortho-McNeil", "Janssen", "Scientific", "Affairs,", "and", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p72_s0", "idA": "1430306_12_item1_p131_s4", "sentA": "Jazz studies of Rekinla showed that a treatment that affects sleep quality can improve FM symptoms to meet FDA requirements for an effective product.", "sentB": "This study also showed that VLD CBP taken between dinner and bedtime resulted in a significant improvement in sleep quality.", "type": 2, "words": ["<tag1>", "Jazz", "studies", "of", "Rekinla", "showed", "that", "a", "treatment", "that", "affects", "sleep", "quality", "can", "improve", "FM", "symptoms", "to", "meet", "FDA", "requirements", "for", "an", "effective", "product.", "<tag2>", "This", "study", "also", "showed", "that", "VLD", "CBP", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "sleep", "quality.", "<tag3>"], "wordsA": ["Jazz", "studies", "of", "Rekinla", "showed", "that", "a", "treatment", "that", "affects", "sleep", "quality", "can", "improve", "FM", "symptoms", "to", "meet", "FDA", "requirements", "for", "an", "effective", "product."], "wordsB": ["This", "study", "also", "showed", "that", "VLD", "CBP", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "sleep", "quality."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p95_s1", "idA": "1430306_12_item1_p135_s1", "sentA": "In addition, we have one trademark application pending.", "sentB": "CROs we have engaged in this effort include Caliper, Cerep, Millipore, and DiscoveRx.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "one", "trademark", "application", "pending.", "<tag2>", "CROs", "we", "have", "engaged", "in", "this", "effort", "include", "Caliper,", "Cerep,", "Millipore,", "and", "DiscoveRx.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "one", "trademark", "application", "pending."], "wordsB": ["CROs", "we", "have", "engaged", "in", "this", "effort", "include", "Caliper,", "Cerep,", "Millipore,", "and", "DiscoveRx."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p60_s4", "idA": "1430306_12_item1_p140_s0", "sentA": "We have one employee dedicated to research and development.", "sentB": "We have developed other innovative formulations of CBP, including TNX-102 gelcap.", "type": 2, "words": ["<tag1>", "We", "have", "one", "employee", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "developed", "other", "innovative", "formulations", "of", "CBP,", "including", "TNX-102", "gelcap.", "<tag3>"], "wordsA": ["We", "have", "one", "employee", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "developed", "other", "innovative", "formulations", "of", "CBP,", "including", "TNX-102", "gelcap."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p140_s1", "idA": "1430306_12_item1_p140_s1", "sentA": "We anticipate that our research and development expenditures will increase several fold as we move TNX-102 and TNX-105 into clinical development and investigate other product candidates for incorporation into our portfolio.", "sentB": "We anticipate that our research and development expenditures will increase several fold as we advance TNX-102 SL into late-stage clinical development and advance other candidates in our pipeline.", "type": 2, "words": ["<tag1>", "We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "move", "TNX-102", "and", "TNX-105", "into", "clinical", "development", "and", "investigate", "other", "product", "candidates", "for", "incorporation", "into", "our", "portfolio.", "<tag2>", "We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "advance", "TNX-102", "SL", "into", "late-stage", "clinical", "development", "and", "advance", "other", "candidates", "in", "our", "pipeline.", "<tag3>"], "wordsA": ["We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "move", "TNX-102", "and", "TNX-105", "into", "clinical", "development", "and", "investigate", "other", "product", "candidates", "for", "incorporation", "into", "our", "portfolio."], "wordsB": ["We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "advance", "TNX-102", "SL", "into", "late-stage", "clinical", "development", "and", "advance", "other", "candidates", "in", "our", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p140_s4", "idA": "1430306_12_item1_p140_s4", "sentA": "We expect to use third parties to conduct our preclinical and clinical trials.", "sentB": "We have used, and expect to continue to use, third parties to conduct our preclinical and clinical studies.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "use", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "trials.", "<tag2>", "We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies.", "<tag3>"], "wordsA": ["We", "expect", "to", "use", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "trials."], "wordsB": ["We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p97_s1", "idA": "1430306_12_item1_p140_s4", "sentA": "We expect to use third parties to conduct our preclinical and clinical trials.", "sentB": "We expect to be able to use TNX-102 SL tablets manufactured for the FM studies in the initial PTSD clinical trials.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "use", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "trials.", "<tag2>", "We", "expect", "to", "be", "able", "to", "use", "TNX-102", "SL", "tablets", "manufactured", "for", "the", "FM", "studies", "in", "the", "initial", "PTSD", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "expect", "to", "use", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "trials."], "wordsB": ["We", "expect", "to", "be", "able", "to", "use", "TNX-102", "SL", "tablets", "manufactured", "for", "the", "FM", "studies", "in", "the", "initial", "PTSD", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p141_s0", "idA": "1430306_12_item1_p141_s0", "sentA": "We intend to contract with third parties for the manufacture of our compounds for investigational purposes, for preclinical and clinical testing and for any FDA approved products for commercial sale.", "sentB": "We have contracted with third parties for the manufacture of TNX-102 SL for investigational purposes, including preclinical and clinical testing, as follows:", "type": 2, "words": ["<tag1>", "We", "intend", "to", "contract", "with", "third", "parties", "for", "the", "manufacture", "of", "our", "compounds", "for", "investigational", "purposes,", "for", "preclinical", "and", "clinical", "testing", "and", "for", "any", "FDA", "approved", "products", "for", "commercial", "sale.", "<tag2>", "We", "have", "contracted", "with", "third", "parties", "for", "the", "manufacture", "of", "TNX-102", "SL", "for", "investigational", "purposes,", "including", "preclinical", "and", "clinical", "testing,", "as", "follows:", "<tag3>"], "wordsA": ["We", "intend", "to", "contract", "with", "third", "parties", "for", "the", "manufacture", "of", "our", "compounds", "for", "investigational", "purposes,", "for", "preclinical", "and", "clinical", "testing", "and", "for", "any", "FDA", "approved", "products", "for", "commercial", "sale."], "wordsB": ["We", "have", "contracted", "with", "third", "parties", "for", "the", "manufacture", "of", "TNX-102", "SL", "for", "investigational", "purposes,", "including", "preclinical", "and", "clinical", "testing,", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p79_s5", "idA": "1430306_12_item1_p141_s1", "sentA": "We have contracted with Lipocine Inc. to manufacture TNX-102 for use in our ongoing pharmacokinetic study.", "sentB": "We have contracted with a contract manufacturing organization, or CMO, to manufacture and perform stability testing on TNX-102 SL tablets for this Phase 2b study.", "type": 2, "words": ["<tag1>", "We", "have", "contracted", "with", "Lipocine", "Inc.", "to", "manufacture", "TNX-102", "for", "use", "in", "our", "ongoing", "pharmacokinetic", "study.", "<tag2>", "We", "have", "contracted", "with", "a", "contract", "manufacturing", "organization,", "or", "CMO,", "to", "manufacture", "and", "perform", "stability", "testing", "on", "TNX-102", "SL", "tablets", "for", "this", "Phase", "2b", "study.", "<tag3>"], "wordsA": ["We", "have", "contracted", "with", "Lipocine", "Inc.", "to", "manufacture", "TNX-102", "for", "use", "in", "our", "ongoing", "pharmacokinetic", "study."], "wordsB": ["We", "have", "contracted", "with", "a", "contract", "manufacturing", "organization,", "or", "CMO,", "to", "manufacture", "and", "perform", "stability", "testing", "on", "TNX-102", "SL", "tablets", "for", "this", "Phase", "2b", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p142_s0", "idA": "1430306_12_item1_p142_s0", "sentA": "All of our compounds are small molecules, generally constructed using industry standard processes and use readily accessible raw materials.", "sentB": "All of our compounds are small molecules, synthesized using industry standard processes, and our drug products are formulated using commercially available raw materials.", "type": 2, "words": ["<tag1>", "All", "of", "our", "compounds", "are", "small", "molecules,", "generally", "constructed", "using", "industry", "standard", "processes", "and", "use", "readily", "accessible", "raw", "materials.", "<tag2>", "All", "of", "our", "compounds", "are", "small", "molecules,", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "raw", "materials.", "<tag3>"], "wordsA": ["All", "of", "our", "compounds", "are", "small", "molecules,", "generally", "constructed", "using", "industry", "standard", "processes", "and", "use", "readily", "accessible", "raw", "materials."], "wordsB": ["All", "of", "our", "compounds", "are", "small", "molecules,", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "raw", "materials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p144_s0", "idA": "1430306_12_item1_p144_s0", "sentA": "The FDA regulates, among other things, the research, manufacture, promotion and distribution of drugs in the United States under the FFDCA and other statutes and implementing regulations.", "sentB": "The FDA regulates, among other things, the research, manufacture, promotion and distribution of drugs in the United States under the FDCA and other statutes and implementing regulations.", "type": 2, "words": ["<tag1>", "The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FFDCA", "and", "other", "statutes", "and", "implementing", "regulations.", "<tag2>", "The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations.", "<tag3>"], "wordsA": ["The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FFDCA", "and", "other", "statutes", "and", "implementing", "regulations."], "wordsB": ["The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p75_s0", "idA": "1430306_12_item1_p145_s0", "sentA": "FDA review and approval of the NDA prior to any commercial marketing, sale or shipment of the drug.", "sentB": "Our preclinical animal studies demonstrated that our sublingual formulations provide faster delivery and more efficient systemic absorption of CBP as compared to current oral forms of the drug.", "type": 2, "words": ["<tag1>", "FDA", "review", "and", "approval", "of", "the", "NDA", "prior", "to", "any", "commercial", "marketing,", "sale", "or", "shipment", "of", "the", "drug.", "<tag2>", "Our", "preclinical", "animal", "studies", "demonstrated", "that", "our", "sublingual", "formulations", "provide", "faster", "delivery", "and", "more", "efficient", "systemic", "absorption", "of", "CBP", "as", "compared", "to", "current", "oral", "forms", "of", "the", "drug.", "<tag3>"], "wordsA": ["FDA", "review", "and", "approval", "of", "the", "NDA", "prior", "to", "any", "commercial", "marketing,", "sale", "or", "shipment", "of", "the", "drug."], "wordsB": ["Our", "preclinical", "animal", "studies", "demonstrated", "that", "our", "sublingual", "formulations", "provide", "faster", "delivery", "and", "more", "efficient", "systemic", "absorption", "of", "CBP", "as", "compared", "to", "current", "oral", "forms", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p150_s1", "idA": "1430306_12_item1_p150_s1", "sentA": "Each protocol is submitted to the FDA as part of the IND.", "sentB": "Each protocol for a U.S. study is submitted to the FDA as part of the IND.", "type": 2, "words": ["<tag1>", "Each", "protocol", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND.", "<tag2>", "Each", "protocol", "for", "a", "U.S.", "study", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND.", "<tag3>"], "wordsA": ["Each", "protocol", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND."], "wordsB": ["Each", "protocol", "for", "a", "U.S.", "study", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p154_s0", "idA": "1430306_12_item1_p154_s0", "sentA": "Phase 2 clinical trials are conducted in a limited patient population to gather evidence about the efficacy of the product candidate for specific, targeted indications; to determine dosage tolerance and optimal dosage; and to identify possible adverse effects and safety risks.", "sentB": "Phase 2 clinical trials are generally conducted in a limited patient population to gather evidence about the efficacy of the product candidate for specific, targeted indications; to determine dosage tolerance and optimal dosage; and to identify possible adverse effects and safety risks.", "type": 2, "words": ["<tag1>", "Phase", "2", "clinical", "trials", "are", "conducted", "in", "a", "limited", "patient", "population", "to", "gather", "evidence", "about", "the", "efficacy", "of", "the", "product", "candidate", "for", "specific,", "targeted", "indications;", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage;", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag2>", "Phase", "2", "clinical", "trials", "are", "generally", "conducted", "in", "a", "limited", "patient", "population", "to", "gather", "evidence", "about", "the", "efficacy", "of", "the", "product", "candidate", "for", "specific,", "targeted", "indications;", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage;", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag3>"], "wordsA": ["Phase", "2", "clinical", "trials", "are", "conducted", "in", "a", "limited", "patient", "population", "to", "gather", "evidence", "about", "the", "efficacy", "of", "the", "product", "candidate", "for", "specific,", "targeted", "indications;", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage;", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks."], "wordsB": ["Phase", "2", "clinical", "trials", "are", "generally", "conducted", "in", "a", "limited", "patient", "population", "to", "gather", "evidence", "about", "the", "efficacy", "of", "the", "product", "candidate", "for", "specific,", "targeted", "indications;", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage;", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p154_s1", "idA": "1430306_12_item1_p155_s0", "sentA": "Phase 3 clinical trials are undertaken to evaluate clinical efficacy and to test for safety in an expanded patient population at geographically dispersed clinical trial sites.", "sentB": "Phase 2 clinical trials, in particular Phase 2b trials, can be undertaken to evaluate clinical efficacy and to test for safety in an expanded patient population at geographically dispersed clinical trial sites.", "type": 2, "words": ["<tag1>", "Phase", "3", "clinical", "trials", "are", "undertaken", "to", "evaluate", "clinical", "efficacy", "and", "to", "test", "for", "safety", "in", "an", "expanded", "patient", "population", "at", "geographically", "dispersed", "clinical", "trial", "sites.", "<tag2>", "Phase", "2", "clinical", "trials,", "in", "particular", "Phase", "2b", "trials,", "can", "be", "undertaken", "to", "evaluate", "clinical", "efficacy", "and", "to", "test", "for", "safety", "in", "an", "expanded", "patient", "population", "at", "geographically", "dispersed", "clinical", "trial", "sites.", "<tag3>"], "wordsA": ["Phase", "3", "clinical", "trials", "are", "undertaken", "to", "evaluate", "clinical", "efficacy", "and", "to", "test", "for", "safety", "in", "an", "expanded", "patient", "population", "at", "geographically", "dispersed", "clinical", "trial", "sites."], "wordsB": ["Phase", "2", "clinical", "trials,", "in", "particular", "Phase", "2b", "trials,", "can", "be", "undertaken", "to", "evaluate", "clinical", "efficacy", "and", "to", "test", "for", "safety", "in", "an", "expanded", "patient", "population", "at", "geographically", "dispersed", "clinical", "trial", "sites."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p76_s6", "idA": "1430306_12_item1_p156_s1", "sentA": "Reports detailing the results of the clinical trials must be submitted at least annually to the FDA and safety reports must be submitted for serious and unexpected adverse events.", "sentB": "In the study, all of the CBP formulations were well-tolerated, and there were no unexpected adverse events.", "type": 2, "words": ["<tag1>", "Reports", "detailing", "the", "results", "of", "the", "clinical", "trials", "must", "be", "submitted", "at", "least", "annually", "to", "the", "FDA", "and", "safety", "reports", "must", "be", "submitted", "for", "serious", "and", "unexpected", "adverse", "events.", "<tag2>", "In", "the", "study,", "all", "of", "the", "CBP", "formulations", "were", "well-tolerated,", "and", "there", "were", "no", "unexpected", "adverse", "events.", "<tag3>"], "wordsA": ["Reports", "detailing", "the", "results", "of", "the", "clinical", "trials", "must", "be", "submitted", "at", "least", "annually", "to", "the", "FDA", "and", "safety", "reports", "must", "be", "submitted", "for", "serious", "and", "unexpected", "adverse", "events."], "wordsB": ["In", "the", "study,", "all", "of", "the", "CBP", "formulations", "were", "well-tolerated,", "and", "there", "were", "no", "unexpected", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p159_s1", "idA": "1430306_12_item1_p159_s1", "sentA": "The FDA is not bound by the recommendation of an advisory committee, but it considers them carefully when making decisions.", "sentB": "The FDA is not bound by the recommendations of an advisory committee, but it considers them carefully when making decisions.", "type": 2, "words": ["<tag1>", "The", "FDA", "is", "not", "bound", "by", "the", "recommendation", "of", "an", "advisory", "committee,", "but", "it", "considers", "them", "carefully", "when", "making", "decisions.", "<tag2>", "The", "FDA", "is", "not", "bound", "by", "the", "recommendations", "of", "an", "advisory", "committee,", "but", "it", "considers", "them", "carefully", "when", "making", "decisions.", "<tag3>"], "wordsA": ["The", "FDA", "is", "not", "bound", "by", "the", "recommendation", "of", "an", "advisory", "committee,", "but", "it", "considers", "them", "carefully", "when", "making", "decisions."], "wordsB": ["The", "FDA", "is", "not", "bound", "by", "the", "recommendations", "of", "an", "advisory", "committee,", "but", "it", "considers", "them", "carefully", "when", "making", "decisions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p15_s0", "idA": "1430306_12_item1_p15_s0", "sentA": "In 2009, Tonix Sub contracted with the Toronto Psychiatric Research Foundation to analyze the sleep data from the 2001 Phase 2a study of 36 patients with fibromyalgia syndrome, or FM (the Moldofsky Study ), who were treated with bedtime VLD cyclobenzaprine or placebo.", "sentB": "In 2009, Tonix Sub contracted with the Toronto Psychiatric Research Foundation to analyze the sleep data from a Phase 2a trial of bedtime VLD CBP in fibromyalgia, or FM (the Moldofsky Study ).", "type": 2, "words": ["<tag1>", "In", "2009,", "Tonix", "Sub", "contracted", "with", "the", "Toronto", "Psychiatric", "Research", "Foundation", "to", "analyze", "the", "sleep", "data", "from", "the", "2001", "Phase", "2a", "study", "of", "36", "patients", "with", "fibromyalgia", "syndrome,", "or", "FM", "(the", "Moldofsky", "Study", "),", "who", "were", "treated", "with", "bedtime", "VLD", "cyclobenzaprine", "or", "placebo.", "<tag2>", "In", "2009,", "Tonix", "Sub", "contracted", "with", "the", "Toronto", "Psychiatric", "Research", "Foundation", "to", "analyze", "the", "sleep", "data", "from", "a", "Phase", "2a", "trial", "of", "bedtime", "VLD", "CBP", "in", "fibromyalgia,", "or", "FM", "(the", "Moldofsky", "Study", ").", "<tag3>"], "wordsA": ["In", "2009,", "Tonix", "Sub", "contracted", "with", "the", "Toronto", "Psychiatric", "Research", "Foundation", "to", "analyze", "the", "sleep", "data", "from", "the", "2001", "Phase", "2a", "study", "of", "36", "patients", "with", "fibromyalgia", "syndrome,", "or", "FM", "(the", "Moldofsky", "Study", "),", "who", "were", "treated", "with", "bedtime", "VLD", "cyclobenzaprine", "or", "placebo."], "wordsB": ["In", "2009,", "Tonix", "Sub", "contracted", "with", "the", "Toronto", "Psychiatric", "Research", "Foundation", "to", "analyze", "the", "sleep", "data", "from", "a", "Phase", "2a", "trial", "of", "bedtime", "VLD", "CBP", "in", "fibromyalgia,", "or", "FM", "(the", "Moldofsky", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p15_s2", "idA": "1430306_12_item1_p15_s2", "sentA": "( Caliper ) to analyze the interactions of cyclobenzaprine with certain receptors.", "sentB": "In addition, in 2009, Tonix Sub contracted with Caliper Life Sciences Inc., or Caliper, to analyze the interactions of CBP with certain receptors.", "type": 2, "words": ["<tag1>", "(", "Caliper", ")", "to", "analyze", "the", "interactions", "of", "cyclobenzaprine", "with", "certain", "receptors.", "<tag2>", "In", "addition,", "in", "2009,", "Tonix", "Sub", "contracted", "with", "Caliper", "Life", "Sciences", "Inc.,", "or", "Caliper,", "to", "analyze", "the", "interactions", "of", "CBP", "with", "certain", "receptors.", "<tag3>"], "wordsA": ["(", "Caliper", ")", "to", "analyze", "the", "interactions", "of", "cyclobenzaprine", "with", "certain", "receptors."], "wordsB": ["In", "addition,", "in", "2009,", "Tonix", "Sub", "contracted", "with", "Caliper", "Life", "Sciences", "Inc.,", "or", "Caliper,", "to", "analyze", "the", "interactions", "of", "CBP", "with", "certain", "receptors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p95_s0", "idA": "1430306_12_item1_p15_s2", "sentA": "( Caliper ) to analyze the interactions of cyclobenzaprine with certain receptors.", "sentB": "As very little information was available on the biochemical effects of CBP and its primary metabolite, norcyclobenzaprine, or nCBP, in the central nervous system, we have engaged several CROs to better understand the interactions of these agents with certain receptors in the brain.", "type": 2, "words": ["<tag1>", "(", "Caliper", ")", "to", "analyze", "the", "interactions", "of", "cyclobenzaprine", "with", "certain", "receptors.", "<tag2>", "As", "very", "little", "information", "was", "available", "on", "the", "biochemical", "effects", "of", "CBP", "and", "its", "primary", "metabolite,", "norcyclobenzaprine,", "or", "nCBP,", "in", "the", "central", "nervous", "system,", "we", "have", "engaged", "several", "CROs", "to", "better", "understand", "the", "interactions", "of", "these", "agents", "with", "certain", "receptors", "in", "the", "brain.", "<tag3>"], "wordsA": ["(", "Caliper", ")", "to", "analyze", "the", "interactions", "of", "cyclobenzaprine", "with", "certain", "receptors."], "wordsB": ["As", "very", "little", "information", "was", "available", "on", "the", "biochemical", "effects", "of", "CBP", "and", "its", "primary", "metabolite,", "norcyclobenzaprine,", "or", "nCBP,", "in", "the", "central", "nervous", "system,", "we", "have", "engaged", "several", "CROs", "to", "better", "understand", "the", "interactions", "of", "these", "agents", "with", "certain", "receptors", "in", "the", "brain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p160_s0", "idA": "1430306_12_item1_p160_s0", "sentA": "There are two types of NDAs: the full NDA and the Section 505(b)(2) NDA.", "sentB": "There are two types of NDAs: the Section 505(b)(1) NDA, or full NDA, and the Section 505(b)(2) NDA.", "type": 2, "words": ["<tag1>", "There", "are", "two", "types", "of", "NDAs:", "the", "full", "NDA", "and", "the", "Section", "505(b)(2)", "NDA.", "<tag2>", "There", "are", "two", "types", "of", "NDAs:", "the", "Section", "505(b)(1)", "NDA,", "or", "full", "NDA,", "and", "the", "Section", "505(b)(2)", "NDA.", "<tag3>"], "wordsA": ["There", "are", "two", "types", "of", "NDAs:", "the", "full", "NDA", "and", "the", "Section", "505(b)(2)", "NDA."], "wordsB": ["There", "are", "two", "types", "of", "NDAs:", "the", "Section", "505(b)(1)", "NDA,", "or", "full", "NDA,", "and", "the", "Section", "505(b)(2)", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p28_s4", "idA": "1430306_12_item1_p160_s0", "sentA": "There are two types of NDAs: the full NDA and the Section 505(b)(2) NDA.", "sentB": "As one of three types of new drug applications, the 505(b)(2) NDA allows drug companies to obtain FDA approval of new drug products without having to conduct the full complement of safety and efficacy trials, which is often the most time-consuming and expensive part of the drug development process.", "type": 2, "words": ["<tag1>", "There", "are", "two", "types", "of", "NDAs:", "the", "full", "NDA", "and", "the", "Section", "505(b)(2)", "NDA.", "<tag2>", "As", "one", "of", "three", "types", "of", "new", "drug", "applications,", "the", "505(b)(2)", "NDA", "allows", "drug", "companies", "to", "obtain", "FDA", "approval", "of", "new", "drug", "products", "without", "having", "to", "conduct", "the", "full", "complement", "of", "safety", "and", "efficacy", "trials,", "which", "is", "often", "the", "most", "time-consuming", "and", "expensive", "part", "of", "the", "drug", "development", "process.", "<tag3>"], "wordsA": ["There", "are", "two", "types", "of", "NDAs:", "the", "full", "NDA", "and", "the", "Section", "505(b)(2)", "NDA."], "wordsB": ["As", "one", "of", "three", "types", "of", "new", "drug", "applications,", "the", "505(b)(2)", "NDA", "allows", "drug", "companies", "to", "obtain", "FDA", "approval", "of", "new", "drug", "products", "without", "having", "to", "conduct", "the", "full", "complement", "of", "safety", "and", "efficacy", "trials,", "which", "is", "often", "the", "most", "time-consuming", "and", "expensive", "part", "of", "the", "drug", "development", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p106_s2", "idA": "1430306_12_item1_p161_s0", "sentA": "NDAs that might, if accepted by the FDA, save time and expense in the development and testing of our product candidates.", "sentB": "Some of the data has been collected and some data is still awaiting the development and validation of assays.", "type": 2, "words": ["<tag1>", "NDAs", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates.", "<tag2>", "Some", "of", "the", "data", "has", "been", "collected", "and", "some", "data", "is", "still", "awaiting", "the", "development", "and", "validation", "of", "assays.", "<tag3>"], "wordsA": ["NDAs", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates."], "wordsB": ["Some", "of", "the", "data", "has", "been", "collected", "and", "some", "data", "is", "still", "awaiting", "the", "development", "and", "validation", "of", "assays."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p161_s1", "idA": "1430306_12_item1_p161_s1", "sentA": "A full NDA is submitted under Section 505(b)(1) of the FFDCA, and must contain full reports of investigations conducted by the applicant to demonstrate the safety and effectiveness of the drug.", "sentB": "A full NDA is submitted under Section 505(b)(1) of the FDCA, and must contain full reports of investigations conducted by the applicant to demonstrate the safety and effectiveness of the drug.", "type": 2, "words": ["<tag1>", "A", "full", "NDA", "is", "submitted", "under", "Section", "505(b)(1)", "of", "the", "FFDCA,", "and", "must", "contain", "full", "reports", "of", "investigations", "conducted", "by", "the", "applicant", "to", "demonstrate", "the", "safety", "and", "effectiveness", "of", "the", "drug.", "<tag2>", "A", "full", "NDA", "is", "submitted", "under", "Section", "505(b)(1)", "of", "the", "FDCA,", "and", "must", "contain", "full", "reports", "of", "investigations", "conducted", "by", "the", "applicant", "to", "demonstrate", "the", "safety", "and", "effectiveness", "of", "the", "drug.", "<tag3>"], "wordsA": ["A", "full", "NDA", "is", "submitted", "under", "Section", "505(b)(1)", "of", "the", "FFDCA,", "and", "must", "contain", "full", "reports", "of", "investigations", "conducted", "by", "the", "applicant", "to", "demonstrate", "the", "safety", "and", "effectiveness", "of", "the", "drug."], "wordsB": ["A", "full", "NDA", "is", "submitted", "under", "Section", "505(b)(1)", "of", "the", "FDCA,", "and", "must", "contain", "full", "reports", "of", "investigations", "conducted", "by", "the", "applicant", "to", "demonstrate", "the", "safety", "and", "effectiveness", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p163_s0", "idA": "1430306_12_item1_p163_s0", "sentA": "Because we are developing new formulations of previously approved chemical entities, such as cyclobenzaprine, our drug approval strategy is to submit Section 505(b)(2) NDAs to the FDA.", "sentB": "Because we are developing new formulations of previously approved chemical entities, such as CBP, our drug approval strategy is to submit Section 505(b)(2) NDAs to the FDA.", "type": 2, "words": ["<tag1>", "Because", "we", "are", "developing", "new", "formulations", "of", "previously", "approved", "chemical", "entities,", "such", "as", "cyclobenzaprine,", "our", "drug", "approval", "strategy", "is", "to", "submit", "Section", "505(b)(2)", "NDAs", "to", "the", "FDA.", "<tag2>", "Because", "we", "are", "developing", "new", "formulations", "of", "previously", "approved", "chemical", "entities,", "such", "as", "CBP,", "our", "drug", "approval", "strategy", "is", "to", "submit", "Section", "505(b)(2)", "NDAs", "to", "the", "FDA.", "<tag3>"], "wordsA": ["Because", "we", "are", "developing", "new", "formulations", "of", "previously", "approved", "chemical", "entities,", "such", "as", "cyclobenzaprine,", "our", "drug", "approval", "strategy", "is", "to", "submit", "Section", "505(b)(2)", "NDAs", "to", "the", "FDA."], "wordsB": ["Because", "we", "are", "developing", "new", "formulations", "of", "previously", "approved", "chemical", "entities,", "such", "as", "CBP,", "our", "drug", "approval", "strategy", "is", "to", "submit", "Section", "505(b)(2)", "NDAs", "to", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p164_s0", "idA": "1430306_12_item1_p164_s0", "sentA": "Based on our intent to file under Section 505(b)(2) with respect to our two lead product candidates, we believe it is unlikely the development process for these product candidates will follow the ordinary course of Phase 1, Phase 2 and Phase 3 studies.", "sentB": "Based on our intent to file under Section 505(b)(2) with respect to our lead product candidate, we believe it is unlikely the development process for this product candidate will follow the ordinary course of Phase 1, Phase 2 and Phase 3 studies.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "two", "lead", "product", "candidates,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "these", "product", "candidates", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies.", "<tag2>", "Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "lead", "product", "candidate,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "this", "product", "candidate", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies.", "<tag3>"], "wordsA": ["Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "two", "lead", "product", "candidates,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "these", "product", "candidates", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies."], "wordsB": ["Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "lead", "product", "candidate,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "this", "product", "candidate", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p165_s0", "idA": "1430306_12_item1_p164_s1", "sentA": "Our planned human pharmacokinetics study of reformulated cyclobenzaprine pills will represent the first use of TNX-102 in humans and could therefore be described as Phase 1.", "sentB": "Our human pharmacokinetic studies of reformulated CBP dosage forms represented the first use of TNX-102 SL and TNX-102 gelcap, or collectively, TNX-102, in humans and could therefore be described as Phase 1.", "type": 2, "words": ["<tag1>", "Our", "planned", "human", "pharmacokinetics", "study", "of", "reformulated", "cyclobenzaprine", "pills", "will", "represent", "the", "first", "use", "of", "TNX-102", "in", "humans", "and", "could", "therefore", "be", "described", "as", "Phase", "1.", "<tag2>", "Our", "human", "pharmacokinetic", "studies", "of", "reformulated", "CBP", "dosage", "forms", "represented", "the", "first", "use", "of", "TNX-102", "SL", "and", "TNX-102", "gelcap,", "or", "collectively,", "TNX-102,", "in", "humans", "and", "could", "therefore", "be", "described", "as", "Phase", "1.", "<tag3>"], "wordsA": ["Our", "planned", "human", "pharmacokinetics", "study", "of", "reformulated", "cyclobenzaprine", "pills", "will", "represent", "the", "first", "use", "of", "TNX-102", "in", "humans", "and", "could", "therefore", "be", "described", "as", "Phase", "1."], "wordsB": ["Our", "human", "pharmacokinetic", "studies", "of", "reformulated", "CBP", "dosage", "forms", "represented", "the", "first", "use", "of", "TNX-102", "SL", "and", "TNX-102", "gelcap,", "or", "collectively,", "TNX-102,", "in", "humans", "and", "could", "therefore", "be", "described", "as", "Phase", "1."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p165_s1", "idA": "1430306_12_item1_p164_s2", "sentA": "However, because the study will compare TNX-102 to existing approved formulations of cyclobenzaprine and will specify the comparable ability to deliver effective levels of cyclobenzaprine to the bloodstream of FM patients, this study will also provide a reference to the therapeutic effects previously observed in our dose-ranging clinical study of immediate-release cyclobenzaprine tablets in FM patients.", "sentB": "However, because these studies compared TNX-102 to existing approved formulations of CBP and specified the comparable ability to deliver effective levels of CBP to the bloodstream of FM patients, these studies provide a reference to the therapeutic effects previously observed in our dose-ranging clinical study of CBP IR capsules in FM patients.", "type": 2, "words": ["<tag1>", "However,", "because", "the", "study", "will", "compare", "TNX-102", "to", "existing", "approved", "formulations", "of", "cyclobenzaprine", "and", "will", "specify", "the", "comparable", "ability", "to", "deliver", "effective", "levels", "of", "cyclobenzaprine", "to", "the", "bloodstream", "of", "FM", "patients,", "this", "study", "will", "also", "provide", "a", "reference", "to", "the", "therapeutic", "effects", "previously", "observed", "in", "our", "dose-ranging", "clinical", "study", "of", "immediate-release", "cyclobenzaprine", "tablets", "in", "FM", "patients.", "<tag2>", "However,", "because", "these", "studies", "compared", "TNX-102", "to", "existing", "approved", "formulations", "of", "CBP", "and", "specified", "the", "comparable", "ability", "to", "deliver", "effective", "levels", "of", "CBP", "to", "the", "bloodstream", "of", "FM", "patients,", "these", "studies", "provide", "a", "reference", "to", "the", "therapeutic", "effects", "previously", "observed", "in", "our", "dose-ranging", "clinical", "study", "of", "CBP", "IR", "capsules", "in", "FM", "patients.", "<tag3>"], "wordsA": ["However,", "because", "the", "study", "will", "compare", "TNX-102", "to", "existing", "approved", "formulations", "of", "cyclobenzaprine", "and", "will", "specify", "the", "comparable", "ability", "to", "deliver", "effective", "levels", "of", "cyclobenzaprine", "to", "the", "bloodstream", "of", "FM", "patients,", "this", "study", "will", "also", "provide", "a", "reference", "to", "the", "therapeutic", "effects", "previously", "observed", "in", "our", "dose-ranging", "clinical", "study", "of", "immediate-release", "cyclobenzaprine", "tablets", "in", "FM", "patients."], "wordsB": ["However,", "because", "these", "studies", "compared", "TNX-102", "to", "existing", "approved", "formulations", "of", "CBP", "and", "specified", "the", "comparable", "ability", "to", "deliver", "effective", "levels", "of", "CBP", "to", "the", "bloodstream", "of", "FM", "patients,", "these", "studies", "provide", "a", "reference", "to", "the", "therapeutic", "effects", "previously", "observed", "in", "our", "dose-ranging", "clinical", "study", "of", "CBP", "IR", "capsules", "in", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p166_s0", "idA": "1430306_12_item1_p164_s4", "sentA": "Because our double-blind, randomized, placebo-controlled, dose-ranging study on bedtime cyclobenzaprine was performed in Canada, we have not had meetings with the FDA s Center for Drug Evaluation and Research to discuss our approach and plans.", "sentB": "Because our double-blind, randomized, placebo-controlled, dose-ranging study on bedtime CBP was performed in Canada, we did not meet with the FDA s Center for Drug Evaluation and Research to discuss our approach and plans until August 2011.", "type": 2, "words": ["<tag1>", "Because", "our", "double-blind,", "randomized,", "placebo-controlled,", "dose-ranging", "study", "on", "bedtime", "cyclobenzaprine", "was", "performed", "in", "Canada,", "we", "have", "not", "had", "meetings", "with", "the", "FDA", "s", "Center", "for", "Drug", "Evaluation", "and", "Research", "to", "discuss", "our", "approach", "and", "plans.", "<tag2>", "Because", "our", "double-blind,", "randomized,", "placebo-controlled,", "dose-ranging", "study", "on", "bedtime", "CBP", "was", "performed", "in", "Canada,", "we", "did", "not", "meet", "with", "the", "FDA", "s", "Center", "for", "Drug", "Evaluation", "and", "Research", "to", "discuss", "our", "approach", "and", "plans", "until", "August", "2011.", "<tag3>"], "wordsA": ["Because", "our", "double-blind,", "randomized,", "placebo-controlled,", "dose-ranging", "study", "on", "bedtime", "cyclobenzaprine", "was", "performed", "in", "Canada,", "we", "have", "not", "had", "meetings", "with", "the", "FDA", "s", "Center", "for", "Drug", "Evaluation", "and", "Research", "to", "discuss", "our", "approach", "and", "plans."], "wordsB": ["Because", "our", "double-blind,", "randomized,", "placebo-controlled,", "dose-ranging", "study", "on", "bedtime", "CBP", "was", "performed", "in", "Canada,", "we", "did", "not", "meet", "with", "the", "FDA", "s", "Center", "for", "Drug", "Evaluation", "and", "Research", "to", "discuss", "our", "approach", "and", "plans", "until", "August", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p163_s4", "idA": "1430306_12_item1_p168_s1", "sentA": "If the FDA s interpretation of Section 505(b)(2) is successfully challenged in court, the FDA may be required to change its interpretation of Section 505(b)(2) which could delay or even prevent the FDA from approving any Section 505(b)(2) NDA that we submit.", "sentB": "If CBP-containing products are withdrawn from the market by the FDA for any reason, we may not be able to reference such products to support our anticipated TNX-102 SL 505(b)(2) NDA, and we may be required to follow the requirements of Section 505(b)(1).", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "s", "interpretation", "of", "Section", "505(b)(2)", "is", "successfully", "challenged", "in", "court,", "the", "FDA", "may", "be", "required", "to", "change", "its", "interpretation", "of", "Section", "505(b)(2)", "which", "could", "delay", "or", "even", "prevent", "the", "FDA", "from", "approving", "any", "Section", "505(b)(2)", "NDA", "that", "we", "submit.", "<tag2>", "If", "CBP-containing", "products", "are", "withdrawn", "from", "the", "market", "by", "the", "FDA", "for", "any", "reason,", "we", "may", "not", "be", "able", "to", "reference", "such", "products", "to", "support", "our", "anticipated", "TNX-102", "SL", "505(b)(2)", "NDA,", "and", "we", "may", "be", "required", "to", "follow", "the", "requirements", "of", "Section", "505(b)(1).", "<tag3>"], "wordsA": ["If", "the", "FDA", "s", "interpretation", "of", "Section", "505(b)(2)", "is", "successfully", "challenged", "in", "court,", "the", "FDA", "may", "be", "required", "to", "change", "its", "interpretation", "of", "Section", "505(b)(2)", "which", "could", "delay", "or", "even", "prevent", "the", "FDA", "from", "approving", "any", "Section", "505(b)(2)", "NDA", "that", "we", "submit."], "wordsB": ["If", "CBP-containing", "products", "are", "withdrawn", "from", "the", "market", "by", "the", "FDA", "for", "any", "reason,", "we", "may", "not", "be", "able", "to", "reference", "such", "products", "to", "support", "our", "anticipated", "TNX-102", "SL", "505(b)(2)", "NDA,", "and", "we", "may", "be", "required", "to", "follow", "the", "requirements", "of", "Section", "505(b)(1)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p15_s4", "idA": "1430306_12_item1_p16_s1", "sentA": "Dr. Lederman is managing partner of Lederman Co. Between June 2010 and October 2011, Tonix Sub was active in recruiting new officers and directors and started dosing normal healthy volunteers for the pharmacokinetic trial for TNX-102.", "sentB": "Dr. Lederman is managing partner of Lederman Co. Between June 2010 and October 2011, Tonix Sub was active in recruiting new officers and directors and initiating preclinical and clinical development of novel CBP formulations.", "type": 2, "words": ["<tag1>", "Dr.", "Lederman", "is", "managing", "partner", "of", "Lederman", "Co.", "Between", "June", "2010", "and", "October", "2011,", "Tonix", "Sub", "was", "active", "in", "recruiting", "new", "officers", "and", "directors", "and", "started", "dosing", "normal", "healthy", "volunteers", "for", "the", "pharmacokinetic", "trial", "for", "TNX-102.", "<tag2>", "Dr.", "Lederman", "is", "managing", "partner", "of", "Lederman", "Co.", "Between", "June", "2010", "and", "October", "2011,", "Tonix", "Sub", "was", "active", "in", "recruiting", "new", "officers", "and", "directors", "and", "initiating", "preclinical", "and", "clinical", "development", "of", "novel", "CBP", "formulations.", "<tag3>"], "wordsA": ["Dr.", "Lederman", "is", "managing", "partner", "of", "Lederman", "Co.", "Between", "June", "2010", "and", "October", "2011,", "Tonix", "Sub", "was", "active", "in", "recruiting", "new", "officers", "and", "directors", "and", "started", "dosing", "normal", "healthy", "volunteers", "for", "the", "pharmacokinetic", "trial", "for", "TNX-102."], "wordsB": ["Dr.", "Lederman", "is", "managing", "partner", "of", "Lederman", "Co.", "Between", "June", "2010", "and", "October", "2011,", "Tonix", "Sub", "was", "active", "in", "recruiting", "new", "officers", "and", "directors", "and", "initiating", "preclinical", "and", "clinical", "development", "of", "novel", "CBP", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p172_s0", "idA": "1430306_12_item1_p170_s0", "sentA": "Market exclusivity provisions under the FFDCA can delay the submission or the approval of Section 505(b)(2) NDAs, thereby delaying a Section 505(b)(2) product from entering the market.", "sentB": "Market exclusivity provisions under the FDCA can delay the submission or the approval of Section 505(b)(2) NDAs, thereby delaying a Section 505(b)(2) product from entering the market.", "type": 2, "words": ["<tag1>", "Market", "exclusivity", "provisions", "under", "the", "FFDCA", "can", "delay", "the", "submission", "or", "the", "approval", "of", "Section", "505(b)(2)", "NDAs,", "thereby", "delaying", "a", "Section", "505(b)(2)", "product", "from", "entering", "the", "market.", "<tag2>", "Market", "exclusivity", "provisions", "under", "the", "FDCA", "can", "delay", "the", "submission", "or", "the", "approval", "of", "Section", "505(b)(2)", "NDAs,", "thereby", "delaying", "a", "Section", "505(b)(2)", "product", "from", "entering", "the", "market.", "<tag3>"], "wordsA": ["Market", "exclusivity", "provisions", "under", "the", "FFDCA", "can", "delay", "the", "submission", "or", "the", "approval", "of", "Section", "505(b)(2)", "NDAs,", "thereby", "delaying", "a", "Section", "505(b)(2)", "product", "from", "entering", "the", "market."], "wordsB": ["Market", "exclusivity", "provisions", "under", "the", "FDCA", "can", "delay", "the", "submission", "or", "the", "approval", "of", "Section", "505(b)(2)", "NDAs,", "thereby", "delaying", "a", "Section", "505(b)(2)", "product", "from", "entering", "the", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p173_s0", "idA": "1430306_12_item1_p171_s0", "sentA": "The FFDCA provides five-year marketing exclusivity to the first applicant to gain approval of an NDA for a new chemical entity, or NCE, meaning that the FDA has not previously approved any other drug containing the same active moiety.", "sentB": "The FDCA provides five-year marketing exclusivity to the first applicant to gain approval of an NDA for a new chemical entity, or NCE, meaning that the FDA has not previously approved any other drug containing the same active moiety.", "type": 2, "words": ["<tag1>", "The", "FFDCA", "provides", "five-year", "marketing", "exclusivity", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "a", "new", "chemical", "entity,", "or", "NCE,", "meaning", "that", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "drug", "containing", "the", "same", "active", "moiety.", "<tag2>", "The", "FDCA", "provides", "five-year", "marketing", "exclusivity", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "a", "new", "chemical", "entity,", "or", "NCE,", "meaning", "that", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "drug", "containing", "the", "same", "active", "moiety.", "<tag3>"], "wordsA": ["The", "FFDCA", "provides", "five-year", "marketing", "exclusivity", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "a", "new", "chemical", "entity,", "or", "NCE,", "meaning", "that", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "drug", "containing", "the", "same", "active", "moiety."], "wordsB": ["The", "FDCA", "provides", "five-year", "marketing", "exclusivity", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "a", "new", "chemical", "entity,", "or", "NCE,", "meaning", "that", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "drug", "containing", "the", "same", "active", "moiety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p21_s0", "idA": "1430306_12_item1_p171_s1", "sentA": "This exclusivity prohibits the submission of a Section 505(b)(2) NDA for any drug product containing the active ingredient during the five-year exclusivity period.", "sentB": "While some new applications can use the commercially-available form of a given drug, in other cases, reformulating the active ingredient may improve the active ingredient s safety or effectiveness in treating the condition.", "type": 2, "words": ["<tag1>", "This", "exclusivity", "prohibits", "the", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "any", "drug", "product", "containing", "the", "active", "ingredient", "during", "the", "five-year", "exclusivity", "period.", "<tag2>", "While", "some", "new", "applications", "can", "use", "the", "commercially-available", "form", "of", "a", "given", "drug,", "in", "other", "cases,", "reformulating", "the", "active", "ingredient", "may", "improve", "the", "active", "ingredient", "s", "safety", "or", "effectiveness", "in", "treating", "the", "condition.", "<tag3>"], "wordsA": ["This", "exclusivity", "prohibits", "the", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "any", "drug", "product", "containing", "the", "active", "ingredient", "during", "the", "five-year", "exclusivity", "period."], "wordsB": ["While", "some", "new", "applications", "can", "use", "the", "commercially-available", "form", "of", "a", "given", "drug,", "in", "other", "cases,", "reformulating", "the", "active", "ingredient", "may", "improve", "the", "active", "ingredient", "s", "safety", "or", "effectiveness", "in", "treating", "the", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p80_s4", "idA": "1430306_12_item1_p171_s1", "sentA": "This exclusivity prohibits the submission of a Section 505(b)(2) NDA for any drug product containing the active ingredient during the five-year exclusivity period.", "sentB": "We expect the data from this study to serve as a bridge , in that they will allow us to use the CBP IR tablet as the reference product in our submission of a Section 505(b)(2) NDA for TNX-102 SL.", "type": 2, "words": ["<tag1>", "This", "exclusivity", "prohibits", "the", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "any", "drug", "product", "containing", "the", "active", "ingredient", "during", "the", "five-year", "exclusivity", "period.", "<tag2>", "We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", ",", "in", "that", "they", "will", "allow", "us", "to", "use", "the", "CBP", "IR", "tablet", "as", "the", "reference", "product", "in", "our", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "TNX-102", "SL.", "<tag3>"], "wordsA": ["This", "exclusivity", "prohibits", "the", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "any", "drug", "product", "containing", "the", "active", "ingredient", "during", "the", "five-year", "exclusivity", "period."], "wordsB": ["We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", ",", "in", "that", "they", "will", "allow", "us", "to", "use", "the", "CBP", "IR", "tablet", "as", "the", "reference", "product", "in", "our", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p173_s3", "idA": "1430306_12_item1_p171_s3", "sentA": "The FFDCA also provides three years of marketing exclusivity for the approval of new and supplemental NDAs for product changes, including, among other things, new indications, dosage forms, routes of administration or strengths of an existing drug, or for a new use, if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by FDA to be essential to the approval of the application.", "sentB": "The FDCA also provides three years of marketing exclusivity for the approval of new and supplemental NDAs for product changes, including, among other things, new indications, dosage forms, routes of administration or strengths of an existing drug, or for a new use, if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by FDA to be essential to the approval of the application.", "type": 2, "words": ["<tag1>", "The", "FFDCA", "also", "provides", "three", "years", "of", "marketing", "exclusivity", "for", "the", "approval", "of", "new", "and", "supplemental", "NDAs", "for", "product", "changes,", "including,", "among", "other", "things,", "new", "indications,", "dosage", "forms,", "routes", "of", "administration", "or", "strengths", "of", "an", "existing", "drug,", "or", "for", "a", "new", "use,", "if", "new", "clinical", "investigations,", "other", "than", "bioavailability", "studies,", "that", "were", "conducted", "or", "sponsored", "by", "the", "applicant", "are", "deemed", "by", "FDA", "to", "be", "essential", "to", "the", "approval", "of", "the", "application.", "<tag2>", "The", "FDCA", "also", "provides", "three", "years", "of", "marketing", "exclusivity", "for", "the", "approval", "of", "new", "and", "supplemental", "NDAs", "for", "product", "changes,", "including,", "among", "other", "things,", "new", "indications,", "dosage", "forms,", "routes", "of", "administration", "or", "strengths", "of", "an", "existing", "drug,", "or", "for", "a", "new", "use,", "if", "new", "clinical", "investigations,", "other", "than", "bioavailability", "studies,", "that", "were", "conducted", "or", "sponsored", "by", "the", "applicant", "are", "deemed", "by", "FDA", "to", "be", "essential", "to", "the", "approval", "of", "the", "application.", "<tag3>"], "wordsA": ["The", "FFDCA", "also", "provides", "three", "years", "of", "marketing", "exclusivity", "for", "the", "approval", "of", "new", "and", "supplemental", "NDAs", "for", "product", "changes,", "including,", "among", "other", "things,", "new", "indications,", "dosage", "forms,", "routes", "of", "administration", "or", "strengths", "of", "an", "existing", "drug,", "or", "for", "a", "new", "use,", "if", "new", "clinical", "investigations,", "other", "than", "bioavailability", "studies,", "that", "were", "conducted", "or", "sponsored", "by", "the", "applicant", "are", "deemed", "by", "FDA", "to", "be", "essential", "to", "the", "approval", "of", "the", "application."], "wordsB": ["The", "FDCA", "also", "provides", "three", "years", "of", "marketing", "exclusivity", "for", "the", "approval", "of", "new", "and", "supplemental", "NDAs", "for", "product", "changes,", "including,", "among", "other", "things,", "new", "indications,", "dosage", "forms,", "routes", "of", "administration", "or", "strengths", "of", "an", "existing", "drug,", "or", "for", "a", "new", "use,", "if", "new", "clinical", "investigations,", "other", "than", "bioavailability", "studies,", "that", "were", "conducted", "or", "sponsored", "by", "the", "applicant", "are", "deemed", "by", "FDA", "to", "be", "essential", "to", "the", "approval", "of", "the", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p28_s2", "idA": "1430306_12_item1_p174_s1", "sentA": "They also are entitled to the patent protections described above, based on patents that are listed in the FDA s Orange Book in the same manner as patents claiming drugs and uses approved for NDAs submitted as full NDAs.", "sentB": "In addition to CBP, TNX-102 SL contains excipients, which are well-characterized, are listed in the Inactive Ingredient Guide and are approved for pharmaceutical use.", "type": 2, "words": ["<tag1>", "They", "also", "are", "entitled", "to", "the", "patent", "protections", "described", "above,", "based", "on", "patents", "that", "are", "listed", "in", "the", "FDA", "s", "Orange", "Book", "in", "the", "same", "manner", "as", "patents", "claiming", "drugs", "and", "uses", "approved", "for", "NDAs", "submitted", "as", "full", "NDAs.", "<tag2>", "In", "addition", "to", "CBP,", "TNX-102", "SL", "contains", "excipients,", "which", "are", "well-characterized,", "are", "listed", "in", "the", "Inactive", "Ingredient", "Guide", "and", "are", "approved", "for", "pharmaceutical", "use.", "<tag3>"], "wordsA": ["They", "also", "are", "entitled", "to", "the", "patent", "protections", "described", "above,", "based", "on", "patents", "that", "are", "listed", "in", "the", "FDA", "s", "Orange", "Book", "in", "the", "same", "manner", "as", "patents", "claiming", "drugs", "and", "uses", "approved", "for", "NDAs", "submitted", "as", "full", "NDAs."], "wordsB": ["In", "addition", "to", "CBP,", "TNX-102", "SL", "contains", "excipients,", "which", "are", "well-characterized,", "are", "listed", "in", "the", "Inactive", "Ingredient", "Guide", "and", "are", "approved", "for", "pharmaceutical", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p19_s2", "idA": "1430306_12_item1_p17_s0", "sentA": "Lederman Co predominantly provides us with clinical development expertise.", "sentB": "The ongoing evolution in the understanding of certain CNS disorders provides us with opportunities to develop such agents as proprietary products for new indications.", "type": 2, "words": ["<tag1>", "Lederman", "Co", "predominantly", "provides", "us", "with", "clinical", "development", "expertise.", "<tag2>", "The", "ongoing", "evolution", "in", "the", "understanding", "of", "certain", "CNS", "disorders", "provides", "us", "with", "opportunities", "to", "develop", "such", "agents", "as", "proprietary", "products", "for", "new", "indications.", "<tag3>"], "wordsA": ["Lederman", "Co", "predominantly", "provides", "us", "with", "clinical", "development", "expertise."], "wordsB": ["The", "ongoing", "evolution", "in", "the", "understanding", "of", "certain", "CNS", "disorders", "provides", "us", "with", "opportunities", "to", "develop", "such", "agents", "as", "proprietary", "products", "for", "new", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p16_s1", "idA": "1430306_12_item1_p17_s1", "sentA": "L L predominantly provides us with scientific development expertise.", "sentB": "L L predominantly provided us with scientific development expertise until the termination of the consulting agreement in June 2012.", "type": 2, "words": ["<tag1>", "L", "L", "predominantly", "provides", "us", "with", "scientific", "development", "expertise.", "<tag2>", "L", "L", "predominantly", "provided", "us", "with", "scientific", "development", "expertise", "until", "the", "termination", "of", "the", "consulting", "agreement", "in", "June", "2012.", "<tag3>"], "wordsA": ["L", "L", "predominantly", "provides", "us", "with", "scientific", "development", "expertise."], "wordsB": ["L", "L", "predominantly", "provided", "us", "with", "scientific", "development", "expertise", "until", "the", "termination", "of", "the", "consulting", "agreement", "in", "June", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p17_s1", "idA": "1430306_12_item1_p17_s3", "sentA": "For example, we have contracted with PharmaNet Canada, Inc., or PharmaNet Canada, to develop methods for analyzing cyclobenzaprine in the blood and to conduct a human clinical study to evaluate the performance of our formulation technology.", "sentB": "For example, we have contracted with PharmaNet Canada to develop methods for analyzing CBP in the blood and to conduct human clinical studies to evaluate the performance of our formulation technology.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "have", "contracted", "with", "PharmaNet", "Canada,", "Inc.,", "or", "PharmaNet", "Canada,", "to", "develop", "methods", "for", "analyzing", "cyclobenzaprine", "in", "the", "blood", "and", "to", "conduct", "a", "human", "clinical", "study", "to", "evaluate", "the", "performance", "of", "our", "formulation", "technology.", "<tag2>", "For", "example,", "we", "have", "contracted", "with", "PharmaNet", "Canada", "to", "develop", "methods", "for", "analyzing", "CBP", "in", "the", "blood", "and", "to", "conduct", "human", "clinical", "studies", "to", "evaluate", "the", "performance", "of", "our", "formulation", "technology.", "<tag3>"], "wordsA": ["For", "example,", "we", "have", "contracted", "with", "PharmaNet", "Canada,", "Inc.,", "or", "PharmaNet", "Canada,", "to", "develop", "methods", "for", "analyzing", "cyclobenzaprine", "in", "the", "blood", "and", "to", "conduct", "a", "human", "clinical", "study", "to", "evaluate", "the", "performance", "of", "our", "formulation", "technology."], "wordsB": ["For", "example,", "we", "have", "contracted", "with", "PharmaNet", "Canada", "to", "develop", "methods", "for", "analyzing", "CBP", "in", "the", "blood", "and", "to", "conduct", "human", "clinical", "studies", "to", "evaluate", "the", "performance", "of", "our", "formulation", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p88_s2", "idA": "1430306_12_item1_p17_s3", "sentA": "For example, we have contracted with PharmaNet Canada, Inc., or PharmaNet Canada, to develop methods for analyzing cyclobenzaprine in the blood and to conduct a human clinical study to evaluate the performance of our formulation technology.", "sentB": "For example, we have recently filed patent applications on TNX-102 SL which, if issued, would be expected to provide protection from generic substitution until 2033.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "have", "contracted", "with", "PharmaNet", "Canada,", "Inc.,", "or", "PharmaNet", "Canada,", "to", "develop", "methods", "for", "analyzing", "cyclobenzaprine", "in", "the", "blood", "and", "to", "conduct", "a", "human", "clinical", "study", "to", "evaluate", "the", "performance", "of", "our", "formulation", "technology.", "<tag2>", "For", "example,", "we", "have", "recently", "filed", "patent", "applications", "on", "TNX-102", "SL", "which,", "if", "issued,", "would", "be", "expected", "to", "provide", "protection", "from", "generic", "substitution", "until", "2033.", "<tag3>"], "wordsA": ["For", "example,", "we", "have", "contracted", "with", "PharmaNet", "Canada,", "Inc.,", "or", "PharmaNet", "Canada,", "to", "develop", "methods", "for", "analyzing", "cyclobenzaprine", "in", "the", "blood", "and", "to", "conduct", "a", "human", "clinical", "study", "to", "evaluate", "the", "performance", "of", "our", "formulation", "technology."], "wordsB": ["For", "example,", "we", "have", "recently", "filed", "patent", "applications", "on", "TNX-102", "SL", "which,", "if", "issued,", "would", "be", "expected", "to", "provide", "protection", "from", "generic", "substitution", "until", "2033."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p184_s0", "idA": "1430306_12_item1_p182_s1", "sentA": "We intend to hire two additional full-time employees in the near future a Chief Financial Officer and a senior director of drug development/ controller as well as a part-time senior director of research.", "sentB": "As of March 8, 2013, we had two full-time employees, Leland Gershell, our Chief Financial Officer, and Bruce Daugherty, our Senior Director of Drug Development and Controller, as well as one part-time senior director of research.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "hire", "two", "additional", "full-time", "employees", "in", "the", "near", "future", "a", "Chief", "Financial", "Officer", "and", "a", "senior", "director", "of", "drug", "development/", "controller", "as", "well", "as", "a", "part-time", "senior", "director", "of", "research.", "<tag2>", "As", "of", "March", "8,", "2013,", "we", "had", "two", "full-time", "employees,", "Leland", "Gershell,", "our", "Chief", "Financial", "Officer,", "and", "Bruce", "Daugherty,", "our", "Senior", "Director", "of", "Drug", "Development", "and", "Controller,", "as", "well", "as", "one", "part-time", "senior", "director", "of", "research.", "<tag3>"], "wordsA": ["We", "intend", "to", "hire", "two", "additional", "full-time", "employees", "in", "the", "near", "future", "a", "Chief", "Financial", "Officer", "and", "a", "senior", "director", "of", "drug", "development/", "controller", "as", "well", "as", "a", "part-time", "senior", "director", "of", "research."], "wordsB": ["As", "of", "March", "8,", "2013,", "we", "had", "two", "full-time", "employees,", "Leland", "Gershell,", "our", "Chief", "Financial", "Officer,", "and", "Bruce", "Daugherty,", "our", "Senior", "Director", "of", "Drug", "Development", "and", "Controller,", "as", "well", "as", "one", "part-time", "senior", "director", "of", "research."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p185_s0", "idA": "1430306_12_item1_p183_s0", "sentA": "In addition, we rely on consultants instead of employees for critical activities, including Seth Lederman who serves as our Chief Executive Officer and as President of Tonix Sub pursuant to a consulting agreement with Lederman Co., and Seth Lederman and Donald Landry who provide scientific consulting pursuant to a consulting agreement with L L Technologies, LLC.", "sentB": "In addition, we rely on consultants instead of employees for critical activities, including Seth Lederman who serves as our Chief Executive Officer and as President of Tonix Sub pursuant to a consulting agreement with Lederman Co.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "rely", "on", "consultants", "instead", "of", "employees", "for", "critical", "activities,", "including", "Seth", "Lederman", "who", "serves", "as", "our", "Chief", "Executive", "Officer", "and", "as", "President", "of", "Tonix", "Sub", "pursuant", "to", "a", "consulting", "agreement", "with", "Lederman", "Co.,", "and", "Seth", "Lederman", "and", "Donald", "Landry", "who", "provide", "scientific", "consulting", "pursuant", "to", "a", "consulting", "agreement", "with", "L", "L", "Technologies,", "LLC.", "<tag2>", "In", "addition,", "we", "rely", "on", "consultants", "instead", "of", "employees", "for", "critical", "activities,", "including", "Seth", "Lederman", "who", "serves", "as", "our", "Chief", "Executive", "Officer", "and", "as", "President", "of", "Tonix", "Sub", "pursuant", "to", "a", "consulting", "agreement", "with", "Lederman", "Co.", "<tag3>"], "wordsA": ["In", "addition,", "we", "rely", "on", "consultants", "instead", "of", "employees", "for", "critical", "activities,", "including", "Seth", "Lederman", "who", "serves", "as", "our", "Chief", "Executive", "Officer", "and", "as", "President", "of", "Tonix", "Sub", "pursuant", "to", "a", "consulting", "agreement", "with", "Lederman", "Co.,", "and", "Seth", "Lederman", "and", "Donald", "Landry", "who", "provide", "scientific", "consulting", "pursuant", "to", "a", "consulting", "agreement", "with", "L", "L", "Technologies,", "LLC."], "wordsB": ["In", "addition,", "we", "rely", "on", "consultants", "instead", "of", "employees", "for", "critical", "activities,", "including", "Seth", "Lederman", "who", "serves", "as", "our", "Chief", "Executive", "Officer", "and", "as", "President", "of", "Tonix", "Sub", "pursuant", "to", "a", "consulting", "agreement", "with", "Lederman", "Co."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p11_s0", "idA": "1430306_12_item1_p18_s1", "sentA": "In August 2010, Tonix Sub formed Krele.", "sentB": "Tonix Sub formed in June 2007 as Krele Pharmaceuticals, Inc. by L L and Plumbline LLC, or Plumbline.", "type": 2, "words": ["<tag1>", "In", "August", "2010,", "Tonix", "Sub", "formed", "Krele.", "<tag2>", "Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline", "LLC,", "or", "Plumbline.", "<tag3>"], "wordsA": ["In", "August", "2010,", "Tonix", "Sub", "formed", "Krele."], "wordsB": ["Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline", "LLC,", "or", "Plumbline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p19_s0", "idA": "1430306_12_item1_p19_s0", "sentA": "We are a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions that may be safer and more effective than currently available treatments.", "sentB": "We are a specialty pharmaceutical company focused on developing novel pharmaceutical products for challenging disorders of the CNS.", "type": 2, "words": ["<tag1>", "We", "are", "a", "specialty", "pharmaceutical", "company", "focused", "on", "developing", "new", "pharmaceutical", "products", "for", "CNS", "conditions", "that", "may", "be", "safer", "and", "more", "effective", "than", "currently", "available", "treatments.", "<tag2>", "We", "are", "a", "specialty", "pharmaceutical", "company", "focused", "on", "developing", "novel", "pharmaceutical", "products", "for", "challenging", "disorders", "of", "the", "CNS.", "<tag3>"], "wordsA": ["We", "are", "a", "specialty", "pharmaceutical", "company", "focused", "on", "developing", "new", "pharmaceutical", "products", "for", "CNS", "conditions", "that", "may", "be", "safer", "and", "more", "effective", "than", "currently", "available", "treatments."], "wordsB": ["We", "are", "a", "specialty", "pharmaceutical", "company", "focused", "on", "developing", "novel", "pharmaceutical", "products", "for", "challenging", "disorders", "of", "the", "CNS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p19_s1", "idA": "1430306_12_item1_p19_s1", "sentA": "We use ongoing advances in science and medicine to search for potential therapeutic solutions among already existing prescription pharmaceutical agents that have been successfully used in patients for other conditions.", "sentB": "We search for potential therapeutic solutions among known pharmaceutical agents that lack regulatory approval for the indications we seek, but may be approved for use in other indications.", "type": 2, "words": ["<tag1>", "We", "use", "ongoing", "advances", "in", "science", "and", "medicine", "to", "search", "for", "potential", "therapeutic", "solutions", "among", "already", "existing", "prescription", "pharmaceutical", "agents", "that", "have", "been", "successfully", "used", "in", "patients", "for", "other", "conditions.", "<tag2>", "We", "search", "for", "potential", "therapeutic", "solutions", "among", "known", "pharmaceutical", "agents", "that", "lack", "regulatory", "approval", "for", "the", "indications", "we", "seek,", "but", "may", "be", "approved", "for", "use", "in", "other", "indications.", "<tag3>"], "wordsA": ["We", "use", "ongoing", "advances", "in", "science", "and", "medicine", "to", "search", "for", "potential", "therapeutic", "solutions", "among", "already", "existing", "prescription", "pharmaceutical", "agents", "that", "have", "been", "successfully", "used", "in", "patients", "for", "other", "conditions."], "wordsB": ["We", "search", "for", "potential", "therapeutic", "solutions", "among", "known", "pharmaceutical", "agents", "that", "lack", "regulatory", "approval", "for", "the", "indications", "we", "seek,", "but", "may", "be", "approved", "for", "use", "in", "other", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p19_s3", "idA": "1430306_12_item1_p19_s2", "sentA": "We create new dose formulations for these agents with the intent to developing products that are optimized for the new therapeutic uses or indications that we target.", "sentB": "We typically seek to create new dose and formulation options that are tailored to the therapeutic uses to which we apply these agents.", "type": 2, "words": ["<tag1>", "We", "create", "new", "dose", "formulations", "for", "these", "agents", "with", "the", "intent", "to", "developing", "products", "that", "are", "optimized", "for", "the", "new", "therapeutic", "uses", "or", "indications", "that", "we", "target.", "<tag2>", "We", "typically", "seek", "to", "create", "new", "dose", "and", "formulation", "options", "that", "are", "tailored", "to", "the", "therapeutic", "uses", "to", "which", "we", "apply", "these", "agents.", "<tag3>"], "wordsA": ["We", "create", "new", "dose", "formulations", "for", "these", "agents", "with", "the", "intent", "to", "developing", "products", "that", "are", "optimized", "for", "the", "new", "therapeutic", "uses", "or", "indications", "that", "we", "target."], "wordsB": ["We", "typically", "seek", "to", "create", "new", "dose", "and", "formulation", "options", "that", "are", "tailored", "to", "the", "therapeutic", "uses", "to", "which", "we", "apply", "these", "agents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p107_s3", "idA": "1430306_12_item1_p19_s3", "sentA": "Our projects are in the development phase, and we currently do not market any products.", "sentB": "We currently do not plan to exercise the option with Lipocine.", "type": 2, "words": ["<tag1>", "Our", "projects", "are", "in", "the", "development", "phase,", "and", "we", "currently", "do", "not", "market", "any", "products.", "<tag2>", "We", "currently", "do", "not", "plan", "to", "exercise", "the", "option", "with", "Lipocine.", "<tag3>"], "wordsA": ["Our", "projects", "are", "in", "the", "development", "phase,", "and", "we", "currently", "do", "not", "market", "any", "products."], "wordsB": ["We", "currently", "do", "not", "plan", "to", "exercise", "the", "option", "with", "Lipocine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p37_s0", "idA": "1430306_12_item1_p20_s0", "sentA": "The process of taking a new drug formulation from concept through testing to approval for a new indication by the U.S. Food and Drug Administration ( FDA ) is a time-consuming, costly and high-risk process.", "sentB": "The process to bring a new drug formulation from concept through testing to approval for a new indication by the FDA is a time-consuming, costly and high-risk process.", "type": 2, "words": ["<tag1>", "The", "process", "of", "taking", "a", "new", "drug", "formulation", "from", "concept", "through", "testing", "to", "approval", "for", "a", "new", "indication", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(", "FDA", ")", "is", "a", "time-consuming,", "costly", "and", "high-risk", "process.", "<tag2>", "The", "process", "to", "bring", "a", "new", "drug", "formulation", "from", "concept", "through", "testing", "to", "approval", "for", "a", "new", "indication", "by", "the", "FDA", "is", "a", "time-consuming,", "costly", "and", "high-risk", "process.", "<tag3>"], "wordsA": ["The", "process", "of", "taking", "a", "new", "drug", "formulation", "from", "concept", "through", "testing", "to", "approval", "for", "a", "new", "indication", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(", "FDA", ")", "is", "a", "time-consuming,", "costly", "and", "high-risk", "process."], "wordsB": ["The", "process", "to", "bring", "a", "new", "drug", "formulation", "from", "concept", "through", "testing", "to", "approval", "for", "a", "new", "indication", "by", "the", "FDA", "is", "a", "time-consuming,", "costly", "and", "high-risk", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p38_s1", "idA": "1430306_12_item1_p21_s1", "sentA": "Neither laboratory nor animal studies predict the properties of drugs in humans, so designing new formulations can result in a large number of unpredictable outcomes.", "sentB": "Neither laboratory nor animal studies predict the properties of drugs in humans, so designing new formulations can result in a large number of unexpected outcomes.", "type": 2, "words": ["<tag1>", "Neither", "laboratory", "nor", "animal", "studies", "predict", "the", "properties", "of", "drugs", "in", "humans,", "so", "designing", "new", "formulations", "can", "result", "in", "a", "large", "number", "of", "unpredictable", "outcomes.", "<tag2>", "Neither", "laboratory", "nor", "animal", "studies", "predict", "the", "properties", "of", "drugs", "in", "humans,", "so", "designing", "new", "formulations", "can", "result", "in", "a", "large", "number", "of", "unexpected", "outcomes.", "<tag3>"], "wordsA": ["Neither", "laboratory", "nor", "animal", "studies", "predict", "the", "properties", "of", "drugs", "in", "humans,", "so", "designing", "new", "formulations", "can", "result", "in", "a", "large", "number", "of", "unpredictable", "outcomes."], "wordsB": ["Neither", "laboratory", "nor", "animal", "studies", "predict", "the", "properties", "of", "drugs", "in", "humans,", "so", "designing", "new", "formulations", "can", "result", "in", "a", "large", "number", "of", "unexpected", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p39_s0", "idA": "1430306_12_item1_p22_s0", "sentA": "The first set of clinical trials, which are sometimes referred to as Phase 1 studies, are performed by administering new drug formulations to a limited number of healthy human volunteers and are designed to test the initial concept of the drug formulation and to determine the correct dosage to be tested subsequently on patients affected with the target disorder.", "sentB": "The Phase 1 studies are performed by administering new drug formulations to a limited number of healthy human volunteers and are designed to test the initial concept of the drug formulation and to determine the correct dosage to be tested subsequently on patients affected with the target disorder.", "type": 2, "words": ["<tag1>", "The", "first", "set", "of", "clinical", "trials,", "which", "are", "sometimes", "referred", "to", "as", "Phase", "1", "studies,", "are", "performed", "by", "administering", "new", "drug", "formulations", "to", "a", "limited", "number", "of", "healthy", "human", "volunteers", "and", "are", "designed", "to", "test", "the", "initial", "concept", "of", "the", "drug", "formulation", "and", "to", "determine", "the", "correct", "dosage", "to", "be", "tested", "subsequently", "on", "patients", "affected", "with", "the", "target", "disorder.", "<tag2>", "The", "Phase", "1", "studies", "are", "performed", "by", "administering", "new", "drug", "formulations", "to", "a", "limited", "number", "of", "healthy", "human", "volunteers", "and", "are", "designed", "to", "test", "the", "initial", "concept", "of", "the", "drug", "formulation", "and", "to", "determine", "the", "correct", "dosage", "to", "be", "tested", "subsequently", "on", "patients", "affected", "with", "the", "target", "disorder.", "<tag3>"], "wordsA": ["The", "first", "set", "of", "clinical", "trials,", "which", "are", "sometimes", "referred", "to", "as", "Phase", "1", "studies,", "are", "performed", "by", "administering", "new", "drug", "formulations", "to", "a", "limited", "number", "of", "healthy", "human", "volunteers", "and", "are", "designed", "to", "test", "the", "initial", "concept", "of", "the", "drug", "formulation", "and", "to", "determine", "the", "correct", "dosage", "to", "be", "tested", "subsequently", "on", "patients", "affected", "with", "the", "target", "disorder."], "wordsB": ["The", "Phase", "1", "studies", "are", "performed", "by", "administering", "new", "drug", "formulations", "to", "a", "limited", "number", "of", "healthy", "human", "volunteers", "and", "are", "designed", "to", "test", "the", "initial", "concept", "of", "the", "drug", "formulation", "and", "to", "determine", "the", "correct", "dosage", "to", "be", "tested", "subsequently", "on", "patients", "affected", "with", "the", "target", "disorder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p39_s1", "idA": "1430306_12_item1_p22_s1", "sentA": "The initial Phase 1 studies can take up to a year to complete, however, since we reformulate versions of approved drugs for new uses, we may need to devote less time to Phase I studies since our testing is informed by significant prior human research that we believe allows us to reduce the possible outcomes.", "sentB": "The initial Phase 1 studies can take up to a year or more to complete, however, since we reformulate versions of approved drugs for new uses, we may need to devote less time to Phase 1 studies since our testing is informed by significant prior human research that we believe allows us to reduce the possible safety-related outcomes.", "type": 2, "words": ["<tag1>", "The", "initial", "Phase", "1", "studies", "can", "take", "up", "to", "a", "year", "to", "complete,", "however,", "since", "we", "reformulate", "versions", "of", "approved", "drugs", "for", "new", "uses,", "we", "may", "need", "to", "devote", "less", "time", "to", "Phase", "I", "studies", "since", "our", "testing", "is", "informed", "by", "significant", "prior", "human", "research", "that", "we", "believe", "allows", "us", "to", "reduce", "the", "possible", "outcomes.", "<tag2>", "The", "initial", "Phase", "1", "studies", "can", "take", "up", "to", "a", "year", "or", "more", "to", "complete,", "however,", "since", "we", "reformulate", "versions", "of", "approved", "drugs", "for", "new", "uses,", "we", "may", "need", "to", "devote", "less", "time", "to", "Phase", "1", "studies", "since", "our", "testing", "is", "informed", "by", "significant", "prior", "human", "research", "that", "we", "believe", "allows", "us", "to", "reduce", "the", "possible", "safety-related", "outcomes.", "<tag3>"], "wordsA": ["The", "initial", "Phase", "1", "studies", "can", "take", "up", "to", "a", "year", "to", "complete,", "however,", "since", "we", "reformulate", "versions", "of", "approved", "drugs", "for", "new", "uses,", "we", "may", "need", "to", "devote", "less", "time", "to", "Phase", "I", "studies", "since", "our", "testing", "is", "informed", "by", "significant", "prior", "human", "research", "that", "we", "believe", "allows", "us", "to", "reduce", "the", "possible", "outcomes."], "wordsB": ["The", "initial", "Phase", "1", "studies", "can", "take", "up", "to", "a", "year", "or", "more", "to", "complete,", "however,", "since", "we", "reformulate", "versions", "of", "approved", "drugs", "for", "new", "uses,", "we", "may", "need", "to", "devote", "less", "time", "to", "Phase", "1", "studies", "since", "our", "testing", "is", "informed", "by", "significant", "prior", "human", "research", "that", "we", "believe", "allows", "us", "to", "reduce", "the", "possible", "safety-related", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p40_s0", "idA": "1430306_12_item1_p22_s2", "sentA": "The next step in the process is to conduct a larger study in which the new drug formulation is administered to human patients affected with the targeted disorder, which can be referred to as a first pivotal study, a Phase 2b study or a Phase 3 study.", "sentB": "The next step in the process is to conduct a proof-of-concept efficacy study to identify the effective dose(s).", "type": 2, "words": ["<tag1>", "The", "next", "step", "in", "the", "process", "is", "to", "conduct", "a", "larger", "study", "in", "which", "the", "new", "drug", "formulation", "is", "administered", "to", "human", "patients", "affected", "with", "the", "targeted", "disorder,", "which", "can", "be", "referred", "to", "as", "a", "first", "pivotal", "study,", "a", "Phase", "2b", "study", "or", "a", "Phase", "3", "study.", "<tag2>", "The", "next", "step", "in", "the", "process", "is", "to", "conduct", "a", "proof-of-concept", "efficacy", "study", "to", "identify", "the", "effective", "dose(s).", "<tag3>"], "wordsA": ["The", "next", "step", "in", "the", "process", "is", "to", "conduct", "a", "larger", "study", "in", "which", "the", "new", "drug", "formulation", "is", "administered", "to", "human", "patients", "affected", "with", "the", "targeted", "disorder,", "which", "can", "be", "referred", "to", "as", "a", "first", "pivotal", "study,", "a", "Phase", "2b", "study", "or", "a", "Phase", "3", "study."], "wordsB": ["The", "next", "step", "in", "the", "process", "is", "to", "conduct", "a", "proof-of-concept", "efficacy", "study", "to", "identify", "the", "effective", "dose(s)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p40_s2", "idA": "1430306_12_item1_p22_s2", "sentA": "The next step in the process is to conduct a larger study in which the new drug formulation is administered to human patients affected with the targeted disorder, which can be referred to as a first pivotal study, a Phase 2b study or a Phase 3 study.", "sentB": "A larger study in which the selected formulation has been optimized for the target indication can be referred to as a first pivotal study, a Phase 2b study or a Phase 3 study.", "type": 2, "words": ["<tag1>", "The", "next", "step", "in", "the", "process", "is", "to", "conduct", "a", "larger", "study", "in", "which", "the", "new", "drug", "formulation", "is", "administered", "to", "human", "patients", "affected", "with", "the", "targeted", "disorder,", "which", "can", "be", "referred", "to", "as", "a", "first", "pivotal", "study,", "a", "Phase", "2b", "study", "or", "a", "Phase", "3", "study.", "<tag2>", "A", "larger", "study", "in", "which", "the", "selected", "formulation", "has", "been", "optimized", "for", "the", "target", "indication", "can", "be", "referred", "to", "as", "a", "first", "pivotal", "study,", "a", "Phase", "2b", "study", "or", "a", "Phase", "3", "study.", "<tag3>"], "wordsA": ["The", "next", "step", "in", "the", "process", "is", "to", "conduct", "a", "larger", "study", "in", "which", "the", "new", "drug", "formulation", "is", "administered", "to", "human", "patients", "affected", "with", "the", "targeted", "disorder,", "which", "can", "be", "referred", "to", "as", "a", "first", "pivotal", "study,", "a", "Phase", "2b", "study", "or", "a", "Phase", "3", "study."], "wordsB": ["A", "larger", "study", "in", "which", "the", "selected", "formulation", "has", "been", "optimized", "for", "the", "target", "indication", "can", "be", "referred", "to", "as", "a", "first", "pivotal", "study,", "a", "Phase", "2b", "study", "or", "a", "Phase", "3", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p41_s0", "idA": "1430306_12_item1_p23_s0", "sentA": "The first pivotal study for a condition like FM typically takes a year to complete and then several more months to interpret the data.", "sentB": "The first pivotal study for a condition like FM typically takes a year to complete and two to three months for data analysis.", "type": 2, "words": ["<tag1>", "The", "first", "pivotal", "study", "for", "a", "condition", "like", "FM", "typically", "takes", "a", "year", "to", "complete", "and", "then", "several", "more", "months", "to", "interpret", "the", "data.", "<tag2>", "The", "first", "pivotal", "study", "for", "a", "condition", "like", "FM", "typically", "takes", "a", "year", "to", "complete", "and", "two", "to", "three", "months", "for", "data", "analysis.", "<tag3>"], "wordsA": ["The", "first", "pivotal", "study", "for", "a", "condition", "like", "FM", "typically", "takes", "a", "year", "to", "complete", "and", "then", "several", "more", "months", "to", "interpret", "the", "data."], "wordsB": ["The", "first", "pivotal", "study", "for", "a", "condition", "like", "FM", "typically", "takes", "a", "year", "to", "complete", "and", "two", "to", "three", "months", "for", "data", "analysis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p41_s1", "idA": "1430306_12_item1_p23_s1", "sentA": "If the first pivotal study proves the drug is effective and safe, then a second pivotal study is conducted, which can also be referred to as a Phase 3 study.", "sentB": "If the first pivotal study suggests the drug is safe and effective, then a second pivotal confirmatory Phase 3 study is conducted.", "type": 2, "words": ["<tag1>", "If", "the", "first", "pivotal", "study", "proves", "the", "drug", "is", "effective", "and", "safe,", "then", "a", "second", "pivotal", "study", "is", "conducted,", "which", "can", "also", "be", "referred", "to", "as", "a", "Phase", "3", "study.", "<tag2>", "If", "the", "first", "pivotal", "study", "suggests", "the", "drug", "is", "safe", "and", "effective,", "then", "a", "second", "pivotal", "confirmatory", "Phase", "3", "study", "is", "conducted.", "<tag3>"], "wordsA": ["If", "the", "first", "pivotal", "study", "proves", "the", "drug", "is", "effective", "and", "safe,", "then", "a", "second", "pivotal", "study", "is", "conducted,", "which", "can", "also", "be", "referred", "to", "as", "a", "Phase", "3", "study."], "wordsB": ["If", "the", "first", "pivotal", "study", "suggests", "the", "drug", "is", "safe", "and", "effective,", "then", "a", "second", "pivotal", "confirmatory", "Phase", "3", "study", "is", "conducted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p41_s2", "idA": "1430306_12_item1_p23_s2", "sentA": "The second pivotal study for a condition like FM would typically take 18 months to complete.", "sentB": "The second pivotal study in FM typically takes 18 months to complete including data analysis.", "type": 2, "words": ["<tag1>", "The", "second", "pivotal", "study", "for", "a", "condition", "like", "FM", "would", "typically", "take", "18", "months", "to", "complete.", "<tag2>", "The", "second", "pivotal", "study", "in", "FM", "typically", "takes", "18", "months", "to", "complete", "including", "data", "analysis.", "<tag3>"], "wordsA": ["The", "second", "pivotal", "study", "for", "a", "condition", "like", "FM", "would", "typically", "take", "18", "months", "to", "complete."], "wordsB": ["The", "second", "pivotal", "study", "in", "FM", "typically", "takes", "18", "months", "to", "complete", "including", "data", "analysis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p41_s5", "idA": "1430306_12_item1_p23_s5", "sentA": "We believe it would take approximately three months to file the FDA application and another 14 months for FDA approval.", "sentB": "We believe it would take approximately six months to prepare and file the NDA and another 14 months to obtain final FDA approval.", "type": 2, "words": ["<tag1>", "We", "believe", "it", "would", "take", "approximately", "three", "months", "to", "file", "the", "FDA", "application", "and", "another", "14", "months", "for", "FDA", "approval.", "<tag2>", "We", "believe", "it", "would", "take", "approximately", "six", "months", "to", "prepare", "and", "file", "the", "NDA", "and", "another", "14", "months", "to", "obtain", "final", "FDA", "approval.", "<tag3>"], "wordsA": ["We", "believe", "it", "would", "take", "approximately", "three", "months", "to", "file", "the", "FDA", "application", "and", "another", "14", "months", "for", "FDA", "approval."], "wordsB": ["We", "believe", "it", "would", "take", "approximately", "six", "months", "to", "prepare", "and", "file", "the", "NDA", "and", "another", "14", "months", "to", "obtain", "final", "FDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p41_s7", "idA": "1430306_12_item1_p23_s7", "sentA": "Therefore, it typically takes more than five years to bring a new formulation of a drug to market for a new indication, and any delays in the process, such as lack of capital necessary to run clinical trials, unexpected results, adverse effects, or difficulty in recruiting willing subjects for trials, would result in additional time before a drug could be available for sale.", "sentB": "Therefore, it typically takes more than five years to bring a new formulation of an approved drug to market for a different indication, and any delays in the process, such as lack of capital necessary to run clinical trials, unexpected results, adverse effects, or difficulty in recruiting willing subjects for trials, would result in additional time before a drug could be approved for marketing.", "type": 2, "words": ["<tag1>", "Therefore,", "it", "typically", "takes", "more", "than", "five", "years", "to", "bring", "a", "new", "formulation", "of", "a", "drug", "to", "market", "for", "a", "new", "indication,", "and", "any", "delays", "in", "the", "process,", "such", "as", "lack", "of", "capital", "necessary", "to", "run", "clinical", "trials,", "unexpected", "results,", "adverse", "effects,", "or", "difficulty", "in", "recruiting", "willing", "subjects", "for", "trials,", "would", "result", "in", "additional", "time", "before", "a", "drug", "could", "be", "available", "for", "sale.", "<tag2>", "Therefore,", "it", "typically", "takes", "more", "than", "five", "years", "to", "bring", "a", "new", "formulation", "of", "an", "approved", "drug", "to", "market", "for", "a", "different", "indication,", "and", "any", "delays", "in", "the", "process,", "such", "as", "lack", "of", "capital", "necessary", "to", "run", "clinical", "trials,", "unexpected", "results,", "adverse", "effects,", "or", "difficulty", "in", "recruiting", "willing", "subjects", "for", "trials,", "would", "result", "in", "additional", "time", "before", "a", "drug", "could", "be", "approved", "for", "marketing.", "<tag3>"], "wordsA": ["Therefore,", "it", "typically", "takes", "more", "than", "five", "years", "to", "bring", "a", "new", "formulation", "of", "a", "drug", "to", "market", "for", "a", "new", "indication,", "and", "any", "delays", "in", "the", "process,", "such", "as", "lack", "of", "capital", "necessary", "to", "run", "clinical", "trials,", "unexpected", "results,", "adverse", "effects,", "or", "difficulty", "in", "recruiting", "willing", "subjects", "for", "trials,", "would", "result", "in", "additional", "time", "before", "a", "drug", "could", "be", "available", "for", "sale."], "wordsB": ["Therefore,", "it", "typically", "takes", "more", "than", "five", "years", "to", "bring", "a", "new", "formulation", "of", "an", "approved", "drug", "to", "market", "for", "a", "different", "indication,", "and", "any", "delays", "in", "the", "process,", "such", "as", "lack", "of", "capital", "necessary", "to", "run", "clinical", "trials,", "unexpected", "results,", "adverse", "effects,", "or", "difficulty", "in", "recruiting", "willing", "subjects", "for", "trials,", "would", "result", "in", "additional", "time", "before", "a", "drug", "could", "be", "approved", "for", "marketing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p60_s1", "idA": "1430306_12_item1_p24_s0", "sentA": "Our lead product candidate, TNX-102, is a new optimized dosage form of cyclobenzaprine.", "sentB": "Our lead product, TNX-102 SL is a novel sublingual tablet form of VLD CBP that we have tested in pre-clinical and clinical studies.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate,", "TNX-102,", "is", "a", "new", "optimized", "dosage", "form", "of", "cyclobenzaprine.", "<tag2>", "Our", "lead", "product,", "TNX-102", "SL", "is", "a", "novel", "sublingual", "tablet", "form", "of", "VLD", "CBP", "that", "we", "have", "tested", "in", "pre-clinical", "and", "clinical", "studies.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate,", "TNX-102,", "is", "a", "new", "optimized", "dosage", "form", "of", "cyclobenzaprine."], "wordsB": ["Our", "lead", "product,", "TNX-102", "SL", "is", "a", "novel", "sublingual", "tablet", "form", "of", "VLD", "CBP", "that", "we", "have", "tested", "in", "pre-clinical", "and", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p22_s2", "idA": "1430306_12_item1_p24_s1", "sentA": "TNX-102 is being developed for the management of FM.", "sentB": "TNX-102 SL is distinct from these products as it is being developed at a dose level significantly below the lowest marketed doses of Flexeril and Amrix.", "type": 2, "words": ["<tag1>", "TNX-102", "is", "being", "developed", "for", "the", "management", "of", "FM.", "<tag2>", "TNX-102", "SL", "is", "distinct", "from", "these", "products", "as", "it", "is", "being", "developed", "at", "a", "dose", "level", "significantly", "below", "the", "lowest", "marketed", "doses", "of", "Flexeril", "and", "Amrix.", "<tag3>"], "wordsA": ["TNX-102", "is", "being", "developed", "for", "the", "management", "of", "FM."], "wordsB": ["TNX-102", "SL", "is", "distinct", "from", "these", "products", "as", "it", "is", "being", "developed", "at", "a", "dose", "level", "significantly", "below", "the", "lowest", "marketed", "doses", "of", "Flexeril", "and", "Amrix."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p25_s0", "idA": "1430306_12_item1_p24_s1", "sentA": "TNX-102 is being developed for the management of FM.", "sentB": "As a result of these promising results, we are advancing TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "TNX-102", "is", "being", "developed", "for", "the", "management", "of", "FM.", "<tag2>", "As", "a", "result", "of", "these", "promising", "results,", "we", "are", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["TNX-102", "is", "being", "developed", "for", "the", "management", "of", "FM."], "wordsB": ["As", "a", "result", "of", "these", "promising", "results,", "we", "are", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p26_s0", "idA": "1430306_12_item1_p24_s1", "sentA": "TNX-102 is being developed for the management of FM.", "sentB": "We are also advancing TNX-102 SL for the management of PTSD.", "type": 2, "words": ["<tag1>", "TNX-102", "is", "being", "developed", "for", "the", "management", "of", "FM.", "<tag2>", "We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag3>"], "wordsA": ["TNX-102", "is", "being", "developed", "for", "the", "management", "of", "FM."], "wordsB": ["We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p22_s1", "idA": "1430306_12_item1_p26_s0", "sentA": "Cyclobenzaprine is the active pharmaceutical ingredient of two FDA approved and widely prescribed muscle relaxant products: Flexeril , an immediate-release form, marketed by the McNeil Specialty Pharmaceuticals division of Johnson Johnson, and Amrix , a controlled release form marketed by Cephalon.", "sentB": "TNX-102 SL is a novel dose and formulation of CBP, the active pharmaceutical ingredient of two widely prescribed muscle relaxant products, Flexeril and Amrix.", "type": 2, "words": ["<tag1>", "Cyclobenzaprine", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "FDA", "approved", "and", "widely", "prescribed", "muscle", "relaxant", "products:", "Flexeril", ",", "an", "immediate-release", "form,", "marketed", "by", "the", "McNeil", "Specialty", "Pharmaceuticals", "division", "of", "Johnson", "Johnson,", "and", "Amrix", ",", "a", "controlled", "release", "form", "marketed", "by", "Cephalon.", "<tag2>", "TNX-102", "SL", "is", "a", "novel", "dose", "and", "formulation", "of", "CBP,", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "muscle", "relaxant", "products,", "Flexeril", "and", "Amrix.", "<tag3>"], "wordsA": ["Cyclobenzaprine", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "FDA", "approved", "and", "widely", "prescribed", "muscle", "relaxant", "products:", "Flexeril", ",", "an", "immediate-release", "form,", "marketed", "by", "the", "McNeil", "Specialty", "Pharmaceuticals", "division", "of", "Johnson", "Johnson,", "and", "Amrix", ",", "a", "controlled", "release", "form", "marketed", "by", "Cephalon."], "wordsB": ["TNX-102", "SL", "is", "a", "novel", "dose", "and", "formulation", "of", "CBP,", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "muscle", "relaxant", "products,", "Flexeril", "and", "Amrix."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p56_s2", "idA": "1430306_12_item1_p26_s1", "sentA": "Generic copies of Flexeril (cyclobenzaprine in the immediate-release form) are available and many patients receive a generic when their physician prescribes Flexeril.", "sentB": "McNeil has discontinued the manufacture of Flexeril.", "type": 2, "words": ["<tag1>", "Generic", "copies", "of", "Flexeril", "(cyclobenzaprine", "in", "the", "immediate-release", "form)", "are", "available", "and", "many", "patients", "receive", "a", "generic", "when", "their", "physician", "prescribes", "Flexeril.", "<tag2>", "McNeil", "has", "discontinued", "the", "manufacture", "of", "Flexeril.", "<tag3>"], "wordsA": ["Generic", "copies", "of", "Flexeril", "(cyclobenzaprine", "in", "the", "immediate-release", "form)", "are", "available", "and", "many", "patients", "receive", "a", "generic", "when", "their", "physician", "prescribes", "Flexeril."], "wordsB": ["McNeil", "has", "discontinued", "the", "manufacture", "of", "Flexeril."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p106_s3", "idA": "1430306_12_item1_p27_s1", "sentA": "We are working to optimize the dose and formulation of TNX-102 to treat FM safely and effectively.", "sentB": "We are working to analyze the data and write the Final Report, which is anticipated to be completed in 2013.", "type": 2, "words": ["<tag1>", "We", "are", "working", "to", "optimize", "the", "dose", "and", "formulation", "of", "TNX-102", "to", "treat", "FM", "safely", "and", "effectively.", "<tag2>", "We", "are", "working", "to", "analyze", "the", "data", "and", "write", "the", "Final", "Report,", "which", "is", "anticipated", "to", "be", "completed", "in", "2013.", "<tag3>"], "wordsA": ["We", "are", "working", "to", "optimize", "the", "dose", "and", "formulation", "of", "TNX-102", "to", "treat", "FM", "safely", "and", "effectively."], "wordsB": ["We", "are", "working", "to", "analyze", "the", "data", "and", "write", "the", "Final", "Report,", "which", "is", "anticipated", "to", "be", "completed", "in", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p106_s1", "idA": "1430306_12_item1_p27_s3", "sentA": "We have conducted an initial study of TNX-102 and are currently undertaking a comparative pharmacokinetic and bioavailability study, of which the clinical phase was completed by the end of 2011, and the analysis of the subjects blood samples will be completed in the first half of 2012.", "sentB": "The clinical phase of the Stage II trial was completed during the fourth quarter of 2011.", "type": 2, "words": ["<tag1>", "We", "have", "conducted", "an", "initial", "study", "of", "TNX-102", "and", "are", "currently", "undertaking", "a", "comparative", "pharmacokinetic", "and", "bioavailability", "study,", "of", "which", "the", "clinical", "phase", "was", "completed", "by", "the", "end", "of", "2011,", "and", "the", "analysis", "of", "the", "subjects", "blood", "samples", "will", "be", "completed", "in", "the", "first", "half", "of", "2012.", "<tag2>", "The", "clinical", "phase", "of", "the", "Stage", "II", "trial", "was", "completed", "during", "the", "fourth", "quarter", "of", "2011.", "<tag3>"], "wordsA": ["We", "have", "conducted", "an", "initial", "study", "of", "TNX-102", "and", "are", "currently", "undertaking", "a", "comparative", "pharmacokinetic", "and", "bioavailability", "study,", "of", "which", "the", "clinical", "phase", "was", "completed", "by", "the", "end", "of", "2011,", "and", "the", "analysis", "of", "the", "subjects", "blood", "samples", "will", "be", "completed", "in", "the", "first", "half", "of", "2012."], "wordsB": ["The", "clinical", "phase", "of", "the", "Stage", "II", "trial", "was", "completed", "during", "the", "fourth", "quarter", "of", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p22_s6", "idA": "1430306_12_item1_p28_s0", "sentA": "Our other leading product candidate, TNX-105, which we are also developing, is a new dose form of cyclobenzaprine to treat symptoms of post-traumatic stress disorder, or PTSD.", "sentB": "We are also developing TNX-102 SL for the treatment of post-traumatic stress disorder, or PTSD, for which we held a pre-IND meeting with the FDA in October 2012.", "type": 2, "words": ["<tag1>", "Our", "other", "leading", "product", "candidate,", "TNX-105,", "which", "we", "are", "also", "developing,", "is", "a", "new", "dose", "form", "of", "cyclobenzaprine", "to", "treat", "symptoms", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD.", "<tag2>", "We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "for", "which", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012.", "<tag3>"], "wordsA": ["Our", "other", "leading", "product", "candidate,", "TNX-105,", "which", "we", "are", "also", "developing,", "is", "a", "new", "dose", "form", "of", "cyclobenzaprine", "to", "treat", "symptoms", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD."], "wordsB": ["We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "for", "which", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p89_s0", "idA": "1430306_12_item1_p28_s1", "sentA": "PTSD is a psychiatric disorder that begins in the aftermath of traumatic experiences.", "sentB": "We are also developing TNX-102 SL for the management of PTSD, a psychiatric disorder that begins in the aftermath of traumatic experiences.", "type": 2, "words": ["<tag1>", "PTSD", "is", "a", "psychiatric", "disorder", "that", "begins", "in", "the", "aftermath", "of", "traumatic", "experiences.", "<tag2>", "We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD,", "a", "psychiatric", "disorder", "that", "begins", "in", "the", "aftermath", "of", "traumatic", "experiences.", "<tag3>"], "wordsA": ["PTSD", "is", "a", "psychiatric", "disorder", "that", "begins", "in", "the", "aftermath", "of", "traumatic", "experiences."], "wordsB": ["We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD,", "a", "psychiatric", "disorder", "that", "begins", "in", "the", "aftermath", "of", "traumatic", "experiences."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p27_s0", "idA": "1430306_12_item1_p29_s0", "sentA": "Cyclobenzaprine is the active pharmaceutical ingredient in each of our lead product candidates.", "sentB": "CBP is the active pharmaceutical ingredient in our lead product candidate, TNX-102 SL.", "type": 2, "words": ["<tag1>", "Cyclobenzaprine", "is", "the", "active", "pharmaceutical", "ingredient", "in", "each", "of", "our", "lead", "product", "candidates.", "<tag2>", "CBP", "is", "the", "active", "pharmaceutical", "ingredient", "in", "our", "lead", "product", "candidate,", "TNX-102", "SL.", "<tag3>"], "wordsA": ["Cyclobenzaprine", "is", "the", "active", "pharmaceutical", "ingredient", "in", "each", "of", "our", "lead", "product", "candidates."], "wordsB": ["CBP", "is", "the", "active", "pharmaceutical", "ingredient", "in", "our", "lead", "product", "candidate,", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p28_s1", "idA": "1430306_12_item1_p29_s1", "sentA": "We are utilizing drug delivery technology to produce new formulations.", "sentB": "We have utilized drug delivery technology to produce new formulations of CBP.", "type": 2, "words": ["<tag1>", "We", "are", "utilizing", "drug", "delivery", "technology", "to", "produce", "new", "formulations.", "<tag2>", "We", "have", "utilized", "drug", "delivery", "technology", "to", "produce", "new", "formulations", "of", "CBP.", "<tag3>"], "wordsA": ["We", "are", "utilizing", "drug", "delivery", "technology", "to", "produce", "new", "formulations."], "wordsB": ["We", "have", "utilized", "drug", "delivery", "technology", "to", "produce", "new", "formulations", "of", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p28_s3", "idA": "1430306_12_item1_p29_s3", "sentA": "As a result, we anticipate seeking FDA marketing approval of our lead product candidates, TNX-102 and TNX-105, through the NDA process under Section 505(b)(2) of the U.S. Federal Food, Drug and Cosmetic Act, or the FFDCA, which we also refer to as Section 505(b)(2).", "sentB": "As a result, we anticipate seeking FDA marketing approval of TNX-102 SL through a 505(b)(2) NDA.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "anticipate", "seeking", "FDA", "marketing", "approval", "of", "our", "lead", "product", "candidates,", "TNX-102", "and", "TNX-105,", "through", "the", "NDA", "process", "under", "Section", "505(b)(2)", "of", "the", "U.S.", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act,", "or", "the", "FFDCA,", "which", "we", "also", "refer", "to", "as", "Section", "505(b)(2).", "<tag2>", "As", "a", "result,", "we", "anticipate", "seeking", "FDA", "marketing", "approval", "of", "TNX-102", "SL", "through", "a", "505(b)(2)", "NDA.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "anticipate", "seeking", "FDA", "marketing", "approval", "of", "our", "lead", "product", "candidates,", "TNX-102", "and", "TNX-105,", "through", "the", "NDA", "process", "under", "Section", "505(b)(2)", "of", "the", "U.S.", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act,", "or", "the", "FFDCA,", "which", "we", "also", "refer", "to", "as", "Section", "505(b)(2)."], "wordsB": ["As", "a", "result,", "we", "anticipate", "seeking", "FDA", "marketing", "approval", "of", "TNX-102", "SL", "through", "a", "505(b)(2)", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p28_s5", "idA": "1430306_12_item1_p29_s4", "sentA": "This process permits the FDA to make some safety and effectiveness determinations through review of materials in the public domain or in already approved NDAs of products containing cyclobenzaprine.", "sentB": "As the 505(b)(2) NDA permits the drug manufacturer to rely on the agency s findings for a previously-approved drug, published literature, or both, it permits the FDA to make some safety and effectiveness determinations through the review of materials in the public domain or in already approved NDAs of products containing CBP.", "type": 2, "words": ["<tag1>", "This", "process", "permits", "the", "FDA", "to", "make", "some", "safety", "and", "effectiveness", "determinations", "through", "review", "of", "materials", "in", "the", "public", "domain", "or", "in", "already", "approved", "NDAs", "of", "products", "containing", "cyclobenzaprine.", "<tag2>", "As", "the", "505(b)(2)", "NDA", "permits", "the", "drug", "manufacturer", "to", "rely", "on", "the", "agency", "s", "findings", "for", "a", "previously-approved", "drug,", "published", "literature,", "or", "both,", "it", "permits", "the", "FDA", "to", "make", "some", "safety", "and", "effectiveness", "determinations", "through", "the", "review", "of", "materials", "in", "the", "public", "domain", "or", "in", "already", "approved", "NDAs", "of", "products", "containing", "CBP.", "<tag3>"], "wordsA": ["This", "process", "permits", "the", "FDA", "to", "make", "some", "safety", "and", "effectiveness", "determinations", "through", "review", "of", "materials", "in", "the", "public", "domain", "or", "in", "already", "approved", "NDAs", "of", "products", "containing", "cyclobenzaprine."], "wordsB": ["As", "the", "505(b)(2)", "NDA", "permits", "the", "drug", "manufacturer", "to", "rely", "on", "the", "agency", "s", "findings", "for", "a", "previously-approved", "drug,", "published", "literature,", "or", "both,", "it", "permits", "the", "FDA", "to", "make", "some", "safety", "and", "effectiveness", "determinations", "through", "the", "review", "of", "materials", "in", "the", "public", "domain", "or", "in", "already", "approved", "NDAs", "of", "products", "containing", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p28_s6", "idA": "1430306_12_item1_p29_s5", "sentA": "This approach would spare us some of the burden of generating all of this data for ourselves and may allow our lead product candidates to progress through a shorter development pathway than is typical for pharmaceutical products based on novel active ingredients.", "sentB": "The 505(b)(2) regulatory pathway would spare us some of the burden of generating all of this data for ourselves and may allow TNX-102 SL to progress through a shorter development pathway than is typical for pharmaceutical products based on novel active ingredients.", "type": 2, "words": ["<tag1>", "This", "approach", "would", "spare", "us", "some", "of", "the", "burden", "of", "generating", "all", "of", "this", "data", "for", "ourselves", "and", "may", "allow", "our", "lead", "product", "candidates", "to", "progress", "through", "a", "shorter", "development", "pathway", "than", "is", "typical", "for", "pharmaceutical", "products", "based", "on", "novel", "active", "ingredients.", "<tag2>", "The", "505(b)(2)", "regulatory", "pathway", "would", "spare", "us", "some", "of", "the", "burden", "of", "generating", "all", "of", "this", "data", "for", "ourselves", "and", "may", "allow", "TNX-102", "SL", "to", "progress", "through", "a", "shorter", "development", "pathway", "than", "is", "typical", "for", "pharmaceutical", "products", "based", "on", "novel", "active", "ingredients.", "<tag3>"], "wordsA": ["This", "approach", "would", "spare", "us", "some", "of", "the", "burden", "of", "generating", "all", "of", "this", "data", "for", "ourselves", "and", "may", "allow", "our", "lead", "product", "candidates", "to", "progress", "through", "a", "shorter", "development", "pathway", "than", "is", "typical", "for", "pharmaceutical", "products", "based", "on", "novel", "active", "ingredients."], "wordsB": ["The", "505(b)(2)", "regulatory", "pathway", "would", "spare", "us", "some", "of", "the", "burden", "of", "generating", "all", "of", "this", "data", "for", "ourselves", "and", "may", "allow", "TNX-102", "SL", "to", "progress", "through", "a", "shorter", "development", "pathway", "than", "is", "typical", "for", "pharmaceutical", "products", "based", "on", "novel", "active", "ingredients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p22_s0", "idA": "1430306_12_item1_p29_s6", "sentA": "We have not filed an NDA for either of our lead product candidates.", "sentB": "We are currently devoting the majority of our efforts to the development of our lead product candidate, TNX-102 sublingual tablet, or TNX-102 SL.", "type": 2, "words": ["<tag1>", "We", "have", "not", "filed", "an", "NDA", "for", "either", "of", "our", "lead", "product", "candidates.", "<tag2>", "We", "are", "currently", "devoting", "the", "majority", "of", "our", "efforts", "to", "the", "development", "of", "our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL.", "<tag3>"], "wordsA": ["We", "have", "not", "filed", "an", "NDA", "for", "either", "of", "our", "lead", "product", "candidates."], "wordsB": ["We", "are", "currently", "devoting", "the", "majority", "of", "our", "efforts", "to", "the", "development", "of", "our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p29_s0", "idA": "1430306_12_item1_p29_s6", "sentA": "We have not filed an NDA for either of our lead product candidates.", "sentB": "We have not filed an NDA for TNX-102 SL for any indications.", "type": 2, "words": ["<tag1>", "We", "have", "not", "filed", "an", "NDA", "for", "either", "of", "our", "lead", "product", "candidates.", "<tag2>", "We", "have", "not", "filed", "an", "NDA", "for", "TNX-102", "SL", "for", "any", "indications.", "<tag3>"], "wordsA": ["We", "have", "not", "filed", "an", "NDA", "for", "either", "of", "our", "lead", "product", "candidates."], "wordsB": ["We", "have", "not", "filed", "an", "NDA", "for", "TNX-102", "SL", "for", "any", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p74_s0", "idA": "1430306_12_item1_p29_s6", "sentA": "We have not filed an NDA for either of our lead product candidates.", "sentB": "We have conducted two preclinical and two clinical studies of our sublingual formulations of CBP, which have evaluated the pharmacokinetics of these formulations as well as their bioequivalence to oral CBP.", "type": 2, "words": ["<tag1>", "We", "have", "not", "filed", "an", "NDA", "for", "either", "of", "our", "lead", "product", "candidates.", "<tag2>", "We", "have", "conducted", "two", "preclinical", "and", "two", "clinical", "studies", "of", "our", "sublingual", "formulations", "of", "CBP,", "which", "have", "evaluated", "the", "pharmacokinetics", "of", "these", "formulations", "as", "well", "as", "their", "bioequivalence", "to", "oral", "CBP.", "<tag3>"], "wordsA": ["We", "have", "not", "filed", "an", "NDA", "for", "either", "of", "our", "lead", "product", "candidates."], "wordsB": ["We", "have", "conducted", "two", "preclinical", "and", "two", "clinical", "studies", "of", "our", "sublingual", "formulations", "of", "CBP,", "which", "have", "evaluated", "the", "pharmacokinetics", "of", "these", "formulations", "as", "well", "as", "their", "bioequivalence", "to", "oral", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p31_s0", "idA": "1430306_12_item1_p30_s0", "sentA": "We also have a pipeline of several other product candidates that we are constantly evaluating.", "sentB": "We also have a pipeline of other product candidates, including TNX-201 and TNX-301.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "pipeline", "of", "several", "other", "product", "candidates", "that", "we", "are", "constantly", "evaluating.", "<tag2>", "We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-201", "and", "TNX-301.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "pipeline", "of", "several", "other", "product", "candidates", "that", "we", "are", "constantly", "evaluating."], "wordsB": ["We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-201", "and", "TNX-301."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p32_s0", "idA": "1430306_12_item1_p30_s1", "sentA": "For example, we are developing TNX-201, which is a treatment for certain types of headaches and TNX-301, which is a potential treatment for alcohol dependence and addiction.", "sentB": "TNX-201 is based on isometheptene mucate and is under development as a treatment for certain types of headaches.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "are", "developing", "TNX-201,", "which", "is", "a", "treatment", "for", "certain", "types", "of", "headaches", "and", "TNX-301,", "which", "is", "a", "potential", "treatment", "for", "alcohol", "dependence", "and", "addiction.", "<tag2>", "TNX-201", "is", "based", "on", "isometheptene", "mucate", "and", "is", "under", "development", "as", "a", "treatment", "for", "certain", "types", "of", "headaches.", "<tag3>"], "wordsA": ["For", "example,", "we", "are", "developing", "TNX-201,", "which", "is", "a", "treatment", "for", "certain", "types", "of", "headaches", "and", "TNX-301,", "which", "is", "a", "potential", "treatment", "for", "alcohol", "dependence", "and", "addiction."], "wordsB": ["TNX-201", "is", "based", "on", "isometheptene", "mucate", "and", "is", "under", "development", "as", "a", "treatment", "for", "certain", "types", "of", "headaches."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p48_s8", "idA": "1430306_12_item1_p30_s1", "sentA": "For example, we are developing TNX-201, which is a treatment for certain types of headaches and TNX-301, which is a potential treatment for alcohol dependence and addiction.", "sentB": "For example, we filed a patent application seeking to protect novel pharmacokinetic properties of CBP as enabled by TNX-102 SL.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "are", "developing", "TNX-201,", "which", "is", "a", "treatment", "for", "certain", "types", "of", "headaches", "and", "TNX-301,", "which", "is", "a", "potential", "treatment", "for", "alcohol", "dependence", "and", "addiction.", "<tag2>", "For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "novel", "pharmacokinetic", "properties", "of", "CBP", "as", "enabled", "by", "TNX-102", "SL.", "<tag3>"], "wordsA": ["For", "example,", "we", "are", "developing", "TNX-201,", "which", "is", "a", "treatment", "for", "certain", "types", "of", "headaches", "and", "TNX-301,", "which", "is", "a", "potential", "treatment", "for", "alcohol", "dependence", "and", "addiction."], "wordsB": ["For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "novel", "pharmacokinetic", "properties", "of", "CBP", "as", "enabled", "by", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p33_s0", "idA": "1430306_12_item1_p31_s0", "sentA": "For commercial reasons, we normally do not disclose the identities of the active ingredients or targeted indications of products in our pipeline until a U.S. patent has been allowed.", "sentB": "For competitive reasons, we do not disclose the identities of the active ingredients or targeted indications in our pipeline until a U.S. patent has been allowed or issued.", "type": 2, "words": ["<tag1>", "For", "commercial", "reasons,", "we", "normally", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "of", "products", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed.", "<tag2>", "For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued.", "<tag3>"], "wordsA": ["For", "commercial", "reasons,", "we", "normally", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "of", "products", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed."], "wordsB": ["For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p33_s1", "idA": "1430306_12_item1_p31_s1", "sentA": "Consistent with our mission, these product candidates are, or likely will be, reformulations of active ingredients that have been used by patients in other FDA-approved products.", "sentB": "Consistent with our mission, these product candidates are or likely will be reformulations of active ingredients that have been used in humans in other products and that are designed for new CNS therapeutic indications.", "type": 2, "words": ["<tag1>", "Consistent", "with", "our", "mission,", "these", "product", "candidates", "are,", "or", "likely", "will", "be,", "reformulations", "of", "active", "ingredients", "that", "have", "been", "used", "by", "patients", "in", "other", "FDA-approved", "products.", "<tag2>", "Consistent", "with", "our", "mission,", "these", "product", "candidates", "are", "or", "likely", "will", "be", "reformulations", "of", "active", "ingredients", "that", "have", "been", "used", "in", "humans", "in", "other", "products", "and", "that", "are", "designed", "for", "new", "CNS", "therapeutic", "indications.", "<tag3>"], "wordsA": ["Consistent", "with", "our", "mission,", "these", "product", "candidates", "are,", "or", "likely", "will", "be,", "reformulations", "of", "active", "ingredients", "that", "have", "been", "used", "by", "patients", "in", "other", "FDA-approved", "products."], "wordsB": ["Consistent", "with", "our", "mission,", "these", "product", "candidates", "are", "or", "likely", "will", "be", "reformulations", "of", "active", "ingredients", "that", "have", "been", "used", "in", "humans", "in", "other", "products", "and", "that", "are", "designed", "for", "new", "CNS", "therapeutic", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p34_s0", "idA": "1430306_12_item1_p31_s3", "sentA": "In other cases, we expect that the products will be formulated to match earlier predicate products closely enough to rely, in part, on their regulatory review and status.", "sentB": "In other cases, the products will be formulated to match predicate products closely enough to be considered generic copies or similarly enough to other marketed products to rely (in part) on their regulatory review and approval, as well as available published data.", "type": 2, "words": ["<tag1>", "In", "other", "cases,", "we", "expect", "that", "the", "products", "will", "be", "formulated", "to", "match", "earlier", "predicate", "products", "closely", "enough", "to", "rely,", "in", "part,", "on", "their", "regulatory", "review", "and", "status.", "<tag2>", "In", "other", "cases,", "the", "products", "will", "be", "formulated", "to", "match", "predicate", "products", "closely", "enough", "to", "be", "considered", "generic", "copies", "or", "similarly", "enough", "to", "other", "marketed", "products", "to", "rely", "(in", "part)", "on", "their", "regulatory", "review", "and", "approval,", "as", "well", "as", "available", "published", "data.", "<tag3>"], "wordsA": ["In", "other", "cases,", "we", "expect", "that", "the", "products", "will", "be", "formulated", "to", "match", "earlier", "predicate", "products", "closely", "enough", "to", "rely,", "in", "part,", "on", "their", "regulatory", "review", "and", "status."], "wordsB": ["In", "other", "cases,", "the", "products", "will", "be", "formulated", "to", "match", "predicate", "products", "closely", "enough", "to", "be", "considered", "generic", "copies", "or", "similarly", "enough", "to", "other", "marketed", "products", "to", "rely", "(in", "part)", "on", "their", "regulatory", "review", "and", "approval,", "as", "well", "as", "available", "published", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p35_s0", "idA": "1430306_12_item1_p32_s0", "sentA": "There may be instances where the predicate product is a medicine that was reviewed for safety and effectiveness by the National Academy of Sciences under the Drug Evaluation and Safety Initiative, or DESI, and would be considered by the FDA to be an unapproved product.", "sentB": "The predicate product may be approved by the FDA under an NDA or may have been reviewed for safety and effectiveness by the National Academy of Sciences under the Drug Efficacy Study Implementation, or DESI, program, in which case they would be considered by FDA to be unapproved products .", "type": 2, "words": ["<tag1>", "There", "may", "be", "instances", "where", "the", "predicate", "product", "is", "a", "medicine", "that", "was", "reviewed", "for", "safety", "and", "effectiveness", "by", "the", "National", "Academy", "of", "Sciences", "under", "the", "Drug", "Evaluation", "and", "Safety", "Initiative,", "or", "DESI,", "and", "would", "be", "considered", "by", "the", "FDA", "to", "be", "an", "unapproved", "product.", "<tag2>", "The", "predicate", "product", "may", "be", "approved", "by", "the", "FDA", "under", "an", "NDA", "or", "may", "have", "been", "reviewed", "for", "safety", "and", "effectiveness", "by", "the", "National", "Academy", "of", "Sciences", "under", "the", "Drug", "Efficacy", "Study", "Implementation,", "or", "DESI,", "program,", "in", "which", "case", "they", "would", "be", "considered", "by", "FDA", "to", "be", "unapproved", "products", ".", "<tag3>"], "wordsA": ["There", "may", "be", "instances", "where", "the", "predicate", "product", "is", "a", "medicine", "that", "was", "reviewed", "for", "safety", "and", "effectiveness", "by", "the", "National", "Academy", "of", "Sciences", "under", "the", "Drug", "Evaluation", "and", "Safety", "Initiative,", "or", "DESI,", "and", "would", "be", "considered", "by", "the", "FDA", "to", "be", "an", "unapproved", "product."], "wordsB": ["The", "predicate", "product", "may", "be", "approved", "by", "the", "FDA", "under", "an", "NDA", "or", "may", "have", "been", "reviewed", "for", "safety", "and", "effectiveness", "by", "the", "National", "Academy", "of", "Sciences", "under", "the", "Drug", "Efficacy", "Study", "Implementation,", "or", "DESI,", "program,", "in", "which", "case", "they", "would", "be", "considered", "by", "FDA", "to", "be", "unapproved", "products", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p35_s1", "idA": "1430306_12_item1_p32_s1", "sentA": "For DESI products, it is our intent also to develop NDA versions by modernizing the chemistry, manufacturing and controls and to perform new clinical studies to support an NDA filing under Section 505(b)(2).", "sentB": "For DESI products, it is our intent to develop NDA versions to meet current Good Manufacturing Practices, or cGMP, and the International Conference on Harmonisation, or ICH, requirements to seek approval under the 505(b)(2) regulatory pathway.", "type": 2, "words": ["<tag1>", "For", "DESI", "products,", "it", "is", "our", "intent", "also", "to", "develop", "NDA", "versions", "by", "modernizing", "the", "chemistry,", "manufacturing", "and", "controls", "and", "to", "perform", "new", "clinical", "studies", "to", "support", "an", "NDA", "filing", "under", "Section", "505(b)(2).", "<tag2>", "For", "DESI", "products,", "it", "is", "our", "intent", "to", "develop", "NDA", "versions", "to", "meet", "current", "Good", "Manufacturing", "Practices,", "or", "cGMP,", "and", "the", "International", "Conference", "on", "Harmonisation,", "or", "ICH,", "requirements", "to", "seek", "approval", "under", "the", "505(b)(2)", "regulatory", "pathway.", "<tag3>"], "wordsA": ["For", "DESI", "products,", "it", "is", "our", "intent", "also", "to", "develop", "NDA", "versions", "by", "modernizing", "the", "chemistry,", "manufacturing", "and", "controls", "and", "to", "perform", "new", "clinical", "studies", "to", "support", "an", "NDA", "filing", "under", "Section", "505(b)(2)."], "wordsB": ["For", "DESI", "products,", "it", "is", "our", "intent", "to", "develop", "NDA", "versions", "to", "meet", "current", "Good", "Manufacturing", "Practices,", "or", "cGMP,", "and", "the", "International", "Conference", "on", "Harmonisation,", "or", "ICH,", "requirements", "to", "seek", "approval", "under", "the", "505(b)(2)", "regulatory", "pathway."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p36_s1", "idA": "1430306_12_item1_p33_s1", "sentA": "We anticipate that sometime in 2012 we will begin developing formulations for TNX-201 and possibly TNX-301, but do not expect to start clinical trials until 2013 at the earliest.", "sentB": "We may perform non-clinical development work on TNX-201 and possibly on TNX-301, but we do not expect to start clinical trials of either of these candidates until 2014 at the earliest.", "type": 2, "words": ["<tag1>", "We", "anticipate", "that", "sometime", "in", "2012", "we", "will", "begin", "developing", "formulations", "for", "TNX-201", "and", "possibly", "TNX-301,", "but", "do", "not", "expect", "to", "start", "clinical", "trials", "until", "2013", "at", "the", "earliest.", "<tag2>", "We", "may", "perform", "non-clinical", "development", "work", "on", "TNX-201", "and", "possibly", "on", "TNX-301,", "but", "we", "do", "not", "expect", "to", "start", "clinical", "trials", "of", "either", "of", "these", "candidates", "until", "2014", "at", "the", "earliest.", "<tag3>"], "wordsA": ["We", "anticipate", "that", "sometime", "in", "2012", "we", "will", "begin", "developing", "formulations", "for", "TNX-201", "and", "possibly", "TNX-301,", "but", "do", "not", "expect", "to", "start", "clinical", "trials", "until", "2013", "at", "the", "earliest."], "wordsB": ["We", "may", "perform", "non-clinical", "development", "work", "on", "TNX-201", "and", "possibly", "on", "TNX-301,", "but", "we", "do", "not", "expect", "to", "start", "clinical", "trials", "of", "either", "of", "these", "candidates", "until", "2014", "at", "the", "earliest."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p42_s0", "idA": "1430306_12_item1_p34_s0", "sentA": "Krele s mission is to commercialize products that are generic versions of predicate NDA products or existing marketed products that it may acquire from other pharmaceutical companies.", "sentB": "In August 2010, we formed Krele to commercialize products that are generic versions of predicate NDA products.", "type": 2, "words": ["<tag1>", "Krele", "s", "mission", "is", "to", "commercialize", "products", "that", "are", "generic", "versions", "of", "predicate", "NDA", "products", "or", "existing", "marketed", "products", "that", "it", "may", "acquire", "from", "other", "pharmaceutical", "companies.", "<tag2>", "In", "August", "2010,", "we", "formed", "Krele", "to", "commercialize", "products", "that", "are", "generic", "versions", "of", "predicate", "NDA", "products.", "<tag3>"], "wordsA": ["Krele", "s", "mission", "is", "to", "commercialize", "products", "that", "are", "generic", "versions", "of", "predicate", "NDA", "products", "or", "existing", "marketed", "products", "that", "it", "may", "acquire", "from", "other", "pharmaceutical", "companies."], "wordsB": ["In", "August", "2010,", "we", "formed", "Krele", "to", "commercialize", "products", "that", "are", "generic", "versions", "of", "predicate", "NDA", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p42_s1", "idA": "1430306_12_item1_p34_s2", "sentA": "We anticipate that when one of our branded products loses patent protection, Krele may market generic versions of it.", "sentB": "We anticipate that when our branded products lose patent protection, Krele may market authorized generic versions of them.", "type": 2, "words": ["<tag1>", "We", "anticipate", "that", "when", "one", "of", "our", "branded", "products", "loses", "patent", "protection,", "Krele", "may", "market", "generic", "versions", "of", "it.", "<tag2>", "We", "anticipate", "that", "when", "our", "branded", "products", "lose", "patent", "protection,", "Krele", "may", "market", "authorized", "generic", "versions", "of", "them.", "<tag3>"], "wordsA": ["We", "anticipate", "that", "when", "one", "of", "our", "branded", "products", "loses", "patent", "protection,", "Krele", "may", "market", "generic", "versions", "of", "it."], "wordsB": ["We", "anticipate", "that", "when", "our", "branded", "products", "lose", "patent", "protection,", "Krele", "may", "market", "authorized", "generic", "versions", "of", "them."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p42_s2", "idA": "1430306_12_item1_p34_s4", "sentA": "Krele may also develop or acquire generic products approved under Abbreviated New Drug Applications ( ANDAs ).", "sentB": "Krele also may develop or acquire generic products approved under ANDAs and we may market branded versions (branded generics) of such products.", "type": 2, "words": ["<tag1>", "Krele", "may", "also", "develop", "or", "acquire", "generic", "products", "approved", "under", "Abbreviated", "New", "Drug", "Applications", "(", "ANDAs", ").", "<tag2>", "Krele", "also", "may", "develop", "or", "acquire", "generic", "products", "approved", "under", "ANDAs", "and", "we", "may", "market", "branded", "versions", "(branded", "generics)", "of", "such", "products.", "<tag3>"], "wordsA": ["Krele", "may", "also", "develop", "or", "acquire", "generic", "products", "approved", "under", "Abbreviated", "New", "Drug", "Applications", "(", "ANDAs", ")."], "wordsB": ["Krele", "also", "may", "develop", "or", "acquire", "generic", "products", "approved", "under", "ANDAs", "and", "we", "may", "market", "branded", "versions", "(branded", "generics)", "of", "such", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p21_s1", "idA": "1430306_12_item1_p34_s5", "sentA": "For ANDAs, the predicate product is a medicine approved by the U.S. Food and Drug Administration (the FDA ) under an NDA.", "sentB": "If we demonstrate success in our formal development programs, we will seek marketing approval from the U.S. Food and Drug Administration, or FDA.", "type": 2, "words": ["<tag1>", "For", "ANDAs,", "the", "predicate", "product", "is", "a", "medicine", "approved", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", ")", "under", "an", "NDA.", "<tag2>", "If", "we", "demonstrate", "success", "in", "our", "formal", "development", "programs,", "we", "will", "seek", "marketing", "approval", "from", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA.", "<tag3>"], "wordsA": ["For", "ANDAs,", "the", "predicate", "product", "is", "a", "medicine", "approved", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(the", "FDA", ")", "under", "an", "NDA."], "wordsB": ["If", "we", "demonstrate", "success", "in", "our", "formal", "development", "programs,", "we", "will", "seek", "marketing", "approval", "from", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p46_s1", "idA": "1430306_12_item1_p37_s1", "sentA": "We believe our lead product candidates may be approvable under pathways that are potentially shorter than those typically available for drug products based on novel active ingredients.", "sentB": "We believe our lead product candidates may be approvable under pathways that are potentially shorter than those typically available for drug products based on novel active ingredients (Section 505(b)(1)).", "type": 2, "words": ["<tag1>", "We", "believe", "our", "lead", "product", "candidates", "may", "be", "approvable", "under", "pathways", "that", "are", "potentially", "shorter", "than", "those", "typically", "available", "for", "drug", "products", "based", "on", "novel", "active", "ingredients.", "<tag2>", "We", "believe", "our", "lead", "product", "candidates", "may", "be", "approvable", "under", "pathways", "that", "are", "potentially", "shorter", "than", "those", "typically", "available", "for", "drug", "products", "based", "on", "novel", "active", "ingredients", "(Section", "505(b)(1)).", "<tag3>"], "wordsA": ["We", "believe", "our", "lead", "product", "candidates", "may", "be", "approvable", "under", "pathways", "that", "are", "potentially", "shorter", "than", "those", "typically", "available", "for", "drug", "products", "based", "on", "novel", "active", "ingredients."], "wordsB": ["We", "believe", "our", "lead", "product", "candidates", "may", "be", "approvable", "under", "pathways", "that", "are", "potentially", "shorter", "than", "those", "typically", "available", "for", "drug", "products", "based", "on", "novel", "active", "ingredients", "(Section", "505(b)(1))."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p46_s2", "idA": "1430306_12_item1_p37_s2", "sentA": "By focusing on developing new formulations of approved drugs for new uses, we believe that we will be able to use the Section 505(b)(2) pathway for FDA approval.", "sentB": "By focusing on developing new formulations of approved drugs for new uses, we believe that we will be able to use the Section 505(b)(2) regulatory pathway for NDA approval.", "type": 2, "words": ["<tag1>", "By", "focusing", "on", "developing", "new", "formulations", "of", "approved", "drugs", "for", "new", "uses,", "we", "believe", "that", "we", "will", "be", "able", "to", "use", "the", "Section", "505(b)(2)", "pathway", "for", "FDA", "approval.", "<tag2>", "By", "focusing", "on", "developing", "new", "formulations", "of", "approved", "drugs", "for", "new", "uses,", "we", "believe", "that", "we", "will", "be", "able", "to", "use", "the", "Section", "505(b)(2)", "regulatory", "pathway", "for", "NDA", "approval.", "<tag3>"], "wordsA": ["By", "focusing", "on", "developing", "new", "formulations", "of", "approved", "drugs", "for", "new", "uses,", "we", "believe", "that", "we", "will", "be", "able", "to", "use", "the", "Section", "505(b)(2)", "pathway", "for", "FDA", "approval."], "wordsB": ["By", "focusing", "on", "developing", "new", "formulations", "of", "approved", "drugs", "for", "new", "uses,", "we", "believe", "that", "we", "will", "be", "able", "to", "use", "the", "Section", "505(b)(2)", "regulatory", "pathway", "for", "NDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p46_s4", "idA": "1430306_12_item1_p37_s4", "sentA": "Doing so may help reduce the size and scope of our preclinical and clinical trials.", "sentB": "Our use of this information may help reduce the size and scope of our preclinical and clinical trials.", "type": 2, "words": ["<tag1>", "Doing", "so", "may", "help", "reduce", "the", "size", "and", "scope", "of", "our", "preclinical", "and", "clinical", "trials.", "<tag2>", "Our", "use", "of", "this", "information", "may", "help", "reduce", "the", "size", "and", "scope", "of", "our", "preclinical", "and", "clinical", "trials.", "<tag3>"], "wordsA": ["Doing", "so", "may", "help", "reduce", "the", "size", "and", "scope", "of", "our", "preclinical", "and", "clinical", "trials."], "wordsB": ["Our", "use", "of", "this", "information", "may", "help", "reduce", "the", "size", "and", "scope", "of", "our", "preclinical", "and", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p47_s3", "idA": "1430306_12_item1_p38_s3", "sentA": "For companies involved in the ethical development and marketing of prescription drugs in the US, FDA approval of a new use or new label indication is the only legal basis of marketing claims.", "sentB": "For companies involved in the ethical development and marketing of prescription drugs in the US, FDA approval of a new use or new label indication is the only legal basis of marketing claims for that use or indication.", "type": 2, "words": ["<tag1>", "For", "companies", "involved", "in", "the", "ethical", "development", "and", "marketing", "of", "prescription", "drugs", "in", "the", "US,", "FDA", "approval", "of", "a", "new", "use", "or", "new", "label", "indication", "is", "the", "only", "legal", "basis", "of", "marketing", "claims.", "<tag2>", "For", "companies", "involved", "in", "the", "ethical", "development", "and", "marketing", "of", "prescription", "drugs", "in", "the", "US,", "FDA", "approval", "of", "a", "new", "use", "or", "new", "label", "indication", "is", "the", "only", "legal", "basis", "of", "marketing", "claims", "for", "that", "use", "or", "indication.", "<tag3>"], "wordsA": ["For", "companies", "involved", "in", "the", "ethical", "development", "and", "marketing", "of", "prescription", "drugs", "in", "the", "US,", "FDA", "approval", "of", "a", "new", "use", "or", "new", "label", "indication", "is", "the", "only", "legal", "basis", "of", "marketing", "claims."], "wordsB": ["For", "companies", "involved", "in", "the", "ethical", "development", "and", "marketing", "of", "prescription", "drugs", "in", "the", "US,", "FDA", "approval", "of", "a", "new", "use", "or", "new", "label", "indication", "is", "the", "only", "legal", "basis", "of", "marketing", "claims", "for", "that", "use", "or", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p48_s0", "idA": "1430306_12_item1_p39_s0", "sentA": "We are pursuing a two-pronged patent strategy by seeking intellectual property protection for our methods of use for certain known active pharmaceutical ingredients and by seeking patents to protect the formulation technologies we employ.", "sentB": "We are pursuing a multi-pronged patent strategy by seeking intellectual property protection on several aspects of our products.", "type": 2, "words": ["<tag1>", "We", "are", "pursuing", "a", "two-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "for", "our", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients", "and", "by", "seeking", "patents", "to", "protect", "the", "formulation", "technologies", "we", "employ.", "<tag2>", "We", "are", "pursuing", "a", "multi-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "on", "several", "aspects", "of", "our", "products.", "<tag3>"], "wordsA": ["We", "are", "pursuing", "a", "two-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "for", "our", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients", "and", "by", "seeking", "patents", "to", "protect", "the", "formulation", "technologies", "we", "employ."], "wordsB": ["We", "are", "pursuing", "a", "multi-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "on", "several", "aspects", "of", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p48_s1", "idA": "1430306_12_item1_p39_s0", "sentA": "We are pursuing a two-pronged patent strategy by seeking intellectual property protection for our methods of use for certain known active pharmaceutical ingredients and by seeking patents to protect the formulation technologies we employ.", "sentB": "Aspects we seek to protect include, among others, methods of use for certain known active pharmaceutical ingredients, formulation technologies incorporated into our products, and performance characteristics of our products in the human body.", "type": 2, "words": ["<tag1>", "We", "are", "pursuing", "a", "two-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "for", "our", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients", "and", "by", "seeking", "patents", "to", "protect", "the", "formulation", "technologies", "we", "employ.", "<tag2>", "Aspects", "we", "seek", "to", "protect", "include,", "among", "others,", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients,", "formulation", "technologies", "incorporated", "into", "our", "products,", "and", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body.", "<tag3>"], "wordsA": ["We", "are", "pursuing", "a", "two-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "for", "our", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients", "and", "by", "seeking", "patents", "to", "protect", "the", "formulation", "technologies", "we", "employ."], "wordsB": ["Aspects", "we", "seek", "to", "protect", "include,", "among", "others,", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients,", "formulation", "technologies", "incorporated", "into", "our", "products,", "and", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p48_s3", "idA": "1430306_12_item1_p39_s3", "sentA": "For example, the invention of bedtime VLD cyclobenzaprine as a treatment for FM was novel and unexpected when our patents were filed in 2000.", "sentB": "For example, the invention of bedtime VLD CBP as a treatment for FM was novel and unexpected when our patents were filed in 2000.", "type": 2, "words": ["<tag1>", "For", "example,", "the", "invention", "of", "bedtime", "VLD", "cyclobenzaprine", "as", "a", "treatment", "for", "FM", "was", "novel", "and", "unexpected", "when", "our", "patents", "were", "filed", "in", "2000.", "<tag2>", "For", "example,", "the", "invention", "of", "bedtime", "VLD", "CBP", "as", "a", "treatment", "for", "FM", "was", "novel", "and", "unexpected", "when", "our", "patents", "were", "filed", "in", "2000.", "<tag3>"], "wordsA": ["For", "example,", "the", "invention", "of", "bedtime", "VLD", "cyclobenzaprine", "as", "a", "treatment", "for", "FM", "was", "novel", "and", "unexpected", "when", "our", "patents", "were", "filed", "in", "2000."], "wordsB": ["For", "example,", "the", "invention", "of", "bedtime", "VLD", "CBP", "as", "a", "treatment", "for", "FM", "was", "novel", "and", "unexpected", "when", "our", "patents", "were", "filed", "in", "2000."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p48_s6", "idA": "1430306_12_item1_p39_s4", "sentA": "With respect to formulation patents, we believe our products will be protected by patents that describe inventions of technology for making new formulations and possibly also by patents that describe the invention of products that achieve novel and useful blood levels at certain times after administration.", "sentB": "With respect to formulation patents, we believe our products will be protected by patents that describe inventions of technology for making new formulations, which may include novel routes of delivery for the active ingredients.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "formulation", "patents,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "inventions", "of", "technology", "for", "making", "new", "formulations", "and", "possibly", "also", "by", "patents", "that", "describe", "the", "invention", "of", "products", "that", "achieve", "novel", "and", "useful", "blood", "levels", "at", "certain", "times", "after", "administration.", "<tag2>", "With", "respect", "to", "formulation", "patents,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "inventions", "of", "technology", "for", "making", "new", "formulations,", "which", "may", "include", "novel", "routes", "of", "delivery", "for", "the", "active", "ingredients.", "<tag3>"], "wordsA": ["With", "respect", "to", "formulation", "patents,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "inventions", "of", "technology", "for", "making", "new", "formulations", "and", "possibly", "also", "by", "patents", "that", "describe", "the", "invention", "of", "products", "that", "achieve", "novel", "and", "useful", "blood", "levels", "at", "certain", "times", "after", "administration."], "wordsB": ["With", "respect", "to", "formulation", "patents,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "inventions", "of", "technology", "for", "making", "new", "formulations,", "which", "may", "include", "novel", "routes", "of", "delivery", "for", "the", "active", "ingredients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p48_s7", "idA": "1430306_12_item1_p39_s4", "sentA": "With respect to formulation patents, we believe our products will be protected by patents that describe inventions of technology for making new formulations and possibly also by patents that describe the invention of products that achieve novel and useful blood levels at certain times after administration.", "sentB": "With respect to patents related to the performance characteristics of our products in the human body, we believe our products will be protected by patents that describe novel pharmacokinetic properties of the active ingredient, as well as of its active metabolites, at certain times after administration.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "formulation", "patents,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "inventions", "of", "technology", "for", "making", "new", "formulations", "and", "possibly", "also", "by", "patents", "that", "describe", "the", "invention", "of", "products", "that", "achieve", "novel", "and", "useful", "blood", "levels", "at", "certain", "times", "after", "administration.", "<tag2>", "With", "respect", "to", "patents", "related", "to", "the", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "novel", "pharmacokinetic", "properties", "of", "the", "active", "ingredient,", "as", "well", "as", "of", "its", "active", "metabolites,", "at", "certain", "times", "after", "administration.", "<tag3>"], "wordsA": ["With", "respect", "to", "formulation", "patents,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "inventions", "of", "technology", "for", "making", "new", "formulations", "and", "possibly", "also", "by", "patents", "that", "describe", "the", "invention", "of", "products", "that", "achieve", "novel", "and", "useful", "blood", "levels", "at", "certain", "times", "after", "administration."], "wordsB": ["With", "respect", "to", "patents", "related", "to", "the", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "novel", "pharmacokinetic", "properties", "of", "the", "active", "ingredient,", "as", "well", "as", "of", "its", "active", "metabolites,", "at", "certain", "times", "after", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p49_s2", "idA": "1430306_12_item1_p40_s2", "sentA": "We believe TNX-102 might help in the management of FM by reducing pain and other symptoms, such as fatigue.", "sentB": "We believe TNX-102 SL might help in the management of FM by reducing pain and other symptoms, such as fatigue.", "type": 2, "words": ["<tag1>", "We", "believe", "TNX-102", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue.", "<tag2>", "We", "believe", "TNX-102", "SL", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue.", "<tag3>"], "wordsA": ["We", "believe", "TNX-102", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue."], "wordsB": ["We", "believe", "TNX-102", "SL", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p49_s3", "idA": "1430306_12_item1_p40_s3", "sentA": "In addition, we believe that bedtime treatment with TNX-102 will have fewer day time side-effects than off-label bedtime treatment with immediate release cyclobenzaprine.", "sentB": "In addition, we believe that bedtime treatment with TNX-102 SL will have fewer day time side-effects than off-label bedtime treatment with immediate-release CBP, or CBP IR.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate", "release", "cyclobenzaprine.", "<tag2>", "In", "addition,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "SL", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate-release", "CBP,", "or", "CBP", "IR.", "<tag3>"], "wordsA": ["In", "addition,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate", "release", "cyclobenzaprine."], "wordsB": ["In", "addition,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "SL", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate-release", "CBP,", "or", "CBP", "IR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p49_s4", "idA": "1430306_12_item1_p40_s4", "sentA": "For FM, we believe an FDA-approved product would capture some of the off-label use of generic cyclobenzaprine.", "sentB": "For FM, we believe an FDA-approved product would capture some of the off-label use of generic CBP.", "type": 2, "words": ["<tag1>", "For", "FM,", "we", "believe", "an", "FDA-approved", "product", "would", "capture", "some", "of", "the", "off-label", "use", "of", "generic", "cyclobenzaprine.", "<tag2>", "For", "FM,", "we", "believe", "an", "FDA-approved", "product", "would", "capture", "some", "of", "the", "off-label", "use", "of", "generic", "CBP.", "<tag3>"], "wordsA": ["For", "FM,", "we", "believe", "an", "FDA-approved", "product", "would", "capture", "some", "of", "the", "off-label", "use", "of", "generic", "cyclobenzaprine."], "wordsB": ["For", "FM,", "we", "believe", "an", "FDA-approved", "product", "would", "capture", "some", "of", "the", "off-label", "use", "of", "generic", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p49_s5", "idA": "1430306_12_item1_p40_s5", "sentA": "Because FDA approvals are based on objective data, we believe that third-party payors will provide reimbursement for an FDA approved product, even at a premium price relative to other drugs that are used off-label, such as immediate-release cyclobenzaprine, tizanidine, baclofen, carisoprodol or metaxalone.", "sentB": "Because FDA approvals are based on objective data, we believe that third-party payors will provide reimbursement for an FDA approved product, even at a premium price relative to other drugs that are used off-label, such as CBP IR, tizanidine, baclofen, carisoprodol or metaxalone.", "type": 2, "words": ["<tag1>", "Because", "FDA", "approvals", "are", "based", "on", "objective", "data,", "we", "believe", "that", "third-party", "payors", "will", "provide", "reimbursement", "for", "an", "FDA", "approved", "product,", "even", "at", "a", "premium", "price", "relative", "to", "other", "drugs", "that", "are", "used", "off-label,", "such", "as", "immediate-release", "cyclobenzaprine,", "tizanidine,", "baclofen,", "carisoprodol", "or", "metaxalone.", "<tag2>", "Because", "FDA", "approvals", "are", "based", "on", "objective", "data,", "we", "believe", "that", "third-party", "payors", "will", "provide", "reimbursement", "for", "an", "FDA", "approved", "product,", "even", "at", "a", "premium", "price", "relative", "to", "other", "drugs", "that", "are", "used", "off-label,", "such", "as", "CBP", "IR,", "tizanidine,", "baclofen,", "carisoprodol", "or", "metaxalone.", "<tag3>"], "wordsA": ["Because", "FDA", "approvals", "are", "based", "on", "objective", "data,", "we", "believe", "that", "third-party", "payors", "will", "provide", "reimbursement", "for", "an", "FDA", "approved", "product,", "even", "at", "a", "premium", "price", "relative", "to", "other", "drugs", "that", "are", "used", "off-label,", "such", "as", "immediate-release", "cyclobenzaprine,", "tizanidine,", "baclofen,", "carisoprodol", "or", "metaxalone."], "wordsB": ["Because", "FDA", "approvals", "are", "based", "on", "objective", "data,", "we", "believe", "that", "third-party", "payors", "will", "provide", "reimbursement", "for", "an", "FDA", "approved", "product,", "even", "at", "a", "premium", "price", "relative", "to", "other", "drugs", "that", "are", "used", "off-label,", "such", "as", "CBP", "IR,", "tizanidine,", "baclofen,", "carisoprodol", "or", "metaxalone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p49_s6", "idA": "1430306_12_item1_p40_s6", "sentA": "For example, third-party payors reimburse for using FDA approved Lyrica and Cymbalta for fibromyalgia over off-label generic versions of Neurontin (gabapentin) and generic anti-depressants, respectively.", "sentB": "For example, third-party payors reimburse the use of Lyrica and Cymbalta for FM despite the availability of off-label generic versions of drugs with similar mechanisms of action, for example, Neurontin (gabapentin) and generic anti-depressants, respectively.", "type": 2, "words": ["<tag1>", "For", "example,", "third-party", "payors", "reimburse", "for", "using", "FDA", "approved", "Lyrica", "and", "Cymbalta", "for", "fibromyalgia", "over", "off-label", "generic", "versions", "of", "Neurontin", "(gabapentin)", "and", "generic", "anti-depressants,", "respectively.", "<tag2>", "For", "example,", "third-party", "payors", "reimburse", "the", "use", "of", "Lyrica", "and", "Cymbalta", "for", "FM", "despite", "the", "availability", "of", "off-label", "generic", "versions", "of", "drugs", "with", "similar", "mechanisms", "of", "action,", "for", "example,", "Neurontin", "(gabapentin)", "and", "generic", "anti-depressants,", "respectively.", "<tag3>"], "wordsA": ["For", "example,", "third-party", "payors", "reimburse", "for", "using", "FDA", "approved", "Lyrica", "and", "Cymbalta", "for", "fibromyalgia", "over", "off-label", "generic", "versions", "of", "Neurontin", "(gabapentin)", "and", "generic", "anti-depressants,", "respectively."], "wordsB": ["For", "example,", "third-party", "payors", "reimburse", "the", "use", "of", "Lyrica", "and", "Cymbalta", "for", "FM", "despite", "the", "availability", "of", "off-label", "generic", "versions", "of", "drugs", "with", "similar", "mechanisms", "of", "action,", "for", "example,", "Neurontin", "(gabapentin)", "and", "generic", "anti-depressants,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p50_s1", "idA": "1430306_12_item1_p41_s1", "sentA": "We believe certain of our drug development candidates, including TNX-102 and TNX-105, can be developed and marketed more effectively by companies that already have significant drug development and marketing capabilities.", "sentB": "We believe certain of our drug development candidates, including TNX-102 SL, can be developed and marketed more effectively by companies that already have significant drug development and marketing capabilities.", "type": 2, "words": ["<tag1>", "We", "believe", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "and", "TNX-105,", "can", "be", "developed", "and", "marketed", "more", "effectively", "by", "companies", "that", "already", "have", "significant", "drug", "development", "and", "marketing", "capabilities.", "<tag2>", "We", "believe", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "SL,", "can", "be", "developed", "and", "marketed", "more", "effectively", "by", "companies", "that", "already", "have", "significant", "drug", "development", "and", "marketing", "capabilities.", "<tag3>"], "wordsA": ["We", "believe", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "and", "TNX-105,", "can", "be", "developed", "and", "marketed", "more", "effectively", "by", "companies", "that", "already", "have", "significant", "drug", "development", "and", "marketing", "capabilities."], "wordsB": ["We", "believe", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "SL,", "can", "be", "developed", "and", "marketed", "more", "effectively", "by", "companies", "that", "already", "have", "significant", "drug", "development", "and", "marketing", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p115_s1", "idA": "1430306_12_item1_p42_s0", "sentA": "Our lead product candidates are TNX-102, for the treatment of FM and TNX-105 for the treatment of PTSD.", "sentB": "According to Decision Resources, U.S. sales of prescription drugs specifically for the treatment of FM totaled $1.4 billion in 2011.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidates", "are", "TNX-102,", "for", "the", "treatment", "of", "FM", "and", "TNX-105", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "According", "to", "Decision", "Resources,", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "$1.4", "billion", "in", "2011.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidates", "are", "TNX-102,", "for", "the", "treatment", "of", "FM", "and", "TNX-105", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["According", "to", "Decision", "Resources,", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "$1.4", "billion", "in", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p22_s5", "idA": "1430306_12_item1_p42_s0", "sentA": "Our lead product candidates are TNX-102, for the treatment of FM and TNX-105 for the treatment of PTSD.", "sentB": "We are currently developing TNX-102 SL for the treatment of FM under an Investigational New Drug application, or IND, filed in the US, and under three Clinical Trial Applications, or CTAs, filed in Canada.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidates", "are", "TNX-102,", "for", "the", "treatment", "of", "FM", "and", "TNX-105", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "We", "are", "currently", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "filed", "in", "the", "US,", "and", "under", "three", "Clinical", "Trial", "Applications,", "or", "CTAs,", "filed", "in", "Canada.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidates", "are", "TNX-102,", "for", "the", "treatment", "of", "FM", "and", "TNX-105", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["We", "are", "currently", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "filed", "in", "the", "US,", "and", "under", "three", "Clinical", "Trial", "Applications,", "or", "CTAs,", "filed", "in", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p51_s0", "idA": "1430306_12_item1_p42_s0", "sentA": "Our lead product candidates are TNX-102, for the treatment of FM and TNX-105 for the treatment of PTSD.", "sentB": "Our lead product candidate is TNX-102 SL, for the treatment of FM and PTSD.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidates", "are", "TNX-102,", "for", "the", "treatment", "of", "FM", "and", "TNX-105", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidates", "are", "TNX-102,", "for", "the", "treatment", "of", "FM", "and", "TNX-105", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p51_s1", "idA": "1430306_12_item1_p42_s1", "sentA": "Both of these consist of cyclobenzaprine in a mixture of inactive ingredients that are called excipients , which we believe will improve the absorption rate of cyclobenzaprine in ways that will optimize the product for bedtime treatment.", "sentB": "TNX-102 SL consists of CBP in a mixture of inactive ingredients that are called excipients , which we believe will improve the absorption rate of CBP in ways that will optimize the product for bedtime treatment.", "type": 2, "words": ["<tag1>", "Both", "of", "these", "consist", "of", "cyclobenzaprine", "in", "a", "mixture", "of", "inactive", "ingredients", "that", "are", "called", "excipients", ",", "which", "we", "believe", "will", "improve", "the", "absorption", "rate", "of", "cyclobenzaprine", "in", "ways", "that", "will", "optimize", "the", "product", "for", "bedtime", "treatment.", "<tag2>", "TNX-102", "SL", "consists", "of", "CBP", "in", "a", "mixture", "of", "inactive", "ingredients", "that", "are", "called", "excipients", ",", "which", "we", "believe", "will", "improve", "the", "absorption", "rate", "of", "CBP", "in", "ways", "that", "will", "optimize", "the", "product", "for", "bedtime", "treatment.", "<tag3>"], "wordsA": ["Both", "of", "these", "consist", "of", "cyclobenzaprine", "in", "a", "mixture", "of", "inactive", "ingredients", "that", "are", "called", "excipients", ",", "which", "we", "believe", "will", "improve", "the", "absorption", "rate", "of", "cyclobenzaprine", "in", "ways", "that", "will", "optimize", "the", "product", "for", "bedtime", "treatment."], "wordsB": ["TNX-102", "SL", "consists", "of", "CBP", "in", "a", "mixture", "of", "inactive", "ingredients", "that", "are", "called", "excipients", ",", "which", "we", "believe", "will", "improve", "the", "absorption", "rate", "of", "CBP", "in", "ways", "that", "will", "optimize", "the", "product", "for", "bedtime", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p52_s0", "idA": "1430306_12_item1_p43_s0", "sentA": "Cyclobenzaprine was first synthesized in 1961 by Merck, and the 10 mg Flexeril immediate-release dose form was FDA approved in 1977 for the relief of muscle spasm associated with acute, painful musculoskeletal conditions as an adjunct to rest and physical therapy.", "sentB": "CBP was first synthesized in 1961 by Merck, and the 10 mg Flexeril immediate-release, or IR, dose form was FDA approved in 1977 for the relief of muscle spasm associated with acute, painful musculoskeletal conditions as an adjunct to rest and physical therapy.", "type": 2, "words": ["<tag1>", "Cyclobenzaprine", "was", "first", "synthesized", "in", "1961", "by", "Merck,", "and", "the", "10", "mg", "Flexeril", "immediate-release", "dose", "form", "was", "FDA", "approved", "in", "1977", "for", "the", "relief", "of", "muscle", "spasm", "associated", "with", "acute,", "painful", "musculoskeletal", "conditions", "as", "an", "adjunct", "to", "rest", "and", "physical", "therapy.", "<tag2>", "CBP", "was", "first", "synthesized", "in", "1961", "by", "Merck,", "and", "the", "10", "mg", "Flexeril", "immediate-release,", "or", "IR,", "dose", "form", "was", "FDA", "approved", "in", "1977", "for", "the", "relief", "of", "muscle", "spasm", "associated", "with", "acute,", "painful", "musculoskeletal", "conditions", "as", "an", "adjunct", "to", "rest", "and", "physical", "therapy.", "<tag3>"], "wordsA": ["Cyclobenzaprine", "was", "first", "synthesized", "in", "1961", "by", "Merck,", "and", "the", "10", "mg", "Flexeril", "immediate-release", "dose", "form", "was", "FDA", "approved", "in", "1977", "for", "the", "relief", "of", "muscle", "spasm", "associated", "with", "acute,", "painful", "musculoskeletal", "conditions", "as", "an", "adjunct", "to", "rest", "and", "physical", "therapy."], "wordsB": ["CBP", "was", "first", "synthesized", "in", "1961", "by", "Merck,", "and", "the", "10", "mg", "Flexeril", "immediate-release,", "or", "IR,", "dose", "form", "was", "FDA", "approved", "in", "1977", "for", "the", "relief", "of", "muscle", "spasm", "associated", "with", "acute,", "painful", "musculoskeletal", "conditions", "as", "an", "adjunct", "to", "rest", "and", "physical", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p53_s0", "idA": "1430306_12_item1_p44_s0", "sentA": "Although a number of clinical studies have addressed the potential use and benefit of cyclobenzaprine in treating symptoms of FM, to our knowledge these studies have not motivated a sponsor to pursue FDA approval.", "sentB": "Although a number of clinical studies have addressed the potential use and benefit of CBP in treating symptoms of FM, to our knowledge these studies have not motivated a sponsor to pursue FDA approval.", "type": 2, "words": ["<tag1>", "Although", "a", "number", "of", "clinical", "studies", "have", "addressed", "the", "potential", "use", "and", "benefit", "of", "cyclobenzaprine", "in", "treating", "symptoms", "of", "FM,", "to", "our", "knowledge", "these", "studies", "have", "not", "motivated", "a", "sponsor", "to", "pursue", "FDA", "approval.", "<tag2>", "Although", "a", "number", "of", "clinical", "studies", "have", "addressed", "the", "potential", "use", "and", "benefit", "of", "CBP", "in", "treating", "symptoms", "of", "FM,", "to", "our", "knowledge", "these", "studies", "have", "not", "motivated", "a", "sponsor", "to", "pursue", "FDA", "approval.", "<tag3>"], "wordsA": ["Although", "a", "number", "of", "clinical", "studies", "have", "addressed", "the", "potential", "use", "and", "benefit", "of", "cyclobenzaprine", "in", "treating", "symptoms", "of", "FM,", "to", "our", "knowledge", "these", "studies", "have", "not", "motivated", "a", "sponsor", "to", "pursue", "FDA", "approval."], "wordsB": ["Although", "a", "number", "of", "clinical", "studies", "have", "addressed", "the", "potential", "use", "and", "benefit", "of", "CBP", "in", "treating", "symptoms", "of", "FM,", "to", "our", "knowledge", "these", "studies", "have", "not", "motivated", "a", "sponsor", "to", "pursue", "FDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p54_s0", "idA": "1430306_12_item1_p45_s0", "sentA": "Based on cyclobenzaprine s safety and efficacy for treating muscle spasm, in the 1990s, Merck conducted studies to support an application to market a 5 mg Flexeril tablet (low dose) for the over-the-counter, or OTC, market, where patients can purchase medicine without a physician s prescription.", "sentB": "Based on CBP s safety and efficacy for treating muscle spasm, in the 1990s, Merck conducted studies to support an application to market a 5 mg Flexeril tablet (low dose) for the over-the-counter, or OTC, market, whereby patients can purchase medicine without a physician s prescription.", "type": 2, "words": ["<tag1>", "Based", "on", "cyclobenzaprine", "s", "safety", "and", "efficacy", "for", "treating", "muscle", "spasm,", "in", "the", "1990s,", "Merck", "conducted", "studies", "to", "support", "an", "application", "to", "market", "a", "5", "mg", "Flexeril", "tablet", "(low", "dose)", "for", "the", "over-the-counter,", "or", "OTC,", "market,", "where", "patients", "can", "purchase", "medicine", "without", "a", "physician", "s", "prescription.", "<tag2>", "Based", "on", "CBP", "s", "safety", "and", "efficacy", "for", "treating", "muscle", "spasm,", "in", "the", "1990s,", "Merck", "conducted", "studies", "to", "support", "an", "application", "to", "market", "a", "5", "mg", "Flexeril", "tablet", "(low", "dose)", "for", "the", "over-the-counter,", "or", "OTC,", "market,", "whereby", "patients", "can", "purchase", "medicine", "without", "a", "physician", "s", "prescription.", "<tag3>"], "wordsA": ["Based", "on", "cyclobenzaprine", "s", "safety", "and", "efficacy", "for", "treating", "muscle", "spasm,", "in", "the", "1990s,", "Merck", "conducted", "studies", "to", "support", "an", "application", "to", "market", "a", "5", "mg", "Flexeril", "tablet", "(low", "dose)", "for", "the", "over-the-counter,", "or", "OTC,", "market,", "where", "patients", "can", "purchase", "medicine", "without", "a", "physician", "s", "prescription."], "wordsB": ["Based", "on", "CBP", "s", "safety", "and", "efficacy", "for", "treating", "muscle", "spasm,", "in", "the", "1990s,", "Merck", "conducted", "studies", "to", "support", "an", "application", "to", "market", "a", "5", "mg", "Flexeril", "tablet", "(low", "dose)", "for", "the", "over-the-counter,", "or", "OTC,", "market,", "whereby", "patients", "can", "purchase", "medicine", "without", "a", "physician", "s", "prescription."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p57_s0", "idA": "1430306_12_item1_p48_s0", "sentA": "Despite the approved uses of cyclobenzaprine in treating muscle spasm, we believe current marketed formulations of cyclobenzaprine are limited for treating FM by unpredictable absorption.", "sentB": "Despite the approved uses of CBP in treating muscle spasm, we believe current marketed formulations of CBP are limited for treating FM by slow and unpredictable absorption.", "type": 2, "words": ["<tag1>", "Despite", "the", "approved", "uses", "of", "cyclobenzaprine", "in", "treating", "muscle", "spasm,", "we", "believe", "current", "marketed", "formulations", "of", "cyclobenzaprine", "are", "limited", "for", "treating", "FM", "by", "unpredictable", "absorption.", "<tag2>", "Despite", "the", "approved", "uses", "of", "CBP", "in", "treating", "muscle", "spasm,", "we", "believe", "current", "marketed", "formulations", "of", "CBP", "are", "limited", "for", "treating", "FM", "by", "slow", "and", "unpredictable", "absorption.", "<tag3>"], "wordsA": ["Despite", "the", "approved", "uses", "of", "cyclobenzaprine", "in", "treating", "muscle", "spasm,", "we", "believe", "current", "marketed", "formulations", "of", "cyclobenzaprine", "are", "limited", "for", "treating", "FM", "by", "unpredictable", "absorption."], "wordsB": ["Despite", "the", "approved", "uses", "of", "CBP", "in", "treating", "muscle", "spasm,", "we", "believe", "current", "marketed", "formulations", "of", "CBP", "are", "limited", "for", "treating", "FM", "by", "slow", "and", "unpredictable", "absorption."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p58_s1", "idA": "1430306_12_item1_p49_s0", "sentA": "As described in the Flexeril package insert, the amount of cyclobenzaprine absorbed into the bloodstream varies between 33-55% of the dose ingested.", "sentB": "As described in the Flexeril package insert, the amount of CBP absorbed into the bloodstream varies between 33-55% of the dose ingested.", "type": 2, "words": ["<tag1>", "As", "described", "in", "the", "Flexeril", "package", "insert,", "the", "amount", "of", "cyclobenzaprine", "absorbed", "into", "the", "bloodstream", "varies", "between", "33-55%", "of", "the", "dose", "ingested.", "<tag2>", "As", "described", "in", "the", "Flexeril", "package", "insert,", "the", "amount", "of", "CBP", "absorbed", "into", "the", "bloodstream", "varies", "between", "33-55%", "of", "the", "dose", "ingested.", "<tag3>"], "wordsA": ["As", "described", "in", "the", "Flexeril", "package", "insert,", "the", "amount", "of", "cyclobenzaprine", "absorbed", "into", "the", "bloodstream", "varies", "between", "33-55%", "of", "the", "dose", "ingested."], "wordsB": ["As", "described", "in", "the", "Flexeril", "package", "insert,", "the", "amount", "of", "CBP", "absorbed", "into", "the", "bloodstream", "varies", "between", "33-55%", "of", "the", "dose", "ingested."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p58_s4", "idA": "1430306_12_item1_p49_s3", "sentA": "The uncertainties in absorption rates make it challenging for a physician contemplating a bedtime treatment for FM to ensure the intended therapeutic effect is achieved without risking side effects like next-day drowsiness, which could result if the patient has too much cyclobenzaprine remaining in the bloodstream the next day.", "sentB": "The uncertainties in absorption rates make it challenging for a physician contemplating a bedtime treatment for FM to ensure the intended therapeutic effect is achieved without risking side effects like next-day drowsiness, which could result if the patient has too much CBP remaining in the bloodstream the next day.", "type": 2, "words": ["<tag1>", "The", "uncertainties", "in", "absorption", "rates", "make", "it", "challenging", "for", "a", "physician", "contemplating", "a", "bedtime", "treatment", "for", "FM", "to", "ensure", "the", "intended", "therapeutic", "effect", "is", "achieved", "without", "risking", "side", "effects", "like", "next-day", "drowsiness,", "which", "could", "result", "if", "the", "patient", "has", "too", "much", "cyclobenzaprine", "remaining", "in", "the", "bloodstream", "the", "next", "day.", "<tag2>", "The", "uncertainties", "in", "absorption", "rates", "make", "it", "challenging", "for", "a", "physician", "contemplating", "a", "bedtime", "treatment", "for", "FM", "to", "ensure", "the", "intended", "therapeutic", "effect", "is", "achieved", "without", "risking", "side", "effects", "like", "next-day", "drowsiness,", "which", "could", "result", "if", "the", "patient", "has", "too", "much", "CBP", "remaining", "in", "the", "bloodstream", "the", "next", "day.", "<tag3>"], "wordsA": ["The", "uncertainties", "in", "absorption", "rates", "make", "it", "challenging", "for", "a", "physician", "contemplating", "a", "bedtime", "treatment", "for", "FM", "to", "ensure", "the", "intended", "therapeutic", "effect", "is", "achieved", "without", "risking", "side", "effects", "like", "next-day", "drowsiness,", "which", "could", "result", "if", "the", "patient", "has", "too", "much", "cyclobenzaprine", "remaining", "in", "the", "bloodstream", "the", "next", "day."], "wordsB": ["The", "uncertainties", "in", "absorption", "rates", "make", "it", "challenging", "for", "a", "physician", "contemplating", "a", "bedtime", "treatment", "for", "FM", "to", "ensure", "the", "intended", "therapeutic", "effect", "is", "achieved", "without", "risking", "side", "effects", "like", "next-day", "drowsiness,", "which", "could", "result", "if", "the", "patient", "has", "too", "much", "CBP", "remaining", "in", "the", "bloodstream", "the", "next", "day."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p59_s0", "idA": "1430306_12_item1_p50_s0", "sentA": "If a product could deliver a predictable absorption rate of cyclobenzaprine, it would mean patients would be less likely to receive too little drug to receive a therapeutic effect.", "sentB": "If a product could provide rapid and consistent absorption of CBP, patients would be more likely to receive a drug exposure profile that is aligned with the intended period of exposure and less likely to receive too little drug to receive a therapeutic effect.", "type": 2, "words": ["<tag1>", "If", "a", "product", "could", "deliver", "a", "predictable", "absorption", "rate", "of", "cyclobenzaprine,", "it", "would", "mean", "patients", "would", "be", "less", "likely", "to", "receive", "too", "little", "drug", "to", "receive", "a", "therapeutic", "effect.", "<tag2>", "If", "a", "product", "could", "provide", "rapid", "and", "consistent", "absorption", "of", "CBP,", "patients", "would", "be", "more", "likely", "to", "receive", "a", "drug", "exposure", "profile", "that", "is", "aligned", "with", "the", "intended", "period", "of", "exposure", "and", "less", "likely", "to", "receive", "too", "little", "drug", "to", "receive", "a", "therapeutic", "effect.", "<tag3>"], "wordsA": ["If", "a", "product", "could", "deliver", "a", "predictable", "absorption", "rate", "of", "cyclobenzaprine,", "it", "would", "mean", "patients", "would", "be", "less", "likely", "to", "receive", "too", "little", "drug", "to", "receive", "a", "therapeutic", "effect."], "wordsB": ["If", "a", "product", "could", "provide", "rapid", "and", "consistent", "absorption", "of", "CBP,", "patients", "would", "be", "more", "likely", "to", "receive", "a", "drug", "exposure", "profile", "that", "is", "aligned", "with", "the", "intended", "period", "of", "exposure", "and", "less", "likely", "to", "receive", "too", "little", "drug", "to", "receive", "a", "therapeutic", "effect."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p59_s2", "idA": "1430306_12_item1_p50_s2", "sentA": "An optimal VLD cyclobenzaprine product could have faster absorption, faster clearance and more predictable effects than the immediate release tablet format.", "sentB": "An optimal VLD CBP product could have faster absorption, faster clearance and more predictable effects than the IR tablet format.", "type": 2, "words": ["<tag1>", "An", "optimal", "VLD", "cyclobenzaprine", "product", "could", "have", "faster", "absorption,", "faster", "clearance", "and", "more", "predictable", "effects", "than", "the", "immediate", "release", "tablet", "format.", "<tag2>", "An", "optimal", "VLD", "CBP", "product", "could", "have", "faster", "absorption,", "faster", "clearance", "and", "more", "predictable", "effects", "than", "the", "IR", "tablet", "format.", "<tag3>"], "wordsA": ["An", "optimal", "VLD", "cyclobenzaprine", "product", "could", "have", "faster", "absorption,", "faster", "clearance", "and", "more", "predictable", "effects", "than", "the", "immediate", "release", "tablet", "format."], "wordsB": ["An", "optimal", "VLD", "CBP", "product", "could", "have", "faster", "absorption,", "faster", "clearance", "and", "more", "predictable", "effects", "than", "the", "IR", "tablet", "format."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p23_s3", "idA": "1430306_12_item1_p51_s0", "sentA": "We are testing a number of technologies to optimize the properties of TNX-102 for FM and TNX-105 for PTSD.", "sentB": "We have conducted several clinical and pre-clinical pharmacokinetic studies of TNX-102 SL which we believe support its development as a novel therapeutic product for FM and PTSD, and which demonstrate a number of potentially advantageous characteristics as compared to current CBP-containing products, none of which are approved for these indications.", "type": 2, "words": ["<tag1>", "We", "are", "testing", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "TNX-102", "for", "FM", "and", "TNX-105", "for", "PTSD.", "<tag2>", "We", "have", "conducted", "several", "clinical", "and", "pre-clinical", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "which", "we", "believe", "support", "its", "development", "as", "a", "novel", "therapeutic", "product", "for", "FM", "and", "PTSD,", "and", "which", "demonstrate", "a", "number", "of", "potentially", "advantageous", "characteristics", "as", "compared", "to", "current", "CBP-containing", "products,", "none", "of", "which", "are", "approved", "for", "these", "indications.", "<tag3>"], "wordsA": ["We", "are", "testing", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "TNX-102", "for", "FM", "and", "TNX-105", "for", "PTSD."], "wordsB": ["We", "have", "conducted", "several", "clinical", "and", "pre-clinical", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "which", "we", "believe", "support", "its", "development", "as", "a", "novel", "therapeutic", "product", "for", "FM", "and", "PTSD,", "and", "which", "demonstrate", "a", "number", "of", "potentially", "advantageous", "characteristics", "as", "compared", "to", "current", "CBP-containing", "products,", "none", "of", "which", "are", "approved", "for", "these", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p60_s0", "idA": "1430306_12_item1_p51_s0", "sentA": "We are testing a number of technologies to optimize the properties of TNX-102 for FM and TNX-105 for PTSD.", "sentB": "We have tested a number of technologies to optimize the properties of VLD CBP as a bedtime therapy for FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "testing", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "TNX-102", "for", "FM", "and", "TNX-105", "for", "PTSD.", "<tag2>", "We", "have", "tested", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "VLD", "CBP", "as", "a", "bedtime", "therapy", "for", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "testing", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "TNX-102", "for", "FM", "and", "TNX-105", "for", "PTSD."], "wordsB": ["We", "have", "tested", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "VLD", "CBP", "as", "a", "bedtime", "therapy", "for", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p60_s3", "idA": "1430306_12_item1_p51_s0", "sentA": "We are testing a number of technologies to optimize the properties of TNX-102 for FM and TNX-105 for PTSD.", "sentB": "We believe the unique properties of TNX-102 SL, as demonstrated by the results of our studies, support its development in both FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "testing", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "TNX-102", "for", "FM", "and", "TNX-105", "for", "PTSD.", "<tag2>", "We", "believe", "the", "unique", "properties", "of", "TNX-102", "SL,", "as", "demonstrated", "by", "the", "results", "of", "our", "studies,", "support", "its", "development", "in", "both", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "testing", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "TNX-102", "for", "FM", "and", "TNX-105", "for", "PTSD."], "wordsB": ["We", "believe", "the", "unique", "properties", "of", "TNX-102", "SL,", "as", "demonstrated", "by", "the", "results", "of", "our", "studies,", "support", "its", "development", "in", "both", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p61_s0", "idA": "1430306_12_item1_p52_s0", "sentA": "TNX-102, our most advanced product candidate, is a bedtime pill containing VLD cyclobenzaprine (2.4 mg).", "sentB": "TNX-102 SL, our most advanced product candidate, is a rapidly disintegrating tablet containing VLD CBP that is designed to be placed under the tongue at bedtime.", "type": 2, "words": ["<tag1>", "TNX-102,", "our", "most", "advanced", "product", "candidate,", "is", "a", "bedtime", "pill", "containing", "VLD", "cyclobenzaprine", "(2.4", "mg).", "<tag2>", "TNX-102", "SL,", "our", "most", "advanced", "product", "candidate,", "is", "a", "rapidly", "disintegrating", "tablet", "containing", "VLD", "CBP", "that", "is", "designed", "to", "be", "placed", "under", "the", "tongue", "at", "bedtime.", "<tag3>"], "wordsA": ["TNX-102,", "our", "most", "advanced", "product", "candidate,", "is", "a", "bedtime", "pill", "containing", "VLD", "cyclobenzaprine", "(2.4", "mg)."], "wordsB": ["TNX-102", "SL,", "our", "most", "advanced", "product", "candidate,", "is", "a", "rapidly", "disintegrating", "tablet", "containing", "VLD", "CBP", "that", "is", "designed", "to", "be", "placed", "under", "the", "tongue", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p61_s1", "idA": "1430306_12_item1_p52_s1", "sentA": "The development of TNX-102 is supported by the results of the Moldofsky Study of VLD cyclobenzaprine in FM patients.", "sentB": "The development of TNX-102 SL in FM is supported by the results of the Moldofsky Study, which evaluated oral administration of CBP at doses below the lowest marketed dose in the evening, as well as by preclinical and comparative clinical pharmacokinetic studies.", "type": 2, "words": ["<tag1>", "The", "development", "of", "TNX-102", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study", "of", "VLD", "cyclobenzaprine", "in", "FM", "patients.", "<tag2>", "The", "development", "of", "TNX-102", "SL", "in", "FM", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study,", "which", "evaluated", "oral", "administration", "of", "CBP", "at", "doses", "below", "the", "lowest", "marketed", "dose", "in", "the", "evening,", "as", "well", "as", "by", "preclinical", "and", "comparative", "clinical", "pharmacokinetic", "studies.", "<tag3>"], "wordsA": ["The", "development", "of", "TNX-102", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study", "of", "VLD", "cyclobenzaprine", "in", "FM", "patients."], "wordsB": ["The", "development", "of", "TNX-102", "SL", "in", "FM", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study,", "which", "evaluated", "oral", "administration", "of", "CBP", "at", "doses", "below", "the", "lowest", "marketed", "dose", "in", "the", "evening,", "as", "well", "as", "by", "preclinical", "and", "comparative", "clinical", "pharmacokinetic", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p77_s3", "idA": "1430306_12_item1_p52_s1", "sentA": "The development of TNX-102 is supported by the results of the Moldofsky Study of VLD cyclobenzaprine in FM patients.", "sentB": "In comparison to oral administration of the 5 mg CBP tablet, both sublingual doses of TNX-102 SL demonstrated faster systemic absorption.", "type": 2, "words": ["<tag1>", "The", "development", "of", "TNX-102", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study", "of", "VLD", "cyclobenzaprine", "in", "FM", "patients.", "<tag2>", "In", "comparison", "to", "oral", "administration", "of", "the", "5", "mg", "CBP", "tablet,", "both", "sublingual", "doses", "of", "TNX-102", "SL", "demonstrated", "faster", "systemic", "absorption.", "<tag3>"], "wordsA": ["The", "development", "of", "TNX-102", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study", "of", "VLD", "cyclobenzaprine", "in", "FM", "patients."], "wordsB": ["In", "comparison", "to", "oral", "administration", "of", "the", "5", "mg", "CBP", "tablet,", "both", "sublingual", "doses", "of", "TNX-102", "SL", "demonstrated", "faster", "systemic", "absorption."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p99_s2", "idA": "1430306_12_item1_p52_s1", "sentA": "The development of TNX-102 is supported by the results of the Moldofsky Study of VLD cyclobenzaprine in FM patients.", "sentB": "We expect the results of the Phase 2 trial to determine dose levels in these Phase 3 trials, but like the Phase 2 trial, TNX-102 SL may be dosed flexibly.", "type": 2, "words": ["<tag1>", "The", "development", "of", "TNX-102", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study", "of", "VLD", "cyclobenzaprine", "in", "FM", "patients.", "<tag2>", "We", "expect", "the", "results", "of", "the", "Phase", "2", "trial", "to", "determine", "dose", "levels", "in", "these", "Phase", "3", "trials,", "but", "like", "the", "Phase", "2", "trial,", "TNX-102", "SL", "may", "be", "dosed", "flexibly.", "<tag3>"], "wordsA": ["The", "development", "of", "TNX-102", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study", "of", "VLD", "cyclobenzaprine", "in", "FM", "patients."], "wordsB": ["We", "expect", "the", "results", "of", "the", "Phase", "2", "trial", "to", "determine", "dose", "levels", "in", "these", "Phase", "3", "trials,", "but", "like", "the", "Phase", "2", "trial,", "TNX-102", "SL", "may", "be", "dosed", "flexibly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p104_s2", "idA": "1430306_12_item1_p57_s0", "sentA": "Our motivation to focus our efforts on developing TNX-102 for FM stems from the results of a clinical study on 36 patients in 2001, the related rights to which we acquired from L L. Specifically, this study was a randomized, double-blind, placebo-controlled, dose-escalating eight week trial conducted at two study centers.", "sentB": "The Stage II work involved supporting us in our efforts to conduct a clinical trial study, based on the Stage I work, and is expected to conclude upon the completion of a final report on the results of the clinical study (the Final Report ).", "type": 2, "words": ["<tag1>", "Our", "motivation", "to", "focus", "our", "efforts", "on", "developing", "TNX-102", "for", "FM", "stems", "from", "the", "results", "of", "a", "clinical", "study", "on", "36", "patients", "in", "2001,", "the", "related", "rights", "to", "which", "we", "acquired", "from", "L", "L.", "Specifically,", "this", "study", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "dose-escalating", "eight", "week", "trial", "conducted", "at", "two", "study", "centers.", "<tag2>", "The", "Stage", "II", "work", "involved", "supporting", "us", "in", "our", "efforts", "to", "conduct", "a", "clinical", "trial", "study,", "based", "on", "the", "Stage", "I", "work,", "and", "is", "expected", "to", "conclude", "upon", "the", "completion", "of", "a", "final", "report", "on", "the", "results", "of", "the", "clinical", "study", "(the", "Final", "Report", ").", "<tag3>"], "wordsA": ["Our", "motivation", "to", "focus", "our", "efforts", "on", "developing", "TNX-102", "for", "FM", "stems", "from", "the", "results", "of", "a", "clinical", "study", "on", "36", "patients", "in", "2001,", "the", "related", "rights", "to", "which", "we", "acquired", "from", "L", "L.", "Specifically,", "this", "study", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "dose-escalating", "eight", "week", "trial", "conducted", "at", "two", "study", "centers."], "wordsB": ["The", "Stage", "II", "work", "involved", "supporting", "us", "in", "our", "efforts", "to", "conduct", "a", "clinical", "trial", "study,", "based", "on", "the", "Stage", "I", "work,", "and", "is", "expected", "to", "conclude", "upon", "the", "completion", "of", "a", "final", "report", "on", "the", "results", "of", "the", "clinical", "study", "(the", "Final", "Report", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p66_s0", "idA": "1430306_12_item1_p57_s0", "sentA": "Our motivation to focus our efforts on developing TNX-102 for FM stems from the results of a clinical study on 36 patients in 2001, the related rights to which we acquired from L L. Specifically, this study was a randomized, double-blind, placebo-controlled, dose-escalating eight week trial conducted at two study centers.", "sentB": "Our motivation to focus our efforts on developing TNX-102 SL for FM stems from the results of the Moldofsky Study, the related rights to which we acquired from L L. Specifically, this study was a randomized, double-blind, placebo-controlled, dose-escalating eight week trial conducted at two study centers.", "type": 2, "words": ["<tag1>", "Our", "motivation", "to", "focus", "our", "efforts", "on", "developing", "TNX-102", "for", "FM", "stems", "from", "the", "results", "of", "a", "clinical", "study", "on", "36", "patients", "in", "2001,", "the", "related", "rights", "to", "which", "we", "acquired", "from", "L", "L.", "Specifically,", "this", "study", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "dose-escalating", "eight", "week", "trial", "conducted", "at", "two", "study", "centers.", "<tag2>", "Our", "motivation", "to", "focus", "our", "efforts", "on", "developing", "TNX-102", "SL", "for", "FM", "stems", "from", "the", "results", "of", "the", "Moldofsky", "Study,", "the", "related", "rights", "to", "which", "we", "acquired", "from", "L", "L.", "Specifically,", "this", "study", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "dose-escalating", "eight", "week", "trial", "conducted", "at", "two", "study", "centers.", "<tag3>"], "wordsA": ["Our", "motivation", "to", "focus", "our", "efforts", "on", "developing", "TNX-102", "for", "FM", "stems", "from", "the", "results", "of", "a", "clinical", "study", "on", "36", "patients", "in", "2001,", "the", "related", "rights", "to", "which", "we", "acquired", "from", "L", "L.", "Specifically,", "this", "study", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "dose-escalating", "eight", "week", "trial", "conducted", "at", "two", "study", "centers."], "wordsB": ["Our", "motivation", "to", "focus", "our", "efforts", "on", "developing", "TNX-102", "SL", "for", "FM", "stems", "from", "the", "results", "of", "the", "Moldofsky", "Study,", "the", "related", "rights", "to", "which", "we", "acquired", "from", "L", "L.", "Specifically,", "this", "study", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "dose-escalating", "eight", "week", "trial", "conducted", "at", "two", "study", "centers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p118_s0", "idA": "1430306_12_item1_p57_s1", "sentA": "The study subjects met ACR criteria for FM.", "sentB": "Despite the wide use of muscle relaxants by FM patients, this category lacks a product approved for FM.", "type": 2, "words": ["<tag1>", "The", "study", "subjects", "met", "ACR", "criteria", "for", "FM.", "<tag2>", "Despite", "the", "wide", "use", "of", "muscle", "relaxants", "by", "FM", "patients,", "this", "category", "lacks", "a", "product", "approved", "for", "FM.", "<tag3>"], "wordsA": ["The", "study", "subjects", "met", "ACR", "criteria", "for", "FM."], "wordsB": ["Despite", "the", "wide", "use", "of", "muscle", "relaxants", "by", "FM", "patients,", "this", "category", "lacks", "a", "product", "approved", "for", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p67_s0", "idA": "1430306_12_item1_p58_s0", "sentA": "Patients received VLD cyclobenzaprine immediate-release 1 mg capsules or corresponding placebo capsules to ingest after dinner and before bedtime.", "sentB": "Patients received VLD CBP IR 1 mg capsules or corresponding placebo capsules to ingest after dinner and before bedtime.", "type": 2, "words": ["<tag1>", "Patients", "received", "VLD", "cyclobenzaprine", "immediate-release", "1", "mg", "capsules", "or", "corresponding", "placebo", "capsules", "to", "ingest", "after", "dinner", "and", "before", "bedtime.", "<tag2>", "Patients", "received", "VLD", "CBP", "IR", "1", "mg", "capsules", "or", "corresponding", "placebo", "capsules", "to", "ingest", "after", "dinner", "and", "before", "bedtime.", "<tag3>"], "wordsA": ["Patients", "received", "VLD", "cyclobenzaprine", "immediate-release", "1", "mg", "capsules", "or", "corresponding", "placebo", "capsules", "to", "ingest", "after", "dinner", "and", "before", "bedtime."], "wordsB": ["Patients", "received", "VLD", "CBP", "IR", "1", "mg", "capsules", "or", "corresponding", "placebo", "capsules", "to", "ingest", "after", "dinner", "and", "before", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p67_s1", "idA": "1430306_12_item1_p58_s1", "sentA": "Initially, patients took one capsule each evening, but over the course of the study, they were allowed to increase the number of tablets taken in increments of one capsule per week.", "sentB": "Initially, patients took one capsule each evening, but over the course of the study, they were allowed to increase the number of capsules taken in increments of one capsule per week.", "type": 2, "words": ["<tag1>", "Initially,", "patients", "took", "one", "capsule", "each", "evening,", "but", "over", "the", "course", "of", "the", "study,", "they", "were", "allowed", "to", "increase", "the", "number", "of", "tablets", "taken", "in", "increments", "of", "one", "capsule", "per", "week.", "<tag2>", "Initially,", "patients", "took", "one", "capsule", "each", "evening,", "but", "over", "the", "course", "of", "the", "study,", "they", "were", "allowed", "to", "increase", "the", "number", "of", "capsules", "taken", "in", "increments", "of", "one", "capsule", "per", "week.", "<tag3>"], "wordsA": ["Initially,", "patients", "took", "one", "capsule", "each", "evening,", "but", "over", "the", "course", "of", "the", "study,", "they", "were", "allowed", "to", "increase", "the", "number", "of", "tablets", "taken", "in", "increments", "of", "one", "capsule", "per", "week."], "wordsB": ["Initially,", "patients", "took", "one", "capsule", "each", "evening,", "but", "over", "the", "course", "of", "the", "study,", "they", "were", "allowed", "to", "increase", "the", "number", "of", "capsules", "taken", "in", "increments", "of", "one", "capsule", "per", "week."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p67_s2", "idA": "1430306_12_item1_p58_s2", "sentA": "The maximum number of capsules allowed was four per evening, which would be a total dose of 4 mg immediate-release cyclobenzaprine.", "sentB": "The maximum number of capsules allowed was four per evening, which would be a total dose of 4 mg CBP IR.", "type": 2, "words": ["<tag1>", "The", "maximum", "number", "of", "capsules", "allowed", "was", "four", "per", "evening,", "which", "would", "be", "a", "total", "dose", "of", "4", "mg", "immediate-release", "cyclobenzaprine.", "<tag2>", "The", "maximum", "number", "of", "capsules", "allowed", "was", "four", "per", "evening,", "which", "would", "be", "a", "total", "dose", "of", "4", "mg", "CBP", "IR.", "<tag3>"], "wordsA": ["The", "maximum", "number", "of", "capsules", "allowed", "was", "four", "per", "evening,", "which", "would", "be", "a", "total", "dose", "of", "4", "mg", "immediate-release", "cyclobenzaprine."], "wordsB": ["The", "maximum", "number", "of", "capsules", "allowed", "was", "four", "per", "evening,", "which", "would", "be", "a", "total", "dose", "of", "4", "mg", "CBP", "IR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p68_s0", "idA": "1430306_12_item1_p59_s0", "sentA": "Patients treated with VLD cyclobenzaprine demonstrated significant improvements in pain, fatigue and tenderness at week 8 relative to baseline whereas, placebo-treated patients did not improve (Figure 1).", "sentB": "Patients treated with VLD CBP demonstrated significant improvements in pain, fatigue and tenderness at week 8 relative to baseline, whereas placebo-treated patients did not improve (Figure 1).", "type": 2, "words": ["<tag1>", "Patients", "treated", "with", "VLD", "cyclobenzaprine", "demonstrated", "significant", "improvements", "in", "pain,", "fatigue", "and", "tenderness", "at", "week", "8", "relative", "to", "baseline", "whereas,", "placebo-treated", "patients", "did", "not", "improve", "(Figure", "1).", "<tag2>", "Patients", "treated", "with", "VLD", "CBP", "demonstrated", "significant", "improvements", "in", "pain,", "fatigue", "and", "tenderness", "at", "week", "8", "relative", "to", "baseline,", "whereas", "placebo-treated", "patients", "did", "not", "improve", "(Figure", "1).", "<tag3>"], "wordsA": ["Patients", "treated", "with", "VLD", "cyclobenzaprine", "demonstrated", "significant", "improvements", "in", "pain,", "fatigue", "and", "tenderness", "at", "week", "8", "relative", "to", "baseline", "whereas,", "placebo-treated", "patients", "did", "not", "improve", "(Figure", "1)."], "wordsB": ["Patients", "treated", "with", "VLD", "CBP", "demonstrated", "significant", "improvements", "in", "pain,", "fatigue", "and", "tenderness", "at", "week", "8", "relative", "to", "baseline,", "whereas", "placebo-treated", "patients", "did", "not", "improve", "(Figure", "1)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p69_s0", "idA": "1430306_12_item1_p60_s0", "sentA": "VLD cyclobenzaprine treatment resulted in significant reductions in total Hospital Anxiety and Depression Scale, or HAD, which measures symptoms of anxiety and depression, and the HAD depression subscale which measures depressive symptoms (Figure 1).", "sentB": "VLD CBP treatment resulted in significant reductions in total Hospital Anxiety and Depression Scale, or HAD, which measures symptoms of anxiety and depression, and the HAD depression subscale which measures depressive symptoms (Figure 1).", "type": 2, "words": ["<tag1>", "VLD", "cyclobenzaprine", "treatment", "resulted", "in", "significant", "reductions", "in", "total", "Hospital", "Anxiety", "and", "Depression", "Scale,", "or", "HAD,", "which", "measures", "symptoms", "of", "anxiety", "and", "depression,", "and", "the", "HAD", "depression", "subscale", "which", "measures", "depressive", "symptoms", "(Figure", "1).", "<tag2>", "VLD", "CBP", "treatment", "resulted", "in", "significant", "reductions", "in", "total", "Hospital", "Anxiety", "and", "Depression", "Scale,", "or", "HAD,", "which", "measures", "symptoms", "of", "anxiety", "and", "depression,", "and", "the", "HAD", "depression", "subscale", "which", "measures", "depressive", "symptoms", "(Figure", "1).", "<tag3>"], "wordsA": ["VLD", "cyclobenzaprine", "treatment", "resulted", "in", "significant", "reductions", "in", "total", "Hospital", "Anxiety", "and", "Depression", "Scale,", "or", "HAD,", "which", "measures", "symptoms", "of", "anxiety", "and", "depression,", "and", "the", "HAD", "depression", "subscale", "which", "measures", "depressive", "symptoms", "(Figure", "1)."], "wordsB": ["VLD", "CBP", "treatment", "resulted", "in", "significant", "reductions", "in", "total", "Hospital", "Anxiety", "and", "Depression", "Scale,", "or", "HAD,", "which", "measures", "symptoms", "of", "anxiety", "and", "depression,", "and", "the", "HAD", "depression", "subscale", "which", "measures", "depressive", "symptoms", "(Figure", "1)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p70_s0", "idA": "1430306_12_item1_p61_s0", "sentA": "This study showed treatment with VLD cyclobenzaprine:", "sentB": "This study showed treatment with VLD CBP:", "type": 2, "words": ["<tag1>", "This", "study", "showed", "treatment", "with", "VLD", "cyclobenzaprine:", "<tag2>", "This", "study", "showed", "treatment", "with", "VLD", "CBP:", "<tag3>"], "wordsA": ["This", "study", "showed", "treatment", "with", "VLD", "cyclobenzaprine:"], "wordsB": ["This", "study", "showed", "treatment", "with", "VLD", "CBP:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p24_s0", "idA": "1430306_12_item1_p62_s0", "sentA": "was well tolerated, with no serious adverse events, or SAEs, or discontinuations due to adverse events, or AEs.", "sentB": "TNX-102 SL was generally well-tolerated, with no serious adverse events reported in this study.", "type": 2, "words": ["<tag1>", "was", "well", "tolerated,", "with", "no", "serious", "adverse", "events,", "or", "SAEs,", "or", "discontinuations", "due", "to", "adverse", "events,", "or", "AEs.", "<tag2>", "TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "this", "study.", "<tag3>"], "wordsA": ["was", "well", "tolerated,", "with", "no", "serious", "adverse", "events,", "or", "SAEs,", "or", "discontinuations", "due", "to", "adverse", "events,", "or", "AEs."], "wordsB": ["TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p30_s1", "idA": "1430306_12_item1_p63_s0", "sentA": "We have conducted a human clinical study being conducted by a contract research organization, or CRO, under an US Investigational New Drug Application, or IND, and a Canadian Clinical Trial Application.", "sentB": "We have developed TNX-102 gelcap under an agreement with Lipocine, a contract formulation developer and small-scale manufacturer.", "type": 2, "words": ["<tag1>", "We", "have", "conducted", "a", "human", "clinical", "study", "being", "conducted", "by", "a", "contract", "research", "organization,", "or", "CRO,", "under", "an", "US", "Investigational", "New", "Drug", "Application,", "or", "IND,", "and", "a", "Canadian", "Clinical", "Trial", "Application.", "<tag2>", "We", "have", "developed", "TNX-102", "gelcap", "under", "an", "agreement", "with", "Lipocine,", "a", "contract", "formulation", "developer", "and", "small-scale", "manufacturer.", "<tag3>"], "wordsA": ["We", "have", "conducted", "a", "human", "clinical", "study", "being", "conducted", "by", "a", "contract", "research", "organization,", "or", "CRO,", "under", "an", "US", "Investigational", "New", "Drug", "Application,", "or", "IND,", "and", "a", "Canadian", "Clinical", "Trial", "Application."], "wordsB": ["We", "have", "developed", "TNX-102", "gelcap", "under", "an", "agreement", "with", "Lipocine,", "a", "contract", "formulation", "developer", "and", "small-scale", "manufacturer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p76_s1", "idA": "1430306_12_item1_p63_s1", "sentA": "We received FDA and Health Canada clearance for this study, which was conducted in Canada.", "sentB": "This single-dose study was conducted in Canada.", "type": 2, "words": ["<tag1>", "We", "received", "FDA", "and", "Health", "Canada", "clearance", "for", "this", "study,", "which", "was", "conducted", "in", "Canada.", "<tag2>", "This", "single-dose", "study", "was", "conducted", "in", "Canada.", "<tag3>"], "wordsA": ["We", "received", "FDA", "and", "Health", "Canada", "clearance", "for", "this", "study,", "which", "was", "conducted", "in", "Canada."], "wordsB": ["This", "single-dose", "study", "was", "conducted", "in", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p77_s1", "idA": "1430306_12_item1_p63_s1", "sentA": "We received FDA and Health Canada clearance for this study, which was conducted in Canada.", "sentB": "This study was conducted in Canada.", "type": 2, "words": ["<tag1>", "We", "received", "FDA", "and", "Health", "Canada", "clearance", "for", "this", "study,", "which", "was", "conducted", "in", "Canada.", "<tag2>", "This", "study", "was", "conducted", "in", "Canada.", "<tag3>"], "wordsA": ["We", "received", "FDA", "and", "Health", "Canada", "clearance", "for", "this", "study,", "which", "was", "conducted", "in", "Canada."], "wordsB": ["This", "study", "was", "conducted", "in", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p77_s4", "idA": "1430306_12_item1_p64_s2", "sentA": "This study seeks to measure the circulating blood levels of cyclobenzaprine after oral administration of the TNX-102 candidate formulation in a fed or fasting state and determine how they compare to the blood levels resulting from oral administration of the currently marketed product in a fasting state.", "sentB": "After administration of TNX-102 SL, blood levels of CBP were significantly higher at 20, 30, 45 and 60 minutes relative to administration of the 5 mg CBP tablet.", "type": 2, "words": ["<tag1>", "This", "study", "seeks", "to", "measure", "the", "circulating", "blood", "levels", "of", "cyclobenzaprine", "after", "oral", "administration", "of", "the", "TNX-102", "candidate", "formulation", "in", "a", "fed", "or", "fasting", "state", "and", "determine", "how", "they", "compare", "to", "the", "blood", "levels", "resulting", "from", "oral", "administration", "of", "the", "currently", "marketed", "product", "in", "a", "fasting", "state.", "<tag2>", "After", "administration", "of", "TNX-102", "SL,", "blood", "levels", "of", "CBP", "were", "significantly", "higher", "at", "20,", "30,", "45", "and", "60", "minutes", "relative", "to", "administration", "of", "the", "5", "mg", "CBP", "tablet.", "<tag3>"], "wordsA": ["This", "study", "seeks", "to", "measure", "the", "circulating", "blood", "levels", "of", "cyclobenzaprine", "after", "oral", "administration", "of", "the", "TNX-102", "candidate", "formulation", "in", "a", "fed", "or", "fasting", "state", "and", "determine", "how", "they", "compare", "to", "the", "blood", "levels", "resulting", "from", "oral", "administration", "of", "the", "currently", "marketed", "product", "in", "a", "fasting", "state."], "wordsB": ["After", "administration", "of", "TNX-102", "SL,", "blood", "levels", "of", "CBP", "were", "significantly", "higher", "at", "20,", "30,", "45", "and", "60", "minutes", "relative", "to", "administration", "of", "the", "5", "mg", "CBP", "tablet."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p77_s0", "idA": "1430306_12_item1_p65_s0", "sentA": "If our pharmacokinetic study is successful, we expect to advance the clinical development of TNX-102 for the management of FM by conducting a larger Phase 2b placebo-controlled study.", "sentB": "Our second clinical study of sublingual CBP evaluated TNX-102 SL, the sublingual tablet formulation we expect to advance into further development.", "type": 2, "words": ["<tag1>", "If", "our", "pharmacokinetic", "study", "is", "successful,", "we", "expect", "to", "advance", "the", "clinical", "development", "of", "TNX-102", "for", "the", "management", "of", "FM", "by", "conducting", "a", "larger", "Phase", "2b", "placebo-controlled", "study.", "<tag2>", "Our", "second", "clinical", "study", "of", "sublingual", "CBP", "evaluated", "TNX-102", "SL,", "the", "sublingual", "tablet", "formulation", "we", "expect", "to", "advance", "into", "further", "development.", "<tag3>"], "wordsA": ["If", "our", "pharmacokinetic", "study", "is", "successful,", "we", "expect", "to", "advance", "the", "clinical", "development", "of", "TNX-102", "for", "the", "management", "of", "FM", "by", "conducting", "a", "larger", "Phase", "2b", "placebo-controlled", "study."], "wordsB": ["Our", "second", "clinical", "study", "of", "sublingual", "CBP", "evaluated", "TNX-102", "SL,", "the", "sublingual", "tablet", "formulation", "we", "expect", "to", "advance", "into", "further", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p78_s0", "idA": "1430306_12_item1_p65_s0", "sentA": "If our pharmacokinetic study is successful, we expect to advance the clinical development of TNX-102 for the management of FM by conducting a larger Phase 2b placebo-controlled study.", "sentB": "We expect to advance the clinical development of TNX-102 SL, containing 2.8 mg CBP, for the management of FM by conducting a Phase 2b study.", "type": 2, "words": ["<tag1>", "If", "our", "pharmacokinetic", "study", "is", "successful,", "we", "expect", "to", "advance", "the", "clinical", "development", "of", "TNX-102", "for", "the", "management", "of", "FM", "by", "conducting", "a", "larger", "Phase", "2b", "placebo-controlled", "study.", "<tag2>", "We", "expect", "to", "advance", "the", "clinical", "development", "of", "TNX-102", "SL,", "containing", "2.8", "mg", "CBP,", "for", "the", "management", "of", "FM", "by", "conducting", "a", "Phase", "2b", "study.", "<tag3>"], "wordsA": ["If", "our", "pharmacokinetic", "study", "is", "successful,", "we", "expect", "to", "advance", "the", "clinical", "development", "of", "TNX-102", "for", "the", "management", "of", "FM", "by", "conducting", "a", "larger", "Phase", "2b", "placebo-controlled", "study."], "wordsB": ["We", "expect", "to", "advance", "the", "clinical", "development", "of", "TNX-102", "SL,", "containing", "2.8", "mg", "CBP,", "for", "the", "management", "of", "FM", "by", "conducting", "a", "Phase", "2b", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p22_s7", "idA": "1430306_12_item1_p65_s2", "sentA": "We expect that our proposed Phase 2b will be one of the two clinical efficacy trials required for FDA approval.", "sentB": "We expect that any applications we submit for FDA approval of TNX-102 SL will be submitted under Section 505(b)(2) of FDCA, which we believe will allow for a shorter timeline of clinical development as compared to that needed to fulfill the requirements of Section 505(b)(1), under which NCEs are generally reviewed.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "our", "proposed", "Phase", "2b", "will", "be", "one", "of", "the", "two", "clinical", "efficacy", "trials", "required", "for", "FDA", "approval.", "<tag2>", "We", "expect", "that", "any", "applications", "we", "submit", "for", "FDA", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "NCEs", "are", "generally", "reviewed.", "<tag3>"], "wordsA": ["We", "expect", "that", "our", "proposed", "Phase", "2b", "will", "be", "one", "of", "the", "two", "clinical", "efficacy", "trials", "required", "for", "FDA", "approval."], "wordsB": ["We", "expect", "that", "any", "applications", "we", "submit", "for", "FDA", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "NCEs", "are", "generally", "reviewed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p40_s3", "idA": "1430306_12_item1_p65_s2", "sentA": "We expect that our proposed Phase 2b will be one of the two clinical efficacy trials required for FDA approval.", "sentB": "If the results of this study are positive and are accepted by the FDA as fulfilling the requirements of a registrational study, then this study may be considered to be one of the two pivotal studies typically required for drug approval.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "our", "proposed", "Phase", "2b", "will", "be", "one", "of", "the", "two", "clinical", "efficacy", "trials", "required", "for", "FDA", "approval.", "<tag2>", "If", "the", "results", "of", "this", "study", "are", "positive", "and", "are", "accepted", "by", "the", "FDA", "as", "fulfilling", "the", "requirements", "of", "a", "registrational", "study,", "then", "this", "study", "may", "be", "considered", "to", "be", "one", "of", "the", "two", "pivotal", "studies", "typically", "required", "for", "drug", "approval.", "<tag3>"], "wordsA": ["We", "expect", "that", "our", "proposed", "Phase", "2b", "will", "be", "one", "of", "the", "two", "clinical", "efficacy", "trials", "required", "for", "FDA", "approval."], "wordsB": ["If", "the", "results", "of", "this", "study", "are", "positive", "and", "are", "accepted", "by", "the", "FDA", "as", "fulfilling", "the", "requirements", "of", "a", "registrational", "study,", "then", "this", "study", "may", "be", "considered", "to", "be", "one", "of", "the", "two", "pivotal", "studies", "typically", "required", "for", "drug", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p78_s3", "idA": "1430306_12_item1_p65_s2", "sentA": "We expect that our proposed Phase 2b will be one of the two clinical efficacy trials required for FDA approval.", "sentB": "We expect that our proposed Phase 2b study, if successful and accepted by the FDA, will be one of the two pivotal studies required to support the NDA approval.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "our", "proposed", "Phase", "2b", "will", "be", "one", "of", "the", "two", "clinical", "efficacy", "trials", "required", "for", "FDA", "approval.", "<tag2>", "We", "expect", "that", "our", "proposed", "Phase", "2b", "study,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval.", "<tag3>"], "wordsA": ["We", "expect", "that", "our", "proposed", "Phase", "2b", "will", "be", "one", "of", "the", "two", "clinical", "efficacy", "trials", "required", "for", "FDA", "approval."], "wordsB": ["We", "expect", "that", "our", "proposed", "Phase", "2b", "study,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p79_s0", "idA": "1430306_12_item1_p66_s0", "sentA": "We expect the outcome measures for efficacy in this study will be similar to those utilized by drug products currently approved for use in FM.", "sentB": "We expect the primary efficacy measure in this study will be the change in pain severity at week 12 with TNX-102 SL as compared to placebo, as assessed by the Numeric Rating Scale, or NRS.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "outcome", "measures", "for", "efficacy", "in", "this", "study", "will", "be", "similar", "to", "those", "utilized", "by", "drug", "products", "currently", "approved", "for", "use", "in", "FM.", "<tag2>", "We", "expect", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS.", "<tag3>"], "wordsA": ["We", "expect", "the", "outcome", "measures", "for", "efficacy", "in", "this", "study", "will", "be", "similar", "to", "those", "utilized", "by", "drug", "products", "currently", "approved", "for", "use", "in", "FM."], "wordsB": ["We", "expect", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p79_s1", "idA": "1430306_12_item1_p66_s0", "sentA": "We expect the outcome measures for efficacy in this study will be similar to those utilized by drug products currently approved for use in FM.", "sentB": "This endpoint is similar to that utilized by drug products currently approved for use in FM.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "outcome", "measures", "for", "efficacy", "in", "this", "study", "will", "be", "similar", "to", "those", "utilized", "by", "drug", "products", "currently", "approved", "for", "use", "in", "FM.", "<tag2>", "This", "endpoint", "is", "similar", "to", "that", "utilized", "by", "drug", "products", "currently", "approved", "for", "use", "in", "FM.", "<tag3>"], "wordsA": ["We", "expect", "the", "outcome", "measures", "for", "efficacy", "in", "this", "study", "will", "be", "similar", "to", "those", "utilized", "by", "drug", "products", "currently", "approved", "for", "use", "in", "FM."], "wordsB": ["This", "endpoint", "is", "similar", "to", "that", "utilized", "by", "drug", "products", "currently", "approved", "for", "use", "in", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p79_s2", "idA": "1430306_12_item1_p66_s1", "sentA": "Specific efficacy outcome measures will include the Brief Pain Inventory, the Patient Global Impression of Change (PGIC) and the Fibromyalgia Impact Questionnaire (FIQ).", "sentB": "We will also collect information on other outcome measures, including NRS scores at other timepoints, the Fibromyalgia Impact Questionnaire, and the Patient Global Impression of Change.", "type": 2, "words": ["<tag1>", "Specific", "efficacy", "outcome", "measures", "will", "include", "the", "Brief", "Pain", "Inventory,", "the", "Patient", "Global", "Impression", "of", "Change", "(PGIC)", "and", "the", "Fibromyalgia", "Impact", "Questionnaire", "(FIQ).", "<tag2>", "We", "will", "also", "collect", "information", "on", "other", "outcome", "measures,", "including", "NRS", "scores", "at", "other", "timepoints,", "the", "Fibromyalgia", "Impact", "Questionnaire,", "and", "the", "Patient", "Global", "Impression", "of", "Change.", "<tag3>"], "wordsA": ["Specific", "efficacy", "outcome", "measures", "will", "include", "the", "Brief", "Pain", "Inventory,", "the", "Patient", "Global", "Impression", "of", "Change", "(PGIC)", "and", "the", "Fibromyalgia", "Impact", "Questionnaire", "(FIQ)."], "wordsB": ["We", "will", "also", "collect", "information", "on", "other", "outcome", "measures,", "including", "NRS", "scores", "at", "other", "timepoints,", "the", "Fibromyalgia", "Impact", "Questionnaire,", "and", "the", "Patient", "Global", "Impression", "of", "Change."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p98_s4", "idA": "1430306_12_item1_p66_s1", "sentA": "Specific efficacy outcome measures will include the Brief Pain Inventory, the Patient Global Impression of Change (PGIC) and the Fibromyalgia Impact Questionnaire (FIQ).", "sentB": "Secondary outcome variables may include the PTSD Dream Rating Scale, the PTSD Checklist, the Clinical Global Impression of Improvement, the Pittsburgh Sleep Quality Index and the Beck Depression Inventory.", "type": 2, "words": ["<tag1>", "Specific", "efficacy", "outcome", "measures", "will", "include", "the", "Brief", "Pain", "Inventory,", "the", "Patient", "Global", "Impression", "of", "Change", "(PGIC)", "and", "the", "Fibromyalgia", "Impact", "Questionnaire", "(FIQ).", "<tag2>", "Secondary", "outcome", "variables", "may", "include", "the", "PTSD", "Dream", "Rating", "Scale,", "the", "PTSD", "Checklist,", "the", "Clinical", "Global", "Impression", "of", "Improvement,", "the", "Pittsburgh", "Sleep", "Quality", "Index", "and", "the", "Beck", "Depression", "Inventory.", "<tag3>"], "wordsA": ["Specific", "efficacy", "outcome", "measures", "will", "include", "the", "Brief", "Pain", "Inventory,", "the", "Patient", "Global", "Impression", "of", "Change", "(PGIC)", "and", "the", "Fibromyalgia", "Impact", "Questionnaire", "(FIQ)."], "wordsB": ["Secondary", "outcome", "variables", "may", "include", "the", "PTSD", "Dream", "Rating", "Scale,", "the", "PTSD", "Checklist,", "the", "Clinical", "Global", "Impression", "of", "Improvement,", "the", "Pittsburgh", "Sleep", "Quality", "Index", "and", "the", "Beck", "Depression", "Inventory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p25_s3", "idA": "1430306_12_item1_p66_s4", "sentA": "We expect the study will enroll a first patient in the third quarter of 2012 and will be completed in the third quarter of 2013.", "sentB": "Under the IND, we plan to initiate a potential pivotal efficacy trial (Phase 2b) in FM in the third quarter of 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "Under", "the", "IND,", "we", "plan", "to", "initiate", "a", "potential", "pivotal", "efficacy", "trial", "(Phase", "2b)", "in", "FM", "in", "the", "third", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["Under", "the", "IND,", "we", "plan", "to", "initiate", "a", "potential", "pivotal", "efficacy", "trial", "(Phase", "2b)", "in", "FM", "in", "the", "third", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p26_s1", "idA": "1430306_12_item1_p66_s4", "sentA": "We expect the study will enroll a first patient in the third quarter of 2012 and will be completed in the third quarter of 2013.", "sentB": "We held a pre-IND meeting with the FDA in October 2012, and we plan to file an IND for this indication in the third quarter of 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p26_s2", "idA": "1430306_12_item1_p66_s4", "sentA": "We expect the study will enroll a first patient in the third quarter of 2012 and will be completed in the third quarter of 2013.", "sentB": "We then plan to conduct a clinical proof-of-concept trial of TNX-102 SL in PTSD in the fourth quarter of 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p60_s2", "idA": "1430306_12_item1_p66_s4", "sentA": "We expect the study will enroll a first patient in the third quarter of 2012 and will be completed in the third quarter of 2013.", "sentB": "We intend to enter TNX-102 SL into a potential pivotal clinical trial program in FM in the third quarter of 2013, and into a Phase 2 trial in PTSD in the fourth quarter of 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "We", "intend", "to", "enter", "TNX-102", "SL", "into", "a", "potential", "pivotal", "clinical", "trial", "program", "in", "FM", "in", "the", "third", "quarter", "of", "2013,", "and", "into", "a", "Phase", "2", "trial", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["We", "intend", "to", "enter", "TNX-102", "SL", "into", "a", "potential", "pivotal", "clinical", "trial", "program", "in", "FM", "in", "the", "third", "quarter", "of", "2013,", "and", "into", "a", "Phase", "2", "trial", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p79_s4", "idA": "1430306_12_item1_p66_s4", "sentA": "We expect the study will enroll a first patient in the third quarter of 2012 and will be completed in the third quarter of 2013.", "sentB": "Subsequent to receiving FDA concurrence with our proposed protocol, including the methodology for primary endpoint analysis, the study will begin enrollment in the third quarter of 2013 and will be completed in the second half of 2014.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "Subsequent", "to", "receiving", "FDA", "concurrence", "with", "our", "proposed", "protocol,", "including", "the", "methodology", "for", "primary", "endpoint", "analysis,", "the", "study", "will", "begin", "enrollment", "in", "the", "third", "quarter", "of", "2013", "and", "will", "be", "completed", "in", "the", "second", "half", "of", "2014.", "<tag3>"], "wordsA": ["We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["Subsequent", "to", "receiving", "FDA", "concurrence", "with", "our", "proposed", "protocol,", "including", "the", "methodology", "for", "primary", "endpoint", "analysis,", "the", "study", "will", "begin", "enrollment", "in", "the", "third", "quarter", "of", "2013", "and", "will", "be", "completed", "in", "the", "second", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p97_s0", "idA": "1430306_12_item1_p66_s4", "sentA": "We expect the study will enroll a first patient in the third quarter of 2012 and will be completed in the third quarter of 2013.", "sentB": "Based on the recommendations and guidance received at our October 2012 pre-IND meeting with the FDA, we plan to file an IND application for TNX-102 SL in the PTSD indication in the third quarter of 2013, and to conduct a Phase 2 trial in the fourth quarter of 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "Based", "on", "the", "recommendations", "and", "guidance", "received", "at", "our", "October", "2012", "pre-IND", "meeting", "with", "the", "FDA,", "we", "plan", "to", "file", "an", "IND", "application", "for", "TNX-102", "SL", "in", "the", "PTSD", "indication", "in", "the", "third", "quarter", "of", "2013,", "and", "to", "conduct", "a", "Phase", "2", "trial", "in", "the", "fourth", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["Based", "on", "the", "recommendations", "and", "guidance", "received", "at", "our", "October", "2012", "pre-IND", "meeting", "with", "the", "FDA,", "we", "plan", "to", "file", "an", "IND", "application", "for", "TNX-102", "SL", "in", "the", "PTSD", "indication", "in", "the", "third", "quarter", "of", "2013,", "and", "to", "conduct", "a", "Phase", "2", "trial", "in", "the", "fourth", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p98_s3", "idA": "1430306_12_item1_p66_s4", "sentA": "We expect the study will enroll a first patient in the third quarter of 2012 and will be completed in the third quarter of 2013.", "sentB": "The primary efficacy measure will be the change in the Clinician-Administered PTSD Scale from baseline to week six.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "The", "primary", "efficacy", "measure", "will", "be", "the", "change", "in", "the", "Clinician-Administered", "PTSD", "Scale", "from", "baseline", "to", "week", "six.", "<tag3>"], "wordsA": ["We", "expect", "the", "study", "will", "enroll", "a", "first", "patient", "in", "the", "third", "quarter", "of", "2012", "and", "will", "be", "completed", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["The", "primary", "efficacy", "measure", "will", "be", "the", "change", "in", "the", "Clinician-Administered", "PTSD", "Scale", "from", "baseline", "to", "week", "six."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p80_s0", "idA": "1430306_12_item1_p67_s0", "sentA": "Since cyclobenzaprine will be used chronically in TNX-102, we will study TNX-102 in comparison to immediate-release cyclobenzaprine in multiple day dosing (once daily).", "sentB": "Since CBP will be used chronically in TNX-102 SL, we will study TNX-102 SL in comparison to CBP IR in a multiple-day dosing (once daily) study.", "type": 2, "words": ["<tag1>", "Since", "cyclobenzaprine", "will", "be", "used", "chronically", "in", "TNX-102,", "we", "will", "study", "TNX-102", "in", "comparison", "to", "immediate-release", "cyclobenzaprine", "in", "multiple", "day", "dosing", "(once", "daily).", "<tag2>", "Since", "CBP", "will", "be", "used", "chronically", "in", "TNX-102", "SL,", "we", "will", "study", "TNX-102", "SL", "in", "comparison", "to", "CBP", "IR", "in", "a", "multiple-day", "dosing", "(once", "daily)", "study.", "<tag3>"], "wordsA": ["Since", "cyclobenzaprine", "will", "be", "used", "chronically", "in", "TNX-102,", "we", "will", "study", "TNX-102", "in", "comparison", "to", "immediate-release", "cyclobenzaprine", "in", "multiple", "day", "dosing", "(once", "daily)."], "wordsB": ["Since", "CBP", "will", "be", "used", "chronically", "in", "TNX-102", "SL,", "we", "will", "study", "TNX-102", "SL", "in", "comparison", "to", "CBP", "IR", "in", "a", "multiple-day", "dosing", "(once", "daily)", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p80_s1", "idA": "1430306_12_item1_p67_s1", "sentA": "Subjects will ingest TNX-102 or immediate-release cyclobenzaprine for four or more days.", "sentB": "Subjects will receive TNX-102 SL or CBP IR for four or more consecutive days.", "type": 2, "words": ["<tag1>", "Subjects", "will", "ingest", "TNX-102", "or", "immediate-release", "cyclobenzaprine", "for", "four", "or", "more", "days.", "<tag2>", "Subjects", "will", "receive", "TNX-102", "SL", "or", "CBP", "IR", "for", "four", "or", "more", "consecutive", "days.", "<tag3>"], "wordsA": ["Subjects", "will", "ingest", "TNX-102", "or", "immediate-release", "cyclobenzaprine", "for", "four", "or", "more", "days."], "wordsB": ["Subjects", "will", "receive", "TNX-102", "SL", "or", "CBP", "IR", "for", "four", "or", "more", "consecutive", "days."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p76_s3", "idA": "1430306_12_item1_p67_s2", "sentA": "Peak and trough blood levels of cyclobenzaprine will be measured.", "sentB": "The study measured circulating blood levels of CBP at pre-defined time-points over six days after receiving study medication.", "type": 2, "words": ["<tag1>", "Peak", "and", "trough", "blood", "levels", "of", "cyclobenzaprine", "will", "be", "measured.", "<tag2>", "The", "study", "measured", "circulating", "blood", "levels", "of", "CBP", "at", "pre-defined", "time-points", "over", "six", "days", "after", "receiving", "study", "medication.", "<tag3>"], "wordsA": ["Peak", "and", "trough", "blood", "levels", "of", "cyclobenzaprine", "will", "be", "measured."], "wordsB": ["The", "study", "measured", "circulating", "blood", "levels", "of", "CBP", "at", "pre-defined", "time-points", "over", "six", "days", "after", "receiving", "study", "medication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p80_s2", "idA": "1430306_12_item1_p67_s2", "sentA": "Peak and trough blood levels of cyclobenzaprine will be measured.", "sentB": "Peak and trough blood levels of CBP will be measured.", "type": 2, "words": ["<tag1>", "Peak", "and", "trough", "blood", "levels", "of", "cyclobenzaprine", "will", "be", "measured.", "<tag2>", "Peak", "and", "trough", "blood", "levels", "of", "CBP", "will", "be", "measured.", "<tag3>"], "wordsA": ["Peak", "and", "trough", "blood", "levels", "of", "cyclobenzaprine", "will", "be", "measured."], "wordsB": ["Peak", "and", "trough", "blood", "levels", "of", "CBP", "will", "be", "measured."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p80_s3", "idA": "1430306_12_item1_p67_s3", "sentA": "The results of this study will provide information regarding blood levels of cyclobenzaprine when taken in a multiple day regimen.", "sentB": "The results of this study will provide information regarding blood levels of CBP resulting from use of the marketed IR tablet and our sublingual TNX-102 SL tablet when taken in a multiple day regimen.", "type": 2, "words": ["<tag1>", "The", "results", "of", "this", "study", "will", "provide", "information", "regarding", "blood", "levels", "of", "cyclobenzaprine", "when", "taken", "in", "a", "multiple", "day", "regimen.", "<tag2>", "The", "results", "of", "this", "study", "will", "provide", "information", "regarding", "blood", "levels", "of", "CBP", "resulting", "from", "use", "of", "the", "marketed", "IR", "tablet", "and", "our", "sublingual", "TNX-102", "SL", "tablet", "when", "taken", "in", "a", "multiple", "day", "regimen.", "<tag3>"], "wordsA": ["The", "results", "of", "this", "study", "will", "provide", "information", "regarding", "blood", "levels", "of", "cyclobenzaprine", "when", "taken", "in", "a", "multiple", "day", "regimen."], "wordsB": ["The", "results", "of", "this", "study", "will", "provide", "information", "regarding", "blood", "levels", "of", "CBP", "resulting", "from", "use", "of", "the", "marketed", "IR", "tablet", "and", "our", "sublingual", "TNX-102", "SL", "tablet", "when", "taken", "in", "a", "multiple", "day", "regimen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p41_s3", "idA": "1430306_12_item1_p68_s0", "sentA": "We plan to conduct a small study designed to compare the bedtime use of TNX-102 and immediate-release cyclobenzaprine on next morning drowsiness.", "sentB": "To meet the ICH long-term safety exposure requirement, we plan to conduct one or more long-term safety exposure studies of TNX-102 SL to support the chronic use of TNX-102 SL in FM.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "compare", "the", "bedtime", "use", "of", "TNX-102", "and", "immediate-release", "cyclobenzaprine", "on", "next", "morning", "drowsiness.", "<tag2>", "To", "meet", "the", "ICH", "long-term", "safety", "exposure", "requirement,", "we", "plan", "to", "conduct", "one", "or", "more", "long-term", "safety", "exposure", "studies", "of", "TNX-102", "SL", "to", "support", "the", "chronic", "use", "of", "TNX-102", "SL", "in", "FM.", "<tag3>"], "wordsA": ["We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "compare", "the", "bedtime", "use", "of", "TNX-102", "and", "immediate-release", "cyclobenzaprine", "on", "next", "morning", "drowsiness."], "wordsB": ["To", "meet", "the", "ICH", "long-term", "safety", "exposure", "requirement,", "we", "plan", "to", "conduct", "one", "or", "more", "long-term", "safety", "exposure", "studies", "of", "TNX-102", "SL", "to", "support", "the", "chronic", "use", "of", "TNX-102", "SL", "in", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p81_s0", "idA": "1430306_12_item1_p68_s0", "sentA": "We plan to conduct a small study designed to compare the bedtime use of TNX-102 and immediate-release cyclobenzaprine on next morning drowsiness.", "sentB": "We plan to conduct a small study designed to evaluate next morning drowsiness and other cognitive measures following the bedtime use of TNX-102 SL and the bedtime use of CBP IR.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "compare", "the", "bedtime", "use", "of", "TNX-102", "and", "immediate-release", "cyclobenzaprine", "on", "next", "morning", "drowsiness.", "<tag2>", "We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "evaluate", "next", "morning", "drowsiness", "and", "other", "cognitive", "measures", "following", "the", "bedtime", "use", "of", "TNX-102", "SL", "and", "the", "bedtime", "use", "of", "CBP", "IR.", "<tag3>"], "wordsA": ["We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "compare", "the", "bedtime", "use", "of", "TNX-102", "and", "immediate-release", "cyclobenzaprine", "on", "next", "morning", "drowsiness."], "wordsB": ["We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "evaluate", "next", "morning", "drowsiness", "and", "other", "cognitive", "measures", "following", "the", "bedtime", "use", "of", "TNX-102", "SL", "and", "the", "bedtime", "use", "of", "CBP", "IR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p98_s0", "idA": "1430306_12_item1_p68_s0", "sentA": "We plan to conduct a small study designed to compare the bedtime use of TNX-102 and immediate-release cyclobenzaprine on next morning drowsiness.", "sentB": "We plan to use the IND to support a small clinical study to ascertain the potential efficacy of TNX-102 SL in this disorder.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "compare", "the", "bedtime", "use", "of", "TNX-102", "and", "immediate-release", "cyclobenzaprine", "on", "next", "morning", "drowsiness.", "<tag2>", "We", "plan", "to", "use", "the", "IND", "to", "support", "a", "small", "clinical", "study", "to", "ascertain", "the", "potential", "efficacy", "of", "TNX-102", "SL", "in", "this", "disorder.", "<tag3>"], "wordsA": ["We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "compare", "the", "bedtime", "use", "of", "TNX-102", "and", "immediate-release", "cyclobenzaprine", "on", "next", "morning", "drowsiness."], "wordsB": ["We", "plan", "to", "use", "the", "IND", "to", "support", "a", "small", "clinical", "study", "to", "ascertain", "the", "potential", "efficacy", "of", "TNX-102", "SL", "in", "this", "disorder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p81_s1", "idA": "1430306_12_item1_p68_s1", "sentA": "The goal of this study is to determine the potential benefit of TNX-102 compared with immediate-release cyclobenzaprine on next morning drowsiness.", "sentB": "The goal of this study is to determine the potential benefit of TNX-102 SL compared with CBP IR on next morning drowsiness and on other cognitive functions.", "type": 2, "words": ["<tag1>", "The", "goal", "of", "this", "study", "is", "to", "determine", "the", "potential", "benefit", "of", "TNX-102", "compared", "with", "immediate-release", "cyclobenzaprine", "on", "next", "morning", "drowsiness.", "<tag2>", "The", "goal", "of", "this", "study", "is", "to", "determine", "the", "potential", "benefit", "of", "TNX-102", "SL", "compared", "with", "CBP", "IR", "on", "next", "morning", "drowsiness", "and", "on", "other", "cognitive", "functions.", "<tag3>"], "wordsA": ["The", "goal", "of", "this", "study", "is", "to", "determine", "the", "potential", "benefit", "of", "TNX-102", "compared", "with", "immediate-release", "cyclobenzaprine", "on", "next", "morning", "drowsiness."], "wordsB": ["The", "goal", "of", "this", "study", "is", "to", "determine", "the", "potential", "benefit", "of", "TNX-102", "SL", "compared", "with", "CBP", "IR", "on", "next", "morning", "drowsiness", "and", "on", "other", "cognitive", "functions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p82_s0", "idA": "1430306_12_item1_p69_s0", "sentA": "If our Phase 2b study is successful, then we expect to conduct a Phase 3 study in support of product registration.", "sentB": "If our Phase 2b study of TNX-102 SL is successful, then we expect to conduct a Phase 3 confirmatory study in support of product registration.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2b", "study", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "study", "in", "support", "of", "product", "registration.", "<tag2>", "If", "our", "Phase", "2b", "study", "of", "TNX-102", "SL", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "confirmatory", "study", "in", "support", "of", "product", "registration.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2b", "study", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "study", "in", "support", "of", "product", "registration."], "wordsB": ["If", "our", "Phase", "2b", "study", "of", "TNX-102", "SL", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "confirmatory", "study", "in", "support", "of", "product", "registration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p82_s1", "idA": "1430306_12_item1_p69_s1", "sentA": "At this time, we plan to conduct one large scale, randomized, double-blind, placebo-controlled Phase 3 study in which patients with FM will receive TNX-102 or placebo for six months.", "sentB": "At that time, we plan to conduct a randomized, double-blind, placebo-controlled Phase 3 study in which patients with FM will receive TNX-102 SL or placebo at bedtime nightly for 12 weeks.", "type": 2, "words": ["<tag1>", "At", "this", "time,", "we", "plan", "to", "conduct", "one", "large", "scale,", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "in", "which", "patients", "with", "FM", "will", "receive", "TNX-102", "or", "placebo", "for", "six", "months.", "<tag2>", "At", "that", "time,", "we", "plan", "to", "conduct", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "in", "which", "patients", "with", "FM", "will", "receive", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks.", "<tag3>"], "wordsA": ["At", "this", "time,", "we", "plan", "to", "conduct", "one", "large", "scale,", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "in", "which", "patients", "with", "FM", "will", "receive", "TNX-102", "or", "placebo", "for", "six", "months."], "wordsB": ["At", "that", "time,", "we", "plan", "to", "conduct", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "in", "which", "patients", "with", "FM", "will", "receive", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p84_s2", "idA": "1430306_12_item1_p69_s1", "sentA": "At this time, we plan to conduct one large scale, randomized, double-blind, placebo-controlled Phase 3 study in which patients with FM will receive TNX-102 or placebo for six months.", "sentB": "We plan to conduct open-label extension studies in which patients may be eligible to enroll following their completion of our Phase 2b and Phase 3 safety and efficacy trials in FM.", "type": 2, "words": ["<tag1>", "At", "this", "time,", "we", "plan", "to", "conduct", "one", "large", "scale,", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "in", "which", "patients", "with", "FM", "will", "receive", "TNX-102", "or", "placebo", "for", "six", "months.", "<tag2>", "We", "plan", "to", "conduct", "open-label", "extension", "studies", "in", "which", "patients", "may", "be", "eligible", "to", "enroll", "following", "their", "completion", "of", "our", "Phase", "2b", "and", "Phase", "3", "safety", "and", "efficacy", "trials", "in", "FM.", "<tag3>"], "wordsA": ["At", "this", "time,", "we", "plan", "to", "conduct", "one", "large", "scale,", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "in", "which", "patients", "with", "FM", "will", "receive", "TNX-102", "or", "placebo", "for", "six", "months."], "wordsB": ["We", "plan", "to", "conduct", "open-label", "extension", "studies", "in", "which", "patients", "may", "be", "eligible", "to", "enroll", "following", "their", "completion", "of", "our", "Phase", "2b", "and", "Phase", "3", "safety", "and", "efficacy", "trials", "in", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p82_s2", "idA": "1430306_12_item1_p69_s2", "sentA": "It is likely that the outcome measures for efficacy in this study will be similar to those used in the Phase 2b study.", "sentB": "It is likely that the primary efficacy measure in this study will be the change in pain severity with TNX-102 SL as compared to placebo at week 12, assessed by the NRS, similar to the primary efficacy measure of the Phase 2b study.", "type": 2, "words": ["<tag1>", "It", "is", "likely", "that", "the", "outcome", "measures", "for", "efficacy", "in", "this", "study", "will", "be", "similar", "to", "those", "used", "in", "the", "Phase", "2b", "study.", "<tag2>", "It", "is", "likely", "that", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "with", "TNX-102", "SL", "as", "compared", "to", "placebo", "at", "week", "12,", "assessed", "by", "the", "NRS,", "similar", "to", "the", "primary", "efficacy", "measure", "of", "the", "Phase", "2b", "study.", "<tag3>"], "wordsA": ["It", "is", "likely", "that", "the", "outcome", "measures", "for", "efficacy", "in", "this", "study", "will", "be", "similar", "to", "those", "used", "in", "the", "Phase", "2b", "study."], "wordsB": ["It", "is", "likely", "that", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "with", "TNX-102", "SL", "as", "compared", "to", "placebo", "at", "week", "12,", "assessed", "by", "the", "NRS,", "similar", "to", "the", "primary", "efficacy", "measure", "of", "the", "Phase", "2b", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p99_s3", "idA": "1430306_12_item1_p69_s2", "sentA": "It is likely that the outcome measures for efficacy in this study will be similar to those used in the Phase 2b study.", "sentB": "The primary endpoints for both Phase 3 studies are anticipated to be similar to those proposed to be featured in the Phase 2 study, and as with the Phase 2 study, in addition to standardized measures of PTSD symptomatology and severity, polysomnograms may be obtained.", "type": 2, "words": ["<tag1>", "It", "is", "likely", "that", "the", "outcome", "measures", "for", "efficacy", "in", "this", "study", "will", "be", "similar", "to", "those", "used", "in", "the", "Phase", "2b", "study.", "<tag2>", "The", "primary", "endpoints", "for", "both", "Phase", "3", "studies", "are", "anticipated", "to", "be", "similar", "to", "those", "proposed", "to", "be", "featured", "in", "the", "Phase", "2", "study,", "and", "as", "with", "the", "Phase", "2", "study,", "in", "addition", "to", "standardized", "measures", "of", "PTSD", "symptomatology", "and", "severity,", "polysomnograms", "may", "be", "obtained.", "<tag3>"], "wordsA": ["It", "is", "likely", "that", "the", "outcome", "measures", "for", "efficacy", "in", "this", "study", "will", "be", "similar", "to", "those", "used", "in", "the", "Phase", "2b", "study."], "wordsB": ["The", "primary", "endpoints", "for", "both", "Phase", "3", "studies", "are", "anticipated", "to", "be", "similar", "to", "those", "proposed", "to", "be", "featured", "in", "the", "Phase", "2", "study,", "and", "as", "with", "the", "Phase", "2", "study,", "in", "addition", "to", "standardized", "measures", "of", "PTSD", "symptomatology", "and", "severity,", "polysomnograms", "may", "be", "obtained."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p83_s0", "idA": "1430306_12_item1_p69_s3", "sentA": "Other outcome measures will be carefully considered to best support desired label claims and optimal marketing message for product differentiation.", "sentB": "Secondary outcome measures will be carefully considered to best support desired label claims and to optimize the marketing message for product differentiation.", "type": 2, "words": ["<tag1>", "Other", "outcome", "measures", "will", "be", "carefully", "considered", "to", "best", "support", "desired", "label", "claims", "and", "optimal", "marketing", "message", "for", "product", "differentiation.", "<tag2>", "Secondary", "outcome", "measures", "will", "be", "carefully", "considered", "to", "best", "support", "desired", "label", "claims", "and", "to", "optimize", "the", "marketing", "message", "for", "product", "differentiation.", "<tag3>"], "wordsA": ["Other", "outcome", "measures", "will", "be", "carefully", "considered", "to", "best", "support", "desired", "label", "claims", "and", "optimal", "marketing", "message", "for", "product", "differentiation."], "wordsB": ["Secondary", "outcome", "measures", "will", "be", "carefully", "considered", "to", "best", "support", "desired", "label", "claims", "and", "to", "optimize", "the", "marketing", "message", "for", "product", "differentiation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p78_s1", "idA": "1430306_12_item1_p69_s4", "sentA": "We expect that at least 300 FM patients will be enrolled in this trial.", "sentB": "In this multicenter, randomized, double-blind, placebo-controlled clinical trial, FM patients will be administered either TNX-102 SL or placebo at bedtime nightly for 12 weeks.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "at", "least", "300", "FM", "patients", "will", "be", "enrolled", "in", "this", "trial.", "<tag2>", "In", "this", "multicenter,", "randomized,", "double-blind,", "placebo-controlled", "clinical", "trial,", "FM", "patients", "will", "be", "administered", "either", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks.", "<tag3>"], "wordsA": ["We", "expect", "that", "at", "least", "300", "FM", "patients", "will", "be", "enrolled", "in", "this", "trial."], "wordsB": ["In", "this", "multicenter,", "randomized,", "double-blind,", "placebo-controlled", "clinical", "trial,", "FM", "patients", "will", "be", "administered", "either", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p83_s1", "idA": "1430306_12_item1_p69_s4", "sentA": "We expect that at least 300 FM patients will be enrolled in this trial.", "sentB": "We expect approximately 300 FM patients will be enrolled in this trial.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "at", "least", "300", "FM", "patients", "will", "be", "enrolled", "in", "this", "trial.", "<tag2>", "We", "expect", "approximately", "300", "FM", "patients", "will", "be", "enrolled", "in", "this", "trial.", "<tag3>"], "wordsA": ["We", "expect", "that", "at", "least", "300", "FM", "patients", "will", "be", "enrolled", "in", "this", "trial."], "wordsB": ["We", "expect", "approximately", "300", "FM", "patients", "will", "be", "enrolled", "in", "this", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p104_s3", "idA": "1430306_12_item1_p6_s0", "sentA": "Upon completion of the Share Exchange, the Tonix Shareholders received an aggregate of 22,666,667 shares of our Common Stock.", "sentB": "Upon completion of the Final Report, we have the right, within 30 days after the Final Report, to exercise an exclusive worldwide license to the Lipocine technology.", "type": 2, "words": ["<tag1>", "Upon", "completion", "of", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "received", "an", "aggregate", "of", "22,666,667", "shares", "of", "our", "Common", "Stock.", "<tag2>", "Upon", "completion", "of", "the", "Final", "Report,", "we", "have", "the", "right,", "within", "30", "days", "after", "the", "Final", "Report,", "to", "exercise", "an", "exclusive", "worldwide", "license", "to", "the", "Lipocine", "technology.", "<tag3>"], "wordsA": ["Upon", "completion", "of", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "received", "an", "aggregate", "of", "22,666,667", "shares", "of", "our", "Common", "Stock."], "wordsB": ["Upon", "completion", "of", "the", "Final", "Report,", "we", "have", "the", "right,", "within", "30", "days", "after", "the", "Final", "Report,", "to", "exercise", "an", "exclusive", "worldwide", "license", "to", "the", "Lipocine", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p84_s0", "idA": "1430306_12_item1_p70_s0", "sentA": "To study the safety of our product in chronic use, we expect to conduct an open label study in which approximately 300 FM subjects would receive TNX-102 for up to one year.", "sentB": "To evaluate the safety of TNX-102 SL for chronic use, we expect to conduct one or more long-term open-label safety exposure studies.", "type": 2, "words": ["<tag1>", "To", "study", "the", "safety", "of", "our", "product", "in", "chronic", "use,", "we", "expect", "to", "conduct", "an", "open", "label", "study", "in", "which", "approximately", "300", "FM", "subjects", "would", "receive", "TNX-102", "for", "up", "to", "one", "year.", "<tag2>", "To", "evaluate", "the", "safety", "of", "TNX-102", "SL", "for", "chronic", "use,", "we", "expect", "to", "conduct", "one", "or", "more", "long-term", "open-label", "safety", "exposure", "studies.", "<tag3>"], "wordsA": ["To", "study", "the", "safety", "of", "our", "product", "in", "chronic", "use,", "we", "expect", "to", "conduct", "an", "open", "label", "study", "in", "which", "approximately", "300", "FM", "subjects", "would", "receive", "TNX-102", "for", "up", "to", "one", "year."], "wordsB": ["To", "evaluate", "the", "safety", "of", "TNX-102", "SL", "for", "chronic", "use,", "we", "expect", "to", "conduct", "one", "or", "more", "long-term", "open-label", "safety", "exposure", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p84_s1", "idA": "1430306_12_item1_p70_s1", "sentA": "Together with our other studies, we believe this safety exposure study will support the FDA and international regulatory requirements to provide data for at least 300 subjects treated with TNX-102 for six months and at least 100 subjects treated for 1 year.", "sentB": "The FDA agreed that the safety database needed to support a 505(b)(2) NDA submission for TNX-102 SL would contain a total exposure of at least 300 FM patients, with at least 100 patients receiving TNX-102 SL for six months and at least 50 patients for one year.", "type": 2, "words": ["<tag1>", "Together", "with", "our", "other", "studies,", "we", "believe", "this", "safety", "exposure", "study", "will", "support", "the", "FDA", "and", "international", "regulatory", "requirements", "to", "provide", "data", "for", "at", "least", "300", "subjects", "treated", "with", "TNX-102", "for", "six", "months", "and", "at", "least", "100", "subjects", "treated", "for", "1", "year.", "<tag2>", "The", "FDA", "agreed", "that", "the", "safety", "database", "needed", "to", "support", "a", "505(b)(2)", "NDA", "submission", "for", "TNX-102", "SL", "would", "contain", "a", "total", "exposure", "of", "at", "least", "300", "FM", "patients,", "with", "at", "least", "100", "patients", "receiving", "TNX-102", "SL", "for", "six", "months", "and", "at", "least", "50", "patients", "for", "one", "year.", "<tag3>"], "wordsA": ["Together", "with", "our", "other", "studies,", "we", "believe", "this", "safety", "exposure", "study", "will", "support", "the", "FDA", "and", "international", "regulatory", "requirements", "to", "provide", "data", "for", "at", "least", "300", "subjects", "treated", "with", "TNX-102", "for", "six", "months", "and", "at", "least", "100", "subjects", "treated", "for", "1", "year."], "wordsB": ["The", "FDA", "agreed", "that", "the", "safety", "database", "needed", "to", "support", "a", "505(b)(2)", "NDA", "submission", "for", "TNX-102", "SL", "would", "contain", "a", "total", "exposure", "of", "at", "least", "300", "FM", "patients,", "with", "at", "least", "100", "patients", "receiving", "TNX-102", "SL", "for", "six", "months", "and", "at", "least", "50", "patients", "for", "one", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p85_s0", "idA": "1430306_12_item1_p71_s0", "sentA": "The approvals of Lyrica, Cymbalta and Savella establish a regulatory approval standard for management of FM.", "sentB": "The FDA approvals of Lyrica, Cymbalta and Savella establish a regulatory approval standard for the management of FM.", "type": 2, "words": ["<tag1>", "The", "approvals", "of", "Lyrica,", "Cymbalta", "and", "Savella", "establish", "a", "regulatory", "approval", "standard", "for", "management", "of", "FM.", "<tag2>", "The", "FDA", "approvals", "of", "Lyrica,", "Cymbalta", "and", "Savella", "establish", "a", "regulatory", "approval", "standard", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["The", "approvals", "of", "Lyrica,", "Cymbalta", "and", "Savella", "establish", "a", "regulatory", "approval", "standard", "for", "management", "of", "FM."], "wordsB": ["The", "FDA", "approvals", "of", "Lyrica,", "Cymbalta", "and", "Savella", "establish", "a", "regulatory", "approval", "standard", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p25_s1", "idA": "1430306_12_item1_p72_s1", "sentA": "The phase 3 study design will be discussed with the FDA at the EOP2 meeting to receive regulatory acceptance for a differentiated product for the management of FM.", "sentB": "We held a Pre-Phase 3 meeting with the FDA in February 2013, at which we discussed the design of the clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "The", "phase", "3", "study", "design", "will", "be", "discussed", "with", "the", "FDA", "at", "the", "EOP2", "meeting", "to", "receive", "regulatory", "acceptance", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM.", "<tag2>", "We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["The", "phase", "3", "study", "design", "will", "be", "discussed", "with", "the", "FDA", "at", "the", "EOP2", "meeting", "to", "receive", "regulatory", "acceptance", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM."], "wordsB": ["We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p87_s2", "idA": "1430306_12_item1_p72_s1", "sentA": "The phase 3 study design will be discussed with the FDA at the EOP2 meeting to receive regulatory acceptance for a differentiated product for the management of FM.", "sentB": "We held a Pre-Phase 3 meeting with the FDA in February 2013, at which we discussed the nature and extent of the Phase 2b and Phase 3 clinical trials we need to conduct to so as to receive regulatory acceptance of our proposed NDA plan for a differentiated product for the management of FM.", "type": 2, "words": ["<tag1>", "The", "phase", "3", "study", "design", "will", "be", "discussed", "with", "the", "FDA", "at", "the", "EOP2", "meeting", "to", "receive", "regulatory", "acceptance", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM.", "<tag2>", "We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "Phase", "2b", "and", "Phase", "3", "clinical", "trials", "we", "need", "to", "conduct", "to", "so", "as", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["The", "phase", "3", "study", "design", "will", "be", "discussed", "with", "the", "FDA", "at", "the", "EOP2", "meeting", "to", "receive", "regulatory", "acceptance", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM."], "wordsB": ["We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "Phase", "2b", "and", "Phase", "3", "clinical", "trials", "we", "need", "to", "conduct", "to", "so", "as", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p85_s2", "idA": "1430306_12_item1_p73_s0", "sentA": "We hope to register TNX-102 with the FDA through the provisions of Section 505(b)(2).", "sentB": "We hope to register TNX-102 SL with the FDA through the provisions of Section 505(b)(2).", "type": 2, "words": ["<tag1>", "We", "hope", "to", "register", "TNX-102", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2).", "<tag2>", "We", "hope", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2).", "<tag3>"], "wordsA": ["We", "hope", "to", "register", "TNX-102", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2)."], "wordsB": ["We", "hope", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p86_s0", "idA": "1430306_12_item1_p74_s0", "sentA": "The 505(b)(2)-based product development plan for TNX-102 is designed to leverage the safety data that has been generated by other manufacturers for cyclobenzaprine-containing products and accepted by the FDA in support of their product registration.", "sentB": "The 505(b)(2)-based product development plan for TNX-102 SL is designed to leverage the safety data that have been generated by other manufacturers for CBP-containing products and accepted by the FDA in support of their product registrations, in addition to the safety data we generate.", "type": 2, "words": ["<tag1>", "The", "505(b)(2)-based", "product", "development", "plan", "for", "TNX-102", "is", "designed", "to", "leverage", "the", "safety", "data", "that", "has", "been", "generated", "by", "other", "manufacturers", "for", "cyclobenzaprine-containing", "products", "and", "accepted", "by", "the", "FDA", "in", "support", "of", "their", "product", "registration.", "<tag2>", "The", "505(b)(2)-based", "product", "development", "plan", "for", "TNX-102", "SL", "is", "designed", "to", "leverage", "the", "safety", "data", "that", "have", "been", "generated", "by", "other", "manufacturers", "for", "CBP-containing", "products", "and", "accepted", "by", "the", "FDA", "in", "support", "of", "their", "product", "registrations,", "in", "addition", "to", "the", "safety", "data", "we", "generate.", "<tag3>"], "wordsA": ["The", "505(b)(2)-based", "product", "development", "plan", "for", "TNX-102", "is", "designed", "to", "leverage", "the", "safety", "data", "that", "has", "been", "generated", "by", "other", "manufacturers", "for", "cyclobenzaprine-containing", "products", "and", "accepted", "by", "the", "FDA", "in", "support", "of", "their", "product", "registration."], "wordsB": ["The", "505(b)(2)-based", "product", "development", "plan", "for", "TNX-102", "SL", "is", "designed", "to", "leverage", "the", "safety", "data", "that", "have", "been", "generated", "by", "other", "manufacturers", "for", "CBP-containing", "products", "and", "accepted", "by", "the", "FDA", "in", "support", "of", "their", "product", "registrations,", "in", "addition", "to", "the", "safety", "data", "we", "generate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p87_s0", "idA": "1430306_12_item1_p75_s0", "sentA": "TNX-102 contains significantly less active cyclobenzaprine than other marketed products.", "sentB": "TNX-102 SL contains significantly less active CBP than other marketed products.", "type": 2, "words": ["<tag1>", "TNX-102", "contains", "significantly", "less", "active", "cyclobenzaprine", "than", "other", "marketed", "products.", "<tag2>", "TNX-102", "SL", "contains", "significantly", "less", "active", "CBP", "than", "other", "marketed", "products.", "<tag3>"], "wordsA": ["TNX-102", "contains", "significantly", "less", "active", "cyclobenzaprine", "than", "other", "marketed", "products."], "wordsB": ["TNX-102", "SL", "contains", "significantly", "less", "active", "CBP", "than", "other", "marketed", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p87_s1", "idA": "1430306_12_item1_p75_s1", "sentA": "We believe that the safety data package from these products will provide adequate safety margin to support TNX-102 development.", "sentB": "We believe that the safety data package from these products and the CBP prescriptions utilization database analyzed by IMS Health Incorporated will provide adequate safety margin to support TNX-102 SL development.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "safety", "data", "package", "from", "these", "products", "will", "provide", "adequate", "safety", "margin", "to", "support", "TNX-102", "development.", "<tag2>", "We", "believe", "that", "the", "safety", "data", "package", "from", "these", "products", "and", "the", "CBP", "prescriptions", "utilization", "database", "analyzed", "by", "IMS", "Health", "Incorporated", "will", "provide", "adequate", "safety", "margin", "to", "support", "TNX-102", "SL", "development.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "safety", "data", "package", "from", "these", "products", "will", "provide", "adequate", "safety", "margin", "to", "support", "TNX-102", "development."], "wordsB": ["We", "believe", "that", "the", "safety", "data", "package", "from", "these", "products", "and", "the", "CBP", "prescriptions", "utilization", "database", "analyzed", "by", "IMS", "Health", "Incorporated", "will", "provide", "adequate", "safety", "margin", "to", "support", "TNX-102", "SL", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p166_s1", "idA": "1430306_12_item1_p76_s0", "sentA": "On August 11, 2011, we had a pre-IND meeting with the Division of Anesthesia, Analgesia and Addiction Products within the Center for Drug Evaluation and Research at the FDA to discuss the IND and NDA requirement of TNX-102 for the management of FM.", "sentB": "In February 2013, we held a Pre-Phase 3 meeting with the FDA to discuss the clinical and nonclinical requirements to register TNX-102 SL for the management of FM based on the 505(b)(2) regulatory pathway.", "type": 2, "words": ["<tag1>", "On", "August", "11,", "2011,", "we", "had", "a", "pre-IND", "meeting", "with", "the", "Division", "of", "Anesthesia,", "Analgesia", "and", "Addiction", "Products", "within", "the", "Center", "for", "Drug", "Evaluation", "and", "Research", "at", "the", "FDA", "to", "discuss", "the", "IND", "and", "NDA", "requirement", "of", "TNX-102", "for", "the", "management", "of", "FM.", "<tag2>", "In", "February", "2013,", "we", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "to", "discuss", "the", "clinical", "and", "nonclinical", "requirements", "to", "register", "TNX-102", "SL", "for", "the", "management", "of", "FM", "based", "on", "the", "505(b)(2)", "regulatory", "pathway.", "<tag3>"], "wordsA": ["On", "August", "11,", "2011,", "we", "had", "a", "pre-IND", "meeting", "with", "the", "Division", "of", "Anesthesia,", "Analgesia", "and", "Addiction", "Products", "within", "the", "Center", "for", "Drug", "Evaluation", "and", "Research", "at", "the", "FDA", "to", "discuss", "the", "IND", "and", "NDA", "requirement", "of", "TNX-102", "for", "the", "management", "of", "FM."], "wordsB": ["In", "February", "2013,", "we", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "to", "discuss", "the", "clinical", "and", "nonclinical", "requirements", "to", "register", "TNX-102", "SL", "for", "the", "management", "of", "FM", "based", "on", "the", "505(b)(2)", "regulatory", "pathway."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p30_s2", "idA": "1430306_12_item1_p76_s0", "sentA": "On August 11, 2011, we had a pre-IND meeting with the Division of Anesthesia, Analgesia and Addiction Products within the Center for Drug Evaluation and Research at the FDA to discuss the IND and NDA requirement of TNX-102 for the management of FM.", "sentB": "Although we had met with the FDA to discuss the TNX-102 gelcap development program in August 2011 and we have generated clinical data that support the further development of TNX-102 gelcap, we currently do not plan to advance this candidate.", "type": 2, "words": ["<tag1>", "On", "August", "11,", "2011,", "we", "had", "a", "pre-IND", "meeting", "with", "the", "Division", "of", "Anesthesia,", "Analgesia", "and", "Addiction", "Products", "within", "the", "Center", "for", "Drug", "Evaluation", "and", "Research", "at", "the", "FDA", "to", "discuss", "the", "IND", "and", "NDA", "requirement", "of", "TNX-102", "for", "the", "management", "of", "FM.", "<tag2>", "Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate.", "<tag3>"], "wordsA": ["On", "August", "11,", "2011,", "we", "had", "a", "pre-IND", "meeting", "with", "the", "Division", "of", "Anesthesia,", "Analgesia", "and", "Addiction", "Products", "within", "the", "Center", "for", "Drug", "Evaluation", "and", "Research", "at", "the", "FDA", "to", "discuss", "the", "IND", "and", "NDA", "requirement", "of", "TNX-102", "for", "the", "management", "of", "FM."], "wordsB": ["Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p60_s5", "idA": "1430306_12_item1_p76_s0", "sentA": "On August 11, 2011, we had a pre-IND meeting with the Division of Anesthesia, Analgesia and Addiction Products within the Center for Drug Evaluation and Research at the FDA to discuss the IND and NDA requirement of TNX-102 for the management of FM.", "sentB": "Although we had met with the FDA to discuss the TNX-102 gelcap development program in August 2011 and we have generated clinical data that support the further development of TNX-102 gelcap, we currently do not plan to advance this candidate.", "type": 2, "words": ["<tag1>", "On", "August", "11,", "2011,", "we", "had", "a", "pre-IND", "meeting", "with", "the", "Division", "of", "Anesthesia,", "Analgesia", "and", "Addiction", "Products", "within", "the", "Center", "for", "Drug", "Evaluation", "and", "Research", "at", "the", "FDA", "to", "discuss", "the", "IND", "and", "NDA", "requirement", "of", "TNX-102", "for", "the", "management", "of", "FM.", "<tag2>", "Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate.", "<tag3>"], "wordsA": ["On", "August", "11,", "2011,", "we", "had", "a", "pre-IND", "meeting", "with", "the", "Division", "of", "Anesthesia,", "Analgesia", "and", "Addiction", "Products", "within", "the", "Center", "for", "Drug", "Evaluation", "and", "Research", "at", "the", "FDA", "to", "discuss", "the", "IND", "and", "NDA", "requirement", "of", "TNX-102", "for", "the", "management", "of", "FM."], "wordsB": ["Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p89_s1", "idA": "1430306_12_item1_p76_s0", "sentA": "On August 11, 2011, we had a pre-IND meeting with the Division of Anesthesia, Analgesia and Addiction Products within the Center for Drug Evaluation and Research at the FDA to discuss the IND and NDA requirement of TNX-102 for the management of FM.", "sentB": "We held a pre-IND meeting with the FDA in October 2012, at which our clinical program for PTSD was discussed.", "type": 2, "words": ["<tag1>", "On", "August", "11,", "2011,", "we", "had", "a", "pre-IND", "meeting", "with", "the", "Division", "of", "Anesthesia,", "Analgesia", "and", "Addiction", "Products", "within", "the", "Center", "for", "Drug", "Evaluation", "and", "Research", "at", "the", "FDA", "to", "discuss", "the", "IND", "and", "NDA", "requirement", "of", "TNX-102", "for", "the", "management", "of", "FM.", "<tag2>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "at", "which", "our", "clinical", "program", "for", "PTSD", "was", "discussed.", "<tag3>"], "wordsA": ["On", "August", "11,", "2011,", "we", "had", "a", "pre-IND", "meeting", "with", "the", "Division", "of", "Anesthesia,", "Analgesia", "and", "Addiction", "Products", "within", "the", "Center", "for", "Drug", "Evaluation", "and", "Research", "at", "the", "FDA", "to", "discuss", "the", "IND", "and", "NDA", "requirement", "of", "TNX-102", "for", "the", "management", "of", "FM."], "wordsB": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "at", "which", "our", "clinical", "program", "for", "PTSD", "was", "discussed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p88_s0", "idA": "1430306_12_item1_p77_s0", "sentA": "If NDA approval is granted for TNX-102, in addition to the 3-year marketing exclusivity granted, TNX-102 is expected to be covered under patents that extend through at least 2021, during which time it should not be subject to generic substitution.", "sentB": "If NDA approval of TNX-102 SL is granted, in addition to the three-year marketing exclusivity granted by law, we expect this product to be protected by patents that extend through at least 2021, during which time it should not be subject to generic substitution.", "type": 2, "words": ["<tag1>", "If", "NDA", "approval", "is", "granted", "for", "TNX-102,", "in", "addition", "to", "the", "3-year", "marketing", "exclusivity", "granted,", "TNX-102", "is", "expected", "to", "be", "covered", "under", "patents", "that", "extend", "through", "at", "least", "2021,", "during", "which", "time", "it", "should", "not", "be", "subject", "to", "generic", "substitution.", "<tag2>", "If", "NDA", "approval", "of", "TNX-102", "SL", "is", "granted,", "in", "addition", "to", "the", "three-year", "marketing", "exclusivity", "granted", "by", "law,", "we", "expect", "this", "product", "to", "be", "protected", "by", "patents", "that", "extend", "through", "at", "least", "2021,", "during", "which", "time", "it", "should", "not", "be", "subject", "to", "generic", "substitution.", "<tag3>"], "wordsA": ["If", "NDA", "approval", "is", "granted", "for", "TNX-102,", "in", "addition", "to", "the", "3-year", "marketing", "exclusivity", "granted,", "TNX-102", "is", "expected", "to", "be", "covered", "under", "patents", "that", "extend", "through", "at", "least", "2021,", "during", "which", "time", "it", "should", "not", "be", "subject", "to", "generic", "substitution."], "wordsB": ["If", "NDA", "approval", "of", "TNX-102", "SL", "is", "granted,", "in", "addition", "to", "the", "three-year", "marketing", "exclusivity", "granted", "by", "law,", "we", "expect", "this", "product", "to", "be", "protected", "by", "patents", "that", "extend", "through", "at", "least", "2021,", "during", "which", "time", "it", "should", "not", "be", "subject", "to", "generic", "substitution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p88_s1", "idA": "1430306_12_item1_p77_s1", "sentA": "We plan to continue to support the TNX-102 program with new patent applications as we obtain data from the clinical evaluation of our new formulation in healthy human subjects and FM patients.", "sentB": "We plan to continue to support the TNX-102 SL program with new patent applications as we obtain data from the clinical evaluation of our new formulation in healthy human subjects and in FM patients.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "support", "the", "TNX-102", "program", "with", "new", "patent", "applications", "as", "we", "obtain", "data", "from", "the", "clinical", "evaluation", "of", "our", "new", "formulation", "in", "healthy", "human", "subjects", "and", "FM", "patients.", "<tag2>", "We", "plan", "to", "continue", "to", "support", "the", "TNX-102", "SL", "program", "with", "new", "patent", "applications", "as", "we", "obtain", "data", "from", "the", "clinical", "evaluation", "of", "our", "new", "formulation", "in", "healthy", "human", "subjects", "and", "in", "FM", "patients.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "support", "the", "TNX-102", "program", "with", "new", "patent", "applications", "as", "we", "obtain", "data", "from", "the", "clinical", "evaluation", "of", "our", "new", "formulation", "in", "healthy", "human", "subjects", "and", "FM", "patients."], "wordsB": ["We", "plan", "to", "continue", "to", "support", "the", "TNX-102", "SL", "program", "with", "new", "patent", "applications", "as", "we", "obtain", "data", "from", "the", "clinical", "evaluation", "of", "our", "new", "formulation", "in", "healthy", "human", "subjects", "and", "in", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p62_s1", "idA": "1430306_12_item1_p79_s1", "sentA": "In addition, symptom overlaps may exist between patients diagnosed with FM or PTSD.", "sentB": "We believe that CBP exerts its benefit in FM via its ability to improve the restorative quality of sleep, which has been shown to be frequently impaired in patients with FM or PTSD.", "type": 2, "words": ["<tag1>", "In", "addition,", "symptom", "overlaps", "may", "exist", "between", "patients", "diagnosed", "with", "FM", "or", "PTSD.", "<tag2>", "We", "believe", "that", "CBP", "exerts", "its", "benefit", "in", "FM", "via", "its", "ability", "to", "improve", "the", "restorative", "quality", "of", "sleep,", "which", "has", "been", "shown", "to", "be", "frequently", "impaired", "in", "patients", "with", "FM", "or", "PTSD.", "<tag3>"], "wordsA": ["In", "addition,", "symptom", "overlaps", "may", "exist", "between", "patients", "diagnosed", "with", "FM", "or", "PTSD."], "wordsB": ["We", "believe", "that", "CBP", "exerts", "its", "benefit", "in", "FM", "via", "its", "ability", "to", "improve", "the", "restorative", "quality", "of", "sleep,", "which", "has", "been", "shown", "to", "be", "frequently", "impaired", "in", "patients", "with", "FM", "or", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p90_s2", "idA": "1430306_12_item1_p79_s2", "sentA": "61(5):663-9.2006), 49% of PTSD patients met the ACR criteria for FM compared to 5% of major depression patients.", "sentB": "Res. 2006, 61(5):663-9), 49% of PTSD patients met the ACR criteria for FM compared to 5% of major depression patients.", "type": 2, "words": ["<tag1>", "61(5):663-9.2006),", "49%", "of", "PTSD", "patients", "met", "the", "ACR", "criteria", "for", "FM", "compared", "to", "5%", "of", "major", "depression", "patients.", "<tag2>", "Res.", "2006,", "61(5):663-9),", "49%", "of", "PTSD", "patients", "met", "the", "ACR", "criteria", "for", "FM", "compared", "to", "5%", "of", "major", "depression", "patients.", "<tag3>"], "wordsA": ["61(5):663-9.2006),", "49%", "of", "PTSD", "patients", "met", "the", "ACR", "criteria", "for", "FM", "compared", "to", "5%", "of", "major", "depression", "patients."], "wordsB": ["Res.", "2006,", "61(5):663-9),", "49%", "of", "PTSD", "patients", "met", "the", "ACR", "criteria", "for", "FM", "compared", "to", "5%", "of", "major", "depression", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p90_s3", "idA": "1430306_12_item1_p79_s3", "sentA": "32(1):38-50), 57% of the sample had symptoms associated with PTSD.", "sentB": "Arthritis Rheum. 2002, 32(1):38-50), 57% of the sample had symptoms associated with PTSD.", "type": 2, "words": ["<tag1>", "32(1):38-50),", "57%", "of", "the", "sample", "had", "symptoms", "associated", "with", "PTSD.", "<tag2>", "Arthritis", "Rheum.", "2002,", "32(1):38-50),", "57%", "of", "the", "sample", "had", "symptoms", "associated", "with", "PTSD.", "<tag3>"], "wordsA": ["32(1):38-50),", "57%", "of", "the", "sample", "had", "symptoms", "associated", "with", "PTSD."], "wordsB": ["Arthritis", "Rheum.", "2002,", "32(1):38-50),", "57%", "of", "the", "sample", "had", "symptoms", "associated", "with", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p98_s1", "idA": "1430306_12_item1_p79_s3", "sentA": "32(1):38-50), 57% of the sample had symptoms associated with PTSD.", "sentB": "This will be a randomized, double-blind, placebo-controlled, crossover study in subjects with PTSD.", "type": 2, "words": ["<tag1>", "32(1):38-50),", "57%", "of", "the", "sample", "had", "symptoms", "associated", "with", "PTSD.", "<tag2>", "This", "will", "be", "a", "randomized,", "double-blind,", "placebo-controlled,", "crossover", "study", "in", "subjects", "with", "PTSD.", "<tag3>"], "wordsA": ["32(1):38-50),", "57%", "of", "the", "sample", "had", "symptoms", "associated", "with", "PTSD."], "wordsB": ["This", "will", "be", "a", "randomized,", "double-blind,", "placebo-controlled,", "crossover", "study", "in", "subjects", "with", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p93_s0", "idA": "1430306_12_item1_p81_s0", "sentA": "Our rationale for studying the effects of cyclobenzaprine in PTSD derives from the following:", "sentB": "Our rationale for studying the effects of CBP in PTSD derives from the following:", "type": 2, "words": ["<tag1>", "Our", "rationale", "for", "studying", "the", "effects", "of", "cyclobenzaprine", "in", "PTSD", "derives", "from", "the", "following:", "<tag2>", "Our", "rationale", "for", "studying", "the", "effects", "of", "CBP", "in", "PTSD", "derives", "from", "the", "following:", "<tag3>"], "wordsA": ["Our", "rationale", "for", "studying", "the", "effects", "of", "cyclobenzaprine", "in", "PTSD", "derives", "from", "the", "following:"], "wordsB": ["Our", "rationale", "for", "studying", "the", "effects", "of", "CBP", "in", "PTSD", "derives", "from", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p94_s0", "idA": "1430306_12_item1_p82_s0", "sentA": "in studies conducted by Caliper, cyclobenzaprine interacts with a receptor on brain cells called the serotonin type 2a receptor.", "sentB": "in studies conducted by Caliper, CBP interacts with a receptor on brain cells called the serotonin type 2a receptor.", "type": 2, "words": ["<tag1>", "in", "studies", "conducted", "by", "Caliper,", "cyclobenzaprine", "interacts", "with", "a", "receptor", "on", "brain", "cells", "called", "the", "serotonin", "type", "2a", "receptor.", "<tag2>", "in", "studies", "conducted", "by", "Caliper,", "CBP", "interacts", "with", "a", "receptor", "on", "brain", "cells", "called", "the", "serotonin", "type", "2a", "receptor.", "<tag3>"], "wordsA": ["in", "studies", "conducted", "by", "Caliper,", "cyclobenzaprine", "interacts", "with", "a", "receptor", "on", "brain", "cells", "called", "the", "serotonin", "type", "2a", "receptor."], "wordsB": ["in", "studies", "conducted", "by", "Caliper,", "CBP", "interacts", "with", "a", "receptor", "on", "brain", "cells", "called", "the", "serotonin", "type", "2a", "receptor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p94_s2", "idA": "1430306_12_item1_p82_s2", "sentA": "Therefore, it is our belief that cyclobenzaprine, because it binds to the serotonin type 2a receptor, will have a therapeutic effect in treating PTSD like other compounds that bind to it.", "sentB": "Therefore, it is our belief that CBP, because it binds to the serotonin type 2a receptor, will have a therapeutic effect in treating PTSD.", "type": 2, "words": ["<tag1>", "Therefore,", "it", "is", "our", "belief", "that", "cyclobenzaprine,", "because", "it", "binds", "to", "the", "serotonin", "type", "2a", "receptor,", "will", "have", "a", "therapeutic", "effect", "in", "treating", "PTSD", "like", "other", "compounds", "that", "bind", "to", "it.", "<tag2>", "Therefore,", "it", "is", "our", "belief", "that", "CBP,", "because", "it", "binds", "to", "the", "serotonin", "type", "2a", "receptor,", "will", "have", "a", "therapeutic", "effect", "in", "treating", "PTSD.", "<tag3>"], "wordsA": ["Therefore,", "it", "is", "our", "belief", "that", "cyclobenzaprine,", "because", "it", "binds", "to", "the", "serotonin", "type", "2a", "receptor,", "will", "have", "a", "therapeutic", "effect", "in", "treating", "PTSD", "like", "other", "compounds", "that", "bind", "to", "it."], "wordsB": ["Therefore,", "it", "is", "our", "belief", "that", "CBP,", "because", "it", "binds", "to", "the", "serotonin", "type", "2a", "receptor,", "will", "have", "a", "therapeutic", "effect", "in", "treating", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p95_s2", "idA": "1430306_12_item1_p85_s0", "sentA": "Caliper provided us proprietary data from their database, which showed cyclobenzaprine binds to the serotonin type 2a receptor.", "sentB": "Results from a series of binding and functional studies show that both of these molecules are potent antagonists of the serotonin type 2a and the histamine H1 receptors, which known to have effects on sleep and sleep maintenance.", "type": 2, "words": ["<tag1>", "Caliper", "provided", "us", "proprietary", "data", "from", "their", "database,", "which", "showed", "cyclobenzaprine", "binds", "to", "the", "serotonin", "type", "2a", "receptor.", "<tag2>", "Results", "from", "a", "series", "of", "binding", "and", "functional", "studies", "show", "that", "both", "of", "these", "molecules", "are", "potent", "antagonists", "of", "the", "serotonin", "type", "2a", "and", "the", "histamine", "H1", "receptors,", "which", "known", "to", "have", "effects", "on", "sleep", "and", "sleep", "maintenance.", "<tag3>"], "wordsA": ["Caliper", "provided", "us", "proprietary", "data", "from", "their", "database,", "which", "showed", "cyclobenzaprine", "binds", "to", "the", "serotonin", "type", "2a", "receptor."], "wordsB": ["Results", "from", "a", "series", "of", "binding", "and", "functional", "studies", "show", "that", "both", "of", "these", "molecules", "are", "potent", "antagonists", "of", "the", "serotonin", "type", "2a", "and", "the", "histamine", "H1", "receptors,", "which", "known", "to", "have", "effects", "on", "sleep", "and", "sleep", "maintenance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p96_s0", "idA": "1430306_12_item1_p86_s0", "sentA": "We anticipate that the dose for treatment of PTSD symptoms may be higher than that of TNX-102 for FM.", "sentB": "We anticipate that the dose of TNX-102 SL sufficient to treat PTSD symptoms may be higher than that sufficient to treat FM.", "type": 2, "words": ["<tag1>", "We", "anticipate", "that", "the", "dose", "for", "treatment", "of", "PTSD", "symptoms", "may", "be", "higher", "than", "that", "of", "TNX-102", "for", "FM.", "<tag2>", "We", "anticipate", "that", "the", "dose", "of", "TNX-102", "SL", "sufficient", "to", "treat", "PTSD", "symptoms", "may", "be", "higher", "than", "that", "sufficient", "to", "treat", "FM.", "<tag3>"], "wordsA": ["We", "anticipate", "that", "the", "dose", "for", "treatment", "of", "PTSD", "symptoms", "may", "be", "higher", "than", "that", "of", "TNX-102", "for", "FM."], "wordsB": ["We", "anticipate", "that", "the", "dose", "of", "TNX-102", "SL", "sufficient", "to", "treat", "PTSD", "symptoms", "may", "be", "higher", "than", "that", "sufficient", "to", "treat", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p96_s1", "idA": "1430306_12_item1_p86_s1", "sentA": "We plan to utilize the data obtained from the pharmacokinetic study of TNX-102 to design a Phase 2a study for TNX-105.", "sentB": "We plan to utilize the data obtained from our pharmacokinetic studies of TNX-102 SL to inform the design of efficacy trials in PTSD.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "utilize", "the", "data", "obtained", "from", "the", "pharmacokinetic", "study", "of", "TNX-102", "to", "design", "a", "Phase", "2a", "study", "for", "TNX-105.", "<tag2>", "We", "plan", "to", "utilize", "the", "data", "obtained", "from", "our", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "to", "inform", "the", "design", "of", "efficacy", "trials", "in", "PTSD.", "<tag3>"], "wordsA": ["We", "plan", "to", "utilize", "the", "data", "obtained", "from", "the", "pharmacokinetic", "study", "of", "TNX-102", "to", "design", "a", "Phase", "2a", "study", "for", "TNX-105."], "wordsB": ["We", "plan", "to", "utilize", "the", "data", "obtained", "from", "our", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "to", "inform", "the", "design", "of", "efficacy", "trials", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p78_s2", "idA": "1430306_12_item1_p88_s1", "sentA": "We expect to engage a CRO to conduct this study on our behalf.", "sentB": "We expect to enroll 100-200 patients into this study.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "engage", "a", "CRO", "to", "conduct", "this", "study", "on", "our", "behalf.", "<tag2>", "We", "expect", "to", "enroll", "100-200", "patients", "into", "this", "study.", "<tag3>"], "wordsA": ["We", "expect", "to", "engage", "a", "CRO", "to", "conduct", "this", "study", "on", "our", "behalf."], "wordsB": ["We", "expect", "to", "enroll", "100-200", "patients", "into", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p79_s3", "idA": "1430306_12_item1_p88_s1", "sentA": "We expect to engage a CRO to conduct this study on our behalf.", "sentB": "We expect to engage a clinical research organization, or CRO, to conduct and manage this study under our direction.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "engage", "a", "CRO", "to", "conduct", "this", "study", "on", "our", "behalf.", "<tag2>", "We", "expect", "to", "engage", "a", "clinical", "research", "organization,", "or", "CRO,", "to", "conduct", "and", "manage", "this", "study", "under", "our", "direction.", "<tag3>"], "wordsA": ["We", "expect", "to", "engage", "a", "CRO", "to", "conduct", "this", "study", "on", "our", "behalf."], "wordsB": ["We", "expect", "to", "engage", "a", "clinical", "research", "organization,", "or", "CRO,", "to", "conduct", "and", "manage", "this", "study", "under", "our", "direction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p99_s0", "idA": "1430306_12_item1_p91_s0", "sentA": "If our Phase 2b study is successful, we expect to conduct a Phase 3 program in support of an NDA.", "sentB": "If our Phase 2 trial of TNX-102 SL in PTSD is successful, we intend to conduct two multicenter, double-blind, placebo-controlled, Phase 3 studies designed to evaluate the efficacy, safety, and tolerability of TNX-102 SL in patients with PTSD.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2b", "study", "is", "successful,", "we", "expect", "to", "conduct", "a", "Phase", "3", "program", "in", "support", "of", "an", "NDA.", "<tag2>", "If", "our", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "intend", "to", "conduct", "two", "multicenter,", "double-blind,", "placebo-controlled,", "Phase", "3", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "TNX-102", "SL", "in", "patients", "with", "PTSD.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2b", "study", "is", "successful,", "we", "expect", "to", "conduct", "a", "Phase", "3", "program", "in", "support", "of", "an", "NDA."], "wordsB": ["If", "our", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "intend", "to", "conduct", "two", "multicenter,", "double-blind,", "placebo-controlled,", "Phase", "3", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "TNX-102", "SL", "in", "patients", "with", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p100_s1", "idA": "1430306_12_item1_p92_s2", "sentA": "We believe these studies will result in a differentiated product for the treatment of PTSD.", "sentB": "We believe our clinical development program of TNX-102 SL and the chronic safety data generated from the TNX-102 SL FM NDA program will result in a differentiated product suitable for chronic use for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "these", "studies", "will", "result", "in", "a", "differentiated", "product", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "chronic", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "FM", "NDA", "program", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "these", "studies", "will", "result", "in", "a", "differentiated", "product", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "chronic", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "FM", "NDA", "program", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p100_s2", "idA": "1430306_12_item1_p93_s1", "sentA": "We believe that the clinical trials in our development plan, if successful, will satisfy the requirements for sufficient evidence of clinical efficacy and safety to support an NDA.", "sentB": "We believe that our planned clinical trials in PTSD, if successful, will provide sufficient evidence of clinical efficacy and safety to support a 505(b)(2) NDA for TNX-102 SL for the management of PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "clinical", "trials", "in", "our", "development", "plan,", "if", "successful,", "will", "satisfy", "the", "requirements", "for", "sufficient", "evidence", "of", "clinical", "efficacy", "and", "safety", "to", "support", "an", "NDA.", "<tag2>", "We", "believe", "that", "our", "planned", "clinical", "trials", "in", "PTSD,", "if", "successful,", "will", "provide", "sufficient", "evidence", "of", "clinical", "efficacy", "and", "safety", "to", "support", "a", "505(b)(2)", "NDA", "for", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "clinical", "trials", "in", "our", "development", "plan,", "if", "successful,", "will", "satisfy", "the", "requirements", "for", "sufficient", "evidence", "of", "clinical", "efficacy", "and", "safety", "to", "support", "an", "NDA."], "wordsB": ["We", "believe", "that", "our", "planned", "clinical", "trials", "in", "PTSD,", "if", "successful,", "will", "provide", "sufficient", "evidence", "of", "clinical", "efficacy", "and", "safety", "to", "support", "a", "505(b)(2)", "NDA", "for", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p48_s5", "idA": "1430306_12_item1_p94_s1", "sentA": "The USPTO has not yet allowed or granted any claims protecting the use of TNX-105.", "sentB": "For example, we filed a patent application seeking to protect the use of CBP in PTSD.", "type": 2, "words": ["<tag1>", "The", "USPTO", "has", "not", "yet", "allowed", "or", "granted", "any", "claims", "protecting", "the", "use", "of", "TNX-105.", "<tag2>", "For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD.", "<tag3>"], "wordsA": ["The", "USPTO", "has", "not", "yet", "allowed", "or", "granted", "any", "claims", "protecting", "the", "use", "of", "TNX-105."], "wordsB": ["For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p72_s1", "idA": "1430306_12_item1_p95_s0", "sentA": "We are investigating different technologies to improve the absorption of cyclobenzaprine.", "sentB": "We believe that CBP exerts its benefit in FM via its ability to improve the restorative quality of sleep, which has been shown to be frequently impaired in patients with FM.", "type": 2, "words": ["<tag1>", "We", "are", "investigating", "different", "technologies", "to", "improve", "the", "absorption", "of", "cyclobenzaprine.", "<tag2>", "We", "believe", "that", "CBP", "exerts", "its", "benefit", "in", "FM", "via", "its", "ability", "to", "improve", "the", "restorative", "quality", "of", "sleep,", "which", "has", "been", "shown", "to", "be", "frequently", "impaired", "in", "patients", "with", "FM.", "<tag3>"], "wordsA": ["We", "are", "investigating", "different", "technologies", "to", "improve", "the", "absorption", "of", "cyclobenzaprine."], "wordsB": ["We", "believe", "that", "CBP", "exerts", "its", "benefit", "in", "FM", "via", "its", "ability", "to", "improve", "the", "restorative", "quality", "of", "sleep,", "which", "has", "been", "shown", "to", "be", "frequently", "impaired", "in", "patients", "with", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p103_s1", "idA": "1430306_12_item1_p95_s1", "sentA": "For example, we identified and obtained an exclusive worldwide option on technology from Lipocine, Inc. ( Lipocine ) that employs mixtures of different types of lipids.", "sentB": "Pursuant to the Feasibility Agreement, we identified and obtained an exclusive worldwide option on technology from Lipocine that employs mixtures of different types of lipids to envelop CBP molecules in the small intestine and facilitate absorption into the bloodstream.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "identified", "and", "obtained", "an", "exclusive", "worldwide", "option", "on", "technology", "from", "Lipocine,", "Inc.", "(", "Lipocine", ")", "that", "employs", "mixtures", "of", "different", "types", "of", "lipids.", "<tag2>", "Pursuant", "to", "the", "Feasibility", "Agreement,", "we", "identified", "and", "obtained", "an", "exclusive", "worldwide", "option", "on", "technology", "from", "Lipocine", "that", "employs", "mixtures", "of", "different", "types", "of", "lipids", "to", "envelop", "CBP", "molecules", "in", "the", "small", "intestine", "and", "facilitate", "absorption", "into", "the", "bloodstream.", "<tag3>"], "wordsA": ["For", "example,", "we", "identified", "and", "obtained", "an", "exclusive", "worldwide", "option", "on", "technology", "from", "Lipocine,", "Inc.", "(", "Lipocine", ")", "that", "employs", "mixtures", "of", "different", "types", "of", "lipids."], "wordsB": ["Pursuant", "to", "the", "Feasibility", "Agreement,", "we", "identified", "and", "obtained", "an", "exclusive", "worldwide", "option", "on", "technology", "from", "Lipocine", "that", "employs", "mixtures", "of", "different", "types", "of", "lipids", "to", "envelop", "CBP", "molecules", "in", "the", "small", "intestine", "and", "facilitate", "absorption", "into", "the", "bloodstream."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p105_s0", "idA": "1430306_12_item1_p95_s2", "sentA": "Under our agreement, Lipocine studied a number of combinations of lipids for their ability to form micelles that solubilize the free base of cyclobenzaprine and which might serve as inactive ingredients in a gelatin capsule formulation.", "sentB": "Under the Feasibility Agreement, Lipocine completed the Stage I work, which involved studying a number of combinations of lipids for their ability to form micelles that solubilize the free base of CBP and which might serve as inactive ingredients in a gelatin capsule formulation.", "type": 2, "words": ["<tag1>", "Under", "our", "agreement,", "Lipocine", "studied", "a", "number", "of", "combinations", "of", "lipids", "for", "their", "ability", "to", "form", "micelles", "that", "solubilize", "the", "free", "base", "of", "cyclobenzaprine", "and", "which", "might", "serve", "as", "inactive", "ingredients", "in", "a", "gelatin", "capsule", "formulation.", "<tag2>", "Under", "the", "Feasibility", "Agreement,", "Lipocine", "completed", "the", "Stage", "I", "work,", "which", "involved", "studying", "a", "number", "of", "combinations", "of", "lipids", "for", "their", "ability", "to", "form", "micelles", "that", "solubilize", "the", "free", "base", "of", "CBP", "and", "which", "might", "serve", "as", "inactive", "ingredients", "in", "a", "gelatin", "capsule", "formulation.", "<tag3>"], "wordsA": ["Under", "our", "agreement,", "Lipocine", "studied", "a", "number", "of", "combinations", "of", "lipids", "for", "their", "ability", "to", "form", "micelles", "that", "solubilize", "the", "free", "base", "of", "cyclobenzaprine", "and", "which", "might", "serve", "as", "inactive", "ingredients", "in", "a", "gelatin", "capsule", "formulation."], "wordsB": ["Under", "the", "Feasibility", "Agreement,", "Lipocine", "completed", "the", "Stage", "I", "work,", "which", "involved", "studying", "a", "number", "of", "combinations", "of", "lipids", "for", "their", "ability", "to", "form", "micelles", "that", "solubilize", "the", "free", "base", "of", "CBP", "and", "which", "might", "serve", "as", "inactive", "ingredients", "in", "a", "gelatin", "capsule", "formulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p105_s1", "idA": "1430306_12_item1_p95_s3", "sentA": "We selected a candidate formulation based on properties that included the dispersion of the active ingredient in simulated gastric or small-intestinal fluids and the stability of the formulation over time prior to testing.", "sentB": "We selected a candidate formulation, TNX-102 gelcap, based on properties that included the dispersion of the active ingredient in simulated gastric or small-intestinal fluids and the stability of the formulation over time prior to testing.", "type": 2, "words": ["<tag1>", "We", "selected", "a", "candidate", "formulation", "based", "on", "properties", "that", "included", "the", "dispersion", "of", "the", "active", "ingredient", "in", "simulated", "gastric", "or", "small-intestinal", "fluids", "and", "the", "stability", "of", "the", "formulation", "over", "time", "prior", "to", "testing.", "<tag2>", "We", "selected", "a", "candidate", "formulation,", "TNX-102", "gelcap,", "based", "on", "properties", "that", "included", "the", "dispersion", "of", "the", "active", "ingredient", "in", "simulated", "gastric", "or", "small-intestinal", "fluids", "and", "the", "stability", "of", "the", "formulation", "over", "time", "prior", "to", "testing.", "<tag3>"], "wordsA": ["We", "selected", "a", "candidate", "formulation", "based", "on", "properties", "that", "included", "the", "dispersion", "of", "the", "active", "ingredient", "in", "simulated", "gastric", "or", "small-intestinal", "fluids", "and", "the", "stability", "of", "the", "formulation", "over", "time", "prior", "to", "testing."], "wordsB": ["We", "selected", "a", "candidate", "formulation,", "TNX-102", "gelcap,", "based", "on", "properties", "that", "included", "the", "dispersion", "of", "the", "active", "ingredient", "in", "simulated", "gastric", "or", "small-intestinal", "fluids", "and", "the", "stability", "of", "the", "formulation", "over", "time", "prior", "to", "testing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p105_s2", "idA": "1430306_12_item1_p95_s4", "sentA": "Lipocine was also engaged to manufacture gelatin capsules of TNX-102 for use in our pharmacokinetic trial.", "sentB": "Lipocine was also engaged to manufacture gelatin capsules of TNX-102 gelcap for use in a pharmacokinetic trial.", "type": 2, "words": ["<tag1>", "Lipocine", "was", "also", "engaged", "to", "manufacture", "gelatin", "capsules", "of", "TNX-102", "for", "use", "in", "our", "pharmacokinetic", "trial.", "<tag2>", "Lipocine", "was", "also", "engaged", "to", "manufacture", "gelatin", "capsules", "of", "TNX-102", "gelcap", "for", "use", "in", "a", "pharmacokinetic", "trial.", "<tag3>"], "wordsA": ["Lipocine", "was", "also", "engaged", "to", "manufacture", "gelatin", "capsules", "of", "TNX-102", "for", "use", "in", "our", "pharmacokinetic", "trial."], "wordsB": ["Lipocine", "was", "also", "engaged", "to", "manufacture", "gelatin", "capsules", "of", "TNX-102", "gelcap", "for", "use", "in", "a", "pharmacokinetic", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p106_s4", "idA": "1430306_12_item1_p96_s1", "sentA": "Pursuant to the agreement, we have an option to license Lipocine s US patent 6,294,192 Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents and US Patent 6,451,339 Compositions and methods for improved delivery of hydrophobic agents .", "sentB": "After completion of the Final Report, we will have 30 days to decide whether to exercise the option to license Lipocine s US patent 6,294,192 Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents and US Patent 6,451,339 Compositions and methods for improved delivery of hydrophobic agents .", "type": 2, "words": ["<tag1>", "Pursuant", "to", "the", "agreement,", "we", "have", "an", "option", "to", "license", "Lipocine", "s", "US", "patent", "6,294,192", "Triglyceride-free", "compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "therapeutic", "agents", "and", "US", "Patent", "6,451,339", "Compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "agents", ".", "<tag2>", "After", "completion", "of", "the", "Final", "Report,", "we", "will", "have", "30", "days", "to", "decide", "whether", "to", "exercise", "the", "option", "to", "license", "Lipocine", "s", "US", "patent", "6,294,192", "Triglyceride-free", "compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "therapeutic", "agents", "and", "US", "Patent", "6,451,339", "Compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "agents", ".", "<tag3>"], "wordsA": ["Pursuant", "to", "the", "agreement,", "we", "have", "an", "option", "to", "license", "Lipocine", "s", "US", "patent", "6,294,192", "Triglyceride-free", "compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "therapeutic", "agents", "and", "US", "Patent", "6,451,339", "Compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "agents", "."], "wordsB": ["After", "completion", "of", "the", "Final", "Report,", "we", "will", "have", "30", "days", "to", "decide", "whether", "to", "exercise", "the", "option", "to", "license", "Lipocine", "s", "US", "patent", "6,294,192", "Triglyceride-free", "compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "therapeutic", "agents", "and", "US", "Patent", "6,451,339", "Compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "agents", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p107_s0", "idA": "1430306_12_item1_p96_s3", "sentA": "If we exercise the option to license these patents, we will be obligated to pay Lipocine low single-digit percentage royalties based on net sales or mid-teen sublicense fees based on the consideration that we receive from a licensee.", "sentB": "If we elect to exercise the option, we will execute a license agreement with Lipocine.", "type": 2, "words": ["<tag1>", "If", "we", "exercise", "the", "option", "to", "license", "these", "patents,", "we", "will", "be", "obligated", "to", "pay", "Lipocine", "low", "single-digit", "percentage", "royalties", "based", "on", "net", "sales", "or", "mid-teen", "sublicense", "fees", "based", "on", "the", "consideration", "that", "we", "receive", "from", "a", "licensee.", "<tag2>", "If", "we", "elect", "to", "exercise", "the", "option,", "we", "will", "execute", "a", "license", "agreement", "with", "Lipocine.", "<tag3>"], "wordsA": ["If", "we", "exercise", "the", "option", "to", "license", "these", "patents,", "we", "will", "be", "obligated", "to", "pay", "Lipocine", "low", "single-digit", "percentage", "royalties", "based", "on", "net", "sales", "or", "mid-teen", "sublicense", "fees", "based", "on", "the", "consideration", "that", "we", "receive", "from", "a", "licensee."], "wordsB": ["If", "we", "elect", "to", "exercise", "the", "option,", "we", "will", "execute", "a", "license", "agreement", "with", "Lipocine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p23_s0", "idA": "1430306_12_item1_p98_s13", "sentA": "Based on the study, we have selected a candidate formulation for cyclobenzaprine to be dosed at bedtime.", "sentB": "TNX-102 SL is a small, rapidly disintegrating tablet containing CBP for sublingual administration at bedtime.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "study,", "we", "have", "selected", "a", "candidate", "formulation", "for", "cyclobenzaprine", "to", "be", "dosed", "at", "bedtime.", "<tag2>", "TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration", "at", "bedtime.", "<tag3>"], "wordsA": ["Based", "on", "the", "study,", "we", "have", "selected", "a", "candidate", "formulation", "for", "cyclobenzaprine", "to", "be", "dosed", "at", "bedtime."], "wordsB": ["TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p23_s4", "idA": "1430306_12_item1_p98_s13", "sentA": "Based on the study, we have selected a candidate formulation for cyclobenzaprine to be dosed at bedtime.", "sentB": "Based on our Phase 1 comparative study, we have observed that, as compared to oral CBP tablets, TNX-102 SL results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following administration.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "study,", "we", "have", "selected", "a", "candidate", "formulation", "for", "cyclobenzaprine", "to", "be", "dosed", "at", "bedtime.", "<tag2>", "Based", "on", "our", "Phase", "1", "comparative", "study,", "we", "have", "observed", "that,", "as", "compared", "to", "oral", "CBP", "tablets,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration.", "<tag3>"], "wordsA": ["Based", "on", "the", "study,", "we", "have", "selected", "a", "candidate", "formulation", "for", "cyclobenzaprine", "to", "be", "dosed", "at", "bedtime."], "wordsB": ["Based", "on", "our", "Phase", "1", "comparative", "study,", "we", "have", "observed", "that,", "as", "compared", "to", "oral", "CBP", "tablets,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p98_s2", "idA": "1430306_12_item1_p98_s13", "sentA": "Based on the study, we have selected a candidate formulation for cyclobenzaprine to be dosed at bedtime.", "sentB": "TNX-102 SL and placebo will be administered once daily at bedtime.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "study,", "we", "have", "selected", "a", "candidate", "formulation", "for", "cyclobenzaprine", "to", "be", "dosed", "at", "bedtime.", "<tag2>", "TNX-102", "SL", "and", "placebo", "will", "be", "administered", "once", "daily", "at", "bedtime.", "<tag3>"], "wordsA": ["Based", "on", "the", "study,", "we", "have", "selected", "a", "candidate", "formulation", "for", "cyclobenzaprine", "to", "be", "dosed", "at", "bedtime."], "wordsB": ["TNX-102", "SL", "and", "placebo", "will", "be", "administered", "once", "daily", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_13_item1_p9_s0", "idA": "1430306_12_item1_p9_s0", "sentA": "In 1996, Seth Lederman, MD, and Donald Landry, MD, PhD, formed L L Technologies, LLC, ( L L ), to develop medications for central nervous system ( CNS ) conditions.", "sentB": "In 1996, Seth Lederman, MD, and Donald Landry, MD, PhD, formed L L Technologies, LLC, or L L, to develop medications for CNS conditions.", "type": 2, "words": ["<tag1>", "In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies,", "LLC,", "(", "L", "L", "),", "to", "develop", "medications", "for", "central", "nervous", "system", "(", "CNS", ")", "conditions.", "<tag2>", "In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies,", "LLC,", "or", "L", "L,", "to", "develop", "medications", "for", "CNS", "conditions.", "<tag3>"], "wordsA": ["In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies,", "LLC,", "(", "L", "L", "),", "to", "develop", "medications", "for", "central", "nervous", "system", "(", "CNS", ")", "conditions."], "wordsB": ["In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies,", "LLC,", "or", "L", "L,", "to", "develop", "medications", "for", "CNS", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p108_s1", "idA": "1430306_13_item1_p100_s1", "sentA": "We believe our clinical development program of TNX-102 SL and the chronic safety data generated from the TNX-102 SL FM NDA program will result in a differentiated product suitable for chronic use for the treatment of PTSD.", "sentB": "We believe our clinical development program of TNX-102 SL and the long term safety data generated from the TNX-102 SL FM NDA program will result in a differentiated product suitable for chronic use for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "chronic", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "FM", "NDA", "program", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "long", "term", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "FM", "NDA", "program", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "chronic", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "FM", "NDA", "program", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "long", "term", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "FM", "NDA", "program", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p110_s0", "idA": "1430306_13_item1_p101_s0", "sentA": "TNX-102 SL is a small tablet that rapidly disintegrates in saliva and transmucosally delivers CBP into the systemic circulation.", "sentB": "TNX-102 SL is a small tablet that rapidly disintegrates in saliva and delivers CBP across the mucosal membrane into the systemic circulation.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "small", "tablet", "that", "rapidly", "disintegrates", "in", "saliva", "and", "transmucosally", "delivers", "CBP", "into", "the", "systemic", "circulation.", "<tag2>", "TNX-102", "SL", "is", "a", "small", "tablet", "that", "rapidly", "disintegrates", "in", "saliva", "and", "delivers", "CBP", "across", "the", "mucosal", "membrane", "into", "the", "systemic", "circulation.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "small", "tablet", "that", "rapidly", "disintegrates", "in", "saliva", "and", "transmucosally", "delivers", "CBP", "into", "the", "systemic", "circulation."], "wordsB": ["TNX-102", "SL", "is", "a", "small", "tablet", "that", "rapidly", "disintegrates", "in", "saliva", "and", "delivers", "CBP", "across", "the", "mucosal", "membrane", "into", "the", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p110_s2", "idA": "1430306_13_item1_p101_s1", "sentA": "TNX-102 SL contains sublingual absorption-enabling ingredients that promote a local oral environment that facilitates oromucosal absorption of CBP.", "sentB": "TNX-102 SL contains sublingual absorption-enabling ingredients that promote a local oral environment that facilitates mucosal absorption of CBP.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "contains", "sublingual", "absorption-enabling", "ingredients", "that", "promote", "a", "local", "oral", "environment", "that", "facilitates", "oromucosal", "absorption", "of", "CBP.", "<tag2>", "TNX-102", "SL", "contains", "sublingual", "absorption-enabling", "ingredients", "that", "promote", "a", "local", "oral", "environment", "that", "facilitates", "mucosal", "absorption", "of", "CBP.", "<tag3>"], "wordsA": ["TNX-102", "SL", "contains", "sublingual", "absorption-enabling", "ingredients", "that", "promote", "a", "local", "oral", "environment", "that", "facilitates", "oromucosal", "absorption", "of", "CBP."], "wordsB": ["TNX-102", "SL", "contains", "sublingual", "absorption-enabling", "ingredients", "that", "promote", "a", "local", "oral", "environment", "that", "facilitates", "mucosal", "absorption", "of", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p110_s3", "idA": "1430306_13_item1_p102_s0", "sentA": "We own all rights to TNX-102 SL in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "sentB": "These include agents that favor a mildly basic salivary pH. We own all rights to TNX-102 SL in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "type": 2, "words": ["<tag1>", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag2>", "These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag3>"], "wordsA": ["We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "wordsB": ["These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p111_s2", "idA": "1430306_13_item1_p105_s1", "sentA": "We selected a candidate formulation, TNX-102 gelcap, based on properties that included the dispersion of the active ingredient in simulated gastric or small-intestinal fluids and the stability of the formulation over time prior to testing.", "sentB": "We selected a candidate formulation, TNX-102 gelcap, based on properties that included the dispersion of CBP in simulated gastric or small-intestinal fluids and the stability of the formulation over time.", "type": 2, "words": ["<tag1>", "We", "selected", "a", "candidate", "formulation,", "TNX-102", "gelcap,", "based", "on", "properties", "that", "included", "the", "dispersion", "of", "the", "active", "ingredient", "in", "simulated", "gastric", "or", "small-intestinal", "fluids", "and", "the", "stability", "of", "the", "formulation", "over", "time", "prior", "to", "testing.", "<tag2>", "We", "selected", "a", "candidate", "formulation,", "TNX-102", "gelcap,", "based", "on", "properties", "that", "included", "the", "dispersion", "of", "CBP", "in", "simulated", "gastric", "or", "small-intestinal", "fluids", "and", "the", "stability", "of", "the", "formulation", "over", "time.", "<tag3>"], "wordsA": ["We", "selected", "a", "candidate", "formulation,", "TNX-102", "gelcap,", "based", "on", "properties", "that", "included", "the", "dispersion", "of", "the", "active", "ingredient", "in", "simulated", "gastric", "or", "small-intestinal", "fluids", "and", "the", "stability", "of", "the", "formulation", "over", "time", "prior", "to", "testing."], "wordsB": ["We", "selected", "a", "candidate", "formulation,", "TNX-102", "gelcap,", "based", "on", "properties", "that", "included", "the", "dispersion", "of", "CBP", "in", "simulated", "gastric", "or", "small-intestinal", "fluids", "and", "the", "stability", "of", "the", "formulation", "over", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p111_s3", "idA": "1430306_13_item1_p105_s2", "sentA": "Lipocine was also engaged to manufacture gelatin capsules of TNX-102 gelcap for use in a pharmacokinetic trial.", "sentB": "Lipocine was also engaged to manufacture gelatin capsules of TNX-102 gelcap for use in a pharmacokinetic trial, for which we reported results in April 2012.", "type": 2, "words": ["<tag1>", "Lipocine", "was", "also", "engaged", "to", "manufacture", "gelatin", "capsules", "of", "TNX-102", "gelcap", "for", "use", "in", "a", "pharmacokinetic", "trial.", "<tag2>", "Lipocine", "was", "also", "engaged", "to", "manufacture", "gelatin", "capsules", "of", "TNX-102", "gelcap", "for", "use", "in", "a", "pharmacokinetic", "trial,", "for", "which", "we", "reported", "results", "in", "April", "2012.", "<tag3>"], "wordsA": ["Lipocine", "was", "also", "engaged", "to", "manufacture", "gelatin", "capsules", "of", "TNX-102", "gelcap", "for", "use", "in", "a", "pharmacokinetic", "trial."], "wordsB": ["Lipocine", "was", "also", "engaged", "to", "manufacture", "gelatin", "capsules", "of", "TNX-102", "gelcap", "for", "use", "in", "a", "pharmacokinetic", "trial,", "for", "which", "we", "reported", "results", "in", "April", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p111_s4", "idA": "1430306_13_item1_p106_s4", "sentA": "After completion of the Final Report, we will have 30 days to decide whether to exercise the option to license Lipocine s US patent 6,294,192 Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents and US Patent 6,451,339 Compositions and methods for improved delivery of hydrophobic agents .", "sentB": "In March 2014, we completed the final report of the pharmacokinetic trial (the Final Report ) and had 30 days to decide whether to exercise the option to license certain technology owned by Lipocine.", "type": 2, "words": ["<tag1>", "After", "completion", "of", "the", "Final", "Report,", "we", "will", "have", "30", "days", "to", "decide", "whether", "to", "exercise", "the", "option", "to", "license", "Lipocine", "s", "US", "patent", "6,294,192", "Triglyceride-free", "compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "therapeutic", "agents", "and", "US", "Patent", "6,451,339", "Compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "agents", ".", "<tag2>", "In", "March", "2014,", "we", "completed", "the", "final", "report", "of", "the", "pharmacokinetic", "trial", "(the", "Final", "Report", ")", "and", "had", "30", "days", "to", "decide", "whether", "to", "exercise", "the", "option", "to", "license", "certain", "technology", "owned", "by", "Lipocine.", "<tag3>"], "wordsA": ["After", "completion", "of", "the", "Final", "Report,", "we", "will", "have", "30", "days", "to", "decide", "whether", "to", "exercise", "the", "option", "to", "license", "Lipocine", "s", "US", "patent", "6,294,192", "Triglyceride-free", "compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "therapeutic", "agents", "and", "US", "Patent", "6,451,339", "Compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "agents", "."], "wordsB": ["In", "March", "2014,", "we", "completed", "the", "final", "report", "of", "the", "pharmacokinetic", "trial", "(the", "Final", "Report", ")", "and", "had", "30", "days", "to", "decide", "whether", "to", "exercise", "the", "option", "to", "license", "certain", "technology", "owned", "by", "Lipocine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p111_s5", "idA": "1430306_13_item1_p106_s4", "sentA": "After completion of the Final Report, we will have 30 days to decide whether to exercise the option to license Lipocine s US patent 6,294,192 Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents and US Patent 6,451,339 Compositions and methods for improved delivery of hydrophobic agents .", "sentB": "Following our receipt of the Final Report, in March 2014, we notified Lipocine of our decision to not exercise the option, although we own all the work product, information and data from the studies conducted.", "type": 2, "words": ["<tag1>", "After", "completion", "of", "the", "Final", "Report,", "we", "will", "have", "30", "days", "to", "decide", "whether", "to", "exercise", "the", "option", "to", "license", "Lipocine", "s", "US", "patent", "6,294,192", "Triglyceride-free", "compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "therapeutic", "agents", "and", "US", "Patent", "6,451,339", "Compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "agents", ".", "<tag2>", "Following", "our", "receipt", "of", "the", "Final", "Report,", "in", "March", "2014,", "we", "notified", "Lipocine", "of", "our", "decision", "to", "not", "exercise", "the", "option,", "although", "we", "own", "all", "the", "work", "product,", "information", "and", "data", "from", "the", "studies", "conducted.", "<tag3>"], "wordsA": ["After", "completion", "of", "the", "Final", "Report,", "we", "will", "have", "30", "days", "to", "decide", "whether", "to", "exercise", "the", "option", "to", "license", "Lipocine", "s", "US", "patent", "6,294,192", "Triglyceride-free", "compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "therapeutic", "agents", "and", "US", "Patent", "6,451,339", "Compositions", "and", "methods", "for", "improved", "delivery", "of", "hydrophobic", "agents", "."], "wordsB": ["Following", "our", "receipt", "of", "the", "Final", "Report,", "in", "March", "2014,", "we", "notified", "Lipocine", "of", "our", "decision", "to", "not", "exercise", "the", "option,", "although", "we", "own", "all", "the", "work", "product,", "information", "and", "data", "from", "the", "studies", "conducted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p115_s0", "idA": "1430306_13_item1_p111_s0", "sentA": "In 2007, Lyrica (pregabalin) became the first medicine approved by the FDA for the management of FM.", "sentB": "In 2007, Lyrica became the first medicine approved by the FDA for the management of FM.", "type": 2, "words": ["<tag1>", "In", "2007,", "Lyrica", "(pregabalin)", "became", "the", "first", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "In", "2007,", "Lyrica", "became", "the", "first", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["In", "2007,", "Lyrica", "(pregabalin)", "became", "the", "first", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["In", "2007,", "Lyrica", "became", "the", "first", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p115_s2", "idA": "1430306_13_item1_p111_s2", "sentA": "In 2008, Cymbalta (duloxetine) became the second medicine approved by the FDA for the management of FM.", "sentB": "In 2008, Cymbalta became the second medicine approved by the FDA for the management of FM.", "type": 2, "words": ["<tag1>", "In", "2008,", "Cymbalta", "(duloxetine)", "became", "the", "second", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "In", "2008,", "Cymbalta", "became", "the", "second", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["In", "2008,", "Cymbalta", "(duloxetine)", "became", "the", "second", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["In", "2008,", "Cymbalta", "became", "the", "second", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p29_s2", "idA": "1430306_13_item1_p112_s0", "sentA": "FM shares a number of symptoms with depression, and a number of FM patients are believed to experience depression as a co-existing condition.", "sentB": "The peak incidence of FM occurs at 20 50 years of age, and 80-90% of diagnosed patients are female.", "type": 2, "words": ["<tag1>", "FM", "shares", "a", "number", "of", "symptoms", "with", "depression,", "and", "a", "number", "of", "FM", "patients", "are", "believed", "to", "experience", "depression", "as", "a", "co-existing", "condition.", "<tag2>", "The", "peak", "incidence", "of", "FM", "occurs", "at", "20", "50", "years", "of", "age,", "and", "80-90%", "of", "diagnosed", "patients", "are", "female.", "<tag3>"], "wordsA": ["FM", "shares", "a", "number", "of", "symptoms", "with", "depression,", "and", "a", "number", "of", "FM", "patients", "are", "believed", "to", "experience", "depression", "as", "a", "co-existing", "condition."], "wordsB": ["The", "peak", "incidence", "of", "FM", "occurs", "at", "20", "50", "years", "of", "age,", "and", "80-90%", "of", "diagnosed", "patients", "are", "female."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p117_s0", "idA": "1430306_13_item1_p113_s0", "sentA": "Savella (milnacipran) was the third medicine approved by the FDA for the management of FM.", "sentB": "Savella was the third medicine approved by the FDA for the management of FM.", "type": 2, "words": ["<tag1>", "Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "Savella", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["Savella", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p31_s1", "idA": "1430306_13_item1_p113_s0", "sentA": "Savella (milnacipran) was the third medicine approved by the FDA for the management of FM.", "sentB": "Three drugs, Lyrica (pregabalin), Cymbalta (duloxetine), and Savella (milnacipran), are approved by the FDA for the management of FM and are believed to act upon molecular pathways involved in central pain.", "type": 2, "words": ["<tag1>", "Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "Three", "drugs,", "Lyrica", "(pregabalin),", "Cymbalta", "(duloxetine),", "and", "Savella", "(milnacipran),", "are", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM", "and", "are", "believed", "to", "act", "upon", "molecular", "pathways", "involved", "in", "central", "pain.", "<tag3>"], "wordsA": ["Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["Three", "drugs,", "Lyrica", "(pregabalin),", "Cymbalta", "(duloxetine),", "and", "Savella", "(milnacipran),", "are", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM", "and", "are", "believed", "to", "act", "upon", "molecular", "pathways", "involved", "in", "central", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p119_s1", "idA": "1430306_13_item1_p115_s1", "sentA": "According to Decision Resources, U.S. sales of prescription drugs specifically for the treatment of FM totaled $1.4 billion in 2011.", "sentB": "Based on information obtained from publicly available sources, we believe U.S. sales of prescription drugs specifically for the treatment of FM totaled approximately $1.5 billion in 2012, and we believe this segment had grown at a compounded annual growth rate of approximately 14% in 2007 12.", "type": 2, "words": ["<tag1>", "According", "to", "Decision", "Resources,", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "$1.4", "billion", "in", "2011.", "<tag2>", "Based", "on", "information", "obtained", "from", "publicly", "available", "sources,", "we", "believe", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "approximately", "$1.5", "billion", "in", "2012,", "and", "we", "believe", "this", "segment", "had", "grown", "at", "a", "compounded", "annual", "growth", "rate", "of", "approximately", "14%", "in", "2007", "12.", "<tag3>"], "wordsA": ["According", "to", "Decision", "Resources,", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "$1.4", "billion", "in", "2011."], "wordsB": ["Based", "on", "information", "obtained", "from", "publicly", "available", "sources,", "we", "believe", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "approximately", "$1.5", "billion", "in", "2012,", "and", "we", "believe", "this", "segment", "had", "grown", "at", "a", "compounded", "annual", "growth", "rate", "of", "approximately", "14%", "in", "2007", "12."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p33_s1", "idA": "1430306_13_item1_p115_s1", "sentA": "According to Decision Resources, U.S. sales of prescription drugs specifically for the treatment of FM totaled $1.4 billion in 2011.", "sentB": "Based on information obtained from publicly available sources, we believe U.S. sales of prescription drugs specifically for the treatment of FM totaled approximately $1.5 billion in 2012, and we believe this segment had grown at a compounded annual growth rate of approximately 14% between 2007 and 2012.", "type": 2, "words": ["<tag1>", "According", "to", "Decision", "Resources,", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "$1.4", "billion", "in", "2011.", "<tag2>", "Based", "on", "information", "obtained", "from", "publicly", "available", "sources,", "we", "believe", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "approximately", "$1.5", "billion", "in", "2012,", "and", "we", "believe", "this", "segment", "had", "grown", "at", "a", "compounded", "annual", "growth", "rate", "of", "approximately", "14%", "between", "2007", "and", "2012.", "<tag3>"], "wordsA": ["According", "to", "Decision", "Resources,", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "$1.4", "billion", "in", "2011."], "wordsB": ["Based", "on", "information", "obtained", "from", "publicly", "available", "sources,", "we", "believe", "U.S.", "sales", "of", "prescription", "drugs", "specifically", "for", "the", "treatment", "of", "FM", "totaled", "approximately", "$1.5", "billion", "in", "2012,", "and", "we", "believe", "this", "segment", "had", "grown", "at", "a", "compounded", "annual", "growth", "rate", "of", "approximately", "14%", "between", "2007", "and", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p119_s2", "idA": "1430306_13_item1_p115_s2", "sentA": "This figure includes sales of Cymbalta, Lyrica, and Savella of $595 million, $504 million, and $110 million, respectively.", "sentB": "Based on information obtained from publicly available sources, we believe 2012 sales of Cymbalta, Lyrica, and Savella were approximately $600 million, $475 million, and $100 million, respectively.", "type": 2, "words": ["<tag1>", "This", "figure", "includes", "sales", "of", "Cymbalta,", "Lyrica,", "and", "Savella", "of", "$595", "million,", "$504", "million,", "and", "$110", "million,", "respectively.", "<tag2>", "Based", "on", "information", "obtained", "from", "publicly", "available", "sources,", "we", "believe", "2012", "sales", "of", "Cymbalta,", "Lyrica,", "and", "Savella", "were", "approximately", "$600", "million,", "$475", "million,", "and", "$100", "million,", "respectively.", "<tag3>"], "wordsA": ["This", "figure", "includes", "sales", "of", "Cymbalta,", "Lyrica,", "and", "Savella", "of", "$595", "million,", "$504", "million,", "and", "$110", "million,", "respectively."], "wordsB": ["Based", "on", "information", "obtained", "from", "publicly", "available", "sources,", "we", "believe", "2012", "sales", "of", "Cymbalta,", "Lyrica,", "and", "Savella", "were", "approximately", "$600", "million,", "$475", "million,", "and", "$100", "million,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p33_s2", "idA": "1430306_13_item1_p115_s2", "sentA": "This figure includes sales of Cymbalta, Lyrica, and Savella of $595 million, $504 million, and $110 million, respectively.", "sentB": "Based on information obtained from publicly available sources, we believe 2012 sales of Cymbalta, Lyrica, and Savella in FM were approximately $600 million, $475 million, and $100 million, respectively.", "type": 2, "words": ["<tag1>", "This", "figure", "includes", "sales", "of", "Cymbalta,", "Lyrica,", "and", "Savella", "of", "$595", "million,", "$504", "million,", "and", "$110", "million,", "respectively.", "<tag2>", "Based", "on", "information", "obtained", "from", "publicly", "available", "sources,", "we", "believe", "2012", "sales", "of", "Cymbalta,", "Lyrica,", "and", "Savella", "in", "FM", "were", "approximately", "$600", "million,", "$475", "million,", "and", "$100", "million,", "respectively.", "<tag3>"], "wordsA": ["This", "figure", "includes", "sales", "of", "Cymbalta,", "Lyrica,", "and", "Savella", "of", "$595", "million,", "$504", "million,", "and", "$110", "million,", "respectively."], "wordsB": ["Based", "on", "information", "obtained", "from", "publicly", "available", "sources,", "we", "believe", "2012", "sales", "of", "Cymbalta,", "Lyrica,", "and", "Savella", "in", "FM", "were", "approximately", "$600", "million,", "$475", "million,", "and", "$100", "million,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p121_s2", "idA": "1430306_13_item1_p117_s2", "sentA": "Despite the significant FM-related sales growth of the three products approved for FM following their approvals for this indication, according to Adivo Associates, the unit volume of medications prescribed to specifically treat FM has been nearly flat since 2007, implying that the sales growth of the approved products was mainly driven by patients switching from off-label, generic medications to on-label, branded medications.", "sentB": "Despite the significant FM-related sales growth of the three products approved for FM following their approvals for this indication, according to market research performed by Frost and Sullivan on our behalf, the unit volume of medications prescribed to specifically treat FM had been nearly flat between 2007 and 2010, implying that the sales growth of the approved products was mainly driven by patients switching from off-label, generic medications to on-label, branded medications.", "type": 2, "words": ["<tag1>", "Despite", "the", "significant", "FM-related", "sales", "growth", "of", "the", "three", "products", "approved", "for", "FM", "following", "their", "approvals", "for", "this", "indication,", "according", "to", "Adivo", "Associates,", "the", "unit", "volume", "of", "medications", "prescribed", "to", "specifically", "treat", "FM", "has", "been", "nearly", "flat", "since", "2007,", "implying", "that", "the", "sales", "growth", "of", "the", "approved", "products", "was", "mainly", "driven", "by", "patients", "switching", "from", "off-label,", "generic", "medications", "to", "on-label,", "branded", "medications.", "<tag2>", "Despite", "the", "significant", "FM-related", "sales", "growth", "of", "the", "three", "products", "approved", "for", "FM", "following", "their", "approvals", "for", "this", "indication,", "according", "to", "market", "research", "performed", "by", "Frost", "and", "Sullivan", "on", "our", "behalf,", "the", "unit", "volume", "of", "medications", "prescribed", "to", "specifically", "treat", "FM", "had", "been", "nearly", "flat", "between", "2007", "and", "2010,", "implying", "that", "the", "sales", "growth", "of", "the", "approved", "products", "was", "mainly", "driven", "by", "patients", "switching", "from", "off-label,", "generic", "medications", "to", "on-label,", "branded", "medications.", "<tag3>"], "wordsA": ["Despite", "the", "significant", "FM-related", "sales", "growth", "of", "the", "three", "products", "approved", "for", "FM", "following", "their", "approvals", "for", "this", "indication,", "according", "to", "Adivo", "Associates,", "the", "unit", "volume", "of", "medications", "prescribed", "to", "specifically", "treat", "FM", "has", "been", "nearly", "flat", "since", "2007,", "implying", "that", "the", "sales", "growth", "of", "the", "approved", "products", "was", "mainly", "driven", "by", "patients", "switching", "from", "off-label,", "generic", "medications", "to", "on-label,", "branded", "medications."], "wordsB": ["Despite", "the", "significant", "FM-related", "sales", "growth", "of", "the", "three", "products", "approved", "for", "FM", "following", "their", "approvals", "for", "this", "indication,", "according", "to", "market", "research", "performed", "by", "Frost", "and", "Sullivan", "on", "our", "behalf,", "the", "unit", "volume", "of", "medications", "prescribed", "to", "specifically", "treat", "FM", "had", "been", "nearly", "flat", "between", "2007", "and", "2010,", "implying", "that", "the", "sales", "growth", "of", "the", "approved", "products", "was", "mainly", "driven", "by", "patients", "switching", "from", "off-label,", "generic", "medications", "to", "on-label,", "branded", "medications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p123_s0", "idA": "1430306_13_item1_p118_s0", "sentA": "Despite the wide use of muscle relaxants by FM patients, this category lacks a product approved for FM.", "sentB": "Despite the availability and use of a variety of pharmacologic and non-pharmacologic interventions, FM remains a significant unmet medical need.", "type": 2, "words": ["<tag1>", "Despite", "the", "wide", "use", "of", "muscle", "relaxants", "by", "FM", "patients,", "this", "category", "lacks", "a", "product", "approved", "for", "FM.", "<tag2>", "Despite", "the", "availability", "and", "use", "of", "a", "variety", "of", "pharmacologic", "and", "non-pharmacologic", "interventions,", "FM", "remains", "a", "significant", "unmet", "medical", "need.", "<tag3>"], "wordsA": ["Despite", "the", "wide", "use", "of", "muscle", "relaxants", "by", "FM", "patients,", "this", "category", "lacks", "a", "product", "approved", "for", "FM."], "wordsB": ["Despite", "the", "availability", "and", "use", "of", "a", "variety", "of", "pharmacologic", "and", "non-pharmacologic", "interventions,", "FM", "remains", "a", "significant", "unmet", "medical", "need."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p34_s0", "idA": "1430306_13_item1_p118_s0", "sentA": "Despite the wide use of muscle relaxants by FM patients, this category lacks a product approved for FM.", "sentB": "Despite the availability and use of a variety of pharmacologic and non-pharmacologic interventions, FM remains a significant unmet medical need.", "type": 2, "words": ["<tag1>", "Despite", "the", "wide", "use", "of", "muscle", "relaxants", "by", "FM", "patients,", "this", "category", "lacks", "a", "product", "approved", "for", "FM.", "<tag2>", "Despite", "the", "availability", "and", "use", "of", "a", "variety", "of", "pharmacologic", "and", "non-pharmacologic", "interventions,", "FM", "remains", "a", "significant", "unmet", "medical", "need.", "<tag3>"], "wordsA": ["Despite", "the", "wide", "use", "of", "muscle", "relaxants", "by", "FM", "patients,", "this", "category", "lacks", "a", "product", "approved", "for", "FM."], "wordsB": ["Despite", "the", "availability", "and", "use", "of", "a", "variety", "of", "pharmacologic", "and", "non-pharmacologic", "interventions,", "FM", "remains", "a", "significant", "unmet", "medical", "need."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p122_s3", "idA": "1430306_13_item1_p118_s3", "sentA": "According to Adivo Associates, 20 million daily doses of the Flexeril brand and its associated CBP IR generic products were prescribed off-label for FM in 2011 and accounted for approximately 48% of the daily doses of muscle relaxants prescribed for FM that year.", "sentB": "According to Frost and Sullivan, 48 million doses of the Flexeril brand and its associated CBP IR generic products were prescribed off-label for FM in 2010 and accounted for approximately 35% of the daily doses of muscle relaxants prescribed for FM that year.", "type": 2, "words": ["<tag1>", "According", "to", "Adivo", "Associates,", "20", "million", "daily", "doses", "of", "the", "Flexeril", "brand", "and", "its", "associated", "CBP", "IR", "generic", "products", "were", "prescribed", "off-label", "for", "FM", "in", "2011", "and", "accounted", "for", "approximately", "48%", "of", "the", "daily", "doses", "of", "muscle", "relaxants", "prescribed", "for", "FM", "that", "year.", "<tag2>", "According", "to", "Frost", "and", "Sullivan,", "48", "million", "doses", "of", "the", "Flexeril", "brand", "and", "its", "associated", "CBP", "IR", "generic", "products", "were", "prescribed", "off-label", "for", "FM", "in", "2010", "and", "accounted", "for", "approximately", "35%", "of", "the", "daily", "doses", "of", "muscle", "relaxants", "prescribed", "for", "FM", "that", "year.", "<tag3>"], "wordsA": ["According", "to", "Adivo", "Associates,", "20", "million", "daily", "doses", "of", "the", "Flexeril", "brand", "and", "its", "associated", "CBP", "IR", "generic", "products", "were", "prescribed", "off-label", "for", "FM", "in", "2011", "and", "accounted", "for", "approximately", "48%", "of", "the", "daily", "doses", "of", "muscle", "relaxants", "prescribed", "for", "FM", "that", "year."], "wordsB": ["According", "to", "Frost", "and", "Sullivan,", "48", "million", "doses", "of", "the", "Flexeril", "brand", "and", "its", "associated", "CBP", "IR", "generic", "products", "were", "prescribed", "off-label", "for", "FM", "in", "2010", "and", "accounted", "for", "approximately", "35%", "of", "the", "daily", "doses", "of", "muscle", "relaxants", "prescribed", "for", "FM", "that", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p123_s2", "idA": "1430306_13_item1_p118_s4", "sentA": "These figures indicate that muscle relaxants in general, and CBP in particular, have been widely adopted in FM despite the lack of an approval for this disorder.", "sentB": "Prescription pain and sleep medications are often taken off-label for symptomatic relief, despite the lack of evidence that such medications provide a meaningful or durable therapeutic effect.", "type": 2, "words": ["<tag1>", "These", "figures", "indicate", "that", "muscle", "relaxants", "in", "general,", "and", "CBP", "in", "particular,", "have", "been", "widely", "adopted", "in", "FM", "despite", "the", "lack", "of", "an", "approval", "for", "this", "disorder.", "<tag2>", "Prescription", "pain", "and", "sleep", "medications", "are", "often", "taken", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect.", "<tag3>"], "wordsA": ["These", "figures", "indicate", "that", "muscle", "relaxants", "in", "general,", "and", "CBP", "in", "particular,", "have", "been", "widely", "adopted", "in", "FM", "despite", "the", "lack", "of", "an", "approval", "for", "this", "disorder."], "wordsB": ["Prescription", "pain", "and", "sleep", "medications", "are", "often", "taken", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p34_s2", "idA": "1430306_13_item1_p118_s4", "sentA": "These figures indicate that muscle relaxants in general, and CBP in particular, have been widely adopted in FM despite the lack of an approval for this disorder.", "sentB": "Prescription pain and sleep medications are frequently taken off-label for symptomatic relief, despite the lack of evidence that such medications provide a meaningful or durable therapeutic effect.", "type": 2, "words": ["<tag1>", "These", "figures", "indicate", "that", "muscle", "relaxants", "in", "general,", "and", "CBP", "in", "particular,", "have", "been", "widely", "adopted", "in", "FM", "despite", "the", "lack", "of", "an", "approval", "for", "this", "disorder.", "<tag2>", "Prescription", "pain", "and", "sleep", "medications", "are", "frequently", "taken", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect.", "<tag3>"], "wordsA": ["These", "figures", "indicate", "that", "muscle", "relaxants", "in", "general,", "and", "CBP", "in", "particular,", "have", "been", "widely", "adopted", "in", "FM", "despite", "the", "lack", "of", "an", "approval", "for", "this", "disorder."], "wordsB": ["Prescription", "pain", "and", "sleep", "medications", "are", "frequently", "taken", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p11_s0", "idA": "1430306_13_item1_p11_s0", "sentA": "Tonix Sub formed in June 2007 as Krele Pharmaceuticals, Inc. by L L and Plumbline LLC, or Plumbline.", "sentB": "Tonix Sub formed in June 2007 as Krele Pharmaceuticals, Inc. by L L and Plumbline.", "type": 2, "words": ["<tag1>", "Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline", "LLC,", "or", "Plumbline.", "<tag2>", "Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline.", "<tag3>"], "wordsA": ["Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline", "LLC,", "or", "Plumbline."], "wordsB": ["Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p126_s2", "idA": "1430306_13_item1_p120_s2", "sentA": "Symptoms like pain, fatigue, disturbed sleep or altered mood are characteristics of more than one condition.", "sentB": "Symptoms like pain, fatigue, disturbed sleep, cognitive/concentration problems or altered mood are characteristics of more than one condition.", "type": 2, "words": ["<tag1>", "Symptoms", "like", "pain,", "fatigue,", "disturbed", "sleep", "or", "altered", "mood", "are", "characteristics", "of", "more", "than", "one", "condition.", "<tag2>", "Symptoms", "like", "pain,", "fatigue,", "disturbed", "sleep,", "cognitive/concentration", "problems", "or", "altered", "mood", "are", "characteristics", "of", "more", "than", "one", "condition.", "<tag3>"], "wordsA": ["Symptoms", "like", "pain,", "fatigue,", "disturbed", "sleep", "or", "altered", "mood", "are", "characteristics", "of", "more", "than", "one", "condition."], "wordsB": ["Symptoms", "like", "pain,", "fatigue,", "disturbed", "sleep,", "cognitive/concentration", "problems", "or", "altered", "mood", "are", "characteristics", "of", "more", "than", "one", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p28_s1", "idA": "1430306_13_item1_p126_s0", "sentA": "We believe the market for the treatment of FM is underserved, which we believe fuels a need for new therapeutic options.", "sentB": "Our Phase 1 studies demonstrated TNX-102 SL to exhibit a pharmacokinetic profile that we believe supports chronic bedtime administration for the treatment of FM, and is distinct from those of currently-available CBP products.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "market", "for", "the", "treatment", "of", "FM", "is", "underserved,", "which", "we", "believe", "fuels", "a", "need", "for", "new", "therapeutic", "options.", "<tag2>", "Our", "Phase", "1", "studies", "demonstrated", "TNX-102", "SL", "to", "exhibit", "a", "pharmacokinetic", "profile", "that", "we", "believe", "supports", "chronic", "bedtime", "administration", "for", "the", "treatment", "of", "FM,", "and", "is", "distinct", "from", "those", "of", "currently-available", "CBP", "products.", "<tag3>"], "wordsA": ["We", "believe", "the", "market", "for", "the", "treatment", "of", "FM", "is", "underserved,", "which", "we", "believe", "fuels", "a", "need", "for", "new", "therapeutic", "options."], "wordsB": ["Our", "Phase", "1", "studies", "demonstrated", "TNX-102", "SL", "to", "exhibit", "a", "pharmacokinetic", "profile", "that", "we", "believe", "supports", "chronic", "bedtime", "administration", "for", "the", "treatment", "of", "FM,", "and", "is", "distinct", "from", "those", "of", "currently-available", "CBP", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p132_s1", "idA": "1430306_13_item1_p126_s1", "sentA": "Due to the market acceptance of FM treatments (such as Lyrica, Cymbalta and Savella), we believe there will be a growing interest in alternative drug treatment options.", "sentB": "Due to the market acceptance of approved FM treatments Cymbalta, Lyrica and Savella, we believe there will be significant interest in effective and well-tolerated drug treatment options.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "market", "acceptance", "of", "FM", "treatments", "(such", "as", "Lyrica,", "Cymbalta", "and", "Savella),", "we", "believe", "there", "will", "be", "a", "growing", "interest", "in", "alternative", "drug", "treatment", "options.", "<tag2>", "Due", "to", "the", "market", "acceptance", "of", "approved", "FM", "treatments", "Cymbalta,", "Lyrica", "and", "Savella,", "we", "believe", "there", "will", "be", "significant", "interest", "in", "effective", "and", "well-tolerated", "drug", "treatment", "options.", "<tag3>"], "wordsA": ["Due", "to", "the", "market", "acceptance", "of", "FM", "treatments", "(such", "as", "Lyrica,", "Cymbalta", "and", "Savella),", "we", "believe", "there", "will", "be", "a", "growing", "interest", "in", "alternative", "drug", "treatment", "options."], "wordsB": ["Due", "to", "the", "market", "acceptance", "of", "approved", "FM", "treatments", "Cymbalta,", "Lyrica", "and", "Savella,", "we", "believe", "there", "will", "be", "significant", "interest", "in", "effective", "and", "well-tolerated", "drug", "treatment", "options."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p133_s0", "idA": "1430306_13_item1_p127_s0", "sentA": "We believe that if TNX-102 SL won FDA approval, it would be an appealing option because it has an entirely different mechanism of action from the currently approved products and we expect TNX-102 SL will be recommended for use at bedtime.", "sentB": "We believe that if TNX-102 SL won FDA approval, it would be an appealing option because it is believed to act by a different mechanism of action from the currently approved products, and we expect TNX-102 SL will be recommended for use at bedtime.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "if", "TNX-102", "SL", "won", "FDA", "approval,", "it", "would", "be", "an", "appealing", "option", "because", "it", "has", "an", "entirely", "different", "mechanism", "of", "action", "from", "the", "currently", "approved", "products", "and", "we", "expect", "TNX-102", "SL", "will", "be", "recommended", "for", "use", "at", "bedtime.", "<tag2>", "We", "believe", "that", "if", "TNX-102", "SL", "won", "FDA", "approval,", "it", "would", "be", "an", "appealing", "option", "because", "it", "is", "believed", "to", "act", "by", "a", "different", "mechanism", "of", "action", "from", "the", "currently", "approved", "products,", "and", "we", "expect", "TNX-102", "SL", "will", "be", "recommended", "for", "use", "at", "bedtime.", "<tag3>"], "wordsA": ["We", "believe", "that", "if", "TNX-102", "SL", "won", "FDA", "approval,", "it", "would", "be", "an", "appealing", "option", "because", "it", "has", "an", "entirely", "different", "mechanism", "of", "action", "from", "the", "currently", "approved", "products", "and", "we", "expect", "TNX-102", "SL", "will", "be", "recommended", "for", "use", "at", "bedtime."], "wordsB": ["We", "believe", "that", "if", "TNX-102", "SL", "won", "FDA", "approval,", "it", "would", "be", "an", "appealing", "option", "because", "it", "is", "believed", "to", "act", "by", "a", "different", "mechanism", "of", "action", "from", "the", "currently", "approved", "products,", "and", "we", "expect", "TNX-102", "SL", "will", "be", "recommended", "for", "use", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p32_s0", "idA": "1430306_13_item1_p128_s2", "sentA": "Cymbalta and Savella act on the CNS in ways that are believed to interfere with sleep, while data support the view that CBP, the active ingredient in TNX-102 SL, improves sleep quality.", "sentB": "Cymbalta and Savella are believed to directly inhibit the reuptake of serotonin and norepinephrine by nerves, and are referred to as Serotonin and Norepinephrine Reuptake Inhibitors, or SNRIs.", "type": 2, "words": ["<tag1>", "Cymbalta", "and", "Savella", "act", "on", "the", "CNS", "in", "ways", "that", "are", "believed", "to", "interfere", "with", "sleep,", "while", "data", "support", "the", "view", "that", "CBP,", "the", "active", "ingredient", "in", "TNX-102", "SL,", "improves", "sleep", "quality.", "<tag2>", "Cymbalta", "and", "Savella", "are", "believed", "to", "directly", "inhibit", "the", "reuptake", "of", "serotonin", "and", "norepinephrine", "by", "nerves,", "and", "are", "referred", "to", "as", "Serotonin", "and", "Norepinephrine", "Reuptake", "Inhibitors,", "or", "SNRIs.", "<tag3>"], "wordsA": ["Cymbalta", "and", "Savella", "act", "on", "the", "CNS", "in", "ways", "that", "are", "believed", "to", "interfere", "with", "sleep,", "while", "data", "support", "the", "view", "that", "CBP,", "the", "active", "ingredient", "in", "TNX-102", "SL,", "improves", "sleep", "quality."], "wordsB": ["Cymbalta", "and", "Savella", "are", "believed", "to", "directly", "inhibit", "the", "reuptake", "of", "serotonin", "and", "norepinephrine", "by", "nerves,", "and", "are", "referred", "to", "as", "Serotonin", "and", "Norepinephrine", "Reuptake", "Inhibitors,", "or", "SNRIs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p136_s0", "idA": "1430306_13_item1_p130_s0", "sentA": "The markets for medicines to treat FM, PTSD and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "sentB": "The markets for medicines to treat FM, PTSD, ETTH and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "type": 2, "words": ["<tag1>", "The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag2>", "The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD,", "ETTH", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag3>"], "wordsA": ["The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "wordsB": ["The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD,", "ETTH", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p152_s2", "idA": "1430306_13_item1_p130_s0", "sentA": "The markets for medicines to treat FM, PTSD and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "sentB": "The patent portfolio for TNX-102 SL relating to the Iglehart Technology includes patent applications directed to pharmaceutical compositions containing CBP, CBP formulations, and methods for treating FM and other CNS conditions utilizing CBP.", "type": 2, "words": ["<tag1>", "The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag2>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Iglehart", "Technology", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP.", "<tag3>"], "wordsA": ["The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "wordsB": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Iglehart", "Technology", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p153_s1", "idA": "1430306_13_item1_p130_s0", "sentA": "The markets for medicines to treat FM, PTSD and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "sentB": "The patent portfolio for TNX-102 SL relating to the PK Technology includes patent applications directed to pharmaceutical compositions containing CBP, CBP formulations, and methods for treating FM and other CNS conditions utilizing CBP.", "type": 2, "words": ["<tag1>", "The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag2>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP.", "<tag3>"], "wordsA": ["The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "wordsB": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p136_s1", "idA": "1430306_13_item1_p130_s1", "sentA": "Pfizer (Lyrica), Eli Lilly (Cymbalta) and Forest Laboratories/Cyprus Biosciences (Savella) market FDA approved drugs for FM.", "sentB": "Eli Lilly (Cymbalta), Forest Laboratories (Savella), and Pfizer (Lyrica) market FDA approved drugs for FM.", "type": 2, "words": ["<tag1>", "Pfizer", "(Lyrica),", "Eli", "Lilly", "(Cymbalta)", "and", "Forest", "Laboratories/Cyprus", "Biosciences", "(Savella)", "market", "FDA", "approved", "drugs", "for", "FM.", "<tag2>", "Eli", "Lilly", "(Cymbalta),", "Forest", "Laboratories", "(Savella),", "and", "Pfizer", "(Lyrica)", "market", "FDA", "approved", "drugs", "for", "FM.", "<tag3>"], "wordsA": ["Pfizer", "(Lyrica),", "Eli", "Lilly", "(Cymbalta)", "and", "Forest", "Laboratories/Cyprus", "Biosciences", "(Savella)", "market", "FDA", "approved", "drugs", "for", "FM."], "wordsB": ["Eli", "Lilly", "(Cymbalta),", "Forest", "Laboratories", "(Savella),", "and", "Pfizer", "(Lyrica)", "market", "FDA", "approved", "drugs", "for", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p137_s0", "idA": "1430306_13_item1_p130_s2", "sentA": "Pfizer (Zoloft) and GlaxoSmithKline (Paxil) market FDA approved drugs for PTSD.", "sentB": "GlaxoSmithKline (Paxil) and Pfizer (Zoloft) market FDA approved drugs for PTSD.", "type": 2, "words": ["<tag1>", "Pfizer", "(Zoloft)", "and", "GlaxoSmithKline", "(Paxil)", "market", "FDA", "approved", "drugs", "for", "PTSD.", "<tag2>", "GlaxoSmithKline", "(Paxil)", "and", "Pfizer", "(Zoloft)", "market", "FDA", "approved", "drugs", "for", "PTSD.", "<tag3>"], "wordsA": ["Pfizer", "(Zoloft)", "and", "GlaxoSmithKline", "(Paxil)", "market", "FDA", "approved", "drugs", "for", "PTSD."], "wordsB": ["GlaxoSmithKline", "(Paxil)", "and", "Pfizer", "(Zoloft)", "market", "FDA", "approved", "drugs", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p139_s0", "idA": "1430306_13_item1_p131_s0", "sentA": "As of February 2013, we are aware of several companies pursuing treatments for FM, including Chelsea Therapeutics, Johnson and Johnson, Meda, Pfizer, Synthetic Biologics, Teva, and Theravance.", "sentB": "As of March 2014, we are aware of several companies developing prescription medications for FM, including Allergan, Chelsea Therapeutics, Meda, Merck, Pfizer, RiboCor and Theravance.", "type": 2, "words": ["<tag1>", "As", "of", "February", "2013,", "we", "are", "aware", "of", "several", "companies", "pursuing", "treatments", "for", "FM,", "including", "Chelsea", "Therapeutics,", "Johnson", "and", "Johnson,", "Meda,", "Pfizer,", "Synthetic", "Biologics,", "Teva,", "and", "Theravance.", "<tag2>", "As", "of", "March", "2014,", "we", "are", "aware", "of", "several", "companies", "developing", "prescription", "medications", "for", "FM,", "including", "Allergan,", "Chelsea", "Therapeutics,", "Meda,", "Merck,", "Pfizer,", "RiboCor", "and", "Theravance.", "<tag3>"], "wordsA": ["As", "of", "February", "2013,", "we", "are", "aware", "of", "several", "companies", "pursuing", "treatments", "for", "FM,", "including", "Chelsea", "Therapeutics,", "Johnson", "and", "Johnson,", "Meda,", "Pfizer,", "Synthetic", "Biologics,", "Teva,", "and", "Theravance."], "wordsB": ["As", "of", "March", "2014,", "we", "are", "aware", "of", "several", "companies", "developing", "prescription", "medications", "for", "FM,", "including", "Allergan,", "Chelsea", "Therapeutics,", "Meda,", "Merck,", "Pfizer,", "RiboCor", "and", "Theravance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p142_s0", "idA": "1430306_13_item1_p132_s0", "sentA": "A number of companies are specifically engaged in developing drugs for PTSD, including AstraZeneca, UCB, GlaxoSmithKline, Ortho-McNeil Janssen Scientific Affairs, and Pfizer.", "sentB": "A number of companies are developing prescription medications for PTSD, including AstraZeneca, Biotie, Forest, GlaxoSmithKline, Lundbeck, Marinus Pharmaceuticals, Merck, Nanotherapeutics, Johnson and Johnson, Pfizer, and UCB.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "specifically", "engaged", "in", "developing", "drugs", "for", "PTSD,", "including", "AstraZeneca,", "UCB,", "GlaxoSmithKline,", "Ortho-McNeil", "Janssen", "Scientific", "Affairs,", "and", "Pfizer.", "<tag2>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "AstraZeneca,", "Biotie,", "Forest,", "GlaxoSmithKline,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Nanotherapeutics,", "Johnson", "and", "Johnson,", "Pfizer,", "and", "UCB.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "specifically", "engaged", "in", "developing", "drugs", "for", "PTSD,", "including", "AstraZeneca,", "UCB,", "GlaxoSmithKline,", "Ortho-McNeil", "Janssen", "Scientific", "Affairs,", "and", "Pfizer."], "wordsB": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "AstraZeneca,", "Biotie,", "Forest,", "GlaxoSmithKline,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Nanotherapeutics,", "Johnson", "and", "Johnson,", "Pfizer,", "and", "UCB."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p143_s0", "idA": "1430306_13_item1_p132_s0", "sentA": "A number of companies are specifically engaged in developing drugs for PTSD, including AstraZeneca, UCB, GlaxoSmithKline, Ortho-McNeil Janssen Scientific Affairs, and Pfizer.", "sentB": "A number of companies are developing prescription medications for tension-type headache, including Bayer, GlaxoSmithKline, and Pfizer.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "specifically", "engaged", "in", "developing", "drugs", "for", "PTSD,", "including", "AstraZeneca,", "UCB,", "GlaxoSmithKline,", "Ortho-McNeil", "Janssen", "Scientific", "Affairs,", "and", "Pfizer.", "<tag2>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "tension-type", "headache,", "including", "Bayer,", "GlaxoSmithKline,", "and", "Pfizer.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "specifically", "engaged", "in", "developing", "drugs", "for", "PTSD,", "including", "AstraZeneca,", "UCB,", "GlaxoSmithKline,", "Ortho-McNeil", "Janssen", "Scientific", "Affairs,", "and", "Pfizer."], "wordsB": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "tension-type", "headache,", "including", "Bayer,", "GlaxoSmithKline,", "and", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p142_s1", "idA": "1430306_13_item1_p133_s0", "sentA": "Medications that may be used for the treatment of PTSD include anti-depressants such as: nefazodone and trazodone; the antihistamine cyproheptadine and certain atypical antipsychotics such as olanzapine and risperidone.", "sentB": "Medications that are used off-label for the treatment of PTSD include anti-depressants, such as nefazodone and trazodone; the antihistamine cyproheptadine; and certain atypical antipsychotics, such as olanzapine and risperidone.", "type": 2, "words": ["<tag1>", "Medications", "that", "may", "be", "used", "for", "the", "treatment", "of", "PTSD", "include", "anti-depressants", "such", "as:", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine", "and", "certain", "atypical", "antipsychotics", "such", "as", "olanzapine", "and", "risperidone.", "<tag2>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone.", "<tag3>"], "wordsA": ["Medications", "that", "may", "be", "used", "for", "the", "treatment", "of", "PTSD", "include", "anti-depressants", "such", "as:", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine", "and", "certain", "atypical", "antipsychotics", "such", "as", "olanzapine", "and", "risperidone."], "wordsB": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p145_s0", "idA": "1430306_13_item1_p134_s0", "sentA": "Proprietary protection for our product candidates, technology and processes are important to our business and we seek patent protection in the U.S. and internationally when we deem appropriate.", "sentB": "We strive to protect the proprietary technology that we believe is important to our business, including our proprietary technology platform, our product candidates, and our processes.", "type": 2, "words": ["<tag1>", "Proprietary", "protection", "for", "our", "product", "candidates,", "technology", "and", "processes", "are", "important", "to", "our", "business", "and", "we", "seek", "patent", "protection", "in", "the", "U.S.", "and", "internationally", "when", "we", "deem", "appropriate.", "<tag2>", "We", "strive", "to", "protect", "the", "proprietary", "technology", "that", "we", "believe", "is", "important", "to", "our", "business,", "including", "our", "proprietary", "technology", "platform,", "our", "product", "candidates,", "and", "our", "processes.", "<tag3>"], "wordsA": ["Proprietary", "protection", "for", "our", "product", "candidates,", "technology", "and", "processes", "are", "important", "to", "our", "business", "and", "we", "seek", "patent", "protection", "in", "the", "U.S.", "and", "internationally", "when", "we", "deem", "appropriate."], "wordsB": ["We", "strive", "to", "protect", "the", "proprietary", "technology", "that", "we", "believe", "is", "important", "to", "our", "business,", "including", "our", "proprietary", "technology", "platform,", "our", "product", "candidates,", "and", "our", "processes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p145_s1", "idA": "1430306_13_item1_p134_s0", "sentA": "Proprietary protection for our product candidates, technology and processes are important to our business and we seek patent protection in the U.S. and internationally when we deem appropriate.", "sentB": "We seek patent protection in the United States and internationally for our products, their methods of use and processes of manufacture, and any other technology to which we have rights, where available and when appropriate.", "type": 2, "words": ["<tag1>", "Proprietary", "protection", "for", "our", "product", "candidates,", "technology", "and", "processes", "are", "important", "to", "our", "business", "and", "we", "seek", "patent", "protection", "in", "the", "U.S.", "and", "internationally", "when", "we", "deem", "appropriate.", "<tag2>", "We", "seek", "patent", "protection", "in", "the", "United", "States", "and", "internationally", "for", "our", "products,", "their", "methods", "of", "use", "and", "processes", "of", "manufacture,", "and", "any", "other", "technology", "to", "which", "we", "have", "rights,", "where", "available", "and", "when", "appropriate.", "<tag3>"], "wordsA": ["Proprietary", "protection", "for", "our", "product", "candidates,", "technology", "and", "processes", "are", "important", "to", "our", "business", "and", "we", "seek", "patent", "protection", "in", "the", "U.S.", "and", "internationally", "when", "we", "deem", "appropriate."], "wordsB": ["We", "seek", "patent", "protection", "in", "the", "United", "States", "and", "internationally", "for", "our", "products,", "their", "methods", "of", "use", "and", "processes", "of", "manufacture,", "and", "any", "other", "technology", "to", "which", "we", "have", "rights,", "where", "available", "and", "when", "appropriate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p145_s2", "idA": "1430306_13_item1_p134_s1", "sentA": "We also rely on trade secrets, know-how and continuing technological advances to protect various aspects of our core technology.", "sentB": "We also rely on trade secrets that may be important to the development of our business.", "type": 2, "words": ["<tag1>", "We", "also", "rely", "on", "trade", "secrets,", "know-how", "and", "continuing", "technological", "advances", "to", "protect", "various", "aspects", "of", "our", "core", "technology.", "<tag2>", "We", "also", "rely", "on", "trade", "secrets", "that", "may", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag3>"], "wordsA": ["We", "also", "rely", "on", "trade", "secrets,", "know-how", "and", "continuing", "technological", "advances", "to", "protect", "various", "aspects", "of", "our", "core", "technology."], "wordsB": ["We", "also", "rely", "on", "trade", "secrets", "that", "may", "be", "important", "to", "the", "development", "of", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p146_s1", "idA": "1430306_13_item1_p134_s1", "sentA": "We also rely on trade secrets, know-how and continuing technological advances to protect various aspects of our core technology.", "sentB": "We also rely on continuing technological innovation and in-licensing opportunities to develop and maintain our proprietary position.", "type": 2, "words": ["<tag1>", "We", "also", "rely", "on", "trade", "secrets,", "know-how", "and", "continuing", "technological", "advances", "to", "protect", "various", "aspects", "of", "our", "core", "technology.", "<tag2>", "We", "also", "rely", "on", "continuing", "technological", "innovation", "and", "in-licensing", "opportunities", "to", "develop", "and", "maintain", "our", "proprietary", "position.", "<tag3>"], "wordsA": ["We", "also", "rely", "on", "trade", "secrets,", "know-how", "and", "continuing", "technological", "advances", "to", "protect", "various", "aspects", "of", "our", "core", "technology."], "wordsB": ["We", "also", "rely", "on", "continuing", "technological", "innovation", "and", "in-licensing", "opportunities", "to", "develop", "and", "maintain", "our", "proprietary", "position."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p162_s1", "idA": "1430306_13_item1_p134_s2", "sentA": "We require our employees, consultants and scientific collaborators to execute confidentiality and invention assignment agreements with us.", "sentB": "We seek to protect our proprietary technology and processes, in part, by confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors, and commercial partners.", "type": 2, "words": ["<tag1>", "We", "require", "our", "employees,", "consultants", "and", "scientific", "collaborators", "to", "execute", "confidentiality", "and", "invention", "assignment", "agreements", "with", "us.", "<tag2>", "We", "seek", "to", "protect", "our", "proprietary", "technology", "and", "processes,", "in", "part,", "by", "confidentiality", "agreements", "and", "invention", "assignment", "agreements", "with", "our", "employees,", "consultants,", "scientific", "advisors,", "contractors,", "and", "commercial", "partners.", "<tag3>"], "wordsA": ["We", "require", "our", "employees,", "consultants", "and", "scientific", "collaborators", "to", "execute", "confidentiality", "and", "invention", "assignment", "agreements", "with", "us."], "wordsB": ["We", "seek", "to", "protect", "our", "proprietary", "technology", "and", "processes,", "in", "part,", "by", "confidentiality", "agreements", "and", "invention", "assignment", "agreements", "with", "our", "employees,", "consultants,", "scientific", "advisors,", "contractors,", "and", "commercial", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p157_s0", "idA": "1430306_13_item1_p135_s0", "sentA": "We own numerous patents and have patent applications pending in the United States and abroad.", "sentB": "The patent portfolio for disulfiram and selegiline combinations includes patents and patent applications.", "type": 2, "words": ["<tag1>", "We", "own", "numerous", "patents", "and", "have", "patent", "applications", "pending", "in", "the", "United", "States", "and", "abroad.", "<tag2>", "The", "patent", "portfolio", "for", "disulfiram", "and", "selegiline", "combinations", "includes", "patents", "and", "patent", "applications.", "<tag3>"], "wordsA": ["We", "own", "numerous", "patents", "and", "have", "patent", "applications", "pending", "in", "the", "United", "States", "and", "abroad."], "wordsB": ["The", "patent", "portfolio", "for", "disulfiram", "and", "selegiline", "combinations", "includes", "patents", "and", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p163_s0", "idA": "1430306_13_item1_p135_s0", "sentA": "We own numerous patents and have patent applications pending in the United States and abroad.", "sentB": "We seek trademark protection in the United States and outside of the United States where available and when appropriate.", "type": 2, "words": ["<tag1>", "We", "own", "numerous", "patents", "and", "have", "patent", "applications", "pending", "in", "the", "United", "States", "and", "abroad.", "<tag2>", "We", "seek", "trademark", "protection", "in", "the", "United", "States", "and", "outside", "of", "the", "United", "States", "where", "available", "and", "when", "appropriate.", "<tag3>"], "wordsA": ["We", "own", "numerous", "patents", "and", "have", "patent", "applications", "pending", "in", "the", "United", "States", "and", "abroad."], "wordsB": ["We", "seek", "trademark", "protection", "in", "the", "United", "States", "and", "outside", "of", "the", "United", "States", "where", "available", "and", "when", "appropriate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p163_s1", "idA": "1430306_13_item1_p135_s0", "sentA": "We own numerous patents and have patent applications pending in the United States and abroad.", "sentB": "We have applied for a trademark for Tonix Pharmaceuticals in the United States.", "type": 2, "words": ["<tag1>", "We", "own", "numerous", "patents", "and", "have", "patent", "applications", "pending", "in", "the", "United", "States", "and", "abroad.", "<tag2>", "We", "have", "applied", "for", "a", "trademark", "for", "Tonix", "Pharmaceuticals", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["We", "own", "numerous", "patents", "and", "have", "patent", "applications", "pending", "in", "the", "United", "States", "and", "abroad."], "wordsB": ["We", "have", "applied", "for", "a", "trademark", "for", "Tonix", "Pharmaceuticals", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p44_s3", "idA": "1430306_13_item1_p135_s1", "sentA": "In addition, we have one trademark application pending.", "sentB": "In addition, we recently acquired rights to intellectual property on the development of protective agents against radiation exposure and on the development of novel smallpox vaccines.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "one", "trademark", "application", "pending.", "<tag2>", "In", "addition,", "we", "recently", "acquired", "rights", "to", "intellectual", "property", "on", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure", "and", "on", "the", "development", "of", "novel", "smallpox", "vaccines.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "one", "trademark", "application", "pending."], "wordsB": ["In", "addition,", "we", "recently", "acquired", "rights", "to", "intellectual", "property", "on", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure", "and", "on", "the", "development", "of", "novel", "smallpox", "vaccines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p146_s0", "idA": "1430306_13_item1_p136_s1", "sentA": "Our ability to stop third parties from making, using, selling, offering to sell or importing our products depends on the extent to which we have rights under valid and enforceable patents or trade secrets that cover these activities.", "sentB": "Our success will depend on 1) the ability to obtain and maintain patent and other proprietary rights in commercially important technology, inventions and know-how related to our business, 2) the validity and enforceability of our patents, 3) the continued confidentiality of our trade secrets, and 4) our ability to operate without infringing the valid and enforceable patents and proprietary rights of third parties.", "type": 2, "words": ["<tag1>", "Our", "ability", "to", "stop", "third", "parties", "from", "making,", "using,", "selling,", "offering", "to", "sell", "or", "importing", "our", "products", "depends", "on", "the", "extent", "to", "which", "we", "have", "rights", "under", "valid", "and", "enforceable", "patents", "or", "trade", "secrets", "that", "cover", "these", "activities.", "<tag2>", "Our", "success", "will", "depend", "on", "1)", "the", "ability", "to", "obtain", "and", "maintain", "patent", "and", "other", "proprietary", "rights", "in", "commercially", "important", "technology,", "inventions", "and", "know-how", "related", "to", "our", "business,", "2)", "the", "validity", "and", "enforceability", "of", "our", "patents,", "3)", "the", "continued", "confidentiality", "of", "our", "trade", "secrets,", "and", "4)", "our", "ability", "to", "operate", "without", "infringing", "the", "valid", "and", "enforceable", "patents", "and", "proprietary", "rights", "of", "third", "parties.", "<tag3>"], "wordsA": ["Our", "ability", "to", "stop", "third", "parties", "from", "making,", "using,", "selling,", "offering", "to", "sell", "or", "importing", "our", "products", "depends", "on", "the", "extent", "to", "which", "we", "have", "rights", "under", "valid", "and", "enforceable", "patents", "or", "trade", "secrets", "that", "cover", "these", "activities."], "wordsB": ["Our", "success", "will", "depend", "on", "1)", "the", "ability", "to", "obtain", "and", "maintain", "patent", "and", "other", "proprietary", "rights", "in", "commercially", "important", "technology,", "inventions", "and", "know-how", "related", "to", "our", "business,", "2)", "the", "validity", "and", "enforceability", "of", "our", "patents,", "3)", "the", "continued", "confidentiality", "of", "our", "trade", "secrets,", "and", "4)", "our", "ability", "to", "operate", "without", "infringing", "the", "valid", "and", "enforceable", "patents", "and", "proprietary", "rights", "of", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p166_s0", "idA": "1430306_13_item1_p138_s0", "sentA": "Our current patent applications that are pending are as follows:", "sentB": "Our current pending patent applications are as follows:", "type": 2, "words": ["<tag1>", "Our", "current", "patent", "applications", "that", "are", "pending", "are", "as", "follows:", "<tag2>", "Our", "current", "pending", "patent", "applications", "are", "as", "follows:", "<tag3>"], "wordsA": ["Our", "current", "patent", "applications", "that", "are", "pending", "are", "as", "follows:"], "wordsB": ["Our", "current", "pending", "patent", "applications", "are", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p20_s1", "idA": "1430306_13_item1_p13_s0", "sentA": "In connection with founding Tonix Sub, L L and Plumbline entered into an intellectual property transfer and assignment agreement with Tonix Sub for the purpose of assigning patents and transferring intellectual property and know-how in exchange for shares of common stock of Tonix Sub.", "sentB": "On December 31, 2013, Tonix Barbados entered into a license agreement and a cost-sharing agreement with Tonix Sub, pursuant to which Tonix Barbados acquired the rights to develop and commercialize TNX-102 SL and TNX-201 for non-US markets in exchange for (1) cost sharing of research and development costs going forward and (2) royalties of 8% and 6% on net sales of TNX-102 SL and TNX-201, respectively.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "founding", "Tonix", "Sub,", "L", "L", "and", "Plumbline", "entered", "into", "an", "intellectual", "property", "transfer", "and", "assignment", "agreement", "with", "Tonix", "Sub", "for", "the", "purpose", "of", "assigning", "patents", "and", "transferring", "intellectual", "property", "and", "know-how", "in", "exchange", "for", "shares", "of", "common", "stock", "of", "Tonix", "Sub.", "<tag2>", "On", "December", "31,", "2013,", "Tonix", "Barbados", "entered", "into", "a", "license", "agreement", "and", "a", "cost-sharing", "agreement", "with", "Tonix", "Sub,", "pursuant", "to", "which", "Tonix", "Barbados", "acquired", "the", "rights", "to", "develop", "and", "commercialize", "TNX-102", "SL", "and", "TNX-201", "for", "non-US", "markets", "in", "exchange", "for", "(1)", "cost", "sharing", "of", "research", "and", "development", "costs", "going", "forward", "and", "(2)", "royalties", "of", "8%", "and", "6%", "on", "net", "sales", "of", "TNX-102", "SL", "and", "TNX-201,", "respectively.", "<tag3>"], "wordsA": ["In", "connection", "with", "founding", "Tonix", "Sub,", "L", "L", "and", "Plumbline", "entered", "into", "an", "intellectual", "property", "transfer", "and", "assignment", "agreement", "with", "Tonix", "Sub", "for", "the", "purpose", "of", "assigning", "patents", "and", "transferring", "intellectual", "property", "and", "know-how", "in", "exchange", "for", "shares", "of", "common", "stock", "of", "Tonix", "Sub."], "wordsB": ["On", "December", "31,", "2013,", "Tonix", "Barbados", "entered", "into", "a", "license", "agreement", "and", "a", "cost-sharing", "agreement", "with", "Tonix", "Sub,", "pursuant", "to", "which", "Tonix", "Barbados", "acquired", "the", "rights", "to", "develop", "and", "commercialize", "TNX-102", "SL", "and", "TNX-201", "for", "non-US", "markets", "in", "exchange", "for", "(1)", "cost", "sharing", "of", "research", "and", "development", "costs", "going", "forward", "and", "(2)", "royalties", "of", "8%", "and", "6%", "on", "net", "sales", "of", "TNX-102", "SL", "and", "TNX-201,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p28_s0", "idA": "1430306_13_item1_p140_s0", "sentA": "We have one employee dedicated to research and development.", "sentB": "We have completed four Phase 1 studies under Canadian Clinical Trial Applications.", "type": 2, "words": ["<tag1>", "We", "have", "one", "employee", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "completed", "four", "Phase", "1", "studies", "under", "Canadian", "Clinical", "Trial", "Applications.", "<tag3>"], "wordsA": ["We", "have", "one", "employee", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "completed", "four", "Phase", "1", "studies", "under", "Canadian", "Clinical", "Trial", "Applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p45_s3", "idA": "1430306_13_item1_p140_s0", "sentA": "We have one employee dedicated to research and development.", "sentB": "We plan to perform non-clinical research and development on these programs in 2014.", "type": 2, "words": ["<tag1>", "We", "have", "one", "employee", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "plan", "to", "perform", "non-clinical", "research", "and", "development", "on", "these", "programs", "in", "2014.", "<tag3>"], "wordsA": ["We", "have", "one", "employee", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "plan", "to", "perform", "non-clinical", "research", "and", "development", "on", "these", "programs", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p89_s0", "idA": "1430306_13_item1_p140_s2", "sentA": "We need to raise additional capital to fund our development plans and there is no certainty that we will be successful in continuing to attract new investments.", "sentB": "Based on the Flexeril labeling and post-marketing surveillance information, there is no evidence of abuse for CBP.", "type": 2, "words": ["<tag1>", "We", "need", "to", "raise", "additional", "capital", "to", "fund", "our", "development", "plans", "and", "there", "is", "no", "certainty", "that", "we", "will", "be", "successful", "in", "continuing", "to", "attract", "new", "investments.", "<tag2>", "Based", "on", "the", "Flexeril", "labeling", "and", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "CBP.", "<tag3>"], "wordsA": ["We", "need", "to", "raise", "additional", "capital", "to", "fund", "our", "development", "plans", "and", "there", "is", "no", "certainty", "that", "we", "will", "be", "successful", "in", "continuing", "to", "attract", "new", "investments."], "wordsB": ["Based", "on", "the", "Flexeril", "labeling", "and", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p169_s0", "idA": "1430306_13_item1_p141_s0", "sentA": "We have contracted with third parties for the manufacture of TNX-102 SL for investigational purposes, including preclinical and clinical testing, as follows:", "sentB": "We have contracted with third-party contract manufacturing organizations, or CMOs, for the manufacture of TNX-102 SL for investigational purposes, including preclinical and clinical testing, as follows:", "type": 2, "words": ["<tag1>", "We", "have", "contracted", "with", "third", "parties", "for", "the", "manufacture", "of", "TNX-102", "SL", "for", "investigational", "purposes,", "including", "preclinical", "and", "clinical", "testing,", "as", "follows:", "<tag2>", "We", "have", "contracted", "with", "third-party", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "for", "investigational", "purposes,", "including", "preclinical", "and", "clinical", "testing,", "as", "follows:", "<tag3>"], "wordsA": ["We", "have", "contracted", "with", "third", "parties", "for", "the", "manufacture", "of", "TNX-102", "SL", "for", "investigational", "purposes,", "including", "preclinical", "and", "clinical", "testing,", "as", "follows:"], "wordsB": ["We", "have", "contracted", "with", "third-party", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "for", "investigational", "purposes,", "including", "preclinical", "and", "clinical", "testing,", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p88_s2", "idA": "1430306_13_item1_p145_s0", "sentA": "FDA review and approval of the NDA prior to any commercial marketing, sale or shipment of the drug.", "sentB": "We plan to submit these draft toxicology protocols for FDA review and seek agreement on the doses and facilities chosen for these studies.", "type": 2, "words": ["<tag1>", "FDA", "review", "and", "approval", "of", "the", "NDA", "prior", "to", "any", "commercial", "marketing,", "sale", "or", "shipment", "of", "the", "drug.", "<tag2>", "We", "plan", "to", "submit", "these", "draft", "toxicology", "protocols", "for", "FDA", "review", "and", "seek", "agreement", "on", "the", "doses", "and", "facilities", "chosen", "for", "these", "studies.", "<tag3>"], "wordsA": ["FDA", "review", "and", "approval", "of", "the", "NDA", "prior", "to", "any", "commercial", "marketing,", "sale", "or", "shipment", "of", "the", "drug."], "wordsB": ["We", "plan", "to", "submit", "these", "draft", "toxicology", "protocols", "for", "FDA", "review", "and", "seek", "agreement", "on", "the", "doses", "and", "facilities", "chosen", "for", "these", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p147_s0", "idA": "1430306_13_item1_p146_s0", "sentA": "The testing and approval process requires substantial time, effort and financial resources, and we cannot be certain that any approvals for our product candidates will be granted on a timely basis, if at all.", "sentB": "We cannot be certain that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications we may own or license in the future, nor can we be certain that any of our existing patents or any patents we may own or license in the future will be useful in protecting our technology.", "type": 2, "words": ["<tag1>", "The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort", "and", "financial", "resources,", "and", "we", "cannot", "be", "certain", "that", "any", "approvals", "for", "our", "product", "candidates", "will", "be", "granted", "on", "a", "timely", "basis,", "if", "at", "all.", "<tag2>", "We", "cannot", "be", "certain", "that", "patents", "will", "be", "granted", "with", "respect", "to", "any", "of", "our", "pending", "patent", "applications", "or", "with", "respect", "to", "any", "patent", "applications", "we", "may", "own", "or", "license", "in", "the", "future,", "nor", "can", "we", "be", "certain", "that", "any", "of", "our", "existing", "patents", "or", "any", "patents", "we", "may", "own", "or", "license", "in", "the", "future", "will", "be", "useful", "in", "protecting", "our", "technology.", "<tag3>"], "wordsA": ["The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort", "and", "financial", "resources,", "and", "we", "cannot", "be", "certain", "that", "any", "approvals", "for", "our", "product", "candidates", "will", "be", "granted", "on", "a", "timely", "basis,", "if", "at", "all."], "wordsB": ["We", "cannot", "be", "certain", "that", "patents", "will", "be", "granted", "with", "respect", "to", "any", "of", "our", "pending", "patent", "applications", "or", "with", "respect", "to", "any", "patent", "applications", "we", "may", "own", "or", "license", "in", "the", "future,", "nor", "can", "we", "be", "certain", "that", "any", "of", "our", "existing", "patents", "or", "any", "patents", "we", "may", "own", "or", "license", "in", "the", "future", "will", "be", "useful", "in", "protecting", "our", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p150_s0", "idA": "1430306_13_item1_p150_s1", "sentA": "Each protocol for a U.S. study is submitted to the FDA as part of the IND.", "sentB": "The term of a U.S. patent that covers an FDA-approved drug may also be eligible for patent term extension, which permits patent term restoration as compensation for the patent term lost during the FDA regulatory review process.", "type": 2, "words": ["<tag1>", "Each", "protocol", "for", "a", "U.S.", "study", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND.", "<tag2>", "The", "term", "of", "a", "U.S.", "patent", "that", "covers", "an", "FDA-approved", "drug", "may", "also", "be", "eligible", "for", "patent", "term", "extension,", "which", "permits", "patent", "term", "restoration", "as", "compensation", "for", "the", "patent", "term", "lost", "during", "the", "FDA", "regulatory", "review", "process.", "<tag3>"], "wordsA": ["Each", "protocol", "for", "a", "U.S.", "study", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND."], "wordsB": ["The", "term", "of", "a", "U.S.", "patent", "that", "covers", "an", "FDA-approved", "drug", "may", "also", "be", "eligible", "for", "patent", "term", "extension,", "which", "permits", "patent", "term", "restoration", "as", "compensation", "for", "the", "patent", "term", "lost", "during", "the", "FDA", "regulatory", "review", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p158_s2", "idA": "1430306_13_item1_p150_s1", "sentA": "Each protocol for a U.S. study is submitted to the FDA as part of the IND.", "sentB": "With respect to the radioprotection drug candidate, we acquired U.S. non-provisional Patent Application No. 14,203,733 and related intellectual property rights.", "type": 2, "words": ["<tag1>", "Each", "protocol", "for", "a", "U.S.", "study", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND.", "<tag2>", "With", "respect", "to", "the", "radioprotection", "drug", "candidate,", "we", "acquired", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,203,733", "and", "related", "intellectual", "property", "rights.", "<tag3>"], "wordsA": ["Each", "protocol", "for", "a", "U.S.", "study", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND."], "wordsB": ["With", "respect", "to", "the", "radioprotection", "drug", "candidate,", "we", "acquired", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,203,733", "and", "related", "intellectual", "property", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p141_s0", "idA": "1430306_13_item1_p157_s1", "sentA": "An NDA also must contain extensive manufacturing information, as well as proposed labeling for the finished product.", "sentB": "benzodiazepine as well as non-benzodiazepine sedative hypnotics.", "type": 2, "words": ["<tag1>", "An", "NDA", "also", "must", "contain", "extensive", "manufacturing", "information,", "as", "well", "as", "proposed", "labeling", "for", "the", "finished", "product.", "<tag2>", "benzodiazepine", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics.", "<tag3>"], "wordsA": ["An", "NDA", "also", "must", "contain", "extensive", "manufacturing", "information,", "as", "well", "as", "proposed", "labeling", "for", "the", "finished", "product."], "wordsB": ["benzodiazepine", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p156_s0", "idA": "1430306_13_item1_p157_s1", "sentA": "An NDA also must contain extensive manufacturing information, as well as proposed labeling for the finished product.", "sentB": "The Isometheptene Technology patent portfolio includes U.S. Patent Application No. 14/158,735 as well as U.S. Provisional Patent Application Nos.", "type": 2, "words": ["<tag1>", "An", "NDA", "also", "must", "contain", "extensive", "manufacturing", "information,", "as", "well", "as", "proposed", "labeling", "for", "the", "finished", "product.", "<tag2>", "The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Provisional", "Patent", "Application", "Nos.", "<tag3>"], "wordsA": ["An", "NDA", "also", "must", "contain", "extensive", "manufacturing", "information,", "as", "well", "as", "proposed", "labeling", "for", "the", "finished", "product."], "wordsB": ["The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Provisional", "Patent", "Application", "Nos."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p206_s0", "idA": "1430306_13_item1_p157_s6", "sentA": "Prior to approval, the FDA will conduct an inspection of the manufacturing facilities to assess compliance with cGMP.", "sentB": "If a drug is designated as Breakthrough Therapy, the FDA will expedite the development and review of such drug.", "type": 2, "words": ["<tag1>", "Prior", "to", "approval,", "the", "FDA", "will", "conduct", "an", "inspection", "of", "the", "manufacturing", "facilities", "to", "assess", "compliance", "with", "cGMP.", "<tag2>", "If", "a", "drug", "is", "designated", "as", "Breakthrough", "Therapy,", "the", "FDA", "will", "expedite", "the", "development", "and", "review", "of", "such", "drug.", "<tag3>"], "wordsA": ["Prior", "to", "approval,", "the", "FDA", "will", "conduct", "an", "inspection", "of", "the", "manufacturing", "facilities", "to", "assess", "compliance", "with", "cGMP."], "wordsB": ["If", "a", "drug", "is", "designated", "as", "Breakthrough", "Therapy,", "the", "FDA", "will", "expedite", "the", "development", "and", "review", "of", "such", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p42_s3", "idA": "1430306_13_item1_p158_s2", "sentA": "In this event, the NDA must be resubmitted with the additional information and is subject to review before the FDA accepts it for filing.", "sentB": "The selection of a single isomer of IMH for development may confer an improved clinical profile as compared to the racemic mixture, consistent with the FDA Stereoisomeric Drugs Development Policy, and is supported by our pharmacology data.", "type": 2, "words": ["<tag1>", "In", "this", "event,", "the", "NDA", "must", "be", "resubmitted", "with", "the", "additional", "information", "and", "is", "subject", "to", "review", "before", "the", "FDA", "accepts", "it", "for", "filing.", "<tag2>", "The", "selection", "of", "a", "single", "isomer", "of", "IMH", "for", "development", "may", "confer", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "racemic", "mixture,", "consistent", "with", "the", "FDA", "Stereoisomeric", "Drugs", "Development", "Policy,", "and", "is", "supported", "by", "our", "pharmacology", "data.", "<tag3>"], "wordsA": ["In", "this", "event,", "the", "NDA", "must", "be", "resubmitted", "with", "the", "additional", "information", "and", "is", "subject", "to", "review", "before", "the", "FDA", "accepts", "it", "for", "filing."], "wordsB": ["The", "selection", "of", "a", "single", "isomer", "of", "IMH", "for", "development", "may", "confer", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "racemic", "mixture,", "consistent", "with", "the", "FDA", "Stereoisomeric", "Drugs", "Development", "Policy,", "and", "is", "supported", "by", "our", "pharmacology", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p92_s0", "idA": "1430306_13_item1_p158_s2", "sentA": "In this event, the NDA must be resubmitted with the additional information and is subject to review before the FDA accepts it for filing.", "sentB": "Based our discussions with the FDA and the FDA formal meeting minutes, we will not have to conduct special populations (geriatric and renal/hepatic impaired), drug-drug interaction or a cardiovascular safety study to support the NDA filing.", "type": 2, "words": ["<tag1>", "In", "this", "event,", "the", "NDA", "must", "be", "resubmitted", "with", "the", "additional", "information", "and", "is", "subject", "to", "review", "before", "the", "FDA", "accepts", "it", "for", "filing.", "<tag2>", "Based", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "formal", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "a", "cardiovascular", "safety", "study", "to", "support", "the", "NDA", "filing.", "<tag3>"], "wordsA": ["In", "this", "event,", "the", "NDA", "must", "be", "resubmitted", "with", "the", "additional", "information", "and", "is", "subject", "to", "review", "before", "the", "FDA", "accepts", "it", "for", "filing."], "wordsB": ["Based", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "formal", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "a", "cardiovascular", "safety", "study", "to", "support", "the", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p15_s0", "idA": "1430306_13_item1_p15_s0", "sentA": "In 2009, Tonix Sub contracted with the Toronto Psychiatric Research Foundation to analyze the sleep data from a Phase 2a trial of bedtime VLD CBP in fibromyalgia, or FM (the Moldofsky Study ).", "sentB": "In 2009, Tonix Sub contracted with the Toronto Psychiatric Research Foundation to analyze the sleep data from a Phase 2a trial of nighttime VLD CBP in fibromyalgia, or FM ( the Moldofsky Study ).", "type": 2, "words": ["<tag1>", "In", "2009,", "Tonix", "Sub", "contracted", "with", "the", "Toronto", "Psychiatric", "Research", "Foundation", "to", "analyze", "the", "sleep", "data", "from", "a", "Phase", "2a", "trial", "of", "bedtime", "VLD", "CBP", "in", "fibromyalgia,", "or", "FM", "(the", "Moldofsky", "Study", ").", "<tag2>", "In", "2009,", "Tonix", "Sub", "contracted", "with", "the", "Toronto", "Psychiatric", "Research", "Foundation", "to", "analyze", "the", "sleep", "data", "from", "a", "Phase", "2a", "trial", "of", "nighttime", "VLD", "CBP", "in", "fibromyalgia,", "or", "FM", "(", "the", "Moldofsky", "Study", ").", "<tag3>"], "wordsA": ["In", "2009,", "Tonix", "Sub", "contracted", "with", "the", "Toronto", "Psychiatric", "Research", "Foundation", "to", "analyze", "the", "sleep", "data", "from", "a", "Phase", "2a", "trial", "of", "bedtime", "VLD", "CBP", "in", "fibromyalgia,", "or", "FM", "(the", "Moldofsky", "Study", ")."], "wordsB": ["In", "2009,", "Tonix", "Sub", "contracted", "with", "the", "Toronto", "Psychiatric", "Research", "Foundation", "to", "analyze", "the", "sleep", "data", "from", "a", "Phase", "2a", "trial", "of", "nighttime", "VLD", "CBP", "in", "fibromyalgia,", "or", "FM", "(", "the", "Moldofsky", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p188_s1", "idA": "1430306_13_item1_p161_s0", "sentA": "NDAs that might, if accepted by the FDA, save time and expense in the development and testing of our product candidates.", "sentB": "We intend to file Section 505(b)(2) NDAs for TNX-102 SL for FM and PTSD, and for certain other products, that might, if accepted by the FDA, save time and expense in the development and testing of our product candidates.", "type": 2, "words": ["<tag1>", "NDAs", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates.", "<tag2>", "We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["NDAs", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates."], "wordsB": ["We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p190_s0", "idA": "1430306_13_item1_p163_s0", "sentA": "Because we are developing new formulations of previously approved chemical entities, such as CBP, our drug approval strategy is to submit Section 505(b)(2) NDAs to the FDA.", "sentB": "Our drug approval strategy for our new formulations of approved chemical entities is to submit Section 505(b)(2) NDAs to the FDA.", "type": 2, "words": ["<tag1>", "Because", "we", "are", "developing", "new", "formulations", "of", "previously", "approved", "chemical", "entities,", "such", "as", "CBP,", "our", "drug", "approval", "strategy", "is", "to", "submit", "Section", "505(b)(2)", "NDAs", "to", "the", "FDA.", "<tag2>", "Our", "drug", "approval", "strategy", "for", "our", "new", "formulations", "of", "approved", "chemical", "entities", "is", "to", "submit", "Section", "505(b)(2)", "NDAs", "to", "the", "FDA.", "<tag3>"], "wordsA": ["Because", "we", "are", "developing", "new", "formulations", "of", "previously", "approved", "chemical", "entities,", "such", "as", "CBP,", "our", "drug", "approval", "strategy", "is", "to", "submit", "Section", "505(b)(2)", "NDAs", "to", "the", "FDA."], "wordsB": ["Our", "drug", "approval", "strategy", "for", "our", "new", "formulations", "of", "approved", "chemical", "entities", "is", "to", "submit", "Section", "505(b)(2)", "NDAs", "to", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p190_s2", "idA": "1430306_13_item1_p163_s1", "sentA": "The FDA may not agree that our product candidates are approvable as Section 505(b)(2) NDAs.", "sentB": "The FDA may not agree that this product candidate is approvable for FM or PTSD as Section 505(b)(2) NDAs.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "not", "agree", "that", "our", "product", "candidates", "are", "approvable", "as", "Section", "505(b)(2)", "NDAs.", "<tag2>", "The", "FDA", "may", "not", "agree", "that", "this", "product", "candidate", "is", "approvable", "for", "FM", "or", "PTSD", "as", "Section", "505(b)(2)", "NDAs.", "<tag3>"], "wordsA": ["The", "FDA", "may", "not", "agree", "that", "our", "product", "candidates", "are", "approvable", "as", "Section", "505(b)(2)", "NDAs."], "wordsB": ["The", "FDA", "may", "not", "agree", "that", "this", "product", "candidate", "is", "approvable", "for", "FM", "or", "PTSD", "as", "Section", "505(b)(2)", "NDAs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p190_s3", "idA": "1430306_13_item1_p163_s2", "sentA": "If the FDA determines that Section 505(b)(2) NDAs are not appropriate and that full NDAs are required for our product candidates, the time and financial resources required to obtain FDA approval for our product candidates could substantially and materially increase, and our products might be less likely to be approved.", "sentB": "If the FDA determines that Section 505(b)(2) NDAs are not appropriate and that full NDAs are required for TNX-102 SL, the time and financial resources required to obtain FDA approval for TNX-102 SL could substantially and materially increase, and TNX-102 SL might be less likely to be approved.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "determines", "that", "Section", "505(b)(2)", "NDAs", "are", "not", "appropriate", "and", "that", "full", "NDAs", "are", "required", "for", "our", "product", "candidates,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "our", "product", "candidates", "could", "substantially", "and", "materially", "increase,", "and", "our", "products", "might", "be", "less", "likely", "to", "be", "approved.", "<tag2>", "If", "the", "FDA", "determines", "that", "Section", "505(b)(2)", "NDAs", "are", "not", "appropriate", "and", "that", "full", "NDAs", "are", "required", "for", "TNX-102", "SL,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "TNX-102", "SL", "could", "substantially", "and", "materially", "increase,", "and", "TNX-102", "SL", "might", "be", "less", "likely", "to", "be", "approved.", "<tag3>"], "wordsA": ["If", "the", "FDA", "determines", "that", "Section", "505(b)(2)", "NDAs", "are", "not", "appropriate", "and", "that", "full", "NDAs", "are", "required", "for", "our", "product", "candidates,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "our", "product", "candidates", "could", "substantially", "and", "materially", "increase,", "and", "our", "products", "might", "be", "less", "likely", "to", "be", "approved."], "wordsB": ["If", "the", "FDA", "determines", "that", "Section", "505(b)(2)", "NDAs", "are", "not", "appropriate", "and", "that", "full", "NDAs", "are", "required", "for", "TNX-102", "SL,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "TNX-102", "SL", "could", "substantially", "and", "materially", "increase,", "and", "TNX-102", "SL", "might", "be", "less", "likely", "to", "be", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p190_s4", "idA": "1430306_13_item1_p163_s3", "sentA": "If the FDA requires full NDAs for our product candidates, or requires more extensive testing and development for some other reason, our ability to compete with alternative products that arrive on the market more quickly than our product candidates would be adversely impacted.", "sentB": "If the FDA requires full NDAs for TNX-102 SL, or requires more extensive testing and development for some other reason, our ability to compete with alternative products that arrive on the market more quickly than our product candidates would be adversely impacted.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "requires", "full", "NDAs", "for", "our", "product", "candidates,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted.", "<tag2>", "If", "the", "FDA", "requires", "full", "NDAs", "for", "TNX-102", "SL,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted.", "<tag3>"], "wordsA": ["If", "the", "FDA", "requires", "full", "NDAs", "for", "our", "product", "candidates,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted."], "wordsB": ["If", "the", "FDA", "requires", "full", "NDAs", "for", "TNX-102", "SL,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p162_s4", "idA": "1430306_13_item1_p163_s4", "sentA": "If CBP-containing products are withdrawn from the market by the FDA for any reason, we may not be able to reference such products to support our anticipated TNX-102 SL 505(b)(2) NDA, and we may be required to follow the requirements of Section 505(b)(1).", "sentB": "While we have confidence in these individuals, organizations and systems, agreements or security measures may be breached, and we may not have adequate remedies for any breach.", "type": 2, "words": ["<tag1>", "If", "CBP-containing", "products", "are", "withdrawn", "from", "the", "market", "by", "the", "FDA", "for", "any", "reason,", "we", "may", "not", "be", "able", "to", "reference", "such", "products", "to", "support", "our", "anticipated", "TNX-102", "SL", "505(b)(2)", "NDA,", "and", "we", "may", "be", "required", "to", "follow", "the", "requirements", "of", "Section", "505(b)(1).", "<tag2>", "While", "we", "have", "confidence", "in", "these", "individuals,", "organizations", "and", "systems,", "agreements", "or", "security", "measures", "may", "be", "breached,", "and", "we", "may", "not", "have", "adequate", "remedies", "for", "any", "breach.", "<tag3>"], "wordsA": ["If", "CBP-containing", "products", "are", "withdrawn", "from", "the", "market", "by", "the", "FDA", "for", "any", "reason,", "we", "may", "not", "be", "able", "to", "reference", "such", "products", "to", "support", "our", "anticipated", "TNX-102", "SL", "505(b)(2)", "NDA,", "and", "we", "may", "be", "required", "to", "follow", "the", "requirements", "of", "Section", "505(b)(1)."], "wordsB": ["While", "we", "have", "confidence", "in", "these", "individuals,", "organizations", "and", "systems,", "agreements", "or", "security", "measures", "may", "be", "breached,", "and", "we", "may", "not", "have", "adequate", "remedies", "for", "any", "breach."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p191_s0", "idA": "1430306_13_item1_p164_s0", "sentA": "Based on our intent to file under Section 505(b)(2) with respect to our lead product candidate, we believe it is unlikely the development process for this product candidate will follow the ordinary course of Phase 1, Phase 2 and Phase 3 studies.", "sentB": "Based on our intent to file under Section 505(b)(2) with respect to our lead product candidate, TNX-102 SL for FM and PTSD, we believe it is unlikely the development process for this product candidate will follow the ordinary course of Phase 1, Phase 2 and Phase 3 studies.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "lead", "product", "candidate,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "this", "product", "candidate", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies.", "<tag2>", "Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "lead", "product", "candidate,", "TNX-102", "SL", "for", "FM", "and", "PTSD,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "this", "product", "candidate", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies.", "<tag3>"], "wordsA": ["Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "lead", "product", "candidate,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "this", "product", "candidate", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies."], "wordsB": ["Based", "on", "our", "intent", "to", "file", "under", "Section", "505(b)(2)", "with", "respect", "to", "our", "lead", "product", "candidate,", "TNX-102", "SL", "for", "FM", "and", "PTSD,", "we", "believe", "it", "is", "unlikely", "the", "development", "process", "for", "this", "product", "candidate", "will", "follow", "the", "ordinary", "course", "of", "Phase", "1,", "Phase", "2", "and", "Phase", "3", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p192_s0", "idA": "1430306_13_item1_p165_s0", "sentA": "Our human pharmacokinetic studies of reformulated CBP dosage forms represented the first use of TNX-102 SL and TNX-102 gelcap, or collectively, TNX-102, in humans and could therefore be described as Phase 1.", "sentB": "Our human pharmacokinetic studies of TNX-102 SL represented the first use of sublingual CBP in humans and could therefore be described as Phase 1.", "type": 2, "words": ["<tag1>", "Our", "human", "pharmacokinetic", "studies", "of", "reformulated", "CBP", "dosage", "forms", "represented", "the", "first", "use", "of", "TNX-102", "SL", "and", "TNX-102", "gelcap,", "or", "collectively,", "TNX-102,", "in", "humans", "and", "could", "therefore", "be", "described", "as", "Phase", "1.", "<tag2>", "Our", "human", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "represented", "the", "first", "use", "of", "sublingual", "CBP", "in", "humans", "and", "could", "therefore", "be", "described", "as", "Phase", "1.", "<tag3>"], "wordsA": ["Our", "human", "pharmacokinetic", "studies", "of", "reformulated", "CBP", "dosage", "forms", "represented", "the", "first", "use", "of", "TNX-102", "SL", "and", "TNX-102", "gelcap,", "or", "collectively,", "TNX-102,", "in", "humans", "and", "could", "therefore", "be", "described", "as", "Phase", "1."], "wordsB": ["Our", "human", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "represented", "the", "first", "use", "of", "sublingual", "CBP", "in", "humans", "and", "could", "therefore", "be", "described", "as", "Phase", "1."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p192_s1", "idA": "1430306_13_item1_p165_s1", "sentA": "However, because these studies compared TNX-102 to existing approved formulations of CBP and specified the comparable ability to deliver effective levels of CBP to the bloodstream of FM patients, these studies provide a reference to the therapeutic effects previously observed in our dose-ranging clinical study of CBP IR capsules in FM patients.", "sentB": "However, because these studies compared TNX-102 SL to existing approved formulations of CBP and specified the comparable ability to deliver effective levels of CBP to the bloodstream of FM patients, these studies provide a reference to the therapeutic effects previously observed in our dose-ranging clinical study of TNX-102 capsules in FM patients.", "type": 2, "words": ["<tag1>", "However,", "because", "these", "studies", "compared", "TNX-102", "to", "existing", "approved", "formulations", "of", "CBP", "and", "specified", "the", "comparable", "ability", "to", "deliver", "effective", "levels", "of", "CBP", "to", "the", "bloodstream", "of", "FM", "patients,", "these", "studies", "provide", "a", "reference", "to", "the", "therapeutic", "effects", "previously", "observed", "in", "our", "dose-ranging", "clinical", "study", "of", "CBP", "IR", "capsules", "in", "FM", "patients.", "<tag2>", "However,", "because", "these", "studies", "compared", "TNX-102", "SL", "to", "existing", "approved", "formulations", "of", "CBP", "and", "specified", "the", "comparable", "ability", "to", "deliver", "effective", "levels", "of", "CBP", "to", "the", "bloodstream", "of", "FM", "patients,", "these", "studies", "provide", "a", "reference", "to", "the", "therapeutic", "effects", "previously", "observed", "in", "our", "dose-ranging", "clinical", "study", "of", "TNX-102", "capsules", "in", "FM", "patients.", "<tag3>"], "wordsA": ["However,", "because", "these", "studies", "compared", "TNX-102", "to", "existing", "approved", "formulations", "of", "CBP", "and", "specified", "the", "comparable", "ability", "to", "deliver", "effective", "levels", "of", "CBP", "to", "the", "bloodstream", "of", "FM", "patients,", "these", "studies", "provide", "a", "reference", "to", "the", "therapeutic", "effects", "previously", "observed", "in", "our", "dose-ranging", "clinical", "study", "of", "CBP", "IR", "capsules", "in", "FM", "patients."], "wordsB": ["However,", "because", "these", "studies", "compared", "TNX-102", "SL", "to", "existing", "approved", "formulations", "of", "CBP", "and", "specified", "the", "comparable", "ability", "to", "deliver", "effective", "levels", "of", "CBP", "to", "the", "bloodstream", "of", "FM", "patients,", "these", "studies", "provide", "a", "reference", "to", "the", "therapeutic", "effects", "previously", "observed", "in", "our", "dose-ranging", "clinical", "study", "of", "TNX-102", "capsules", "in", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p193_s1", "idA": "1430306_13_item1_p166_s1", "sentA": "In February 2013, we held a Pre-Phase 3 meeting with the FDA to discuss the clinical and nonclinical requirements to register TNX-102 SL for the management of FM based on the 505(b)(2) regulatory pathway.", "sentB": "In February 2013, we held an End-of-Phase 2/Pre-Phase 3 meeting with the FDA to discuss the clinical and nonclinical requirements to register TNX-102 SL for the management of FM based on the 505(b)(2) regulatory pathway.", "type": 2, "words": ["<tag1>", "In", "February", "2013,", "we", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "to", "discuss", "the", "clinical", "and", "nonclinical", "requirements", "to", "register", "TNX-102", "SL", "for", "the", "management", "of", "FM", "based", "on", "the", "505(b)(2)", "regulatory", "pathway.", "<tag2>", "In", "February", "2013,", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "to", "discuss", "the", "clinical", "and", "nonclinical", "requirements", "to", "register", "TNX-102", "SL", "for", "the", "management", "of", "FM", "based", "on", "the", "505(b)(2)", "regulatory", "pathway.", "<tag3>"], "wordsA": ["In", "February", "2013,", "we", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "to", "discuss", "the", "clinical", "and", "nonclinical", "requirements", "to", "register", "TNX-102", "SL", "for", "the", "management", "of", "FM", "based", "on", "the", "505(b)(2)", "regulatory", "pathway."], "wordsB": ["In", "February", "2013,", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "to", "discuss", "the", "clinical", "and", "nonclinical", "requirements", "to", "register", "TNX-102", "SL", "for", "the", "management", "of", "FM", "based", "on", "the", "505(b)(2)", "regulatory", "pathway."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p150_s2", "idA": "1430306_13_item1_p167_s0", "sentA": "An applicant submitting a Section 505(b)(2) NDA must certify to the FDA with respect to the patent status of the reference drug upon which the applicant relies in support of approval of its drug.", "sentB": "The length of the patent term extension is related to the length of time the drug is under regulatory review.", "type": 2, "words": ["<tag1>", "An", "applicant", "submitting", "a", "Section", "505(b)(2)", "NDA", "must", "certify", "to", "the", "FDA", "with", "respect", "to", "the", "patent", "status", "of", "the", "reference", "drug", "upon", "which", "the", "applicant", "relies", "in", "support", "of", "approval", "of", "its", "drug.", "<tag2>", "The", "length", "of", "the", "patent", "term", "extension", "is", "related", "to", "the", "length", "of", "time", "the", "drug", "is", "under", "regulatory", "review.", "<tag3>"], "wordsA": ["An", "applicant", "submitting", "a", "Section", "505(b)(2)", "NDA", "must", "certify", "to", "the", "FDA", "with", "respect", "to", "the", "patent", "status", "of", "the", "reference", "drug", "upon", "which", "the", "applicant", "relies", "in", "support", "of", "approval", "of", "its", "drug."], "wordsB": ["The", "length", "of", "the", "patent", "term", "extension", "is", "related", "to", "the", "length", "of", "time", "the", "drug", "is", "under", "regulatory", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p150_s3", "idA": "1430306_13_item1_p169_s0", "sentA": "The filing of a patent infringement lawsuit within 45 days of the receipt of the notification may prevent the FDA from approving the Section 505(b)(2) NDA for 30 months from the date of the receipt of the notification unless the court determines that a longer or shorter period is appropriate because either party to the action failed to reasonably cooperate in expediting the action.", "sentB": "A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only one patent applicable to an approved drug may be extended.", "type": 2, "words": ["<tag1>", "The", "filing", "of", "a", "patent", "infringement", "lawsuit", "within", "45", "days", "of", "the", "receipt", "of", "the", "notification", "may", "prevent", "the", "FDA", "from", "approving", "the", "Section", "505(b)(2)", "NDA", "for", "30", "months", "from", "the", "date", "of", "the", "receipt", "of", "the", "notification", "unless", "the", "court", "determines", "that", "a", "longer", "or", "shorter", "period", "is", "appropriate", "because", "either", "party", "to", "the", "action", "failed", "to", "reasonably", "cooperate", "in", "expediting", "the", "action.", "<tag2>", "A", "patent", "term", "extension", "cannot", "extend", "the", "remaining", "term", "of", "a", "patent", "beyond", "a", "total", "of", "14", "years", "from", "the", "date", "of", "product", "approval", "and", "only", "one", "patent", "applicable", "to", "an", "approved", "drug", "may", "be", "extended.", "<tag3>"], "wordsA": ["The", "filing", "of", "a", "patent", "infringement", "lawsuit", "within", "45", "days", "of", "the", "receipt", "of", "the", "notification", "may", "prevent", "the", "FDA", "from", "approving", "the", "Section", "505(b)(2)", "NDA", "for", "30", "months", "from", "the", "date", "of", "the", "receipt", "of", "the", "notification", "unless", "the", "court", "determines", "that", "a", "longer", "or", "shorter", "period", "is", "appropriate", "because", "either", "party", "to", "the", "action", "failed", "to", "reasonably", "cooperate", "in", "expediting", "the", "action."], "wordsB": ["A", "patent", "term", "extension", "cannot", "extend", "the", "remaining", "term", "of", "a", "patent", "beyond", "a", "total", "of", "14", "years", "from", "the", "date", "of", "product", "approval", "and", "only", "one", "patent", "applicable", "to", "an", "approved", "drug", "may", "be", "extended."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p200_s0", "idA": "1430306_13_item1_p173_s0", "sentA": "The FDCA provides five-year marketing exclusivity to the first applicant to gain approval of an NDA for a new chemical entity, or NCE, meaning that the FDA has not previously approved any other drug containing the same active moiety.", "sentB": "The FDCA provides five-year marketing exclusivity to the first applicant to gain approval of an NDA for an NCE, meaning that the FDA has not previously approved any other drug containing the same active moiety.", "type": 2, "words": ["<tag1>", "The", "FDCA", "provides", "five-year", "marketing", "exclusivity", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "a", "new", "chemical", "entity,", "or", "NCE,", "meaning", "that", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "drug", "containing", "the", "same", "active", "moiety.", "<tag2>", "The", "FDCA", "provides", "five-year", "marketing", "exclusivity", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "an", "NCE,", "meaning", "that", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "drug", "containing", "the", "same", "active", "moiety.", "<tag3>"], "wordsA": ["The", "FDCA", "provides", "five-year", "marketing", "exclusivity", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "a", "new", "chemical", "entity,", "or", "NCE,", "meaning", "that", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "drug", "containing", "the", "same", "active", "moiety."], "wordsB": ["The", "FDCA", "provides", "five-year", "marketing", "exclusivity", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "an", "NCE,", "meaning", "that", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "drug", "containing", "the", "same", "active", "moiety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p50_s0", "idA": "1430306_13_item1_p174_s0", "sentA": "Other types of exclusivity in the United States include orphan drug exclusivity and pediatric exclusivity.", "sentB": "We expect to develop TNX-201 under Section 505(b)(1), the pathway followed for an NCE or marketed drug without an approved NDA in the United States.", "type": 2, "words": ["<tag1>", "Other", "types", "of", "exclusivity", "in", "the", "United", "States", "include", "orphan", "drug", "exclusivity", "and", "pediatric", "exclusivity.", "<tag2>", "We", "expect", "to", "develop", "TNX-201", "under", "Section", "505(b)(1),", "the", "pathway", "followed", "for", "an", "NCE", "or", "marketed", "drug", "without", "an", "approved", "NDA", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["Other", "types", "of", "exclusivity", "in", "the", "United", "States", "include", "orphan", "drug", "exclusivity", "and", "pediatric", "exclusivity."], "wordsB": ["We", "expect", "to", "develop", "TNX-201", "under", "Section", "505(b)(1),", "the", "pathway", "followed", "for", "an", "NCE", "or", "marketed", "drug", "without", "an", "approved", "NDA", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p150_s1", "idA": "1430306_13_item1_p180_s0", "sentA": "Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label.", "sentB": "The Hatch-Waxman Amendments permit a patent term extension of up to five years beyond the statutory 20 year term of the patent for the approved product.", "type": 2, "words": ["<tag1>", "Drugs", "may", "be", "promoted", "only", "for", "the", "approved", "indications", "and", "in", "accordance", "with", "the", "provisions", "of", "the", "approved", "label.", "<tag2>", "The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20", "year", "term", "of", "the", "patent", "for", "the", "approved", "product.", "<tag3>"], "wordsA": ["Drugs", "may", "be", "promoted", "only", "for", "the", "approved", "indications", "and", "in", "accordance", "with", "the", "provisions", "of", "the", "approved", "label."], "wordsB": ["The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20", "year", "term", "of", "the", "patent", "for", "the", "approved", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p204_s0", "idA": "1430306_13_item1_p182_s0", "sentA": "In September 2007, the Food and Drug Administration Amendments Act of 2007, or FDAAA, became law.", "sentB": "On July 9, 2012, the Food and Drug Administration Safety and Innovation Act, or FDASIA, was signed.", "type": 2, "words": ["<tag1>", "In", "September", "2007,", "the", "Food", "and", "Drug", "Administration", "Amendments", "Act", "of", "2007,", "or", "FDAAA,", "became", "law.", "<tag2>", "On", "July", "9,", "2012,", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act,", "or", "FDASIA,", "was", "signed.", "<tag3>"], "wordsA": ["In", "September", "2007,", "the", "Food", "and", "Drug", "Administration", "Amendments", "Act", "of", "2007,", "or", "FDAAA,", "became", "law."], "wordsB": ["On", "July", "9,", "2012,", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act,", "or", "FDASIA,", "was", "signed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p206_s3", "idA": "1430306_13_item1_p183_s0", "sentA": "The FDA has not yet implemented many of the provisions of the FDAAA, so we cannot predict the impact of the new legislation on the pharmaceutical industry or our business.", "sentB": "We cannot predict the likelihood of success in seeking Breakthrough Therapy designation.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "not", "yet", "implemented", "many", "of", "the", "provisions", "of", "the", "FDAAA,", "so", "we", "cannot", "predict", "the", "impact", "of", "the", "new", "legislation", "on", "the", "pharmaceutical", "industry", "or", "our", "business.", "<tag2>", "We", "cannot", "predict", "the", "likelihood", "of", "success", "in", "seeking", "Breakthrough", "Therapy", "designation.", "<tag3>"], "wordsA": ["The", "FDA", "has", "not", "yet", "implemented", "many", "of", "the", "provisions", "of", "the", "FDAAA,", "so", "we", "cannot", "predict", "the", "impact", "of", "the", "new", "legislation", "on", "the", "pharmaceutical", "industry", "or", "our", "business."], "wordsB": ["We", "cannot", "predict", "the", "likelihood", "of", "success", "in", "seeking", "Breakthrough", "Therapy", "designation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p214_s0", "idA": "1430306_13_item1_p184_s0", "sentA": "As of March 8, 2013, we had two full-time employees, Leland Gershell, our Chief Financial Officer, and Bruce Daugherty, our Senior Director of Drug Development and Controller, as well as one part-time senior director of research.", "sentB": "As of March 26, 2014, we had six full-time employees, of whom three are executives, one is finance and investor relations, and two are administrative.", "type": 2, "words": ["<tag1>", "As", "of", "March", "8,", "2013,", "we", "had", "two", "full-time", "employees,", "Leland", "Gershell,", "our", "Chief", "Financial", "Officer,", "and", "Bruce", "Daugherty,", "our", "Senior", "Director", "of", "Drug", "Development", "and", "Controller,", "as", "well", "as", "one", "part-time", "senior", "director", "of", "research.", "<tag2>", "As", "of", "March", "26,", "2014,", "we", "had", "six", "full-time", "employees,", "of", "whom", "three", "are", "executives,", "one", "is", "finance", "and", "investor", "relations,", "and", "two", "are", "administrative.", "<tag3>"], "wordsA": ["As", "of", "March", "8,", "2013,", "we", "had", "two", "full-time", "employees,", "Leland", "Gershell,", "our", "Chief", "Financial", "Officer,", "and", "Bruce", "Daugherty,", "our", "Senior", "Director", "of", "Drug", "Development", "and", "Controller,", "as", "well", "as", "one", "part-time", "senior", "director", "of", "research."], "wordsB": ["As", "of", "March", "26,", "2014,", "we", "had", "six", "full-time", "employees,", "of", "whom", "three", "are", "executives,", "one", "is", "finance", "and", "investor", "relations,", "and", "two", "are", "administrative."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p20_s0", "idA": "1430306_13_item1_p18_s1", "sentA": "In August 2010, Tonix Sub formed Krele.", "sentB": "On October 24, 2013, Tonix Sub formed Tonix Barbados.", "type": 2, "words": ["<tag1>", "In", "August", "2010,", "Tonix", "Sub", "formed", "Krele.", "<tag2>", "On", "October", "24,", "2013,", "Tonix", "Sub", "formed", "Tonix", "Barbados.", "<tag3>"], "wordsA": ["In", "August", "2010,", "Tonix", "Sub", "formed", "Krele."], "wordsB": ["On", "October", "24,", "2013,", "Tonix", "Sub", "formed", "Tonix", "Barbados."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p21_s0", "idA": "1430306_13_item1_p19_s0", "sentA": "We are a specialty pharmaceutical company focused on developing novel pharmaceutical products for challenging disorders of the CNS.", "sentB": "We are a pharmaceutical company dedicated to the development of novel pharmaceutical products for challenging problems.", "type": 2, "words": ["<tag1>", "We", "are", "a", "specialty", "pharmaceutical", "company", "focused", "on", "developing", "novel", "pharmaceutical", "products", "for", "challenging", "disorders", "of", "the", "CNS.", "<tag2>", "We", "are", "a", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "novel", "pharmaceutical", "products", "for", "challenging", "problems.", "<tag3>"], "wordsA": ["We", "are", "a", "specialty", "pharmaceutical", "company", "focused", "on", "developing", "novel", "pharmaceutical", "products", "for", "challenging", "disorders", "of", "the", "CNS."], "wordsB": ["We", "are", "a", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "novel", "pharmaceutical", "products", "for", "challenging", "problems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p90_s2", "idA": "1430306_13_item1_p1_s1", "sentA": "Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements.", "sentB": "The product s comparability will be supported by the bioequivalence results from the bridging study, TNX-CY-F105.", "type": 2, "words": ["<tag1>", "Consequently,", "forward-looking", "statements", "are", "inherently", "subject", "to", "risks", "and", "uncertainties", "and", "actual", "results", "and", "outcomes", "may", "differ", "materially", "from", "the", "results", "and", "outcomes", "discussed", "in", "or", "anticipated", "by", "the", "forward-looking", "statements.", "<tag2>", "The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "bridging", "study,", "TNX-CY-F105.", "<tag3>"], "wordsA": ["Consequently,", "forward-looking", "statements", "are", "inherently", "subject", "to", "risks", "and", "uncertainties", "and", "actual", "results", "and", "outcomes", "may", "differ", "materially", "from", "the", "results", "and", "outcomes", "discussed", "in", "or", "anticipated", "by", "the", "forward-looking", "statements."], "wordsB": ["The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "bridging", "study,", "TNX-CY-F105."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p109_s3", "idA": "1430306_13_item1_p22_s0", "sentA": "We are currently devoting the majority of our efforts to the development of our lead product candidate, TNX-102 sublingual tablet, or TNX-102 SL.", "sentB": "The Breakthrough Therapy designation process is a new and uncertain process, in which the majority of requests for designation have been denied.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "devoting", "the", "majority", "of", "our", "efforts", "to", "the", "development", "of", "our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL.", "<tag2>", "The", "Breakthrough", "Therapy", "designation", "process", "is", "a", "new", "and", "uncertain", "process,", "in", "which", "the", "majority", "of", "requests", "for", "designation", "have", "been", "denied.", "<tag3>"], "wordsA": ["We", "are", "currently", "devoting", "the", "majority", "of", "our", "efforts", "to", "the", "development", "of", "our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL."], "wordsB": ["The", "Breakthrough", "Therapy", "designation", "process", "is", "a", "new", "and", "uncertain", "process,", "in", "which", "the", "majority", "of", "requests", "for", "designation", "have", "been", "denied."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p206_s2", "idA": "1430306_13_item1_p22_s0", "sentA": "We are currently devoting the majority of our efforts to the development of our lead product candidate, TNX-102 sublingual tablet, or TNX-102 SL.", "sentB": "The Breakthrough Therapy designation process is relatively new, and the majority of requests for designation have been denied.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "devoting", "the", "majority", "of", "our", "efforts", "to", "the", "development", "of", "our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL.", "<tag2>", "The", "Breakthrough", "Therapy", "designation", "process", "is", "relatively", "new,", "and", "the", "majority", "of", "requests", "for", "designation", "have", "been", "denied.", "<tag3>"], "wordsA": ["We", "are", "currently", "devoting", "the", "majority", "of", "our", "efforts", "to", "the", "development", "of", "our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL."], "wordsB": ["The", "Breakthrough", "Therapy", "designation", "process", "is", "relatively", "new,", "and", "the", "majority", "of", "requests", "for", "designation", "have", "been", "denied."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p23_s2", "idA": "1430306_13_item1_p22_s1", "sentA": "TNX-102 SL is a novel dose and formulation of CBP, the active pharmaceutical ingredient of two widely prescribed muscle relaxant products, Flexeril and Amrix.", "sentB": "CBP is the active pharmaceutical ingredient of two widely prescribed products, and we are pursuing the development of TNX-102 SL for indications distinct from those for which current CBP products are approved.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "novel", "dose", "and", "formulation", "of", "CBP,", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "muscle", "relaxant", "products,", "Flexeril", "and", "Amrix.", "<tag2>", "CBP", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "products,", "and", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "indications", "distinct", "from", "those", "for", "which", "current", "CBP", "products", "are", "approved.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "novel", "dose", "and", "formulation", "of", "CBP,", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "muscle", "relaxant", "products,", "Flexeril", "and", "Amrix."], "wordsB": ["CBP", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "products,", "and", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "indications", "distinct", "from", "those", "for", "which", "current", "CBP", "products", "are", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p32_s1", "idA": "1430306_13_item1_p22_s1", "sentA": "TNX-102 SL is a novel dose and formulation of CBP, the active pharmaceutical ingredient of two widely prescribed muscle relaxant products, Flexeril and Amrix.", "sentB": "CBP, the active ingredient of TNX-102 SL, is a selective antagonist of serotonin and norepinephrine receptors as well as an inhibitor of serotonin and norepinephrine reuptake, and we refer to it as a Serotonin and Norepinephrine receptor Antagonist and Reuptake Inhibitor, or SNARI.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "novel", "dose", "and", "formulation", "of", "CBP,", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "muscle", "relaxant", "products,", "Flexeril", "and", "Amrix.", "<tag2>", "CBP,", "the", "active", "ingredient", "of", "TNX-102", "SL,", "is", "a", "selective", "antagonist", "of", "serotonin", "and", "norepinephrine", "receptors", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake,", "and", "we", "refer", "to", "it", "as", "a", "Serotonin", "and", "Norepinephrine", "receptor", "Antagonist", "and", "Reuptake", "Inhibitor,", "or", "SNARI.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "novel", "dose", "and", "formulation", "of", "CBP,", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "muscle", "relaxant", "products,", "Flexeril", "and", "Amrix."], "wordsB": ["CBP,", "the", "active", "ingredient", "of", "TNX-102", "SL,", "is", "a", "selective", "antagonist", "of", "serotonin", "and", "norepinephrine", "receptors", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake,", "and", "we", "refer", "to", "it", "as", "a", "Serotonin", "and", "Norepinephrine", "receptor", "Antagonist", "and", "Reuptake", "Inhibitor,", "or", "SNARI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p44_s1", "idA": "1430306_13_item1_p22_s1", "sentA": "TNX-102 SL is a novel dose and formulation of CBP, the active pharmaceutical ingredient of two widely prescribed muscle relaxant products, Flexeril and Amrix.", "sentB": "TNX-301 is a fixed dose combination of two FDA-approved drugs, disulfiram and selegiline.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "novel", "dose", "and", "formulation", "of", "CBP,", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "muscle", "relaxant", "products,", "Flexeril", "and", "Amrix.", "<tag2>", "TNX-301", "is", "a", "fixed", "dose", "combination", "of", "two", "FDA-approved", "drugs,", "disulfiram", "and", "selegiline.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "novel", "dose", "and", "formulation", "of", "CBP,", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "muscle", "relaxant", "products,", "Flexeril", "and", "Amrix."], "wordsB": ["TNX-301", "is", "a", "fixed", "dose", "combination", "of", "two", "FDA-approved", "drugs,", "disulfiram", "and", "selegiline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p23_s3", "idA": "1430306_13_item1_p22_s2", "sentA": "TNX-102 SL is distinct from these products as it is being developed at a dose level significantly below the lowest marketed doses of Flexeril and Amrix.", "sentB": "We believe that TNX-102 SL is an optimized CBP product for the treatment of FM and PTSD, and is distinct from current CBP products in three ways: (1) it is being developed at a dose level significantly below the lowest marketed doses of current CBP products; (2) it is placed under the tongue, to disintegrate, dissolve and provide sublingual absorption, whereas current CBP products are swallowed and provide absorption in the small intestine; and (3) it is being developed for chronic use, whereas current CBP products are marketed for two to three weeks of use.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "distinct", "from", "these", "products", "as", "it", "is", "being", "developed", "at", "a", "dose", "level", "significantly", "below", "the", "lowest", "marketed", "doses", "of", "Flexeril", "and", "Amrix.", "<tag2>", "We", "believe", "that", "TNX-102", "SL", "is", "an", "optimized", "CBP", "product", "for", "the", "treatment", "of", "FM", "and", "PTSD,", "and", "is", "distinct", "from", "current", "CBP", "products", "in", "three", "ways:", "(1)", "it", "is", "being", "developed", "at", "a", "dose", "level", "significantly", "below", "the", "lowest", "marketed", "doses", "of", "current", "CBP", "products;", "(2)", "it", "is", "placed", "under", "the", "tongue,", "to", "disintegrate,", "dissolve", "and", "provide", "sublingual", "absorption,", "whereas", "current", "CBP", "products", "are", "swallowed", "and", "provide", "absorption", "in", "the", "small", "intestine;", "and", "(3)", "it", "is", "being", "developed", "for", "chronic", "use,", "whereas", "current", "CBP", "products", "are", "marketed", "for", "two", "to", "three", "weeks", "of", "use.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "distinct", "from", "these", "products", "as", "it", "is", "being", "developed", "at", "a", "dose", "level", "significantly", "below", "the", "lowest", "marketed", "doses", "of", "Flexeril", "and", "Amrix."], "wordsB": ["We", "believe", "that", "TNX-102", "SL", "is", "an", "optimized", "CBP", "product", "for", "the", "treatment", "of", "FM", "and", "PTSD,", "and", "is", "distinct", "from", "current", "CBP", "products", "in", "three", "ways:", "(1)", "it", "is", "being", "developed", "at", "a", "dose", "level", "significantly", "below", "the", "lowest", "marketed", "doses", "of", "current", "CBP", "products;", "(2)", "it", "is", "placed", "under", "the", "tongue,", "to", "disintegrate,", "dissolve", "and", "provide", "sublingual", "absorption,", "whereas", "current", "CBP", "products", "are", "swallowed", "and", "provide", "absorption", "in", "the", "small", "intestine;", "and", "(3)", "it", "is", "being", "developed", "for", "chronic", "use,", "whereas", "current", "CBP", "products", "are", "marketed", "for", "two", "to", "three", "weeks", "of", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p144_s1", "idA": "1430306_13_item1_p22_s4", "sentA": "TNX-102 SL is also intended for chronic use, whereas Flexeril and Amrix are marketed for two to three weeks of use.", "sentB": "Our patent portfolio, described more fully below, includes claims directed to TNX-102 SL compositions and methods of use.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "also", "intended", "for", "chronic", "use,", "whereas", "Flexeril", "and", "Amrix", "are", "marketed", "for", "two", "to", "three", "weeks", "of", "use.", "<tag2>", "Our", "patent", "portfolio,", "described", "more", "fully", "below,", "includes", "claims", "directed", "to", "TNX-102", "SL", "compositions", "and", "methods", "of", "use.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "also", "intended", "for", "chronic", "use,", "whereas", "Flexeril", "and", "Amrix", "are", "marketed", "for", "two", "to", "three", "weeks", "of", "use."], "wordsB": ["Our", "patent", "portfolio,", "described", "more", "fully", "below,", "includes", "claims", "directed", "to", "TNX-102", "SL", "compositions", "and", "methods", "of", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p27_s0", "idA": "1430306_13_item1_p22_s5", "sentA": "We are currently developing TNX-102 SL for the treatment of FM under an Investigational New Drug application, or IND, filed in the US, and under three Clinical Trial Applications, or CTAs, filed in Canada.", "sentB": "We are developing TNX-102 SL for the treatment of FM under a U.S. Investigational New Drug application, or IND, and we held an End-of-Phase 2/Pre-Phase 3 meeting with the FDA in February 2013.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "filed", "in", "the", "US,", "and", "under", "three", "Clinical", "Trial", "Applications,", "or", "CTAs,", "filed", "in", "Canada.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "a", "U.S.", "Investigational", "New", "Drug", "application,", "or", "IND,", "and", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013.", "<tag3>"], "wordsA": ["We", "are", "currently", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "Investigational", "New", "Drug", "application,", "or", "IND,", "filed", "in", "the", "US,", "and", "under", "three", "Clinical", "Trial", "Applications,", "or", "CTAs,", "filed", "in", "Canada."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "a", "U.S.", "Investigational", "New", "Drug", "application,", "or", "IND,", "and", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p22_s1", "idA": "1430306_13_item1_p22_s6", "sentA": "We are also developing TNX-102 SL for the treatment of post-traumatic stress disorder, or PTSD, for which we held a pre-IND meeting with the FDA in October 2012.", "sentB": "We also have development programs for the management of post-traumatic stress disorder, or PTSD, in which central pain is a component, and for the relief of episodic tension-type headache, or ETTH.", "type": 2, "words": ["<tag1>", "We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "for", "which", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012.", "<tag2>", "We", "also", "have", "development", "programs", "for", "the", "management", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "in", "which", "central", "pain", "is", "a", "component,", "and", "for", "the", "relief", "of", "episodic", "tension-type", "headache,", "or", "ETTH.", "<tag3>"], "wordsA": ["We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "for", "which", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012."], "wordsB": ["We", "also", "have", "development", "programs", "for", "the", "management", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "in", "which", "central", "pain", "is", "a", "component,", "and", "for", "the", "relief", "of", "episodic", "tension-type", "headache,", "or", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p42_s4", "idA": "1430306_13_item1_p22_s6", "sentA": "We are also developing TNX-102 SL for the treatment of post-traumatic stress disorder, or PTSD, for which we held a pre-IND meeting with the FDA in October 2012.", "sentB": "We held a pre-IND meeting with the FDA in January 2014 to discuss the regulatory pathway for the development of TNX-201 for the treatment of ETTH.", "type": 2, "words": ["<tag1>", "We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "for", "which", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012.", "<tag2>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "January", "2014", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH.", "<tag3>"], "wordsA": ["We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "for", "which", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012."], "wordsB": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "January", "2014", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p24_s0", "idA": "1430306_13_item1_p22_s7", "sentA": "We expect that any applications we submit for FDA approval of TNX-102 SL will be submitted under Section 505(b)(2) of FDCA, which we believe will allow for a shorter timeline of clinical development as compared to that needed to fulfill the requirements of Section 505(b)(1), under which NCEs are generally reviewed.", "sentB": "We expect that any applications we submit to the Food and Drug Administration, or FDA, for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, which we believe will allow for a shorter timeline of clinical and non-clinical development as compared to that needed to fulfill the requirements of Section 505(b)(1), under which new chemical entities, or NCEs, that have never been marketed in the United States, are generally developed to meet the FDA s requirements for new drug approvals.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "any", "applications", "we", "submit", "for", "FDA", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "NCEs", "are", "generally", "reviewed.", "<tag2>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "marketed", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "requirements", "for", "new", "drug", "approvals.", "<tag3>"], "wordsA": ["We", "expect", "that", "any", "applications", "we", "submit", "for", "FDA", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "NCEs", "are", "generally", "reviewed."], "wordsB": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "marketed", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "requirements", "for", "new", "drug", "approvals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p23_s0", "idA": "1430306_13_item1_p23_s0", "sentA": "TNX-102 SL is a small, rapidly disintegrating tablet containing CBP for sublingual administration at bedtime.", "sentB": "Our lead product candidate, TNX-102 sublingual tablet, or TNX-102 SL, is a small, rapidly disintegrating tablet containing CBP for sublingual administration.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration", "at", "bedtime.", "<tag2>", "Our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL,", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration", "at", "bedtime."], "wordsB": ["Our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL,", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p25_s0", "idA": "1430306_13_item1_p23_s3", "sentA": "We have conducted several clinical and pre-clinical pharmacokinetic studies of TNX-102 SL which we believe support its development as a novel therapeutic product for FM and PTSD, and which demonstrate a number of potentially advantageous characteristics as compared to current CBP-containing products, none of which are approved for these indications.", "sentB": "We have conducted several clinical and non-clinical pharmacokinetic studies of TNX-102 sublingual formulations, which we believe support the development of TNX-102 SL as a novel therapeutic product for FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "have", "conducted", "several", "clinical", "and", "pre-clinical", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "which", "we", "believe", "support", "its", "development", "as", "a", "novel", "therapeutic", "product", "for", "FM", "and", "PTSD,", "and", "which", "demonstrate", "a", "number", "of", "potentially", "advantageous", "characteristics", "as", "compared", "to", "current", "CBP-containing", "products,", "none", "of", "which", "are", "approved", "for", "these", "indications.", "<tag2>", "We", "have", "conducted", "several", "clinical", "and", "non-clinical", "pharmacokinetic", "studies", "of", "TNX-102", "sublingual", "formulations,", "which", "we", "believe", "support", "the", "development", "of", "TNX-102", "SL", "as", "a", "novel", "therapeutic", "product", "for", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "have", "conducted", "several", "clinical", "and", "pre-clinical", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "which", "we", "believe", "support", "its", "development", "as", "a", "novel", "therapeutic", "product", "for", "FM", "and", "PTSD,", "and", "which", "demonstrate", "a", "number", "of", "potentially", "advantageous", "characteristics", "as", "compared", "to", "current", "CBP-containing", "products,", "none", "of", "which", "are", "approved", "for", "these", "indications."], "wordsB": ["We", "have", "conducted", "several", "clinical", "and", "non-clinical", "pharmacokinetic", "studies", "of", "TNX-102", "sublingual", "formulations,", "which", "we", "believe", "support", "the", "development", "of", "TNX-102", "SL", "as", "a", "novel", "therapeutic", "product", "for", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p25_s1", "idA": "1430306_13_item1_p23_s3", "sentA": "We have conducted several clinical and pre-clinical pharmacokinetic studies of TNX-102 SL which we believe support its development as a novel therapeutic product for FM and PTSD, and which demonstrate a number of potentially advantageous characteristics as compared to current CBP-containing products, none of which are approved for these indications.", "sentB": "Results from these studies demonstrate a number of potentially advantageous characteristics as compared to current CBP-containing products (Flexeril and Amrix ), which are not approved for these indications.", "type": 2, "words": ["<tag1>", "We", "have", "conducted", "several", "clinical", "and", "pre-clinical", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "which", "we", "believe", "support", "its", "development", "as", "a", "novel", "therapeutic", "product", "for", "FM", "and", "PTSD,", "and", "which", "demonstrate", "a", "number", "of", "potentially", "advantageous", "characteristics", "as", "compared", "to", "current", "CBP-containing", "products,", "none", "of", "which", "are", "approved", "for", "these", "indications.", "<tag2>", "Results", "from", "these", "studies", "demonstrate", "a", "number", "of", "potentially", "advantageous", "characteristics", "as", "compared", "to", "current", "CBP-containing", "products", "(Flexeril", "and", "Amrix", "),", "which", "are", "not", "approved", "for", "these", "indications.", "<tag3>"], "wordsA": ["We", "have", "conducted", "several", "clinical", "and", "pre-clinical", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "which", "we", "believe", "support", "its", "development", "as", "a", "novel", "therapeutic", "product", "for", "FM", "and", "PTSD,", "and", "which", "demonstrate", "a", "number", "of", "potentially", "advantageous", "characteristics", "as", "compared", "to", "current", "CBP-containing", "products,", "none", "of", "which", "are", "approved", "for", "these", "indications."], "wordsB": ["Results", "from", "these", "studies", "demonstrate", "a", "number", "of", "potentially", "advantageous", "characteristics", "as", "compared", "to", "current", "CBP-containing", "products", "(Flexeril", "and", "Amrix", "),", "which", "are", "not", "approved", "for", "these", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p25_s2", "idA": "1430306_13_item1_p23_s4", "sentA": "Based on our Phase 1 comparative study, we have observed that, as compared to oral CBP tablets, TNX-102 SL results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following administration.", "sentB": "For example, our Phase 1 comparative studies showed that TNX-102 SL results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following administration relative to oral CBP tablets.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "Phase", "1", "comparative", "study,", "we", "have", "observed", "that,", "as", "compared", "to", "oral", "CBP", "tablets,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration.", "<tag2>", "For", "example,", "our", "Phase", "1", "comparative", "studies", "showed", "that", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration", "relative", "to", "oral", "CBP", "tablets.", "<tag3>"], "wordsA": ["Based", "on", "our", "Phase", "1", "comparative", "study,", "we", "have", "observed", "that,", "as", "compared", "to", "oral", "CBP", "tablets,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration."], "wordsB": ["For", "example,", "our", "Phase", "1", "comparative", "studies", "showed", "that", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration", "relative", "to", "oral", "CBP", "tablets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p26_s0", "idA": "1430306_13_item1_p24_s0", "sentA": "TNX-102 SL was generally well-tolerated, with no serious adverse events reported in this study.", "sentB": "TNX-102 SL was generally well-tolerated, with no serious adverse events reported in these studies.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "this", "study.", "<tag2>", "TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag3>"], "wordsA": ["TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "this", "study."], "wordsB": ["TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p109_s1", "idA": "1430306_13_item1_p25_s1", "sentA": "We held a Pre-Phase 3 meeting with the FDA in February 2013, at which we discussed the design of the clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "sentB": "We plan to meet with the FDA when we complete the POC efficacy study to further discuss the development plan, especially the design of the pivotal studies.", "type": 2, "words": ["<tag1>", "We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "POC", "efficacy", "study", "to", "further", "discuss", "the", "development", "plan,", "especially", "the", "design", "of", "the", "pivotal", "studies.", "<tag3>"], "wordsA": ["We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "POC", "efficacy", "study", "to", "further", "discuss", "the", "development", "plan,", "especially", "the", "design", "of", "the", "pivotal", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p36_s0", "idA": "1430306_13_item1_p25_s1", "sentA": "We held a Pre-Phase 3 meeting with the FDA in February 2013, at which we discussed the design of the clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "sentB": "At our End-of-Phase 2/Pre-Phase 3 meeting with the FDA, we discussed the design of our clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p41_s3", "idA": "1430306_13_item1_p25_s1", "sentA": "We held a Pre-Phase 3 meeting with the FDA in February 2013, at which we discussed the design of the clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "sentB": "Based on the results of the POC trial, we will meet with the FDA to finalize the design of the registration studies to support the PTSD NDA.", "type": 2, "words": ["<tag1>", "We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "Based", "on", "the", "results", "of", "the", "POC", "trial,", "we", "will", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "studies", "to", "support", "the", "PTSD", "NDA.", "<tag3>"], "wordsA": ["We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["Based", "on", "the", "results", "of", "the", "POC", "trial,", "we", "will", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "studies", "to", "support", "the", "PTSD", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p90_s1", "idA": "1430306_13_item1_p25_s1", "sentA": "We held a Pre-Phase 3 meeting with the FDA in February 2013, at which we discussed the design of the clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "sentB": "For the second pivotal study and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "type": 2, "words": ["<tag1>", "We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "For", "the", "second", "pivotal", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag3>"], "wordsA": ["We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "design", "of", "the", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["For", "the", "second", "pivotal", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p107_s1", "idA": "1430306_13_item1_p25_s2", "sentA": "We believe that positive results from two adequate, well-controlled safety and efficacy studies and the completion of long-term open-label safety exposure studies would support the approval of TNX-102 SL by the FDA for the management of FM.", "sentB": "We believe the approval will be comprised of positive results from two adequate, well-controlled efficacy and safety studies and long-term (6 and 12 month) safety exposure data.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "completion", "of", "long-term", "open-label", "safety", "exposure", "studies", "would", "support", "the", "approval", "of", "TNX-102", "SL", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "We", "believe", "the", "approval", "will", "be", "comprised", "of", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(6", "and", "12", "month)", "safety", "exposure", "data.", "<tag3>"], "wordsA": ["We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "completion", "of", "long-term", "open-label", "safety", "exposure", "studies", "would", "support", "the", "approval", "of", "TNX-102", "SL", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["We", "believe", "the", "approval", "will", "be", "comprised", "of", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(6", "and", "12", "month)", "safety", "exposure", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p36_s1", "idA": "1430306_13_item1_p25_s2", "sentA": "We believe that positive results from two adequate, well-controlled safety and efficacy studies and the completion of long-term open-label safety exposure studies would support the approval of TNX-102 SL by the FDA for the management of FM.", "sentB": "We believe that positive results from two adequate, well-controlled safety and efficacy studies and the establishment of long-term safety for chronic use would support the approval of TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "completion", "of", "long-term", "open-label", "safety", "exposure", "studies", "would", "support", "the", "approval", "of", "TNX-102", "SL", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "establishment", "of", "long-term", "safety", "for", "chronic", "use", "would", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "completion", "of", "long-term", "open-label", "safety", "exposure", "studies", "would", "support", "the", "approval", "of", "TNX-102", "SL", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "establishment", "of", "long-term", "safety", "for", "chronic", "use", "would", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p41_s4", "idA": "1430306_13_item1_p25_s2", "sentA": "We believe that positive results from two adequate, well-controlled safety and efficacy studies and the completion of long-term open-label safety exposure studies would support the approval of TNX-102 SL by the FDA for the management of FM.", "sentB": "We believe the approval will be based upon positive results from two adequate, well-controlled efficacy and safety studies and long-term (6 and 12 month) safety exposure data.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "completion", "of", "long-term", "open-label", "safety", "exposure", "studies", "would", "support", "the", "approval", "of", "TNX-102", "SL", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "We", "believe", "the", "approval", "will", "be", "based", "upon", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(6", "and", "12", "month)", "safety", "exposure", "data.", "<tag3>"], "wordsA": ["We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "completion", "of", "long-term", "open-label", "safety", "exposure", "studies", "would", "support", "the", "approval", "of", "TNX-102", "SL", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["We", "believe", "the", "approval", "will", "be", "based", "upon", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(6", "and", "12", "month)", "safety", "exposure", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p158_s0", "idA": "1430306_13_item1_p26_s0", "sentA": "We are also advancing TNX-102 SL for the management of PTSD.", "sentB": "We are currently developing TNX-102 SL for the management of post-traumatic stress disorder, an indication that is relevant to biodefense.", "type": 2, "words": ["<tag1>", "We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "We", "are", "currently", "developing", "TNX-102", "SL", "for", "the", "management", "of", "post-traumatic", "stress", "disorder,", "an", "indication", "that", "is", "relevant", "to", "biodefense.", "<tag3>"], "wordsA": ["We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["We", "are", "currently", "developing", "TNX-102", "SL", "for", "the", "management", "of", "post-traumatic", "stress", "disorder,", "an", "indication", "that", "is", "relevant", "to", "biodefense."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p190_s1", "idA": "1430306_13_item1_p26_s0", "sentA": "We are also advancing TNX-102 SL for the management of PTSD.", "sentB": "As such, we plan to submit NDAs under Section 505(b)(2) for TNX-102 SL for FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "As", "such,", "we", "plan", "to", "submit", "NDAs", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["As", "such,", "we", "plan", "to", "submit", "NDAs", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p22_s0", "idA": "1430306_13_item1_p26_s0", "sentA": "We are also advancing TNX-102 SL for the management of PTSD.", "sentB": "Our most advanced development program is for the management of fibromyalgia, or FM, a central pain syndrome.", "type": 2, "words": ["<tag1>", "We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "Our", "most", "advanced", "development", "program", "is", "for", "the", "management", "of", "fibromyalgia,", "or", "FM,", "a", "central", "pain", "syndrome.", "<tag3>"], "wordsA": ["We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["Our", "most", "advanced", "development", "program", "is", "for", "the", "management", "of", "fibromyalgia,", "or", "FM,", "a", "central", "pain", "syndrome."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p23_s1", "idA": "1430306_13_item1_p26_s0", "sentA": "We are also advancing TNX-102 SL for the management of PTSD.", "sentB": "We are developing TNX-102 SL as a bedtime therapy for the management of FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "as", "a", "bedtime", "therapy", "for", "the", "management", "of", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "as", "a", "bedtime", "therapy", "for", "the", "management", "of", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p109_s0", "idA": "1430306_13_item1_p26_s1", "sentA": "We held a pre-IND meeting with the FDA in October 2012, and we plan to file an IND for this indication in the third quarter of 2013.", "sentB": "We held a pre-IND meeting with the FDA on TNX-102 SL in PTSD in October 2012, and we expect to file an IND in the second quarter of 2014 and to initiate a POC study in the third quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "on", "TNX-102", "SL", "in", "PTSD", "in", "October", "2012,", "and", "we", "expect", "to", "file", "an", "IND", "in", "the", "second", "quarter", "of", "2014", "and", "to", "initiate", "a", "POC", "study", "in", "the", "third", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "on", "TNX-102", "SL", "in", "PTSD", "in", "October", "2012,", "and", "we", "expect", "to", "file", "an", "IND", "in", "the", "second", "quarter", "of", "2014", "and", "to", "initiate", "a", "POC", "study", "in", "the", "third", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p41_s1", "idA": "1430306_13_item1_p26_s1", "sentA": "We held a pre-IND meeting with the FDA in October 2012, and we plan to file an IND for this indication in the third quarter of 2013.", "sentB": "We held a pre-IND meeting with the FDA in October 2012, and we plan to file an IND to pursue this indication in the second quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "to", "pursue", "this", "indication", "in", "the", "second", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "to", "pursue", "this", "indication", "in", "the", "second", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p56_s2", "idA": "1430306_13_item1_p26_s1", "sentA": "We held a pre-IND meeting with the FDA in October 2012, and we plan to file an IND for this indication in the third quarter of 2013.", "sentB": "Therefore, we plan to work with CSOs to develop the capabilities of building a sales force, initially through contracting, and we may eventually internalize the sales and marketing capabilities.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "Therefore,", "we", "plan", "to", "work", "with", "CSOs", "to", "develop", "the", "capabilities", "of", "building", "a", "sales", "force,", "initially", "through", "contracting,", "and", "we", "may", "eventually", "internalize", "the", "sales", "and", "marketing", "capabilities.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["Therefore,", "we", "plan", "to", "work", "with", "CSOs", "to", "develop", "the", "capabilities", "of", "building", "a", "sales", "force,", "initially", "through", "contracting,", "and", "we", "may", "eventually", "internalize", "the", "sales", "and", "marketing", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p97_s2", "idA": "1430306_13_item1_p26_s1", "sentA": "We held a pre-IND meeting with the FDA in October 2012, and we plan to file an IND for this indication in the third quarter of 2013.", "sentB": "We plan to file an IND in the second quarter of 2014 to support the initiation of a POC efficacy study in the third quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "We", "plan", "to", "file", "an", "IND", "in", "the", "second", "quarter", "of", "2014", "to", "support", "the", "initiation", "of", "a", "POC", "efficacy", "study", "in", "the", "third", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "October", "2012,", "and", "we", "plan", "to", "file", "an", "IND", "for", "this", "indication", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["We", "plan", "to", "file", "an", "IND", "in", "the", "second", "quarter", "of", "2014", "to", "support", "the", "initiation", "of", "a", "POC", "efficacy", "study", "in", "the", "third", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p109_s2", "idA": "1430306_13_item1_p26_s2", "sentA": "We then plan to conduct a clinical proof-of-concept trial of TNX-102 SL in PTSD in the fourth quarter of 2013.", "sentB": "If the results from the POC efficacy study are positive, we plan to seek a Breakthrough Therapy designation for TNX-102 SL in PTSD.", "type": 2, "words": ["<tag1>", "We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "If", "the", "results", "from", "the", "POC", "efficacy", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD.", "<tag3>"], "wordsA": ["We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["If", "the", "results", "from", "the", "POC", "efficacy", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p38_s3", "idA": "1430306_13_item1_p26_s2", "sentA": "We then plan to conduct a clinical proof-of-concept trial of TNX-102 SL in PTSD in the fourth quarter of 2013.", "sentB": "We expect to report initial efficacy results from the BESTFIT trial in the fourth quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p41_s2", "idA": "1430306_13_item1_p26_s2", "sentA": "We then plan to conduct a clinical proof-of-concept trial of TNX-102 SL in PTSD in the fourth quarter of 2013.", "sentB": "We plan to begin a Proof-of-Concept (POC) trial of TNX-102 SL in subjects with military-related PTSD in the third quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "We", "plan", "to", "begin", "a", "Proof-of-Concept", "(POC)", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD", "in", "the", "third", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["We", "plan", "to", "begin", "a", "Proof-of-Concept", "(POC)", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD", "in", "the", "third", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p42_s5", "idA": "1430306_13_item1_p26_s2", "sentA": "We then plan to conduct a clinical proof-of-concept trial of TNX-102 SL in PTSD in the fourth quarter of 2013.", "sentB": "The initial IND for TNX-201 will not require any additional nonclinical data to support a first-in-man study, and we plan to conduct a Phase I comparative pharmacokinetic and safety study in the fourth quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "The", "initial", "IND", "for", "TNX-201", "will", "not", "require", "any", "additional", "nonclinical", "data", "to", "support", "a", "first-in-man", "study,", "and", "we", "plan", "to", "conduct", "a", "Phase", "I", "comparative", "pharmacokinetic", "and", "safety", "study", "in", "the", "fourth", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["The", "initial", "IND", "for", "TNX-201", "will", "not", "require", "any", "additional", "nonclinical", "data", "to", "support", "a", "first-in-man", "study,", "and", "we", "plan", "to", "conduct", "a", "Phase", "I", "comparative", "pharmacokinetic", "and", "safety", "study", "in", "the", "fourth", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p83_s3", "idA": "1430306_13_item1_p26_s2", "sentA": "We then plan to conduct a clinical proof-of-concept trial of TNX-102 SL in PTSD in the fourth quarter of 2013.", "sentB": "The study began in September 2013 and we expect to announce initial results in the fourth quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "The", "study", "began", "in", "September", "2013", "and", "we", "expect", "to", "announce", "initial", "results", "in", "the", "fourth", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "then", "plan", "to", "conduct", "a", "clinical", "proof-of-concept", "trial", "of", "TNX-102", "SL", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["The", "study", "began", "in", "September", "2013", "and", "we", "expect", "to", "announce", "initial", "results", "in", "the", "fourth", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p149_s0", "idA": "1430306_13_item1_p28_s0", "sentA": "CBP has been approved by the FDA in the U.S. since 1977.", "sentB": "In the United States, a patent s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office, or PTO, in granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier-filed patent.", "type": 2, "words": ["<tag1>", "CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977.", "<tag2>", "In", "the", "United", "States,", "a", "patent", "s", "term", "may", "be", "lengthened", "by", "patent", "term", "adjustment,", "which", "compensates", "a", "patentee", "for", "administrative", "delays", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "in", "granting", "a", "patent,", "or", "may", "be", "shortened", "if", "a", "patent", "is", "terminally", "disclaimed", "over", "an", "earlier-filed", "patent.", "<tag3>"], "wordsA": ["CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977."], "wordsB": ["In", "the", "United", "States,", "a", "patent", "s", "term", "may", "be", "lengthened", "by", "patent", "term", "adjustment,", "which", "compensates", "a", "patentee", "for", "administrative", "delays", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "in", "granting", "a", "patent,", "or", "may", "be", "shortened", "if", "a", "patent", "is", "terminally", "disclaimed", "over", "an", "earlier-filed", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p160_s2", "idA": "1430306_13_item1_p28_s0", "sentA": "CBP has been approved by the FDA in the U.S. since 1977.", "sentB": "We believe that these technologies, after further development, may be of interest to biodefense agencies in the U.S. and other countries.", "type": 2, "words": ["<tag1>", "CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977.", "<tag2>", "We", "believe", "that", "these", "technologies,", "after", "further", "development,", "may", "be", "of", "interest", "to", "biodefense", "agencies", "in", "the", "U.S.", "and", "other", "countries.", "<tag3>"], "wordsA": ["CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977."], "wordsB": ["We", "believe", "that", "these", "technologies,", "after", "further", "development,", "may", "be", "of", "interest", "to", "biodefense", "agencies", "in", "the", "U.S.", "and", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p29_s1", "idA": "1430306_13_item1_p28_s0", "sentA": "CBP has been approved by the FDA in the U.S. since 1977.", "sentB": "According to the National Institutes of Health, there are approximately five million people suffering from FM in the U.S.", "type": 2, "words": ["<tag1>", "CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977.", "<tag2>", "According", "to", "the", "National", "Institutes", "of", "Health,", "there", "are", "approximately", "five", "million", "people", "suffering", "from", "FM", "in", "the", "U.S.", "<tag3>"], "wordsA": ["CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977."], "wordsB": ["According", "to", "the", "National", "Institutes", "of", "Health,", "there", "are", "approximately", "five", "million", "people", "suffering", "from", "FM", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p42_s1", "idA": "1430306_13_item1_p28_s0", "sentA": "CBP has been approved by the FDA in the U.S. since 1977.", "sentB": "Although currently not approved for any indication, IMH has an extensive history of use as a prescription pharmaceutical in the U.S. as a mixture of two mirror-image isomers, also known as a racemic mixture.", "type": 2, "words": ["<tag1>", "CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977.", "<tag2>", "Although", "currently", "not", "approved", "for", "any", "indication,", "IMH", "has", "an", "extensive", "history", "of", "use", "as", "a", "prescription", "pharmaceutical", "in", "the", "U.S.", "as", "a", "mixture", "of", "two", "mirror-image", "isomers,", "also", "known", "as", "a", "racemic", "mixture.", "<tag3>"], "wordsA": ["CBP", "has", "been", "approved", "by", "the", "FDA", "in", "the", "U.S.", "since", "1977."], "wordsB": ["Although", "currently", "not", "approved", "for", "any", "indication,", "IMH", "has", "an", "extensive", "history", "of", "use", "as", "a", "prescription", "pharmaceutical", "in", "the", "U.S.", "as", "a", "mixture", "of", "two", "mirror-image", "isomers,", "also", "known", "as", "a", "racemic", "mixture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p72_s1", "idA": "1430306_13_item1_p28_s1", "sentA": "We have utilized drug delivery technology to produce new formulations of CBP.", "sentB": "Each TNX-102 capsule contained 1 mg of CBP.", "type": 2, "words": ["<tag1>", "We", "have", "utilized", "drug", "delivery", "technology", "to", "produce", "new", "formulations", "of", "CBP.", "<tag2>", "Each", "TNX-102", "capsule", "contained", "1", "mg", "of", "CBP.", "<tag3>"], "wordsA": ["We", "have", "utilized", "drug", "delivery", "technology", "to", "produce", "new", "formulations", "of", "CBP."], "wordsB": ["Each", "TNX-102", "capsule", "contained", "1", "mg", "of", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p89_s1", "idA": "1430306_13_item1_p28_s3", "sentA": "As a result, we anticipate seeking FDA marketing approval of TNX-102 SL through a 505(b)(2) NDA.", "sentB": "As a result, we will not have to assess the abuse potential of TNX-102 SL for the NDA submission.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "anticipate", "seeking", "FDA", "marketing", "approval", "of", "TNX-102", "SL", "through", "a", "505(b)(2)", "NDA.", "<tag2>", "As", "a", "result,", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "anticipate", "seeking", "FDA", "marketing", "approval", "of", "TNX-102", "SL", "through", "a", "505(b)(2)", "NDA."], "wordsB": ["As", "a", "result,", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p38_s1", "idA": "1430306_13_item1_p29_s0", "sentA": "We have not filed an NDA for TNX-102 SL for any indications.", "sentB": "If successful, this trial will serve as the first of two pivotal studies to support an NDA for TNX-102 SL in FM.", "type": 2, "words": ["<tag1>", "We", "have", "not", "filed", "an", "NDA", "for", "TNX-102", "SL", "for", "any", "indications.", "<tag2>", "If", "successful,", "this", "trial", "will", "serve", "as", "the", "first", "of", "two", "pivotal", "studies", "to", "support", "an", "NDA", "for", "TNX-102", "SL", "in", "FM.", "<tag3>"], "wordsA": ["We", "have", "not", "filed", "an", "NDA", "for", "TNX-102", "SL", "for", "any", "indications."], "wordsB": ["If", "successful,", "this", "trial", "will", "serve", "as", "the", "first", "of", "two", "pivotal", "studies", "to", "support", "an", "NDA", "for", "TNX-102", "SL", "in", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p85_s3", "idA": "1430306_13_item1_p29_s0", "sentA": "We have not filed an NDA for TNX-102 SL for any indications.", "sentB": "These will be carefully selected to support competitive labeling for TNX-102 SL for FM.", "type": 2, "words": ["<tag1>", "We", "have", "not", "filed", "an", "NDA", "for", "TNX-102", "SL", "for", "any", "indications.", "<tag2>", "These", "will", "be", "carefully", "selected", "to", "support", "competitive", "labeling", "for", "TNX-102", "SL", "for", "FM.", "<tag3>"], "wordsA": ["We", "have", "not", "filed", "an", "NDA", "for", "TNX-102", "SL", "for", "any", "indications."], "wordsB": ["These", "will", "be", "carefully", "selected", "to", "support", "competitive", "labeling", "for", "TNX-102", "SL", "for", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p43_s1", "idA": "1430306_13_item1_p30_s1", "sentA": "We have developed TNX-102 gelcap under an agreement with Lipocine, a contract formulation developer and small-scale manufacturer.", "sentB": "We have developed TNX-102 gelcap under an agreement with Lipocine, Inc., or Lipocine, a contract formulation developer and small-scale manufacturer.", "type": 2, "words": ["<tag1>", "We", "have", "developed", "TNX-102", "gelcap", "under", "an", "agreement", "with", "Lipocine,", "a", "contract", "formulation", "developer", "and", "small-scale", "manufacturer.", "<tag2>", "We", "have", "developed", "TNX-102", "gelcap", "under", "an", "agreement", "with", "Lipocine,", "Inc.,", "or", "Lipocine,", "a", "contract", "formulation", "developer", "and", "small-scale", "manufacturer.", "<tag3>"], "wordsA": ["We", "have", "developed", "TNX-102", "gelcap", "under", "an", "agreement", "with", "Lipocine,", "a", "contract", "formulation", "developer", "and", "small-scale", "manufacturer."], "wordsB": ["We", "have", "developed", "TNX-102", "gelcap", "under", "an", "agreement", "with", "Lipocine,", "Inc.,", "or", "Lipocine,", "a", "contract", "formulation", "developer", "and", "small-scale", "manufacturer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p43_s2", "idA": "1430306_13_item1_p30_s2", "sentA": "Although we had met with the FDA to discuss the TNX-102 gelcap development program in August 2011 and we have generated clinical data that support the further development of TNX-102 gelcap, we currently do not plan to advance this candidate.", "sentB": "We met with the FDA to discuss the TNX-102 gelcap development program in August 2011 and have generated clinical data that support the further development of this candidate.", "type": 2, "words": ["<tag1>", "Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate.", "<tag2>", "We", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "this", "candidate.", "<tag3>"], "wordsA": ["Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate."], "wordsB": ["We", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "this", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p43_s3", "idA": "1430306_13_item1_p30_s2", "sentA": "Although we had met with the FDA to discuss the TNX-102 gelcap development program in August 2011 and we have generated clinical data that support the further development of TNX-102 gelcap, we currently do not plan to advance this candidate.", "sentB": "However, we currently do not plan to advance TNX-102 gelcap, and in March 2014, we notified Lipocine of our decision to not exercise our option to license Lipocine s technology, although we own all the work product, information and data from the studies conducted.", "type": 2, "words": ["<tag1>", "Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate.", "<tag2>", "However,", "we", "currently", "do", "not", "plan", "to", "advance", "TNX-102", "gelcap,", "and", "in", "March", "2014,", "we", "notified", "Lipocine", "of", "our", "decision", "to", "not", "exercise", "our", "option", "to", "license", "Lipocine", "s", "technology,", "although", "we", "own", "all", "the", "work", "product,", "information", "and", "data", "from", "the", "studies", "conducted.", "<tag3>"], "wordsA": ["Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate."], "wordsB": ["However,", "we", "currently", "do", "not", "plan", "to", "advance", "TNX-102", "gelcap,", "and", "in", "March", "2014,", "we", "notified", "Lipocine", "of", "our", "decision", "to", "not", "exercise", "our", "option", "to", "license", "Lipocine", "s", "technology,", "although", "we", "own", "all", "the", "work", "product,", "information", "and", "data", "from", "the", "studies", "conducted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p22_s2", "idA": "1430306_13_item1_p31_s0", "sentA": "We also have a pipeline of other product candidates, including TNX-201 and TNX-301.", "sentB": "We also have a pipeline of additional product candidates that we plan to develop for other CNS indications.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-201", "and", "TNX-301.", "<tag2>", "We", "also", "have", "a", "pipeline", "of", "additional", "product", "candidates", "that", "we", "plan", "to", "develop", "for", "other", "CNS", "indications.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-201", "and", "TNX-301."], "wordsB": ["We", "also", "have", "a", "pipeline", "of", "additional", "product", "candidates", "that", "we", "plan", "to", "develop", "for", "other", "CNS", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p44_s0", "idA": "1430306_13_item1_p31_s0", "sentA": "We also have a pipeline of other product candidates, including TNX-201 and TNX-301.", "sentB": "We also have a pipeline of other product candidates, including TNX-301.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-201", "and", "TNX-301.", "<tag2>", "We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-301.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-201", "and", "TNX-301."], "wordsB": ["We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-301."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p42_s0", "idA": "1430306_13_item1_p32_s0", "sentA": "TNX-201 is based on isometheptene mucate and is under development as a treatment for certain types of headaches.", "sentB": "TNX-201 is a single isomer of isometheptene mucate (IMH) and is under development as a treatment for ETTH, an indication believed to affect approximately 20% of the global adult population.", "type": 2, "words": ["<tag1>", "TNX-201", "is", "based", "on", "isometheptene", "mucate", "and", "is", "under", "development", "as", "a", "treatment", "for", "certain", "types", "of", "headaches.", "<tag2>", "TNX-201", "is", "a", "single", "isomer", "of", "isometheptene", "mucate", "(IMH)", "and", "is", "under", "development", "as", "a", "treatment", "for", "ETTH,", "an", "indication", "believed", "to", "affect", "approximately", "20%", "of", "the", "global", "adult", "population.", "<tag3>"], "wordsA": ["TNX-201", "is", "based", "on", "isometheptene", "mucate", "and", "is", "under", "development", "as", "a", "treatment", "for", "certain", "types", "of", "headaches."], "wordsB": ["TNX-201", "is", "a", "single", "isomer", "of", "isometheptene", "mucate", "(IMH)", "and", "is", "under", "development", "as", "a", "treatment", "for", "ETTH,", "an", "indication", "believed", "to", "affect", "approximately", "20%", "of", "the", "global", "adult", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p44_s2", "idA": "1430306_13_item1_p32_s0", "sentA": "TNX-201 is based on isometheptene mucate and is under development as a treatment for certain types of headaches.", "sentB": "We intend to develop TNX-301 under the 505(b)(2) provision as a treatment for alcohol abuse and dependence, and plan to begin formulation work on TNX-301 in 2014.", "type": 2, "words": ["<tag1>", "TNX-201", "is", "based", "on", "isometheptene", "mucate", "and", "is", "under", "development", "as", "a", "treatment", "for", "certain", "types", "of", "headaches.", "<tag2>", "We", "intend", "to", "develop", "TNX-301", "under", "the", "505(b)(2)", "provision", "as", "a", "treatment", "for", "alcohol", "abuse", "and", "dependence,", "and", "plan", "to", "begin", "formulation", "work", "on", "TNX-301", "in", "2014.", "<tag3>"], "wordsA": ["TNX-201", "is", "based", "on", "isometheptene", "mucate", "and", "is", "under", "development", "as", "a", "treatment", "for", "certain", "types", "of", "headaches."], "wordsB": ["We", "intend", "to", "develop", "TNX-301", "under", "the", "505(b)(2)", "provision", "as", "a", "treatment", "for", "alcohol", "abuse", "and", "dependence,", "and", "plan", "to", "begin", "formulation", "work", "on", "TNX-301", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p119_s3", "idA": "1430306_13_item1_p33_s0", "sentA": "For competitive reasons, we do not disclose the identities of the active ingredients or targeted indications in our pipeline until a U.S. patent has been allowed or issued.", "sentB": "Cymbalta lost its U.S. patent exclusivity in December 2013.", "type": 2, "words": ["<tag1>", "For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued.", "<tag2>", "Cymbalta", "lost", "its", "U.S.", "patent", "exclusivity", "in", "December", "2013.", "<tag3>"], "wordsA": ["For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued."], "wordsB": ["Cymbalta", "lost", "its", "U.S.", "patent", "exclusivity", "in", "December", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p136_s2", "idA": "1430306_13_item1_p33_s0", "sentA": "For competitive reasons, we do not disclose the identities of the active ingredients or targeted indications in our pipeline until a U.S. patent has been allowed or issued.", "sentB": "Cymbalta lost its U.S. patent exclusivity in December 2013.", "type": 2, "words": ["<tag1>", "For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued.", "<tag2>", "Cymbalta", "lost", "its", "U.S.", "patent", "exclusivity", "in", "December", "2013.", "<tag3>"], "wordsA": ["For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued."], "wordsB": ["Cymbalta", "lost", "its", "U.S.", "patent", "exclusivity", "in", "December", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p137_s1", "idA": "1430306_13_item1_p33_s0", "sentA": "For competitive reasons, we do not disclose the identities of the active ingredients or targeted indications in our pipeline until a U.S. patent has been allowed or issued.", "sentB": "Paxil and Zoloft lost their U.S. patent exclusivities in 2003 and 2006, respectively.", "type": 2, "words": ["<tag1>", "For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued.", "<tag2>", "Paxil", "and", "Zoloft", "lost", "their", "U.S.", "patent", "exclusivities", "in", "2003", "and", "2006,", "respectively.", "<tag3>"], "wordsA": ["For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued."], "wordsB": ["Paxil", "and", "Zoloft", "lost", "their", "U.S.", "patent", "exclusivities", "in", "2003", "and", "2006,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p46_s0", "idA": "1430306_13_item1_p33_s0", "sentA": "For competitive reasons, we do not disclose the identities of the active ingredients or targeted indications in our pipeline until a U.S. patent has been allowed or issued.", "sentB": "For competitive reasons, we typically do not disclose the identities of the active ingredients or targeted indications in our pipeline until a U.S. patent has been allowed or issued.", "type": 2, "words": ["<tag1>", "For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued.", "<tag2>", "For", "competitive", "reasons,", "we", "typically", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued.", "<tag3>"], "wordsA": ["For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued."], "wordsB": ["For", "competitive", "reasons,", "we", "typically", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p54_s7", "idA": "1430306_13_item1_p33_s0", "sentA": "For competitive reasons, we do not disclose the identities of the active ingredients or targeted indications in our pipeline until a U.S. patent has been allowed or issued.", "sentB": "Cymbalta lost its U.S. patent exclusivity in December 2013.", "type": 2, "words": ["<tag1>", "For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued.", "<tag2>", "Cymbalta", "lost", "its", "U.S.", "patent", "exclusivity", "in", "December", "2013.", "<tag3>"], "wordsA": ["For", "competitive", "reasons,", "we", "do", "not", "disclose", "the", "identities", "of", "the", "active", "ingredients", "or", "targeted", "indications", "in", "our", "pipeline", "until", "a", "U.S.", "patent", "has", "been", "allowed", "or", "issued."], "wordsB": ["Cymbalta", "lost", "its", "U.S.", "patent", "exclusivity", "in", "December", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p204_s1", "idA": "1430306_13_item1_p37_s0", "sentA": "The process to bring a new drug formulation from concept through testing to approval for a new indication by the FDA is a time-consuming, costly and high-risk process.", "sentB": "FDASIA Section 902 provides for a new drug designation Breakthrough Therapy.", "type": 2, "words": ["<tag1>", "The", "process", "to", "bring", "a", "new", "drug", "formulation", "from", "concept", "through", "testing", "to", "approval", "for", "a", "new", "indication", "by", "the", "FDA", "is", "a", "time-consuming,", "costly", "and", "high-risk", "process.", "<tag2>", "FDASIA", "Section", "902", "provides", "for", "a", "new", "drug", "designation", "Breakthrough", "Therapy.", "<tag3>"], "wordsA": ["The", "process", "to", "bring", "a", "new", "drug", "formulation", "from", "concept", "through", "testing", "to", "approval", "for", "a", "new", "indication", "by", "the", "FDA", "is", "a", "time-consuming,", "costly", "and", "high-risk", "process."], "wordsB": ["FDASIA", "Section", "902", "provides", "for", "a", "new", "drug", "designation", "Breakthrough", "Therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p3_s0", "idA": "1430306_13_item1_p3_s0", "sentA": "This Annual Report on Form 10-K includes the accounts of Tonix Pharmaceuticals Holding Corp. ( Tonix ) and its wholly-owned subsidiaries, as follows, collectively referred to as we , us or the Company : Tonix Pharmaceuticals, Inc., a Delaware corporation ( Tonix Sub ) and Krele LLC, a Delaware limited liability company ( Krele ).", "sentB": "This Annual Report on Form 10-K includes the accounts of Tonix Pharmaceuticals Holding Corp. ( Tonix ) and its wholly-owned subsidiaries, as follows, collectively referred to as we , us or the Company : Tonix Pharmaceuticals, Inc., a Delaware corporation (\"Tonix Sub\"), Krele LLC, a Delaware limited liability company (\"Krele\"), Tonix Pharmaceuticals (Canada), Inc., a corporation incorporated under the laws of the province of New Brunswick, Canada (\"Tonix Canada\") and Tonix Pharmaceuticals (Barbados) Ltd., a corporation incorporated under the laws of Barbados (\"Tonix Barbados\").", "type": 2, "words": ["<tag1>", "This", "Annual", "Report", "on", "Form", "10-K", "includes", "the", "accounts", "of", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "(", "Tonix", ")", "and", "its", "wholly-owned", "subsidiaries,", "as", "follows,", "collectively", "referred", "to", "as", "we", ",", "us", "or", "the", "Company", ":", "Tonix", "Pharmaceuticals,", "Inc.,", "a", "Delaware", "corporation", "(", "Tonix", "Sub", ")", "and", "Krele", "LLC,", "a", "Delaware", "limited", "liability", "company", "(", "Krele", ").", "<tag2>", "This", "Annual", "Report", "on", "Form", "10-K", "includes", "the", "accounts", "of", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "(", "Tonix", ")", "and", "its", "wholly-owned", "subsidiaries,", "as", "follows,", "collectively", "referred", "to", "as", "we", ",", "us", "or", "the", "Company", ":", "Tonix", "Pharmaceuticals,", "Inc.,", "a", "Delaware", "corporation", "(\"Tonix", "Sub\"),", "Krele", "LLC,", "a", "Delaware", "limited", "liability", "company", "(\"Krele\"),", "Tonix", "Pharmaceuticals", "(Canada),", "Inc.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "the", "province", "of", "New", "Brunswick,", "Canada", "(\"Tonix", "Canada\")", "and", "Tonix", "Pharmaceuticals", "(Barbados)", "Ltd.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "Barbados", "(\"Tonix", "Barbados\").", "<tag3>"], "wordsA": ["This", "Annual", "Report", "on", "Form", "10-K", "includes", "the", "accounts", "of", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "(", "Tonix", ")", "and", "its", "wholly-owned", "subsidiaries,", "as", "follows,", "collectively", "referred", "to", "as", "we", ",", "us", "or", "the", "Company", ":", "Tonix", "Pharmaceuticals,", "Inc.,", "a", "Delaware", "corporation", "(", "Tonix", "Sub", ")", "and", "Krele", "LLC,", "a", "Delaware", "limited", "liability", "company", "(", "Krele", ")."], "wordsB": ["This", "Annual", "Report", "on", "Form", "10-K", "includes", "the", "accounts", "of", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "(", "Tonix", ")", "and", "its", "wholly-owned", "subsidiaries,", "as", "follows,", "collectively", "referred", "to", "as", "we", ",", "us", "or", "the", "Company", ":", "Tonix", "Pharmaceuticals,", "Inc.,", "a", "Delaware", "corporation", "(\"Tonix", "Sub\"),", "Krele", "LLC,", "a", "Delaware", "limited", "liability", "company", "(\"Krele\"),", "Tonix", "Pharmaceuticals", "(Canada),", "Inc.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "the", "province", "of", "New", "Brunswick,", "Canada", "(\"Tonix", "Canada\")", "and", "Tonix", "Pharmaceuticals", "(Barbados)", "Ltd.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "Barbados", "(\"Tonix", "Barbados\")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p204_s2", "idA": "1430306_13_item1_p3_s1", "sentA": "Tonix Sub is a wholly-owned subsidiary of Tonix and Krele is a wholly-owned subsidiary of Tonix Sub.", "sentB": "A Breakthrough Therapy is a drug:", "type": 2, "words": ["<tag1>", "Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "and", "Krele", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "Sub.", "<tag2>", "A", "Breakthrough", "Therapy", "is", "a", "drug:", "<tag3>"], "wordsA": ["Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "and", "Krele", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "Sub."], "wordsB": ["A", "Breakthrough", "Therapy", "is", "a", "drug:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p3_s1", "idA": "1430306_13_item1_p3_s1", "sentA": "Tonix Sub is a wholly-owned subsidiary of Tonix and Krele is a wholly-owned subsidiary of Tonix Sub.", "sentB": "Tonix Sub is a wholly-owned subsidiary of Tonix, and Krele, Tonix Canada and Tonix Barbados are wholly-owned subsidiaries of Tonix Sub.", "type": 2, "words": ["<tag1>", "Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "and", "Krele", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "Sub.", "<tag2>", "Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix,", "and", "Krele,", "Tonix", "Canada", "and", "Tonix", "Barbados", "are", "wholly-owned", "subsidiaries", "of", "Tonix", "Sub.", "<tag3>"], "wordsA": ["Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "and", "Krele", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "Sub."], "wordsB": ["Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix,", "and", "Krele,", "Tonix", "Canada", "and", "Tonix", "Barbados", "are", "wholly-owned", "subsidiaries", "of", "Tonix", "Sub."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p107_s2", "idA": "1430306_13_item1_p41_s3", "sentA": "To meet the ICH long-term safety exposure requirement, we plan to conduct one or more long-term safety exposure studies of TNX-102 SL to support the chronic use of TNX-102 SL in FM.", "sentB": "We expect the long-term safety exposure data generated by our clinical development of TNX-102 SL in FM can be used to support the PTSD indication.", "type": 2, "words": ["<tag1>", "To", "meet", "the", "ICH", "long-term", "safety", "exposure", "requirement,", "we", "plan", "to", "conduct", "one", "or", "more", "long-term", "safety", "exposure", "studies", "of", "TNX-102", "SL", "to", "support", "the", "chronic", "use", "of", "TNX-102", "SL", "in", "FM.", "<tag2>", "We", "expect", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "can", "be", "used", "to", "support", "the", "PTSD", "indication.", "<tag3>"], "wordsA": ["To", "meet", "the", "ICH", "long-term", "safety", "exposure", "requirement,", "we", "plan", "to", "conduct", "one", "or", "more", "long-term", "safety", "exposure", "studies", "of", "TNX-102", "SL", "to", "support", "the", "chronic", "use", "of", "TNX-102", "SL", "in", "FM."], "wordsB": ["We", "expect", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "can", "be", "used", "to", "support", "the", "PTSD", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p41_s5", "idA": "1430306_13_item1_p41_s3", "sentA": "To meet the ICH long-term safety exposure requirement, we plan to conduct one or more long-term safety exposure studies of TNX-102 SL to support the chronic use of TNX-102 SL in FM.", "sentB": "We expect the long-term safety exposure data generated by our clinical development of TNX-102 SL in FM can be used to support the PTSD indication.", "type": 2, "words": ["<tag1>", "To", "meet", "the", "ICH", "long-term", "safety", "exposure", "requirement,", "we", "plan", "to", "conduct", "one", "or", "more", "long-term", "safety", "exposure", "studies", "of", "TNX-102", "SL", "to", "support", "the", "chronic", "use", "of", "TNX-102", "SL", "in", "FM.", "<tag2>", "We", "expect", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "can", "be", "used", "to", "support", "the", "PTSD", "indication.", "<tag3>"], "wordsA": ["To", "meet", "the", "ICH", "long-term", "safety", "exposure", "requirement,", "we", "plan", "to", "conduct", "one", "or", "more", "long-term", "safety", "exposure", "studies", "of", "TNX-102", "SL", "to", "support", "the", "chronic", "use", "of", "TNX-102", "SL", "in", "FM."], "wordsB": ["We", "expect", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "can", "be", "used", "to", "support", "the", "PTSD", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p84_s1", "idA": "1430306_13_item1_p41_s3", "sentA": "To meet the ICH long-term safety exposure requirement, we plan to conduct one or more long-term safety exposure studies of TNX-102 SL to support the chronic use of TNX-102 SL in FM.", "sentB": "The goal is to obtain sufficient 6 and 12 month safety exposure data in FM patients to meet the NDA submission requirement.", "type": 2, "words": ["<tag1>", "To", "meet", "the", "ICH", "long-term", "safety", "exposure", "requirement,", "we", "plan", "to", "conduct", "one", "or", "more", "long-term", "safety", "exposure", "studies", "of", "TNX-102", "SL", "to", "support", "the", "chronic", "use", "of", "TNX-102", "SL", "in", "FM.", "<tag2>", "The", "goal", "is", "to", "obtain", "sufficient", "6", "and", "12", "month", "safety", "exposure", "data", "in", "FM", "patients", "to", "meet", "the", "NDA", "submission", "requirement.", "<tag3>"], "wordsA": ["To", "meet", "the", "ICH", "long-term", "safety", "exposure", "requirement,", "we", "plan", "to", "conduct", "one", "or", "more", "long-term", "safety", "exposure", "studies", "of", "TNX-102", "SL", "to", "support", "the", "chronic", "use", "of", "TNX-102", "SL", "in", "FM."], "wordsB": ["The", "goal", "is", "to", "obtain", "sufficient", "6", "and", "12", "month", "safety", "exposure", "data", "in", "FM", "patients", "to", "meet", "the", "NDA", "submission", "requirement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p45_s2", "idA": "1430306_13_item1_p41_s4", "sentA": "Assuming our clinical development of TNX-102 SL in FM meets with success, we would submit an NDA to the FDA seeking marketing approval of TNX-102 SL for the management of FM.", "sentB": "As we interact with the United States Department of Defense and related biodefense agencies regarding our development of TNX-102 SL for PTSD, we believe these technologies will expand our interaction and cooperation with such agencies.", "type": 2, "words": ["<tag1>", "Assuming", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "meets", "with", "success,", "we", "would", "submit", "an", "NDA", "to", "the", "FDA", "seeking", "marketing", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "As", "we", "interact", "with", "the", "United", "States", "Department", "of", "Defense", "and", "related", "biodefense", "agencies", "regarding", "our", "development", "of", "TNX-102", "SL", "for", "PTSD,", "we", "believe", "these", "technologies", "will", "expand", "our", "interaction", "and", "cooperation", "with", "such", "agencies.", "<tag3>"], "wordsA": ["Assuming", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "meets", "with", "success,", "we", "would", "submit", "an", "NDA", "to", "the", "FDA", "seeking", "marketing", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["As", "we", "interact", "with", "the", "United", "States", "Department", "of", "Defense", "and", "related", "biodefense", "agencies", "regarding", "our", "development", "of", "TNX-102", "SL", "for", "PTSD,", "we", "believe", "these", "technologies", "will", "expand", "our", "interaction", "and", "cooperation", "with", "such", "agencies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p40_s1", "idA": "1430306_13_item1_p41_s5", "sentA": "We believe it would take approximately six months to prepare and file the NDA and another 14 months to obtain final FDA approval.", "sentB": "The goal is to obtain sufficient 6 and 12 month exposure data in FM patients to meet the NDA submission requirement.", "type": 2, "words": ["<tag1>", "We", "believe", "it", "would", "take", "approximately", "six", "months", "to", "prepare", "and", "file", "the", "NDA", "and", "another", "14", "months", "to", "obtain", "final", "FDA", "approval.", "<tag2>", "The", "goal", "is", "to", "obtain", "sufficient", "6", "and", "12", "month", "exposure", "data", "in", "FM", "patients", "to", "meet", "the", "NDA", "submission", "requirement.", "<tag3>"], "wordsA": ["We", "believe", "it", "would", "take", "approximately", "six", "months", "to", "prepare", "and", "file", "the", "NDA", "and", "another", "14", "months", "to", "obtain", "final", "FDA", "approval."], "wordsB": ["The", "goal", "is", "to", "obtain", "sufficient", "6", "and", "12", "month", "exposure", "data", "in", "FM", "patients", "to", "meet", "the", "NDA", "submission", "requirement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p17_s0", "idA": "1430306_13_item1_p42_s0", "sentA": "In August 2010, we formed Krele to commercialize products that are generic versions of predicate NDA products.", "sentB": "In August 2010, we formed Krele to commercialize products that are generic versions of predicate New Drug Application, or NDA, products.", "type": 2, "words": ["<tag1>", "In", "August", "2010,", "we", "formed", "Krele", "to", "commercialize", "products", "that", "are", "generic", "versions", "of", "predicate", "NDA", "products.", "<tag2>", "In", "August", "2010,", "we", "formed", "Krele", "to", "commercialize", "products", "that", "are", "generic", "versions", "of", "predicate", "New", "Drug", "Application,", "or", "NDA,", "products.", "<tag3>"], "wordsA": ["In", "August", "2010,", "we", "formed", "Krele", "to", "commercialize", "products", "that", "are", "generic", "versions", "of", "predicate", "NDA", "products."], "wordsB": ["In", "August", "2010,", "we", "formed", "Krele", "to", "commercialize", "products", "that", "are", "generic", "versions", "of", "predicate", "New", "Drug", "Application,", "or", "NDA,", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p56_s1", "idA": "1430306_13_item1_p42_s2", "sentA": "Krele also may develop or acquire generic products approved under ANDAs and we may market branded versions (branded generics) of such products.", "sentB": "The flexibility and scalability of such organizations has made it possible for many emerging companies to decide to market their own products.", "type": 2, "words": ["<tag1>", "Krele", "also", "may", "develop", "or", "acquire", "generic", "products", "approved", "under", "ANDAs", "and", "we", "may", "market", "branded", "versions", "(branded", "generics)", "of", "such", "products.", "<tag2>", "The", "flexibility", "and", "scalability", "of", "such", "organizations", "has", "made", "it", "possible", "for", "many", "emerging", "companies", "to", "decide", "to", "market", "their", "own", "products.", "<tag3>"], "wordsA": ["Krele", "also", "may", "develop", "or", "acquire", "generic", "products", "approved", "under", "ANDAs", "and", "we", "may", "market", "branded", "versions", "(branded", "generics)", "of", "such", "products."], "wordsB": ["The", "flexibility", "and", "scalability", "of", "such", "organizations", "has", "made", "it", "possible", "for", "many", "emerging", "companies", "to", "decide", "to", "market", "their", "own", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p161_s0", "idA": "1430306_13_item1_p44_s0", "sentA": "Our objective is to develop and commercialize our product candidates to treat CNS conditions, including FM and PTSD.", "sentB": "In addition to patents, we rely on trade secrets and know-how to develop and maintain our competitive position.", "type": 2, "words": ["<tag1>", "Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates", "to", "treat", "CNS", "conditions,", "including", "FM", "and", "PTSD.", "<tag2>", "In", "addition", "to", "patents,", "we", "rely", "on", "trade", "secrets", "and", "know-how", "to", "develop", "and", "maintain", "our", "competitive", "position.", "<tag3>"], "wordsA": ["Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates", "to", "treat", "CNS", "conditions,", "including", "FM", "and", "PTSD."], "wordsB": ["In", "addition", "to", "patents,", "we", "rely", "on", "trade", "secrets", "and", "know-how", "to", "develop", "and", "maintain", "our", "competitive", "position."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p47_s0", "idA": "1430306_13_item1_p44_s0", "sentA": "Our objective is to develop and commercialize our product candidates to treat CNS conditions, including FM and PTSD.", "sentB": "Our objective is to develop and commercialize our product candidates to treat CNS conditions, including FM, PTSD and ETTH.", "type": 2, "words": ["<tag1>", "Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates", "to", "treat", "CNS", "conditions,", "including", "FM", "and", "PTSD.", "<tag2>", "Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates", "to", "treat", "CNS", "conditions,", "including", "FM,", "PTSD", "and", "ETTH.", "<tag3>"], "wordsA": ["Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates", "to", "treat", "CNS", "conditions,", "including", "FM", "and", "PTSD."], "wordsB": ["Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates", "to", "treat", "CNS", "conditions,", "including", "FM,", "PTSD", "and", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p48_s0", "idA": "1430306_13_item1_p46_s2", "sentA": "By focusing on developing new formulations of approved drugs for new uses, we believe that we will be able to use the Section 505(b)(2) regulatory pathway for NDA approval.", "sentB": "establish and maintain a sales and marketing infrastructure, such that we will be able to effectively commercialize our products once approved.", "type": 2, "words": ["<tag1>", "By", "focusing", "on", "developing", "new", "formulations", "of", "approved", "drugs", "for", "new", "uses,", "we", "believe", "that", "we", "will", "be", "able", "to", "use", "the", "Section", "505(b)(2)", "regulatory", "pathway", "for", "NDA", "approval.", "<tag2>", "establish", "and", "maintain", "a", "sales", "and", "marketing", "infrastructure,", "such", "that", "we", "will", "be", "able", "to", "effectively", "commercialize", "our", "products", "once", "approved.", "<tag3>"], "wordsA": ["By", "focusing", "on", "developing", "new", "formulations", "of", "approved", "drugs", "for", "new", "uses,", "we", "believe", "that", "we", "will", "be", "able", "to", "use", "the", "Section", "505(b)(2)", "regulatory", "pathway", "for", "NDA", "approval."], "wordsB": ["establish", "and", "maintain", "a", "sales", "and", "marketing", "infrastructure,", "such", "that", "we", "will", "be", "able", "to", "effectively", "commercialize", "our", "products", "once", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p150_s5", "idA": "1430306_13_item1_p47_s3", "sentA": "For companies involved in the ethical development and marketing of prescription drugs in the US, FDA approval of a new use or new label indication is the only legal basis of marketing claims for that use or indication.", "sentB": "When possible, depending upon the length of clinical trials and other factors involved in the filing of a new drug application, or NDA, we expect to apply for patent term extensions for patents covering our product candidates and their methods of use.", "type": 2, "words": ["<tag1>", "For", "companies", "involved", "in", "the", "ethical", "development", "and", "marketing", "of", "prescription", "drugs", "in", "the", "US,", "FDA", "approval", "of", "a", "new", "use", "or", "new", "label", "indication", "is", "the", "only", "legal", "basis", "of", "marketing", "claims", "for", "that", "use", "or", "indication.", "<tag2>", "When", "possible,", "depending", "upon", "the", "length", "of", "clinical", "trials", "and", "other", "factors", "involved", "in", "the", "filing", "of", "a", "new", "drug", "application,", "or", "NDA,", "we", "expect", "to", "apply", "for", "patent", "term", "extensions", "for", "patents", "covering", "our", "product", "candidates", "and", "their", "methods", "of", "use.", "<tag3>"], "wordsA": ["For", "companies", "involved", "in", "the", "ethical", "development", "and", "marketing", "of", "prescription", "drugs", "in", "the", "US,", "FDA", "approval", "of", "a", "new", "use", "or", "new", "label", "indication", "is", "the", "only", "legal", "basis", "of", "marketing", "claims", "for", "that", "use", "or", "indication."], "wordsB": ["When", "possible,", "depending", "upon", "the", "length", "of", "clinical", "trials", "and", "other", "factors", "involved", "in", "the", "filing", "of", "a", "new", "drug", "application,", "or", "NDA,", "we", "expect", "to", "apply", "for", "patent", "term", "extensions", "for", "patents", "covering", "our", "product", "candidates", "and", "their", "methods", "of", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p161_s1", "idA": "1430306_13_item1_p48_s0", "sentA": "We are pursuing a multi-pronged patent strategy by seeking intellectual property protection on several aspects of our products.", "sentB": "For example, significant aspects of our proprietary technology platform are based on unpatented trade secrets and know-how.", "type": 2, "words": ["<tag1>", "We", "are", "pursuing", "a", "multi-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "on", "several", "aspects", "of", "our", "products.", "<tag2>", "For", "example,", "significant", "aspects", "of", "our", "proprietary", "technology", "platform", "are", "based", "on", "unpatented", "trade", "secrets", "and", "know-how.", "<tag3>"], "wordsA": ["We", "are", "pursuing", "a", "multi-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "on", "several", "aspects", "of", "our", "products."], "wordsB": ["For", "example,", "significant", "aspects", "of", "our", "proprietary", "technology", "platform", "are", "based", "on", "unpatented", "trade", "secrets", "and", "know-how."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p52_s0", "idA": "1430306_13_item1_p48_s0", "sentA": "We are pursuing a multi-pronged patent strategy by seeking intellectual property protection on several aspects of our products.", "sentB": "Adopt a multi-pronged patent strategy .", "type": 2, "words": ["<tag1>", "We", "are", "pursuing", "a", "multi-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "on", "several", "aspects", "of", "our", "products.", "<tag2>", "Adopt", "a", "multi-pronged", "patent", "strategy", ".", "<tag3>"], "wordsA": ["We", "are", "pursuing", "a", "multi-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "on", "several", "aspects", "of", "our", "products."], "wordsB": ["Adopt", "a", "multi-pronged", "patent", "strategy", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p53_s1", "idA": "1430306_13_item1_p48_s1", "sentA": "Aspects we seek to protect include, among others, methods of use for certain known active pharmaceutical ingredients, formulation technologies incorporated into our products, and performance characteristics of our products in the human body.", "sentB": "Aspects we seek to protect include, among others, methods of use for certain known active pharmaceutical ingredients, formulation technologies incorporated into our products, performance characteristics of our products in the human body and the composition-of-matter of our products .", "type": 2, "words": ["<tag1>", "Aspects", "we", "seek", "to", "protect", "include,", "among", "others,", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients,", "formulation", "technologies", "incorporated", "into", "our", "products,", "and", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body.", "<tag2>", "Aspects", "we", "seek", "to", "protect", "include,", "among", "others,", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients,", "formulation", "technologies", "incorporated", "into", "our", "products,", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body", "and", "the", "composition-of-matter", "of", "our", "products", ".", "<tag3>"], "wordsA": ["Aspects", "we", "seek", "to", "protect", "include,", "among", "others,", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients,", "formulation", "technologies", "incorporated", "into", "our", "products,", "and", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body."], "wordsB": ["Aspects", "we", "seek", "to", "protect", "include,", "among", "others,", "methods", "of", "use", "for", "certain", "known", "active", "pharmaceutical", "ingredients,", "formulation", "technologies", "incorporated", "into", "our", "products,", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body", "and", "the", "composition-of-matter", "of", "our", "products", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p53_s3", "idA": "1430306_13_item1_p48_s3", "sentA": "For example, the invention of bedtime VLD CBP as a treatment for FM was novel and unexpected when our patents were filed in 2000.", "sentB": "For example, the invention of bedtime TNX-102 as a treatment for FM was novel and unexpected when our patents were filed in 2000.", "type": 2, "words": ["<tag1>", "For", "example,", "the", "invention", "of", "bedtime", "VLD", "CBP", "as", "a", "treatment", "for", "FM", "was", "novel", "and", "unexpected", "when", "our", "patents", "were", "filed", "in", "2000.", "<tag2>", "For", "example,", "the", "invention", "of", "bedtime", "TNX-102", "as", "a", "treatment", "for", "FM", "was", "novel", "and", "unexpected", "when", "our", "patents", "were", "filed", "in", "2000.", "<tag3>"], "wordsA": ["For", "example,", "the", "invention", "of", "bedtime", "VLD", "CBP", "as", "a", "treatment", "for", "FM", "was", "novel", "and", "unexpected", "when", "our", "patents", "were", "filed", "in", "2000."], "wordsB": ["For", "example,", "the", "invention", "of", "bedtime", "TNX-102", "as", "a", "treatment", "for", "FM", "was", "novel", "and", "unexpected", "when", "our", "patents", "were", "filed", "in", "2000."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p53_s9", "idA": "1430306_13_item1_p48_s5", "sentA": "For example, we filed a patent application seeking to protect the use of CBP in PTSD.", "sentB": "In the case of TNX-201, for which the active ingredient is a single isomer of racemic isometheptene, we have filed a patent application seeking to protect the composition-of-matter of oral dosage forms that contain only the single isomer and not the racemic mixture.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD.", "<tag2>", "In", "the", "case", "of", "TNX-201,", "for", "which", "the", "active", "ingredient", "is", "a", "single", "isomer", "of", "racemic", "isometheptene,", "we", "have", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "composition-of-matter", "of", "oral", "dosage", "forms", "that", "contain", "only", "the", "single", "isomer", "and", "not", "the", "racemic", "mixture.", "<tag3>"], "wordsA": ["For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD."], "wordsB": ["In", "the", "case", "of", "TNX-201,", "for", "which", "the", "active", "ingredient", "is", "a", "single", "isomer", "of", "racemic", "isometheptene,", "we", "have", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "composition-of-matter", "of", "oral", "dosage", "forms", "that", "contain", "only", "the", "single", "isomer", "and", "not", "the", "racemic", "mixture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p160_s0", "idA": "1430306_13_item1_p48_s7", "sentA": "With respect to patents related to the performance characteristics of our products in the human body, we believe our products will be protected by patents that describe novel pharmacokinetic properties of the active ingredient, as well as of its active metabolites, at certain times after administration.", "sentB": "With respect to the smallpox vaccine candidate, the Company acquired US non-provisional Patent Application No. 14,207,727 and related intellectual property rights.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "patents", "related", "to", "the", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "novel", "pharmacokinetic", "properties", "of", "the", "active", "ingredient,", "as", "well", "as", "of", "its", "active", "metabolites,", "at", "certain", "times", "after", "administration.", "<tag2>", "With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "the", "Company", "acquired", "US", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights.", "<tag3>"], "wordsA": ["With", "respect", "to", "patents", "related", "to", "the", "performance", "characteristics", "of", "our", "products", "in", "the", "human", "body,", "we", "believe", "our", "products", "will", "be", "protected", "by", "patents", "that", "describe", "novel", "pharmacokinetic", "properties", "of", "the", "active", "ingredient,", "as", "well", "as", "of", "its", "active", "metabolites,", "at", "certain", "times", "after", "administration."], "wordsB": ["With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "the", "Company", "acquired", "US", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p151_s0", "idA": "1430306_13_item1_p49_s0", "sentA": "Provide clear value propositions to third-party payors to merit reimbursement for our product candidates .", "sentB": "The patent portfolios for our proprietary technology platform and our three most advanced product candidates as of March 21, 2014 are summarized below.", "type": 2, "words": ["<tag1>", "Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", ".", "<tag2>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "21,", "2014", "are", "summarized", "below.", "<tag3>"], "wordsA": ["Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", "."], "wordsB": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "21,", "2014", "are", "summarized", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p55_s1", "idA": "1430306_13_item1_p49_s2", "sentA": "We believe TNX-102 SL might help in the management of FM by reducing pain and other symptoms, such as fatigue.", "sentB": "We believe TNX-102 SL and TNX-201 can be marketed to physicians in the United States by means of a sales force built by or engaged by us.", "type": 2, "words": ["<tag1>", "We", "believe", "TNX-102", "SL", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue.", "<tag2>", "We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "physicians", "in", "the", "United", "States", "by", "means", "of", "a", "sales", "force", "built", "by", "or", "engaged", "by", "us.", "<tag3>"], "wordsA": ["We", "believe", "TNX-102", "SL", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue."], "wordsB": ["We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "physicians", "in", "the", "United", "States", "by", "means", "of", "a", "sales", "force", "built", "by", "or", "engaged", "by", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p54_s3", "idA": "1430306_13_item1_p49_s3", "sentA": "In addition, we believe that bedtime treatment with TNX-102 SL will have fewer day time side-effects than off-label bedtime treatment with immediate-release CBP, or CBP IR.", "sentB": "In addition, primarily as a result of its lower dosage, we believe that bedtime treatment with TNX-102 SL will have fewer day time side-effects than off-label bedtime treatment with immediate-release CBP products approved for the treatment of muscle spasm, or CBP IR.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "SL", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate-release", "CBP,", "or", "CBP", "IR.", "<tag2>", "In", "addition,", "primarily", "as", "a", "result", "of", "its", "lower", "dosage,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "SL", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate-release", "CBP", "products", "approved", "for", "the", "treatment", "of", "muscle", "spasm,", "or", "CBP", "IR.", "<tag3>"], "wordsA": ["In", "addition,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "SL", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate-release", "CBP,", "or", "CBP", "IR."], "wordsB": ["In", "addition,", "primarily", "as", "a", "result", "of", "its", "lower", "dosage,", "we", "believe", "that", "bedtime", "treatment", "with", "TNX-102", "SL", "will", "have", "fewer", "day", "time", "side-effects", "than", "off-label", "bedtime", "treatment", "with", "immediate-release", "CBP", "products", "approved", "for", "the", "treatment", "of", "muscle", "spasm,", "or", "CBP", "IR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p54_s4", "idA": "1430306_13_item1_p49_s4", "sentA": "For FM, we believe an FDA-approved product would capture some of the off-label use of generic CBP.", "sentB": "For FM, we believe an FDA-approved product would capture some of the off-label use of CBP IR.", "type": 2, "words": ["<tag1>", "For", "FM,", "we", "believe", "an", "FDA-approved", "product", "would", "capture", "some", "of", "the", "off-label", "use", "of", "generic", "CBP.", "<tag2>", "For", "FM,", "we", "believe", "an", "FDA-approved", "product", "would", "capture", "some", "of", "the", "off-label", "use", "of", "CBP", "IR.", "<tag3>"], "wordsA": ["For", "FM,", "we", "believe", "an", "FDA-approved", "product", "would", "capture", "some", "of", "the", "off-label", "use", "of", "generic", "CBP."], "wordsB": ["For", "FM,", "we", "believe", "an", "FDA-approved", "product", "would", "capture", "some", "of", "the", "off-label", "use", "of", "CBP", "IR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p54_s6", "idA": "1430306_13_item1_p49_s6", "sentA": "For example, third-party payors reimburse the use of Lyrica and Cymbalta for FM despite the availability of off-label generic versions of drugs with similar mechanisms of action, for example, Neurontin (gabapentin) and generic anti-depressants, respectively.", "sentB": "For example, third-party payors reimburse the use of Lyrica, Cymbalta and Savella for FM despite the availability of off-label generic versions of drugs with similar mechanisms of action, for example, Neurontin (gabapentin) and generic anti-depressants, respectively.", "type": 2, "words": ["<tag1>", "For", "example,", "third-party", "payors", "reimburse", "the", "use", "of", "Lyrica", "and", "Cymbalta", "for", "FM", "despite", "the", "availability", "of", "off-label", "generic", "versions", "of", "drugs", "with", "similar", "mechanisms", "of", "action,", "for", "example,", "Neurontin", "(gabapentin)", "and", "generic", "anti-depressants,", "respectively.", "<tag2>", "For", "example,", "third-party", "payors", "reimburse", "the", "use", "of", "Lyrica,", "Cymbalta", "and", "Savella", "for", "FM", "despite", "the", "availability", "of", "off-label", "generic", "versions", "of", "drugs", "with", "similar", "mechanisms", "of", "action,", "for", "example,", "Neurontin", "(gabapentin)", "and", "generic", "anti-depressants,", "respectively.", "<tag3>"], "wordsA": ["For", "example,", "third-party", "payors", "reimburse", "the", "use", "of", "Lyrica", "and", "Cymbalta", "for", "FM", "despite", "the", "availability", "of", "off-label", "generic", "versions", "of", "drugs", "with", "similar", "mechanisms", "of", "action,", "for", "example,", "Neurontin", "(gabapentin)", "and", "generic", "anti-depressants,", "respectively."], "wordsB": ["For", "example,", "third-party", "payors", "reimburse", "the", "use", "of", "Lyrica,", "Cymbalta", "and", "Savella", "for", "FM", "despite", "the", "availability", "of", "off-label", "generic", "versions", "of", "drugs", "with", "similar", "mechanisms", "of", "action,", "for", "example,", "Neurontin", "(gabapentin)", "and", "generic", "anti-depressants,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p56_s3", "idA": "1430306_13_item1_p50_s1", "sentA": "We believe certain of our drug development candidates, including TNX-102 SL, can be developed and marketed more effectively by companies that already have significant drug development and marketing capabilities.", "sentB": "Another option for certain of our drug development candidates, including TNX-102 SL and TNX-201, would be to partner with companies that already have significant marketing capabilities in the same, or similar, therapeutic areas.", "type": 2, "words": ["<tag1>", "We", "believe", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "SL,", "can", "be", "developed", "and", "marketed", "more", "effectively", "by", "companies", "that", "already", "have", "significant", "drug", "development", "and", "marketing", "capabilities.", "<tag2>", "Another", "option", "for", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "SL", "and", "TNX-201,", "would", "be", "to", "partner", "with", "companies", "that", "already", "have", "significant", "marketing", "capabilities", "in", "the", "same,", "or", "similar,", "therapeutic", "areas.", "<tag3>"], "wordsA": ["We", "believe", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "SL,", "can", "be", "developed", "and", "marketed", "more", "effectively", "by", "companies", "that", "already", "have", "significant", "drug", "development", "and", "marketing", "capabilities."], "wordsB": ["Another", "option", "for", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "SL", "and", "TNX-201,", "would", "be", "to", "partner", "with", "companies", "that", "already", "have", "significant", "marketing", "capabilities", "in", "the", "same,", "or", "similar,", "therapeutic", "areas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p56_s4", "idA": "1430306_13_item1_p50_s2", "sentA": "We will seek to enter into collaborations with pharmaceutical or biotechnology companies for the commercialization of these product candidates at the times we believe most effective.", "sentB": "If we determine that such a strategy would be more favorable than developing our own sales capabilities, we would seek to enter into collaborations with pharmaceutical or biotechnology companies for the commercialization of our products.", "type": 2, "words": ["<tag1>", "We", "will", "seek", "to", "enter", "into", "collaborations", "with", "pharmaceutical", "or", "biotechnology", "companies", "for", "the", "commercialization", "of", "these", "product", "candidates", "at", "the", "times", "we", "believe", "most", "effective.", "<tag2>", "If", "we", "determine", "that", "such", "a", "strategy", "would", "be", "more", "favorable", "than", "developing", "our", "own", "sales", "capabilities,", "we", "would", "seek", "to", "enter", "into", "collaborations", "with", "pharmaceutical", "or", "biotechnology", "companies", "for", "the", "commercialization", "of", "our", "products.", "<tag3>"], "wordsA": ["We", "will", "seek", "to", "enter", "into", "collaborations", "with", "pharmaceutical", "or", "biotechnology", "companies", "for", "the", "commercialization", "of", "these", "product", "candidates", "at", "the", "times", "we", "believe", "most", "effective."], "wordsB": ["If", "we", "determine", "that", "such", "a", "strategy", "would", "be", "more", "favorable", "than", "developing", "our", "own", "sales", "capabilities,", "we", "would", "seek", "to", "enter", "into", "collaborations", "with", "pharmaceutical", "or", "biotechnology", "companies", "for", "the", "commercialization", "of", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p140_s0", "idA": "1430306_13_item1_p51_s0", "sentA": "Our lead product candidate is TNX-102 SL, for the treatment of FM and PTSD.", "sentB": "Medications that are used off-label for the treatment of FM include:", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p57_s0", "idA": "1430306_13_item1_p51_s0", "sentA": "Our lead product candidate is TNX-102 SL, for the treatment of FM and PTSD.", "sentB": "Our lead product candidate is TNX-102 SL, which we are developing for the treatment of FM and PTSD.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p42_s2", "idA": "1430306_13_item1_p52_s0", "sentA": "CBP was first synthesized in 1961 by Merck, and the 10 mg Flexeril immediate-release, or IR, dose form was FDA approved in 1977 for the relief of muscle spasm associated with acute, painful musculoskeletal conditions as an adjunct to rest and physical therapy.", "sentB": "Racemic IMH has been marketed in combination products for the relief of tension and vascular headaches (examples include Midrin and MigraTen ).", "type": 2, "words": ["<tag1>", "CBP", "was", "first", "synthesized", "in", "1961", "by", "Merck,", "and", "the", "10", "mg", "Flexeril", "immediate-release,", "or", "IR,", "dose", "form", "was", "FDA", "approved", "in", "1977", "for", "the", "relief", "of", "muscle", "spasm", "associated", "with", "acute,", "painful", "musculoskeletal", "conditions", "as", "an", "adjunct", "to", "rest", "and", "physical", "therapy.", "<tag2>", "Racemic", "IMH", "has", "been", "marketed", "in", "combination", "products", "for", "the", "relief", "of", "tension", "and", "vascular", "headaches", "(examples", "include", "Midrin", "and", "MigraTen", ").", "<tag3>"], "wordsA": ["CBP", "was", "first", "synthesized", "in", "1961", "by", "Merck,", "and", "the", "10", "mg", "Flexeril", "immediate-release,", "or", "IR,", "dose", "form", "was", "FDA", "approved", "in", "1977", "for", "the", "relief", "of", "muscle", "spasm", "associated", "with", "acute,", "painful", "musculoskeletal", "conditions", "as", "an", "adjunct", "to", "rest", "and", "physical", "therapy."], "wordsB": ["Racemic", "IMH", "has", "been", "marketed", "in", "combination", "products", "for", "the", "relief", "of", "tension", "and", "vascular", "headaches", "(examples", "include", "Midrin", "and", "MigraTen", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p60_s0", "idA": "1430306_13_item1_p54_s0", "sentA": "Based on CBP s safety and efficacy for treating muscle spasm, in the 1990s, Merck conducted studies to support an application to market a 5 mg Flexeril tablet (low dose) for the over-the-counter, or OTC, market, whereby patients can purchase medicine without a physician s prescription.", "sentB": "Based on CBP s safety and efficacy for treating muscle spasm, in the 1990s, Merck conducted studies to support an application to market a 5 mg Flexeril tablet for the over-the-counter, or OTC, market, whereby patients can purchase medicine without a physician s prescription.", "type": 2, "words": ["<tag1>", "Based", "on", "CBP", "s", "safety", "and", "efficacy", "for", "treating", "muscle", "spasm,", "in", "the", "1990s,", "Merck", "conducted", "studies", "to", "support", "an", "application", "to", "market", "a", "5", "mg", "Flexeril", "tablet", "(low", "dose)", "for", "the", "over-the-counter,", "or", "OTC,", "market,", "whereby", "patients", "can", "purchase", "medicine", "without", "a", "physician", "s", "prescription.", "<tag2>", "Based", "on", "CBP", "s", "safety", "and", "efficacy", "for", "treating", "muscle", "spasm,", "in", "the", "1990s,", "Merck", "conducted", "studies", "to", "support", "an", "application", "to", "market", "a", "5", "mg", "Flexeril", "tablet", "for", "the", "over-the-counter,", "or", "OTC,", "market,", "whereby", "patients", "can", "purchase", "medicine", "without", "a", "physician", "s", "prescription.", "<tag3>"], "wordsA": ["Based", "on", "CBP", "s", "safety", "and", "efficacy", "for", "treating", "muscle", "spasm,", "in", "the", "1990s,", "Merck", "conducted", "studies", "to", "support", "an", "application", "to", "market", "a", "5", "mg", "Flexeril", "tablet", "(low", "dose)", "for", "the", "over-the-counter,", "or", "OTC,", "market,", "whereby", "patients", "can", "purchase", "medicine", "without", "a", "physician", "s", "prescription."], "wordsB": ["Based", "on", "CBP", "s", "safety", "and", "efficacy", "for", "treating", "muscle", "spasm,", "in", "the", "1990s,", "Merck", "conducted", "studies", "to", "support", "an", "application", "to", "market", "a", "5", "mg", "Flexeril", "tablet", "for", "the", "over-the-counter,", "or", "OTC,", "market,", "whereby", "patients", "can", "purchase", "medicine", "without", "a", "physician", "s", "prescription."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p61_s0", "idA": "1430306_13_item1_p55_s0", "sentA": "Merck divested the Flexeril franchise to Alza Pharmaceuticals, or Alza.", "sentB": "Merck divested the Flexeril franchise to Alza Pharmaceuticals, or Alza, which was subsequently acquired by Johnson and Johnson and Flexeril is part of its McNeil Consumer Healthcare division, or McNeil.", "type": 2, "words": ["<tag1>", "Merck", "divested", "the", "Flexeril", "franchise", "to", "Alza", "Pharmaceuticals,", "or", "Alza.", "<tag2>", "Merck", "divested", "the", "Flexeril", "franchise", "to", "Alza", "Pharmaceuticals,", "or", "Alza,", "which", "was", "subsequently", "acquired", "by", "Johnson", "and", "Johnson", "and", "Flexeril", "is", "part", "of", "its", "McNeil", "Consumer", "Healthcare", "division,", "or", "McNeil.", "<tag3>"], "wordsA": ["Merck", "divested", "the", "Flexeril", "franchise", "to", "Alza", "Pharmaceuticals,", "or", "Alza."], "wordsB": ["Merck", "divested", "the", "Flexeril", "franchise", "to", "Alza", "Pharmaceuticals,", "or", "Alza,", "which", "was", "subsequently", "acquired", "by", "Johnson", "and", "Johnson", "and", "Flexeril", "is", "part", "of", "its", "McNeil", "Consumer", "Healthcare", "division,", "or", "McNeil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p122_s5", "idA": "1430306_13_item1_p57_s0", "sentA": "Despite the approved uses of CBP in treating muscle spasm, we believe current marketed formulations of CBP are limited for treating FM by slow and unpredictable absorption.", "sentB": "As FM patients do not typically experience muscle spasm, we believe that the use of muscle relaxants in FM is off-label from a regulatory perspective and provides therapeutic effects to FM patients that are different from those in treating muscle spasm.", "type": 2, "words": ["<tag1>", "Despite", "the", "approved", "uses", "of", "CBP", "in", "treating", "muscle", "spasm,", "we", "believe", "current", "marketed", "formulations", "of", "CBP", "are", "limited", "for", "treating", "FM", "by", "slow", "and", "unpredictable", "absorption.", "<tag2>", "As", "FM", "patients", "do", "not", "typically", "experience", "muscle", "spasm,", "we", "believe", "that", "the", "use", "of", "muscle", "relaxants", "in", "FM", "is", "off-label", "from", "a", "regulatory", "perspective", "and", "provides", "therapeutic", "effects", "to", "FM", "patients", "that", "are", "different", "from", "those", "in", "treating", "muscle", "spasm.", "<tag3>"], "wordsA": ["Despite", "the", "approved", "uses", "of", "CBP", "in", "treating", "muscle", "spasm,", "we", "believe", "current", "marketed", "formulations", "of", "CBP", "are", "limited", "for", "treating", "FM", "by", "slow", "and", "unpredictable", "absorption."], "wordsB": ["As", "FM", "patients", "do", "not", "typically", "experience", "muscle", "spasm,", "we", "believe", "that", "the", "use", "of", "muscle", "relaxants", "in", "FM", "is", "off-label", "from", "a", "regulatory", "perspective", "and", "provides", "therapeutic", "effects", "to", "FM", "patients", "that", "are", "different", "from", "those", "in", "treating", "muscle", "spasm."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p148_s0", "idA": "1430306_13_item1_p58_s1", "sentA": "As described in the Flexeril package insert, the amount of CBP absorbed into the bloodstream varies between 33-55% of the dose ingested.", "sentB": "The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained.", "type": 2, "words": ["<tag1>", "As", "described", "in", "the", "Flexeril", "package", "insert,", "the", "amount", "of", "CBP", "absorbed", "into", "the", "bloodstream", "varies", "between", "33-55%", "of", "the", "dose", "ingested.", "<tag2>", "The", "term", "of", "individual", "patents", "depends", "upon", "the", "legal", "term", "of", "the", "patents", "in", "the", "countries", "in", "which", "they", "are", "obtained.", "<tag3>"], "wordsA": ["As", "described", "in", "the", "Flexeril", "package", "insert,", "the", "amount", "of", "CBP", "absorbed", "into", "the", "bloodstream", "varies", "between", "33-55%", "of", "the", "dose", "ingested."], "wordsB": ["The", "term", "of", "individual", "patents", "depends", "upon", "the", "legal", "term", "of", "the", "patents", "in", "the", "countries", "in", "which", "they", "are", "obtained."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p65_s1", "idA": "1430306_13_item1_p59_s1", "sentA": "Conversely, patients would be less likely to be over-dosed, which might lead to potential side effects, including next-day drowsiness.", "sentB": "Conversely, patients would be less likely to receive too much drug, which might lead to potential side effects, including next-day drowsiness.", "type": 2, "words": ["<tag1>", "Conversely,", "patients", "would", "be", "less", "likely", "to", "be", "over-dosed,", "which", "might", "lead", "to", "potential", "side", "effects,", "including", "next-day", "drowsiness.", "<tag2>", "Conversely,", "patients", "would", "be", "less", "likely", "to", "receive", "too", "much", "drug,", "which", "might", "lead", "to", "potential", "side", "effects,", "including", "next-day", "drowsiness.", "<tag3>"], "wordsA": ["Conversely,", "patients", "would", "be", "less", "likely", "to", "be", "over-dosed,", "which", "might", "lead", "to", "potential", "side", "effects,", "including", "next-day", "drowsiness."], "wordsB": ["Conversely,", "patients", "would", "be", "less", "likely", "to", "receive", "too", "much", "drug,", "which", "might", "lead", "to", "potential", "side", "effects,", "including", "next-day", "drowsiness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p65_s2", "idA": "1430306_13_item1_p59_s2", "sentA": "An optimal VLD CBP product could have faster absorption, faster clearance and more predictable effects than the IR tablet format.", "sentB": "An optimal bedtime CBP product could have faster absorption, lower blood levels in the morning and more predictable effects than the IR tablet format.", "type": 2, "words": ["<tag1>", "An", "optimal", "VLD", "CBP", "product", "could", "have", "faster", "absorption,", "faster", "clearance", "and", "more", "predictable", "effects", "than", "the", "IR", "tablet", "format.", "<tag2>", "An", "optimal", "bedtime", "CBP", "product", "could", "have", "faster", "absorption,", "lower", "blood", "levels", "in", "the", "morning", "and", "more", "predictable", "effects", "than", "the", "IR", "tablet", "format.", "<tag3>"], "wordsA": ["An", "optimal", "VLD", "CBP", "product", "could", "have", "faster", "absorption,", "faster", "clearance", "and", "more", "predictable", "effects", "than", "the", "IR", "tablet", "format."], "wordsB": ["An", "optimal", "bedtime", "CBP", "product", "could", "have", "faster", "absorption,", "lower", "blood", "levels", "in", "the", "morning", "and", "more", "predictable", "effects", "than", "the", "IR", "tablet", "format."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p5_s0", "idA": "1430306_13_item1_p5_s0", "sentA": "In the Share Exchange, the Tonix Shareholders exchanged their shares of Tonix Sub for newly issued shares of our common stock ( Common Stock ).", "sentB": "In the Share Exchange, the Tonix Shareholders exchanged their shares of Tonix Sub for newly issued shares of common stock.", "type": 2, "words": ["<tag1>", "In", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "exchanged", "their", "shares", "of", "Tonix", "Sub", "for", "newly", "issued", "shares", "of", "our", "common", "stock", "(", "Common", "Stock", ").", "<tag2>", "In", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "exchanged", "their", "shares", "of", "Tonix", "Sub", "for", "newly", "issued", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["In", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "exchanged", "their", "shares", "of", "Tonix", "Sub", "for", "newly", "issued", "shares", "of", "our", "common", "stock", "(", "Common", "Stock", ")."], "wordsB": ["In", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "exchanged", "their", "shares", "of", "Tonix", "Sub", "for", "newly", "issued", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p66_s0", "idA": "1430306_13_item1_p60_s0", "sentA": "We have tested a number of technologies to optimize the properties of VLD CBP as a bedtime therapy for FM and PTSD.", "sentB": "We have tested a number of technologies to optimize the properties of CBP as a bedtime therapy for FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "have", "tested", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "VLD", "CBP", "as", "a", "bedtime", "therapy", "for", "FM", "and", "PTSD.", "<tag2>", "We", "have", "tested", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "CBP", "as", "a", "bedtime", "therapy", "for", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "have", "tested", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "VLD", "CBP", "as", "a", "bedtime", "therapy", "for", "FM", "and", "PTSD."], "wordsB": ["We", "have", "tested", "a", "number", "of", "technologies", "to", "optimize", "the", "properties", "of", "CBP", "as", "a", "bedtime", "therapy", "for", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p144_s0", "idA": "1430306_13_item1_p60_s1", "sentA": "Our lead product, TNX-102 SL is a novel sublingual tablet form of VLD CBP that we have tested in pre-clinical and clinical studies.", "sentB": "We believe that we have an extensive patent portfolio and substantial know-how relating to TNX-102 SL and our other product candidates.", "type": 2, "words": ["<tag1>", "Our", "lead", "product,", "TNX-102", "SL", "is", "a", "novel", "sublingual", "tablet", "form", "of", "VLD", "CBP", "that", "we", "have", "tested", "in", "pre-clinical", "and", "clinical", "studies.", "<tag2>", "We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates.", "<tag3>"], "wordsA": ["Our", "lead", "product,", "TNX-102", "SL", "is", "a", "novel", "sublingual", "tablet", "form", "of", "VLD", "CBP", "that", "we", "have", "tested", "in", "pre-clinical", "and", "clinical", "studies."], "wordsB": ["We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p66_s1", "idA": "1430306_13_item1_p60_s1", "sentA": "Our lead product, TNX-102 SL is a novel sublingual tablet form of VLD CBP that we have tested in pre-clinical and clinical studies.", "sentB": "Our lead product, TNX-102 SL is a novel sublingual tablet form of CBP that we have tested in pre-clinical and clinical studies.", "type": 2, "words": ["<tag1>", "Our", "lead", "product,", "TNX-102", "SL", "is", "a", "novel", "sublingual", "tablet", "form", "of", "VLD", "CBP", "that", "we", "have", "tested", "in", "pre-clinical", "and", "clinical", "studies.", "<tag2>", "Our", "lead", "product,", "TNX-102", "SL", "is", "a", "novel", "sublingual", "tablet", "form", "of", "CBP", "that", "we", "have", "tested", "in", "pre-clinical", "and", "clinical", "studies.", "<tag3>"], "wordsA": ["Our", "lead", "product,", "TNX-102", "SL", "is", "a", "novel", "sublingual", "tablet", "form", "of", "VLD", "CBP", "that", "we", "have", "tested", "in", "pre-clinical", "and", "clinical", "studies."], "wordsB": ["Our", "lead", "product,", "TNX-102", "SL", "is", "a", "novel", "sublingual", "tablet", "form", "of", "CBP", "that", "we", "have", "tested", "in", "pre-clinical", "and", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p27_s1", "idA": "1430306_13_item1_p60_s2", "sentA": "We intend to enter TNX-102 SL into a potential pivotal clinical trial program in FM in the third quarter of 2013, and into a Phase 2 trial in PTSD in the fourth quarter of 2013.", "sentB": "TNX-102 SL is currently in a Phase 2b/3 clinical trial for the improvement of pain in subjects with FM, from which we expect to report initial results in the fourth quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "enter", "TNX-102", "SL", "into", "a", "potential", "pivotal", "clinical", "trial", "program", "in", "FM", "in", "the", "third", "quarter", "of", "2013,", "and", "into", "a", "Phase", "2", "trial", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "TNX-102", "SL", "is", "currently", "in", "a", "Phase", "2b/3", "clinical", "trial", "for", "the", "improvement", "of", "pain", "in", "subjects", "with", "FM,", "from", "which", "we", "expect", "to", "report", "initial", "results", "in", "the", "fourth", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "intend", "to", "enter", "TNX-102", "SL", "into", "a", "potential", "pivotal", "clinical", "trial", "program", "in", "FM", "in", "the", "third", "quarter", "of", "2013,", "and", "into", "a", "Phase", "2", "trial", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["TNX-102", "SL", "is", "currently", "in", "a", "Phase", "2b/3", "clinical", "trial", "for", "the", "improvement", "of", "pain", "in", "subjects", "with", "FM,", "from", "which", "we", "expect", "to", "report", "initial", "results", "in", "the", "fourth", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p66_s2", "idA": "1430306_13_item1_p60_s2", "sentA": "We intend to enter TNX-102 SL into a potential pivotal clinical trial program in FM in the third quarter of 2013, and into a Phase 2 trial in PTSD in the fourth quarter of 2013.", "sentB": "We entered TNX-102 SL into a potential pivotal clinical trial in FM in September 2013, and we plan to begin a POC trial in PTSD in the third quarter of 2014.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "enter", "TNX-102", "SL", "into", "a", "potential", "pivotal", "clinical", "trial", "program", "in", "FM", "in", "the", "third", "quarter", "of", "2013,", "and", "into", "a", "Phase", "2", "trial", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "We", "entered", "TNX-102", "SL", "into", "a", "potential", "pivotal", "clinical", "trial", "in", "FM", "in", "September", "2013,", "and", "we", "plan", "to", "begin", "a", "POC", "trial", "in", "PTSD", "in", "the", "third", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "intend", "to", "enter", "TNX-102", "SL", "into", "a", "potential", "pivotal", "clinical", "trial", "program", "in", "FM", "in", "the", "third", "quarter", "of", "2013,", "and", "into", "a", "Phase", "2", "trial", "in", "PTSD", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["We", "entered", "TNX-102", "SL", "into", "a", "potential", "pivotal", "clinical", "trial", "in", "FM", "in", "September", "2013,", "and", "we", "plan", "to", "begin", "a", "POC", "trial", "in", "PTSD", "in", "the", "third", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p153_s0", "idA": "1430306_13_item1_p60_s3", "sentA": "We believe the unique properties of TNX-102 SL, as demonstrated by the results of our studies, support its development in both FM and PTSD.", "sentB": "The unique pharmacokinetic profile of TNX-102 was discovered by Tonix and its development partners and is termed the PK Technology.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "unique", "properties", "of", "TNX-102", "SL,", "as", "demonstrated", "by", "the", "results", "of", "our", "studies,", "support", "its", "development", "in", "both", "FM", "and", "PTSD.", "<tag2>", "The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology.", "<tag3>"], "wordsA": ["We", "believe", "the", "unique", "properties", "of", "TNX-102", "SL,", "as", "demonstrated", "by", "the", "results", "of", "our", "studies,", "support", "its", "development", "in", "both", "FM", "and", "PTSD."], "wordsB": ["The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p50_s2", "idA": "1430306_13_item1_p60_s5", "sentA": "Although we had met with the FDA to discuss the TNX-102 gelcap development program in August 2011 and we have generated clinical data that support the further development of TNX-102 gelcap, we currently do not plan to advance this candidate.", "sentB": "While we expect to pursue the development of TNX-301 under Section 505(b)(2), we have not yet discussed this candidate with the FDA.", "type": 2, "words": ["<tag1>", "Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate.", "<tag2>", "While", "we", "expect", "to", "pursue", "the", "development", "of", "TNX-301", "under", "Section", "505(b)(2),", "we", "have", "not", "yet", "discussed", "this", "candidate", "with", "the", "FDA.", "<tag3>"], "wordsA": ["Although", "we", "had", "met", "with", "the", "FDA", "to", "discuss", "the", "TNX-102", "gelcap", "development", "program", "in", "August", "2011", "and", "we", "have", "generated", "clinical", "data", "that", "support", "the", "further", "development", "of", "TNX-102", "gelcap,", "we", "currently", "do", "not", "plan", "to", "advance", "this", "candidate."], "wordsB": ["While", "we", "expect", "to", "pursue", "the", "development", "of", "TNX-301", "under", "Section", "505(b)(2),", "we", "have", "not", "yet", "discussed", "this", "candidate", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p67_s0", "idA": "1430306_13_item1_p61_s0", "sentA": "TNX-102 SL, our most advanced product candidate, is a rapidly disintegrating tablet containing VLD CBP that is designed to be placed under the tongue at bedtime.", "sentB": "TNX-102 SL, our lead product candidate, is a rapidly disintegrating tablet containing CBP that is designed to be placed under the tongue at bedtime.", "type": 2, "words": ["<tag1>", "TNX-102", "SL,", "our", "most", "advanced", "product", "candidate,", "is", "a", "rapidly", "disintegrating", "tablet", "containing", "VLD", "CBP", "that", "is", "designed", "to", "be", "placed", "under", "the", "tongue", "at", "bedtime.", "<tag2>", "TNX-102", "SL,", "our", "lead", "product", "candidate,", "is", "a", "rapidly", "disintegrating", "tablet", "containing", "CBP", "that", "is", "designed", "to", "be", "placed", "under", "the", "tongue", "at", "bedtime.", "<tag3>"], "wordsA": ["TNX-102", "SL,", "our", "most", "advanced", "product", "candidate,", "is", "a", "rapidly", "disintegrating", "tablet", "containing", "VLD", "CBP", "that", "is", "designed", "to", "be", "placed", "under", "the", "tongue", "at", "bedtime."], "wordsB": ["TNX-102", "SL,", "our", "lead", "product", "candidate,", "is", "a", "rapidly", "disintegrating", "tablet", "containing", "CBP", "that", "is", "designed", "to", "be", "placed", "under", "the", "tongue", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p67_s1", "idA": "1430306_13_item1_p61_s1", "sentA": "The development of TNX-102 SL in FM is supported by the results of the Moldofsky Study, which evaluated oral administration of CBP at doses below the lowest marketed dose in the evening, as well as by preclinical and comparative clinical pharmacokinetic studies.", "sentB": "The development of TNX-102 SL in FM is supported by the results of the Moldofsky Study, which evaluated oral administration of TNX-102 capsules in the evening, as well as by preclinical and comparative clinical pharmacokinetic studies.", "type": 2, "words": ["<tag1>", "The", "development", "of", "TNX-102", "SL", "in", "FM", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study,", "which", "evaluated", "oral", "administration", "of", "CBP", "at", "doses", "below", "the", "lowest", "marketed", "dose", "in", "the", "evening,", "as", "well", "as", "by", "preclinical", "and", "comparative", "clinical", "pharmacokinetic", "studies.", "<tag2>", "The", "development", "of", "TNX-102", "SL", "in", "FM", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study,", "which", "evaluated", "oral", "administration", "of", "TNX-102", "capsules", "in", "the", "evening,", "as", "well", "as", "by", "preclinical", "and", "comparative", "clinical", "pharmacokinetic", "studies.", "<tag3>"], "wordsA": ["The", "development", "of", "TNX-102", "SL", "in", "FM", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study,", "which", "evaluated", "oral", "administration", "of", "CBP", "at", "doses", "below", "the", "lowest", "marketed", "dose", "in", "the", "evening,", "as", "well", "as", "by", "preclinical", "and", "comparative", "clinical", "pharmacokinetic", "studies."], "wordsB": ["The", "development", "of", "TNX-102", "SL", "in", "FM", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study,", "which", "evaluated", "oral", "administration", "of", "TNX-102", "capsules", "in", "the", "evening,", "as", "well", "as", "by", "preclinical", "and", "comparative", "clinical", "pharmacokinetic", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p27_s2", "idA": "1430306_13_item1_p62_s0", "sentA": "In the Moldofsky Study, which was a randomized, double-blind, placebo-controlled, Phase 2a trial, it was demonstrated that VLD CBP in a capsule swallowed between dinner and bedtime resulted in significant decreases in next-day pain and other core FM symptoms, as well as in a significant improvement in sleep quality.", "sentB": "Our therapeutic strategy is supported by results from a randomized, double-blind, placebo-controlled Phase 2a study of low dose TNX-102 immediate release capsules, or TNX-102 capsules, which we have also referred to as VLD CBP, taken between dinner and bedtime in 36 subjects with FM, which demonstrated a significant decrease in pain and other symptoms after eight weeks of treatment.", "type": 2, "words": ["<tag1>", "In", "the", "Moldofsky", "Study,", "which", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "Phase", "2a", "trial,", "it", "was", "demonstrated", "that", "VLD", "CBP", "in", "a", "capsule", "swallowed", "between", "dinner", "and", "bedtime", "resulted", "in", "significant", "decreases", "in", "next-day", "pain", "and", "other", "core", "FM", "symptoms,", "as", "well", "as", "in", "a", "significant", "improvement", "in", "sleep", "quality.", "<tag2>", "Our", "therapeutic", "strategy", "is", "supported", "by", "results", "from", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2a", "study", "of", "low", "dose", "TNX-102", "immediate", "release", "capsules,", "or", "TNX-102", "capsules,", "which", "we", "have", "also", "referred", "to", "as", "VLD", "CBP,", "taken", "between", "dinner", "and", "bedtime", "in", "36", "subjects", "with", "FM,", "which", "demonstrated", "a", "significant", "decrease", "in", "pain", "and", "other", "symptoms", "after", "eight", "weeks", "of", "treatment.", "<tag3>"], "wordsA": ["In", "the", "Moldofsky", "Study,", "which", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "Phase", "2a", "trial,", "it", "was", "demonstrated", "that", "VLD", "CBP", "in", "a", "capsule", "swallowed", "between", "dinner", "and", "bedtime", "resulted", "in", "significant", "decreases", "in", "next-day", "pain", "and", "other", "core", "FM", "symptoms,", "as", "well", "as", "in", "a", "significant", "improvement", "in", "sleep", "quality."], "wordsB": ["Our", "therapeutic", "strategy", "is", "supported", "by", "results", "from", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2a", "study", "of", "low", "dose", "TNX-102", "immediate", "release", "capsules,", "or", "TNX-102", "capsules,", "which", "we", "have", "also", "referred", "to", "as", "VLD", "CBP,", "taken", "between", "dinner", "and", "bedtime", "in", "36", "subjects", "with", "FM,", "which", "demonstrated", "a", "significant", "decrease", "in", "pain", "and", "other", "symptoms", "after", "eight", "weeks", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p68_s0", "idA": "1430306_13_item1_p62_s0", "sentA": "In the Moldofsky Study, which was a randomized, double-blind, placebo-controlled, Phase 2a trial, it was demonstrated that VLD CBP in a capsule swallowed between dinner and bedtime resulted in significant decreases in next-day pain and other core FM symptoms, as well as in a significant improvement in sleep quality.", "sentB": "In the Moldofsky Study, which was a randomized, double-blind, placebo-controlled, Phase 2a trial, it was demonstrated that TNX-102 capsules, swallowed between dinner and bedtime, resulted in significant decreases in next-day pain and other core FM symptoms after eight weeks of treatment, as well as in a significant improvement in sleep quality.", "type": 2, "words": ["<tag1>", "In", "the", "Moldofsky", "Study,", "which", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "Phase", "2a", "trial,", "it", "was", "demonstrated", "that", "VLD", "CBP", "in", "a", "capsule", "swallowed", "between", "dinner", "and", "bedtime", "resulted", "in", "significant", "decreases", "in", "next-day", "pain", "and", "other", "core", "FM", "symptoms,", "as", "well", "as", "in", "a", "significant", "improvement", "in", "sleep", "quality.", "<tag2>", "In", "the", "Moldofsky", "Study,", "which", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "Phase", "2a", "trial,", "it", "was", "demonstrated", "that", "TNX-102", "capsules,", "swallowed", "between", "dinner", "and", "bedtime,", "resulted", "in", "significant", "decreases", "in", "next-day", "pain", "and", "other", "core", "FM", "symptoms", "after", "eight", "weeks", "of", "treatment,", "as", "well", "as", "in", "a", "significant", "improvement", "in", "sleep", "quality.", "<tag3>"], "wordsA": ["In", "the", "Moldofsky", "Study,", "which", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "Phase", "2a", "trial,", "it", "was", "demonstrated", "that", "VLD", "CBP", "in", "a", "capsule", "swallowed", "between", "dinner", "and", "bedtime", "resulted", "in", "significant", "decreases", "in", "next-day", "pain", "and", "other", "core", "FM", "symptoms,", "as", "well", "as", "in", "a", "significant", "improvement", "in", "sleep", "quality."], "wordsB": ["In", "the", "Moldofsky", "Study,", "which", "was", "a", "randomized,", "double-blind,", "placebo-controlled,", "Phase", "2a", "trial,", "it", "was", "demonstrated", "that", "TNX-102", "capsules,", "swallowed", "between", "dinner", "and", "bedtime,", "resulted", "in", "significant", "decreases", "in", "next-day", "pain", "and", "other", "core", "FM", "symptoms", "after", "eight", "weeks", "of", "treatment,", "as", "well", "as", "in", "a", "significant", "improvement", "in", "sleep", "quality."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p124_s0", "idA": "1430306_13_item1_p62_s2", "sentA": "Current CBP products are believed to be widely used off-label by FM patients.", "sentB": "An important goal of FM treatment is to reduce the dependence on opiate analgesic as well as on benzodiazepine and non-benzodiazepine sedative-hypnotic medications by FM patients.", "type": 2, "words": ["<tag1>", "Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients.", "<tag2>", "An", "important", "goal", "of", "FM", "treatment", "is", "to", "reduce", "the", "dependence", "on", "opiate", "analgesic", "as", "well", "as", "on", "benzodiazepine", "and", "non-benzodiazepine", "sedative-hypnotic", "medications", "by", "FM", "patients.", "<tag3>"], "wordsA": ["Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients."], "wordsB": ["An", "important", "goal", "of", "FM", "treatment", "is", "to", "reduce", "the", "dependence", "on", "opiate", "analgesic", "as", "well", "as", "on", "benzodiazepine", "and", "non-benzodiazepine", "sedative-hypnotic", "medications", "by", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p31_s0", "idA": "1430306_13_item1_p62_s2", "sentA": "Current CBP products are believed to be widely used off-label by FM patients.", "sentB": "Although the disordered brain processes that underlie FM are yet to be fully understood, the mechanisms of drugs that treat central pain are believed to target certain aspects of nerve signaling.", "type": 2, "words": ["<tag1>", "Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients.", "<tag2>", "Although", "the", "disordered", "brain", "processes", "that", "underlie", "FM", "are", "yet", "to", "be", "fully", "understood,", "the", "mechanisms", "of", "drugs", "that", "treat", "central", "pain", "are", "believed", "to", "target", "certain", "aspects", "of", "nerve", "signaling.", "<tag3>"], "wordsA": ["Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients."], "wordsB": ["Although", "the", "disordered", "brain", "processes", "that", "underlie", "FM", "are", "yet", "to", "be", "fully", "understood,", "the", "mechanisms", "of", "drugs", "that", "treat", "central", "pain", "are", "believed", "to", "target", "certain", "aspects", "of", "nerve", "signaling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p35_s0", "idA": "1430306_13_item1_p62_s2", "sentA": "Current CBP products are believed to be widely used off-label by FM patients.", "sentB": "An important goal of FM treatment is to reduce the dependence on opiate analgesic as well as on benzodiazepine and non-benzodiazepine sedative-hypnotic medications by FM patients.", "type": 2, "words": ["<tag1>", "Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients.", "<tag2>", "An", "important", "goal", "of", "FM", "treatment", "is", "to", "reduce", "the", "dependence", "on", "opiate", "analgesic", "as", "well", "as", "on", "benzodiazepine", "and", "non-benzodiazepine", "sedative-hypnotic", "medications", "by", "FM", "patients.", "<tag3>"], "wordsA": ["Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients."], "wordsB": ["An", "important", "goal", "of", "FM", "treatment", "is", "to", "reduce", "the", "dependence", "on", "opiate", "analgesic", "as", "well", "as", "on", "benzodiazepine", "and", "non-benzodiazepine", "sedative-hypnotic", "medications", "by", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p69_s1", "idA": "1430306_13_item1_p64_s0", "sentA": "In 2007, Pfizer s Lyrica (pregabalin) became the first medicine approved by the FDA for the management of FM.", "sentB": "In 2007, Pfizer s Lyrica became the first medicine approved by the FDA for the management of FM.", "type": 2, "words": ["<tag1>", "In", "2007,", "Pfizer", "s", "Lyrica", "(pregabalin)", "became", "the", "first", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "In", "2007,", "Pfizer", "s", "Lyrica", "became", "the", "first", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["In", "2007,", "Pfizer", "s", "Lyrica", "(pregabalin)", "became", "the", "first", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["In", "2007,", "Pfizer", "s", "Lyrica", "became", "the", "first", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p69_s2", "idA": "1430306_13_item1_p64_s1", "sentA": "In 2008, Eli Lilly s Cymbalta (duloxetine) became the second medicine approved by the FDA for the management of FM.", "sentB": "In 2008, Eli Lilly s Cymbalta became the second medicine approved by the FDA for the management of FM.", "type": 2, "words": ["<tag1>", "In", "2008,", "Eli", "Lilly", "s", "Cymbalta", "(duloxetine)", "became", "the", "second", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "In", "2008,", "Eli", "Lilly", "s", "Cymbalta", "became", "the", "second", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["In", "2008,", "Eli", "Lilly", "s", "Cymbalta", "(duloxetine)", "became", "the", "second", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["In", "2008,", "Eli", "Lilly", "s", "Cymbalta", "became", "the", "second", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p69_s3", "idA": "1430306_13_item1_p64_s2", "sentA": "In 2009, Savella (milnacipran) was the third medicine approved by the FDA for the management of FM.", "sentB": "In 2009, Savella was the third medicine approved by the FDA for the management of FM.", "type": 2, "words": ["<tag1>", "In", "2009,", "Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "In", "2009,", "Savella", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["In", "2009,", "Savella", "(milnacipran)", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["In", "2009,", "Savella", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p71_s1", "idA": "1430306_13_item1_p66_s1", "sentA": "The study subjects met ACR criteria for FM.", "sentB": "The study randomized 36 subjects, all of whom met ACR criteria for FM.", "type": 2, "words": ["<tag1>", "The", "study", "subjects", "met", "ACR", "criteria", "for", "FM.", "<tag2>", "The", "study", "randomized", "36", "subjects,", "all", "of", "whom", "met", "ACR", "criteria", "for", "FM.", "<tag3>"], "wordsA": ["The", "study", "subjects", "met", "ACR", "criteria", "for", "FM."], "wordsB": ["The", "study", "randomized", "36", "subjects,", "all", "of", "whom", "met", "ACR", "criteria", "for", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p72_s0", "idA": "1430306_13_item1_p67_s0", "sentA": "Patients received VLD CBP IR 1 mg capsules or corresponding placebo capsules to ingest after dinner and before bedtime.", "sentB": "Patients received TNX-102 capsules or placebo to ingest after dinner and before bedtime.", "type": 2, "words": ["<tag1>", "Patients", "received", "VLD", "CBP", "IR", "1", "mg", "capsules", "or", "corresponding", "placebo", "capsules", "to", "ingest", "after", "dinner", "and", "before", "bedtime.", "<tag2>", "Patients", "received", "TNX-102", "capsules", "or", "placebo", "to", "ingest", "after", "dinner", "and", "before", "bedtime.", "<tag3>"], "wordsA": ["Patients", "received", "VLD", "CBP", "IR", "1", "mg", "capsules", "or", "corresponding", "placebo", "capsules", "to", "ingest", "after", "dinner", "and", "before", "bedtime."], "wordsB": ["Patients", "received", "TNX-102", "capsules", "or", "placebo", "to", "ingest", "after", "dinner", "and", "before", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p72_s2", "idA": "1430306_13_item1_p67_s1", "sentA": "Initially, patients took one capsule each evening, but over the course of the study, they were allowed to increase the number of capsules taken in increments of one capsule per week.", "sentB": "Initially, patients took one capsule each evening, but over the course of the study, they were allowed to increase the number of capsules taken, up to four per evening.", "type": 2, "words": ["<tag1>", "Initially,", "patients", "took", "one", "capsule", "each", "evening,", "but", "over", "the", "course", "of", "the", "study,", "they", "were", "allowed", "to", "increase", "the", "number", "of", "capsules", "taken", "in", "increments", "of", "one", "capsule", "per", "week.", "<tag2>", "Initially,", "patients", "took", "one", "capsule", "each", "evening,", "but", "over", "the", "course", "of", "the", "study,", "they", "were", "allowed", "to", "increase", "the", "number", "of", "capsules", "taken,", "up", "to", "four", "per", "evening.", "<tag3>"], "wordsA": ["Initially,", "patients", "took", "one", "capsule", "each", "evening,", "but", "over", "the", "course", "of", "the", "study,", "they", "were", "allowed", "to", "increase", "the", "number", "of", "capsules", "taken", "in", "increments", "of", "one", "capsule", "per", "week."], "wordsB": ["Initially,", "patients", "took", "one", "capsule", "each", "evening,", "but", "over", "the", "course", "of", "the", "study,", "they", "were", "allowed", "to", "increase", "the", "number", "of", "capsules", "taken,", "up", "to", "four", "per", "evening."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p73_s0", "idA": "1430306_13_item1_p68_s0", "sentA": "Patients treated with VLD CBP demonstrated significant improvements in pain, fatigue and tenderness at week 8 relative to baseline, whereas placebo-treated patients did not improve (Figure 1).", "sentB": "At week eight, patients treated with TNX-102 capsules demonstrated significant improvements in pain, fatigue and tenderness relative to baseline, whereas placebo-treated patients did not improve.", "type": 2, "words": ["<tag1>", "Patients", "treated", "with", "VLD", "CBP", "demonstrated", "significant", "improvements", "in", "pain,", "fatigue", "and", "tenderness", "at", "week", "8", "relative", "to", "baseline,", "whereas", "placebo-treated", "patients", "did", "not", "improve", "(Figure", "1).", "<tag2>", "At", "week", "eight,", "patients", "treated", "with", "TNX-102", "capsules", "demonstrated", "significant", "improvements", "in", "pain,", "fatigue", "and", "tenderness", "relative", "to", "baseline,", "whereas", "placebo-treated", "patients", "did", "not", "improve.", "<tag3>"], "wordsA": ["Patients", "treated", "with", "VLD", "CBP", "demonstrated", "significant", "improvements", "in", "pain,", "fatigue", "and", "tenderness", "at", "week", "8", "relative", "to", "baseline,", "whereas", "placebo-treated", "patients", "did", "not", "improve", "(Figure", "1)."], "wordsB": ["At", "week", "eight,", "patients", "treated", "with", "TNX-102", "capsules", "demonstrated", "significant", "improvements", "in", "pain,", "fatigue", "and", "tenderness", "relative", "to", "baseline,", "whereas", "placebo-treated", "patients", "did", "not", "improve."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p73_s2", "idA": "1430306_13_item1_p69_s0", "sentA": "VLD CBP treatment resulted in significant reductions in total Hospital Anxiety and Depression Scale, or HAD, which measures symptoms of anxiety and depression, and the HAD depression subscale which measures depressive symptoms (Figure 1).", "sentB": "Relative to baseline, treatment with TNX-102 capsules also resulted in a significant reduction in total Hospital Anxiety and Depression Scale score, which measures symptoms of anxiety and depression, and the HAD depression subscore which measures depressive symptoms.", "type": 2, "words": ["<tag1>", "VLD", "CBP", "treatment", "resulted", "in", "significant", "reductions", "in", "total", "Hospital", "Anxiety", "and", "Depression", "Scale,", "or", "HAD,", "which", "measures", "symptoms", "of", "anxiety", "and", "depression,", "and", "the", "HAD", "depression", "subscale", "which", "measures", "depressive", "symptoms", "(Figure", "1).", "<tag2>", "Relative", "to", "baseline,", "treatment", "with", "TNX-102", "capsules", "also", "resulted", "in", "a", "significant", "reduction", "in", "total", "Hospital", "Anxiety", "and", "Depression", "Scale", "score,", "which", "measures", "symptoms", "of", "anxiety", "and", "depression,", "and", "the", "HAD", "depression", "subscore", "which", "measures", "depressive", "symptoms.", "<tag3>"], "wordsA": ["VLD", "CBP", "treatment", "resulted", "in", "significant", "reductions", "in", "total", "Hospital", "Anxiety", "and", "Depression", "Scale,", "or", "HAD,", "which", "measures", "symptoms", "of", "anxiety", "and", "depression,", "and", "the", "HAD", "depression", "subscale", "which", "measures", "depressive", "symptoms", "(Figure", "1)."], "wordsB": ["Relative", "to", "baseline,", "treatment", "with", "TNX-102", "capsules", "also", "resulted", "in", "a", "significant", "reduction", "in", "total", "Hospital", "Anxiety", "and", "Depression", "Scale", "score,", "which", "measures", "symptoms", "of", "anxiety", "and", "depression,", "and", "the", "HAD", "depression", "subscore", "which", "measures", "depressive", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p6_s0", "idA": "1430306_13_item1_p6_s0", "sentA": "Upon completion of the Share Exchange, the Tonix Shareholders received an aggregate of 22,666,667 shares of our Common Stock.", "sentB": "Upon completion of the Share Exchange, the Tonix Shareholders received an aggregate of 1,133,334 shares of our common stock.", "type": 2, "words": ["<tag1>", "Upon", "completion", "of", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "received", "an", "aggregate", "of", "22,666,667", "shares", "of", "our", "Common", "Stock.", "<tag2>", "Upon", "completion", "of", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "received", "an", "aggregate", "of", "1,133,334", "shares", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["Upon", "completion", "of", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "received", "an", "aggregate", "of", "22,666,667", "shares", "of", "our", "Common", "Stock."], "wordsB": ["Upon", "completion", "of", "the", "Share", "Exchange,", "the", "Tonix", "Shareholders", "received", "an", "aggregate", "of", "1,133,334", "shares", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p6_s1", "idA": "1430306_13_item1_p6_s1", "sentA": "Moss returned 1,500,000 shares of Common Stock to us, which were retired, and our existing stockholders retained 4,000,000 shares of Common Stock.", "sentB": "75,000 shares of common stock were returned to us from the prior officer, which were retired, and our existing shareholders retained 200,000 shares of common stock.", "type": 2, "words": ["<tag1>", "Moss", "returned", "1,500,000", "shares", "of", "Common", "Stock", "to", "us,", "which", "were", "retired,", "and", "our", "existing", "stockholders", "retained", "4,000,000", "shares", "of", "Common", "Stock.", "<tag2>", "75,000", "shares", "of", "common", "stock", "were", "returned", "to", "us", "from", "the", "prior", "officer,", "which", "were", "retired,", "and", "our", "existing", "shareholders", "retained", "200,000", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["Moss", "returned", "1,500,000", "shares", "of", "Common", "Stock", "to", "us,", "which", "were", "retired,", "and", "our", "existing", "stockholders", "retained", "4,000,000", "shares", "of", "Common", "Stock."], "wordsB": ["75,000", "shares", "of", "common", "stock", "were", "returned", "to", "us", "from", "the", "prior", "officer,", "which", "were", "retired,", "and", "our", "existing", "shareholders", "retained", "200,000", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p6_s2", "idA": "1430306_13_item1_p6_s2", "sentA": "The 22,666,667 shares issued to the Tonix Shareholders constituted approximately 85% of our 26,666,667 issued and outstanding shares of Common Stock post-Closing.", "sentB": "The 1,133,334 shares issued to the Tonix Shareholders constituted approximately 85% of our 1,333,334 issued and outstanding shares of common stock immediately after the consummation of the Share Exchange.", "type": 2, "words": ["<tag1>", "The", "22,666,667", "shares", "issued", "to", "the", "Tonix", "Shareholders", "constituted", "approximately", "85%", "of", "our", "26,666,667", "issued", "and", "outstanding", "shares", "of", "Common", "Stock", "post-Closing.", "<tag2>", "The", "1,133,334", "shares", "issued", "to", "the", "Tonix", "Shareholders", "constituted", "approximately", "85%", "of", "our", "1,333,334", "issued", "and", "outstanding", "shares", "of", "common", "stock", "immediately", "after", "the", "consummation", "of", "the", "Share", "Exchange.", "<tag3>"], "wordsA": ["The", "22,666,667", "shares", "issued", "to", "the", "Tonix", "Shareholders", "constituted", "approximately", "85%", "of", "our", "26,666,667", "issued", "and", "outstanding", "shares", "of", "Common", "Stock", "post-Closing."], "wordsB": ["The", "1,133,334", "shares", "issued", "to", "the", "Tonix", "Shareholders", "constituted", "approximately", "85%", "of", "our", "1,333,334", "issued", "and", "outstanding", "shares", "of", "common", "stock", "immediately", "after", "the", "consummation", "of", "the", "Share", "Exchange."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p75_s0", "idA": "1430306_13_item1_p70_s0", "sentA": "This study showed treatment with VLD CBP:", "sentB": "As illustrated in Figure 1, this study showed that treatment with TNX-102 capsules as compared to treatment with placebo:", "type": 2, "words": ["<tag1>", "This", "study", "showed", "treatment", "with", "VLD", "CBP:", "<tag2>", "As", "illustrated", "in", "Figure", "1,", "this", "study", "showed", "that", "treatment", "with", "TNX-102", "capsules", "as", "compared", "to", "treatment", "with", "placebo:", "<tag3>"], "wordsA": ["This", "study", "showed", "treatment", "with", "VLD", "CBP:"], "wordsB": ["As", "illustrated", "in", "Figure", "1,", "this", "study", "showed", "that", "treatment", "with", "TNX-102", "capsules", "as", "compared", "to", "treatment", "with", "placebo:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p78_s0", "idA": "1430306_13_item1_p71_s0", "sentA": "was well tolerated, with no serious adverse events, or SAEs, or discontinuations due to adverse events, or AEs.", "sentB": "In this study, TNX-102 capsules were well tolerated, with no serious adverse events or discontinuations due to adverse events.", "type": 2, "words": ["<tag1>", "was", "well", "tolerated,", "with", "no", "serious", "adverse", "events,", "or", "SAEs,", "or", "discontinuations", "due", "to", "adverse", "events,", "or", "AEs.", "<tag2>", "In", "this", "study,", "TNX-102", "capsules", "were", "well", "tolerated,", "with", "no", "serious", "adverse", "events", "or", "discontinuations", "due", "to", "adverse", "events.", "<tag3>"], "wordsA": ["was", "well", "tolerated,", "with", "no", "serious", "adverse", "events,", "or", "SAEs,", "or", "discontinuations", "due", "to", "adverse", "events,", "or", "AEs."], "wordsB": ["In", "this", "study,", "TNX-102", "capsules", "were", "well", "tolerated,", "with", "no", "serious", "adverse", "events", "or", "discontinuations", "due", "to", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p27_s3", "idA": "1430306_13_item1_p72_s0", "sentA": "This study also showed that VLD CBP taken between dinner and bedtime resulted in a significant improvement in sleep quality.", "sentB": "This study also demonstrated that TNX-102 capsules led to a significant improvement in objective measures of sleep quality, which we believe relates to the mechanism by which CBP leads to improvement of FM symptoms.", "type": 2, "words": ["<tag1>", "This", "study", "also", "showed", "that", "VLD", "CBP", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "sleep", "quality.", "<tag2>", "This", "study", "also", "demonstrated", "that", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms.", "<tag3>"], "wordsA": ["This", "study", "also", "showed", "that", "VLD", "CBP", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "sleep", "quality."], "wordsB": ["This", "study", "also", "demonstrated", "that", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p74_s0", "idA": "1430306_13_item1_p72_s0", "sentA": "This study also showed that VLD CBP taken between dinner and bedtime resulted in a significant improvement in sleep quality.", "sentB": "Figure 1: Results of a Phase 2a Study of TNX-102 capsules in FM patients as administered between dinner and bedtime.", "type": 2, "words": ["<tag1>", "This", "study", "also", "showed", "that", "VLD", "CBP", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "sleep", "quality.", "<tag2>", "Figure", "1:", "Results", "of", "a", "Phase", "2a", "Study", "of", "TNX-102", "capsules", "in", "FM", "patients", "as", "administered", "between", "dinner", "and", "bedtime.", "<tag3>"], "wordsA": ["This", "study", "also", "showed", "that", "VLD", "CBP", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "sleep", "quality."], "wordsB": ["Figure", "1:", "Results", "of", "a", "Phase", "2a", "Study", "of", "TNX-102", "capsules", "in", "FM", "patients", "as", "administered", "between", "dinner", "and", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p77_s0", "idA": "1430306_13_item1_p72_s0", "sentA": "This study also showed that VLD CBP taken between dinner and bedtime resulted in a significant improvement in sleep quality.", "sentB": "This study also showed that TNX-102 capsules taken between dinner and bedtime resulted in a significant improvement in objective measures of sleep quality.", "type": 2, "words": ["<tag1>", "This", "study", "also", "showed", "that", "VLD", "CBP", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "sleep", "quality.", "<tag2>", "This", "study", "also", "showed", "that", "TNX-102", "capsules", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality.", "<tag3>"], "wordsA": ["This", "study", "also", "showed", "that", "VLD", "CBP", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "sleep", "quality."], "wordsB": ["This", "study", "also", "showed", "that", "TNX-102", "capsules", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p80_s0", "idA": "1430306_13_item1_p74_s0", "sentA": "We have conducted two preclinical and two clinical studies of our sublingual formulations of CBP, which have evaluated the pharmacokinetics of these formulations as well as their bioequivalence to oral CBP.", "sentB": "We have conducted preclinical and clinical studies of our sublingual formulations of CBP, which have evaluated the pharmacokinetics of these formulations as well as their comparative bioavailability to oral CBP.", "type": 2, "words": ["<tag1>", "We", "have", "conducted", "two", "preclinical", "and", "two", "clinical", "studies", "of", "our", "sublingual", "formulations", "of", "CBP,", "which", "have", "evaluated", "the", "pharmacokinetics", "of", "these", "formulations", "as", "well", "as", "their", "bioequivalence", "to", "oral", "CBP.", "<tag2>", "We", "have", "conducted", "preclinical", "and", "clinical", "studies", "of", "our", "sublingual", "formulations", "of", "CBP,", "which", "have", "evaluated", "the", "pharmacokinetics", "of", "these", "formulations", "as", "well", "as", "their", "comparative", "bioavailability", "to", "oral", "CBP.", "<tag3>"], "wordsA": ["We", "have", "conducted", "two", "preclinical", "and", "two", "clinical", "studies", "of", "our", "sublingual", "formulations", "of", "CBP,", "which", "have", "evaluated", "the", "pharmacokinetics", "of", "these", "formulations", "as", "well", "as", "their", "bioequivalence", "to", "oral", "CBP."], "wordsB": ["We", "have", "conducted", "preclinical", "and", "clinical", "studies", "of", "our", "sublingual", "formulations", "of", "CBP,", "which", "have", "evaluated", "the", "pharmacokinetics", "of", "these", "formulations", "as", "well", "as", "their", "comparative", "bioavailability", "to", "oral", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p81_s0", "idA": "1430306_13_item1_p75_s0", "sentA": "Our preclinical animal studies demonstrated that our sublingual formulations provide faster delivery and more efficient systemic absorption of CBP as compared to current oral forms of the drug.", "sentB": "Our preclinical and clinical studies demonstrated that our sublingual formulations provide faster delivery and more efficient systemic absorption of CBP as compared to current oral forms of the drug.", "type": 2, "words": ["<tag1>", "Our", "preclinical", "animal", "studies", "demonstrated", "that", "our", "sublingual", "formulations", "provide", "faster", "delivery", "and", "more", "efficient", "systemic", "absorption", "of", "CBP", "as", "compared", "to", "current", "oral", "forms", "of", "the", "drug.", "<tag2>", "Our", "preclinical", "and", "clinical", "studies", "demonstrated", "that", "our", "sublingual", "formulations", "provide", "faster", "delivery", "and", "more", "efficient", "systemic", "absorption", "of", "CBP", "as", "compared", "to", "current", "oral", "forms", "of", "the", "drug.", "<tag3>"], "wordsA": ["Our", "preclinical", "animal", "studies", "demonstrated", "that", "our", "sublingual", "formulations", "provide", "faster", "delivery", "and", "more", "efficient", "systemic", "absorption", "of", "CBP", "as", "compared", "to", "current", "oral", "forms", "of", "the", "drug."], "wordsB": ["Our", "preclinical", "and", "clinical", "studies", "demonstrated", "that", "our", "sublingual", "formulations", "provide", "faster", "delivery", "and", "more", "efficient", "systemic", "absorption", "of", "CBP", "as", "compared", "to", "current", "oral", "forms", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p19_s0", "idA": "1430306_13_item1_p77_s1", "sentA": "This study was conducted in Canada.", "sentB": "On April 23, 2013, we formed Tonix Canada.", "type": 2, "words": ["<tag1>", "This", "study", "was", "conducted", "in", "Canada.", "<tag2>", "On", "April", "23,", "2013,", "we", "formed", "Tonix", "Canada.", "<tag3>"], "wordsA": ["This", "study", "was", "conducted", "in", "Canada."], "wordsB": ["On", "April", "23,", "2013,", "we", "formed", "Tonix", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p19_s1", "idA": "1430306_13_item1_p77_s1", "sentA": "This study was conducted in Canada.", "sentB": "Tonix Canada is intended to perform research and development efforts in Canada.", "type": 2, "words": ["<tag1>", "This", "study", "was", "conducted", "in", "Canada.", "<tag2>", "Tonix", "Canada", "is", "intended", "to", "perform", "research", "and", "development", "efforts", "in", "Canada.", "<tag3>"], "wordsA": ["This", "study", "was", "conducted", "in", "Canada."], "wordsB": ["Tonix", "Canada", "is", "intended", "to", "perform", "research", "and", "development", "efforts", "in", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p19_s2", "idA": "1430306_13_item1_p77_s1", "sentA": "This study was conducted in Canada.", "sentB": "As a Canadian entity, we expect Tonix Canada will be entitled to receive certain reimbursable tax credits for research expenditures in Canada.", "type": 2, "words": ["<tag1>", "This", "study", "was", "conducted", "in", "Canada.", "<tag2>", "As", "a", "Canadian", "entity,", "we", "expect", "Tonix", "Canada", "will", "be", "entitled", "to", "receive", "certain", "reimbursable", "tax", "credits", "for", "research", "expenditures", "in", "Canada.", "<tag3>"], "wordsA": ["This", "study", "was", "conducted", "in", "Canada."], "wordsB": ["As", "a", "Canadian", "entity,", "we", "expect", "Tonix", "Canada", "will", "be", "entitled", "to", "receive", "certain", "reimbursable", "tax", "credits", "for", "research", "expenditures", "in", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p82_s0", "idA": "1430306_13_item1_p77_s5", "sentA": "In the study, TNX-102 SL was generally well tolerated.", "sentB": "In three Phase I comparative pharmacokinetic and bioavailability studies, TNX-102 SL was generally well tolerated.", "type": 2, "words": ["<tag1>", "In", "the", "study,", "TNX-102", "SL", "was", "generally", "well", "tolerated.", "<tag2>", "In", "three", "Phase", "I", "comparative", "pharmacokinetic", "and", "bioavailability", "studies,", "TNX-102", "SL", "was", "generally", "well", "tolerated.", "<tag3>"], "wordsA": ["In", "the", "study,", "TNX-102", "SL", "was", "generally", "well", "tolerated."], "wordsB": ["In", "three", "Phase", "I", "comparative", "pharmacokinetic", "and", "bioavailability", "studies,", "TNX-102", "SL", "was", "generally", "well", "tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p188_s2", "idA": "1430306_13_item1_p78_s0", "sentA": "We expect to advance the clinical development of TNX-102 SL, containing 2.8 mg CBP, for the management of FM by conducting a Phase 2b study.", "sentB": "Although the clinical development of TNX-201 can be accelerated due to existing marketing experience, we expect to file a Section 505(b)(1) NDA for TNX-201 and for certain other products.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "advance", "the", "clinical", "development", "of", "TNX-102", "SL,", "containing", "2.8", "mg", "CBP,", "for", "the", "management", "of", "FM", "by", "conducting", "a", "Phase", "2b", "study.", "<tag2>", "Although", "the", "clinical", "development", "of", "TNX-201", "can", "be", "accelerated", "due", "to", "existing", "marketing", "experience,", "we", "expect", "to", "file", "a", "Section", "505(b)(1)", "NDA", "for", "TNX-201", "and", "for", "certain", "other", "products.", "<tag3>"], "wordsA": ["We", "expect", "to", "advance", "the", "clinical", "development", "of", "TNX-102", "SL,", "containing", "2.8", "mg", "CBP,", "for", "the", "management", "of", "FM", "by", "conducting", "a", "Phase", "2b", "study."], "wordsB": ["Although", "the", "clinical", "development", "of", "TNX-201", "can", "be", "accelerated", "due", "to", "existing", "marketing", "experience,", "we", "expect", "to", "file", "a", "Section", "505(b)(1)", "NDA", "for", "TNX-201", "and", "for", "certain", "other", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p37_s1", "idA": "1430306_13_item1_p78_s1", "sentA": "In this multicenter, randomized, double-blind, placebo-controlled clinical trial, FM patients will be administered either TNX-102 SL or placebo at bedtime nightly for 12 weeks.", "sentB": "In this multicenter clinical trial, subjects with FM are treated with either TNX-102 2.8 mg sublingual tablets (SL) or a placebo at bedtime daily for 12 weeks.", "type": 2, "words": ["<tag1>", "In", "this", "multicenter,", "randomized,", "double-blind,", "placebo-controlled", "clinical", "trial,", "FM", "patients", "will", "be", "administered", "either", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks.", "<tag2>", "In", "this", "multicenter", "clinical", "trial,", "subjects", "with", "FM", "are", "treated", "with", "either", "TNX-102", "2.8", "mg", "sublingual", "tablets", "(SL)", "or", "a", "placebo", "at", "bedtime", "daily", "for", "12", "weeks.", "<tag3>"], "wordsA": ["In", "this", "multicenter,", "randomized,", "double-blind,", "placebo-controlled", "clinical", "trial,", "FM", "patients", "will", "be", "administered", "either", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks."], "wordsB": ["In", "this", "multicenter", "clinical", "trial,", "subjects", "with", "FM", "are", "treated", "with", "either", "TNX-102", "2.8", "mg", "sublingual", "tablets", "(SL)", "or", "a", "placebo", "at", "bedtime", "daily", "for", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p37_s2", "idA": "1430306_13_item1_p78_s2", "sentA": "We expect to enroll 100-200 patients into this study.", "sentB": "We expect to enroll approximately 200 patients into this study.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "enroll", "100-200", "patients", "into", "this", "study.", "<tag2>", "We", "expect", "to", "enroll", "approximately", "200", "patients", "into", "this", "study.", "<tag3>"], "wordsA": ["We", "expect", "to", "enroll", "100-200", "patients", "into", "this", "study."], "wordsB": ["We", "expect", "to", "enroll", "approximately", "200", "patients", "into", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p42_s6", "idA": "1430306_13_item1_p78_s3", "sentA": "We expect that our proposed Phase 2b study, if successful and accepted by the FDA, will be one of the two pivotal studies required to support the NDA approval.", "sentB": "Although the development of TNX-201 will be based on the available information on racemic IMH, the NDA approval will be required to conform with the 505(b)(1) NDA requirement.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "our", "proposed", "Phase", "2b", "study,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval.", "<tag2>", "Although", "the", "development", "of", "TNX-201", "will", "be", "based", "on", "the", "available", "information", "on", "racemic", "IMH,", "the", "NDA", "approval", "will", "be", "required", "to", "conform", "with", "the", "505(b)(1)", "NDA", "requirement.", "<tag3>"], "wordsA": ["We", "expect", "that", "our", "proposed", "Phase", "2b", "study,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval."], "wordsB": ["Although", "the", "development", "of", "TNX-201", "will", "be", "based", "on", "the", "available", "information", "on", "racemic", "IMH,", "the", "NDA", "approval", "will", "be", "required", "to", "conform", "with", "the", "505(b)(1)", "NDA", "requirement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p83_s2", "idA": "1430306_13_item1_p78_s3", "sentA": "We expect that our proposed Phase 2b study, if successful and accepted by the FDA, will be one of the two pivotal studies required to support the NDA approval.", "sentB": "We expect that our BESTFIT trial, if successful and accepted by the FDA, will be one of the two pivotal studies required to support the NDA approval.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "our", "proposed", "Phase", "2b", "study,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval.", "<tag2>", "We", "expect", "that", "our", "BESTFIT", "trial,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval.", "<tag3>"], "wordsA": ["We", "expect", "that", "our", "proposed", "Phase", "2b", "study,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval."], "wordsB": ["We", "expect", "that", "our", "BESTFIT", "trial,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p91_s1", "idA": "1430306_13_item1_p78_s3", "sentA": "We expect that our proposed Phase 2b study, if successful and accepted by the FDA, will be one of the two pivotal studies required to support the NDA approval.", "sentB": "Final PSP requirement will be determined at the time of NDA approval.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "our", "proposed", "Phase", "2b", "study,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval.", "<tag2>", "Final", "PSP", "requirement", "will", "be", "determined", "at", "the", "time", "of", "NDA", "approval.", "<tag3>"], "wordsA": ["We", "expect", "that", "our", "proposed", "Phase", "2b", "study,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval."], "wordsB": ["Final", "PSP", "requirement", "will", "be", "determined", "at", "the", "time", "of", "NDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p39_s0", "idA": "1430306_13_item1_p79_s0", "sentA": "We expect the primary efficacy measure in this study will be the change in pain severity at week 12 with TNX-102 SL as compared to placebo, as assessed by the Numeric Rating Scale, or NRS.", "sentB": "The primary efficacy measure in this study will be the change in pain severity at week 12 with TNX-102 SL as compared to placebo, as assessed by the Numeric Rating Scale, or NRS.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS.", "<tag2>", "The", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS.", "<tag3>"], "wordsA": ["We", "expect", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS."], "wordsB": ["The", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p39_s1", "idA": "1430306_13_item1_p79_s1", "sentA": "This endpoint is similar to that utilized by drug products currently approved for use in FM.", "sentB": "This endpoint is similar to that utilized in clinical trials of drug products currently approved for use in FM.", "type": 2, "words": ["<tag1>", "This", "endpoint", "is", "similar", "to", "that", "utilized", "by", "drug", "products", "currently", "approved", "for", "use", "in", "FM.", "<tag2>", "This", "endpoint", "is", "similar", "to", "that", "utilized", "in", "clinical", "trials", "of", "drug", "products", "currently", "approved", "for", "use", "in", "FM.", "<tag3>"], "wordsA": ["This", "endpoint", "is", "similar", "to", "that", "utilized", "by", "drug", "products", "currently", "approved", "for", "use", "in", "FM."], "wordsB": ["This", "endpoint", "is", "similar", "to", "that", "utilized", "in", "clinical", "trials", "of", "drug", "products", "currently", "approved", "for", "use", "in", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p39_s2", "idA": "1430306_13_item1_p79_s2", "sentA": "We will also collect information on other outcome measures, including NRS scores at other timepoints, the Fibromyalgia Impact Questionnaire, and the Patient Global Impression of Change.", "sentB": "We are also collecting information on other outcome measures, including NRS scores at other time points, the revised Fibromyalgia Impact Questionnaire, and the Patient Global Impression of Change.", "type": 2, "words": ["<tag1>", "We", "will", "also", "collect", "information", "on", "other", "outcome", "measures,", "including", "NRS", "scores", "at", "other", "timepoints,", "the", "Fibromyalgia", "Impact", "Questionnaire,", "and", "the", "Patient", "Global", "Impression", "of", "Change.", "<tag2>", "We", "are", "also", "collecting", "information", "on", "other", "outcome", "measures,", "including", "NRS", "scores", "at", "other", "time", "points,", "the", "revised", "Fibromyalgia", "Impact", "Questionnaire,", "and", "the", "Patient", "Global", "Impression", "of", "Change.", "<tag3>"], "wordsA": ["We", "will", "also", "collect", "information", "on", "other", "outcome", "measures,", "including", "NRS", "scores", "at", "other", "timepoints,", "the", "Fibromyalgia", "Impact", "Questionnaire,", "and", "the", "Patient", "Global", "Impression", "of", "Change."], "wordsB": ["We", "are", "also", "collecting", "information", "on", "other", "outcome", "measures,", "including", "NRS", "scores", "at", "other", "time", "points,", "the", "revised", "Fibromyalgia", "Impact", "Questionnaire,", "and", "the", "Patient", "Global", "Impression", "of", "Change."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p38_s2", "idA": "1430306_13_item1_p79_s5", "sentA": "We have contracted with a contract manufacturing organization, or CMO, to manufacture and perform stability testing on TNX-102 SL tablets for this Phase 2b study.", "sentB": "We have engaged Premier Research International, LLC, a contract research organization, or CRO, to provide clinical and data management services for this Phase 2b/3 trial.", "type": 2, "words": ["<tag1>", "We", "have", "contracted", "with", "a", "contract", "manufacturing", "organization,", "or", "CMO,", "to", "manufacture", "and", "perform", "stability", "testing", "on", "TNX-102", "SL", "tablets", "for", "this", "Phase", "2b", "study.", "<tag2>", "We", "have", "engaged", "Premier", "Research", "International,", "LLC,", "a", "contract", "research", "organization,", "or", "CRO,", "to", "provide", "clinical", "and", "data", "management", "services", "for", "this", "Phase", "2b/3", "trial.", "<tag3>"], "wordsA": ["We", "have", "contracted", "with", "a", "contract", "manufacturing", "organization,", "or", "CMO,", "to", "manufacture", "and", "perform", "stability", "testing", "on", "TNX-102", "SL", "tablets", "for", "this", "Phase", "2b", "study."], "wordsB": ["We", "have", "engaged", "Premier", "Research", "International,", "LLC,", "a", "contract", "research", "organization,", "or", "CRO,", "to", "provide", "clinical", "and", "data", "management", "services", "for", "this", "Phase", "2b/3", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p7_s1", "idA": "1430306_13_item1_p7_s1", "sentA": "From and after the Closing Date of the Share Exchange, our primary operations consist of the business and operations of Tonix Sub and Krele.", "sentB": "From and after the consummation of the Share Exchange, our primary operations consist of the business and operations of Tonix Sub and Krele.", "type": 2, "words": ["<tag1>", "From", "and", "after", "the", "Closing", "Date", "of", "the", "Share", "Exchange,", "our", "primary", "operations", "consist", "of", "the", "business", "and", "operations", "of", "Tonix", "Sub", "and", "Krele.", "<tag2>", "From", "and", "after", "the", "consummation", "of", "the", "Share", "Exchange,", "our", "primary", "operations", "consist", "of", "the", "business", "and", "operations", "of", "Tonix", "Sub", "and", "Krele.", "<tag3>"], "wordsA": ["From", "and", "after", "the", "Closing", "Date", "of", "the", "Share", "Exchange,", "our", "primary", "operations", "consist", "of", "the", "business", "and", "operations", "of", "Tonix", "Sub", "and", "Krele."], "wordsB": ["From", "and", "after", "the", "consummation", "of", "the", "Share", "Exchange,", "our", "primary", "operations", "consist", "of", "the", "business", "and", "operations", "of", "Tonix", "Sub", "and", "Krele."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p86_s0", "idA": "1430306_13_item1_p80_s0", "sentA": "Since CBP will be used chronically in TNX-102 SL, we will study TNX-102 SL in comparison to CBP IR in a multiple-day dosing (once daily) study.", "sentB": "Since CBP will be used chronically in TNX-102 SL, we plan to study TNX-102 SL in comparison to CBP IR in a multiple-day dosing (once daily) study.", "type": 2, "words": ["<tag1>", "Since", "CBP", "will", "be", "used", "chronically", "in", "TNX-102", "SL,", "we", "will", "study", "TNX-102", "SL", "in", "comparison", "to", "CBP", "IR", "in", "a", "multiple-day", "dosing", "(once", "daily)", "study.", "<tag2>", "Since", "CBP", "will", "be", "used", "chronically", "in", "TNX-102", "SL,", "we", "plan", "to", "study", "TNX-102", "SL", "in", "comparison", "to", "CBP", "IR", "in", "a", "multiple-day", "dosing", "(once", "daily)", "study.", "<tag3>"], "wordsA": ["Since", "CBP", "will", "be", "used", "chronically", "in", "TNX-102", "SL,", "we", "will", "study", "TNX-102", "SL", "in", "comparison", "to", "CBP", "IR", "in", "a", "multiple-day", "dosing", "(once", "daily)", "study."], "wordsB": ["Since", "CBP", "will", "be", "used", "chronically", "in", "TNX-102", "SL,", "we", "plan", "to", "study", "TNX-102", "SL", "in", "comparison", "to", "CBP", "IR", "in", "a", "multiple-day", "dosing", "(once", "daily)", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p83_s0", "idA": "1430306_13_item1_p82_s0", "sentA": "If our Phase 2b study of TNX-102 SL is successful, then we expect to conduct a Phase 3 confirmatory study in support of product registration.", "sentB": "We are currently conducting a Phase 2b/3 study of TNX-102 SL in FM called the BESTFIT trial.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2b", "study", "of", "TNX-102", "SL", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "confirmatory", "study", "in", "support", "of", "product", "registration.", "<tag2>", "We", "are", "currently", "conducting", "a", "Phase", "2b/3", "study", "of", "TNX-102", "SL", "in", "FM", "called", "the", "BESTFIT", "trial.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2b", "study", "of", "TNX-102", "SL", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "confirmatory", "study", "in", "support", "of", "product", "registration."], "wordsB": ["We", "are", "currently", "conducting", "a", "Phase", "2b/3", "study", "of", "TNX-102", "SL", "in", "FM", "called", "the", "BESTFIT", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p85_s0", "idA": "1430306_13_item1_p82_s0", "sentA": "If our Phase 2b study of TNX-102 SL is successful, then we expect to conduct a Phase 3 confirmatory study in support of product registration.", "sentB": "If our Phase 2b/3 BESTFIT study of TNX-102 SL in FM is successful, then we expect to conduct a 12-week, randomized, double-blind, placebo-controlled confirmatory Phase 3 study of TNX-102 SL in support of product registration.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2b", "study", "of", "TNX-102", "SL", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "confirmatory", "study", "in", "support", "of", "product", "registration.", "<tag2>", "If", "our", "Phase", "2b/3", "BESTFIT", "study", "of", "TNX-102", "SL", "in", "FM", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "12-week,", "randomized,", "double-blind,", "placebo-controlled", "confirmatory", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "support", "of", "product", "registration.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2b", "study", "of", "TNX-102", "SL", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "confirmatory", "study", "in", "support", "of", "product", "registration."], "wordsB": ["If", "our", "Phase", "2b/3", "BESTFIT", "study", "of", "TNX-102", "SL", "in", "FM", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "12-week,", "randomized,", "double-blind,", "placebo-controlled", "confirmatory", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "support", "of", "product", "registration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p88_s1", "idA": "1430306_13_item1_p82_s0", "sentA": "If our Phase 2b study of TNX-102 SL is successful, then we expect to conduct a Phase 3 confirmatory study in support of product registration.", "sentB": "In 2014, we will be selecting an FDA-certified Good Laboratory Practices laboratory to conduct a six month repeated-dose toxicology study in rats, a nine month repeated-dose toxicology study in dogs and a peri- and post-natal Segment III study required for the NDA filing.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2b", "study", "of", "TNX-102", "SL", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "confirmatory", "study", "in", "support", "of", "product", "registration.", "<tag2>", "In", "2014,", "we", "will", "be", "selecting", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six", "month", "repeated-dose", "toxicology", "study", "in", "rats,", "a", "nine", "month", "repeated-dose", "toxicology", "study", "in", "dogs", "and", "a", "peri-", "and", "post-natal", "Segment", "III", "study", "required", "for", "the", "NDA", "filing.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2b", "study", "of", "TNX-102", "SL", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "Phase", "3", "confirmatory", "study", "in", "support", "of", "product", "registration."], "wordsB": ["In", "2014,", "we", "will", "be", "selecting", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six", "month", "repeated-dose", "toxicology", "study", "in", "rats,", "a", "nine", "month", "repeated-dose", "toxicology", "study", "in", "dogs", "and", "a", "peri-", "and", "post-natal", "Segment", "III", "study", "required", "for", "the", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p37_s0", "idA": "1430306_13_item1_p82_s1", "sentA": "At that time, we plan to conduct a randomized, double-blind, placebo-controlled Phase 3 study in which patients with FM will receive TNX-102 SL or placebo at bedtime nightly for 12 weeks.", "sentB": "We are currently conducting the randomized, double-blind, placebo-controlled Phase 2b/3 BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) trial, which we initiated in September 2013 under the IND.", "type": 2, "words": ["<tag1>", "At", "that", "time,", "we", "plan", "to", "conduct", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "in", "which", "patients", "with", "FM", "will", "receive", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks.", "<tag2>", "We", "are", "currently", "conducting", "the", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2b/3", "BEdtime", "Sublingual", "TNX-102", "SL", "as", "Fibromyalgia", "Intervention", "Therapy", "(BESTFIT)", "trial,", "which", "we", "initiated", "in", "September", "2013", "under", "the", "IND.", "<tag3>"], "wordsA": ["At", "that", "time,", "we", "plan", "to", "conduct", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "in", "which", "patients", "with", "FM", "will", "receive", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks."], "wordsB": ["We", "are", "currently", "conducting", "the", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2b/3", "BEdtime", "Sublingual", "TNX-102", "SL", "as", "Fibromyalgia", "Intervention", "Therapy", "(BESTFIT)", "trial,", "which", "we", "initiated", "in", "September", "2013", "under", "the", "IND."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p85_s1", "idA": "1430306_13_item1_p82_s2", "sentA": "It is likely that the primary efficacy measure in this study will be the change in pain severity with TNX-102 SL as compared to placebo at week 12, assessed by the NRS, similar to the primary efficacy measure of the Phase 2b study.", "sentB": "It is likely that the primary efficacy measure in this study will be the change in pain severity with TNX-102 SL as compared to a placebo at week 12, as assessed by the NRS, similar to the primary efficacy measure of BESTFIT.", "type": 2, "words": ["<tag1>", "It", "is", "likely", "that", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "with", "TNX-102", "SL", "as", "compared", "to", "placebo", "at", "week", "12,", "assessed", "by", "the", "NRS,", "similar", "to", "the", "primary", "efficacy", "measure", "of", "the", "Phase", "2b", "study.", "<tag2>", "It", "is", "likely", "that", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "with", "TNX-102", "SL", "as", "compared", "to", "a", "placebo", "at", "week", "12,", "as", "assessed", "by", "the", "NRS,", "similar", "to", "the", "primary", "efficacy", "measure", "of", "BESTFIT.", "<tag3>"], "wordsA": ["It", "is", "likely", "that", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "with", "TNX-102", "SL", "as", "compared", "to", "placebo", "at", "week", "12,", "assessed", "by", "the", "NRS,", "similar", "to", "the", "primary", "efficacy", "measure", "of", "the", "Phase", "2b", "study."], "wordsB": ["It", "is", "likely", "that", "the", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "with", "TNX-102", "SL", "as", "compared", "to", "a", "placebo", "at", "week", "12,", "as", "assessed", "by", "the", "NRS,", "similar", "to", "the", "primary", "efficacy", "measure", "of", "BESTFIT."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p85_s2", "idA": "1430306_13_item1_p83_s0", "sentA": "Secondary outcome measures will be carefully considered to best support desired label claims and to optimize the marketing message for product differentiation.", "sentB": "Secondary outcome measures will be determined based on the results from the BESTFIT study.", "type": 2, "words": ["<tag1>", "Secondary", "outcome", "measures", "will", "be", "carefully", "considered", "to", "best", "support", "desired", "label", "claims", "and", "to", "optimize", "the", "marketing", "message", "for", "product", "differentiation.", "<tag2>", "Secondary", "outcome", "measures", "will", "be", "determined", "based", "on", "the", "results", "from", "the", "BESTFIT", "study.", "<tag3>"], "wordsA": ["Secondary", "outcome", "measures", "will", "be", "carefully", "considered", "to", "best", "support", "desired", "label", "claims", "and", "to", "optimize", "the", "marketing", "message", "for", "product", "differentiation."], "wordsB": ["Secondary", "outcome", "measures", "will", "be", "determined", "based", "on", "the", "results", "from", "the", "BESTFIT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p95_s2", "idA": "1430306_13_item1_p87_s2", "sentA": "We held a Pre-Phase 3 meeting with the FDA in February 2013, at which we discussed the nature and extent of the Phase 2b and Phase 3 clinical trials we need to conduct to so as to receive regulatory acceptance of our proposed NDA plan for a differentiated product for the management of FM.", "sentB": "At our End-of-Phase 2/Pre-Phase 3 meeting we held with the FDA in February 2013, we discussed the nature and extent of the Phase 2b and Phase 3 clinical trials we need to conduct to so as to receive regulatory acceptance of our proposed NDA plan for a differentiated product for the management of FM.", "type": 2, "words": ["<tag1>", "We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "Phase", "2b", "and", "Phase", "3", "clinical", "trials", "we", "need", "to", "conduct", "to", "so", "as", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM.", "<tag2>", "At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "we", "held", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "Phase", "2b", "and", "Phase", "3", "clinical", "trials", "we", "need", "to", "conduct", "to", "so", "as", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["We", "held", "a", "Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "at", "which", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "Phase", "2b", "and", "Phase", "3", "clinical", "trials", "we", "need", "to", "conduct", "to", "so", "as", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM."], "wordsB": ["At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "we", "held", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "Phase", "2b", "and", "Phase", "3", "clinical", "trials", "we", "need", "to", "conduct", "to", "so", "as", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p88_s0", "idA": "1430306_13_item1_p88_s1", "sentA": "We plan to continue to support the TNX-102 SL program with new patent applications as we obtain data from the clinical evaluation of our new formulation in healthy human subjects and in FM patients.", "sentB": "In addition to the clinical data necessary to support the TNX-102 SL 505(b)(2) NDA filing for the fibromyalgia indication, the FDA also clarified the nonclinical studies required for the NDA filing since the information from the reference product is either unavailable for reference or failed to meet the current regulatory standard.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "support", "the", "TNX-102", "SL", "program", "with", "new", "patent", "applications", "as", "we", "obtain", "data", "from", "the", "clinical", "evaluation", "of", "our", "new", "formulation", "in", "healthy", "human", "subjects", "and", "in", "FM", "patients.", "<tag2>", "In", "addition", "to", "the", "clinical", "data", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "fibromyalgia", "indication,", "the", "FDA", "also", "clarified", "the", "nonclinical", "studies", "required", "for", "the", "NDA", "filing", "since", "the", "information", "from", "the", "reference", "product", "is", "either", "unavailable", "for", "reference", "or", "failed", "to", "meet", "the", "current", "regulatory", "standard.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "support", "the", "TNX-102", "SL", "program", "with", "new", "patent", "applications", "as", "we", "obtain", "data", "from", "the", "clinical", "evaluation", "of", "our", "new", "formulation", "in", "healthy", "human", "subjects", "and", "in", "FM", "patients."], "wordsB": ["In", "addition", "to", "the", "clinical", "data", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "fibromyalgia", "indication,", "the", "FDA", "also", "clarified", "the", "nonclinical", "studies", "required", "for", "the", "NDA", "filing", "since", "the", "information", "from", "the", "reference", "product", "is", "either", "unavailable", "for", "reference", "or", "failed", "to", "meet", "the", "current", "regulatory", "standard."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p96_s2", "idA": "1430306_13_item1_p88_s2", "sentA": "For example, we have recently filed patent applications on TNX-102 SL which, if issued, would be expected to provide protection from generic substitution until 2033.", "sentB": "For example, we have recently filed patent applications on TNX-102 SL which, if issued, would be expected to provide protection from generic substitution until at least 2033.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "have", "recently", "filed", "patent", "applications", "on", "TNX-102", "SL", "which,", "if", "issued,", "would", "be", "expected", "to", "provide", "protection", "from", "generic", "substitution", "until", "2033.", "<tag2>", "For", "example,", "we", "have", "recently", "filed", "patent", "applications", "on", "TNX-102", "SL", "which,", "if", "issued,", "would", "be", "expected", "to", "provide", "protection", "from", "generic", "substitution", "until", "at", "least", "2033.", "<tag3>"], "wordsA": ["For", "example,", "we", "have", "recently", "filed", "patent", "applications", "on", "TNX-102", "SL", "which,", "if", "issued,", "would", "be", "expected", "to", "provide", "protection", "from", "generic", "substitution", "until", "2033."], "wordsB": ["For", "example,", "we", "have", "recently", "filed", "patent", "applications", "on", "TNX-102", "SL", "which,", "if", "issued,", "would", "be", "expected", "to", "provide", "protection", "from", "generic", "substitution", "until", "at", "least", "2033."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p49_s1", "idA": "1430306_13_item1_p89_s0", "sentA": "We are also developing TNX-102 SL for the management of PTSD, a psychiatric disorder that begins in the aftermath of traumatic experiences.", "sentB": "We are developing TNX-102 SL under the Section 505(b)(2) FDA pathway.", "type": 2, "words": ["<tag1>", "We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD,", "a", "psychiatric", "disorder", "that", "begins", "in", "the", "aftermath", "of", "traumatic", "experiences.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "under", "the", "Section", "505(b)(2)", "FDA", "pathway.", "<tag3>"], "wordsA": ["We", "are", "also", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD,", "a", "psychiatric", "disorder", "that", "begins", "in", "the", "aftermath", "of", "traumatic", "experiences."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "under", "the", "Section", "505(b)(2)", "FDA", "pathway."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p4_s1", "idA": "1430306_13_item1_p8_s0", "sentA": "On October 11, 2011, we changed our name to Tonix Pharmaceuticals Holding Corp. to reflect our new business.", "sentB": "On October 7, 2011, we executed and consummated the Share Exchange.", "type": 2, "words": ["<tag1>", "On", "October", "11,", "2011,", "we", "changed", "our", "name", "to", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "to", "reflect", "our", "new", "business.", "<tag2>", "On", "October", "7,", "2011,", "we", "executed", "and", "consummated", "the", "Share", "Exchange.", "<tag3>"], "wordsA": ["On", "October", "11,", "2011,", "we", "changed", "our", "name", "to", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "to", "reflect", "our", "new", "business."], "wordsB": ["On", "October", "7,", "2011,", "we", "executed", "and", "consummated", "the", "Share", "Exchange."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p102_s0", "idA": "1430306_13_item1_p94_s0", "sentA": "in studies conducted by Caliper, CBP interacts with a receptor on brain cells called the serotonin type 2a receptor.", "sentB": "in receptor binding studies conducted by Caliper under our direction, CBP interacts with a receptor on brain cells called the serotonin type 2a receptor.", "type": 2, "words": ["<tag1>", "in", "studies", "conducted", "by", "Caliper,", "CBP", "interacts", "with", "a", "receptor", "on", "brain", "cells", "called", "the", "serotonin", "type", "2a", "receptor.", "<tag2>", "in", "receptor", "binding", "studies", "conducted", "by", "Caliper", "under", "our", "direction,", "CBP", "interacts", "with", "a", "receptor", "on", "brain", "cells", "called", "the", "serotonin", "type", "2a", "receptor.", "<tag3>"], "wordsA": ["in", "studies", "conducted", "by", "Caliper,", "CBP", "interacts", "with", "a", "receptor", "on", "brain", "cells", "called", "the", "serotonin", "type", "2a", "receptor."], "wordsB": ["in", "receptor", "binding", "studies", "conducted", "by", "Caliper", "under", "our", "direction,", "CBP", "interacts", "with", "a", "receptor", "on", "brain", "cells", "called", "the", "serotonin", "type", "2a", "receptor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p124_s1", "idA": "1430306_13_item1_p94_s1", "sentA": "Based on numerous peer-reviewed scientific publications, we have identified a number of compounds that bind this receptor that have been shown to have effects in treating PTSD.", "sentB": "Since CBP has no recognized addictive potential, we believe that TNX-102 SL, if approved, could reduce the exposure of FM patients to medications that have not been shown to be effective in treating FM and are associated with significant safety risks.", "type": 2, "words": ["<tag1>", "Based", "on", "numerous", "peer-reviewed", "scientific", "publications,", "we", "have", "identified", "a", "number", "of", "compounds", "that", "bind", "this", "receptor", "that", "have", "been", "shown", "to", "have", "effects", "in", "treating", "PTSD.", "<tag2>", "Since", "CBP", "has", "no", "recognized", "addictive", "potential,", "we", "believe", "that", "TNX-102", "SL,", "if", "approved,", "could", "reduce", "the", "exposure", "of", "FM", "patients", "to", "medications", "that", "have", "not", "been", "shown", "to", "be", "effective", "in", "treating", "FM", "and", "are", "associated", "with", "significant", "safety", "risks.", "<tag3>"], "wordsA": ["Based", "on", "numerous", "peer-reviewed", "scientific", "publications,", "we", "have", "identified", "a", "number", "of", "compounds", "that", "bind", "this", "receptor", "that", "have", "been", "shown", "to", "have", "effects", "in", "treating", "PTSD."], "wordsB": ["Since", "CBP", "has", "no", "recognized", "addictive", "potential,", "we", "believe", "that", "TNX-102", "SL,", "if", "approved,", "could", "reduce", "the", "exposure", "of", "FM", "patients", "to", "medications", "that", "have", "not", "been", "shown", "to", "be", "effective", "in", "treating", "FM", "and", "are", "associated", "with", "significant", "safety", "risks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p35_s1", "idA": "1430306_13_item1_p94_s1", "sentA": "Based on numerous peer-reviewed scientific publications, we have identified a number of compounds that bind this receptor that have been shown to have effects in treating PTSD.", "sentB": "Since CBP has no recognized addictive potential, we believe that TNX-102 SL, if approved, could reduce the exposure of FM patients to medications that have not been shown to be effective in treating FM and are associated with significant safety risks.", "type": 2, "words": ["<tag1>", "Based", "on", "numerous", "peer-reviewed", "scientific", "publications,", "we", "have", "identified", "a", "number", "of", "compounds", "that", "bind", "this", "receptor", "that", "have", "been", "shown", "to", "have", "effects", "in", "treating", "PTSD.", "<tag2>", "Since", "CBP", "has", "no", "recognized", "addictive", "potential,", "we", "believe", "that", "TNX-102", "SL,", "if", "approved,", "could", "reduce", "the", "exposure", "of", "FM", "patients", "to", "medications", "that", "have", "not", "been", "shown", "to", "be", "effective", "in", "treating", "FM", "and", "are", "associated", "with", "significant", "safety", "risks.", "<tag3>"], "wordsA": ["Based", "on", "numerous", "peer-reviewed", "scientific", "publications,", "we", "have", "identified", "a", "number", "of", "compounds", "that", "bind", "this", "receptor", "that", "have", "been", "shown", "to", "have", "effects", "in", "treating", "PTSD."], "wordsB": ["Since", "CBP", "has", "no", "recognized", "addictive", "potential,", "we", "believe", "that", "TNX-102", "SL,", "if", "approved,", "could", "reduce", "the", "exposure", "of", "FM", "patients", "to", "medications", "that", "have", "not", "been", "shown", "to", "be", "effective", "in", "treating", "FM", "and", "are", "associated", "with", "significant", "safety", "risks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p40_s0", "idA": "1430306_13_item1_p96_s1", "sentA": "We plan to utilize the data obtained from our pharmacokinetic studies of TNX-102 SL to inform the design of efficacy trials in PTSD.", "sentB": "In December 2013, we announced the initiation of F203, a 12-month open-label extension study of TNX-102 SL to be taken daily at bedtime, into which patients who have completed the BESTFIT study may enroll.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "utilize", "the", "data", "obtained", "from", "our", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "to", "inform", "the", "design", "of", "efficacy", "trials", "in", "PTSD.", "<tag2>", "In", "December", "2013,", "we", "announced", "the", "initiation", "of", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "to", "be", "taken", "daily", "at", "bedtime,", "into", "which", "patients", "who", "have", "completed", "the", "BESTFIT", "study", "may", "enroll.", "<tag3>"], "wordsA": ["We", "plan", "to", "utilize", "the", "data", "obtained", "from", "our", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "to", "inform", "the", "design", "of", "efficacy", "trials", "in", "PTSD."], "wordsB": ["In", "December", "2013,", "we", "announced", "the", "initiation", "of", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "to", "be", "taken", "daily", "at", "bedtime,", "into", "which", "patients", "who", "have", "completed", "the", "BESTFIT", "study", "may", "enroll."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p84_s0", "idA": "1430306_13_item1_p96_s1", "sentA": "We plan to utilize the data obtained from our pharmacokinetic studies of TNX-102 SL to inform the design of efficacy trials in PTSD.", "sentB": "In December 2013, we announced the initiation of F203, a 12-month open-label extension study of TNX-102 SL to be taken daily at bedtime, into which patients who have completed the BESTFIT study may enroll.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "utilize", "the", "data", "obtained", "from", "our", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "to", "inform", "the", "design", "of", "efficacy", "trials", "in", "PTSD.", "<tag2>", "In", "December", "2013,", "we", "announced", "the", "initiation", "of", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "to", "be", "taken", "daily", "at", "bedtime,", "into", "which", "patients", "who", "have", "completed", "the", "BESTFIT", "study", "may", "enroll.", "<tag3>"], "wordsA": ["We", "plan", "to", "utilize", "the", "data", "obtained", "from", "our", "pharmacokinetic", "studies", "of", "TNX-102", "SL", "to", "inform", "the", "design", "of", "efficacy", "trials", "in", "PTSD."], "wordsB": ["In", "December", "2013,", "we", "announced", "the", "initiation", "of", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "to", "be", "taken", "daily", "at", "bedtime,", "into", "which", "patients", "who", "have", "completed", "the", "BESTFIT", "study", "may", "enroll."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p105_s0", "idA": "1430306_13_item1_p97_s0", "sentA": "Based on the recommendations and guidance received at our October 2012 pre-IND meeting with the FDA, we plan to file an IND application for TNX-102 SL in the PTSD indication in the third quarter of 2013, and to conduct a Phase 2 trial in the fourth quarter of 2013.", "sentB": "Based on the recommendations and guidance received at our October 2012 pre-IND meeting with the FDA and in consultation with experts in this psychiatric disorder, we plan to file an IND application for TNX-102 SL in the PTSD indication in the second quarter of 2014, and to begin a POC trial in the third quarter of 2014.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "recommendations", "and", "guidance", "received", "at", "our", "October", "2012", "pre-IND", "meeting", "with", "the", "FDA,", "we", "plan", "to", "file", "an", "IND", "application", "for", "TNX-102", "SL", "in", "the", "PTSD", "indication", "in", "the", "third", "quarter", "of", "2013,", "and", "to", "conduct", "a", "Phase", "2", "trial", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "Based", "on", "the", "recommendations", "and", "guidance", "received", "at", "our", "October", "2012", "pre-IND", "meeting", "with", "the", "FDA", "and", "in", "consultation", "with", "experts", "in", "this", "psychiatric", "disorder,", "we", "plan", "to", "file", "an", "IND", "application", "for", "TNX-102", "SL", "in", "the", "PTSD", "indication", "in", "the", "second", "quarter", "of", "2014,", "and", "to", "begin", "a", "POC", "trial", "in", "the", "third", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["Based", "on", "the", "recommendations", "and", "guidance", "received", "at", "our", "October", "2012", "pre-IND", "meeting", "with", "the", "FDA,", "we", "plan", "to", "file", "an", "IND", "application", "for", "TNX-102", "SL", "in", "the", "PTSD", "indication", "in", "the", "third", "quarter", "of", "2013,", "and", "to", "conduct", "a", "Phase", "2", "trial", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["Based", "on", "the", "recommendations", "and", "guidance", "received", "at", "our", "October", "2012", "pre-IND", "meeting", "with", "the", "FDA", "and", "in", "consultation", "with", "experts", "in", "this", "psychiatric", "disorder,", "we", "plan", "to", "file", "an", "IND", "application", "for", "TNX-102", "SL", "in", "the", "PTSD", "indication", "in", "the", "second", "quarter", "of", "2014,", "and", "to", "begin", "a", "POC", "trial", "in", "the", "third", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p105_s1", "idA": "1430306_13_item1_p97_s1", "sentA": "We expect to be able to use TNX-102 SL tablets manufactured for the FM studies in the initial PTSD clinical trials.", "sentB": "We expect to be able to use TNX-102 SL tablets manufactured for the FM studies in this clinical trial.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "be", "able", "to", "use", "TNX-102", "SL", "tablets", "manufactured", "for", "the", "FM", "studies", "in", "the", "initial", "PTSD", "clinical", "trials.", "<tag2>", "We", "expect", "to", "be", "able", "to", "use", "TNX-102", "SL", "tablets", "manufactured", "for", "the", "FM", "studies", "in", "this", "clinical", "trial.", "<tag3>"], "wordsA": ["We", "expect", "to", "be", "able", "to", "use", "TNX-102", "SL", "tablets", "manufactured", "for", "the", "FM", "studies", "in", "the", "initial", "PTSD", "clinical", "trials."], "wordsB": ["We", "expect", "to", "be", "able", "to", "use", "TNX-102", "SL", "tablets", "manufactured", "for", "the", "FM", "studies", "in", "this", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p106_s0", "idA": "1430306_13_item1_p98_s0", "sentA": "We plan to use the IND to support a small clinical study to ascertain the potential efficacy of TNX-102 SL in this disorder.", "sentB": "The IND to be filed in the second quarter of 2014 will have the information necessary to support a POC clinical study to ascertain the potential efficacy of TNX-102 SL in PTSD.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "use", "the", "IND", "to", "support", "a", "small", "clinical", "study", "to", "ascertain", "the", "potential", "efficacy", "of", "TNX-102", "SL", "in", "this", "disorder.", "<tag2>", "The", "IND", "to", "be", "filed", "in", "the", "second", "quarter", "of", "2014", "will", "have", "the", "information", "necessary", "to", "support", "a", "POC", "clinical", "study", "to", "ascertain", "the", "potential", "efficacy", "of", "TNX-102", "SL", "in", "PTSD.", "<tag3>"], "wordsA": ["We", "plan", "to", "use", "the", "IND", "to", "support", "a", "small", "clinical", "study", "to", "ascertain", "the", "potential", "efficacy", "of", "TNX-102", "SL", "in", "this", "disorder."], "wordsB": ["The", "IND", "to", "be", "filed", "in", "the", "second", "quarter", "of", "2014", "will", "have", "the", "information", "necessary", "to", "support", "a", "POC", "clinical", "study", "to", "ascertain", "the", "potential", "efficacy", "of", "TNX-102", "SL", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p106_s1", "idA": "1430306_13_item1_p98_s1", "sentA": "This will be a randomized, double-blind, placebo-controlled, crossover study in subjects with PTSD.", "sentB": "We expect this will be a randomized, double-blind, placebo-controlled, parallel study of bedtime TNX-102 SL in military-related PTSD subjects.", "type": 2, "words": ["<tag1>", "This", "will", "be", "a", "randomized,", "double-blind,", "placebo-controlled,", "crossover", "study", "in", "subjects", "with", "PTSD.", "<tag2>", "We", "expect", "this", "will", "be", "a", "randomized,", "double-blind,", "placebo-controlled,", "parallel", "study", "of", "bedtime", "TNX-102", "SL", "in", "military-related", "PTSD", "subjects.", "<tag3>"], "wordsA": ["This", "will", "be", "a", "randomized,", "double-blind,", "placebo-controlled,", "crossover", "study", "in", "subjects", "with", "PTSD."], "wordsB": ["We", "expect", "this", "will", "be", "a", "randomized,", "double-blind,", "placebo-controlled,", "parallel", "study", "of", "bedtime", "TNX-102", "SL", "in", "military-related", "PTSD", "subjects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p106_s2", "idA": "1430306_13_item1_p98_s3", "sentA": "The primary efficacy measure will be the change in the Clinician-Administered PTSD Scale from baseline to week six.", "sentB": "We expect the dosing period to be six weeks, and the primary efficacy measure to be the change in the Clinician-Administered PTSD Scale from baseline to week six.", "type": 2, "words": ["<tag1>", "The", "primary", "efficacy", "measure", "will", "be", "the", "change", "in", "the", "Clinician-Administered", "PTSD", "Scale", "from", "baseline", "to", "week", "six.", "<tag2>", "We", "expect", "the", "dosing", "period", "to", "be", "six", "weeks,", "and", "the", "primary", "efficacy", "measure", "to", "be", "the", "change", "in", "the", "Clinician-Administered", "PTSD", "Scale", "from", "baseline", "to", "week", "six.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "measure", "will", "be", "the", "change", "in", "the", "Clinician-Administered", "PTSD", "Scale", "from", "baseline", "to", "week", "six."], "wordsB": ["We", "expect", "the", "dosing", "period", "to", "be", "six", "weeks,", "and", "the", "primary", "efficacy", "measure", "to", "be", "the", "change", "in", "the", "Clinician-Administered", "PTSD", "Scale", "from", "baseline", "to", "week", "six."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p38_s0", "idA": "1430306_13_item1_p98_s3", "sentA": "The primary efficacy measure will be the change in the Clinician-Administered PTSD Scale from baseline to week six.", "sentB": "The primary efficacy endpoint is change in pain from baseline to week 12.", "type": 2, "words": ["<tag1>", "The", "primary", "efficacy", "measure", "will", "be", "the", "change", "in", "the", "Clinician-Administered", "PTSD", "Scale", "from", "baseline", "to", "week", "six.", "<tag2>", "The", "primary", "efficacy", "endpoint", "is", "change", "in", "pain", "from", "baseline", "to", "week", "12.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "measure", "will", "be", "the", "change", "in", "the", "Clinician-Administered", "PTSD", "Scale", "from", "baseline", "to", "week", "six."], "wordsB": ["The", "primary", "efficacy", "endpoint", "is", "change", "in", "pain", "from", "baseline", "to", "week", "12."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p107_s0", "idA": "1430306_13_item1_p99_s0", "sentA": "If our Phase 2 trial of TNX-102 SL in PTSD is successful, we intend to conduct two multicenter, double-blind, placebo-controlled, Phase 3 studies designed to evaluate the efficacy, safety, and tolerability of TNX-102 SL in patients with PTSD.", "sentB": "If our POC trial of TNX-102 SL in PTSD is successful, we will meet with the FDA to finalize the design of the registration studies to support the PTSD NDA.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "intend", "to", "conduct", "two", "multicenter,", "double-blind,", "placebo-controlled,", "Phase", "3", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "TNX-102", "SL", "in", "patients", "with", "PTSD.", "<tag2>", "If", "our", "POC", "trial", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "studies", "to", "support", "the", "PTSD", "NDA.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "intend", "to", "conduct", "two", "multicenter,", "double-blind,", "placebo-controlled,", "Phase", "3", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "TNX-102", "SL", "in", "patients", "with", "PTSD."], "wordsB": ["If", "our", "POC", "trial", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "studies", "to", "support", "the", "PTSD", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p206_s1", "idA": "1430306_13_item1_p99_s0", "sentA": "If our Phase 2 trial of TNX-102 SL in PTSD is successful, we intend to conduct two multicenter, double-blind, placebo-controlled, Phase 3 studies designed to evaluate the efficacy, safety, and tolerability of TNX-102 SL in patients with PTSD.", "sentB": "In the event that our POC study of TNX-102 SL in PTSD is successful, we will request Breakthrough Therapy designation for TNX-102 SL.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "intend", "to", "conduct", "two", "multicenter,", "double-blind,", "placebo-controlled,", "Phase", "3", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "TNX-102", "SL", "in", "patients", "with", "PTSD.", "<tag2>", "In", "the", "event", "that", "our", "POC", "study", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "request", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "intend", "to", "conduct", "two", "multicenter,", "double-blind,", "placebo-controlled,", "Phase", "3", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "and", "tolerability", "of", "TNX-102", "SL", "in", "patients", "with", "PTSD."], "wordsB": ["In", "the", "event", "that", "our", "POC", "study", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "request", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p88_s3", "idA": "1430306_13_item1_p99_s2", "sentA": "We expect the results of the Phase 2 trial to determine dose levels in these Phase 3 trials, but like the Phase 2 trial, TNX-102 SL may be dosed flexibly.", "sentB": "These studies will be performed concurrently with the Phase 3 study and will be completed ahead of the NDA submission.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "results", "of", "the", "Phase", "2", "trial", "to", "determine", "dose", "levels", "in", "these", "Phase", "3", "trials,", "but", "like", "the", "Phase", "2", "trial,", "TNX-102", "SL", "may", "be", "dosed", "flexibly.", "<tag2>", "These", "studies", "will", "be", "performed", "concurrently", "with", "the", "Phase", "3", "study", "and", "will", "be", "completed", "ahead", "of", "the", "NDA", "submission.", "<tag3>"], "wordsA": ["We", "expect", "the", "results", "of", "the", "Phase", "2", "trial", "to", "determine", "dose", "levels", "in", "these", "Phase", "3", "trials,", "but", "like", "the", "Phase", "2", "trial,", "TNX-102", "SL", "may", "be", "dosed", "flexibly."], "wordsB": ["These", "studies", "will", "be", "performed", "concurrently", "with", "the", "Phase", "3", "study", "and", "will", "be", "completed", "ahead", "of", "the", "NDA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_14_item1_p9_s0", "idA": "1430306_13_item1_p9_s0", "sentA": "In 1996, Seth Lederman, MD, and Donald Landry, MD, PhD, formed L L Technologies, LLC, or L L, to develop medications for CNS conditions.", "sentB": "In 1996, Seth Lederman, MD, and Donald Landry, MD, PhD, formed L L Technologies LLC, or L L, to develop medications for central nervous system, or CNS, conditions.", "type": 2, "words": ["<tag1>", "In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies,", "LLC,", "or", "L", "L,", "to", "develop", "medications", "for", "CNS", "conditions.", "<tag2>", "In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies", "LLC,", "or", "L", "L,", "to", "develop", "medications", "for", "central", "nervous", "system,", "or", "CNS,", "conditions.", "<tag3>"], "wordsA": ["In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies,", "LLC,", "or", "L", "L,", "to", "develop", "medications", "for", "CNS", "conditions."], "wordsB": ["In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies", "LLC,", "or", "L", "L,", "to", "develop", "medications", "for", "central", "nervous", "system,", "or", "CNS,", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p85_s0", "idA": "1430306_14_item1_p101_s0", "sentA": "Our rationale for studying the effects of CBP in PTSD derives from the following:", "sentB": "Our rationale for developing TNX-102 SL for treatment of PTSD derives from the following:", "type": 2, "words": ["<tag1>", "Our", "rationale", "for", "studying", "the", "effects", "of", "CBP", "in", "PTSD", "derives", "from", "the", "following:", "<tag2>", "Our", "rationale", "for", "developing", "TNX-102", "SL", "for", "treatment", "of", "PTSD", "derives", "from", "the", "following:", "<tag3>"], "wordsA": ["Our", "rationale", "for", "studying", "the", "effects", "of", "CBP", "in", "PTSD", "derives", "from", "the", "following:"], "wordsB": ["Our", "rationale", "for", "developing", "TNX-102", "SL", "for", "treatment", "of", "PTSD", "derives", "from", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p86_s0", "idA": "1430306_14_item1_p103_s0", "sentA": "Based on numerous peer-reviewed scientific publications, we have identified a number of compounds that bind this receptor that have been shown to have effects in treating PTSD.", "sentB": "In research from peer-reviewed scientific publications, we have identified a number of compounds that are antagonists of the serotonin 2A or alpha-1 adrenergic receptors that have been shown to have beneficial effects in treating PTSD.", "type": 2, "words": ["<tag1>", "Based", "on", "numerous", "peer-reviewed", "scientific", "publications,", "we", "have", "identified", "a", "number", "of", "compounds", "that", "bind", "this", "receptor", "that", "have", "been", "shown", "to", "have", "effects", "in", "treating", "PTSD.", "<tag2>", "In", "research", "from", "peer-reviewed", "scientific", "publications,", "we", "have", "identified", "a", "number", "of", "compounds", "that", "are", "antagonists", "of", "the", "serotonin", "2A", "or", "alpha-1", "adrenergic", "receptors", "that", "have", "been", "shown", "to", "have", "beneficial", "effects", "in", "treating", "PTSD.", "<tag3>"], "wordsA": ["Based", "on", "numerous", "peer-reviewed", "scientific", "publications,", "we", "have", "identified", "a", "number", "of", "compounds", "that", "bind", "this", "receptor", "that", "have", "been", "shown", "to", "have", "effects", "in", "treating", "PTSD."], "wordsB": ["In", "research", "from", "peer-reviewed", "scientific", "publications,", "we", "have", "identified", "a", "number", "of", "compounds", "that", "are", "antagonists", "of", "the", "serotonin", "2A", "or", "alpha-1", "adrenergic", "receptors", "that", "have", "been", "shown", "to", "have", "beneficial", "effects", "in", "treating", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p86_s1", "idA": "1430306_14_item1_p103_s1", "sentA": "Therefore, it is our belief that CBP, because it binds to the serotonin type 2a receptor, will have a therapeutic effect in treating PTSD.", "sentB": "Therefore, it is our belief that TNX-102 SL, a serotonin 2A and alpha-1 adrenergic receptor antagonist, will have a therapeutic effect in treating PTSD.", "type": 2, "words": ["<tag1>", "Therefore,", "it", "is", "our", "belief", "that", "CBP,", "because", "it", "binds", "to", "the", "serotonin", "type", "2a", "receptor,", "will", "have", "a", "therapeutic", "effect", "in", "treating", "PTSD.", "<tag2>", "Therefore,", "it", "is", "our", "belief", "that", "TNX-102", "SL,", "a", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptor", "antagonist,", "will", "have", "a", "therapeutic", "effect", "in", "treating", "PTSD.", "<tag3>"], "wordsA": ["Therefore,", "it", "is", "our", "belief", "that", "CBP,", "because", "it", "binds", "to", "the", "serotonin", "type", "2a", "receptor,", "will", "have", "a", "therapeutic", "effect", "in", "treating", "PTSD."], "wordsB": ["Therefore,", "it", "is", "our", "belief", "that", "TNX-102", "SL,", "a", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptor", "antagonist,", "will", "have", "a", "therapeutic", "effect", "in", "treating", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p90_s0", "idA": "1430306_14_item1_p108_s0", "sentA": "The approvals by the FDA of Paxil (paroxetine) and Zoloft (sertraline) for treating PTSD established a regulatory approval pathway for symptom reduction in PTSD.", "sentB": "The approvals by the FDA of Paxil and Zoloft for treating PTSD established a regulatory approval pathway for symptom reduction in PTSD.", "type": 2, "words": ["<tag1>", "The", "approvals", "by", "the", "FDA", "of", "Paxil", "(paroxetine)", "and", "Zoloft", "(sertraline)", "for", "treating", "PTSD", "established", "a", "regulatory", "approval", "pathway", "for", "symptom", "reduction", "in", "PTSD.", "<tag2>", "The", "approvals", "by", "the", "FDA", "of", "Paxil", "and", "Zoloft", "for", "treating", "PTSD", "established", "a", "regulatory", "approval", "pathway", "for", "symptom", "reduction", "in", "PTSD.", "<tag3>"], "wordsA": ["The", "approvals", "by", "the", "FDA", "of", "Paxil", "(paroxetine)", "and", "Zoloft", "(sertraline)", "for", "treating", "PTSD", "established", "a", "regulatory", "approval", "pathway", "for", "symptom", "reduction", "in", "PTSD."], "wordsB": ["The", "approvals", "by", "the", "FDA", "of", "Paxil", "and", "Zoloft", "for", "treating", "PTSD", "established", "a", "regulatory", "approval", "pathway", "for", "symptom", "reduction", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p90_s1", "idA": "1430306_14_item1_p108_s1", "sentA": "We believe our clinical development program of TNX-102 SL and the long term safety data generated from the TNX-102 SL FM NDA program will result in a differentiated product suitable for chronic use for the treatment of PTSD.", "sentB": "We believe our clinical development program of TNX-102 SL and the long term safety data generated from the TNX-102 SL NDA for FM will result in a differentiated product suitable for chronic use for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "long", "term", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "FM", "NDA", "program", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "long", "term", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "NDA", "for", "FM", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "long", "term", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "FM", "NDA", "program", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["We", "believe", "our", "clinical", "development", "program", "of", "TNX-102", "SL", "and", "the", "long", "term", "safety", "data", "generated", "from", "the", "TNX-102", "SL", "NDA", "for", "FM", "will", "result", "in", "a", "differentiated", "product", "suitable", "for", "chronic", "use", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p90_s2", "idA": "1430306_14_item1_p108_s2", "sentA": "We believe that our planned clinical trials in PTSD, if successful, will provide sufficient evidence of clinical efficacy and safety to support a 505(b)(2) NDA for TNX-102 SL for the management of PTSD.", "sentB": "We believe that our ongoing and planned clinical trials in PTSD, if successful, will provide sufficient evidence of clinical efficacy and safety to support a 505(b)(2) NDA for TNX-102 SL for the management of PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "planned", "clinical", "trials", "in", "PTSD,", "if", "successful,", "will", "provide", "sufficient", "evidence", "of", "clinical", "efficacy", "and", "safety", "to", "support", "a", "505(b)(2)", "NDA", "for", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "We", "believe", "that", "our", "ongoing", "and", "planned", "clinical", "trials", "in", "PTSD,", "if", "successful,", "will", "provide", "sufficient", "evidence", "of", "clinical", "efficacy", "and", "safety", "to", "support", "a", "505(b)(2)", "NDA", "for", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "planned", "clinical", "trials", "in", "PTSD,", "if", "successful,", "will", "provide", "sufficient", "evidence", "of", "clinical", "efficacy", "and", "safety", "to", "support", "a", "505(b)(2)", "NDA", "for", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["We", "believe", "that", "our", "ongoing", "and", "planned", "clinical", "trials", "in", "PTSD,", "if", "successful,", "will", "provide", "sufficient", "evidence", "of", "clinical", "efficacy", "and", "safety", "to", "support", "a", "505(b)(2)", "NDA", "for", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p69_s2", "idA": "1430306_14_item1_p109_s0", "sentA": "We held a pre-IND meeting with the FDA on TNX-102 SL in PTSD in October 2012, and we expect to file an IND in the second quarter of 2014 and to initiate a POC study in the third quarter of 2014.", "sentB": "We expect to initiate a randomized, double-blind, placebo-controlled, 12-week Phase 3 trial of TNX-102 SL in 500 patients with FM in the second quarter of 2015.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "on", "TNX-102", "SL", "in", "PTSD", "in", "October", "2012,", "and", "we", "expect", "to", "file", "an", "IND", "in", "the", "second", "quarter", "of", "2014", "and", "to", "initiate", "a", "POC", "study", "in", "the", "third", "quarter", "of", "2014.", "<tag2>", "We", "expect", "to", "initiate", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "3", "trial", "of", "TNX-102", "SL", "in", "500", "patients", "with", "FM", "in", "the", "second", "quarter", "of", "2015.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "on", "TNX-102", "SL", "in", "PTSD", "in", "October", "2012,", "and", "we", "expect", "to", "file", "an", "IND", "in", "the", "second", "quarter", "of", "2014", "and", "to", "initiate", "a", "POC", "study", "in", "the", "third", "quarter", "of", "2014."], "wordsB": ["We", "expect", "to", "initiate", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "3", "trial", "of", "TNX-102", "SL", "in", "500", "patients", "with", "FM", "in", "the", "second", "quarter", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p91_s0", "idA": "1430306_14_item1_p109_s1", "sentA": "We plan to meet with the FDA when we complete the POC efficacy study to further discuss the development plan, especially the design of the pivotal studies.", "sentB": "We plan to meet with the FDA when we complete the AtEase study to further discuss our development plan for TNX-102 SL for PTSD, especially the proposed design of the pivotal studies.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "POC", "efficacy", "study", "to", "further", "discuss", "the", "development", "plan,", "especially", "the", "design", "of", "the", "pivotal", "studies.", "<tag2>", "We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "AtEase", "study", "to", "further", "discuss", "our", "development", "plan", "for", "TNX-102", "SL", "for", "PTSD,", "especially", "the", "proposed", "design", "of", "the", "pivotal", "studies.", "<tag3>"], "wordsA": ["We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "POC", "efficacy", "study", "to", "further", "discuss", "the", "development", "plan,", "especially", "the", "design", "of", "the", "pivotal", "studies."], "wordsB": ["We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "AtEase", "study", "to", "further", "discuss", "our", "development", "plan", "for", "TNX-102", "SL", "for", "PTSD,", "especially", "the", "proposed", "design", "of", "the", "pivotal", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p91_s1", "idA": "1430306_14_item1_p109_s2", "sentA": "If the results from the POC efficacy study are positive, we plan to seek a Breakthrough Therapy designation for TNX-102 SL in PTSD.", "sentB": "If the results from the AtEase study are positive, we plan to seek a Breakthrough Therapy designation for TNX-102 SL in PTSD.", "type": 2, "words": ["<tag1>", "If", "the", "results", "from", "the", "POC", "efficacy", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD.", "<tag2>", "If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD.", "<tag3>"], "wordsA": ["If", "the", "results", "from", "the", "POC", "efficacy", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD."], "wordsB": ["If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p55_s0", "idA": "1430306_14_item1_p110_s0", "sentA": "TNX-102 SL is a small tablet that rapidly disintegrates in saliva and delivers CBP across the mucosal membrane into the systemic circulation.", "sentB": "TNX-102 SL is a sublingual tablet formulation of CBP that efficiently delivers CBP across the oral mucosal membrane into the systemic circulation.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "small", "tablet", "that", "rapidly", "disintegrates", "in", "saliva", "and", "delivers", "CBP", "across", "the", "mucosal", "membrane", "into", "the", "systemic", "circulation.", "<tag2>", "TNX-102", "SL", "is", "a", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "small", "tablet", "that", "rapidly", "disintegrates", "in", "saliva", "and", "delivers", "CBP", "across", "the", "mucosal", "membrane", "into", "the", "systemic", "circulation."], "wordsB": ["TNX-102", "SL", "is", "a", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p55_s2", "idA": "1430306_14_item1_p110_s3", "sentA": "These include agents that favor a mildly basic salivary pH. We own all rights to TNX-102 SL in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "sentB": "We own all rights to TNX-102 SL in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "type": 2, "words": ["<tag1>", "These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag2>", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag3>"], "wordsA": ["These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "wordsB": ["We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p56_s2", "idA": "1430306_14_item1_p110_s3", "sentA": "These include agents that favor a mildly basic salivary pH. We own all rights to TNX-102 SL in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "sentB": "These include agents that favor a mildly basic salivary pH.", "type": 2, "words": ["<tag1>", "These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag2>", "These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "<tag3>"], "wordsA": ["These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "wordsB": ["These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p93_s2", "idA": "1430306_14_item1_p110_s3", "sentA": "These include agents that favor a mildly basic salivary pH. We own all rights to TNX-102 SL in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "sentB": "We own all rights to TNX-201 in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "type": 2, "words": ["<tag1>", "These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag2>", "We", "own", "all", "rights", "to", "TNX-201", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag3>"], "wordsA": ["These", "include", "agents", "that", "favor", "a", "mildly", "basic", "salivary", "pH.", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "wordsB": ["We", "own", "all", "rights", "to", "TNX-201", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p43_s0", "idA": "1430306_14_item1_p117_s0", "sentA": "Savella was the third medicine approved by the FDA for the management of FM.", "sentB": "Three drugs, pregabalin (Lyrica ), duloxetine (Cymbalta ), and milnacipran (Savella ), are approved by the FDA for the management of FM, and a variety of drugs are used off-label by FM patients.", "type": 2, "words": ["<tag1>", "Savella", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "Three", "drugs,", "pregabalin", "(Lyrica", "),", "duloxetine", "(Cymbalta", "),", "and", "milnacipran", "(Savella", "),", "are", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM,", "and", "a", "variety", "of", "drugs", "are", "used", "off-label", "by", "FM", "patients.", "<tag3>"], "wordsA": ["Savella", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["Three", "drugs,", "pregabalin", "(Lyrica", "),", "duloxetine", "(Cymbalta", "),", "and", "milnacipran", "(Savella", "),", "are", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM,", "and", "a", "variety", "of", "drugs", "are", "used", "off-label", "by", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p74_s1", "idA": "1430306_14_item1_p117_s0", "sentA": "Savella was the third medicine approved by the FDA for the management of FM.", "sentB": "In 2014, we completed dose-ranging studies to identify the doses requested by the FDA for the chronic toxicity studies to improve the existing CBP labeling.", "type": 2, "words": ["<tag1>", "Savella", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM.", "<tag2>", "In", "2014,", "we", "completed", "dose-ranging", "studies", "to", "identify", "the", "doses", "requested", "by", "the", "FDA", "for", "the", "chronic", "toxicity", "studies", "to", "improve", "the", "existing", "CBP", "labeling.", "<tag3>"], "wordsA": ["Savella", "was", "the", "third", "medicine", "approved", "by", "the", "FDA", "for", "the", "management", "of", "FM."], "wordsB": ["In", "2014,", "we", "completed", "dose-ranging", "studies", "to", "identify", "the", "doses", "requested", "by", "the", "FDA", "for", "the", "chronic", "toxicity", "studies", "to", "improve", "the", "existing", "CBP", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p13_s0", "idA": "1430306_14_item1_p11_s0", "sentA": "Tonix Sub formed in June 2007 as Krele Pharmaceuticals, Inc. by L L and Plumbline.", "sentB": "Tonix Sub formed in June 2007 as Krele Pharmaceuticals, Inc. by L L and Plumbline LLC, or Plumbline.", "type": 2, "words": ["<tag1>", "Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline.", "<tag2>", "Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline", "LLC,", "or", "Plumbline.", "<tag3>"], "wordsA": ["Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline."], "wordsB": ["Tonix", "Sub", "formed", "in", "June", "2007", "as", "Krele", "Pharmaceuticals,", "Inc.", "by", "L", "L", "and", "Plumbline", "LLC,", "or", "Plumbline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p29_s2", "idA": "1430306_14_item1_p123_s1", "sentA": "Many patients fail to adequately respond to the approved medications, or discontinue therapy due to poor tolerability.", "sentB": "Many patients fail to adequately respond to the medications approved for PTSD, and antidepressants, sedative-hypnotics and antipsychotics not approved for PTSD are commonly prescribed despite generally weak evidence in support of their use.", "type": 2, "words": ["<tag1>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "approved", "medications,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability.", "<tag2>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "PTSD,", "and", "antidepressants,", "sedative-hypnotics", "and", "antipsychotics", "not", "approved", "for", "PTSD", "are", "commonly", "prescribed", "despite", "generally", "weak", "evidence", "in", "support", "of", "their", "use.", "<tag3>"], "wordsA": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "approved", "medications,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability."], "wordsB": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "PTSD,", "and", "antidepressants,", "sedative-hypnotics", "and", "antipsychotics", "not", "approved", "for", "PTSD", "are", "commonly", "prescribed", "despite", "generally", "weak", "evidence", "in", "support", "of", "their", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p43_s3", "idA": "1430306_14_item1_p123_s2", "sentA": "Prescription pain and sleep medications are often taken off-label for symptomatic relief, despite the lack of evidence that such medications provide a meaningful or durable therapeutic effect.", "sentB": "Prescription pain and sleep medications are widely used for symptomatic relief, despite the lack of evidence that such medications provide a meaningful or durable therapeutic effect.", "type": 2, "words": ["<tag1>", "Prescription", "pain", "and", "sleep", "medications", "are", "often", "taken", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect.", "<tag2>", "Prescription", "pain", "and", "sleep", "medications", "are", "widely", "used", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect.", "<tag3>"], "wordsA": ["Prescription", "pain", "and", "sleep", "medications", "are", "often", "taken", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect."], "wordsB": ["Prescription", "pain", "and", "sleep", "medications", "are", "widely", "used", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p44_s0", "idA": "1430306_14_item1_p124_s0", "sentA": "An important goal of FM treatment is to reduce the dependence on opiate analgesic as well as on benzodiazepine and non-benzodiazepine sedative-hypnotic medications by FM patients.", "sentB": "An important goal of FM treatment is to reduce the use of opiate analgesics as well as of benzodiazepine and non-benzodiazepine sedative-hypnotic medications typically used by FM patients.", "type": 2, "words": ["<tag1>", "An", "important", "goal", "of", "FM", "treatment", "is", "to", "reduce", "the", "dependence", "on", "opiate", "analgesic", "as", "well", "as", "on", "benzodiazepine", "and", "non-benzodiazepine", "sedative-hypnotic", "medications", "by", "FM", "patients.", "<tag2>", "An", "important", "goal", "of", "FM", "treatment", "is", "to", "reduce", "the", "use", "of", "opiate", "analgesics", "as", "well", "as", "of", "benzodiazepine", "and", "non-benzodiazepine", "sedative-hypnotic", "medications", "typically", "used", "by", "FM", "patients.", "<tag3>"], "wordsA": ["An", "important", "goal", "of", "FM", "treatment", "is", "to", "reduce", "the", "dependence", "on", "opiate", "analgesic", "as", "well", "as", "on", "benzodiazepine", "and", "non-benzodiazepine", "sedative-hypnotic", "medications", "by", "FM", "patients."], "wordsB": ["An", "important", "goal", "of", "FM", "treatment", "is", "to", "reduce", "the", "use", "of", "opiate", "analgesics", "as", "well", "as", "of", "benzodiazepine", "and", "non-benzodiazepine", "sedative-hypnotic", "medications", "typically", "used", "by", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p24_s5", "idA": "1430306_14_item1_p12_s0", "sentA": "Plumbline possessed rights to certain technology for the treatment of alcohol dependence and abuse.", "sentB": "Our pipeline includes a preclinical program for the treatment of alcohol abuse and dependence as well as two preclinical biodefense programs (for protection from smallpox virus and from radiation injury).", "type": 2, "words": ["<tag1>", "Plumbline", "possessed", "rights", "to", "certain", "technology", "for", "the", "treatment", "of", "alcohol", "dependence", "and", "abuse.", "<tag2>", "Our", "pipeline", "includes", "a", "preclinical", "program", "for", "the", "treatment", "of", "alcohol", "abuse", "and", "dependence", "as", "well", "as", "two", "preclinical", "biodefense", "programs", "(for", "protection", "from", "smallpox", "virus", "and", "from", "radiation", "injury).", "<tag3>"], "wordsA": ["Plumbline", "possessed", "rights", "to", "certain", "technology", "for", "the", "treatment", "of", "alcohol", "dependence", "and", "abuse."], "wordsB": ["Our", "pipeline", "includes", "a", "preclinical", "program", "for", "the", "treatment", "of", "alcohol", "abuse", "and", "dependence", "as", "well", "as", "two", "preclinical", "biodefense", "programs", "(for", "protection", "from", "smallpox", "virus", "and", "from", "radiation", "injury)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p48_s0", "idA": "1430306_14_item1_p130_s1", "sentA": "Consequently, physicians may prescribe several different medications concurrently to treat individual symptoms or groups of symptoms.", "sentB": "Patients often take several medications concurrently to address multiple symptoms.", "type": 2, "words": ["<tag1>", "Consequently,", "physicians", "may", "prescribe", "several", "different", "medications", "concurrently", "to", "treat", "individual", "symptoms", "or", "groups", "of", "symptoms.", "<tag2>", "Patients", "often", "take", "several", "medications", "concurrently", "to", "address", "multiple", "symptoms.", "<tag3>"], "wordsA": ["Consequently,", "physicians", "may", "prescribe", "several", "different", "medications", "concurrently", "to", "treat", "individual", "symptoms", "or", "groups", "of", "symptoms."], "wordsB": ["Patients", "often", "take", "several", "medications", "concurrently", "to", "address", "multiple", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p25_s1", "idA": "1430306_14_item1_p135_s2", "sentA": "We believe that key competitive factors that will affect the development and commercial success of our product candidates are efficacy, safety, tolerability, reliability, price and reimbursement level.", "sentB": "We believe that our product candidates offer innovative therapeutic approaches and may provide significant advantages relative to current therapies.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "key", "competitive", "factors", "that", "will", "affect", "the", "development", "and", "commercial", "success", "of", "our", "product", "candidates", "are", "efficacy,", "safety,", "tolerability,", "reliability,", "price", "and", "reimbursement", "level.", "<tag2>", "We", "believe", "that", "our", "product", "candidates", "offer", "innovative", "therapeutic", "approaches", "and", "may", "provide", "significant", "advantages", "relative", "to", "current", "therapies.", "<tag3>"], "wordsA": ["We", "believe", "that", "key", "competitive", "factors", "that", "will", "affect", "the", "development", "and", "commercial", "success", "of", "our", "product", "candidates", "are", "efficacy,", "safety,", "tolerability,", "reliability,", "price", "and", "reimbursement", "level."], "wordsB": ["We", "believe", "that", "our", "product", "candidates", "offer", "innovative", "therapeutic", "approaches", "and", "may", "provide", "significant", "advantages", "relative", "to", "current", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p54_s1", "idA": "1430306_14_item1_p135_s2", "sentA": "We believe that key competitive factors that will affect the development and commercial success of our product candidates are efficacy, safety, tolerability, reliability, price and reimbursement level.", "sentB": "We believe that our product candidates offer innovative therapeutic approaches and may provide significant advantages relative to current therapies.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "key", "competitive", "factors", "that", "will", "affect", "the", "development", "and", "commercial", "success", "of", "our", "product", "candidates", "are", "efficacy,", "safety,", "tolerability,", "reliability,", "price", "and", "reimbursement", "level.", "<tag2>", "We", "believe", "that", "our", "product", "candidates", "offer", "innovative", "therapeutic", "approaches", "and", "may", "provide", "significant", "advantages", "relative", "to", "current", "therapies.", "<tag3>"], "wordsA": ["We", "believe", "that", "key", "competitive", "factors", "that", "will", "affect", "the", "development", "and", "commercial", "success", "of", "our", "product", "candidates", "are", "efficacy,", "safety,", "tolerability,", "reliability,", "price", "and", "reimbursement", "level."], "wordsB": ["We", "believe", "that", "our", "product", "candidates", "offer", "innovative", "therapeutic", "approaches", "and", "may", "provide", "significant", "advantages", "relative", "to", "current", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p32_s1", "idA": "1430306_14_item1_p136_s0", "sentA": "The markets for medicines to treat FM, PTSD, ETTH and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "sentB": "We complement our management team with a network of scientific, clinical, and regulatory advisors that includes recognized experts in the fields of FM, PTSD, ETTH and other central nervous system disorders.", "type": 2, "words": ["<tag1>", "The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD,", "ETTH", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag2>", "We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "FM,", "PTSD,", "ETTH", "and", "other", "central", "nervous", "system", "disorders.", "<tag3>"], "wordsA": ["The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD,", "ETTH", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "wordsB": ["We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "FM,", "PTSD,", "ETTH", "and", "other", "central", "nervous", "system", "disorders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p111_s0", "idA": "1430306_14_item1_p138_s1", "sentA": "Medications prescribed for ETTH include Fiorinal, Fiorinal with Codeine, Fioricet, and their generic equivalents.", "sentB": "Medications that are FDA approved for ETTH include Fiorinal, Fiorinal with Codeine, Fioricet, and their generic equivalents.", "type": 2, "words": ["<tag1>", "Medications", "prescribed", "for", "ETTH", "include", "Fiorinal,", "Fiorinal", "with", "Codeine,", "Fioricet,", "and", "their", "generic", "equivalents.", "<tag2>", "Medications", "that", "are", "FDA", "approved", "for", "ETTH", "include", "Fiorinal,", "Fiorinal", "with", "Codeine,", "Fioricet,", "and", "their", "generic", "equivalents.", "<tag3>"], "wordsA": ["Medications", "prescribed", "for", "ETTH", "include", "Fiorinal,", "Fiorinal", "with", "Codeine,", "Fioricet,", "and", "their", "generic", "equivalents."], "wordsB": ["Medications", "that", "are", "FDA", "approved", "for", "ETTH", "include", "Fiorinal,", "Fiorinal", "with", "Codeine,", "Fioricet,", "and", "their", "generic", "equivalents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p112_s0", "idA": "1430306_14_item1_p139_s0", "sentA": "As of March 2014, we are aware of several companies developing prescription medications for FM, including Allergan, Chelsea Therapeutics, Meda, Merck, Pfizer, RiboCor and Theravance.", "sentB": "A number of companies are developing prescription medications for FM, including Allergan, Daiichi Sankyo, Meda, Merck, Pfizer, RiboCor and Theravance.", "type": 2, "words": ["<tag1>", "As", "of", "March", "2014,", "we", "are", "aware", "of", "several", "companies", "developing", "prescription", "medications", "for", "FM,", "including", "Allergan,", "Chelsea", "Therapeutics,", "Meda,", "Merck,", "Pfizer,", "RiboCor", "and", "Theravance.", "<tag2>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "FM,", "including", "Allergan,", "Daiichi", "Sankyo,", "Meda,", "Merck,", "Pfizer,", "RiboCor", "and", "Theravance.", "<tag3>"], "wordsA": ["As", "of", "March", "2014,", "we", "are", "aware", "of", "several", "companies", "developing", "prescription", "medications", "for", "FM,", "including", "Allergan,", "Chelsea", "Therapeutics,", "Meda,", "Merck,", "Pfizer,", "RiboCor", "and", "Theravance."], "wordsB": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "FM,", "including", "Allergan,", "Daiichi", "Sankyo,", "Meda,", "Merck,", "Pfizer,", "RiboCor", "and", "Theravance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p29_s0", "idA": "1430306_14_item1_p139_s1", "sentA": "Clinical trials in the U.S. are registered with the FDA and reported on the website www.clinicaltrials.gov.", "sentB": "An estimated 3.5% of adults in the U.S. suffer from PTSD, a chronic disorder that is characterized by avoidance, emotional numbing, hyperarousal, and sleep disturbances.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov.", "<tag2>", "An", "estimated", "3.5%", "of", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "sleep", "disturbances.", "<tag3>"], "wordsA": ["Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov."], "wordsB": ["An", "estimated", "3.5%", "of", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "sleep", "disturbances."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p51_s1", "idA": "1430306_14_item1_p139_s1", "sentA": "Clinical trials in the U.S. are registered with the FDA and reported on the website www.clinicaltrials.gov.", "sentB": "However, an analysis of IMS data (period 2008-2014) indicates that approximately 10 million prescriptions for medications intended to treat non-migraine headaches are issued each year in the U.S., a figure that excludes prescriptions for NSAIDs, indicating that many people who suffer from ETTH seek prescription options.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov.", "<tag2>", "However,", "an", "analysis", "of", "IMS", "data", "(period", "2008-2014)", "indicates", "that", "approximately", "10", "million", "prescriptions", "for", "medications", "intended", "to", "treat", "non-migraine", "headaches", "are", "issued", "each", "year", "in", "the", "U.S.,", "a", "figure", "that", "excludes", "prescriptions", "for", "NSAIDs,", "indicating", "that", "many", "people", "who", "suffer", "from", "ETTH", "seek", "prescription", "options.", "<tag3>"], "wordsA": ["Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov."], "wordsB": ["However,", "an", "analysis", "of", "IMS", "data", "(period", "2008-2014)", "indicates", "that", "approximately", "10", "million", "prescriptions", "for", "medications", "intended", "to", "treat", "non-migraine", "headaches", "are", "issued", "each", "year", "in", "the", "U.S.,", "a", "figure", "that", "excludes", "prescriptions", "for", "NSAIDs,", "indicating", "that", "many", "people", "who", "suffer", "from", "ETTH", "seek", "prescription", "options."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p95_s0", "idA": "1430306_14_item1_p139_s1", "sentA": "Clinical trials in the U.S. are registered with the FDA and reported on the website www.clinicaltrials.gov.", "sentB": "Between 1990 and 1998, Midrin was the second most-widely prescribed headache medication in the U.S. (Gibbs et al, Headache 2003;43:330-335).", "type": 2, "words": ["<tag1>", "Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov.", "<tag2>", "Between", "1990", "and", "1998,", "Midrin", "was", "the", "second", "most-widely", "prescribed", "headache", "medication", "in", "the", "U.S.", "(Gibbs", "et", "al,", "Headache", "2003;43:330-335).", "<tag3>"], "wordsA": ["Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov."], "wordsB": ["Between", "1990", "and", "1998,", "Midrin", "was", "the", "second", "most-widely", "prescribed", "headache", "medication", "in", "the", "U.S.", "(Gibbs", "et", "al,", "Headache", "2003;43:330-335)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p96_s0", "idA": "1430306_14_item1_p139_s1", "sentA": "Clinical trials in the U.S. are registered with the FDA and reported on the website www.clinicaltrials.gov.", "sentB": "Products containing IMH were first commercialized in the U.S. between 1938 and 1962.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov.", "<tag2>", "Products", "containing", "IMH", "were", "first", "commercialized", "in", "the", "U.S.", "between", "1938", "and", "1962.", "<tag3>"], "wordsA": ["Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov."], "wordsB": ["Products", "containing", "IMH", "were", "first", "commercialized", "in", "the", "U.S.", "between", "1938", "and", "1962."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p22_s1", "idA": "1430306_14_item1_p13_s0", "sentA": "In connection with founding Tonix Sub, L L and Plumbline entered into an intellectual property transfer and assignment agreement with Tonix Sub for the purpose of assigning patents and transferring intellectual property and know-how in exchange for shares of common stock of Tonix Sub.", "sentB": "Tonix International Holding formed Tonix Ireland for the purpose of manufacturing, trading and developing Tonix products.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "founding", "Tonix", "Sub,", "L", "L", "and", "Plumbline", "entered", "into", "an", "intellectual", "property", "transfer", "and", "assignment", "agreement", "with", "Tonix", "Sub", "for", "the", "purpose", "of", "assigning", "patents", "and", "transferring", "intellectual", "property", "and", "know-how", "in", "exchange", "for", "shares", "of", "common", "stock", "of", "Tonix", "Sub.", "<tag2>", "Tonix", "International", "Holding", "formed", "Tonix", "Ireland", "for", "the", "purpose", "of", "manufacturing,", "trading", "and", "developing", "Tonix", "products.", "<tag3>"], "wordsA": ["In", "connection", "with", "founding", "Tonix", "Sub,", "L", "L", "and", "Plumbline", "entered", "into", "an", "intellectual", "property", "transfer", "and", "assignment", "agreement", "with", "Tonix", "Sub", "for", "the", "purpose", "of", "assigning", "patents", "and", "transferring", "intellectual", "property", "and", "know-how", "in", "exchange", "for", "shares", "of", "common", "stock", "of", "Tonix", "Sub."], "wordsB": ["Tonix", "International", "Holding", "formed", "Tonix", "Ireland", "for", "the", "purpose", "of", "manufacturing,", "trading", "and", "developing", "Tonix", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p113_s0", "idA": "1430306_14_item1_p140_s0", "sentA": "Medications that are used off-label for the treatment of FM include:", "sentB": "Medications that are used off-label for the treatment of FM include gabapentin; anti-depressants, such as amitriptyline, venlafaxine, and trazodone; muscle relaxants, such as cyclobenzaprine; tramadol; opioids; and benzodiazepine, as well as non-benzodiazepine sedative hypnotics.", "type": 2, "words": ["<tag1>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:", "<tag2>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include", "gabapentin;", "anti-depressants,", "such", "as", "amitriptyline,", "venlafaxine,", "and", "trazodone;", "muscle", "relaxants,", "such", "as", "cyclobenzaprine;", "tramadol;", "opioids;", "and", "benzodiazepine,", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics.", "<tag3>"], "wordsA": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:"], "wordsB": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include", "gabapentin;", "anti-depressants,", "such", "as", "amitriptyline,", "venlafaxine,", "and", "trazodone;", "muscle", "relaxants,", "such", "as", "cyclobenzaprine;", "tramadol;", "opioids;", "and", "benzodiazepine,", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p116_s0", "idA": "1430306_14_item1_p140_s0", "sentA": "Medications that are used off-label for the treatment of FM include:", "sentB": "Medications that are used off-label for the treatment of ETTH include simple and combination analgesics, which may include opioids, anti-depressants, such as amitriptyline, and drugs approved for the treatment of migraine, such as sumatriptan.", "type": 2, "words": ["<tag1>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:", "<tag2>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "ETTH", "include", "simple", "and", "combination", "analgesics,", "which", "may", "include", "opioids,", "anti-depressants,", "such", "as", "amitriptyline,", "and", "drugs", "approved", "for", "the", "treatment", "of", "migraine,", "such", "as", "sumatriptan.", "<tag3>"], "wordsA": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:"], "wordsB": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "ETTH", "include", "simple", "and", "combination", "analgesics,", "which", "may", "include", "opioids,", "anti-depressants,", "such", "as", "amitriptyline,", "and", "drugs", "approved", "for", "the", "treatment", "of", "migraine,", "such", "as", "sumatriptan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p52_s0", "idA": "1430306_14_item1_p140_s0", "sentA": "Medications that are used off-label for the treatment of FM include:", "sentB": "All of the products that are FDA-approved for the treatment of ETTH contain butalbital, a barbiturate that is a Drug Enforcement Agency Schedule III substance.", "type": 2, "words": ["<tag1>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:", "<tag2>", "All", "of", "the", "products", "that", "are", "FDA-approved", "for", "the", "treatment", "of", "ETTH", "contain", "butalbital,", "a", "barbiturate", "that", "is", "a", "Drug", "Enforcement", "Agency", "Schedule", "III", "substance.", "<tag3>"], "wordsA": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:"], "wordsB": ["All", "of", "the", "products", "that", "are", "FDA-approved", "for", "the", "treatment", "of", "ETTH", "contain", "butalbital,", "a", "barbiturate", "that", "is", "a", "Drug", "Enforcement", "Agency", "Schedule", "III", "substance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p59_s1", "idA": "1430306_14_item1_p140_s0", "sentA": "Medications that are used off-label for the treatment of FM include:", "sentB": "CBP products are not indicated for the treatment of FM or PTSD, and are approved for acute use (two to three weeks) only.", "type": 2, "words": ["<tag1>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:", "<tag2>", "CBP", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD,", "and", "are", "approved", "for", "acute", "use", "(two", "to", "three", "weeks)", "only.", "<tag3>"], "wordsA": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "FM", "include:"], "wordsB": ["CBP", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD,", "and", "are", "approved", "for", "acute", "use", "(two", "to", "three", "weeks)", "only."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p36_s3", "idA": "1430306_14_item1_p141_s0", "sentA": "benzodiazepine as well as non-benzodiazepine sedative hypnotics.", "sentB": "In the case of TNX-201, we own patent applications protecting its composition-of-matter as well as our discoveries which relate to its molecular target.", "type": 2, "words": ["<tag1>", "benzodiazepine", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics.", "<tag2>", "In", "the", "case", "of", "TNX-201,", "we", "own", "patent", "applications", "protecting", "its", "composition-of-matter", "as", "well", "as", "our", "discoveries", "which", "relate", "to", "its", "molecular", "target.", "<tag3>"], "wordsA": ["benzodiazepine", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics."], "wordsB": ["In", "the", "case", "of", "TNX-201,", "we", "own", "patent", "applications", "protecting", "its", "composition-of-matter", "as", "well", "as", "our", "discoveries", "which", "relate", "to", "its", "molecular", "target."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p47_s2", "idA": "1430306_14_item1_p141_s0", "sentA": "benzodiazepine as well as non-benzodiazepine sedative hypnotics.", "sentB": "Other antidepressants, as well as sedative-hypnotics and antipsychotics, are commonly prescribed off-label despite generally weak clinical evidence in support of their use.", "type": 2, "words": ["<tag1>", "benzodiazepine", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics.", "<tag2>", "Other", "antidepressants,", "as", "well", "as", "sedative-hypnotics", "and", "antipsychotics,", "are", "commonly", "prescribed", "off-label", "despite", "generally", "weak", "clinical", "evidence", "in", "support", "of", "their", "use.", "<tag3>"], "wordsA": ["benzodiazepine", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics."], "wordsB": ["Other", "antidepressants,", "as", "well", "as", "sedative-hypnotics", "and", "antipsychotics,", "are", "commonly", "prescribed", "off-label", "despite", "generally", "weak", "clinical", "evidence", "in", "support", "of", "their", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p66_s7", "idA": "1430306_14_item1_p141_s0", "sentA": "benzodiazepine as well as non-benzodiazepine sedative hypnotics.", "sentB": "In addition, statistically significant improvements with TNX-102 SL were observed on several FIQ-R items (pain, sleep quality, anxiety, stiffness, and sensitivity) as well as on the overall symptom subdomain.", "type": 2, "words": ["<tag1>", "benzodiazepine", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics.", "<tag2>", "In", "addition,", "statistically", "significant", "improvements", "with", "TNX-102", "SL", "were", "observed", "on", "several", "FIQ-R", "items", "(pain,", "sleep", "quality,", "anxiety,", "stiffness,", "and", "sensitivity)", "as", "well", "as", "on", "the", "overall", "symptom", "subdomain.", "<tag3>"], "wordsA": ["benzodiazepine", "as", "well", "as", "non-benzodiazepine", "sedative", "hypnotics."], "wordsB": ["In", "addition,", "statistically", "significant", "improvements", "with", "TNX-102", "SL", "were", "observed", "on", "several", "FIQ-R", "items", "(pain,", "sleep", "quality,", "anxiety,", "stiffness,", "and", "sensitivity)", "as", "well", "as", "on", "the", "overall", "symptom", "subdomain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p114_s0", "idA": "1430306_14_item1_p142_s0", "sentA": "A number of companies are developing prescription medications for PTSD, including AstraZeneca, Biotie, Forest, GlaxoSmithKline, Lundbeck, Marinus Pharmaceuticals, Merck, Nanotherapeutics, Johnson and Johnson, Pfizer, and UCB.", "sentB": "A number of companies are developing prescription medications for PTSD, including Actavis, Johnson and Johnson, Lundbeck, Marinus Pharmaceuticals, Merck, Otsuka, and Pfizer.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "AstraZeneca,", "Biotie,", "Forest,", "GlaxoSmithKline,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Nanotherapeutics,", "Johnson", "and", "Johnson,", "Pfizer,", "and", "UCB.", "<tag2>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "AstraZeneca,", "Biotie,", "Forest,", "GlaxoSmithKline,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Nanotherapeutics,", "Johnson", "and", "Johnson,", "Pfizer,", "and", "UCB."], "wordsB": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p47_s0", "idA": "1430306_14_item1_p142_s1", "sentA": "Medications that are used off-label for the treatment of PTSD include anti-depressants, such as nefazodone and trazodone; the antihistamine cyproheptadine; and certain atypical antipsychotics, such as olanzapine and risperidone.", "sentB": "The treatment of PTSD typically involves a multidimensional approach that includes pharmacologic and psychosocial interventions.", "type": 2, "words": ["<tag1>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone.", "<tag2>", "The", "treatment", "of", "PTSD", "typically", "involves", "a", "multidimensional", "approach", "that", "includes", "pharmacologic", "and", "psychosocial", "interventions.", "<tag3>"], "wordsA": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone."], "wordsB": ["The", "treatment", "of", "PTSD", "typically", "involves", "a", "multidimensional", "approach", "that", "includes", "pharmacologic", "and", "psychosocial", "interventions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p115_s0", "idA": "1430306_14_item1_p143_s0", "sentA": "A number of companies are developing prescription medications for tension-type headache, including Bayer, GlaxoSmithKline, and Pfizer.", "sentB": "A number of companies are developing prescription medications for ETTH, including Bayer, GlaxoSmithKline, and Pfizer.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "tension-type", "headache,", "including", "Bayer,", "GlaxoSmithKline,", "and", "Pfizer.", "<tag2>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "ETTH,", "including", "Bayer,", "GlaxoSmithKline,", "and", "Pfizer.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "tension-type", "headache,", "including", "Bayer,", "GlaxoSmithKline,", "and", "Pfizer."], "wordsB": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "ETTH,", "including", "Bayer,", "GlaxoSmithKline,", "and", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p29_s3", "idA": "1430306_14_item1_p144_s0", "sentA": "We believe that we have an extensive patent portfolio and substantial know-how relating to TNX-102 SL and our other product candidates.", "sentB": "We believe that TNX-102 SL may be ideally suited to address the need for a treatment for PTSD that is effective, safe, and well-tolerated.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates.", "<tag2>", "We", "believe", "that", "TNX-102", "SL", "may", "be", "ideally", "suited", "to", "address", "the", "need", "for", "a", "treatment", "for", "PTSD", "that", "is", "effective,", "safe,", "and", "well-tolerated.", "<tag3>"], "wordsA": ["We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates."], "wordsB": ["We", "believe", "that", "TNX-102", "SL", "may", "be", "ideally", "suited", "to", "address", "the", "need", "for", "a", "treatment", "for", "PTSD", "that", "is", "effective,", "safe,", "and", "well-tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p38_s1", "idA": "1430306_14_item1_p144_s0", "sentA": "We believe that we have an extensive patent portfolio and substantial know-how relating to TNX-102 SL and our other product candidates.", "sentB": "We will seek to maximize the value of TNX-102 SL, TNX-201, and our other product candidates by pursuing other indications and commercial opportunities for such candidates.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates.", "<tag2>", "We", "will", "seek", "to", "maximize", "the", "value", "of", "TNX-102", "SL,", "TNX-201,", "and", "our", "other", "product", "candidates", "by", "pursuing", "other", "indications", "and", "commercial", "opportunities", "for", "such", "candidates.", "<tag3>"], "wordsA": ["We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates."], "wordsB": ["We", "will", "seek", "to", "maximize", "the", "value", "of", "TNX-102", "SL,", "TNX-201,", "and", "our", "other", "product", "candidates", "by", "pursuing", "other", "indications", "and", "commercial", "opportunities", "for", "such", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p117_s2", "idA": "1430306_14_item1_p144_s2", "sentA": "As of March 21, 2014, we are either the owner of record of or own the contractual right to five issued U.S. patents and 26 issued non-U.S. patents.", "sentB": "As of February 23, 2015, we are either the owner of record of or own the contractual right to five issued U.S. patents and 10 issued non-U.S. patents covering 26 jurisdictions.", "type": 2, "words": ["<tag1>", "As", "of", "March", "21,", "2014,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "26", "issued", "non-U.S.", "patents.", "<tag2>", "As", "of", "February", "23,", "2015,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "10", "issued", "non-U.S.", "patents", "covering", "26", "jurisdictions.", "<tag3>"], "wordsA": ["As", "of", "March", "21,", "2014,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "26", "issued", "non-U.S.", "patents."], "wordsB": ["As", "of", "February", "23,", "2015,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "10", "issued", "non-U.S.", "patents", "covering", "26", "jurisdictions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p117_s3", "idA": "1430306_14_item1_p144_s3", "sentA": "We are actively pursuing an additional 13 U.S. patent applications, of which three are provisional and 10 are non-provisional, four international patent applications, and 21 non-U.S. patent applications.", "sentB": "We are actively pursuing an additional 16 U.S. patent applications, of which six are provisional and 10 are non-provisional, three international patent applications, and 36 non-U.S./non-international patent applications.", "type": 2, "words": ["<tag1>", "We", "are", "actively", "pursuing", "an", "additional", "13", "U.S.", "patent", "applications,", "of", "which", "three", "are", "provisional", "and", "10", "are", "non-provisional,", "four", "international", "patent", "applications,", "and", "21", "non-U.S.", "patent", "applications.", "<tag2>", "We", "are", "actively", "pursuing", "an", "additional", "16", "U.S.", "patent", "applications,", "of", "which", "six", "are", "provisional", "and", "10", "are", "non-provisional,", "three", "international", "patent", "applications,", "and", "36", "non-U.S./non-international", "patent", "applications.", "<tag3>"], "wordsA": ["We", "are", "actively", "pursuing", "an", "additional", "13", "U.S.", "patent", "applications,", "of", "which", "three", "are", "provisional", "and", "10", "are", "non-provisional,", "four", "international", "patent", "applications,", "and", "21", "non-U.S.", "patent", "applications."], "wordsB": ["We", "are", "actively", "pursuing", "an", "additional", "16", "U.S.", "patent", "applications,", "of", "which", "six", "are", "provisional", "and", "10", "are", "non-provisional,", "three", "international", "patent", "applications,", "and", "36", "non-U.S./non-international", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p39_s1", "idA": "1430306_14_item1_p145_s2", "sentA": "We also rely on trade secrets that may be important to the development of our business.", "sentB": "Background information on the diseases and related commercial markets that may be addressed by our clinical-stage product candidates is set forth below.", "type": 2, "words": ["<tag1>", "We", "also", "rely", "on", "trade", "secrets", "that", "may", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag2>", "Background", "information", "on", "the", "diseases", "and", "related", "commercial", "markets", "that", "may", "be", "addressed", "by", "our", "clinical-stage", "product", "candidates", "is", "set", "forth", "below.", "<tag3>"], "wordsA": ["We", "also", "rely", "on", "trade", "secrets", "that", "may", "be", "important", "to", "the", "development", "of", "our", "business."], "wordsB": ["Background", "information", "on", "the", "diseases", "and", "related", "commercial", "markets", "that", "may", "be", "addressed", "by", "our", "clinical-stage", "product", "candidates", "is", "set", "forth", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p123_s1", "idA": "1430306_14_item1_p150_s1", "sentA": "The Hatch-Waxman Amendments permit a patent term extension of up to five years beyond the statutory 20 year term of the patent for the approved product.", "sentB": "The Hatch-Waxman Amendments permit a patent term extension of up to five years beyond the statutory 20-year term of the patent for the approved product if the active ingredient has not been previously approved in the U.S.", "type": 2, "words": ["<tag1>", "The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20", "year", "term", "of", "the", "patent", "for", "the", "approved", "product.", "<tag2>", "The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20-year", "term", "of", "the", "patent", "for", "the", "approved", "product", "if", "the", "active", "ingredient", "has", "not", "been", "previously", "approved", "in", "the", "U.S.", "<tag3>"], "wordsA": ["The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20", "year", "term", "of", "the", "patent", "for", "the", "approved", "product."], "wordsB": ["The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20-year", "term", "of", "the", "patent", "for", "the", "approved", "product", "if", "the", "active", "ingredient", "has", "not", "been", "previously", "approved", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p124_s0", "idA": "1430306_14_item1_p151_s0", "sentA": "The patent portfolios for our proprietary technology platform and our three most advanced product candidates as of March 21, 2014 are summarized below.", "sentB": "The patent portfolios for our proprietary technology platform and our three most advanced product candidates as of February 23, 2015 are summarized below.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "21,", "2014", "are", "summarized", "below.", "<tag2>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "February", "23,", "2015", "are", "summarized", "below.", "<tag3>"], "wordsA": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "21,", "2014", "are", "summarized", "below."], "wordsB": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "February", "23,", "2015", "are", "summarized", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p125_s0", "idA": "1430306_14_item1_p152_s2", "sentA": "The patent portfolio for TNX-102 SL relating to the Iglehart Technology includes patent applications directed to pharmaceutical compositions containing CBP, CBP formulations, and methods for treating FM and other CNS conditions utilizing CBP.", "sentB": "Our patent portfolio for TNX-102 SL includes patent applications directed to pharmaceutical compositions containing CBP, CBP formulations, and methods for treating FM and other CNS conditions utilizing CBP.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Iglehart", "Technology", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP.", "<tag2>", "Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Iglehart", "Technology", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP."], "wordsB": ["Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p125_s1", "idA": "1430306_14_item1_p152_s3", "sentA": "The Iglehart Technology portfolio includes issued U.S. patents, such as U.S. Patent Nos. 6,541,523, 6,395,788 and 6,358,944, and corresponding issued foreign counterpart patents or applications.", "sentB": "The portfolio includes issued U.S. patents, such as U.S. Patent Nos. 6,541,523, 6,395,788 and 6,358,944, and corresponding issued foreign counterpart patents or applications.", "type": 2, "words": ["<tag1>", "The", "Iglehart", "Technology", "portfolio", "includes", "issued", "U.S.", "patents,", "such", "as", "U.S.", "Patent", "Nos.", "6,541,523,", "6,395,788", "and", "6,358,944,", "and", "corresponding", "issued", "foreign", "counterpart", "patents", "or", "applications.", "<tag2>", "The", "portfolio", "includes", "issued", "U.S.", "patents,", "such", "as", "U.S.", "Patent", "Nos.", "6,541,523,", "6,395,788", "and", "6,358,944,", "and", "corresponding", "issued", "foreign", "counterpart", "patents", "or", "applications.", "<tag3>"], "wordsA": ["The", "Iglehart", "Technology", "portfolio", "includes", "issued", "U.S.", "patents,", "such", "as", "U.S.", "Patent", "Nos.", "6,541,523,", "6,395,788", "and", "6,358,944,", "and", "corresponding", "issued", "foreign", "counterpart", "patents", "or", "applications."], "wordsB": ["The", "portfolio", "includes", "issued", "U.S.", "patents,", "such", "as", "U.S.", "Patent", "Nos.", "6,541,523,", "6,395,788", "and", "6,358,944,", "and", "corresponding", "issued", "foreign", "counterpart", "patents", "or", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p126_s0", "idA": "1430306_14_item1_p153_s0", "sentA": "The unique pharmacokinetic profile of TNX-102 was discovered by Tonix and its development partners and is termed the PK Technology.", "sentB": "The unique pharmacokinetic profile of TNX-102 SL was discovered by Tonix and its development partners and is termed the PK Technology.", "type": 2, "words": ["<tag1>", "The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology.", "<tag2>", "The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "SL", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology.", "<tag3>"], "wordsA": ["The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology."], "wordsB": ["The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "SL", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p59_s3", "idA": "1430306_14_item1_p153_s0", "sentA": "The unique pharmacokinetic profile of TNX-102 was discovered by Tonix and its development partners and is termed the PK Technology.", "sentB": "Extended-release CBP capsules mimic, and flatten, the pharmacokinetic profile of three times per day immediate-release CBP tablets.", "type": 2, "words": ["<tag1>", "The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology.", "<tag2>", "Extended-release", "CBP", "capsules", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets.", "<tag3>"], "wordsA": ["The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology."], "wordsB": ["Extended-release", "CBP", "capsules", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p128_s0", "idA": "1430306_14_item1_p155_s0", "sentA": "The patent portfolio for TNX-201, relating to isometheptene isomers and termed the Isometheptene Technology includes patent applications directed to a purified isomer of isometheptene, pharmaceutical compositions containing isometheptene, isometheptene formulations, methods for modulating headache and other CNS conditions and treating CNS conditions utilizing isometheptene isomers, and methods of manufacturing isometheptene isomers.", "sentB": "Our patent portfolio for TNX-201, relating to isometheptene isomers and termed the Isometheptene Technology , includes patent applications directed to a purified isomer of isometheptene, pharmaceutical compositions containing isometheptene, isometheptene formulations, methods for modulating headache and other CNS conditions and treating CNS conditions utilizing isometheptene isomers, and methods of manufacturing isometheptene isomers.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "TNX-201,", "relating", "to", "isometheptene", "isomers", "and", "termed", "the", "Isometheptene", "Technology", "includes", "patent", "applications", "directed", "to", "a", "purified", "isomer", "of", "isometheptene,", "pharmaceutical", "compositions", "containing", "isometheptene,", "isometheptene", "formulations,", "methods", "for", "modulating", "headache", "and", "other", "CNS", "conditions", "and", "treating", "CNS", "conditions", "utilizing", "isometheptene", "isomers,", "and", "methods", "of", "manufacturing", "isometheptene", "isomers.", "<tag2>", "Our", "patent", "portfolio", "for", "TNX-201,", "relating", "to", "isometheptene", "isomers", "and", "termed", "the", "Isometheptene", "Technology", ",", "includes", "patent", "applications", "directed", "to", "a", "purified", "isomer", "of", "isometheptene,", "pharmaceutical", "compositions", "containing", "isometheptene,", "isometheptene", "formulations,", "methods", "for", "modulating", "headache", "and", "other", "CNS", "conditions", "and", "treating", "CNS", "conditions", "utilizing", "isometheptene", "isomers,", "and", "methods", "of", "manufacturing", "isometheptene", "isomers.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "TNX-201,", "relating", "to", "isometheptene", "isomers", "and", "termed", "the", "Isometheptene", "Technology", "includes", "patent", "applications", "directed", "to", "a", "purified", "isomer", "of", "isometheptene,", "pharmaceutical", "compositions", "containing", "isometheptene,", "isometheptene", "formulations,", "methods", "for", "modulating", "headache", "and", "other", "CNS", "conditions", "and", "treating", "CNS", "conditions", "utilizing", "isometheptene", "isomers,", "and", "methods", "of", "manufacturing", "isometheptene", "isomers."], "wordsB": ["Our", "patent", "portfolio", "for", "TNX-201,", "relating", "to", "isometheptene", "isomers", "and", "termed", "the", "Isometheptene", "Technology", ",", "includes", "patent", "applications", "directed", "to", "a", "purified", "isomer", "of", "isometheptene,", "pharmaceutical", "compositions", "containing", "isometheptene,", "isometheptene", "formulations,", "methods", "for", "modulating", "headache", "and", "other", "CNS", "conditions", "and", "treating", "CNS", "conditions", "utilizing", "isometheptene", "isomers,", "and", "methods", "of", "manufacturing", "isometheptene", "isomers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p128_s1", "idA": "1430306_14_item1_p156_s0", "sentA": "The Isometheptene Technology patent portfolio includes U.S. Patent Application No. 14/158,735 as well as U.S. Provisional Patent Application Nos.", "sentB": "The Isometheptene Technology patent portfolio includes U.S. Patent Application No. 14/158,735 as well as U.S. Provisional Patent Application No 61/953,715.", "type": 2, "words": ["<tag1>", "The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Provisional", "Patent", "Application", "Nos.", "<tag2>", "The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Provisional", "Patent", "Application", "No", "61/953,715.", "<tag3>"], "wordsA": ["The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Provisional", "Patent", "Application", "Nos."], "wordsB": ["The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Provisional", "Patent", "Application", "No", "61/953,715."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p129_s0", "idA": "1430306_14_item1_p157_s0", "sentA": "The patent portfolio for disulfiram and selegiline combinations includes patents and patent applications.", "sentB": "Our patent portfolio for disulfiram and selegiline combinations includes patents and patent applications.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "disulfiram", "and", "selegiline", "combinations", "includes", "patents", "and", "patent", "applications.", "<tag2>", "Our", "patent", "portfolio", "for", "disulfiram", "and", "selegiline", "combinations", "includes", "patents", "and", "patent", "applications.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "disulfiram", "and", "selegiline", "combinations", "includes", "patents", "and", "patent", "applications."], "wordsB": ["Our", "patent", "portfolio", "for", "disulfiram", "and", "selegiline", "combinations", "includes", "patents", "and", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p36_s2", "idA": "1430306_14_item1_p157_s0", "sentA": "The patent portfolio for disulfiram and selegiline combinations includes patents and patent applications.", "sentB": "In the case of TNX-102 SL, we own patents and patent applications protecting its composition-of-matter, certain methods of its use, its formulation, and its pharmacokinetic properties.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "disulfiram", "and", "selegiline", "combinations", "includes", "patents", "and", "patent", "applications.", "<tag2>", "In", "the", "case", "of", "TNX-102", "SL,", "we", "own", "patents", "and", "patent", "applications", "protecting", "its", "composition-of-matter,", "certain", "methods", "of", "its", "use,", "its", "formulation,", "and", "its", "pharmacokinetic", "properties.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "disulfiram", "and", "selegiline", "combinations", "includes", "patents", "and", "patent", "applications."], "wordsB": ["In", "the", "case", "of", "TNX-102", "SL,", "we", "own", "patents", "and", "patent", "applications", "protecting", "its", "composition-of-matter,", "certain", "methods", "of", "its", "use,", "its", "formulation,", "and", "its", "pharmacokinetic", "properties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p87_s1", "idA": "1430306_14_item1_p157_s2", "sentA": "It includes issued U.S. Patent Nos. 8,093,300 and 8,481,599.", "sentB": "This trial will be conducted at approximately 25 U.S. centers.", "type": 2, "words": ["<tag1>", "It", "includes", "issued", "U.S.", "Patent", "Nos.", "8,093,300", "and", "8,481,599.", "<tag2>", "This", "trial", "will", "be", "conducted", "at", "approximately", "25", "U.S.", "centers.", "<tag3>"], "wordsA": ["It", "includes", "issued", "U.S.", "Patent", "Nos.", "8,093,300", "and", "8,481,599."], "wordsB": ["This", "trial", "will", "be", "conducted", "at", "approximately", "25", "U.S.", "centers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p23_s2", "idA": "1430306_14_item1_p157_s3", "sentA": "The patent expiring last is expected to expire in 2024, excluding any patent term extensions.", "sentB": "In the first quarter of 2015, Tonix Barbados is expected to be dissolved and its assets are to be transferred to Tonix International Holding.", "type": 2, "words": ["<tag1>", "The", "patent", "expiring", "last", "is", "expected", "to", "expire", "in", "2024,", "excluding", "any", "patent", "term", "extensions.", "<tag2>", "In", "the", "first", "quarter", "of", "2015,", "Tonix", "Barbados", "is", "expected", "to", "be", "dissolved", "and", "its", "assets", "are", "to", "be", "transferred", "to", "Tonix", "International", "Holding.", "<tag3>"], "wordsA": ["The", "patent", "expiring", "last", "is", "expected", "to", "expire", "in", "2024,", "excluding", "any", "patent", "term", "extensions."], "wordsB": ["In", "the", "first", "quarter", "of", "2015,", "Tonix", "Barbados", "is", "expected", "to", "be", "dissolved", "and", "its", "assets", "are", "to", "be", "transferred", "to", "Tonix", "International", "Holding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p62_s2", "idA": "1430306_14_item1_p158_s0", "sentA": "We are currently developing TNX-102 SL for the management of post-traumatic stress disorder, an indication that is relevant to biodefense.", "sentB": "These indications are fibromyalgia, for which TNX-102 SL is advancing into Phase 3 development, and post-traumatic stress disorder, for which TNX-102 SL is in Phase 2 development.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "developing", "TNX-102", "SL", "for", "the", "management", "of", "post-traumatic", "stress", "disorder,", "an", "indication", "that", "is", "relevant", "to", "biodefense.", "<tag2>", "These", "indications", "are", "fibromyalgia,", "for", "which", "TNX-102", "SL", "is", "advancing", "into", "Phase", "3", "development,", "and", "post-traumatic", "stress", "disorder,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "2", "development.", "<tag3>"], "wordsA": ["We", "are", "currently", "developing", "TNX-102", "SL", "for", "the", "management", "of", "post-traumatic", "stress", "disorder,", "an", "indication", "that", "is", "relevant", "to", "biodefense."], "wordsB": ["These", "indications", "are", "fibromyalgia,", "for", "which", "TNX-102", "SL", "is", "advancing", "into", "Phase", "3", "development,", "and", "post-traumatic", "stress", "disorder,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "2", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p132_s0", "idA": "1430306_14_item1_p158_s2", "sentA": "With respect to the radioprotection drug candidate, we acquired U.S. non-provisional Patent Application No. 14,203,733 and related intellectual property rights.", "sentB": "With respect to the smallpox vaccine candidate, we acquired U.S. non-provisional Patent Application No. 14,207,727 and related intellectual property rights.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "the", "radioprotection", "drug", "candidate,", "we", "acquired", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,203,733", "and", "related", "intellectual", "property", "rights.", "<tag2>", "With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "we", "acquired", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights.", "<tag3>"], "wordsA": ["With", "respect", "to", "the", "radioprotection", "drug", "candidate,", "we", "acquired", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,203,733", "and", "related", "intellectual", "property", "rights."], "wordsB": ["With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "we", "acquired", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p17_s3", "idA": "1430306_14_item1_p15_s3", "sentA": "In June 2010, Tonix Sub entered into consulting agreements with L L and Lederman Co., LLC, or Lederman Co, and also acquired certain rights to develop isometheptene mucate as a treatment for certain types of headaches from Lederman Co, which we are developing as TNX-201.", "sentB": "In June 2010, Tonix Sub entered into consulting agreements with L L and Lederman Co., LLC, or Lederman Co, and also acquired certain rights to develop isometheptene mucate as a treatment for certain types of headaches from Lederman Co.", "type": 2, "words": ["<tag1>", "In", "June", "2010,", "Tonix", "Sub", "entered", "into", "consulting", "agreements", "with", "L", "L", "and", "Lederman", "Co.,", "LLC,", "or", "Lederman", "Co,", "and", "also", "acquired", "certain", "rights", "to", "develop", "isometheptene", "mucate", "as", "a", "treatment", "for", "certain", "types", "of", "headaches", "from", "Lederman", "Co,", "which", "we", "are", "developing", "as", "TNX-201.", "<tag2>", "In", "June", "2010,", "Tonix", "Sub", "entered", "into", "consulting", "agreements", "with", "L", "L", "and", "Lederman", "Co.,", "LLC,", "or", "Lederman", "Co,", "and", "also", "acquired", "certain", "rights", "to", "develop", "isometheptene", "mucate", "as", "a", "treatment", "for", "certain", "types", "of", "headaches", "from", "Lederman", "Co.", "<tag3>"], "wordsA": ["In", "June", "2010,", "Tonix", "Sub", "entered", "into", "consulting", "agreements", "with", "L", "L", "and", "Lederman", "Co.,", "LLC,", "or", "Lederman", "Co,", "and", "also", "acquired", "certain", "rights", "to", "develop", "isometheptene", "mucate", "as", "a", "treatment", "for", "certain", "types", "of", "headaches", "from", "Lederman", "Co,", "which", "we", "are", "developing", "as", "TNX-201."], "wordsB": ["In", "June", "2010,", "Tonix", "Sub", "entered", "into", "consulting", "agreements", "with", "L", "L", "and", "Lederman", "Co.,", "LLC,", "or", "Lederman", "Co,", "and", "also", "acquired", "certain", "rights", "to", "develop", "isometheptene", "mucate", "as", "a", "treatment", "for", "certain", "types", "of", "headaches", "from", "Lederman", "Co."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p138_s0", "idA": "1430306_14_item1_p163_s0", "sentA": "We seek trademark protection in the United States and outside of the United States where available and when appropriate.", "sentB": "We seek trademark and service mark protection in the United States and outside of the United States where available and when appropriate.", "type": 2, "words": ["<tag1>", "We", "seek", "trademark", "protection", "in", "the", "United", "States", "and", "outside", "of", "the", "United", "States", "where", "available", "and", "when", "appropriate.", "<tag2>", "We", "seek", "trademark", "and", "service", "mark", "protection", "in", "the", "United", "States", "and", "outside", "of", "the", "United", "States", "where", "available", "and", "when", "appropriate.", "<tag3>"], "wordsA": ["We", "seek", "trademark", "protection", "in", "the", "United", "States", "and", "outside", "of", "the", "United", "States", "where", "available", "and", "when", "appropriate."], "wordsB": ["We", "seek", "trademark", "and", "service", "mark", "protection", "in", "the", "United", "States", "and", "outside", "of", "the", "United", "States", "where", "available", "and", "when", "appropriate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p138_s1", "idA": "1430306_14_item1_p163_s1", "sentA": "We have applied for a trademark for Tonix Pharmaceuticals in the United States.", "sentB": "On December 16, 2014, we received U.S. registration number 4,656,463 as a service mark for Tonix Pharmaceuticals in the United States.", "type": 2, "words": ["<tag1>", "We", "have", "applied", "for", "a", "trademark", "for", "Tonix", "Pharmaceuticals", "in", "the", "United", "States.", "<tag2>", "On", "December", "16,", "2014,", "we", "received", "U.S.", "registration", "number", "4,656,463", "as", "a", "service", "mark", "for", "Tonix", "Pharmaceuticals", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["We", "have", "applied", "for", "a", "trademark", "for", "Tonix", "Pharmaceuticals", "in", "the", "United", "States."], "wordsB": ["On", "December", "16,", "2014,", "we", "received", "U.S.", "registration", "number", "4,656,463", "as", "a", "service", "mark", "for", "Tonix", "Pharmaceuticals", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p25_s2", "idA": "1430306_14_item1_p164_s0", "sentA": "Our current patents owned are as follows:", "sentB": "Our clinical-stage product candidates are as follows:", "type": 2, "words": ["<tag1>", "Our", "current", "patents", "owned", "are", "as", "follows:", "<tag2>", "Our", "clinical-stage", "product", "candidates", "are", "as", "follows:", "<tag3>"], "wordsA": ["Our", "current", "patents", "owned", "are", "as", "follows:"], "wordsB": ["Our", "clinical-stage", "product", "candidates", "are", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p139_s0", "idA": "1430306_14_item1_p168_s0", "sentA": "We have one employee dedicated to research and development.", "sentB": "We have eight employees dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "one", "employee", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "eight", "employees", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "one", "employee", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "eight", "employees", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p182_s1", "idA": "1430306_14_item1_p168_s0", "sentA": "We have one employee dedicated to research and development.", "sentB": "We have eight employees dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "one", "employee", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "eight", "employees", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "one", "employee", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "eight", "employees", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p139_s3", "idA": "1430306_14_item1_p168_s3", "sentA": "Our research and development operations are located in New York, NY.", "sentB": "Our research and development operations are located in New York, NY and San Jose, CA.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY.", "<tag2>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY."], "wordsB": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p182_s2", "idA": "1430306_14_item1_p168_s3", "sentA": "Our research and development operations are located in New York, NY.", "sentB": "Our research and development operations are located in New York, NY and San Jose, CA.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY.", "<tag2>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY."], "wordsB": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p182_s3", "idA": "1430306_14_item1_p168_s4", "sentA": "We have used, and expect to continue to use, third parties to conduct our preclinical and clinical studies.", "sentB": "We have used, and expect to continue to use, third parties to conduct our preclinical and clinical studies as well as part-time employees.", "type": 2, "words": ["<tag1>", "We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies.", "<tag2>", "We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies", "as", "well", "as", "part-time", "employees.", "<tag3>"], "wordsA": ["We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies."], "wordsB": ["We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies", "as", "well", "as", "part-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p140_s0", "idA": "1430306_14_item1_p169_s0", "sentA": "We have contracted with third-party contract manufacturing organizations, or CMOs, for the manufacture of TNX-102 SL for investigational purposes, including preclinical and clinical testing, as follows:", "sentB": "We have contracted with third-party cGMP-compliant contract manufacturing organizations, or CMOs, for the manufacture of TNX-102 SL and TNX-201 drug substances and drug products for investigational purposes, including nonclinical and clinical testing.", "type": 2, "words": ["<tag1>", "We", "have", "contracted", "with", "third-party", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "for", "investigational", "purposes,", "including", "preclinical", "and", "clinical", "testing,", "as", "follows:", "<tag2>", "We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "and", "TNX-201", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing.", "<tag3>"], "wordsA": ["We", "have", "contracted", "with", "third-party", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "for", "investigational", "purposes,", "including", "preclinical", "and", "clinical", "testing,", "as", "follows:"], "wordsB": ["We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "and", "TNX-201", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p22_s3", "idA": "1430306_14_item1_p16_s0", "sentA": "In July 2010, Tonix Sub changed its name to Tonix Pharmaceuticals, Inc.", "sentB": "As consideration, Tonix International Holding paid licensing fees to Tonix Sub.", "type": 2, "words": ["<tag1>", "In", "July", "2010,", "Tonix", "Sub", "changed", "its", "name", "to", "Tonix", "Pharmaceuticals,", "Inc.", "<tag2>", "As", "consideration,", "Tonix", "International", "Holding", "paid", "licensing", "fees", "to", "Tonix", "Sub.", "<tag3>"], "wordsA": ["In", "July", "2010,", "Tonix", "Sub", "changed", "its", "name", "to", "Tonix", "Pharmaceuticals,", "Inc."], "wordsB": ["As", "consideration,", "Tonix", "International", "Holding", "paid", "licensing", "fees", "to", "Tonix", "Sub."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p141_s0", "idA": "1430306_14_item1_p170_s0", "sentA": "All of our compounds are small molecules, synthesized using industry standard processes, and our drug products are formulated using commercially available raw materials.", "sentB": "All of our compounds are small molecules, synthesized using industry standard processes, and our drug products are formulated using commercially available pharmaceutical grade excipients.", "type": 2, "words": ["<tag1>", "All", "of", "our", "compounds", "are", "small", "molecules,", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "raw", "materials.", "<tag2>", "All", "of", "our", "compounds", "are", "small", "molecules,", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "pharmaceutical", "grade", "excipients.", "<tag3>"], "wordsA": ["All", "of", "our", "compounds", "are", "small", "molecules,", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "raw", "materials."], "wordsB": ["All", "of", "our", "compounds", "are", "small", "molecules,", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "pharmaceutical", "grade", "excipients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p155_s2", "idA": "1430306_14_item1_p184_s2", "sentA": "Success in early stage clinical trials does not assure success in later stage clinical trials.", "sentB": "Success in early-stage clinical trials does not assure success in later-stage clinical trials.", "type": 2, "words": ["<tag1>", "Success", "in", "early", "stage", "clinical", "trials", "does", "not", "assure", "success", "in", "later", "stage", "clinical", "trials.", "<tag2>", "Success", "in", "early-stage", "clinical", "trials", "does", "not", "assure", "success", "in", "later-stage", "clinical", "trials.", "<tag3>"], "wordsA": ["Success", "in", "early", "stage", "clinical", "trials", "does", "not", "assure", "success", "in", "later", "stage", "clinical", "trials."], "wordsB": ["Success", "in", "early-stage", "clinical", "trials", "does", "not", "assure", "success", "in", "later-stage", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p107_s0", "idA": "1430306_14_item1_p187_s2", "sentA": "The FDA may deny approval of an NDA if the applicable regulatory criteria are not satisfied.", "sentB": "The FDA Animal Efficacy Rule provides a mechanism for product licensure when human efficacy studies are not feasible or ethical.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "deny", "approval", "of", "an", "NDA", "if", "the", "applicable", "regulatory", "criteria", "are", "not", "satisfied.", "<tag2>", "The", "FDA", "Animal", "Efficacy", "Rule", "provides", "a", "mechanism", "for", "product", "licensure", "when", "human", "efficacy", "studies", "are", "not", "feasible", "or", "ethical.", "<tag3>"], "wordsA": ["The", "FDA", "may", "deny", "approval", "of", "an", "NDA", "if", "the", "applicable", "regulatory", "criteria", "are", "not", "satisfied."], "wordsB": ["The", "FDA", "Animal", "Efficacy", "Rule", "provides", "a", "mechanism", "for", "product", "licensure", "when", "human", "efficacy", "studies", "are", "not", "feasible", "or", "ethical."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p54_s2", "idA": "1430306_14_item1_p189_s1", "sentA": "In some cases, extensive, time-consuming, and costly clinical and nonclinical studies may still be required for approval of a Section 505(b)(2) NDA.", "sentB": "The following table summarizes our most advanced product candidates, for which we plan to complete the required clinical and nonclinical studies to support their NDA filings:", "type": 2, "words": ["<tag1>", "In", "some", "cases,", "extensive,", "time-consuming,", "and", "costly", "clinical", "and", "nonclinical", "studies", "may", "still", "be", "required", "for", "approval", "of", "a", "Section", "505(b)(2)", "NDA.", "<tag2>", "The", "following", "table", "summarizes", "our", "most", "advanced", "product", "candidates,", "for", "which", "we", "plan", "to", "complete", "the", "required", "clinical", "and", "nonclinical", "studies", "to", "support", "their", "NDA", "filings:", "<tag3>"], "wordsA": ["In", "some", "cases,", "extensive,", "time-consuming,", "and", "costly", "clinical", "and", "nonclinical", "studies", "may", "still", "be", "required", "for", "approval", "of", "a", "Section", "505(b)(2)", "NDA."], "wordsB": ["The", "following", "table", "summarizes", "our", "most", "advanced", "product", "candidates,", "for", "which", "we", "plan", "to", "complete", "the", "required", "clinical", "and", "nonclinical", "studies", "to", "support", "their", "NDA", "filings:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p21_s0", "idA": "1430306_14_item1_p19_s0", "sentA": "On April 23, 2013, we formed Tonix Canada.", "sentB": "On April 23, 2013, Tonix Sub formed Tonix Canada.", "type": 2, "words": ["<tag1>", "On", "April", "23,", "2013,", "we", "formed", "Tonix", "Canada.", "<tag2>", "On", "April", "23,", "2013,", "Tonix", "Sub", "formed", "Tonix", "Canada.", "<tag3>"], "wordsA": ["On", "April", "23,", "2013,", "we", "formed", "Tonix", "Canada."], "wordsB": ["On", "April", "23,", "2013,", "Tonix", "Sub", "formed", "Tonix", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p67_s1", "idA": "1430306_14_item1_p200_s1", "sentA": "This exclusivity prohibits the submission of a Section 505(b)(2) NDA for any drug product containing the active ingredient during the five-year exclusivity period.", "sentB": "Among subjects randomized to the active and control arms, 86% and 83%, respectively, completed the 12-week dosing period.", "type": 2, "words": ["<tag1>", "This", "exclusivity", "prohibits", "the", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "any", "drug", "product", "containing", "the", "active", "ingredient", "during", "the", "five-year", "exclusivity", "period.", "<tag2>", "Among", "subjects", "randomized", "to", "the", "active", "and", "control", "arms,", "86%", "and", "83%,", "respectively,", "completed", "the", "12-week", "dosing", "period.", "<tag3>"], "wordsA": ["This", "exclusivity", "prohibits", "the", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "any", "drug", "product", "containing", "the", "active", "ingredient", "during", "the", "five-year", "exclusivity", "period."], "wordsB": ["Among", "subjects", "randomized", "to", "the", "active", "and", "control", "arms,", "86%", "and", "83%,", "respectively,", "completed", "the", "12-week", "dosing", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p174_s1", "idA": "1430306_14_item1_p206_s1", "sentA": "In the event that our POC study of TNX-102 SL in PTSD is successful, we will request Breakthrough Therapy designation for TNX-102 SL.", "sentB": "In the event that our AtEase study of TNX-102 SL in PTSD is successful, we will request Breakthrough Therapy designation for TNX-102 SL.", "type": 2, "words": ["<tag1>", "In", "the", "event", "that", "our", "POC", "study", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "request", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL.", "<tag2>", "In", "the", "event", "that", "our", "AtEase", "study", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "request", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL.", "<tag3>"], "wordsA": ["In", "the", "event", "that", "our", "POC", "study", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "request", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL."], "wordsB": ["In", "the", "event", "that", "our", "AtEase", "study", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "request", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p97_s2", "idA": "1430306_14_item1_p207_s4", "sentA": "Any drug products manufactured or distributed by us pursuant to FDA approvals are subject to continuing regulation by the FDA, including:", "sentB": "Under the DESI, products containing IMH are currently sanctioned from marketing by the FDA, although certain combination drug products containing IMH remain on the market in the Unapproved Drug Other category.", "type": 2, "words": ["<tag1>", "Any", "drug", "products", "manufactured", "or", "distributed", "by", "us", "pursuant", "to", "FDA", "approvals", "are", "subject", "to", "continuing", "regulation", "by", "the", "FDA,", "including:", "<tag2>", "Under", "the", "DESI,", "products", "containing", "IMH", "are", "currently", "sanctioned", "from", "marketing", "by", "the", "FDA,", "although", "certain", "combination", "drug", "products", "containing", "IMH", "remain", "on", "the", "market", "in", "the", "Unapproved", "Drug", "Other", "category.", "<tag3>"], "wordsA": ["Any", "drug", "products", "manufactured", "or", "distributed", "by", "us", "pursuant", "to", "FDA", "approvals", "are", "subject", "to", "continuing", "regulation", "by", "the", "FDA,", "including:"], "wordsB": ["Under", "the", "DESI,", "products", "containing", "IMH", "are", "currently", "sanctioned", "from", "marketing", "by", "the", "FDA,", "although", "certain", "combination", "drug", "products", "containing", "IMH", "remain", "on", "the", "market", "in", "the", "Unapproved", "Drug", "Other", "category."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p22_s0", "idA": "1430306_14_item1_p20_s0", "sentA": "On October 24, 2013, Tonix Sub formed Tonix Barbados.", "sentB": "On October 29, 2014, Tonix Sub formed Tonix International Holding for the purpose of acquiring the rights to develop and commercialize Tonix products.", "type": 2, "words": ["<tag1>", "On", "October", "24,", "2013,", "Tonix", "Sub", "formed", "Tonix", "Barbados.", "<tag2>", "On", "October", "29,", "2014,", "Tonix", "Sub", "formed", "Tonix", "International", "Holding", "for", "the", "purpose", "of", "acquiring", "the", "rights", "to", "develop", "and", "commercialize", "Tonix", "products.", "<tag3>"], "wordsA": ["On", "October", "24,", "2013,", "Tonix", "Sub", "formed", "Tonix", "Barbados."], "wordsB": ["On", "October", "29,", "2014,", "Tonix", "Sub", "formed", "Tonix", "International", "Holding", "for", "the", "purpose", "of", "acquiring", "the", "rights", "to", "develop", "and", "commercialize", "Tonix", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p23_s1", "idA": "1430306_14_item1_p20_s1", "sentA": "On December 31, 2013, Tonix Barbados entered into a license agreement and a cost-sharing agreement with Tonix Sub, pursuant to which Tonix Barbados acquired the rights to develop and commercialize TNX-102 SL and TNX-201 for non-US markets in exchange for (1) cost sharing of research and development costs going forward and (2) royalties of 8% and 6% on net sales of TNX-102 SL and TNX-201, respectively.", "sentB": "Tonix Barbados had previously entered into a license agreement and a cost-sharing agreement with Tonix Sub, pursuant to which Tonix Barbados acquired the rights to develop and commercialize certain products (TNX-102 SL and TNX-201) for non-U.S. markets.", "type": 2, "words": ["<tag1>", "On", "December", "31,", "2013,", "Tonix", "Barbados", "entered", "into", "a", "license", "agreement", "and", "a", "cost-sharing", "agreement", "with", "Tonix", "Sub,", "pursuant", "to", "which", "Tonix", "Barbados", "acquired", "the", "rights", "to", "develop", "and", "commercialize", "TNX-102", "SL", "and", "TNX-201", "for", "non-US", "markets", "in", "exchange", "for", "(1)", "cost", "sharing", "of", "research", "and", "development", "costs", "going", "forward", "and", "(2)", "royalties", "of", "8%", "and", "6%", "on", "net", "sales", "of", "TNX-102", "SL", "and", "TNX-201,", "respectively.", "<tag2>", "Tonix", "Barbados", "had", "previously", "entered", "into", "a", "license", "agreement", "and", "a", "cost-sharing", "agreement", "with", "Tonix", "Sub,", "pursuant", "to", "which", "Tonix", "Barbados", "acquired", "the", "rights", "to", "develop", "and", "commercialize", "certain", "products", "(TNX-102", "SL", "and", "TNX-201)", "for", "non-U.S.", "markets.", "<tag3>"], "wordsA": ["On", "December", "31,", "2013,", "Tonix", "Barbados", "entered", "into", "a", "license", "agreement", "and", "a", "cost-sharing", "agreement", "with", "Tonix", "Sub,", "pursuant", "to", "which", "Tonix", "Barbados", "acquired", "the", "rights", "to", "develop", "and", "commercialize", "TNX-102", "SL", "and", "TNX-201", "for", "non-US", "markets", "in", "exchange", "for", "(1)", "cost", "sharing", "of", "research", "and", "development", "costs", "going", "forward", "and", "(2)", "royalties", "of", "8%", "and", "6%", "on", "net", "sales", "of", "TNX-102", "SL", "and", "TNX-201,", "respectively."], "wordsB": ["Tonix", "Barbados", "had", "previously", "entered", "into", "a", "license", "agreement", "and", "a", "cost-sharing", "agreement", "with", "Tonix", "Sub,", "pursuant", "to", "which", "Tonix", "Barbados", "acquired", "the", "rights", "to", "develop", "and", "commercialize", "certain", "products", "(TNX-102", "SL", "and", "TNX-201)", "for", "non-U.S.", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p182_s0", "idA": "1430306_14_item1_p214_s0", "sentA": "As of March 26, 2014, we had six full-time employees, of whom three are executives, one is finance and investor relations, and two are administrative.", "sentB": "As of February 27, 2015, we had 16 full-time employees, of whom seven hold M.D., PharmD. and/or Ph.D. degrees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "26,", "2014,", "we", "had", "six", "full-time", "employees,", "of", "whom", "three", "are", "executives,", "one", "is", "finance", "and", "investor", "relations,", "and", "two", "are", "administrative.", "<tag2>", "As", "of", "February", "27,", "2015,", "we", "had", "16", "full-time", "employees,", "of", "whom", "seven", "hold", "M.D.,", "PharmD.", "and/or", "Ph.D.", "degrees.", "<tag3>"], "wordsA": ["As", "of", "March", "26,", "2014,", "we", "had", "six", "full-time", "employees,", "of", "whom", "three", "are", "executives,", "one", "is", "finance", "and", "investor", "relations,", "and", "two", "are", "administrative."], "wordsB": ["As", "of", "February", "27,", "2015,", "we", "had", "16", "full-time", "employees,", "of", "whom", "seven", "hold", "M.D.,", "PharmD.", "and/or", "Ph.D.", "degrees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p183_s0", "idA": "1430306_14_item1_p214_s1", "sentA": "None of our employees are represented by a labor union, and we believe that our relations with our employees are good.", "sentB": "None of our employees are represented by a collective bargaining agreement, and we believe that our relations with our employees are good.", "type": 2, "words": ["<tag1>", "None", "of", "our", "employees", "are", "represented", "by", "a", "labor", "union,", "and", "we", "believe", "that", "our", "relations", "with", "our", "employees", "are", "good.", "<tag2>", "None", "of", "our", "employees", "are", "represented", "by", "a", "collective", "bargaining", "agreement,", "and", "we", "believe", "that", "our", "relations", "with", "our", "employees", "are", "good.", "<tag3>"], "wordsA": ["None", "of", "our", "employees", "are", "represented", "by", "a", "labor", "union,", "and", "we", "believe", "that", "our", "relations", "with", "our", "employees", "are", "good."], "wordsB": ["None", "of", "our", "employees", "are", "represented", "by", "a", "collective", "bargaining", "agreement,", "and", "we", "believe", "that", "our", "relations", "with", "our", "employees", "are", "good."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p24_s0", "idA": "1430306_14_item1_p21_s0", "sentA": "We are a pharmaceutical company dedicated to the development of novel pharmaceutical products for challenging problems.", "sentB": "We are a clinical-stage pharmaceutical company dedicated to the development of novel prescription products for common yet challenging medical disorders.", "type": 2, "words": ["<tag1>", "We", "are", "a", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "novel", "pharmaceutical", "products", "for", "challenging", "problems.", "<tag2>", "We", "are", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "novel", "prescription", "products", "for", "common", "yet", "challenging", "medical", "disorders.", "<tag3>"], "wordsA": ["We", "are", "a", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "novel", "pharmaceutical", "products", "for", "challenging", "problems."], "wordsB": ["We", "are", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "novel", "prescription", "products", "for", "common", "yet", "challenging", "medical", "disorders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p24_s1", "idA": "1430306_14_item1_p21_s1", "sentA": "Our lead drug development programs are directed toward CNS conditions that manifest with pain that originates in the brain, or central pain.", "sentB": "Our clinical-stage product candidates, TNX-102 SL (cyclobenzaprine HCl sublingual tablet) and TNX-201 ((R)-isometheptene mucate), are directed toward conditions affecting the CNS.", "type": 2, "words": ["<tag1>", "Our", "lead", "drug", "development", "programs", "are", "directed", "toward", "CNS", "conditions", "that", "manifest", "with", "pain", "that", "originates", "in", "the", "brain,", "or", "central", "pain.", "<tag2>", "Our", "clinical-stage", "product", "candidates,", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablet)", "and", "TNX-201", "((R)-isometheptene", "mucate),", "are", "directed", "toward", "conditions", "affecting", "the", "CNS.", "<tag3>"], "wordsA": ["Our", "lead", "drug", "development", "programs", "are", "directed", "toward", "CNS", "conditions", "that", "manifest", "with", "pain", "that", "originates", "in", "the", "brain,", "or", "central", "pain."], "wordsB": ["Our", "clinical-stage", "product", "candidates,", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablet)", "and", "TNX-201", "((R)-isometheptene", "mucate),", "are", "directed", "toward", "conditions", "affecting", "the", "CNS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p26_s0", "idA": "1430306_14_item1_p23_s0", "sentA": "Our lead product candidate, TNX-102 sublingual tablet, or TNX-102 SL, is a small, rapidly disintegrating tablet containing CBP for sublingual administration.", "sentB": "TNX-102 SL is a small, rapidly disintegrating tablet containing cyclobenzaprine for sublingual administration that we are developing for two indications, both of which are underserved by currently available therapies.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL,", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration.", "<tag2>", "TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine", "for", "sublingual", "administration", "that", "we", "are", "developing", "for", "two", "indications,", "both", "of", "which", "are", "underserved", "by", "currently", "available", "therapies.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate,", "TNX-102", "sublingual", "tablet,", "or", "TNX-102", "SL,", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration."], "wordsB": ["TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine", "for", "sublingual", "administration", "that", "we", "are", "developing", "for", "two", "indications,", "both", "of", "which", "are", "underserved", "by", "currently", "available", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p24_s3", "idA": "1430306_14_item1_p23_s1", "sentA": "We are developing TNX-102 SL as a bedtime therapy for the management of FM and PTSD.", "sentB": "We are also developing TNX-102 SL as a potential treatment for post-traumatic stress disorder, or PTSD, and we commenced a Phase 2 trial for this indication in January 2015.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "as", "a", "bedtime", "therapy", "for", "the", "management", "of", "FM", "and", "PTSD.", "<tag2>", "We", "are", "also", "developing", "TNX-102", "SL", "as", "a", "potential", "treatment", "for", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "and", "we", "commenced", "a", "Phase", "2", "trial", "for", "this", "indication", "in", "January", "2015.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "as", "a", "bedtime", "therapy", "for", "the", "management", "of", "FM", "and", "PTSD."], "wordsB": ["We", "are", "also", "developing", "TNX-102", "SL", "as", "a", "potential", "treatment", "for", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "and", "we", "commenced", "a", "Phase", "2", "trial", "for", "this", "indication", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p34_s1", "idA": "1430306_14_item1_p23_s2", "sentA": "CBP is the active pharmaceutical ingredient of two widely prescribed products, and we are pursuing the development of TNX-102 SL for indications distinct from those for which current CBP products are approved.", "sentB": "We currently are pursuing the development of TNX-102 SL for two separate indications, FM and PTSD, and we are developing TNX-201 for ETTH.", "type": 2, "words": ["<tag1>", "CBP", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "products,", "and", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "indications", "distinct", "from", "those", "for", "which", "current", "CBP", "products", "are", "approved.", "<tag2>", "We", "currently", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications,", "FM", "and", "PTSD,", "and", "we", "are", "developing", "TNX-201", "for", "ETTH.", "<tag3>"], "wordsA": ["CBP", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "products,", "and", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "indications", "distinct", "from", "those", "for", "which", "current", "CBP", "products", "are", "approved."], "wordsB": ["We", "currently", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications,", "FM", "and", "PTSD,", "and", "we", "are", "developing", "TNX-201", "for", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p59_s0", "idA": "1430306_14_item1_p23_s2", "sentA": "CBP is the active pharmaceutical ingredient of two widely prescribed products, and we are pursuing the development of TNX-102 SL for indications distinct from those for which current CBP products are approved.", "sentB": "CBP is the active ingredient of two products, or CBP products, that are approved in the U.S. for the treatment of muscle spasm: Flexeril (oral immediate-release tablet, 5 mg and 10 mg dosage forms) and Amrix (oral extended-release capsule, 15 mg and 30 mg dosage forms).", "type": 2, "words": ["<tag1>", "CBP", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "products,", "and", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "indications", "distinct", "from", "those", "for", "which", "current", "CBP", "products", "are", "approved.", "<tag2>", "CBP", "is", "the", "active", "ingredient", "of", "two", "products,", "or", "CBP", "products,", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "Flexeril", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "Amrix", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms).", "<tag3>"], "wordsA": ["CBP", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "products,", "and", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "indications", "distinct", "from", "those", "for", "which", "current", "CBP", "products", "are", "approved."], "wordsB": ["CBP", "is", "the", "active", "ingredient", "of", "two", "products,", "or", "CBP", "products,", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "Flexeril", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "Amrix", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p62_s1", "idA": "1430306_14_item1_p23_s2", "sentA": "CBP is the active pharmaceutical ingredient of two widely prescribed products, and we are pursuing the development of TNX-102 SL for indications distinct from those for which current CBP products are approved.", "sentB": "Currently, we are pursuing the development of TNX-102 SL for two separate indications.", "type": 2, "words": ["<tag1>", "CBP", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "products,", "and", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "indications", "distinct", "from", "those", "for", "which", "current", "CBP", "products", "are", "approved.", "<tag2>", "Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications.", "<tag3>"], "wordsA": ["CBP", "is", "the", "active", "pharmaceutical", "ingredient", "of", "two", "widely", "prescribed", "products,", "and", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "indications", "distinct", "from", "those", "for", "which", "current", "CBP", "products", "are", "approved."], "wordsB": ["Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p62_s0", "idA": "1430306_14_item1_p24_s0", "sentA": "We expect that any applications we submit to the Food and Drug Administration, or FDA, for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, which we believe will allow for a shorter timeline of clinical and non-clinical development as compared to that needed to fulfill the requirements of Section 505(b)(1), under which new chemical entities, or NCEs, that have never been marketed in the United States, are generally developed to meet the FDA s requirements for new drug approvals.", "sentB": "We expect that any applications we submit to the Food and Drug Administration, or FDA, for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, which we believe will allow for a shorter timeline of clinical and non-clinical development as compared to that needed to fulfill the requirements of Section 505(b)(1), under which new chemical entities, or NCEs, that have never been approved in the United States, are generally developed to meet the FDA s new drug registration requirements.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "marketed", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "requirements", "for", "new", "drug", "approvals.", "<tag2>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "new", "drug", "registration", "requirements.", "<tag3>"], "wordsA": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "marketed", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "requirements", "for", "new", "drug", "approvals."], "wordsB": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "new", "drug", "registration", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p59_s2", "idA": "1430306_14_item1_p25_s2", "sentA": "For example, our Phase 1 comparative studies showed that TNX-102 SL results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following administration relative to oral CBP tablets.", "sentB": "Immediate-release, or IR, CBP tablets are recommended for three times per day dosing, which results in relatively stable blood levels of CBP after several days of treatment.", "type": 2, "words": ["<tag1>", "For", "example,", "our", "Phase", "1", "comparative", "studies", "showed", "that", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration", "relative", "to", "oral", "CBP", "tablets.", "<tag2>", "Immediate-release,", "or", "IR,", "CBP", "tablets", "are", "recommended", "for", "three", "times", "per", "day", "dosing,", "which", "results", "in", "relatively", "stable", "blood", "levels", "of", "CBP", "after", "several", "days", "of", "treatment.", "<tag3>"], "wordsA": ["For", "example,", "our", "Phase", "1", "comparative", "studies", "showed", "that", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration", "relative", "to", "oral", "CBP", "tablets."], "wordsB": ["Immediate-release,", "or", "IR,", "CBP", "tablets", "are", "recommended", "for", "three", "times", "per", "day", "dosing,", "which", "results", "in", "relatively", "stable", "blood", "levels", "of", "CBP", "after", "several", "days", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p60_s3", "idA": "1430306_14_item1_p25_s2", "sentA": "For example, our Phase 1 comparative studies showed that TNX-102 SL results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following administration relative to oral CBP tablets.", "sentB": "Our Phase 1 comparative trials showed that, on a dose-adjusted basis, TNX-102 SL results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following sublingual administration relative to oral immediate-release CBP tablets.", "type": 2, "words": ["<tag1>", "For", "example,", "our", "Phase", "1", "comparative", "studies", "showed", "that", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration", "relative", "to", "oral", "CBP", "tablets.", "<tag2>", "Our", "Phase", "1", "comparative", "trials", "showed", "that,", "on", "a", "dose-adjusted", "basis,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "sublingual", "administration", "relative", "to", "oral", "immediate-release", "CBP", "tablets.", "<tag3>"], "wordsA": ["For", "example,", "our", "Phase", "1", "comparative", "studies", "showed", "that", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "administration", "relative", "to", "oral", "CBP", "tablets."], "wordsB": ["Our", "Phase", "1", "comparative", "trials", "showed", "that,", "on", "a", "dose-adjusted", "basis,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "sublingual", "administration", "relative", "to", "oral", "immediate-release", "CBP", "tablets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p68_s1", "idA": "1430306_14_item1_p26_s0", "sentA": "TNX-102 SL was generally well-tolerated, with no serious adverse events reported in these studies.", "sentB": "These local adverse events did not appear to affect either rates of retention of study participants or their compliance with taking TNX-102 SL.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag2>", "These", "local", "adverse", "events", "did", "not", "appear", "to", "affect", "either", "rates", "of", "retention", "of", "study", "participants", "or", "their", "compliance", "with", "taking", "TNX-102", "SL.", "<tag3>"], "wordsA": ["TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "wordsB": ["These", "local", "adverse", "events", "did", "not", "appear", "to", "affect", "either", "rates", "of", "retention", "of", "study", "participants", "or", "their", "compliance", "with", "taking", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p68_s2", "idA": "1430306_14_item1_p26_s0", "sentA": "TNX-102 SL was generally well-tolerated, with no serious adverse events reported in these studies.", "sentB": "Systemic adverse events were similar between TNX-102 SL and placebo.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag2>", "Systemic", "adverse", "events", "were", "similar", "between", "TNX-102", "SL", "and", "placebo.", "<tag3>"], "wordsA": ["TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "wordsB": ["Systemic", "adverse", "events", "were", "similar", "between", "TNX-102", "SL", "and", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p68_s3", "idA": "1430306_14_item1_p26_s0", "sentA": "TNX-102 SL was generally well-tolerated, with no serious adverse events reported in these studies.", "sentB": "No serious adverse events were reported.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag2>", "No", "serious", "adverse", "events", "were", "reported.", "<tag3>"], "wordsA": ["TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "wordsB": ["No", "serious", "adverse", "events", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p61_s1", "idA": "1430306_14_item1_p26_s1", "sentA": "Some subjects experienced transient numbness on the tongue after TNX-102 SL administration, and other side-effects reported were similar to those associated with current CBP products.", "sentB": "Some subjects experienced transient numbness on the tongue after TNX-102 SL administration, and other side-effects reported were similar to those reported with approved CBP products.", "type": 2, "words": ["<tag1>", "Some", "subjects", "experienced", "transient", "numbness", "on", "the", "tongue", "after", "TNX-102", "SL", "administration,", "and", "other", "side-effects", "reported", "were", "similar", "to", "those", "associated", "with", "current", "CBP", "products.", "<tag2>", "Some", "subjects", "experienced", "transient", "numbness", "on", "the", "tongue", "after", "TNX-102", "SL", "administration,", "and", "other", "side-effects", "reported", "were", "similar", "to", "those", "reported", "with", "approved", "CBP", "products.", "<tag3>"], "wordsA": ["Some", "subjects", "experienced", "transient", "numbness", "on", "the", "tongue", "after", "TNX-102", "SL", "administration,", "and", "other", "side-effects", "reported", "were", "similar", "to", "those", "associated", "with", "current", "CBP", "products."], "wordsB": ["Some", "subjects", "experienced", "transient", "numbness", "on", "the", "tongue", "after", "TNX-102", "SL", "administration,", "and", "other", "side-effects", "reported", "were", "similar", "to", "those", "reported", "with", "approved", "CBP", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p63_s0", "idA": "1430306_14_item1_p27_s0", "sentA": "We are developing TNX-102 SL for the treatment of FM under a U.S. Investigational New Drug application, or IND, and we held an End-of-Phase 2/Pre-Phase 3 meeting with the FDA in February 2013.", "sentB": "We are developing TNX-102 SL for the treatment of FM under an effective investigational new drug, or IND, application.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "a", "U.S.", "Investigational", "New", "Drug", "application,", "or", "IND,", "and", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "a", "U.S.", "Investigational", "New", "Drug", "application,", "or", "IND,", "and", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p63_s1", "idA": "1430306_14_item1_p27_s2", "sentA": "Our therapeutic strategy is supported by results from a randomized, double-blind, placebo-controlled Phase 2a study of low dose TNX-102 immediate release capsules, or TNX-102 capsules, which we have also referred to as VLD CBP, taken between dinner and bedtime in 36 subjects with FM, which demonstrated a significant decrease in pain and other symptoms after eight weeks of treatment.", "sentB": "Our therapeutic approach to FM was initially supported by results from a randomized, double-blind, placebo-controlled Phase 2a clinical trial of TNX-102 immediate release capsules, or TNX-102 capsules, which we have also referred to as VLD CBP (Moldofsky et al, J Rheumatol 2011;38:2653-63).", "type": 2, "words": ["<tag1>", "Our", "therapeutic", "strategy", "is", "supported", "by", "results", "from", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2a", "study", "of", "low", "dose", "TNX-102", "immediate", "release", "capsules,", "or", "TNX-102", "capsules,", "which", "we", "have", "also", "referred", "to", "as", "VLD", "CBP,", "taken", "between", "dinner", "and", "bedtime", "in", "36", "subjects", "with", "FM,", "which", "demonstrated", "a", "significant", "decrease", "in", "pain", "and", "other", "symptoms", "after", "eight", "weeks", "of", "treatment.", "<tag2>", "Our", "therapeutic", "approach", "to", "FM", "was", "initially", "supported", "by", "results", "from", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2a", "clinical", "trial", "of", "TNX-102", "immediate", "release", "capsules,", "or", "TNX-102", "capsules,", "which", "we", "have", "also", "referred", "to", "as", "VLD", "CBP", "(Moldofsky", "et", "al,", "J", "Rheumatol", "2011;38:2653-63).", "<tag3>"], "wordsA": ["Our", "therapeutic", "strategy", "is", "supported", "by", "results", "from", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2a", "study", "of", "low", "dose", "TNX-102", "immediate", "release", "capsules,", "or", "TNX-102", "capsules,", "which", "we", "have", "also", "referred", "to", "as", "VLD", "CBP,", "taken", "between", "dinner", "and", "bedtime", "in", "36", "subjects", "with", "FM,", "which", "demonstrated", "a", "significant", "decrease", "in", "pain", "and", "other", "symptoms", "after", "eight", "weeks", "of", "treatment."], "wordsB": ["Our", "therapeutic", "approach", "to", "FM", "was", "initially", "supported", "by", "results", "from", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2a", "clinical", "trial", "of", "TNX-102", "immediate", "release", "capsules,", "or", "TNX-102", "capsules,", "which", "we", "have", "also", "referred", "to", "as", "VLD", "CBP", "(Moldofsky", "et", "al,", "J", "Rheumatol", "2011;38:2653-63)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p63_s3", "idA": "1430306_14_item1_p27_s3", "sentA": "This study also demonstrated that TNX-102 capsules led to a significant improvement in objective measures of sleep quality, which we believe relates to the mechanism by which CBP leads to improvement of FM symptoms.", "sentB": "This study also demonstrated that treatment with TNX-102 capsules led to a significant improvement in objective measures of sleep quality, which we believe relates to the mechanism by which CBP leads to improvement of FM symptoms.", "type": 2, "words": ["<tag1>", "This", "study", "also", "demonstrated", "that", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms.", "<tag2>", "This", "study", "also", "demonstrated", "that", "treatment", "with", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms.", "<tag3>"], "wordsA": ["This", "study", "also", "demonstrated", "that", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms."], "wordsB": ["This", "study", "also", "demonstrated", "that", "treatment", "with", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p66_s6", "idA": "1430306_14_item1_p27_s3", "sentA": "This study also demonstrated that TNX-102 capsules led to a significant improvement in objective measures of sleep quality, which we believe relates to the mechanism by which CBP leads to improvement of FM symptoms.", "sentB": "The study showed statistically significant improvement with TNX-102 SL on measures of sleep quality, including the Patient-Reported Outcomes Measurement Information System, or PROMIS, Sleep Disturbance instrument (p=0.005).", "type": 2, "words": ["<tag1>", "This", "study", "also", "demonstrated", "that", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms.", "<tag2>", "The", "study", "showed", "statistically", "significant", "improvement", "with", "TNX-102", "SL", "on", "measures", "of", "sleep", "quality,", "including", "the", "Patient-Reported", "Outcomes", "Measurement", "Information", "System,", "or", "PROMIS,", "Sleep", "Disturbance", "instrument", "(p=0.005).", "<tag3>"], "wordsA": ["This", "study", "also", "demonstrated", "that", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms."], "wordsB": ["The", "study", "showed", "statistically", "significant", "improvement", "with", "TNX-102", "SL", "on", "measures", "of", "sleep", "quality,", "including", "the", "Patient-Reported", "Outcomes", "Measurement", "Information", "System,", "or", "PROMIS,", "Sleep", "Disturbance", "instrument", "(p=0.005)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p101_s1", "idA": "1430306_14_item1_p28_s0", "sentA": "We have completed four Phase 1 studies under Canadian Clinical Trial Applications.", "sentB": "We have completed a comparative Phase 1 single ascending dose safety, tolerability, and pharmacokinetic study of TNX-201 in 45 healthy volunteers, from which we reported top line results in January 2015.", "type": 2, "words": ["<tag1>", "We", "have", "completed", "four", "Phase", "1", "studies", "under", "Canadian", "Clinical", "Trial", "Applications.", "<tag2>", "We", "have", "completed", "a", "comparative", "Phase", "1", "single", "ascending", "dose", "safety,", "tolerability,", "and", "pharmacokinetic", "study", "of", "TNX-201", "in", "45", "healthy", "volunteers,", "from", "which", "we", "reported", "top", "line", "results", "in", "January", "2015.", "<tag3>"], "wordsA": ["We", "have", "completed", "four", "Phase", "1", "studies", "under", "Canadian", "Clinical", "Trial", "Applications."], "wordsB": ["We", "have", "completed", "a", "comparative", "Phase", "1", "single", "ascending", "dose", "safety,", "tolerability,", "and", "pharmacokinetic", "study", "of", "TNX-201", "in", "45", "healthy", "volunteers,", "from", "which", "we", "reported", "top", "line", "results", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p45_s0", "idA": "1430306_14_item1_p29_s0", "sentA": "FM is a chronic syndrome characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues.", "sentB": "PTSD is a chronic syndrome that may develop after a person is exposed to one or more traumatic events, such as warfare, sexual assault, serious injury, or threat of imminent death.", "type": 2, "words": ["<tag1>", "FM", "is", "a", "chronic", "syndrome", "characterized", "by", "widespread", "musculoskeletal", "pain", "accompanied", "by", "fatigue,", "sleep,", "memory", "and", "mood", "issues.", "<tag2>", "PTSD", "is", "a", "chronic", "syndrome", "that", "may", "develop", "after", "a", "person", "is", "exposed", "to", "one", "or", "more", "traumatic", "events,", "such", "as", "warfare,", "sexual", "assault,", "serious", "injury,", "or", "threat", "of", "imminent", "death.", "<tag3>"], "wordsA": ["FM", "is", "a", "chronic", "syndrome", "characterized", "by", "widespread", "musculoskeletal", "pain", "accompanied", "by", "fatigue,", "sleep,", "memory", "and", "mood", "issues."], "wordsB": ["PTSD", "is", "a", "chronic", "syndrome", "that", "may", "develop", "after", "a", "person", "is", "exposed", "to", "one", "or", "more", "traumatic", "events,", "such", "as", "warfare,", "sexual", "assault,", "serious", "injury,", "or", "threat", "of", "imminent", "death."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p107_s1", "idA": "1430306_14_item1_p29_s1", "sentA": "According to the National Institutes of Health, there are approximately five million people suffering from FM in the U.S.", "sentB": "As a result, the licensure of these biodefense products in the U.S. may not require human efficacy studies, which we believe will reduce our development costs and risks compared to the development of other NCEs or new biologic candidates.", "type": 2, "words": ["<tag1>", "According", "to", "the", "National", "Institutes", "of", "Health,", "there", "are", "approximately", "five", "million", "people", "suffering", "from", "FM", "in", "the", "U.S.", "<tag2>", "As", "a", "result,", "the", "licensure", "of", "these", "biodefense", "products", "in", "the", "U.S.", "may", "not", "require", "human", "efficacy", "studies,", "which", "we", "believe", "will", "reduce", "our", "development", "costs", "and", "risks", "compared", "to", "the", "development", "of", "other", "NCEs", "or", "new", "biologic", "candidates.", "<tag3>"], "wordsA": ["According", "to", "the", "National", "Institutes", "of", "Health,", "there", "are", "approximately", "five", "million", "people", "suffering", "from", "FM", "in", "the", "U.S."], "wordsB": ["As", "a", "result,", "the", "licensure", "of", "these", "biodefense", "products", "in", "the", "U.S.", "may", "not", "require", "human", "efficacy", "studies,", "which", "we", "believe", "will", "reduce", "our", "development", "costs", "and", "risks", "compared", "to", "the", "development", "of", "other", "NCEs", "or", "new", "biologic", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p40_s1", "idA": "1430306_14_item1_p29_s1", "sentA": "According to the National Institutes of Health, there are approximately five million people suffering from FM in the U.S.", "sentB": "According to published estimates, there are approximately five to fifteen million people suffering from FM in the U.S.", "type": 2, "words": ["<tag1>", "According", "to", "the", "National", "Institutes", "of", "Health,", "there", "are", "approximately", "five", "million", "people", "suffering", "from", "FM", "in", "the", "U.S.", "<tag2>", "According", "to", "published", "estimates,", "there", "are", "approximately", "five", "to", "fifteen", "million", "people", "suffering", "from", "FM", "in", "the", "U.S.", "<tag3>"], "wordsA": ["According", "to", "the", "National", "Institutes", "of", "Health,", "there", "are", "approximately", "five", "million", "people", "suffering", "from", "FM", "in", "the", "U.S."], "wordsB": ["According", "to", "published", "estimates,", "there", "are", "approximately", "five", "to", "fifteen", "million", "people", "suffering", "from", "FM", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p41_s0", "idA": "1430306_14_item1_p29_s2", "sentA": "The peak incidence of FM occurs at 20 50 years of age, and 80-90% of diagnosed patients are female.", "sentB": "The peak incidence of FM occurs between 20-50 years of age, and 80-90% of diagnosed patients are female.", "type": 2, "words": ["<tag1>", "The", "peak", "incidence", "of", "FM", "occurs", "at", "20", "50", "years", "of", "age,", "and", "80-90%", "of", "diagnosed", "patients", "are", "female.", "<tag2>", "The", "peak", "incidence", "of", "FM", "occurs", "between", "20-50", "years", "of", "age,", "and", "80-90%", "of", "diagnosed", "patients", "are", "female.", "<tag3>"], "wordsA": ["The", "peak", "incidence", "of", "FM", "occurs", "at", "20", "50", "years", "of", "age,", "and", "80-90%", "of", "diagnosed", "patients", "are", "female."], "wordsB": ["The", "peak", "incidence", "of", "FM", "occurs", "between", "20-50", "years", "of", "age,", "and", "80-90%", "of", "diagnosed", "patients", "are", "female."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p27_s0", "idA": "1430306_14_item1_p30_s0", "sentA": "FM may have a substantial negative impact on social and occupational function, including disrupted relationships with family and friends, social isolation, reduced activities of daily living and leisure activities, avoidance of physical activity, and loss of career or inability to advance in careers or education.", "sentB": "Fibromyalgia is a debilitating syndrome that occurs in up to 15% of U.S. adults and is associated with a substantial negative impact on social and occupational function, including disrupted relationships with family and friends, social isolation, reduced activities of daily living and leisure activities, avoidance of physical activity, and loss of career or inability to advance in careers or education.", "type": 2, "words": ["<tag1>", "FM", "may", "have", "a", "substantial", "negative", "impact", "on", "social", "and", "occupational", "function,", "including", "disrupted", "relationships", "with", "family", "and", "friends,", "social", "isolation,", "reduced", "activities", "of", "daily", "living", "and", "leisure", "activities,", "avoidance", "of", "physical", "activity,", "and", "loss", "of", "career", "or", "inability", "to", "advance", "in", "careers", "or", "education.", "<tag2>", "Fibromyalgia", "is", "a", "debilitating", "syndrome", "that", "occurs", "in", "up", "to", "15%", "of", "U.S.", "adults", "and", "is", "associated", "with", "a", "substantial", "negative", "impact", "on", "social", "and", "occupational", "function,", "including", "disrupted", "relationships", "with", "family", "and", "friends,", "social", "isolation,", "reduced", "activities", "of", "daily", "living", "and", "leisure", "activities,", "avoidance", "of", "physical", "activity,", "and", "loss", "of", "career", "or", "inability", "to", "advance", "in", "careers", "or", "education.", "<tag3>"], "wordsA": ["FM", "may", "have", "a", "substantial", "negative", "impact", "on", "social", "and", "occupational", "function,", "including", "disrupted", "relationships", "with", "family", "and", "friends,", "social", "isolation,", "reduced", "activities", "of", "daily", "living", "and", "leisure", "activities,", "avoidance", "of", "physical", "activity,", "and", "loss", "of", "career", "or", "inability", "to", "advance", "in", "careers", "or", "education."], "wordsB": ["Fibromyalgia", "is", "a", "debilitating", "syndrome", "that", "occurs", "in", "up", "to", "15%", "of", "U.S.", "adults", "and", "is", "associated", "with", "a", "substantial", "negative", "impact", "on", "social", "and", "occupational", "function,", "including", "disrupted", "relationships", "with", "family", "and", "friends,", "social", "isolation,", "reduced", "activities", "of", "daily", "living", "and", "leisure", "activities,", "avoidance", "of", "physical", "activity,", "and", "loss", "of", "career", "or", "inability", "to", "advance", "in", "careers", "or", "education."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p58_s1", "idA": "1430306_14_item1_p32_s0", "sentA": "Cymbalta and Savella are believed to directly inhibit the reuptake of serotonin and norepinephrine by nerves, and are referred to as Serotonin and Norepinephrine Reuptake Inhibitors, or SNRIs.", "sentB": "In FM, pregabalin is believed to exert its clinical benefit primarily by blocking calcium channels, and both duloxetine and milnacipran are believed to exert their clinical benefit mainly by inhibiting the reuptake of serotonin and norepinephrine.", "type": 2, "words": ["<tag1>", "Cymbalta", "and", "Savella", "are", "believed", "to", "directly", "inhibit", "the", "reuptake", "of", "serotonin", "and", "norepinephrine", "by", "nerves,", "and", "are", "referred", "to", "as", "Serotonin", "and", "Norepinephrine", "Reuptake", "Inhibitors,", "or", "SNRIs.", "<tag2>", "In", "FM,", "pregabalin", "is", "believed", "to", "exert", "its", "clinical", "benefit", "primarily", "by", "blocking", "calcium", "channels,", "and", "both", "duloxetine", "and", "milnacipran", "are", "believed", "to", "exert", "their", "clinical", "benefit", "mainly", "by", "inhibiting", "the", "reuptake", "of", "serotonin", "and", "norepinephrine.", "<tag3>"], "wordsA": ["Cymbalta", "and", "Savella", "are", "believed", "to", "directly", "inhibit", "the", "reuptake", "of", "serotonin", "and", "norepinephrine", "by", "nerves,", "and", "are", "referred", "to", "as", "Serotonin", "and", "Norepinephrine", "Reuptake", "Inhibitors,", "or", "SNRIs."], "wordsB": ["In", "FM,", "pregabalin", "is", "believed", "to", "exert", "its", "clinical", "benefit", "primarily", "by", "blocking", "calcium", "channels,", "and", "both", "duloxetine", "and", "milnacipran", "are", "believed", "to", "exert", "their", "clinical", "benefit", "mainly", "by", "inhibiting", "the", "reuptake", "of", "serotonin", "and", "norepinephrine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p58_s0", "idA": "1430306_14_item1_p32_s1", "sentA": "CBP, the active ingredient of TNX-102 SL, is a selective antagonist of serotonin and norepinephrine receptors as well as an inhibitor of serotonin and norepinephrine reuptake, and we refer to it as a Serotonin and Norepinephrine receptor Antagonist and Reuptake Inhibitor, or SNARI.", "sentB": "TNX-102 SL is a serotonin 2A and alpha-1 adrenergic receptor antagonist as well as an inhibitor of serotonin and norepinephrine reuptake, and we refer to it as a Serotonin and Norepinephrine receptor Antagonist and Reuptake Inhibitor, or SNARI.", "type": 2, "words": ["<tag1>", "CBP,", "the", "active", "ingredient", "of", "TNX-102", "SL,", "is", "a", "selective", "antagonist", "of", "serotonin", "and", "norepinephrine", "receptors", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake,", "and", "we", "refer", "to", "it", "as", "a", "Serotonin", "and", "Norepinephrine", "receptor", "Antagonist", "and", "Reuptake", "Inhibitor,", "or", "SNARI.", "<tag2>", "TNX-102", "SL", "is", "a", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptor", "antagonist", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake,", "and", "we", "refer", "to", "it", "as", "a", "Serotonin", "and", "Norepinephrine", "receptor", "Antagonist", "and", "Reuptake", "Inhibitor,", "or", "SNARI.", "<tag3>"], "wordsA": ["CBP,", "the", "active", "ingredient", "of", "TNX-102", "SL,", "is", "a", "selective", "antagonist", "of", "serotonin", "and", "norepinephrine", "receptors", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake,", "and", "we", "refer", "to", "it", "as", "a", "Serotonin", "and", "Norepinephrine", "receptor", "Antagonist", "and", "Reuptake", "Inhibitor,", "or", "SNARI."], "wordsB": ["TNX-102", "SL", "is", "a", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptor", "antagonist", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake,", "and", "we", "refer", "to", "it", "as", "a", "Serotonin", "and", "Norepinephrine", "receptor", "Antagonist", "and", "Reuptake", "Inhibitor,", "or", "SNARI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p43_s1", "idA": "1430306_14_item1_p34_s0", "sentA": "Despite the availability and use of a variety of pharmacologic and non-pharmacologic interventions, FM remains a significant unmet medical need.", "sentB": "Despite these interventions, FM remains a significant unmet medical need.", "type": 2, "words": ["<tag1>", "Despite", "the", "availability", "and", "use", "of", "a", "variety", "of", "pharmacologic", "and", "non-pharmacologic", "interventions,", "FM", "remains", "a", "significant", "unmet", "medical", "need.", "<tag2>", "Despite", "these", "interventions,", "FM", "remains", "a", "significant", "unmet", "medical", "need.", "<tag3>"], "wordsA": ["Despite", "the", "availability", "and", "use", "of", "a", "variety", "of", "pharmacologic", "and", "non-pharmacologic", "interventions,", "FM", "remains", "a", "significant", "unmet", "medical", "need."], "wordsB": ["Despite", "these", "interventions,", "FM", "remains", "a", "significant", "unmet", "medical", "need."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p28_s0", "idA": "1430306_14_item1_p34_s1", "sentA": "Many patients fail to adequately respond to the approved medications, or discontinue therapy due to poor tolerability.", "sentB": "Many patients fail to adequately respond to the medications approved for FM, or discontinue therapy due to poor tolerability.", "type": 2, "words": ["<tag1>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "approved", "medications,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability.", "<tag2>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "FM,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability.", "<tag3>"], "wordsA": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "approved", "medications,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability."], "wordsB": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "FM,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p28_s1", "idA": "1430306_14_item1_p34_s2", "sentA": "Prescription pain and sleep medications are frequently taken off-label for symptomatic relief, despite the lack of evidence that such medications provide a meaningful or durable therapeutic effect.", "sentB": "Prescription pain and sleep medications not approved for FM are frequently taken for symptomatic relief, despite the lack of evidence that such medications provide a meaningful or durable therapeutic effect.", "type": 2, "words": ["<tag1>", "Prescription", "pain", "and", "sleep", "medications", "are", "frequently", "taken", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect.", "<tag2>", "Prescription", "pain", "and", "sleep", "medications", "not", "approved", "for", "FM", "are", "frequently", "taken", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect.", "<tag3>"], "wordsA": ["Prescription", "pain", "and", "sleep", "medications", "are", "frequently", "taken", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect."], "wordsB": ["Prescription", "pain", "and", "sleep", "medications", "not", "approved", "for", "FM", "are", "frequently", "taken", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p31_s1", "idA": "1430306_14_item1_p35_s1", "sentA": "Since CBP has no recognized addictive potential, we believe that TNX-102 SL, if approved, could reduce the exposure of FM patients to medications that have not been shown to be effective in treating FM and are associated with significant safety risks.", "sentB": "Although the approved prescription products for ETTH may have some therapeutic value in treating the primary headache condition, they are associated with significant safety liabilities and pose a risk of abuse and addiction.", "type": 2, "words": ["<tag1>", "Since", "CBP", "has", "no", "recognized", "addictive", "potential,", "we", "believe", "that", "TNX-102", "SL,", "if", "approved,", "could", "reduce", "the", "exposure", "of", "FM", "patients", "to", "medications", "that", "have", "not", "been", "shown", "to", "be", "effective", "in", "treating", "FM", "and", "are", "associated", "with", "significant", "safety", "risks.", "<tag2>", "Although", "the", "approved", "prescription", "products", "for", "ETTH", "may", "have", "some", "therapeutic", "value", "in", "treating", "the", "primary", "headache", "condition,", "they", "are", "associated", "with", "significant", "safety", "liabilities", "and", "pose", "a", "risk", "of", "abuse", "and", "addiction.", "<tag3>"], "wordsA": ["Since", "CBP", "has", "no", "recognized", "addictive", "potential,", "we", "believe", "that", "TNX-102", "SL,", "if", "approved,", "could", "reduce", "the", "exposure", "of", "FM", "patients", "to", "medications", "that", "have", "not", "been", "shown", "to", "be", "effective", "in", "treating", "FM", "and", "are", "associated", "with", "significant", "safety", "risks."], "wordsB": ["Although", "the", "approved", "prescription", "products", "for", "ETTH", "may", "have", "some", "therapeutic", "value", "in", "treating", "the", "primary", "headache", "condition,", "they", "are", "associated", "with", "significant", "safety", "liabilities", "and", "pose", "a", "risk", "of", "abuse", "and", "addiction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p64_s0", "idA": "1430306_14_item1_p36_s0", "sentA": "At our End-of-Phase 2/Pre-Phase 3 meeting with the FDA, we discussed the design of our clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "sentB": "At an End-of-Phase 2/Pre-Phase 3 meeting with the FDA in February 2013, we discussed the design of our clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "At", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["At", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p69_s1", "idA": "1430306_14_item1_p36_s0", "sentA": "At our End-of-Phase 2/Pre-Phase 3 meeting with the FDA, we discussed the design of our clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "sentB": "In January 2015, we announced receipt of the written guidance, whereby the FDA accepted our proposal to use a 30% pain responder analysis as the primary efficacy endpoint in our Phase 3 trial to support the approval of TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "In", "January", "2015,", "we", "announced", "receipt", "of", "the", "written", "guidance,", "whereby", "the", "FDA", "accepted", "our", "proposal", "to", "use", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "Phase", "3", "trial", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["In", "January", "2015,", "we", "announced", "receipt", "of", "the", "written", "guidance,", "whereby", "the", "FDA", "accepted", "our", "proposal", "to", "use", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "Phase", "3", "trial", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p28_s2", "idA": "1430306_14_item1_p36_s1", "sentA": "We believe that positive results from two adequate, well-controlled safety and efficacy studies and the establishment of long-term safety for chronic use would support the approval of TNX-102 SL for the management of FM.", "sentB": "We believe that TNX-102 SL has the potential to broadly and effectively treat the core symptoms of FM with a tolerability profile that is suitable as a first-line therapy and for chronic use.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "establishment", "of", "long-term", "safety", "for", "chronic", "use", "would", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "broadly", "and", "effectively", "treat", "the", "core", "symptoms", "of", "FM", "with", "a", "tolerability", "profile", "that", "is", "suitable", "as", "a", "first-line", "therapy", "and", "for", "chronic", "use.", "<tag3>"], "wordsA": ["We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "establishment", "of", "long-term", "safety", "for", "chronic", "use", "would", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "broadly", "and", "effectively", "treat", "the", "core", "symptoms", "of", "FM", "with", "a", "tolerability", "profile", "that", "is", "suitable", "as", "a", "first-line", "therapy", "and", "for", "chronic", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p64_s1", "idA": "1430306_14_item1_p36_s1", "sentA": "We believe that positive results from two adequate, well-controlled safety and efficacy studies and the establishment of long-term safety for chronic use would support the approval of TNX-102 SL for the management of FM.", "sentB": "On the basis of our discussions with the FDA, we believe that positive results from two adequate, well-controlled efficacy and safety studies and long-term (six- and 12-month) safety exposure studies would provide sufficient evidence of efficacy and safety to support FDA approval of TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "establishment", "of", "long-term", "safety", "for", "chronic", "use", "would", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "On", "the", "basis", "of", "our", "discussions", "with", "the", "FDA,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "provide", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "establishment", "of", "long-term", "safety", "for", "chronic", "use", "would", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["On", "the", "basis", "of", "our", "discussions", "with", "the", "FDA,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "provide", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p89_s1", "idA": "1430306_14_item1_p36_s1", "sentA": "We believe that positive results from two adequate, well-controlled safety and efficacy studies and the establishment of long-term safety for chronic use would support the approval of TNX-102 SL for the management of FM.", "sentB": "Based on our communications with the FDA to date, we believe that positive results from two adequate, well-controlled efficacy and safety studies and long-term (six- and 12-month) safety exposure studies would support FDA approval of TNX-102 SL for the management of PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "establishment", "of", "long-term", "safety", "for", "chronic", "use", "would", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "Based", "on", "our", "communications", "with", "the", "FDA", "to", "date,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "safety", "and", "efficacy", "studies", "and", "the", "establishment", "of", "long-term", "safety", "for", "chronic", "use", "would", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["Based", "on", "our", "communications", "with", "the", "FDA", "to", "date,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p66_s0", "idA": "1430306_14_item1_p37_s1", "sentA": "In this multicenter clinical trial, subjects with FM are treated with either TNX-102 2.8 mg sublingual tablets (SL) or a placebo at bedtime daily for 12 weeks.", "sentB": "In the BESTFIT trial, 205 patients with FM were randomized at 17 U.S. centers to treatment with either TNX-102 SL 2.8 mg or placebo sublingual tablets at bedtime daily for 12 weeks.", "type": 2, "words": ["<tag1>", "In", "this", "multicenter", "clinical", "trial,", "subjects", "with", "FM", "are", "treated", "with", "either", "TNX-102", "2.8", "mg", "sublingual", "tablets", "(SL)", "or", "a", "placebo", "at", "bedtime", "daily", "for", "12", "weeks.", "<tag2>", "In", "the", "BESTFIT", "trial,", "205", "patients", "with", "FM", "were", "randomized", "at", "17", "U.S.", "centers", "to", "treatment", "with", "either", "TNX-102", "SL", "2.8", "mg", "or", "placebo", "sublingual", "tablets", "at", "bedtime", "daily", "for", "12", "weeks.", "<tag3>"], "wordsA": ["In", "this", "multicenter", "clinical", "trial,", "subjects", "with", "FM", "are", "treated", "with", "either", "TNX-102", "2.8", "mg", "sublingual", "tablets", "(SL)", "or", "a", "placebo", "at", "bedtime", "daily", "for", "12", "weeks."], "wordsB": ["In", "the", "BESTFIT", "trial,", "205", "patients", "with", "FM", "were", "randomized", "at", "17", "U.S.", "centers", "to", "treatment", "with", "either", "TNX-102", "SL", "2.8", "mg", "or", "placebo", "sublingual", "tablets", "at", "bedtime", "daily", "for", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p70_s2", "idA": "1430306_14_item1_p37_s2", "sentA": "We expect to enroll approximately 200 patients into this study.", "sentB": "We expect to complete Study F203 in August 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "enroll", "approximately", "200", "patients", "into", "this", "study.", "<tag2>", "We", "expect", "to", "complete", "Study", "F203", "in", "August", "2015.", "<tag3>"], "wordsA": ["We", "expect", "to", "enroll", "approximately", "200", "patients", "into", "this", "study."], "wordsB": ["We", "expect", "to", "complete", "Study", "F203", "in", "August", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p102_s1", "idA": "1430306_14_item1_p38_s0", "sentA": "The primary efficacy endpoint is change in pain from baseline to week 12.", "sentB": "The primary efficacy endpoint will be the difference between the two study arms in the number of subjects who report complete relief from their headache pain at two hours following a dose of study medication.", "type": 2, "words": ["<tag1>", "The", "primary", "efficacy", "endpoint", "is", "change", "in", "pain", "from", "baseline", "to", "week", "12.", "<tag2>", "The", "primary", "efficacy", "endpoint", "will", "be", "the", "difference", "between", "the", "two", "study", "arms", "in", "the", "number", "of", "subjects", "who", "report", "complete", "relief", "from", "their", "headache", "pain", "at", "two", "hours", "following", "a", "dose", "of", "study", "medication.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "endpoint", "is", "change", "in", "pain", "from", "baseline", "to", "week", "12."], "wordsB": ["The", "primary", "efficacy", "endpoint", "will", "be", "the", "difference", "between", "the", "two", "study", "arms", "in", "the", "number", "of", "subjects", "who", "report", "complete", "relief", "from", "their", "headache", "pain", "at", "two", "hours", "following", "a", "dose", "of", "study", "medication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p66_s1", "idA": "1430306_14_item1_p38_s0", "sentA": "The primary efficacy endpoint is change in pain from baseline to week 12.", "sentB": "The primary outcome measure of the BESTFIT trial was the mean change in week 12 average daily pain intensity from baseline on the 11-point Numeric Rating Scale, using a daily telephonic diary.", "type": 2, "words": ["<tag1>", "The", "primary", "efficacy", "endpoint", "is", "change", "in", "pain", "from", "baseline", "to", "week", "12.", "<tag2>", "The", "primary", "outcome", "measure", "of", "the", "BESTFIT", "trial", "was", "the", "mean", "change", "in", "week", "12", "average", "daily", "pain", "intensity", "from", "baseline", "on", "the", "11-point", "Numeric", "Rating", "Scale,", "using", "a", "daily", "telephonic", "diary.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "endpoint", "is", "change", "in", "pain", "from", "baseline", "to", "week", "12."], "wordsB": ["The", "primary", "outcome", "measure", "of", "the", "BESTFIT", "trial", "was", "the", "mean", "change", "in", "week", "12", "average", "daily", "pain", "intensity", "from", "baseline", "on", "the", "11-point", "Numeric", "Rating", "Scale,", "using", "a", "daily", "telephonic", "diary."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p71_s1", "idA": "1430306_14_item1_p38_s1", "sentA": "If successful, this trial will serve as the first of two pivotal studies to support an NDA for TNX-102 SL in FM.", "sentB": "We may elect to conduct this trial in Europe to support our plan to seek European Medicines Agency registration for TNX-102 SL in FM.", "type": 2, "words": ["<tag1>", "If", "successful,", "this", "trial", "will", "serve", "as", "the", "first", "of", "two", "pivotal", "studies", "to", "support", "an", "NDA", "for", "TNX-102", "SL", "in", "FM.", "<tag2>", "We", "may", "elect", "to", "conduct", "this", "trial", "in", "Europe", "to", "support", "our", "plan", "to", "seek", "European", "Medicines", "Agency", "registration", "for", "TNX-102", "SL", "in", "FM.", "<tag3>"], "wordsA": ["If", "successful,", "this", "trial", "will", "serve", "as", "the", "first", "of", "two", "pivotal", "studies", "to", "support", "an", "NDA", "for", "TNX-102", "SL", "in", "FM."], "wordsB": ["We", "may", "elect", "to", "conduct", "this", "trial", "in", "Europe", "to", "support", "our", "plan", "to", "seek", "European", "Medicines", "Agency", "registration", "for", "TNX-102", "SL", "in", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p102_s2", "idA": "1430306_14_item1_p38_s3", "sentA": "We expect to report initial efficacy results from the BESTFIT trial in the fourth quarter of 2014.", "sentB": "We expect to report top line results from this study in the fourth quarter of 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014.", "<tag2>", "We", "expect", "to", "report", "top", "line", "results", "from", "this", "study", "in", "the", "fourth", "quarter", "of", "2015.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014."], "wordsB": ["We", "expect", "to", "report", "top", "line", "results", "from", "this", "study", "in", "the", "fourth", "quarter", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p65_s1", "idA": "1430306_14_item1_p38_s3", "sentA": "We expect to report initial efficacy results from the BESTFIT trial in the fourth quarter of 2014.", "sentB": "We reported preliminary top-line results from the BESTFIT trial in September 2014.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014.", "<tag2>", "We", "reported", "preliminary", "top-line", "results", "from", "the", "BESTFIT", "trial", "in", "September", "2014.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014."], "wordsB": ["We", "reported", "preliminary", "top-line", "results", "from", "the", "BESTFIT", "trial", "in", "September", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p66_s2", "idA": "1430306_14_item1_p38_s3", "sentA": "We expect to report initial efficacy results from the BESTFIT trial in the fourth quarter of 2014.", "sentB": "In the BESTFIT trial, TNX-102 SL did not achieve statistical significance in the primary outcome measure (p=0.172).", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014.", "<tag2>", "In", "the", "BESTFIT", "trial,", "TNX-102", "SL", "did", "not", "achieve", "statistical", "significance", "in", "the", "primary", "outcome", "measure", "(p=0.172).", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014."], "wordsB": ["In", "the", "BESTFIT", "trial,", "TNX-102", "SL", "did", "not", "achieve", "statistical", "significance", "in", "the", "primary", "outcome", "measure", "(p=0.172)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p69_s3", "idA": "1430306_14_item1_p38_s3", "sentA": "We expect to report initial efficacy results from the BESTFIT trial in the fourth quarter of 2014.", "sentB": "We expect to report top line results from this trial in the second half of 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014.", "<tag2>", "We", "expect", "to", "report", "top", "line", "results", "from", "this", "trial", "in", "the", "second", "half", "of", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "initial", "efficacy", "results", "from", "the", "BESTFIT", "trial", "in", "the", "fourth", "quarter", "of", "2014."], "wordsB": ["We", "expect", "to", "report", "top", "line", "results", "from", "this", "trial", "in", "the", "second", "half", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p66_s3", "idA": "1430306_14_item1_p39_s0", "sentA": "The primary efficacy measure in this study will be the change in pain severity at week 12 with TNX-102 SL as compared to placebo, as assessed by the Numeric Rating Scale, or NRS.", "sentB": "However, the trial demonstrated that TNX-102 SL had a statistically significant effect on pain as measured by a 30% responder analysis of the primary pain data (p=0.033), in which a responder is defined as a subject for whom pain intensity was reduced by at least 30% at week 12 as compared to baseline.", "type": 2, "words": ["<tag1>", "The", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS.", "<tag2>", "However,", "the", "trial", "demonstrated", "that", "TNX-102", "SL", "had", "a", "statistically", "significant", "effect", "on", "pain", "as", "measured", "by", "a", "30%", "responder", "analysis", "of", "the", "primary", "pain", "data", "(p=0.033),", "in", "which", "a", "responder", "is", "defined", "as", "a", "subject", "for", "whom", "pain", "intensity", "was", "reduced", "by", "at", "least", "30%", "at", "week", "12", "as", "compared", "to", "baseline.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS."], "wordsB": ["However,", "the", "trial", "demonstrated", "that", "TNX-102", "SL", "had", "a", "statistically", "significant", "effect", "on", "pain", "as", "measured", "by", "a", "30%", "responder", "analysis", "of", "the", "primary", "pain", "data", "(p=0.033),", "in", "which", "a", "responder", "is", "defined", "as", "a", "subject", "for", "whom", "pain", "intensity", "was", "reduced", "by", "at", "least", "30%", "at", "week", "12", "as", "compared", "to", "baseline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p88_s1", "idA": "1430306_14_item1_p39_s0", "sentA": "The primary efficacy measure in this study will be the change in pain severity at week 12 with TNX-102 SL as compared to placebo, as assessed by the Numeric Rating Scale, or NRS.", "sentB": "The primary objective of the AtEase trial is to evaluate the efficacy of TNX-102 SL 2.8 mg as compared to placebo sublingual tablet following eight weeks of treatment using the Clinician-Administered PTSD Scale.", "type": 2, "words": ["<tag1>", "The", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS.", "<tag2>", "The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "eight", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "measure", "in", "this", "study", "will", "be", "the", "change", "in", "pain", "severity", "at", "week", "12", "with", "TNX-102", "SL", "as", "compared", "to", "placebo,", "as", "assessed", "by", "the", "Numeric", "Rating", "Scale,", "or", "NRS."], "wordsB": ["The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "eight", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p66_s5", "idA": "1430306_14_item1_p39_s2", "sentA": "We are also collecting information on other outcome measures, including NRS scores at other time points, the revised Fibromyalgia Impact Questionnaire, and the Patient Global Impression of Change.", "sentB": "The BESTFIT trial also showed statistically significant improvements with TNX-102 SL in the declared secondary analyses of the Patient Global Impression of Change (p=0.025) and the Fibromyalgia Impact Questionnaire-Revised, or FIQ-R (p=0.014).", "type": 2, "words": ["<tag1>", "We", "are", "also", "collecting", "information", "on", "other", "outcome", "measures,", "including", "NRS", "scores", "at", "other", "time", "points,", "the", "revised", "Fibromyalgia", "Impact", "Questionnaire,", "and", "the", "Patient", "Global", "Impression", "of", "Change.", "<tag2>", "The", "BESTFIT", "trial", "also", "showed", "statistically", "significant", "improvements", "with", "TNX-102", "SL", "in", "the", "declared", "secondary", "analyses", "of", "the", "Patient", "Global", "Impression", "of", "Change", "(p=0.025)", "and", "the", "Fibromyalgia", "Impact", "Questionnaire-Revised,", "or", "FIQ-R", "(p=0.014).", "<tag3>"], "wordsA": ["We", "are", "also", "collecting", "information", "on", "other", "outcome", "measures,", "including", "NRS", "scores", "at", "other", "time", "points,", "the", "revised", "Fibromyalgia", "Impact", "Questionnaire,", "and", "the", "Patient", "Global", "Impression", "of", "Change."], "wordsB": ["The", "BESTFIT", "trial", "also", "showed", "statistically", "significant", "improvements", "with", "TNX-102", "SL", "in", "the", "declared", "secondary", "analyses", "of", "the", "Patient", "Global", "Impression", "of", "Change", "(p=0.025)", "and", "the", "Fibromyalgia", "Impact", "Questionnaire-Revised,", "or", "FIQ-R", "(p=0.014)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p3_s0", "idA": "1430306_14_item1_p3_s0", "sentA": "This Annual Report on Form 10-K includes the accounts of Tonix Pharmaceuticals Holding Corp. ( Tonix ) and its wholly-owned subsidiaries, as follows, collectively referred to as we , us or the Company : Tonix Pharmaceuticals, Inc., a Delaware corporation (\"Tonix Sub\"), Krele LLC, a Delaware limited liability company (\"Krele\"), Tonix Pharmaceuticals (Canada), Inc., a corporation incorporated under the laws of the province of New Brunswick, Canada (\"Tonix Canada\") and Tonix Pharmaceuticals (Barbados) Ltd., a corporation incorporated under the laws of Barbados (\"Tonix Barbados\").", "sentB": "This Annual Report on Form 10-K includes the accounts of Tonix Pharmaceuticals Holding Corp., a Nevada corporation ( Tonix ), together with its wholly-owned subsidiaries, as follows, collectively referred to as we , us or the Company : Tonix Pharmaceuticals, Inc., a Delaware corporation ( Tonix Sub ), Krele LLC, a Delaware limited liability company ( Krele ), Tonix Pharmaceuticals (Canada), Inc., a corporation incorporated under the laws of the province of New Brunswick, Canada ( Tonix Canada ), Tonix Pharmaceuticals (Barbados) Ltd., a corporation incorporated under the laws of Barbados ( Tonix Barbados ), Tonix Pharma Holdings Limited, a company limited by shares incorporated under the laws of Ireland ( Tonix International Holding ), and Tonix Pharma Limited, a company limited by shares incorporated under the laws of Ireland ( Tonix Ireland ).", "type": 2, "words": ["<tag1>", "This", "Annual", "Report", "on", "Form", "10-K", "includes", "the", "accounts", "of", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "(", "Tonix", ")", "and", "its", "wholly-owned", "subsidiaries,", "as", "follows,", "collectively", "referred", "to", "as", "we", ",", "us", "or", "the", "Company", ":", "Tonix", "Pharmaceuticals,", "Inc.,", "a", "Delaware", "corporation", "(\"Tonix", "Sub\"),", "Krele", "LLC,", "a", "Delaware", "limited", "liability", "company", "(\"Krele\"),", "Tonix", "Pharmaceuticals", "(Canada),", "Inc.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "the", "province", "of", "New", "Brunswick,", "Canada", "(\"Tonix", "Canada\")", "and", "Tonix", "Pharmaceuticals", "(Barbados)", "Ltd.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "Barbados", "(\"Tonix", "Barbados\").", "<tag2>", "This", "Annual", "Report", "on", "Form", "10-K", "includes", "the", "accounts", "of", "Tonix", "Pharmaceuticals", "Holding", "Corp.,", "a", "Nevada", "corporation", "(", "Tonix", "),", "together", "with", "its", "wholly-owned", "subsidiaries,", "as", "follows,", "collectively", "referred", "to", "as", "we", ",", "us", "or", "the", "Company", ":", "Tonix", "Pharmaceuticals,", "Inc.,", "a", "Delaware", "corporation", "(", "Tonix", "Sub", "),", "Krele", "LLC,", "a", "Delaware", "limited", "liability", "company", "(", "Krele", "),", "Tonix", "Pharmaceuticals", "(Canada),", "Inc.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "the", "province", "of", "New", "Brunswick,", "Canada", "(", "Tonix", "Canada", "),", "Tonix", "Pharmaceuticals", "(Barbados)", "Ltd.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "Barbados", "(", "Tonix", "Barbados", "),", "Tonix", "Pharma", "Holdings", "Limited,", "a", "company", "limited", "by", "shares", "incorporated", "under", "the", "laws", "of", "Ireland", "(", "Tonix", "International", "Holding", "),", "and", "Tonix", "Pharma", "Limited,", "a", "company", "limited", "by", "shares", "incorporated", "under", "the", "laws", "of", "Ireland", "(", "Tonix", "Ireland", ").", "<tag3>"], "wordsA": ["This", "Annual", "Report", "on", "Form", "10-K", "includes", "the", "accounts", "of", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "(", "Tonix", ")", "and", "its", "wholly-owned", "subsidiaries,", "as", "follows,", "collectively", "referred", "to", "as", "we", ",", "us", "or", "the", "Company", ":", "Tonix", "Pharmaceuticals,", "Inc.,", "a", "Delaware", "corporation", "(\"Tonix", "Sub\"),", "Krele", "LLC,", "a", "Delaware", "limited", "liability", "company", "(\"Krele\"),", "Tonix", "Pharmaceuticals", "(Canada),", "Inc.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "the", "province", "of", "New", "Brunswick,", "Canada", "(\"Tonix", "Canada\")", "and", "Tonix", "Pharmaceuticals", "(Barbados)", "Ltd.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "Barbados", "(\"Tonix", "Barbados\")."], "wordsB": ["This", "Annual", "Report", "on", "Form", "10-K", "includes", "the", "accounts", "of", "Tonix", "Pharmaceuticals", "Holding", "Corp.,", "a", "Nevada", "corporation", "(", "Tonix", "),", "together", "with", "its", "wholly-owned", "subsidiaries,", "as", "follows,", "collectively", "referred", "to", "as", "we", ",", "us", "or", "the", "Company", ":", "Tonix", "Pharmaceuticals,", "Inc.,", "a", "Delaware", "corporation", "(", "Tonix", "Sub", "),", "Krele", "LLC,", "a", "Delaware", "limited", "liability", "company", "(", "Krele", "),", "Tonix", "Pharmaceuticals", "(Canada),", "Inc.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "the", "province", "of", "New", "Brunswick,", "Canada", "(", "Tonix", "Canada", "),", "Tonix", "Pharmaceuticals", "(Barbados)", "Ltd.,", "a", "corporation", "incorporated", "under", "the", "laws", "of", "Barbados", "(", "Tonix", "Barbados", "),", "Tonix", "Pharma", "Holdings", "Limited,", "a", "company", "limited", "by", "shares", "incorporated", "under", "the", "laws", "of", "Ireland", "(", "Tonix", "International", "Holding", "),", "and", "Tonix", "Pharma", "Limited,", "a", "company", "limited", "by", "shares", "incorporated", "under", "the", "laws", "of", "Ireland", "(", "Tonix", "Ireland", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p3_s1", "idA": "1430306_14_item1_p3_s1", "sentA": "Tonix Sub is a wholly-owned subsidiary of Tonix, and Krele, Tonix Canada and Tonix Barbados are wholly-owned subsidiaries of Tonix Sub.", "sentB": "Tonix Sub is a wholly-owned subsidiary of Tonix, and Krele and Tonix International Holding are wholly-owned subsidiaries of Tonix Sub.", "type": 2, "words": ["<tag1>", "Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix,", "and", "Krele,", "Tonix", "Canada", "and", "Tonix", "Barbados", "are", "wholly-owned", "subsidiaries", "of", "Tonix", "Sub.", "<tag2>", "Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix,", "and", "Krele", "and", "Tonix", "International", "Holding", "are", "wholly-owned", "subsidiaries", "of", "Tonix", "Sub.", "<tag3>"], "wordsA": ["Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix,", "and", "Krele,", "Tonix", "Canada", "and", "Tonix", "Barbados", "are", "wholly-owned", "subsidiaries", "of", "Tonix", "Sub."], "wordsB": ["Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix,", "and", "Krele", "and", "Tonix", "International", "Holding", "are", "wholly-owned", "subsidiaries", "of", "Tonix", "Sub."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p3_s2", "idA": "1430306_14_item1_p3_s1", "sentA": "Tonix Sub is a wholly-owned subsidiary of Tonix, and Krele, Tonix Canada and Tonix Barbados are wholly-owned subsidiaries of Tonix Sub.", "sentB": "Tonix Canada is a wholly-owned subsidiary of Tonix Ireland and Tonix Barbados is a wholly-owned subsidiary of Tonix International Holding.", "type": 2, "words": ["<tag1>", "Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix,", "and", "Krele,", "Tonix", "Canada", "and", "Tonix", "Barbados", "are", "wholly-owned", "subsidiaries", "of", "Tonix", "Sub.", "<tag2>", "Tonix", "Canada", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "Ireland", "and", "Tonix", "Barbados", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "International", "Holding.", "<tag3>"], "wordsA": ["Tonix", "Sub", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix,", "and", "Krele,", "Tonix", "Canada", "and", "Tonix", "Barbados", "are", "wholly-owned", "subsidiaries", "of", "Tonix", "Sub."], "wordsB": ["Tonix", "Canada", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "Ireland", "and", "Tonix", "Barbados", "is", "a", "wholly-owned", "subsidiary", "of", "Tonix", "International", "Holding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p70_s0", "idA": "1430306_14_item1_p40_s0", "sentA": "In December 2013, we announced the initiation of F203, a 12-month open-label extension study of TNX-102 SL to be taken daily at bedtime, into which patients who have completed the BESTFIT study may enroll.", "sentB": "In December 2013, we commenced Study F203, a 12-month open-label extension study of TNX-102 SL in patients who had completed the BESTFIT trial.", "type": 2, "words": ["<tag1>", "In", "December", "2013,", "we", "announced", "the", "initiation", "of", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "to", "be", "taken", "daily", "at", "bedtime,", "into", "which", "patients", "who", "have", "completed", "the", "BESTFIT", "study", "may", "enroll.", "<tag2>", "In", "December", "2013,", "we", "commenced", "Study", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "in", "patients", "who", "had", "completed", "the", "BESTFIT", "trial.", "<tag3>"], "wordsA": ["In", "December", "2013,", "we", "announced", "the", "initiation", "of", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "to", "be", "taken", "daily", "at", "bedtime,", "into", "which", "patients", "who", "have", "completed", "the", "BESTFIT", "study", "may", "enroll."], "wordsB": ["In", "December", "2013,", "we", "commenced", "Study", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "in", "patients", "who", "had", "completed", "the", "BESTFIT", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p82_s0", "idA": "1430306_14_item1_p41_s0", "sentA": "We are also advancing TNX-102 SL for the management of PTSD.", "sentB": "We are developing TNX-102 SL for the management of PTSD under a separate IND allowed by the FDA in June 2014, and we are currently conducting our AtEase trial, a Phase 2 clinical trial of TNX-102 SL in military-related PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "a", "separate", "IND", "allowed", "by", "the", "FDA", "in", "June", "2014,", "and", "we", "are", "currently", "conducting", "our", "AtEase", "trial,", "a", "Phase", "2", "clinical", "trial", "of", "TNX-102", "SL", "in", "military-related", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "a", "separate", "IND", "allowed", "by", "the", "FDA", "in", "June", "2014,", "and", "we", "are", "currently", "conducting", "our", "AtEase", "trial,", "a", "Phase", "2", "clinical", "trial", "of", "TNX-102", "SL", "in", "military-related", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p92_s0", "idA": "1430306_14_item1_p41_s0", "sentA": "We are also advancing TNX-102 SL for the management of PTSD.", "sentB": "Given TNX-102 SL s pharmacological mode of action, its ability to significantly improve sleep quality as demonstrated in the BESTFIT trial, and the lack of Drug Enforcement Agency scheduling of CBP, we believe TNX-102 SL, if approved, has the potential to serve as an important and differentiated new option for the management of PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "Given", "TNX-102", "SL", "s", "pharmacological", "mode", "of", "action,", "its", "ability", "to", "significantly", "improve", "sleep", "quality", "as", "demonstrated", "in", "the", "BESTFIT", "trial,", "and", "the", "lack", "of", "Drug", "Enforcement", "Agency", "scheduling", "of", "CBP,", "we", "believe", "TNX-102", "SL,", "if", "approved,", "has", "the", "potential", "to", "serve", "as", "an", "important", "and", "differentiated", "new", "option", "for", "the", "management", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "also", "advancing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["Given", "TNX-102", "SL", "s", "pharmacological", "mode", "of", "action,", "its", "ability", "to", "significantly", "improve", "sleep", "quality", "as", "demonstrated", "in", "the", "BESTFIT", "trial,", "and", "the", "lack", "of", "Drug", "Enforcement", "Agency", "scheduling", "of", "CBP,", "we", "believe", "TNX-102", "SL,", "if", "approved,", "has", "the", "potential", "to", "serve", "as", "an", "important", "and", "differentiated", "new", "option", "for", "the", "management", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p24_s4", "idA": "1430306_14_item1_p41_s2", "sentA": "We plan to begin a Proof-of-Concept (POC) trial of TNX-102 SL in subjects with military-related PTSD in the third quarter of 2014.", "sentB": "We expect to begin a Phase 2 trial of TNX-201 in episodic tension-type headache, or ETTH, in the second quarter of 2015.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "begin", "a", "Proof-of-Concept", "(POC)", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD", "in", "the", "third", "quarter", "of", "2014.", "<tag2>", "We", "expect", "to", "begin", "a", "Phase", "2", "trial", "of", "TNX-201", "in", "episodic", "tension-type", "headache,", "or", "ETTH,", "in", "the", "second", "quarter", "of", "2015.", "<tag3>"], "wordsA": ["We", "plan", "to", "begin", "a", "Proof-of-Concept", "(POC)", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD", "in", "the", "third", "quarter", "of", "2014."], "wordsB": ["We", "expect", "to", "begin", "a", "Phase", "2", "trial", "of", "TNX-201", "in", "episodic", "tension-type", "headache,", "or", "ETTH,", "in", "the", "second", "quarter", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p87_s0", "idA": "1430306_14_item1_p41_s2", "sentA": "We plan to begin a Proof-of-Concept (POC) trial of TNX-102 SL in subjects with military-related PTSD in the third quarter of 2014.", "sentB": "In January 2015, we commenced the AtEase trial, a 220-patient, randomized, double-blind, placebo-controlled, 12-week Phase 2 trial of TNX-102 SL in subjects with military-related PTSD.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "begin", "a", "Proof-of-Concept", "(POC)", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD", "in", "the", "third", "quarter", "of", "2014.", "<tag2>", "In", "January", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "220-patient,", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD.", "<tag3>"], "wordsA": ["We", "plan", "to", "begin", "a", "Proof-of-Concept", "(POC)", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD", "in", "the", "third", "quarter", "of", "2014."], "wordsB": ["In", "January", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "220-patient,", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p69_s0", "idA": "1430306_14_item1_p41_s3", "sentA": "Based on the results of the POC trial, we will meet with the FDA to finalize the design of the registration studies to support the PTSD NDA.", "sentB": "Following our report of the results of the BESTFIT trial, we requested guidance from the FDA on our proposed use of a 30% pain responder analysis as the primary efficacy endpoint in our prospective Phase 3 clinical trial.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "results", "of", "the", "POC", "trial,", "we", "will", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "studies", "to", "support", "the", "PTSD", "NDA.", "<tag2>", "Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "prospective", "Phase", "3", "clinical", "trial.", "<tag3>"], "wordsA": ["Based", "on", "the", "results", "of", "the", "POC", "trial,", "we", "will", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "studies", "to", "support", "the", "PTSD", "NDA."], "wordsB": ["Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "prospective", "Phase", "3", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p89_s0", "idA": "1430306_14_item1_p41_s3", "sentA": "Based on the results of the POC trial, we will meet with the FDA to finalize the design of the registration studies to support the PTSD NDA.", "sentB": "If the results of the AtEase trial are positive, we intend to meet with the FDA to finalize the design of the registration program that would be required to support approval of an NDA for this indication.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "results", "of", "the", "POC", "trial,", "we", "will", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "studies", "to", "support", "the", "PTSD", "NDA.", "<tag2>", "If", "the", "results", "of", "the", "AtEase", "trial", "are", "positive,", "we", "intend", "to", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "program", "that", "would", "be", "required", "to", "support", "approval", "of", "an", "NDA", "for", "this", "indication.", "<tag3>"], "wordsA": ["Based", "on", "the", "results", "of", "the", "POC", "trial,", "we", "will", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "studies", "to", "support", "the", "PTSD", "NDA."], "wordsB": ["If", "the", "results", "of", "the", "AtEase", "trial", "are", "positive,", "we", "intend", "to", "meet", "with", "the", "FDA", "to", "finalize", "the", "design", "of", "the", "registration", "program", "that", "would", "be", "required", "to", "support", "approval", "of", "an", "NDA", "for", "this", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p89_s3", "idA": "1430306_14_item1_p41_s5", "sentA": "We expect the long-term safety exposure data generated by our clinical development of TNX-102 SL in FM can be used to support the PTSD indication.", "sentB": "We expect that we can use the long-term safety exposure data generated by our clinical development of TNX-102 SL in FM to supplement the long-term safety exposure data required for the PTSD NDA.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "can", "be", "used", "to", "support", "the", "PTSD", "indication.", "<tag2>", "We", "expect", "that", "we", "can", "use", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "to", "supplement", "the", "long-term", "safety", "exposure", "data", "required", "for", "the", "PTSD", "NDA.", "<tag3>"], "wordsA": ["We", "expect", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "can", "be", "used", "to", "support", "the", "PTSD", "indication."], "wordsB": ["We", "expect", "that", "we", "can", "use", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "to", "supplement", "the", "long-term", "safety", "exposure", "data", "required", "for", "the", "PTSD", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p100_s1", "idA": "1430306_14_item1_p42_s1", "sentA": "Although currently not approved for any indication, IMH has an extensive history of use as a prescription pharmaceutical in the U.S. as a mixture of two mirror-image isomers, also known as a racemic mixture.", "sentB": "These studies have also shown that TNX-201 strongly and selectively binds to receptors in the CNS known as imidazoline type-1 (I1) receptors, where it acts as a receptor agonist.", "type": 2, "words": ["<tag1>", "Although", "currently", "not", "approved", "for", "any", "indication,", "IMH", "has", "an", "extensive", "history", "of", "use", "as", "a", "prescription", "pharmaceutical", "in", "the", "U.S.", "as", "a", "mixture", "of", "two", "mirror-image", "isomers,", "also", "known", "as", "a", "racemic", "mixture.", "<tag2>", "These", "studies", "have", "also", "shown", "that", "TNX-201", "strongly", "and", "selectively", "binds", "to", "receptors", "in", "the", "CNS", "known", "as", "imidazoline", "type-1", "(I1)", "receptors,", "where", "it", "acts", "as", "a", "receptor", "agonist.", "<tag3>"], "wordsA": ["Although", "currently", "not", "approved", "for", "any", "indication,", "IMH", "has", "an", "extensive", "history", "of", "use", "as", "a", "prescription", "pharmaceutical", "in", "the", "U.S.", "as", "a", "mixture", "of", "two", "mirror-image", "isomers,", "also", "known", "as", "a", "racemic", "mixture."], "wordsB": ["These", "studies", "have", "also", "shown", "that", "TNX-201", "strongly", "and", "selectively", "binds", "to", "receptors", "in", "the", "CNS", "known", "as", "imidazoline", "type-1", "(I1)", "receptors,", "where", "it", "acts", "as", "a", "receptor", "agonist."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p94_s0", "idA": "1430306_14_item1_p42_s1", "sentA": "Although currently not approved for any indication, IMH has an extensive history of use as a prescription pharmaceutical in the U.S. as a mixture of two mirror-image isomers, also known as a racemic mixture.", "sentB": "Although currently not approved for any indication, IMH has an extensive history of use as a prescription pharmaceutical in the U.S. as a racemic mixture, which consists of two mirror-image isomers, or IMH enantiomers.", "type": 2, "words": ["<tag1>", "Although", "currently", "not", "approved", "for", "any", "indication,", "IMH", "has", "an", "extensive", "history", "of", "use", "as", "a", "prescription", "pharmaceutical", "in", "the", "U.S.", "as", "a", "mixture", "of", "two", "mirror-image", "isomers,", "also", "known", "as", "a", "racemic", "mixture.", "<tag2>", "Although", "currently", "not", "approved", "for", "any", "indication,", "IMH", "has", "an", "extensive", "history", "of", "use", "as", "a", "prescription", "pharmaceutical", "in", "the", "U.S.", "as", "a", "racemic", "mixture,", "which", "consists", "of", "two", "mirror-image", "isomers,", "or", "IMH", "enantiomers.", "<tag3>"], "wordsA": ["Although", "currently", "not", "approved", "for", "any", "indication,", "IMH", "has", "an", "extensive", "history", "of", "use", "as", "a", "prescription", "pharmaceutical", "in", "the", "U.S.", "as", "a", "mixture", "of", "two", "mirror-image", "isomers,", "also", "known", "as", "a", "racemic", "mixture."], "wordsB": ["Although", "currently", "not", "approved", "for", "any", "indication,", "IMH", "has", "an", "extensive", "history", "of", "use", "as", "a", "prescription", "pharmaceutical", "in", "the", "U.S.", "as", "a", "racemic", "mixture,", "which", "consists", "of", "two", "mirror-image", "isomers,", "or", "IMH", "enantiomers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p94_s1", "idA": "1430306_14_item1_p42_s2", "sentA": "Racemic IMH has been marketed in combination products for the relief of tension and vascular headaches (examples include Midrin and MigraTen ).", "sentB": "Racemic IMH has been marketed as Octin for conditions including tension and vascular headache.", "type": 2, "words": ["<tag1>", "Racemic", "IMH", "has", "been", "marketed", "in", "combination", "products", "for", "the", "relief", "of", "tension", "and", "vascular", "headaches", "(examples", "include", "Midrin", "and", "MigraTen", ").", "<tag2>", "Racemic", "IMH", "has", "been", "marketed", "as", "Octin", "for", "conditions", "including", "tension", "and", "vascular", "headache.", "<tag3>"], "wordsA": ["Racemic", "IMH", "has", "been", "marketed", "in", "combination", "products", "for", "the", "relief", "of", "tension", "and", "vascular", "headaches", "(examples", "include", "Midrin", "and", "MigraTen", ")."], "wordsB": ["Racemic", "IMH", "has", "been", "marketed", "as", "Octin", "for", "conditions", "including", "tension", "and", "vascular", "headache."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p94_s2", "idA": "1430306_14_item1_p42_s2", "sentA": "Racemic IMH has been marketed in combination products for the relief of tension and vascular headaches (examples include Midrin and MigraTen ).", "sentB": "In addition, racemic IMH has been marketed in combination products for the relief of tension and vascular headaches (examples include Midrin , MigraTen and Prodrin ).", "type": 2, "words": ["<tag1>", "Racemic", "IMH", "has", "been", "marketed", "in", "combination", "products", "for", "the", "relief", "of", "tension", "and", "vascular", "headaches", "(examples", "include", "Midrin", "and", "MigraTen", ").", "<tag2>", "In", "addition,", "racemic", "IMH", "has", "been", "marketed", "in", "combination", "products", "for", "the", "relief", "of", "tension", "and", "vascular", "headaches", "(examples", "include", "Midrin", ",", "MigraTen", "and", "Prodrin", ").", "<tag3>"], "wordsA": ["Racemic", "IMH", "has", "been", "marketed", "in", "combination", "products", "for", "the", "relief", "of", "tension", "and", "vascular", "headaches", "(examples", "include", "Midrin", "and", "MigraTen", ")."], "wordsB": ["In", "addition,", "racemic", "IMH", "has", "been", "marketed", "in", "combination", "products", "for", "the", "relief", "of", "tension", "and", "vascular", "headaches", "(examples", "include", "Midrin", ",", "MigraTen", "and", "Prodrin", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p101_s3", "idA": "1430306_14_item1_p42_s3", "sentA": "The selection of a single isomer of IMH for development may confer an improved clinical profile as compared to the racemic mixture, consistent with the FDA Stereoisomeric Drugs Development Policy, and is supported by our pharmacology data.", "sentB": "The absence of any appreciable amount of (S)-isometheptene in TNX-201 study samples indicated the lack of conversion of (R)-isometheptene to the other enantiomer, a finding which supports the rationale of developing TNX-201, a single isomer of IMH.", "type": 2, "words": ["<tag1>", "The", "selection", "of", "a", "single", "isomer", "of", "IMH", "for", "development", "may", "confer", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "racemic", "mixture,", "consistent", "with", "the", "FDA", "Stereoisomeric", "Drugs", "Development", "Policy,", "and", "is", "supported", "by", "our", "pharmacology", "data.", "<tag2>", "The", "absence", "of", "any", "appreciable", "amount", "of", "(S)-isometheptene", "in", "TNX-201", "study", "samples", "indicated", "the", "lack", "of", "conversion", "of", "(R)-isometheptene", "to", "the", "other", "enantiomer,", "a", "finding", "which", "supports", "the", "rationale", "of", "developing", "TNX-201,", "a", "single", "isomer", "of", "IMH.", "<tag3>"], "wordsA": ["The", "selection", "of", "a", "single", "isomer", "of", "IMH", "for", "development", "may", "confer", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "racemic", "mixture,", "consistent", "with", "the", "FDA", "Stereoisomeric", "Drugs", "Development", "Policy,", "and", "is", "supported", "by", "our", "pharmacology", "data."], "wordsB": ["The", "absence", "of", "any", "appreciable", "amount", "of", "(S)-isometheptene", "in", "TNX-201", "study", "samples", "indicated", "the", "lack", "of", "conversion", "of", "(R)-isometheptene", "to", "the", "other", "enantiomer,", "a", "finding", "which", "supports", "the", "rationale", "of", "developing", "TNX-201,", "a", "single", "isomer", "of", "IMH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p98_s1", "idA": "1430306_14_item1_p42_s3", "sentA": "The selection of a single isomer of IMH for development may confer an improved clinical profile as compared to the racemic mixture, consistent with the FDA Stereoisomeric Drugs Development Policy, and is supported by our pharmacology data.", "sentB": "As a result, we believe that TNX-201 may possess an improved clinical profile as compared to the unapproved, but previously marketed, racemic IMH for headache indications.", "type": 2, "words": ["<tag1>", "The", "selection", "of", "a", "single", "isomer", "of", "IMH", "for", "development", "may", "confer", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "racemic", "mixture,", "consistent", "with", "the", "FDA", "Stereoisomeric", "Drugs", "Development", "Policy,", "and", "is", "supported", "by", "our", "pharmacology", "data.", "<tag2>", "As", "a", "result,", "we", "believe", "that", "TNX-201", "may", "possess", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "unapproved,", "but", "previously", "marketed,", "racemic", "IMH", "for", "headache", "indications.", "<tag3>"], "wordsA": ["The", "selection", "of", "a", "single", "isomer", "of", "IMH", "for", "development", "may", "confer", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "racemic", "mixture,", "consistent", "with", "the", "FDA", "Stereoisomeric", "Drugs", "Development", "Policy,", "and", "is", "supported", "by", "our", "pharmacology", "data."], "wordsB": ["As", "a", "result,", "we", "believe", "that", "TNX-201", "may", "possess", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "unapproved,", "but", "previously", "marketed,", "racemic", "IMH", "for", "headache", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p99_s0", "idA": "1430306_14_item1_p42_s3", "sentA": "The selection of a single isomer of IMH for development may confer an improved clinical profile as compared to the racemic mixture, consistent with the FDA Stereoisomeric Drugs Development Policy, and is supported by our pharmacology data.", "sentB": "According to the FDA s Stereoisomeric Drugs Development Policy, the development of a single enantiomer of a racemic drug is particularly desirable in cases in which one enantiomer has a toxic or undesirable pharmacologic effect and the other does not.", "type": 2, "words": ["<tag1>", "The", "selection", "of", "a", "single", "isomer", "of", "IMH", "for", "development", "may", "confer", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "racemic", "mixture,", "consistent", "with", "the", "FDA", "Stereoisomeric", "Drugs", "Development", "Policy,", "and", "is", "supported", "by", "our", "pharmacology", "data.", "<tag2>", "According", "to", "the", "FDA", "s", "Stereoisomeric", "Drugs", "Development", "Policy,", "the", "development", "of", "a", "single", "enantiomer", "of", "a", "racemic", "drug", "is", "particularly", "desirable", "in", "cases", "in", "which", "one", "enantiomer", "has", "a", "toxic", "or", "undesirable", "pharmacologic", "effect", "and", "the", "other", "does", "not.", "<tag3>"], "wordsA": ["The", "selection", "of", "a", "single", "isomer", "of", "IMH", "for", "development", "may", "confer", "an", "improved", "clinical", "profile", "as", "compared", "to", "the", "racemic", "mixture,", "consistent", "with", "the", "FDA", "Stereoisomeric", "Drugs", "Development", "Policy,", "and", "is", "supported", "by", "our", "pharmacology", "data."], "wordsB": ["According", "to", "the", "FDA", "s", "Stereoisomeric", "Drugs", "Development", "Policy,", "the", "development", "of", "a", "single", "enantiomer", "of", "a", "racemic", "drug", "is", "particularly", "desirable", "in", "cases", "in", "which", "one", "enantiomer", "has", "a", "toxic", "or", "undesirable", "pharmacologic", "effect", "and", "the", "other", "does", "not."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p101_s0", "idA": "1430306_14_item1_p42_s4", "sentA": "We held a pre-IND meeting with the FDA in January 2014 to discuss the regulatory pathway for the development of TNX-201 for the treatment of ETTH.", "sentB": "In January 2014, we held a pre-IND meeting with the FDA to discuss the regulatory pathway for the development of TNX-201 for the treatment of ETTH.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "January", "2014", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH.", "<tag2>", "In", "January", "2014,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "January", "2014", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH."], "wordsB": ["In", "January", "2014,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p38_s3", "idA": "1430306_14_item1_p42_s4", "sentA": "We held a pre-IND meeting with the FDA in January 2014 to discuss the regulatory pathway for the development of TNX-201 for the treatment of ETTH.", "sentB": "In the future, we may explore the development of TNX-201 for the treatment of migraine headaches.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "January", "2014", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH.", "<tag2>", "In", "the", "future,", "we", "may", "explore", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "migraine", "headaches.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "January", "2014", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH."], "wordsB": ["In", "the", "future,", "we", "may", "explore", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "migraine", "headaches."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p93_s0", "idA": "1430306_14_item1_p42_s4", "sentA": "We held a pre-IND meeting with the FDA in January 2014 to discuss the regulatory pathway for the development of TNX-201 for the treatment of ETTH.", "sentB": "We are developing TNX-201 for the treatment of ETTH under an IND cleared by the FDA in October 2014.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "January", "2014", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH.", "<tag2>", "We", "are", "developing", "TNX-201", "for", "the", "treatment", "of", "ETTH", "under", "an", "IND", "cleared", "by", "the", "FDA", "in", "October", "2014.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "January", "2014", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH."], "wordsB": ["We", "are", "developing", "TNX-201", "for", "the", "treatment", "of", "ETTH", "under", "an", "IND", "cleared", "by", "the", "FDA", "in", "October", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p103_s0", "idA": "1430306_14_item1_p42_s6", "sentA": "Although the development of TNX-201 will be based on the available information on racemic IMH, the NDA approval will be required to conform with the 505(b)(1) NDA requirement.", "sentB": "Although the clinical development of TNX-201 can be accelerated based on the available information on racemic IMH, approval of any NDA will be as a new chemical entity pursuant to Section 505(b)(1) of the FDCA.", "type": 2, "words": ["<tag1>", "Although", "the", "development", "of", "TNX-201", "will", "be", "based", "on", "the", "available", "information", "on", "racemic", "IMH,", "the", "NDA", "approval", "will", "be", "required", "to", "conform", "with", "the", "505(b)(1)", "NDA", "requirement.", "<tag2>", "Although", "the", "clinical", "development", "of", "TNX-201", "can", "be", "accelerated", "based", "on", "the", "available", "information", "on", "racemic", "IMH,", "approval", "of", "any", "NDA", "will", "be", "as", "a", "new", "chemical", "entity", "pursuant", "to", "Section", "505(b)(1)", "of", "the", "FDCA.", "<tag3>"], "wordsA": ["Although", "the", "development", "of", "TNX-201", "will", "be", "based", "on", "the", "available", "information", "on", "racemic", "IMH,", "the", "NDA", "approval", "will", "be", "required", "to", "conform", "with", "the", "505(b)(1)", "NDA", "requirement."], "wordsB": ["Although", "the", "clinical", "development", "of", "TNX-201", "can", "be", "accelerated", "based", "on", "the", "available", "information", "on", "racemic", "IMH,", "approval", "of", "any", "NDA", "will", "be", "as", "a", "new", "chemical", "entity", "pursuant", "to", "Section", "505(b)(1)", "of", "the", "FDCA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p54_s0", "idA": "1430306_14_item1_p44_s0", "sentA": "We also have a pipeline of other product candidates, including TNX-301.", "sentB": "We currently are focused on developing a portfolio of product candidates, including two product candidates in clinical development for registration in three indications.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-301.", "<tag2>", "We", "currently", "are", "focused", "on", "developing", "a", "portfolio", "of", "product", "candidates,", "including", "two", "product", "candidates", "in", "clinical", "development", "for", "registration", "in", "three", "indications.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-301."], "wordsB": ["We", "currently", "are", "focused", "on", "developing", "a", "portfolio", "of", "product", "candidates,", "including", "two", "product", "candidates", "in", "clinical", "development", "for", "registration", "in", "three", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p5_s0", "idA": "1430306_14_item1_p44_s0", "sentA": "We also have a pipeline of other product candidates, including TNX-301.", "sentB": "This report contains additional trade names and trademarks of other companies.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-301.", "<tag2>", "This", "report", "contains", "additional", "trade", "names", "and", "trademarks", "of", "other", "companies.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-301."], "wordsB": ["This", "report", "contains", "additional", "trade", "names", "and", "trademarks", "of", "other", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p106_s0", "idA": "1430306_14_item1_p44_s1", "sentA": "TNX-301 is a fixed dose combination of two FDA-approved drugs, disulfiram and selegiline.", "sentB": "TNX-301 is a fixed dose combination drug product, or CDP, containing two FDA-approved drugs, disulfiram and selegiline.", "type": 2, "words": ["<tag1>", "TNX-301", "is", "a", "fixed", "dose", "combination", "of", "two", "FDA-approved", "drugs,", "disulfiram", "and", "selegiline.", "<tag2>", "TNX-301", "is", "a", "fixed", "dose", "combination", "drug", "product,", "or", "CDP,", "containing", "two", "FDA-approved", "drugs,", "disulfiram", "and", "selegiline.", "<tag3>"], "wordsA": ["TNX-301", "is", "a", "fixed", "dose", "combination", "of", "two", "FDA-approved", "drugs,", "disulfiram", "and", "selegiline."], "wordsB": ["TNX-301", "is", "a", "fixed", "dose", "combination", "drug", "product,", "or", "CDP,", "containing", "two", "FDA-approved", "drugs,", "disulfiram", "and", "selegiline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p106_s1", "idA": "1430306_14_item1_p44_s2", "sentA": "We intend to develop TNX-301 under the 505(b)(2) provision as a treatment for alcohol abuse and dependence, and plan to begin formulation work on TNX-301 in 2014.", "sentB": "We intend to develop TNX-301 CDP under Section 505(b)(2) of the FDCA as a potential treatment for alcohol abuse and dependence, and we have commenced development work on TNX-301 formulations.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "develop", "TNX-301", "under", "the", "505(b)(2)", "provision", "as", "a", "treatment", "for", "alcohol", "abuse", "and", "dependence,", "and", "plan", "to", "begin", "formulation", "work", "on", "TNX-301", "in", "2014.", "<tag2>", "We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "alcohol", "abuse", "and", "dependence,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations.", "<tag3>"], "wordsA": ["We", "intend", "to", "develop", "TNX-301", "under", "the", "505(b)(2)", "provision", "as", "a", "treatment", "for", "alcohol", "abuse", "and", "dependence,", "and", "plan", "to", "begin", "formulation", "work", "on", "TNX-301", "in", "2014."], "wordsB": ["We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "alcohol", "abuse", "and", "dependence,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p106_s2", "idA": "1430306_14_item1_p44_s3", "sentA": "In addition, we recently acquired rights to intellectual property on the development of protective agents against radiation exposure and on the development of novel smallpox vaccines.", "sentB": "In addition, we own rights to intellectual property on two biodefense technologies: one relating to the development of novel smallpox vaccines; and the other to the development of protective agents against radiation exposure.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "recently", "acquired", "rights", "to", "intellectual", "property", "on", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure", "and", "on", "the", "development", "of", "novel", "smallpox", "vaccines.", "<tag2>", "In", "addition,", "we", "own", "rights", "to", "intellectual", "property", "on", "two", "biodefense", "technologies:", "one", "relating", "to", "the", "development", "of", "novel", "smallpox", "vaccines;", "and", "the", "other", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure.", "<tag3>"], "wordsA": ["In", "addition,", "we", "recently", "acquired", "rights", "to", "intellectual", "property", "on", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure", "and", "on", "the", "development", "of", "novel", "smallpox", "vaccines."], "wordsB": ["In", "addition,", "we", "own", "rights", "to", "intellectual", "property", "on", "two", "biodefense", "technologies:", "one", "relating", "to", "the", "development", "of", "novel", "smallpox", "vaccines;", "and", "the", "other", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p106_s3", "idA": "1430306_14_item1_p45_s3", "sentA": "We plan to perform non-clinical research and development on these programs in 2014.", "sentB": "We have begun non-clinical research and development on these programs.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "perform", "non-clinical", "research", "and", "development", "on", "these", "programs", "in", "2014.", "<tag2>", "We", "have", "begun", "non-clinical", "research", "and", "development", "on", "these", "programs.", "<tag3>"], "wordsA": ["We", "plan", "to", "perform", "non-clinical", "research", "and", "development", "on", "these", "programs", "in", "2014."], "wordsB": ["We", "have", "begun", "non-clinical", "research", "and", "development", "on", "these", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p33_s0", "idA": "1430306_14_item1_p47_s0", "sentA": "Our objective is to develop and commercialize our product candidates to treat CNS conditions, including FM, PTSD and ETTH.", "sentB": "Our objective is to develop and commercialize our product candidates, including TNX-102 SL and TNX-201.", "type": 2, "words": ["<tag1>", "Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates", "to", "treat", "CNS", "conditions,", "including", "FM,", "PTSD", "and", "ETTH.", "<tag2>", "Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "including", "TNX-102", "SL", "and", "TNX-201.", "<tag3>"], "wordsA": ["Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates", "to", "treat", "CNS", "conditions,", "including", "FM,", "PTSD", "and", "ETTH."], "wordsB": ["Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "including", "TNX-102", "SL", "and", "TNX-201."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p33_s1", "idA": "1430306_14_item1_p47_s1", "sentA": "The principal components of our strategy to achieve this objective are to:", "sentB": "The principal components of our strategy are to:", "type": 2, "words": ["<tag1>", "The", "principal", "components", "of", "our", "strategy", "to", "achieve", "this", "objective", "are", "to:", "<tag2>", "The", "principal", "components", "of", "our", "strategy", "are", "to:", "<tag3>"], "wordsA": ["The", "principal", "components", "of", "our", "strategy", "to", "achieve", "this", "objective", "are", "to:"], "wordsB": ["The", "principal", "components", "of", "our", "strategy", "are", "to:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p104_s0", "idA": "1430306_14_item1_p49_s1", "sentA": "We are developing TNX-102 SL under the Section 505(b)(2) FDA pathway.", "sentB": "We are developing TNX-201 with the goal of introducing a safe, effective, and non-addictive treatment option for ETTH.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "under", "the", "Section", "505(b)(2)", "FDA", "pathway.", "<tag2>", "We", "are", "developing", "TNX-201", "with", "the", "goal", "of", "introducing", "a", "safe,", "effective,", "and", "non-addictive", "treatment", "option", "for", "ETTH.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "under", "the", "Section", "505(b)(2)", "FDA", "pathway."], "wordsB": ["We", "are", "developing", "TNX-201", "with", "the", "goal", "of", "introducing", "a", "safe,", "effective,", "and", "non-addictive", "treatment", "option", "for", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p31_s2", "idA": "1430306_14_item1_p49_s1", "sentA": "We are developing TNX-102 SL under the Section 505(b)(2) FDA pathway.", "sentB": "We are developing TNX-201 with the goal of introducing a safe, effective, and non-addictive prescription treatment option for ETTH.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "under", "the", "Section", "505(b)(2)", "FDA", "pathway.", "<tag2>", "We", "are", "developing", "TNX-201", "with", "the", "goal", "of", "introducing", "a", "safe,", "effective,", "and", "non-addictive", "prescription", "treatment", "option", "for", "ETTH.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "under", "the", "Section", "505(b)(2)", "FDA", "pathway."], "wordsB": ["We", "are", "developing", "TNX-201", "with", "the", "goal", "of", "introducing", "a", "safe,", "effective,", "and", "non-addictive", "prescription", "treatment", "option", "for", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p55_s1", "idA": "1430306_14_item1_p49_s1", "sentA": "We are developing TNX-102 SL under the Section 505(b)(2) FDA pathway.", "sentB": "We are developing TNX-102 SL for fibromyalgia and post-traumatic stress disorder.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "under", "the", "Section", "505(b)(2)", "FDA", "pathway.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "fibromyalgia", "and", "post-traumatic", "stress", "disorder.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "under", "the", "Section", "505(b)(2)", "FDA", "pathway."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "fibromyalgia", "and", "post-traumatic", "stress", "disorder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p6_s1", "idA": "1430306_14_item1_p4_s1", "sentA": "On October 7, 2011, we executed and consummated the Share Exchange.", "sentB": "On October 7, 2011, we executed and consummated the share exchange transaction, or the Share Exchange, by and among the Company, Tonix Sub and the stockholders of Tonix Sub, or the Tonix Shareholders.", "type": 2, "words": ["<tag1>", "On", "October", "7,", "2011,", "we", "executed", "and", "consummated", "the", "Share", "Exchange.", "<tag2>", "On", "October", "7,", "2011,", "we", "executed", "and", "consummated", "the", "share", "exchange", "transaction,", "or", "the", "Share", "Exchange,", "by", "and", "among", "the", "Company,", "Tonix", "Sub", "and", "the", "stockholders", "of", "Tonix", "Sub,", "or", "the", "Tonix", "Shareholders.", "<tag3>"], "wordsA": ["On", "October", "7,", "2011,", "we", "executed", "and", "consummated", "the", "Share", "Exchange."], "wordsB": ["On", "October", "7,", "2011,", "we", "executed", "and", "consummated", "the", "share", "exchange", "transaction,", "or", "the", "Share", "Exchange,", "by", "and", "among", "the", "Company,", "Tonix", "Sub", "and", "the", "stockholders", "of", "Tonix", "Sub,", "or", "the", "Tonix", "Shareholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p36_s1", "idA": "1430306_14_item1_p53_s0", "sentA": "We are pursuing a multi-pronged patent strategy by seeking intellectual property protection on several aspects of our products.", "sentB": "We are pursuing a broad patent strategy for our product candidates, and we endeavor to generate new patent applications as supported by our innovations and conceptions as well as to advance their prosecution.", "type": 2, "words": ["<tag1>", "We", "are", "pursuing", "a", "multi-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "on", "several", "aspects", "of", "our", "products.", "<tag2>", "We", "are", "pursuing", "a", "broad", "patent", "strategy", "for", "our", "product", "candidates,", "and", "we", "endeavor", "to", "generate", "new", "patent", "applications", "as", "supported", "by", "our", "innovations", "and", "conceptions", "as", "well", "as", "to", "advance", "their", "prosecution.", "<tag3>"], "wordsA": ["We", "are", "pursuing", "a", "multi-pronged", "patent", "strategy", "by", "seeking", "intellectual", "property", "protection", "on", "several", "aspects", "of", "our", "products."], "wordsB": ["We", "are", "pursuing", "a", "broad", "patent", "strategy", "for", "our", "product", "candidates,", "and", "we", "endeavor", "to", "generate", "new", "patent", "applications", "as", "supported", "by", "our", "innovations", "and", "conceptions", "as", "well", "as", "to", "advance", "their", "prosecution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p38_s2", "idA": "1430306_14_item1_p53_s5", "sentA": "For example, we filed a patent application seeking to protect the use of CBP in PTSD.", "sentB": "For example, we own rights related to the development and commercialization of CBP for generalized anxiety disorder, depression, and fatigue related to disordered sleep.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD.", "<tag2>", "For", "example,", "we", "own", "rights", "related", "to", "the", "development", "and", "commercialization", "of", "CBP", "for", "generalized", "anxiety", "disorder,", "depression,", "and", "fatigue", "related", "to", "disordered", "sleep.", "<tag3>"], "wordsA": ["For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD."], "wordsB": ["For", "example,", "we", "own", "rights", "related", "to", "the", "development", "and", "commercialization", "of", "CBP", "for", "generalized", "anxiety", "disorder,", "depression,", "and", "fatigue", "related", "to", "disordered", "sleep."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p49_s2", "idA": "1430306_14_item1_p53_s5", "sentA": "For example, we filed a patent application seeking to protect the use of CBP in PTSD.", "sentB": "Co-morbid alcohol and substance abuse and dependence, which occur frequently in the PTSD population, generally complicate the use of sedative-hypnotics in these patients.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD.", "<tag2>", "Co-morbid", "alcohol", "and", "substance", "abuse", "and", "dependence,", "which", "occur", "frequently", "in", "the", "PTSD", "population,", "generally", "complicate", "the", "use", "of", "sedative-hypnotics", "in", "these", "patients.", "<tag3>"], "wordsA": ["For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD."], "wordsB": ["Co-morbid", "alcohol", "and", "substance", "abuse", "and", "dependence,", "which", "occur", "frequently", "in", "the", "PTSD", "population,", "generally", "complicate", "the", "use", "of", "sedative-hypnotics", "in", "these", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p51_s0", "idA": "1430306_14_item1_p53_s5", "sentA": "For example, we filed a patent application seeking to protect the use of CBP in PTSD.", "sentB": "Many people who suffer from ETTH are able to adequately manage their symptoms through the use of over-the-counter products containing aspirin, acetaminophen, or non-steroidal anti-inflammatory drugs (NSAIDs).", "type": 2, "words": ["<tag1>", "For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD.", "<tag2>", "Many", "people", "who", "suffer", "from", "ETTH", "are", "able", "to", "adequately", "manage", "their", "symptoms", "through", "the", "use", "of", "over-the-counter", "products", "containing", "aspirin,", "acetaminophen,", "or", "non-steroidal", "anti-inflammatory", "drugs", "(NSAIDs).", "<tag3>"], "wordsA": ["For", "example,", "we", "filed", "a", "patent", "application", "seeking", "to", "protect", "the", "use", "of", "CBP", "in", "PTSD."], "wordsB": ["Many", "people", "who", "suffer", "from", "ETTH", "are", "able", "to", "adequately", "manage", "their", "symptoms", "through", "the", "use", "of", "over-the-counter", "products", "containing", "aspirin,", "acetaminophen,", "or", "non-steroidal", "anti-inflammatory", "drugs", "(NSAIDs)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p24_s6", "idA": "1430306_14_item1_p54_s0", "sentA": "Provide clear value propositions to third-party payors to merit reimbursement for our product candidates .", "sentB": "We hold worldwide development and commercialization rights to all of our product candidates.", "type": 2, "words": ["<tag1>", "Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", ".", "<tag2>", "We", "hold", "worldwide", "development", "and", "commercialization", "rights", "to", "all", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", "."], "wordsB": ["We", "hold", "worldwide", "development", "and", "commercialization", "rights", "to", "all", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p32_s0", "idA": "1430306_14_item1_p54_s0", "sentA": "Provide clear value propositions to third-party payors to merit reimbursement for our product candidates .", "sentB": "We have assembled a management team with significant industry experience to lead the development of our product candidates.", "type": 2, "words": ["<tag1>", "Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", ".", "<tag2>", "We", "have", "assembled", "a", "management", "team", "with", "significant", "industry", "experience", "to", "lead", "the", "development", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", "."], "wordsB": ["We", "have", "assembled", "a", "management", "team", "with", "significant", "industry", "experience", "to", "lead", "the", "development", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p36_s0", "idA": "1430306_14_item1_p54_s0", "sentA": "Provide clear value propositions to third-party payors to merit reimbursement for our product candidates .", "sentB": "Pursue a broad intellectual property strategy to protect our product candidates .", "type": 2, "words": ["<tag1>", "Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", ".", "<tag2>", "Pursue", "a", "broad", "intellectual", "property", "strategy", "to", "protect", "our", "product", "candidates", ".", "<tag3>"], "wordsA": ["Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", "."], "wordsB": ["Pursue", "a", "broad", "intellectual", "property", "strategy", "to", "protect", "our", "product", "candidates", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p37_s0", "idA": "1430306_14_item1_p54_s0", "sentA": "Provide clear value propositions to third-party payors to merit reimbursement for our product candidates .", "sentB": "Provide value propositions to merit market demand and reimbursement for our product candidates .", "type": 2, "words": ["<tag1>", "Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", ".", "<tag2>", "Provide", "value", "propositions", "to", "merit", "market", "demand", "and", "reimbursement", "for", "our", "product", "candidates", ".", "<tag3>"], "wordsA": ["Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", "."], "wordsB": ["Provide", "value", "propositions", "to", "merit", "market", "demand", "and", "reimbursement", "for", "our", "product", "candidates", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p38_s0", "idA": "1430306_14_item1_p54_s0", "sentA": "Provide clear value propositions to third-party payors to merit reimbursement for our product candidates .", "sentB": "Pursue additional indications and commercial opportunities for our product candidates .", "type": 2, "words": ["<tag1>", "Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", ".", "<tag2>", "Pursue", "additional", "indications", "and", "commercial", "opportunities", "for", "our", "product", "candidates", ".", "<tag3>"], "wordsA": ["Provide", "clear", "value", "propositions", "to", "third-party", "payors", "to", "merit", "reimbursement", "for", "our", "product", "candidates", "."], "wordsB": ["Pursue", "additional", "indications", "and", "commercial", "opportunities", "for", "our", "product", "candidates", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p37_s1", "idA": "1430306_14_item1_p54_s1", "sentA": "We are designing our clinical development programs to demonstrate compelling competitive advantages to patients and prescribers and also to demonstrate value propositions to third-party payors.", "sentB": "We are designing the development programs for our product candidates to demonstrate their value propositions to patients, prescribers, and third-party payors.", "type": 2, "words": ["<tag1>", "We", "are", "designing", "our", "clinical", "development", "programs", "to", "demonstrate", "compelling", "competitive", "advantages", "to", "patients", "and", "prescribers", "and", "also", "to", "demonstrate", "value", "propositions", "to", "third-party", "payors.", "<tag2>", "We", "are", "designing", "the", "development", "programs", "for", "our", "product", "candidates", "to", "demonstrate", "their", "value", "propositions", "to", "patients,", "prescribers,", "and", "third-party", "payors.", "<tag3>"], "wordsA": ["We", "are", "designing", "our", "clinical", "development", "programs", "to", "demonstrate", "compelling", "competitive", "advantages", "to", "patients", "and", "prescribers", "and", "also", "to", "demonstrate", "value", "propositions", "to", "third-party", "payors."], "wordsB": ["We", "are", "designing", "the", "development", "programs", "for", "our", "product", "candidates", "to", "demonstrate", "their", "value", "propositions", "to", "patients,", "prescribers,", "and", "third-party", "payors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p46_s0", "idA": "1430306_14_item1_p54_s2", "sentA": "We believe TNX-102 SL might help in the management of FM by reducing pain and other symptoms, such as fatigue.", "sentB": "PTSD is a significant problem among armed forces veterans and other military personnel, but also occurs frequently in the civilian population.", "type": 2, "words": ["<tag1>", "We", "believe", "TNX-102", "SL", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue.", "<tag2>", "PTSD", "is", "a", "significant", "problem", "among", "armed", "forces", "veterans", "and", "other", "military", "personnel,", "but", "also", "occurs", "frequently", "in", "the", "civilian", "population.", "<tag3>"], "wordsA": ["We", "believe", "TNX-102", "SL", "might", "help", "in", "the", "management", "of", "FM", "by", "reducing", "pain", "and", "other", "symptoms,", "such", "as", "fatigue."], "wordsB": ["PTSD", "is", "a", "significant", "problem", "among", "armed", "forces", "veterans", "and", "other", "military", "personnel,", "but", "also", "occurs", "frequently", "in", "the", "civilian", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p34_s0", "idA": "1430306_14_item1_p55_s1", "sentA": "We believe TNX-102 SL and TNX-201 can be marketed to physicians in the United States by means of a sales force built by or engaged by us.", "sentB": "Develop TNX-102 SL and TNX-201 for multiple central nervous system disorders .", "type": 2, "words": ["<tag1>", "We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "physicians", "in", "the", "United", "States", "by", "means", "of", "a", "sales", "force", "built", "by", "or", "engaged", "by", "us.", "<tag2>", "Develop", "TNX-102", "SL", "and", "TNX-201", "for", "multiple", "central", "nervous", "system", "disorders", ".", "<tag3>"], "wordsA": ["We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "physicians", "in", "the", "United", "States", "by", "means", "of", "a", "sales", "force", "built", "by", "or", "engaged", "by", "us."], "wordsB": ["Develop", "TNX-102", "SL", "and", "TNX-201", "for", "multiple", "central", "nervous", "system", "disorders", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p35_s2", "idA": "1430306_14_item1_p55_s1", "sentA": "We believe TNX-102 SL and TNX-201 can be marketed to physicians in the United States by means of a sales force built by or engaged by us.", "sentB": "We believe TNX-102 SL and TNX-201 can be marketed to U.S. physicians either by an internal sales force that we will build or by a contract sales organization, which we would engage.", "type": 2, "words": ["<tag1>", "We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "physicians", "in", "the", "United", "States", "by", "means", "of", "a", "sales", "force", "built", "by", "or", "engaged", "by", "us.", "<tag2>", "We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage.", "<tag3>"], "wordsA": ["We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "physicians", "in", "the", "United", "States", "by", "means", "of", "a", "sales", "force", "built", "by", "or", "engaged", "by", "us."], "wordsB": ["We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p35_s3", "idA": "1430306_14_item1_p56_s3", "sentA": "Another option for certain of our drug development candidates, including TNX-102 SL and TNX-201, would be to partner with companies that already have significant marketing capabilities in the same, or similar, therapeutic areas.", "sentB": "An alternative strategy would be to enter into partnership agreements with drug companies that already have significant marketing capabilities in the same, or similar, therapeutic areas.", "type": 2, "words": ["<tag1>", "Another", "option", "for", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "SL", "and", "TNX-201,", "would", "be", "to", "partner", "with", "companies", "that", "already", "have", "significant", "marketing", "capabilities", "in", "the", "same,", "or", "similar,", "therapeutic", "areas.", "<tag2>", "An", "alternative", "strategy", "would", "be", "to", "enter", "into", "partnership", "agreements", "with", "drug", "companies", "that", "already", "have", "significant", "marketing", "capabilities", "in", "the", "same,", "or", "similar,", "therapeutic", "areas.", "<tag3>"], "wordsA": ["Another", "option", "for", "certain", "of", "our", "drug", "development", "candidates,", "including", "TNX-102", "SL", "and", "TNX-201,", "would", "be", "to", "partner", "with", "companies", "that", "already", "have", "significant", "marketing", "capabilities", "in", "the", "same,", "or", "similar,", "therapeutic", "areas."], "wordsB": ["An", "alternative", "strategy", "would", "be", "to", "enter", "into", "partnership", "agreements", "with", "drug", "companies", "that", "already", "have", "significant", "marketing", "capabilities", "in", "the", "same,", "or", "similar,", "therapeutic", "areas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p24_s2", "idA": "1430306_14_item1_p57_s0", "sentA": "Our lead product candidate is TNX-102 SL, which we are developing for the treatment of FM and PTSD.", "sentB": "In the second quarter of 2015, we expect to initiate a Phase 3 clinical trial of our most advanced candidate, TNX-102 SL, for the treatment of FM.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "In", "the", "second", "quarter", "of", "2015,", "we", "expect", "to", "initiate", "a", "Phase", "3", "clinical", "trial", "of", "our", "most", "advanced", "candidate,", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["In", "the", "second", "quarter", "of", "2015,", "we", "expect", "to", "initiate", "a", "Phase", "3", "clinical", "trial", "of", "our", "most", "advanced", "candidate,", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p30_s0", "idA": "1430306_14_item1_p57_s0", "sentA": "Our lead product candidate is TNX-102 SL, which we are developing for the treatment of FM and PTSD.", "sentB": "TNX-201 is an oral formulation of (R)-isometheptene mucate that we are developing for ETTH.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "TNX-201", "is", "an", "oral", "formulation", "of", "(R)-isometheptene", "mucate", "that", "we", "are", "developing", "for", "ETTH.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["TNX-201", "is", "an", "oral", "formulation", "of", "(R)-isometheptene", "mucate", "that", "we", "are", "developing", "for", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p47_s1", "idA": "1430306_14_item1_p57_s0", "sentA": "Our lead product candidate is TNX-102 SL, which we are developing for the treatment of FM and PTSD.", "sentB": "Two antidepressant drugs, paroxetine (Paxil ) and sertraline (Zoloft ), are FDA-approved for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "Two", "antidepressant", "drugs,", "paroxetine", "(Paxil", ")", "and", "sertraline", "(Zoloft", "),", "are", "FDA-approved", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["Two", "antidepressant", "drugs,", "paroxetine", "(Paxil", ")", "and", "sertraline", "(Zoloft", "),", "are", "FDA-approved", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p58_s3", "idA": "1430306_14_item1_p57_s0", "sentA": "Our lead product candidate is TNX-102 SL, which we are developing for the treatment of FM and PTSD.", "sentB": "As such, TNX-102 SL acts upon cellular receptors that play important roles in the treatment of FM and PTSD, yet also acts upon other receptors in the central nervous system not targeted by products approved for these indications.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "yet", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "yet", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p60_s0", "idA": "1430306_14_item1_p57_s0", "sentA": "Our lead product candidate is TNX-102 SL, which we are developing for the treatment of FM and PTSD.", "sentB": "TNX-102 SL is intended for the treatment of chronic disorders for which poor sleep quality is recognized to play an intrinsic role, including FM and PTSD.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "TNX-102", "SL", "is", "intended", "for", "the", "treatment", "of", "chronic", "disorders", "for", "which", "poor", "sleep", "quality", "is", "recognized", "to", "play", "an", "intrinsic", "role,", "including", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["TNX-102", "SL", "is", "intended", "for", "the", "treatment", "of", "chronic", "disorders", "for", "which", "poor", "sleep", "quality", "is", "recognized", "to", "play", "an", "intrinsic", "role,", "including", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p93_s1", "idA": "1430306_14_item1_p57_s0", "sentA": "Our lead product candidate is TNX-102 SL, which we are developing for the treatment of FM and PTSD.", "sentB": "TNX-201 is an oral formulation of (R)-isometheptene mucate, a single isomer of isometheptene mucate, or IMH, which we are developing for episodic tension-type headache.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "TNX-201", "is", "an", "oral", "formulation", "of", "(R)-isometheptene", "mucate,", "a", "single", "isomer", "of", "isometheptene", "mucate,", "or", "IMH,", "which", "we", "are", "developing", "for", "episodic", "tension-type", "headache.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["TNX-201", "is", "an", "oral", "formulation", "of", "(R)-isometheptene", "mucate,", "a", "single", "isomer", "of", "isometheptene", "mucate,", "or", "IMH,", "which", "we", "are", "developing", "for", "episodic", "tension-type", "headache."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p98_s0", "idA": "1430306_14_item1_p57_s0", "sentA": "Our lead product candidate is TNX-102 SL, which we are developing for the treatment of FM and PTSD.", "sentB": "Based on our evaluation studies, we believe that (R)-isometheptene mucate, which we are developing as TNX-201, is primarily responsible for the efficacy associated with racemic IMH in the treatment of headache, and that (S)-isometheptene mucate, the other IMH enantiomer, may be associated with toxic or undesirable pharmacologic effects.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD.", "<tag2>", "Based", "on", "our", "evaluation", "studies,", "we", "believe", "that", "(R)-isometheptene", "mucate,", "which", "we", "are", "developing", "as", "TNX-201,", "is", "primarily", "responsible", "for", "the", "efficacy", "associated", "with", "racemic", "IMH", "in", "the", "treatment", "of", "headache,", "and", "that", "(S)-isometheptene", "mucate,", "the", "other", "IMH", "enantiomer,", "may", "be", "associated", "with", "toxic", "or", "undesirable", "pharmacologic", "effects.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "TNX-102", "SL,", "which", "we", "are", "developing", "for", "the", "treatment", "of", "FM", "and", "PTSD."], "wordsB": ["Based", "on", "our", "evaluation", "studies,", "we", "believe", "that", "(R)-isometheptene", "mucate,", "which", "we", "are", "developing", "as", "TNX-201,", "is", "primarily", "responsible", "for", "the", "efficacy", "associated", "with", "racemic", "IMH", "in", "the", "treatment", "of", "headache,", "and", "that", "(S)-isometheptene", "mucate,", "the", "other", "IMH", "enantiomer,", "may", "be", "associated", "with", "toxic", "or", "undesirable", "pharmacologic", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p60_s2", "idA": "1430306_14_item1_p66_s3", "sentA": "We believe the unique properties of TNX-102 SL, as demonstrated by the results of our studies, support its development in both FM and PTSD.", "sentB": "We believe the dose and pharmacokinetic parameters of TNX-102 SL will enable it to achieve a desirable balance of efficacy, safety, and tolerability in FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "unique", "properties", "of", "TNX-102", "SL,", "as", "demonstrated", "by", "the", "results", "of", "our", "studies,", "support", "its", "development", "in", "both", "FM", "and", "PTSD.", "<tag2>", "We", "believe", "the", "dose", "and", "pharmacokinetic", "parameters", "of", "TNX-102", "SL", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "the", "unique", "properties", "of", "TNX-102", "SL,", "as", "demonstrated", "by", "the", "results", "of", "our", "studies,", "support", "its", "development", "in", "both", "FM", "and", "PTSD."], "wordsB": ["We", "believe", "the", "dose", "and", "pharmacokinetic", "parameters", "of", "TNX-102", "SL", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p88_s0", "idA": "1430306_14_item1_p67_s0", "sentA": "TNX-102 SL, our lead product candidate, is a rapidly disintegrating tablet containing CBP that is designed to be placed under the tongue at bedtime.", "sentB": "The AtEase trial is designed to study the efficacy and safety of two doses of TNX-102 SL (2.8 mg and 5.6 mg) administered once daily at bedtime.", "type": 2, "words": ["<tag1>", "TNX-102", "SL,", "our", "lead", "product", "candidate,", "is", "a", "rapidly", "disintegrating", "tablet", "containing", "CBP", "that", "is", "designed", "to", "be", "placed", "under", "the", "tongue", "at", "bedtime.", "<tag2>", "The", "AtEase", "trial", "is", "designed", "to", "study", "the", "efficacy", "and", "safety", "of", "two", "doses", "of", "TNX-102", "SL", "(2.8", "mg", "and", "5.6", "mg)", "administered", "once", "daily", "at", "bedtime.", "<tag3>"], "wordsA": ["TNX-102", "SL,", "our", "lead", "product", "candidate,", "is", "a", "rapidly", "disintegrating", "tablet", "containing", "CBP", "that", "is", "designed", "to", "be", "placed", "under", "the", "tongue", "at", "bedtime."], "wordsB": ["The", "AtEase", "trial", "is", "designed", "to", "study", "the", "efficacy", "and", "safety", "of", "two", "doses", "of", "TNX-102", "SL", "(2.8", "mg", "and", "5.6", "mg)", "administered", "once", "daily", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p37_s2", "idA": "1430306_14_item1_p67_s1", "sentA": "The development of TNX-102 SL in FM is supported by the results of the Moldofsky Study, which evaluated oral administration of TNX-102 capsules in the evening, as well as by preclinical and comparative clinical pharmacokinetic studies.", "sentB": "In the cases of TNX-102 SL and TNX-201, we have been engaged in market research and commercial assessment activities, the results of which we may use to inform future commercial strategy.", "type": 2, "words": ["<tag1>", "The", "development", "of", "TNX-102", "SL", "in", "FM", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study,", "which", "evaluated", "oral", "administration", "of", "TNX-102", "capsules", "in", "the", "evening,", "as", "well", "as", "by", "preclinical", "and", "comparative", "clinical", "pharmacokinetic", "studies.", "<tag2>", "In", "the", "cases", "of", "TNX-102", "SL", "and", "TNX-201,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy.", "<tag3>"], "wordsA": ["The", "development", "of", "TNX-102", "SL", "in", "FM", "is", "supported", "by", "the", "results", "of", "the", "Moldofsky", "Study,", "which", "evaluated", "oral", "administration", "of", "TNX-102", "capsules", "in", "the", "evening,", "as", "well", "as", "by", "preclinical", "and", "comparative", "clinical", "pharmacokinetic", "studies."], "wordsB": ["In", "the", "cases", "of", "TNX-102", "SL", "and", "TNX-201,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p58_s2", "idA": "1430306_14_item1_p68_s2", "sentA": "Current CBP products are believed to be widely used off-label by FM patients.", "sentB": "In PTSD, both paroxetine and sertraline are believed to exert their clinical benefit primarily by blocking serotonin reuptake.", "type": 2, "words": ["<tag1>", "Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients.", "<tag2>", "In", "PTSD,", "both", "paroxetine", "and", "sertraline", "are", "believed", "to", "exert", "their", "clinical", "benefit", "primarily", "by", "blocking", "serotonin", "reuptake.", "<tag3>"], "wordsA": ["Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients."], "wordsB": ["In", "PTSD,", "both", "paroxetine", "and", "sertraline", "are", "believed", "to", "exert", "their", "clinical", "benefit", "primarily", "by", "blocking", "serotonin", "reuptake."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p84_s2", "idA": "1430306_14_item1_p68_s2", "sentA": "Current CBP products are believed to be widely used off-label by FM patients.", "sentB": "The sleep disturbances of PTSD, which include nightmares and night terrors, may be more pronounced than those typically experienced by FM patients.", "type": 2, "words": ["<tag1>", "Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients.", "<tag2>", "The", "sleep", "disturbances", "of", "PTSD,", "which", "include", "nightmares", "and", "night", "terrors,", "may", "be", "more", "pronounced", "than", "those", "typically", "experienced", "by", "FM", "patients.", "<tag3>"], "wordsA": ["Current", "CBP", "products", "are", "believed", "to", "be", "widely", "used", "off-label", "by", "FM", "patients."], "wordsB": ["The", "sleep", "disturbances", "of", "PTSD,", "which", "include", "nightmares", "and", "night", "terrors,", "may", "be", "more", "pronounced", "than", "those", "typically", "experienced", "by", "FM", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p57_s0", "idA": "1430306_14_item1_p72_s1", "sentA": "Each TNX-102 capsule contained 1 mg of CBP.", "sentB": "TNX-102 SL contains 2.8 mg of CBP.", "type": 2, "words": ["<tag1>", "Each", "TNX-102", "capsule", "contained", "1", "mg", "of", "CBP.", "<tag2>", "TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP.", "<tag3>"], "wordsA": ["Each", "TNX-102", "capsule", "contained", "1", "mg", "of", "CBP."], "wordsB": ["TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p66_s4", "idA": "1430306_14_item1_p75_s0", "sentA": "As illustrated in Figure 1, this study showed that treatment with TNX-102 capsules as compared to treatment with placebo:", "sentB": "The 30% response rate in the final analysis was 34.0% in the active treatment arm as compared to 20.6% in the control arm.", "type": 2, "words": ["<tag1>", "As", "illustrated", "in", "Figure", "1,", "this", "study", "showed", "that", "treatment", "with", "TNX-102", "capsules", "as", "compared", "to", "treatment", "with", "placebo:", "<tag2>", "The", "30%", "response", "rate", "in", "the", "final", "analysis", "was", "34.0%", "in", "the", "active", "treatment", "arm", "as", "compared", "to", "20.6%", "in", "the", "control", "arm.", "<tag3>"], "wordsA": ["As", "illustrated", "in", "Figure", "1,", "this", "study", "showed", "that", "treatment", "with", "TNX-102", "capsules", "as", "compared", "to", "treatment", "with", "placebo:"], "wordsB": ["The", "30%", "response", "rate", "in", "the", "final", "analysis", "was", "34.0%", "in", "the", "active", "treatment", "arm", "as", "compared", "to", "20.6%", "in", "the", "control", "arm."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p63_s2", "idA": "1430306_14_item1_p77_s0", "sentA": "This study also showed that TNX-102 capsules taken between dinner and bedtime resulted in a significant improvement in objective measures of sleep quality.", "sentB": "This study demonstrated significant decreases in pain and other symptoms in subjects treated with TNX-102 capsules daily between dinner and bedtime for eight weeks.", "type": 2, "words": ["<tag1>", "This", "study", "also", "showed", "that", "TNX-102", "capsules", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality.", "<tag2>", "This", "study", "demonstrated", "significant", "decreases", "in", "pain", "and", "other", "symptoms", "in", "subjects", "treated", "with", "TNX-102", "capsules", "daily", "between", "dinner", "and", "bedtime", "for", "eight", "weeks.", "<tag3>"], "wordsA": ["This", "study", "also", "showed", "that", "TNX-102", "capsules", "taken", "between", "dinner", "and", "bedtime", "resulted", "in", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality."], "wordsB": ["This", "study", "demonstrated", "significant", "decreases", "in", "pain", "and", "other", "symptoms", "in", "subjects", "treated", "with", "TNX-102", "capsules", "daily", "between", "dinner", "and", "bedtime", "for", "eight", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p9_s1", "idA": "1430306_14_item1_p7_s1", "sentA": "From and after the consummation of the Share Exchange, our primary operations consist of the business and operations of Tonix Sub and Krele.", "sentB": "From and after the consummation of the Share Exchange, our primary operations consist of the business and operations of Tonix Sub.", "type": 2, "words": ["<tag1>", "From", "and", "after", "the", "consummation", "of", "the", "Share", "Exchange,", "our", "primary", "operations", "consist", "of", "the", "business", "and", "operations", "of", "Tonix", "Sub", "and", "Krele.", "<tag2>", "From", "and", "after", "the", "consummation", "of", "the", "Share", "Exchange,", "our", "primary", "operations", "consist", "of", "the", "business", "and", "operations", "of", "Tonix", "Sub.", "<tag3>"], "wordsA": ["From", "and", "after", "the", "consummation", "of", "the", "Share", "Exchange,", "our", "primary", "operations", "consist", "of", "the", "business", "and", "operations", "of", "Tonix", "Sub", "and", "Krele."], "wordsB": ["From", "and", "after", "the", "consummation", "of", "the", "Share", "Exchange,", "our", "primary", "operations", "consist", "of", "the", "business", "and", "operations", "of", "Tonix", "Sub."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p67_s0", "idA": "1430306_14_item1_p83_s0", "sentA": "We are currently conducting a Phase 2b/3 study of TNX-102 SL in FM called the BESTFIT trial.", "sentB": "TNX-102 SL was well tolerated in the BESTFIT trial.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "conducting", "a", "Phase", "2b/3", "study", "of", "TNX-102", "SL", "in", "FM", "called", "the", "BESTFIT", "trial.", "<tag2>", "TNX-102", "SL", "was", "well", "tolerated", "in", "the", "BESTFIT", "trial.", "<tag3>"], "wordsA": ["We", "are", "currently", "conducting", "a", "Phase", "2b/3", "study", "of", "TNX-102", "SL", "in", "FM", "called", "the", "BESTFIT", "trial."], "wordsB": ["TNX-102", "SL", "was", "well", "tolerated", "in", "the", "BESTFIT", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p60_s1", "idA": "1430306_14_item1_p83_s1", "sentA": "In this multicenter, randomized, double-blind, placebo-controlled clinical trial, FM patients will be administered either TNX-102 SL or placebo at bedtime nightly for 12 weeks.", "sentB": "We designed TNX-102 SL to be administered once-daily at bedtime in a chronic dosing regimen.", "type": 2, "words": ["<tag1>", "In", "this", "multicenter,", "randomized,", "double-blind,", "placebo-controlled", "clinical", "trial,", "FM", "patients", "will", "be", "administered", "either", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks.", "<tag2>", "We", "designed", "TNX-102", "SL", "to", "be", "administered", "once-daily", "at", "bedtime", "in", "a", "chronic", "dosing", "regimen.", "<tag3>"], "wordsA": ["In", "this", "multicenter,", "randomized,", "double-blind,", "placebo-controlled", "clinical", "trial,", "FM", "patients", "will", "be", "administered", "either", "TNX-102", "SL", "or", "placebo", "at", "bedtime", "nightly", "for", "12", "weeks."], "wordsB": ["We", "designed", "TNX-102", "SL", "to", "be", "administered", "once-daily", "at", "bedtime", "in", "a", "chronic", "dosing", "regimen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p89_s2", "idA": "1430306_14_item1_p83_s2", "sentA": "We expect that our BESTFIT trial, if successful and accepted by the FDA, will be one of the two pivotal studies required to support the NDA approval.", "sentB": "If we achieve our primary outcome measure in the AtEase study, it could qualify as one of the two studies required to support the NDA.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "our", "BESTFIT", "trial,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval.", "<tag2>", "If", "we", "achieve", "our", "primary", "outcome", "measure", "in", "the", "AtEase", "study,", "it", "could", "qualify", "as", "one", "of", "the", "two", "studies", "required", "to", "support", "the", "NDA.", "<tag3>"], "wordsA": ["We", "expect", "that", "our", "BESTFIT", "trial,", "if", "successful", "and", "accepted", "by", "the", "FDA,", "will", "be", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "support", "the", "NDA", "approval."], "wordsB": ["If", "we", "achieve", "our", "primary", "outcome", "measure", "in", "the", "AtEase", "study,", "it", "could", "qualify", "as", "one", "of", "the", "two", "studies", "required", "to", "support", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p70_s1", "idA": "1430306_14_item1_p84_s1", "sentA": "The goal is to obtain sufficient 6 and 12 month safety exposure data in FM patients to meet the NDA submission requirement.", "sentB": "The goal of Study F203 is to obtain the prerequisite six- and 12-month safety exposure data to support NDA filing for approval for the management of FM, a chronic indication.", "type": 2, "words": ["<tag1>", "The", "goal", "is", "to", "obtain", "sufficient", "6", "and", "12", "month", "safety", "exposure", "data", "in", "FM", "patients", "to", "meet", "the", "NDA", "submission", "requirement.", "<tag2>", "The", "goal", "of", "Study", "F203", "is", "to", "obtain", "the", "prerequisite", "six-", "and", "12-month", "safety", "exposure", "data", "to", "support", "NDA", "filing", "for", "approval", "for", "the", "management", "of", "FM,", "a", "chronic", "indication.", "<tag3>"], "wordsA": ["The", "goal", "is", "to", "obtain", "sufficient", "6", "and", "12", "month", "safety", "exposure", "data", "in", "FM", "patients", "to", "meet", "the", "NDA", "submission", "requirement."], "wordsB": ["The", "goal", "of", "Study", "F203", "is", "to", "obtain", "the", "prerequisite", "six-", "and", "12-month", "safety", "exposure", "data", "to", "support", "NDA", "filing", "for", "approval", "for", "the", "management", "of", "FM,", "a", "chronic", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p65_s0", "idA": "1430306_14_item1_p85_s0", "sentA": "If our Phase 2b/3 BESTFIT study of TNX-102 SL in FM is successful, then we expect to conduct a 12-week, randomized, double-blind, placebo-controlled confirmatory Phase 3 study of TNX-102 SL in support of product registration.", "sentB": "In September 2013, we commenced enrollment of our BESTFIT trial, a randomized, double-blind, placebo-controlled Phase 2b clinical trial of TNX-102 SL in FM.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2b/3", "BESTFIT", "study", "of", "TNX-102", "SL", "in", "FM", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "12-week,", "randomized,", "double-blind,", "placebo-controlled", "confirmatory", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "support", "of", "product", "registration.", "<tag2>", "In", "September", "2013,", "we", "commenced", "enrollment", "of", "our", "BESTFIT", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2b", "clinical", "trial", "of", "TNX-102", "SL", "in", "FM.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2b/3", "BESTFIT", "study", "of", "TNX-102", "SL", "in", "FM", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "12-week,", "randomized,", "double-blind,", "placebo-controlled", "confirmatory", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "support", "of", "product", "registration."], "wordsB": ["In", "September", "2013,", "we", "commenced", "enrollment", "of", "our", "BESTFIT", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "2b", "clinical", "trial", "of", "TNX-102", "SL", "in", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p71_s0", "idA": "1430306_14_item1_p85_s0", "sentA": "If our Phase 2b/3 BESTFIT study of TNX-102 SL in FM is successful, then we expect to conduct a 12-week, randomized, double-blind, placebo-controlled confirmatory Phase 3 study of TNX-102 SL in support of product registration.", "sentB": "We expect to conduct a second randomized, double-blind, placebo-controlled Phase 3 clinical trial of TNX-102 SL to support product registration.", "type": 2, "words": ["<tag1>", "If", "our", "Phase", "2b/3", "BESTFIT", "study", "of", "TNX-102", "SL", "in", "FM", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "12-week,", "randomized,", "double-blind,", "placebo-controlled", "confirmatory", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "support", "of", "product", "registration.", "<tag2>", "We", "expect", "to", "conduct", "a", "second", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "clinical", "trial", "of", "TNX-102", "SL", "to", "support", "product", "registration.", "<tag3>"], "wordsA": ["If", "our", "Phase", "2b/3", "BESTFIT", "study", "of", "TNX-102", "SL", "in", "FM", "is", "successful,", "then", "we", "expect", "to", "conduct", "a", "12-week,", "randomized,", "double-blind,", "placebo-controlled", "confirmatory", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "support", "of", "product", "registration."], "wordsB": ["We", "expect", "to", "conduct", "a", "second", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "clinical", "trial", "of", "TNX-102", "SL", "to", "support", "product", "registration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p72_s2", "idA": "1430306_14_item1_p86_s2", "sentA": "We expect the data from this study to serve as a bridge , in that they will allow us to use the CBP IR tablet as the reference product in our submission of a Section 505(b)(2) NDA for TNX-102 SL.", "sentB": "We expect the data from this study to serve as a bridge , in that it will allow us to use the IR CBP tablet as the reference product in our submission of a Section 505(b)(2) NDA for TNX-102 SL.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", ",", "in", "that", "they", "will", "allow", "us", "to", "use", "the", "CBP", "IR", "tablet", "as", "the", "reference", "product", "in", "our", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "TNX-102", "SL.", "<tag2>", "We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", ",", "in", "that", "it", "will", "allow", "us", "to", "use", "the", "IR", "CBP", "tablet", "as", "the", "reference", "product", "in", "our", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "TNX-102", "SL.", "<tag3>"], "wordsA": ["We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", ",", "in", "that", "they", "will", "allow", "us", "to", "use", "the", "CBP", "IR", "tablet", "as", "the", "reference", "product", "in", "our", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "TNX-102", "SL."], "wordsB": ["We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", ",", "in", "that", "it", "will", "allow", "us", "to", "use", "the", "IR", "CBP", "tablet", "as", "the", "reference", "product", "in", "our", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p35_s1", "idA": "1430306_14_item1_p87_s0", "sentA": "We plan to conduct a small study designed to evaluate next morning drowsiness and other cognitive measures following the bedtime use of TNX-102 SL and the bedtime use of CBP IR.", "sentB": "We plan to commercialize TNX-102 SL and TNX-201 for their respective indications either on our own or through collaboration with partners.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "evaluate", "next", "morning", "drowsiness", "and", "other", "cognitive", "measures", "following", "the", "bedtime", "use", "of", "TNX-102", "SL", "and", "the", "bedtime", "use", "of", "CBP", "IR.", "<tag2>", "We", "plan", "to", "commercialize", "TNX-102", "SL", "and", "TNX-201", "for", "their", "respective", "indications", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners.", "<tag3>"], "wordsA": ["We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "evaluate", "next", "morning", "drowsiness", "and", "other", "cognitive", "measures", "following", "the", "bedtime", "use", "of", "TNX-102", "SL", "and", "the", "bedtime", "use", "of", "CBP", "IR."], "wordsB": ["We", "plan", "to", "commercialize", "TNX-102", "SL", "and", "TNX-201", "for", "their", "respective", "indications", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p73_s0", "idA": "1430306_14_item1_p87_s0", "sentA": "We plan to conduct a small study designed to evaluate next morning drowsiness and other cognitive measures following the bedtime use of TNX-102 SL and the bedtime use of CBP IR.", "sentB": "We plan to conduct a small study designed to evaluate next morning drowsiness and other cognitive measures following the bedtime use of TNX-102 SL and the bedtime use of CBP products.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "evaluate", "next", "morning", "drowsiness", "and", "other", "cognitive", "measures", "following", "the", "bedtime", "use", "of", "TNX-102", "SL", "and", "the", "bedtime", "use", "of", "CBP", "IR.", "<tag2>", "We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "evaluate", "next", "morning", "drowsiness", "and", "other", "cognitive", "measures", "following", "the", "bedtime", "use", "of", "TNX-102", "SL", "and", "the", "bedtime", "use", "of", "CBP", "products.", "<tag3>"], "wordsA": ["We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "evaluate", "next", "morning", "drowsiness", "and", "other", "cognitive", "measures", "following", "the", "bedtime", "use", "of", "TNX-102", "SL", "and", "the", "bedtime", "use", "of", "CBP", "IR."], "wordsB": ["We", "plan", "to", "conduct", "a", "small", "study", "designed", "to", "evaluate", "next", "morning", "drowsiness", "and", "other", "cognitive", "measures", "following", "the", "bedtime", "use", "of", "TNX-102", "SL", "and", "the", "bedtime", "use", "of", "CBP", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p73_s1", "idA": "1430306_14_item1_p87_s1", "sentA": "The goal of this study is to determine the potential benefit of TNX-102 SL compared with CBP IR on next morning drowsiness and on other cognitive functions.", "sentB": "The goal of this study is to determine the potential advantages of TNX-102 SL to CBP products on next morning drowsiness and on other cognitive functions.", "type": 2, "words": ["<tag1>", "The", "goal", "of", "this", "study", "is", "to", "determine", "the", "potential", "benefit", "of", "TNX-102", "SL", "compared", "with", "CBP", "IR", "on", "next", "morning", "drowsiness", "and", "on", "other", "cognitive", "functions.", "<tag2>", "The", "goal", "of", "this", "study", "is", "to", "determine", "the", "potential", "advantages", "of", "TNX-102", "SL", "to", "CBP", "products", "on", "next", "morning", "drowsiness", "and", "on", "other", "cognitive", "functions.", "<tag3>"], "wordsA": ["The", "goal", "of", "this", "study", "is", "to", "determine", "the", "potential", "benefit", "of", "TNX-102", "SL", "compared", "with", "CBP", "IR", "on", "next", "morning", "drowsiness", "and", "on", "other", "cognitive", "functions."], "wordsB": ["The", "goal", "of", "this", "study", "is", "to", "determine", "the", "potential", "advantages", "of", "TNX-102", "SL", "to", "CBP", "products", "on", "next", "morning", "drowsiness", "and", "on", "other", "cognitive", "functions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p74_s0", "idA": "1430306_14_item1_p88_s0", "sentA": "In addition to the clinical data necessary to support the TNX-102 SL 505(b)(2) NDA filing for the fibromyalgia indication, the FDA also clarified the nonclinical studies required for the NDA filing since the information from the reference product is either unavailable for reference or failed to meet the current regulatory standard.", "sentB": "In addition to the clinical studies necessary to support the TNX-102 SL 505(b)(2) NDA filing for the fibromyalgia indication, the FDA has accepted our proposal on the nonclinical studies to support the NDA filing, since the information from the reference product is either unavailable for reference or failed to meet the current regulatory standard.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "clinical", "data", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "fibromyalgia", "indication,", "the", "FDA", "also", "clarified", "the", "nonclinical", "studies", "required", "for", "the", "NDA", "filing", "since", "the", "information", "from", "the", "reference", "product", "is", "either", "unavailable", "for", "reference", "or", "failed", "to", "meet", "the", "current", "regulatory", "standard.", "<tag2>", "In", "addition", "to", "the", "clinical", "studies", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "fibromyalgia", "indication,", "the", "FDA", "has", "accepted", "our", "proposal", "on", "the", "nonclinical", "studies", "to", "support", "the", "NDA", "filing,", "since", "the", "information", "from", "the", "reference", "product", "is", "either", "unavailable", "for", "reference", "or", "failed", "to", "meet", "the", "current", "regulatory", "standard.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "clinical", "data", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "fibromyalgia", "indication,", "the", "FDA", "also", "clarified", "the", "nonclinical", "studies", "required", "for", "the", "NDA", "filing", "since", "the", "information", "from", "the", "reference", "product", "is", "either", "unavailable", "for", "reference", "or", "failed", "to", "meet", "the", "current", "regulatory", "standard."], "wordsB": ["In", "addition", "to", "the", "clinical", "studies", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "fibromyalgia", "indication,", "the", "FDA", "has", "accepted", "our", "proposal", "on", "the", "nonclinical", "studies", "to", "support", "the", "NDA", "filing,", "since", "the", "information", "from", "the", "reference", "product", "is", "either", "unavailable", "for", "reference", "or", "failed", "to", "meet", "the", "current", "regulatory", "standard."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p74_s2", "idA": "1430306_14_item1_p88_s1", "sentA": "In 2014, we will be selecting an FDA-certified Good Laboratory Practices laboratory to conduct a six month repeated-dose toxicology study in rats, a nine month repeated-dose toxicology study in dogs and a peri- and post-natal Segment III study required for the NDA filing.", "sentB": "In January 2015, we engaged an FDA-certified Good Laboratory Practices laboratory to conduct a six month repeated-dose toxicology study of TNX-102 SL in rats, a nine month repeated-dose toxicology study in dogs and a peri- and post-natal Segment II study required for the NDA filing.", "type": 2, "words": ["<tag1>", "In", "2014,", "we", "will", "be", "selecting", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six", "month", "repeated-dose", "toxicology", "study", "in", "rats,", "a", "nine", "month", "repeated-dose", "toxicology", "study", "in", "dogs", "and", "a", "peri-", "and", "post-natal", "Segment", "III", "study", "required", "for", "the", "NDA", "filing.", "<tag2>", "In", "January", "2015,", "we", "engaged", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six", "month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "SL", "in", "rats,", "a", "nine", "month", "repeated-dose", "toxicology", "study", "in", "dogs", "and", "a", "peri-", "and", "post-natal", "Segment", "II", "study", "required", "for", "the", "NDA", "filing.", "<tag3>"], "wordsA": ["In", "2014,", "we", "will", "be", "selecting", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six", "month", "repeated-dose", "toxicology", "study", "in", "rats,", "a", "nine", "month", "repeated-dose", "toxicology", "study", "in", "dogs", "and", "a", "peri-", "and", "post-natal", "Segment", "III", "study", "required", "for", "the", "NDA", "filing."], "wordsB": ["In", "January", "2015,", "we", "engaged", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six", "month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "SL", "in", "rats,", "a", "nine", "month", "repeated-dose", "toxicology", "study", "in", "dogs", "and", "a", "peri-", "and", "post-natal", "Segment", "II", "study", "required", "for", "the", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p74_s3", "idA": "1430306_14_item1_p88_s3", "sentA": "These studies will be performed concurrently with the Phase 3 study and will be completed ahead of the NDA submission.", "sentB": "These studies will be performed concurrently with our Phase 3 studies and will be completed ahead of the NDA submission.", "type": 2, "words": ["<tag1>", "These", "studies", "will", "be", "performed", "concurrently", "with", "the", "Phase", "3", "study", "and", "will", "be", "completed", "ahead", "of", "the", "NDA", "submission.", "<tag2>", "These", "studies", "will", "be", "performed", "concurrently", "with", "our", "Phase", "3", "studies", "and", "will", "be", "completed", "ahead", "of", "the", "NDA", "submission.", "<tag3>"], "wordsA": ["These", "studies", "will", "be", "performed", "concurrently", "with", "the", "Phase", "3", "study", "and", "will", "be", "completed", "ahead", "of", "the", "NDA", "submission."], "wordsB": ["These", "studies", "will", "be", "performed", "concurrently", "with", "our", "Phase", "3", "studies", "and", "will", "be", "completed", "ahead", "of", "the", "NDA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p35_s0", "idA": "1430306_14_item1_p89_s1", "sentA": "As a result, we will not have to assess the abuse potential of TNX-102 SL for the NDA submission.", "sentB": "Maximize the commercial potential of TNX-102 SL and TNX-201 .", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission.", "<tag2>", "Maximize", "the", "commercial", "potential", "of", "TNX-102", "SL", "and", "TNX-201", ".", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission."], "wordsB": ["Maximize", "the", "commercial", "potential", "of", "TNX-102", "SL", "and", "TNX-201", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p75_s1", "idA": "1430306_14_item1_p89_s1", "sentA": "As a result, we will not have to assess the abuse potential of TNX-102 SL for the NDA submission.", "sentB": "As a result, the FDA has advised we will not have to assess the abuse potential of TNX-102 SL for the NDA submission.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission.", "<tag2>", "As", "a", "result,", "the", "FDA", "has", "advised", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission."], "wordsB": ["As", "a", "result,", "the", "FDA", "has", "advised", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p76_s0", "idA": "1430306_14_item1_p90_s0", "sentA": "The TNX-102 SL drug product that has been manufactured for our BESTFIT study was manufactured in a small-scale current Good Manufacturing Practice, or cGMP, facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "sentB": "The TNX-102 SL drug product manufactured for our BESTFIT study was manufactured in a small-scale current Good Manufacturing Practice, or cGMP, facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "type": 2, "words": ["<tag1>", "The", "TNX-102", "SL", "drug", "product", "that", "has", "been", "manufactured", "for", "our", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag2>", "The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag3>"], "wordsA": ["The", "TNX-102", "SL", "drug", "product", "that", "has", "been", "manufactured", "for", "our", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "wordsB": ["The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p140_s1", "idA": "1430306_14_item1_p90_s1", "sentA": "For the second pivotal study and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "sentB": "For TNX-102 SL, we have engaged a cGMP facility for manufacturing of to-be-marketed product for Phase 3 clinical and commercial.", "type": 2, "words": ["<tag1>", "For", "the", "second", "pivotal", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag2>", "For", "TNX-102", "SL,", "we", "have", "engaged", "a", "cGMP", "facility", "for", "manufacturing", "of", "to-be-marketed", "product", "for", "Phase", "3", "clinical", "and", "commercial.", "<tag3>"], "wordsA": ["For", "the", "second", "pivotal", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "wordsB": ["For", "TNX-102", "SL,", "we", "have", "engaged", "a", "cGMP", "facility", "for", "manufacturing", "of", "to-be-marketed", "product", "for", "Phase", "3", "clinical", "and", "commercial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p76_s1", "idA": "1430306_14_item1_p90_s1", "sentA": "For the second pivotal study and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "sentB": "For Phase 3 trials and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "type": 2, "words": ["<tag1>", "For", "the", "second", "pivotal", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag2>", "For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag3>"], "wordsA": ["For", "the", "second", "pivotal", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "wordsB": ["For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p76_s2", "idA": "1430306_14_item1_p90_s2", "sentA": "The product s comparability will be supported by the bioequivalence results from the bridging study, TNX-CY-F105.", "sentB": "The product s comparability will be supported by the bioequivalence results from the multiple-dose bridging study, if necessary.", "type": 2, "words": ["<tag1>", "The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "bridging", "study,", "TNX-CY-F105.", "<tag2>", "The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "multiple-dose", "bridging", "study,", "if", "necessary.", "<tag3>"], "wordsA": ["The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "bridging", "study,", "TNX-CY-F105."], "wordsB": ["The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "multiple-dose", "bridging", "study,", "if", "necessary."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p77_s0", "idA": "1430306_14_item1_p91_s0", "sentA": "We have submitted a Pediatric Study Plan, or PSP, which contains a partial waiver of the requirement to submit pediatric assessments per Section 505B(a)(4)(A)(i) of the FDCA.", "sentB": "We have submitted a Pediatric Study Plan, or PSP, which contains a partial waiver of the requirement to submit pediatric assessments of TNX-102 SL per Section 505B(a)(4)(A)(i) of the FDCA.", "type": 2, "words": ["<tag1>", "We", "have", "submitted", "a", "Pediatric", "Study", "Plan,", "or", "PSP,", "which", "contains", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA.", "<tag2>", "We", "have", "submitted", "a", "Pediatric", "Study", "Plan,", "or", "PSP,", "which", "contains", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "of", "TNX-102", "SL", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA.", "<tag3>"], "wordsA": ["We", "have", "submitted", "a", "Pediatric", "Study", "Plan,", "or", "PSP,", "which", "contains", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA."], "wordsB": ["We", "have", "submitted", "a", "Pediatric", "Study", "Plan,", "or", "PSP,", "which", "contains", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "of", "TNX-102", "SL", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p79_s0", "idA": "1430306_14_item1_p93_s2", "sentA": "We hope to register TNX-102 SL with the FDA through the provisions of Section 505(b)(2).", "sentB": "We expect to register TNX-102 SL with the FDA through the provisions of Section 505(b)(2).", "type": 2, "words": ["<tag1>", "We", "hope", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2).", "<tag2>", "We", "expect", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2).", "<tag3>"], "wordsA": ["We", "hope", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2)."], "wordsB": ["We", "expect", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p62_s3", "idA": "1430306_14_item1_p95_s0", "sentA": "TNX-102 SL contains significantly less active CBP than other marketed products.", "sentB": "We believe that TNX-102 SL has the potential to effectively treat these and possibly other CNS indications that are underserved by currently marketed products.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "contains", "significantly", "less", "active", "CBP", "than", "other", "marketed", "products.", "<tag2>", "We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "effectively", "treat", "these", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products.", "<tag3>"], "wordsA": ["TNX-102", "SL", "contains", "significantly", "less", "active", "CBP", "than", "other", "marketed", "products."], "wordsB": ["We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "effectively", "treat", "these", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p80_s1", "idA": "1430306_14_item1_p95_s0", "sentA": "TNX-102 SL contains significantly less active CBP than other marketed products.", "sentB": "TNX-102 SL contains significantly less CBP than other marketed products that contain CBP.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "contains", "significantly", "less", "active", "CBP", "than", "other", "marketed", "products.", "<tag2>", "TNX-102", "SL", "contains", "significantly", "less", "CBP", "than", "other", "marketed", "products", "that", "contain", "CBP.", "<tag3>"], "wordsA": ["TNX-102", "SL", "contains", "significantly", "less", "active", "CBP", "than", "other", "marketed", "products."], "wordsB": ["TNX-102", "SL", "contains", "significantly", "less", "CBP", "than", "other", "marketed", "products", "that", "contain", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p80_s3", "idA": "1430306_14_item1_p95_s2", "sentA": "At our End-of-Phase 2/Pre-Phase 3 meeting we held with the FDA in February 2013, we discussed the nature and extent of the Phase 2b and Phase 3 clinical trials we need to conduct to so as to receive regulatory acceptance of our proposed NDA plan for a differentiated product for the management of FM.", "sentB": "At our End-of-Phase 2/Pre-Phase 3 meeting we held with the FDA in February 2013, we discussed the nature and extent of the clinical trials we need to conduct in order to receive regulatory acceptance of our proposed NDA plan for TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "we", "held", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "Phase", "2b", "and", "Phase", "3", "clinical", "trials", "we", "need", "to", "conduct", "to", "so", "as", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM.", "<tag2>", "At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "we", "held", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "clinical", "trials", "we", "need", "to", "conduct", "in", "order", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "we", "held", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "Phase", "2b", "and", "Phase", "3", "clinical", "trials", "we", "need", "to", "conduct", "to", "so", "as", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "a", "differentiated", "product", "for", "the", "management", "of", "FM."], "wordsB": ["At", "our", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "we", "held", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "nature", "and", "extent", "of", "the", "clinical", "trials", "we", "need", "to", "conduct", "in", "order", "to", "receive", "regulatory", "acceptance", "of", "our", "proposed", "NDA", "plan", "for", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p102_s0", "idA": "1430306_14_item1_p97_s2", "sentA": "We plan to file an IND in the second quarter of 2014 to support the initiation of a POC efficacy study in the third quarter of 2014.", "sentB": "We are preparing to commence a 200-patient Phase 2 study in ETTH in the second quarter of 2015, in which patients will be randomized at approximately 10 U.S. centers to receive TNX-201 140 mg (4 x 35 mg) or placebo capsules.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "file", "an", "IND", "in", "the", "second", "quarter", "of", "2014", "to", "support", "the", "initiation", "of", "a", "POC", "efficacy", "study", "in", "the", "third", "quarter", "of", "2014.", "<tag2>", "We", "are", "preparing", "to", "commence", "a", "200-patient", "Phase", "2", "study", "in", "ETTH", "in", "the", "second", "quarter", "of", "2015,", "in", "which", "patients", "will", "be", "randomized", "at", "approximately", "10", "U.S.", "centers", "to", "receive", "TNX-201", "140", "mg", "(4", "x", "35", "mg)", "or", "placebo", "capsules.", "<tag3>"], "wordsA": ["We", "plan", "to", "file", "an", "IND", "in", "the", "second", "quarter", "of", "2014", "to", "support", "the", "initiation", "of", "a", "POC", "efficacy", "study", "in", "the", "third", "quarter", "of", "2014."], "wordsB": ["We", "are", "preparing", "to", "commence", "a", "200-patient", "Phase", "2", "study", "in", "ETTH", "in", "the", "second", "quarter", "of", "2015,", "in", "which", "patients", "will", "be", "randomized", "at", "approximately", "10", "U.S.", "centers", "to", "receive", "TNX-201", "140", "mg", "(4", "x", "35", "mg)", "or", "placebo", "capsules."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p83_s0", "idA": "1430306_14_item1_p98_s0", "sentA": "A number of parallels have been noted between FM and PTSD.", "sentB": "The clinical presentations of FM and PTSD share a number of similarities and clinical overlap.", "type": 2, "words": ["<tag1>", "A", "number", "of", "parallels", "have", "been", "noted", "between", "FM", "and", "PTSD.", "<tag2>", "The", "clinical", "presentations", "of", "FM", "and", "PTSD", "share", "a", "number", "of", "similarities", "and", "clinical", "overlap.", "<tag3>"], "wordsA": ["A", "number", "of", "parallels", "have", "been", "noted", "between", "FM", "and", "PTSD."], "wordsB": ["The", "clinical", "presentations", "of", "FM", "and", "PTSD", "share", "a", "number", "of", "similarities", "and", "clinical", "overlap."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p83_s1", "idA": "1430306_14_item1_p98_s2", "sentA": "Res. 2006, 61(5):663-9), 49% of PTSD patients met the ACR criteria for FM compared to 5% of major depression patients.", "sentB": "For example, in a survey of males with PTSD or major depression, 49% of PTSD patients met the American College of Rheumatology criteria for FM compared to 5% of major depression patients (Amital et al, J Psychosom Res 2006;61:663-669).", "type": 2, "words": ["<tag1>", "Res.", "2006,", "61(5):663-9),", "49%", "of", "PTSD", "patients", "met", "the", "ACR", "criteria", "for", "FM", "compared", "to", "5%", "of", "major", "depression", "patients.", "<tag2>", "For", "example,", "in", "a", "survey", "of", "males", "with", "PTSD", "or", "major", "depression,", "49%", "of", "PTSD", "patients", "met", "the", "American", "College", "of", "Rheumatology", "criteria", "for", "FM", "compared", "to", "5%", "of", "major", "depression", "patients", "(Amital", "et", "al,", "J", "Psychosom", "Res", "2006;61:663-669).", "<tag3>"], "wordsA": ["Res.", "2006,", "61(5):663-9),", "49%", "of", "PTSD", "patients", "met", "the", "ACR", "criteria", "for", "FM", "compared", "to", "5%", "of", "major", "depression", "patients."], "wordsB": ["For", "example,", "in", "a", "survey", "of", "males", "with", "PTSD", "or", "major", "depression,", "49%", "of", "PTSD", "patients", "met", "the", "American", "College", "of", "Rheumatology", "criteria", "for", "FM", "compared", "to", "5%", "of", "major", "depression", "patients", "(Amital", "et", "al,", "J", "Psychosom", "Res", "2006;61:663-669)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p83_s2", "idA": "1430306_14_item1_p98_s3", "sentA": "Arthritis Rheum. 2002, 32(1):38-50), 57% of the sample had symptoms associated with PTSD.", "sentB": "Conversely, in a different survey of FM patients, 57% of the patients had symptoms associated with PTSD (Cohen et al, Semin Arthritis Rheum 2002;32:38-50).", "type": 2, "words": ["<tag1>", "Arthritis", "Rheum.", "2002,", "32(1):38-50),", "57%", "of", "the", "sample", "had", "symptoms", "associated", "with", "PTSD.", "<tag2>", "Conversely,", "in", "a", "different", "survey", "of", "FM", "patients,", "57%", "of", "the", "patients", "had", "symptoms", "associated", "with", "PTSD", "(Cohen", "et", "al,", "Semin", "Arthritis", "Rheum", "2002;32:38-50).", "<tag3>"], "wordsA": ["Arthritis", "Rheum.", "2002,", "32(1):38-50),", "57%", "of", "the", "sample", "had", "symptoms", "associated", "with", "PTSD."], "wordsB": ["Conversely,", "in", "a", "different", "survey", "of", "FM", "patients,", "57%", "of", "the", "patients", "had", "symptoms", "associated", "with", "PTSD", "(Cohen", "et", "al,", "Semin", "Arthritis", "Rheum", "2002;32:38-50)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p45_s1", "idA": "1430306_14_item1_p99_s0", "sentA": "A core feature of PTSD is sleep disturbance, including insomnia and nightmares.", "sentB": "The core symptom clusters of PTSD are avoidance, emotional numbing, hyperarousal, and intrusion, where the triggering event is commonly re-experienced by the individual through intrusive, recurrent recollections, flashbacks, and nightmares.", "type": 2, "words": ["<tag1>", "A", "core", "feature", "of", "PTSD", "is", "sleep", "disturbance,", "including", "insomnia", "and", "nightmares.", "<tag2>", "The", "core", "symptom", "clusters", "of", "PTSD", "are", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "intrusion,", "where", "the", "triggering", "event", "is", "commonly", "re-experienced", "by", "the", "individual", "through", "intrusive,", "recurrent", "recollections,", "flashbacks,", "and", "nightmares.", "<tag3>"], "wordsA": ["A", "core", "feature", "of", "PTSD", "is", "sleep", "disturbance,", "including", "insomnia", "and", "nightmares."], "wordsB": ["The", "core", "symptom", "clusters", "of", "PTSD", "are", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "intrusion,", "where", "the", "triggering", "event", "is", "commonly", "re-experienced", "by", "the", "individual", "through", "intrusive,", "recurrent", "recollections,", "flashbacks,", "and", "nightmares."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_15_item1_p84_s0", "idA": "1430306_14_item1_p99_s0", "sentA": "A core feature of PTSD is sleep disturbance, including insomnia and nightmares.", "sentB": "As with FM, a core feature of PTSD is sleep disturbance.", "type": 2, "words": ["<tag1>", "A", "core", "feature", "of", "PTSD", "is", "sleep", "disturbance,", "including", "insomnia", "and", "nightmares.", "<tag2>", "As", "with", "FM,", "a", "core", "feature", "of", "PTSD", "is", "sleep", "disturbance.", "<tag3>"], "wordsA": ["A", "core", "feature", "of", "PTSD", "is", "sleep", "disturbance,", "including", "insomnia", "and", "nightmares."], "wordsB": ["As", "with", "FM,", "a", "core", "feature", "of", "PTSD", "is", "sleep", "disturbance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p71_s1", "idA": "1430306_15_item1_p101_s0", "sentA": "In January 2014, we held a pre-IND meeting with the FDA to discuss the regulatory pathway for the development of TNX-201 for the treatment of ETTH.", "sentB": "An End-of-Phase 2 Chemistry, Manufacturing and Controls Meeting has been held in February 2016 to discuss the quality data requirement for the NDA filing.", "type": 2, "words": ["<tag1>", "In", "January", "2014,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH.", "<tag2>", "An", "End-of-Phase", "2", "Chemistry,", "Manufacturing", "and", "Controls", "Meeting", "has", "been", "held", "in", "February", "2016", "to", "discuss", "the", "quality", "data", "requirement", "for", "the", "NDA", "filing.", "<tag3>"], "wordsA": ["In", "January", "2014,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH."], "wordsB": ["An", "End-of-Phase", "2", "Chemistry,", "Manufacturing", "and", "Controls", "Meeting", "has", "been", "held", "in", "February", "2016", "to", "discuss", "the", "quality", "data", "requirement", "for", "the", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p80_s2", "idA": "1430306_15_item1_p101_s0", "sentA": "In January 2014, we held a pre-IND meeting with the FDA to discuss the regulatory pathway for the development of TNX-201 for the treatment of ETTH.", "sentB": "We held a Pre-IND Meeting with the FDA in February 2016 to discuss the clinical development of TNX-301 for AUD.", "type": 2, "words": ["<tag1>", "In", "January", "2014,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH.", "<tag2>", "We", "held", "a", "Pre-IND", "Meeting", "with", "the", "FDA", "in", "February", "2016", "to", "discuss", "the", "clinical", "development", "of", "TNX-301", "for", "AUD.", "<tag3>"], "wordsA": ["In", "January", "2014,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "to", "discuss", "the", "regulatory", "pathway", "for", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "ETTH."], "wordsB": ["We", "held", "a", "Pre-IND", "Meeting", "with", "the", "FDA", "in", "February", "2016", "to", "discuss", "the", "clinical", "development", "of", "TNX-301", "for", "AUD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p50_s0", "idA": "1430306_15_item1_p101_s1", "sentA": "We have completed a comparative Phase 1 single ascending dose safety, tolerability, and pharmacokinetic study of TNX-201 in 45 healthy volunteers, from which we reported top line results in January 2015.", "sentB": "We have completed the clinical phase of a Phase 1 bioequivalence pharmacokinetic study (F105) that compared the pharmacokinetic profiles of single-doses of TNX-102 SL, 2.8 mg tablets manufactured at two facilities: the facility used to produce study medication for our Phase 2b BESTFIT study and the facility used to produce study medication for our ongoing Phase 3 AFFIRM study and the to-be-marketed product.", "type": 2, "words": ["<tag1>", "We", "have", "completed", "a", "comparative", "Phase", "1", "single", "ascending", "dose", "safety,", "tolerability,", "and", "pharmacokinetic", "study", "of", "TNX-201", "in", "45", "healthy", "volunteers,", "from", "which", "we", "reported", "top", "line", "results", "in", "January", "2015.", "<tag2>", "We", "have", "completed", "the", "clinical", "phase", "of", "a", "Phase", "1", "bioequivalence", "pharmacokinetic", "study", "(F105)", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "single-doses", "of", "TNX-102", "SL,", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "the", "facility", "used", "to", "produce", "study", "medication", "for", "our", "Phase", "2b", "BESTFIT", "study", "and", "the", "facility", "used", "to", "produce", "study", "medication", "for", "our", "ongoing", "Phase", "3", "AFFIRM", "study", "and", "the", "to-be-marketed", "product.", "<tag3>"], "wordsA": ["We", "have", "completed", "a", "comparative", "Phase", "1", "single", "ascending", "dose", "safety,", "tolerability,", "and", "pharmacokinetic", "study", "of", "TNX-201", "in", "45", "healthy", "volunteers,", "from", "which", "we", "reported", "top", "line", "results", "in", "January", "2015."], "wordsB": ["We", "have", "completed", "the", "clinical", "phase", "of", "a", "Phase", "1", "bioequivalence", "pharmacokinetic", "study", "(F105)", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "single-doses", "of", "TNX-102", "SL,", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "the", "facility", "used", "to", "produce", "study", "medication", "for", "our", "Phase", "2b", "BESTFIT", "study", "and", "the", "facility", "used", "to", "produce", "study", "medication", "for", "our", "ongoing", "Phase", "3", "AFFIRM", "study", "and", "the", "to-be-marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p78_s2", "idA": "1430306_15_item1_p102_s0", "sentA": "We are preparing to commence a 200-patient Phase 2 study in ETTH in the second quarter of 2015, in which patients will be randomized at approximately 10 U.S. centers to receive TNX-201 140 mg (4 x 35 mg) or placebo capsules.", "sentB": "This trial was conducted at approximately 10 U.S. centers and randomized approximately 150 patients to receive TNX-201 140 mg or placebo capsules.", "type": 2, "words": ["<tag1>", "We", "are", "preparing", "to", "commence", "a", "200-patient", "Phase", "2", "study", "in", "ETTH", "in", "the", "second", "quarter", "of", "2015,", "in", "which", "patients", "will", "be", "randomized", "at", "approximately", "10", "U.S.", "centers", "to", "receive", "TNX-201", "140", "mg", "(4", "x", "35", "mg)", "or", "placebo", "capsules.", "<tag2>", "This", "trial", "was", "conducted", "at", "approximately", "10", "U.S.", "centers", "and", "randomized", "approximately", "150", "patients", "to", "receive", "TNX-201", "140", "mg", "or", "placebo", "capsules.", "<tag3>"], "wordsA": ["We", "are", "preparing", "to", "commence", "a", "200-patient", "Phase", "2", "study", "in", "ETTH", "in", "the", "second", "quarter", "of", "2015,", "in", "which", "patients", "will", "be", "randomized", "at", "approximately", "10", "U.S.", "centers", "to", "receive", "TNX-201", "140", "mg", "(4", "x", "35", "mg)", "or", "placebo", "capsules."], "wordsB": ["This", "trial", "was", "conducted", "at", "approximately", "10", "U.S.", "centers", "and", "randomized", "approximately", "150", "patients", "to", "receive", "TNX-201", "140", "mg", "or", "placebo", "capsules."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p78_s3", "idA": "1430306_15_item1_p102_s1", "sentA": "The primary efficacy endpoint will be the difference between the two study arms in the number of subjects who report complete relief from their headache pain at two hours following a dose of study medication.", "sentB": "This trial assessed efficacy following a dose of study medication according to a variety of measures at several time points, including the difference between the two study arms in the number of subjects who report complete relief from their headache pain at two hours.", "type": 2, "words": ["<tag1>", "The", "primary", "efficacy", "endpoint", "will", "be", "the", "difference", "between", "the", "two", "study", "arms", "in", "the", "number", "of", "subjects", "who", "report", "complete", "relief", "from", "their", "headache", "pain", "at", "two", "hours", "following", "a", "dose", "of", "study", "medication.", "<tag2>", "This", "trial", "assessed", "efficacy", "following", "a", "dose", "of", "study", "medication", "according", "to", "a", "variety", "of", "measures", "at", "several", "time", "points,", "including", "the", "difference", "between", "the", "two", "study", "arms", "in", "the", "number", "of", "subjects", "who", "report", "complete", "relief", "from", "their", "headache", "pain", "at", "two", "hours.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "endpoint", "will", "be", "the", "difference", "between", "the", "two", "study", "arms", "in", "the", "number", "of", "subjects", "who", "report", "complete", "relief", "from", "their", "headache", "pain", "at", "two", "hours", "following", "a", "dose", "of", "study", "medication."], "wordsB": ["This", "trial", "assessed", "efficacy", "following", "a", "dose", "of", "study", "medication", "according", "to", "a", "variety", "of", "measures", "at", "several", "time", "points,", "including", "the", "difference", "between", "the", "two", "study", "arms", "in", "the", "number", "of", "subjects", "who", "report", "complete", "relief", "from", "their", "headache", "pain", "at", "two", "hours."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p80_s1", "idA": "1430306_15_item1_p106_s1", "sentA": "We intend to develop TNX-301 CDP under Section 505(b)(2) of the FDCA as a potential treatment for alcohol abuse and dependence, and we have commenced development work on TNX-301 formulations.", "sentB": "We intend to develop TNX-301 CDP under Section 505(b)(2) of the FDCA as a potential treatment for AUD, and we have commenced development work on TNX-301 formulations.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "alcohol", "abuse", "and", "dependence,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations.", "<tag2>", "We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations.", "<tag3>"], "wordsA": ["We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "alcohol", "abuse", "and", "dependence,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations."], "wordsB": ["We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p84_s0", "idA": "1430306_15_item1_p109_s0", "sentA": "The markets for medicines to treat FM, PTSD, ETTH and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "sentB": "The markets for medicines to treat FM, PTSD and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "type": 2, "words": ["<tag1>", "The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD,", "ETTH", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag2>", "The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag3>"], "wordsA": ["The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD,", "ETTH", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "wordsB": ["The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p35_s1", "idA": "1430306_15_item1_p109_s2", "sentA": "Cymbalta lost its U.S. patent exclusivity in December 2013.", "sentB": "FLEXERIL brand of cyclobenzaprine immediate-release tablet has been discontinued since May 2013.", "type": 2, "words": ["<tag1>", "Cymbalta", "lost", "its", "U.S.", "patent", "exclusivity", "in", "December", "2013.", "<tag2>", "FLEXERIL", "brand", "of", "cyclobenzaprine", "immediate-release", "tablet", "has", "been", "discontinued", "since", "May", "2013.", "<tag3>"], "wordsA": ["Cymbalta", "lost", "its", "U.S.", "patent", "exclusivity", "in", "December", "2013."], "wordsB": ["FLEXERIL", "brand", "of", "cyclobenzaprine", "immediate-release", "tablet", "has", "been", "discontinued", "since", "May", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p88_s0", "idA": "1430306_15_item1_p114_s0", "sentA": "A number of companies are developing prescription medications for PTSD, including Actavis, Johnson and Johnson, Lundbeck, Marinus Pharmaceuticals, Merck, Otsuka, and Pfizer.", "sentB": "A number of companies are developing prescription medications for PTSD, including Actavis, Bionomics, Johnson and Johnson, Lundbeck, Marinus Pharmaceuticals, Merck, Otsuka, and Pfizer.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer.", "<tag2>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Bionomics,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer."], "wordsB": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Bionomics,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p127_s1", "idA": "1430306_15_item1_p114_s1", "sentA": "Medications that are used off-label for the treatment of PTSD include anti-depressants, such as nefazodone and trazodone; the antihistamine cyproheptadine; and certain atypical antipsychotics, such as olanzapine and risperidone.", "sentB": "These clinical trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication, particularly for long-term safety follow-up.", "type": 2, "words": ["<tag1>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone.", "<tag2>", "These", "clinical", "trials", "are", "used", "to", "gain", "additional", "experience", "from", "the", "treatment", "of", "patients", "in", "the", "intended", "therapeutic", "indication,", "particularly", "for", "long-term", "safety", "follow-up.", "<tag3>"], "wordsA": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone."], "wordsB": ["These", "clinical", "trials", "are", "used", "to", "gain", "additional", "experience", "from", "the", "treatment", "of", "patients", "in", "the", "intended", "therapeutic", "indication,", "particularly", "for", "long-term", "safety", "follow-up."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p49_s2", "idA": "1430306_15_item1_p117_s0", "sentA": "We believe that we have an extensive patent portfolio and substantial know-how relating to TNX-102 SL and our other product candidates.", "sentB": "We believe that we have sufficient long-term exposure data from F203 to support an NDA filing for TNX-102 SL.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates.", "<tag2>", "We", "believe", "that", "we", "have", "sufficient", "long-term", "exposure", "data", "from", "F203", "to", "support", "an", "NDA", "filing", "for", "TNX-102", "SL.", "<tag3>"], "wordsA": ["We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates."], "wordsB": ["We", "believe", "that", "we", "have", "sufficient", "long-term", "exposure", "data", "from", "F203", "to", "support", "an", "NDA", "filing", "for", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p109_s0", "idA": "1430306_15_item1_p117_s2", "sentA": "As of February 23, 2015, we are either the owner of record of or own the contractual right to five issued U.S. patents and 10 issued non-U.S. patents covering 26 jurisdictions.", "sentB": "We are the owner of the following U.S. federally registered marks: TONIX PHARMACEUTICALS (Reg.", "type": 2, "words": ["<tag1>", "As", "of", "February", "23,", "2015,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "10", "issued", "non-U.S.", "patents", "covering", "26", "jurisdictions.", "<tag2>", "We", "are", "the", "owner", "of", "the", "following", "U.S.", "federally", "registered", "marks:", "TONIX", "PHARMACEUTICALS", "(Reg.", "<tag3>"], "wordsA": ["As", "of", "February", "23,", "2015,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "10", "issued", "non-U.S.", "patents", "covering", "26", "jurisdictions."], "wordsB": ["We", "are", "the", "owner", "of", "the", "following", "U.S.", "federally", "registered", "marks:", "TONIX", "PHARMACEUTICALS", "(Reg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p89_s2", "idA": "1430306_15_item1_p117_s2", "sentA": "As of February 23, 2015, we are either the owner of record of or own the contractual right to five issued U.S. patents and 10 issued non-U.S. patents covering 26 jurisdictions.", "sentB": "As of March 1, 2016, we are either the owner of record of or own the contractual right to five issued U.S. patents and 26 issued non-U.S. patents.", "type": 2, "words": ["<tag1>", "As", "of", "February", "23,", "2015,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "10", "issued", "non-U.S.", "patents", "covering", "26", "jurisdictions.", "<tag2>", "As", "of", "March", "1,", "2016,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "26", "issued", "non-U.S.", "patents.", "<tag3>"], "wordsA": ["As", "of", "February", "23,", "2015,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "10", "issued", "non-U.S.", "patents", "covering", "26", "jurisdictions."], "wordsB": ["As", "of", "March", "1,", "2016,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "26", "issued", "non-U.S.", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p89_s3", "idA": "1430306_15_item1_p117_s3", "sentA": "We are actively pursuing an additional 16 U.S. patent applications, of which six are provisional and 10 are non-provisional, three international patent applications, and 36 non-U.S./non-international patent applications.", "sentB": "We are actively pursuing an additional 17 U.S. patent applications, of which six are provisional and 11 are non-provisional, five international patent applications, and 70 non-U.S./non-international patent applications.", "type": 2, "words": ["<tag1>", "We", "are", "actively", "pursuing", "an", "additional", "16", "U.S.", "patent", "applications,", "of", "which", "six", "are", "provisional", "and", "10", "are", "non-provisional,", "three", "international", "patent", "applications,", "and", "36", "non-U.S./non-international", "patent", "applications.", "<tag2>", "We", "are", "actively", "pursuing", "an", "additional", "17", "U.S.", "patent", "applications,", "of", "which", "six", "are", "provisional", "and", "11", "are", "non-provisional,", "five", "international", "patent", "applications,", "and", "70", "non-U.S./non-international", "patent", "applications.", "<tag3>"], "wordsA": ["We", "are", "actively", "pursuing", "an", "additional", "16", "U.S.", "patent", "applications,", "of", "which", "six", "are", "provisional", "and", "10", "are", "non-provisional,", "three", "international", "patent", "applications,", "and", "36", "non-U.S./non-international", "patent", "applications."], "wordsB": ["We", "are", "actively", "pursuing", "an", "additional", "17", "U.S.", "patent", "applications,", "of", "which", "six", "are", "provisional", "and", "11", "are", "non-provisional,", "five", "international", "patent", "applications,", "and", "70", "non-U.S./non-international", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p6_s1", "idA": "1430306_15_item1_p11_s0", "sentA": "In 1996, Seth Lederman, MD, and Donald Landry, MD, PhD, formed L L Technologies LLC, or L L, to develop medications for central nervous system, or CNS, conditions.", "sentB": "Our most advanced drug development programs are directed toward disorders affecting the central nervous system, or CNS, and include FM and post-traumatic stress disorder, or PTSD.", "type": 2, "words": ["<tag1>", "In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies", "LLC,", "or", "L", "L,", "to", "develop", "medications", "for", "central", "nervous", "system,", "or", "CNS,", "conditions.", "<tag2>", "Our", "most", "advanced", "drug", "development", "programs", "are", "directed", "toward", "disorders", "affecting", "the", "central", "nervous", "system,", "or", "CNS,", "and", "include", "FM", "and", "post-traumatic", "stress", "disorder,", "or", "PTSD.", "<tag3>"], "wordsA": ["In", "1996,", "Seth", "Lederman,", "MD,", "and", "Donald", "Landry,", "MD,", "PhD,", "formed", "L", "L", "Technologies", "LLC,", "or", "L", "L,", "to", "develop", "medications", "for", "central", "nervous", "system,", "or", "CNS,", "conditions."], "wordsB": ["Our", "most", "advanced", "drug", "development", "programs", "are", "directed", "toward", "disorders", "affecting", "the", "central", "nervous", "system,", "or", "CNS,", "and", "include", "FM", "and", "post-traumatic", "stress", "disorder,", "or", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p71_s2", "idA": "1430306_15_item1_p121_s1", "sentA": "In most countries in which we file, the patent term is 20 years from the date of filing the first non-provisional priority application.", "sentB": "As of the date of this filing, we have not received the FDA official minutes from the meeting.", "type": 2, "words": ["<tag1>", "In", "most", "countries", "in", "which", "we", "file,", "the", "patent", "term", "is", "20", "years", "from", "the", "date", "of", "filing", "the", "first", "non-provisional", "priority", "application.", "<tag2>", "As", "of", "the", "date", "of", "this", "filing,", "we", "have", "not", "received", "the", "FDA", "official", "minutes", "from", "the", "meeting.", "<tag3>"], "wordsA": ["In", "most", "countries", "in", "which", "we", "file,", "the", "patent", "term", "is", "20", "years", "from", "the", "date", "of", "filing", "the", "first", "non-provisional", "priority", "application."], "wordsB": ["As", "of", "the", "date", "of", "this", "filing,", "we", "have", "not", "received", "the", "FDA", "official", "minutes", "from", "the", "meeting."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p80_s3", "idA": "1430306_15_item1_p121_s1", "sentA": "In most countries in which we file, the patent term is 20 years from the date of filing the first non-provisional priority application.", "sentB": "As of the date of this filing, we have not received the FDA official minutes from the meeting.", "type": 2, "words": ["<tag1>", "In", "most", "countries", "in", "which", "we", "file,", "the", "patent", "term", "is", "20", "years", "from", "the", "date", "of", "filing", "the", "first", "non-provisional", "priority", "application.", "<tag2>", "As", "of", "the", "date", "of", "this", "filing,", "we", "have", "not", "received", "the", "FDA", "official", "minutes", "from", "the", "meeting.", "<tag3>"], "wordsA": ["In", "most", "countries", "in", "which", "we", "file,", "the", "patent", "term", "is", "20", "years", "from", "the", "date", "of", "filing", "the", "first", "non-provisional", "priority", "application."], "wordsB": ["As", "of", "the", "date", "of", "this", "filing,", "we", "have", "not", "received", "the", "FDA", "official", "minutes", "from", "the", "meeting."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p96_s0", "idA": "1430306_15_item1_p124_s0", "sentA": "The patent portfolios for our proprietary technology platform and our three most advanced product candidates as of February 23, 2015 are summarized below.", "sentB": "The patent portfolios for our proprietary technology platform and our three most advanced product candidates as of March 1, 2016 are summarized below.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "February", "23,", "2015", "are", "summarized", "below.", "<tag2>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "1,", "2016", "are", "summarized", "below.", "<tag3>"], "wordsA": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "February", "23,", "2015", "are", "summarized", "below."], "wordsB": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "1,", "2016", "are", "summarized", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p97_s0", "idA": "1430306_15_item1_p125_s0", "sentA": "Our patent portfolio for TNX-102 SL includes patent applications directed to pharmaceutical compositions containing CBP, CBP formulations, and methods for treating FM and other CNS conditions utilizing CBP.", "sentB": "Our patent portfolio for TNX-102 SL includes patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating FM and other CNS conditions utilizing these compositions and formulations.", "type": 2, "words": ["<tag1>", "Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP.", "<tag2>", "Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag3>"], "wordsA": ["Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP."], "wordsB": ["Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p98_s1", "idA": "1430306_15_item1_p126_s1", "sentA": "The patent portfolio for TNX-102 SL relating to the PK Technology includes patent applications directed to pharmaceutical compositions containing CBP, CBP formulations, and methods for treating FM and other CNS conditions utilizing CBP.", "sentB": "The patent portfolio for TNX-102 SL relating to the PK Technology includes patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating FM and other CNS conditions utilizing these compositions and formulations.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP.", "<tag2>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "pharmaceutical", "compositions", "containing", "CBP,", "CBP", "formulations,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "CBP."], "wordsB": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p100_s2", "idA": "1430306_15_item1_p127_s3", "sentA": "If U.S. and non-U.S. patents claiming priority from those applications issue, those patents would expire in 2034, excluding any patent term adjustments or extensions.", "sentB": "If U.S. and non-U.S. patents claiming priority from those applications issue, those patents would expire in 2034 and 2035, respectively, excluding any patent term adjustments or extensions.", "type": 2, "words": ["<tag1>", "If", "U.S.", "and", "non-U.S.", "patents", "claiming", "priority", "from", "those", "applications", "issue,", "those", "patents", "would", "expire", "in", "2034,", "excluding", "any", "patent", "term", "adjustments", "or", "extensions.", "<tag2>", "If", "U.S.", "and", "non-U.S.", "patents", "claiming", "priority", "from", "those", "applications", "issue,", "those", "patents", "would", "expire", "in", "2034", "and", "2035,", "respectively,", "excluding", "any", "patent", "term", "adjustments", "or", "extensions.", "<tag3>"], "wordsA": ["If", "U.S.", "and", "non-U.S.", "patents", "claiming", "priority", "from", "those", "applications", "issue,", "those", "patents", "would", "expire", "in", "2034,", "excluding", "any", "patent", "term", "adjustments", "or", "extensions."], "wordsB": ["If", "U.S.", "and", "non-U.S.", "patents", "claiming", "priority", "from", "those", "applications", "issue,", "those", "patents", "would", "expire", "in", "2034", "and", "2035,", "respectively,", "excluding", "any", "patent", "term", "adjustments", "or", "extensions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p99_s3", "idA": "1430306_15_item1_p127_s3", "sentA": "If U.S. and non-U.S. patents claiming priority from those applications issue, those patents would expire in 2034, excluding any patent term adjustments or extensions.", "sentB": "If U.S. and non-U.S. patents claiming priority from those applications issue, those patents would expire in 2034 or 2035, excluding any patent term adjustments or extensions.", "type": 2, "words": ["<tag1>", "If", "U.S.", "and", "non-U.S.", "patents", "claiming", "priority", "from", "those", "applications", "issue,", "those", "patents", "would", "expire", "in", "2034,", "excluding", "any", "patent", "term", "adjustments", "or", "extensions.", "<tag2>", "If", "U.S.", "and", "non-U.S.", "patents", "claiming", "priority", "from", "those", "applications", "issue,", "those", "patents", "would", "expire", "in", "2034", "or", "2035,", "excluding", "any", "patent", "term", "adjustments", "or", "extensions.", "<tag3>"], "wordsA": ["If", "U.S.", "and", "non-U.S.", "patents", "claiming", "priority", "from", "those", "applications", "issue,", "those", "patents", "would", "expire", "in", "2034,", "excluding", "any", "patent", "term", "adjustments", "or", "extensions."], "wordsB": ["If", "U.S.", "and", "non-U.S.", "patents", "claiming", "priority", "from", "those", "applications", "issue,", "those", "patents", "would", "expire", "in", "2034", "or", "2035,", "excluding", "any", "patent", "term", "adjustments", "or", "extensions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p100_s1", "idA": "1430306_15_item1_p128_s1", "sentA": "The Isometheptene Technology patent portfolio includes U.S. Patent Application No. 14/158,735 as well as U.S. Provisional Patent Application No 61/953,715.", "sentB": "The Isometheptene Technology patent portfolio includes U.S. Patent Application No. 14/158,735 as well as U.S. Patent Application No 14/657,885.", "type": 2, "words": ["<tag1>", "The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Provisional", "Patent", "Application", "No", "61/953,715.", "<tag2>", "The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Patent", "Application", "No", "14/657,885.", "<tag3>"], "wordsA": ["The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Provisional", "Patent", "Application", "No", "61/953,715."], "wordsB": ["The", "Isometheptene", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "14/158,735", "as", "well", "as", "U.S.", "Patent", "Application", "No", "14/657,885."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p101_s1", "idA": "1430306_15_item1_p129_s1", "sentA": "It includes claims directed to disulfiram and selegiline, pharmaceutical compositions containing disulfiram and selegiline, disulfiram and selegiline formulations, methods of treating an alcohol use disorder, and methods of modulating alcohol abuse and dependence.", "sentB": "It includes claims directed to disulfiram and selegiline, pharmaceutical compositions containing disulfiram and selegiline, disulfiram and selegiline formulations, methods of treating AUD, and methods of modulating alcohol abuse and dependence.", "type": 2, "words": ["<tag1>", "It", "includes", "claims", "directed", "to", "disulfiram", "and", "selegiline,", "pharmaceutical", "compositions", "containing", "disulfiram", "and", "selegiline,", "disulfiram", "and", "selegiline", "formulations,", "methods", "of", "treating", "an", "alcohol", "use", "disorder,", "and", "methods", "of", "modulating", "alcohol", "abuse", "and", "dependence.", "<tag2>", "It", "includes", "claims", "directed", "to", "disulfiram", "and", "selegiline,", "pharmaceutical", "compositions", "containing", "disulfiram", "and", "selegiline,", "disulfiram", "and", "selegiline", "formulations,", "methods", "of", "treating", "AUD,", "and", "methods", "of", "modulating", "alcohol", "abuse", "and", "dependence.", "<tag3>"], "wordsA": ["It", "includes", "claims", "directed", "to", "disulfiram", "and", "selegiline,", "pharmaceutical", "compositions", "containing", "disulfiram", "and", "selegiline,", "disulfiram", "and", "selegiline", "formulations,", "methods", "of", "treating", "an", "alcohol", "use", "disorder,", "and", "methods", "of", "modulating", "alcohol", "abuse", "and", "dependence."], "wordsB": ["It", "includes", "claims", "directed", "to", "disulfiram", "and", "selegiline,", "pharmaceutical", "compositions", "containing", "disulfiram", "and", "selegiline,", "disulfiram", "and", "selegiline", "formulations,", "methods", "of", "treating", "AUD,", "and", "methods", "of", "modulating", "alcohol", "abuse", "and", "dependence."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p102_s0", "idA": "1430306_15_item1_p130_s0", "sentA": "In March 2014, we acquired the rights to develop two additional biodefense technologies: a new drug candidate that potentially protects humans from certain effects of radiation and a new vaccine candidate against smallpox.", "sentB": "We own the rights to develop a potential biodefense technology, which is a new vaccine candidate against smallpox.", "type": 2, "words": ["<tag1>", "In", "March", "2014,", "we", "acquired", "the", "rights", "to", "develop", "two", "additional", "biodefense", "technologies:", "a", "new", "drug", "candidate", "that", "potentially", "protects", "humans", "from", "certain", "effects", "of", "radiation", "and", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag2>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag3>"], "wordsA": ["In", "March", "2014,", "we", "acquired", "the", "rights", "to", "develop", "two", "additional", "biodefense", "technologies:", "a", "new", "drug", "candidate", "that", "potentially", "protects", "humans", "from", "certain", "effects", "of", "radiation", "and", "a", "new", "vaccine", "candidate", "against", "smallpox."], "wordsB": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p102_s1", "idA": "1430306_15_item1_p132_s0", "sentA": "With respect to the smallpox vaccine candidate, we acquired U.S. non-provisional Patent Application No. 14,207,727 and related intellectual property rights.", "sentB": "With respect to the smallpox vaccine candidate, we own U.S. non-provisional Patent Application No. 14,207,727 and related intellectual property rights.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "we", "acquired", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights.", "<tag2>", "With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "we", "own", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights.", "<tag3>"], "wordsA": ["With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "we", "acquired", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights."], "wordsB": ["With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "we", "own", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p102_s3", "idA": "1430306_15_item1_p132_s2", "sentA": "We believe that these technologies, after further development, may be of interest to biodefense agencies in the U.S. and other countries.", "sentB": "We believe that this technology, after further development, may be of interest to biodefense agencies in the U.S. and other countries.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "these", "technologies,", "after", "further", "development,", "may", "be", "of", "interest", "to", "biodefense", "agencies", "in", "the", "U.S.", "and", "other", "countries.", "<tag2>", "We", "believe", "that", "this", "technology,", "after", "further", "development,", "may", "be", "of", "interest", "to", "biodefense", "agencies", "in", "the", "U.S.", "and", "other", "countries.", "<tag3>"], "wordsA": ["We", "believe", "that", "these", "technologies,", "after", "further", "development,", "may", "be", "of", "interest", "to", "biodefense", "agencies", "in", "the", "U.S.", "and", "other", "countries."], "wordsB": ["We", "believe", "that", "this", "technology,", "after", "further", "development,", "may", "be", "of", "interest", "to", "biodefense", "agencies", "in", "the", "U.S.", "and", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p25_s0", "idA": "1430306_15_item1_p132_s2", "sentA": "We believe that these technologies, after further development, may be of interest to biodefense agencies in the U.S. and other countries.", "sentB": "Based on our market research, we believe that sales in the U.S. of FDA-approved medications for FM were approximately $1.2 billion in 2014, representing approximately 5.6 million prescriptions.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "these", "technologies,", "after", "further", "development,", "may", "be", "of", "interest", "to", "biodefense", "agencies", "in", "the", "U.S.", "and", "other", "countries.", "<tag2>", "Based", "on", "our", "market", "research,", "we", "believe", "that", "sales", "in", "the", "U.S.", "of", "FDA-approved", "medications", "for", "FM", "were", "approximately", "$1.2", "billion", "in", "2014,", "representing", "approximately", "5.6", "million", "prescriptions.", "<tag3>"], "wordsA": ["We", "believe", "that", "these", "technologies,", "after", "further", "development,", "may", "be", "of", "interest", "to", "biodefense", "agencies", "in", "the", "U.S.", "and", "other", "countries."], "wordsB": ["Based", "on", "our", "market", "research,", "we", "believe", "that", "sales", "in", "the", "U.S.", "of", "FDA-approved", "medications", "for", "FM", "were", "approximately", "$1.2", "billion", "in", "2014,", "representing", "approximately", "5.6", "million", "prescriptions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p111_s1", "idA": "1430306_15_item1_p139_s1", "sentA": "We anticipate that our research and development expenditures will increase several fold as we advance TNX-102 SL into late-stage clinical development and advance other candidates in our pipeline.", "sentB": "We anticipate that our research and development expenditures will increase several fold as we continue our late-stage clinical development of TNX-102 SL and advance other candidates in our pipeline.", "type": 2, "words": ["<tag1>", "We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "advance", "TNX-102", "SL", "into", "late-stage", "clinical", "development", "and", "advance", "other", "candidates", "in", "our", "pipeline.", "<tag2>", "We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "continue", "our", "late-stage", "clinical", "development", "of", "TNX-102", "SL", "and", "advance", "other", "candidates", "in", "our", "pipeline.", "<tag3>"], "wordsA": ["We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "advance", "TNX-102", "SL", "into", "late-stage", "clinical", "development", "and", "advance", "other", "candidates", "in", "our", "pipeline."], "wordsB": ["We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "continue", "our", "late-stage", "clinical", "development", "of", "TNX-102", "SL", "and", "advance", "other", "candidates", "in", "our", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p111_s4", "idA": "1430306_15_item1_p139_s4", "sentA": "We have used, and expect to continue to use, third parties to conduct our preclinical and clinical studies.", "sentB": "We have used, and expect to continue to use, third parties to conduct our nonclinical and clinical studies.", "type": 2, "words": ["<tag1>", "We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies.", "<tag2>", "We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "nonclinical", "and", "clinical", "studies.", "<tag3>"], "wordsA": ["We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies."], "wordsB": ["We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "nonclinical", "and", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p112_s0", "idA": "1430306_15_item1_p140_s0", "sentA": "We have contracted with third-party cGMP-compliant contract manufacturing organizations, or CMOs, for the manufacture of TNX-102 SL and TNX-201 drug substances and drug products for investigational purposes, including nonclinical and clinical testing.", "sentB": "We have contracted with third-party cGMP-compliant contract manufacturing organizations, or CMOs, for the manufacture of TNX-102 SL drug substances and drug products for investigational purposes, including nonclinical and clinical testing.", "type": 2, "words": ["<tag1>", "We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "and", "TNX-201", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing.", "<tag2>", "We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing.", "<tag3>"], "wordsA": ["We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "and", "TNX-201", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing."], "wordsB": ["We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p115_s0", "idA": "1430306_15_item1_p143_s0", "sentA": "The FDA regulates, among other things, the research, manufacture, promotion and distribution of drugs in the United States under the FDCA and other statutes and implementing regulations.", "sentB": "The FDA regulates, among other things, the research, manufacture, promotion and distribution of dr ugs in the United States under the FDCA and other statutes and implementing regulations.", "type": 2, "words": ["<tag1>", "The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations.", "<tag2>", "The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "dr", "ugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations.", "<tag3>"], "wordsA": ["The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations."], "wordsB": ["The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "dr", "ugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p116_s0", "idA": "1430306_15_item1_p144_s0", "sentA": "FDA review and approval of the NDA prior to any commercial marketing, sale or shipment of the drug.", "sentB": "FDA review and approval of the NDA or BLA prior to any commercial marketing, sale or shipment of the drug.", "type": 2, "words": ["<tag1>", "FDA", "review", "and", "approval", "of", "the", "NDA", "prior", "to", "any", "commercial", "marketing,", "sale", "or", "shipment", "of", "the", "drug.", "<tag2>", "FDA", "review", "and", "approval", "of", "the", "NDA", "or", "BLA", "prior", "to", "any", "commercial", "marketing,", "sale", "or", "shipment", "of", "the", "drug.", "<tag3>"], "wordsA": ["FDA", "review", "and", "approval", "of", "the", "NDA", "prior", "to", "any", "commercial", "marketing,", "sale", "or", "shipment", "of", "the", "drug."], "wordsB": ["FDA", "review", "and", "approval", "of", "the", "NDA", "or", "BLA", "prior", "to", "any", "commercial", "marketing,", "sale", "or", "shipment", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p132_s2", "idA": "1430306_15_item1_p159_s2", "sentA": "Although the clinical development of TNX-201 can be accelerated due to existing marketing experience, we expect to file a Section 505(b)(1) NDA for TNX-201 and for certain other products.", "sentB": "We may need to file a Section 505(b)(1) NDA for certain other products in the future.", "type": 2, "words": ["<tag1>", "Although", "the", "clinical", "development", "of", "TNX-201", "can", "be", "accelerated", "due", "to", "existing", "marketing", "experience,", "we", "expect", "to", "file", "a", "Section", "505(b)(1)", "NDA", "for", "TNX-201", "and", "for", "certain", "other", "products.", "<tag2>", "We", "may", "need", "to", "file", "a", "Section", "505(b)(1)", "NDA", "for", "certain", "other", "products", "in", "the", "future.", "<tag3>"], "wordsA": ["Although", "the", "clinical", "development", "of", "TNX-201", "can", "be", "accelerated", "due", "to", "existing", "marketing", "experience,", "we", "expect", "to", "file", "a", "Section", "505(b)(1)", "NDA", "for", "TNX-201", "and", "for", "certain", "other", "products."], "wordsB": ["We", "may", "need", "to", "file", "a", "Section", "505(b)(1)", "NDA", "for", "certain", "other", "products", "in", "the", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p5_s1", "idA": "1430306_15_item1_p161_s1", "sentA": "As such, we plan to submit NDAs under Section 505(b)(2) for TNX-102 SL for FM and PTSD.", "sentB": "TNX-102 SL for FM and PTSD is an investigational new drug and has not been approved for any indication.", "type": 2, "words": ["<tag1>", "As", "such,", "we", "plan", "to", "submit", "NDAs", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD.", "<tag2>", "TNX-102", "SL", "for", "FM", "and", "PTSD", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication.", "<tag3>"], "wordsA": ["As", "such,", "we", "plan", "to", "submit", "NDAs", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD."], "wordsB": ["TNX-102", "SL", "for", "FM", "and", "PTSD", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p136_s1", "idA": "1430306_15_item1_p162_s1", "sentA": "With respect to every patent listed in the FDA s Orange Book, which is the FDA s list of approved drug products, as claiming the reference drug or an approved method of use of the reference drug, the Section 505(b)(2) applicant must certify that: (1) there is no patent information listed by the FDA for the reference drug; (2) the listed patent has expired; (3) the listed patent has not expired, but will expire on a particular date; (4) the listed patent is invalid, unenforceable, or will not be infringed by the manufacture, use, or sale of the product in the Section 505(b)(2) NDA; or (5) if the patent is a use patent, that the applicant does not seek approval for a use claimed by the patent.", "sentB": "With respect to every patent listed in the FDA s Orange Book, which is the FDA s list of approved drug products, as claiming the reference drug or an approved method of use of the reference drug, the Section 505(b)(2) applicant must certify that: (1) there is no patent information listed in the orange book for the reference drug; (2) the listed patent has expired; (3) the listed patent has not expired, but will expire on a particular date; (4) the listed patent is invalid or will not be infringed by the manufacture, use, or sale of the product in the Section 505(b)(2) NDA; or (5) if the patent is a use patent, that the applicant does not seek approval for a use claimed by the patent.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "every", "patent", "listed", "in", "the", "FDA", "s", "Orange", "Book,", "which", "is", "the", "FDA", "s", "list", "of", "approved", "drug", "products,", "as", "claiming", "the", "reference", "drug", "or", "an", "approved", "method", "of", "use", "of", "the", "reference", "drug,", "the", "Section", "505(b)(2)", "applicant", "must", "certify", "that:", "(1)", "there", "is", "no", "patent", "information", "listed", "by", "the", "FDA", "for", "the", "reference", "drug;", "(2)", "the", "listed", "patent", "has", "expired;", "(3)", "the", "listed", "patent", "has", "not", "expired,", "but", "will", "expire", "on", "a", "particular", "date;", "(4)", "the", "listed", "patent", "is", "invalid,", "unenforceable,", "or", "will", "not", "be", "infringed", "by", "the", "manufacture,", "use,", "or", "sale", "of", "the", "product", "in", "the", "Section", "505(b)(2)", "NDA;", "or", "(5)", "if", "the", "patent", "is", "a", "use", "patent,", "that", "the", "applicant", "does", "not", "seek", "approval", "for", "a", "use", "claimed", "by", "the", "patent.", "<tag2>", "With", "respect", "to", "every", "patent", "listed", "in", "the", "FDA", "s", "Orange", "Book,", "which", "is", "the", "FDA", "s", "list", "of", "approved", "drug", "products,", "as", "claiming", "the", "reference", "drug", "or", "an", "approved", "method", "of", "use", "of", "the", "reference", "drug,", "the", "Section", "505(b)(2)", "applicant", "must", "certify", "that:", "(1)", "there", "is", "no", "patent", "information", "listed", "in", "the", "orange", "book", "for", "the", "reference", "drug;", "(2)", "the", "listed", "patent", "has", "expired;", "(3)", "the", "listed", "patent", "has", "not", "expired,", "but", "will", "expire", "on", "a", "particular", "date;", "(4)", "the", "listed", "patent", "is", "invalid", "or", "will", "not", "be", "infringed", "by", "the", "manufacture,", "use,", "or", "sale", "of", "the", "product", "in", "the", "Section", "505(b)(2)", "NDA;", "or", "(5)", "if", "the", "patent", "is", "a", "use", "patent,", "that", "the", "applicant", "does", "not", "seek", "approval", "for", "a", "use", "claimed", "by", "the", "patent.", "<tag3>"], "wordsA": ["With", "respect", "to", "every", "patent", "listed", "in", "the", "FDA", "s", "Orange", "Book,", "which", "is", "the", "FDA", "s", "list", "of", "approved", "drug", "products,", "as", "claiming", "the", "reference", "drug", "or", "an", "approved", "method", "of", "use", "of", "the", "reference", "drug,", "the", "Section", "505(b)(2)", "applicant", "must", "certify", "that:", "(1)", "there", "is", "no", "patent", "information", "listed", "by", "the", "FDA", "for", "the", "reference", "drug;", "(2)", "the", "listed", "patent", "has", "expired;", "(3)", "the", "listed", "patent", "has", "not", "expired,", "but", "will", "expire", "on", "a", "particular", "date;", "(4)", "the", "listed", "patent", "is", "invalid,", "unenforceable,", "or", "will", "not", "be", "infringed", "by", "the", "manufacture,", "use,", "or", "sale", "of", "the", "product", "in", "the", "Section", "505(b)(2)", "NDA;", "or", "(5)", "if", "the", "patent", "is", "a", "use", "patent,", "that", "the", "applicant", "does", "not", "seek", "approval", "for", "a", "use", "claimed", "by", "the", "patent."], "wordsB": ["With", "respect", "to", "every", "patent", "listed", "in", "the", "FDA", "s", "Orange", "Book,", "which", "is", "the", "FDA", "s", "list", "of", "approved", "drug", "products,", "as", "claiming", "the", "reference", "drug", "or", "an", "approved", "method", "of", "use", "of", "the", "reference", "drug,", "the", "Section", "505(b)(2)", "applicant", "must", "certify", "that:", "(1)", "there", "is", "no", "patent", "information", "listed", "in", "the", "orange", "book", "for", "the", "reference", "drug;", "(2)", "the", "listed", "patent", "has", "expired;", "(3)", "the", "listed", "patent", "has", "not", "expired,", "but", "will", "expire", "on", "a", "particular", "date;", "(4)", "the", "listed", "patent", "is", "invalid", "or", "will", "not", "be", "infringed", "by", "the", "manufacture,", "use,", "or", "sale", "of", "the", "product", "in", "the", "Section", "505(b)(2)", "NDA;", "or", "(5)", "if", "the", "patent", "is", "a", "use", "patent,", "that", "the", "applicant", "does", "not", "seek", "approval", "for", "a", "use", "claimed", "by", "the", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p138_s1", "idA": "1430306_15_item1_p164_s1", "sentA": "However, the FDA may approve the Section 505(b)(2) NDA before the 30 months have expired if a court decides that the patent is invalid, unenforceable, or not infringed, or if a court enters a settlement order or consent decree stating the patent is invalid or not infringed.", "sentB": "However, the FDA may approve the Section 505(b)(2) NDA before the 30 months have expired if a court decides that the patent is invalid or not infringed, or if a court enters a settlement order or consent decree stating the patent is invalid or not infringed.", "type": 2, "words": ["<tag1>", "However,", "the", "FDA", "may", "approve", "the", "Section", "505(b)(2)", "NDA", "before", "the", "30", "months", "have", "expired", "if", "a", "court", "decides", "that", "the", "patent", "is", "invalid,", "unenforceable,", "or", "not", "infringed,", "or", "if", "a", "court", "enters", "a", "settlement", "order", "or", "consent", "decree", "stating", "the", "patent", "is", "invalid", "or", "not", "infringed.", "<tag2>", "However,", "the", "FDA", "may", "approve", "the", "Section", "505(b)(2)", "NDA", "before", "the", "30", "months", "have", "expired", "if", "a", "court", "decides", "that", "the", "patent", "is", "invalid", "or", "not", "infringed,", "or", "if", "a", "court", "enters", "a", "settlement", "order", "or", "consent", "decree", "stating", "the", "patent", "is", "invalid", "or", "not", "infringed.", "<tag3>"], "wordsA": ["However,", "the", "FDA", "may", "approve", "the", "Section", "505(b)(2)", "NDA", "before", "the", "30", "months", "have", "expired", "if", "a", "court", "decides", "that", "the", "patent", "is", "invalid,", "unenforceable,", "or", "not", "infringed,", "or", "if", "a", "court", "enters", "a", "settlement", "order", "or", "consent", "decree", "stating", "the", "patent", "is", "invalid", "or", "not", "infringed."], "wordsB": ["However,", "the", "FDA", "may", "approve", "the", "Section", "505(b)(2)", "NDA", "before", "the", "30", "months", "have", "expired", "if", "a", "court", "decides", "that", "the", "patent", "is", "invalid", "or", "not", "infringed,", "or", "if", "a", "court", "enters", "a", "settlement", "order", "or", "consent", "decree", "stating", "the", "patent", "is", "invalid", "or", "not", "infringed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p36_s0", "idA": "1430306_15_item1_p177_s0", "sentA": "In addition, the FDA strictly regulates labeling, advertising, promotion and other types of information on products that are placed on the market.", "sentB": "There are numerous generic versions of cyclobenzaprine immediate-release tablets on the market.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "FDA", "strictly", "regulates", "labeling,", "advertising,", "promotion", "and", "other", "types", "of", "information", "on", "products", "that", "are", "placed", "on", "the", "market.", "<tag2>", "There", "are", "numerous", "generic", "versions", "of", "cyclobenzaprine", "immediate-release", "tablets", "on", "the", "market.", "<tag3>"], "wordsA": ["In", "addition,", "the", "FDA", "strictly", "regulates", "labeling,", "advertising,", "promotion", "and", "other", "types", "of", "information", "on", "products", "that", "are", "placed", "on", "the", "market."], "wordsB": ["There", "are", "numerous", "generic", "versions", "of", "cyclobenzaprine", "immediate-release", "tablets", "on", "the", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p156_s0", "idA": "1430306_15_item1_p182_s0", "sentA": "As of February 27, 2015, we had 16 full-time employees, of whom seven hold M.D., PharmD. and/or Ph.D. degrees.", "sentB": "As of March 1, 2016, we had 28 full-time employees, of whom eight hold M.D. or Ph.D. degrees.", "type": 2, "words": ["<tag1>", "As", "of", "February", "27,", "2015,", "we", "had", "16", "full-time", "employees,", "of", "whom", "seven", "hold", "M.D.,", "PharmD.", "and/or", "Ph.D.", "degrees.", "<tag2>", "As", "of", "March", "1,", "2016,", "we", "had", "28", "full-time", "employees,", "of", "whom", "eight", "hold", "M.D.", "or", "Ph.D.", "degrees.", "<tag3>"], "wordsA": ["As", "of", "February", "27,", "2015,", "we", "had", "16", "full-time", "employees,", "of", "whom", "seven", "hold", "M.D.,", "PharmD.", "and/or", "Ph.D.", "degrees."], "wordsB": ["As", "of", "March", "1,", "2016,", "we", "had", "28", "full-time", "employees,", "of", "whom", "eight", "hold", "M.D.", "or", "Ph.D.", "degrees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p111_s0", "idA": "1430306_15_item1_p182_s1", "sentA": "We have eight employees dedicated to research and development.", "sentB": "We have approximately 15 employees dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "eight", "employees", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "approximately", "15", "employees", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "eight", "employees", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "approximately", "15", "employees", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p156_s1", "idA": "1430306_15_item1_p182_s1", "sentA": "We have eight employees dedicated to research and development.", "sentB": "We have 15 employees dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "eight", "employees", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "15", "employees", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "eight", "employees", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "15", "employees", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p111_s3", "idA": "1430306_15_item1_p182_s2", "sentA": "Our research and development operations are located in New York, NY and San Jose, CA.", "sentB": "Our research and development operations are located in New York, NY, San Diego, CA, San Jose, CA, Dublin, Ireland and Montreal, Canada.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA.", "<tag2>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "San", "Jose,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA."], "wordsB": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "San", "Jose,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p156_s2", "idA": "1430306_15_item1_p182_s2", "sentA": "Our research and development operations are located in New York, NY and San Jose, CA.", "sentB": "Our research and development operations are located in New York, NY, San Diego and San Jose, CA, Dublin, Ireland and Montreal, Canada.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA.", "<tag2>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego", "and", "San", "Jose,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA."], "wordsB": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego", "and", "San", "Jose,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p158_s0", "idA": "1430306_15_item1_p182_s2", "sentA": "Our research and development operations are located in New York, NY and San Jose, CA.", "sentB": "Our principal executive offices are located at 509 Madison Avenue, Suite 306, New York, New York 10022, and our telephone number is (212) 980-9155.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA.", "<tag2>", "Our", "principal", "executive", "offices", "are", "located", "at", "509", "Madison", "Avenue,", "Suite", "306,", "New", "York,", "New", "York", "10022,", "and", "our", "telephone", "number", "is", "(212)", "980-9155.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY", "and", "San", "Jose,", "CA."], "wordsB": ["Our", "principal", "executive", "offices", "are", "located", "at", "509", "Madison", "Avenue,", "Suite", "306,", "New", "York,", "New", "York", "10022,", "and", "our", "telephone", "number", "is", "(212)", "980-9155."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p156_s3", "idA": "1430306_15_item1_p182_s3", "sentA": "We have used, and expect to continue to use, third parties to conduct our preclinical and clinical studies as well as part-time employees.", "sentB": "We have used, and expect to continue to use, third parties to conduct our nonclinical and clinical studies as well as part-time employees.", "type": 2, "words": ["<tag1>", "We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies", "as", "well", "as", "part-time", "employees.", "<tag2>", "We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "nonclinical", "and", "clinical", "studies", "as", "well", "as", "part-time", "employees.", "<tag3>"], "wordsA": ["We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "preclinical", "and", "clinical", "studies", "as", "well", "as", "part-time", "employees."], "wordsB": ["We", "have", "used,", "and", "expect", "to", "continue", "to", "use,", "third", "parties", "to", "conduct", "our", "nonclinical", "and", "clinical", "studies", "as", "well", "as", "part-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p6_s0", "idA": "1430306_15_item1_p24_s0", "sentA": "We are a clinical-stage pharmaceutical company dedicated to the development of novel prescription products for common yet challenging medical disorders.", "sentB": "Tonix Pharmaceuticals Holding Corp., together with its subsidiaries (collectively we, our, us, Tonix or the Company ), is a clinical-stage pharmaceutical company dedicated to the invention and development of next-generation medicines.", "type": 2, "words": ["<tag1>", "We", "are", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "novel", "prescription", "products", "for", "common", "yet", "challenging", "medical", "disorders.", "<tag2>", "Tonix", "Pharmaceuticals", "Holding", "Corp.,", "together", "with", "its", "subsidiaries", "(collectively", "we,", "our,", "us,", "Tonix", "or", "the", "Company", "),", "is", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "invention", "and", "development", "of", "next-generation", "medicines.", "<tag3>"], "wordsA": ["We", "are", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "novel", "prescription", "products", "for", "common", "yet", "challenging", "medical", "disorders."], "wordsB": ["Tonix", "Pharmaceuticals", "Holding", "Corp.,", "together", "with", "its", "subsidiaries", "(collectively", "we,", "our,", "us,", "Tonix", "or", "the", "Company", "),", "is", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "invention", "and", "development", "of", "next-generation", "medicines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p48_s0", "idA": "1430306_15_item1_p24_s2", "sentA": "In the second quarter of 2015, we expect to initiate a Phase 3 clinical trial of our most advanced candidate, TNX-102 SL, for the treatment of FM.", "sentB": "In the second quarter of 2015, we commenced the AFFIRM trial, a 500 patient, randomized, double-blind trial comparing TNX-102 SL to placebo (1:1 ratio), in which study medication is administered sublingually once daily at bedtime for 12 weeks.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2015,", "we", "expect", "to", "initiate", "a", "Phase", "3", "clinical", "trial", "of", "our", "most", "advanced", "candidate,", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM.", "<tag2>", "In", "the", "second", "quarter", "of", "2015,", "we", "commenced", "the", "AFFIRM", "trial,", "a", "500", "patient,", "randomized,", "double-blind", "trial", "comparing", "TNX-102", "SL", "to", "placebo", "(1:1", "ratio),", "in", "which", "study", "medication", "is", "administered", "sublingually", "once", "daily", "at", "bedtime", "for", "12", "weeks.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2015,", "we", "expect", "to", "initiate", "a", "Phase", "3", "clinical", "trial", "of", "our", "most", "advanced", "candidate,", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM."], "wordsB": ["In", "the", "second", "quarter", "of", "2015,", "we", "commenced", "the", "AFFIRM", "trial,", "a", "500", "patient,", "randomized,", "double-blind", "trial", "comparing", "TNX-102", "SL", "to", "placebo", "(1:1", "ratio),", "in", "which", "study", "medication", "is", "administered", "sublingually", "once", "daily", "at", "bedtime", "for", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p78_s1", "idA": "1430306_15_item1_p24_s2", "sentA": "In the second quarter of 2015, we expect to initiate a Phase 3 clinical trial of our most advanced candidate, TNX-102 SL, for the treatment of FM.", "sentB": "In the second quarter of 2015, we initiated a single-dose Phase 2 proof-of-concept clinical trial to evaluate the ability of TNX-201 140 mg to improve headache pain as well as its tolerability in patients with ETTH.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2015,", "we", "expect", "to", "initiate", "a", "Phase", "3", "clinical", "trial", "of", "our", "most", "advanced", "candidate,", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM.", "<tag2>", "In", "the", "second", "quarter", "of", "2015,", "we", "initiated", "a", "single-dose", "Phase", "2", "proof-of-concept", "clinical", "trial", "to", "evaluate", "the", "ability", "of", "TNX-201", "140", "mg", "to", "improve", "headache", "pain", "as", "well", "as", "its", "tolerability", "in", "patients", "with", "ETTH.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2015,", "we", "expect", "to", "initiate", "a", "Phase", "3", "clinical", "trial", "of", "our", "most", "advanced", "candidate,", "TNX-102", "SL,", "for", "the", "treatment", "of", "FM."], "wordsB": ["In", "the", "second", "quarter", "of", "2015,", "we", "initiated", "a", "single-dose", "Phase", "2", "proof-of-concept", "clinical", "trial", "to", "evaluate", "the", "ability", "of", "TNX-201", "140", "mg", "to", "improve", "headache", "pain", "as", "well", "as", "its", "tolerability", "in", "patients", "with", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p8_s0", "idA": "1430306_15_item1_p24_s3", "sentA": "We are also developing TNX-102 SL as a potential treatment for post-traumatic stress disorder, or PTSD, and we commenced a Phase 2 trial for this indication in January 2015.", "sentB": "Our lead product candidate, TNX-102 SL (cyclobenzaprine HCl sublingual tablets) is in Phase 3 clinical development as a potential treatment for FM.", "type": 2, "words": ["<tag1>", "We", "are", "also", "developing", "TNX-102", "SL", "as", "a", "potential", "treatment", "for", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "and", "we", "commenced", "a", "Phase", "2", "trial", "for", "this", "indication", "in", "January", "2015.", "<tag2>", "Our", "lead", "product", "candidate,", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "is", "in", "Phase", "3", "clinical", "development", "as", "a", "potential", "treatment", "for", "FM.", "<tag3>"], "wordsA": ["We", "are", "also", "developing", "TNX-102", "SL", "as", "a", "potential", "treatment", "for", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "and", "we", "commenced", "a", "Phase", "2", "trial", "for", "this", "indication", "in", "January", "2015."], "wordsB": ["Our", "lead", "product", "candidate,", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "is", "in", "Phase", "3", "clinical", "development", "as", "a", "potential", "treatment", "for", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p8_s1", "idA": "1430306_15_item1_p24_s3", "sentA": "We are also developing TNX-102 SL as a potential treatment for post-traumatic stress disorder, or PTSD, and we commenced a Phase 2 trial for this indication in January 2015.", "sentB": "In addition, TNX-102 SL is in Phase 2 clinical development as a potential treatment for PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "also", "developing", "TNX-102", "SL", "as", "a", "potential", "treatment", "for", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "and", "we", "commenced", "a", "Phase", "2", "trial", "for", "this", "indication", "in", "January", "2015.", "<tag2>", "In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "also", "developing", "TNX-102", "SL", "as", "a", "potential", "treatment", "for", "post-traumatic", "stress", "disorder,", "or", "PTSD,", "and", "we", "commenced", "a", "Phase", "2", "trial", "for", "this", "indication", "in", "January", "2015."], "wordsB": ["In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p8_s2", "idA": "1430306_15_item1_p24_s5", "sentA": "Our pipeline includes a preclinical program for the treatment of alcohol abuse and dependence as well as two preclinical biodefense programs (for protection from smallpox virus and from radiation injury).", "sentB": "Our nonclinical pipeline includes a development program for the treatment of alcohol use disorders, or AUD, as well as two biodefense development programs for protection from smallpox virus and from radiation injury.", "type": 2, "words": ["<tag1>", "Our", "pipeline", "includes", "a", "preclinical", "program", "for", "the", "treatment", "of", "alcohol", "abuse", "and", "dependence", "as", "well", "as", "two", "preclinical", "biodefense", "programs", "(for", "protection", "from", "smallpox", "virus", "and", "from", "radiation", "injury).", "<tag2>", "Our", "nonclinical", "pipeline", "includes", "a", "development", "program", "for", "the", "treatment", "of", "alcohol", "use", "disorders,", "or", "AUD,", "as", "well", "as", "two", "biodefense", "development", "programs", "for", "protection", "from", "smallpox", "virus", "and", "from", "radiation", "injury.", "<tag3>"], "wordsA": ["Our", "pipeline", "includes", "a", "preclinical", "program", "for", "the", "treatment", "of", "alcohol", "abuse", "and", "dependence", "as", "well", "as", "two", "preclinical", "biodefense", "programs", "(for", "protection", "from", "smallpox", "virus", "and", "from", "radiation", "injury)."], "wordsB": ["Our", "nonclinical", "pipeline", "includes", "a", "development", "program", "for", "the", "treatment", "of", "alcohol", "use", "disorders,", "or", "AUD,", "as", "well", "as", "two", "biodefense", "development", "programs", "for", "protection", "from", "smallpox", "virus", "and", "from", "radiation", "injury."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p10_s0", "idA": "1430306_15_item1_p26_s0", "sentA": "TNX-102 SL is a small, rapidly disintegrating tablet containing cyclobenzaprine for sublingual administration that we are developing for two indications, both of which are underserved by currently available therapies.", "sentB": "TNX-102 SL is a small, rapidly disintegrating tablet containing cyclobenzaprine, or CBP, for sublingual administration and transmucosal absorption.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine", "for", "sublingual", "administration", "that", "we", "are", "developing", "for", "two", "indications,", "both", "of", "which", "are", "underserved", "by", "currently", "available", "therapies.", "<tag2>", "TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine,", "or", "CBP,", "for", "sublingual", "administration", "and", "transmucosal", "absorption.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine", "for", "sublingual", "administration", "that", "we", "are", "developing", "for", "two", "indications,", "both", "of", "which", "are", "underserved", "by", "currently", "available", "therapies."], "wordsB": ["TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine,", "or", "CBP,", "for", "sublingual", "administration", "and", "transmucosal", "absorption."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p11_s0", "idA": "1430306_15_item1_p27_s0", "sentA": "Fibromyalgia is a debilitating syndrome that occurs in up to 15% of U.S. adults and is associated with a substantial negative impact on social and occupational function, including disrupted relationships with family and friends, social isolation, reduced activities of daily living and leisure activities, avoidance of physical activity, and loss of career or inability to advance in careers or education.", "sentB": "Fibromyalgia is a debilitating syndrome that occurs in five to 15 million U.S. adults and is associated with a substantial negative impact on social and occupational function, including disrupted relationships with family and friends, social isolation, reduced activities of daily living and leisure activities, avoidance of physical activity, and loss of career or inability to advance in careers or education.", "type": 2, "words": ["<tag1>", "Fibromyalgia", "is", "a", "debilitating", "syndrome", "that", "occurs", "in", "up", "to", "15%", "of", "U.S.", "adults", "and", "is", "associated", "with", "a", "substantial", "negative", "impact", "on", "social", "and", "occupational", "function,", "including", "disrupted", "relationships", "with", "family", "and", "friends,", "social", "isolation,", "reduced", "activities", "of", "daily", "living", "and", "leisure", "activities,", "avoidance", "of", "physical", "activity,", "and", "loss", "of", "career", "or", "inability", "to", "advance", "in", "careers", "or", "education.", "<tag2>", "Fibromyalgia", "is", "a", "debilitating", "syndrome", "that", "occurs", "in", "five", "to", "15", "million", "U.S.", "adults", "and", "is", "associated", "with", "a", "substantial", "negative", "impact", "on", "social", "and", "occupational", "function,", "including", "disrupted", "relationships", "with", "family", "and", "friends,", "social", "isolation,", "reduced", "activities", "of", "daily", "living", "and", "leisure", "activities,", "avoidance", "of", "physical", "activity,", "and", "loss", "of", "career", "or", "inability", "to", "advance", "in", "careers", "or", "education.", "<tag3>"], "wordsA": ["Fibromyalgia", "is", "a", "debilitating", "syndrome", "that", "occurs", "in", "up", "to", "15%", "of", "U.S.", "adults", "and", "is", "associated", "with", "a", "substantial", "negative", "impact", "on", "social", "and", "occupational", "function,", "including", "disrupted", "relationships", "with", "family", "and", "friends,", "social", "isolation,", "reduced", "activities", "of", "daily", "living", "and", "leisure", "activities,", "avoidance", "of", "physical", "activity,", "and", "loss", "of", "career", "or", "inability", "to", "advance", "in", "careers", "or", "education."], "wordsB": ["Fibromyalgia", "is", "a", "debilitating", "syndrome", "that", "occurs", "in", "five", "to", "15", "million", "U.S.", "adults", "and", "is", "associated", "with", "a", "substantial", "negative", "impact", "on", "social", "and", "occupational", "function,", "including", "disrupted", "relationships", "with", "family", "and", "friends,", "social", "isolation,", "reduced", "activities", "of", "daily", "living", "and", "leisure", "activities,", "avoidance", "of", "physical", "activity,", "and", "loss", "of", "career", "or", "inability", "to", "advance", "in", "careers", "or", "education."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p14_s0", "idA": "1430306_15_item1_p28_s0", "sentA": "Many patients fail to adequately respond to the medications approved for FM, or discontinue therapy due to poor tolerability.", "sentB": "Many patients fail to adequately respond to the medications approved for PTSD.", "type": 2, "words": ["<tag1>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "FM,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability.", "<tag2>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "PTSD.", "<tag3>"], "wordsA": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "FM,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability."], "wordsB": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p13_s0", "idA": "1430306_15_item1_p29_s0", "sentA": "An estimated 3.5% of adults in the U.S. suffer from PTSD, a chronic disorder that is characterized by avoidance, emotional numbing, hyperarousal, and sleep disturbances.", "sentB": "An estimated 8.4 million adults in the U.S. suffer from PTSD, a chronic disorder that is characterized by avoidance, emotional numbing, hyperarousal, and sleep disturbances.", "type": 2, "words": ["<tag1>", "An", "estimated", "3.5%", "of", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "sleep", "disturbances.", "<tag2>", "An", "estimated", "8.4", "million", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "sleep", "disturbances.", "<tag3>"], "wordsA": ["An", "estimated", "3.5%", "of", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "sleep", "disturbances."], "wordsB": ["An", "estimated", "8.4", "million", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "sleep", "disturbances."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p14_s1", "idA": "1430306_15_item1_p29_s2", "sentA": "Many patients fail to adequately respond to the medications approved for PTSD, and antidepressants, sedative-hypnotics and antipsychotics not approved for PTSD are commonly prescribed despite generally weak evidence in support of their use.", "sentB": "Antidepressants, sedative-hypnotics and antipsychotics not approved for PTSD are commonly prescribed despite generally weak evidence in support of their use.", "type": 2, "words": ["<tag1>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "PTSD,", "and", "antidepressants,", "sedative-hypnotics", "and", "antipsychotics", "not", "approved", "for", "PTSD", "are", "commonly", "prescribed", "despite", "generally", "weak", "evidence", "in", "support", "of", "their", "use.", "<tag2>", "Antidepressants,", "sedative-hypnotics", "and", "antipsychotics", "not", "approved", "for", "PTSD", "are", "commonly", "prescribed", "despite", "generally", "weak", "evidence", "in", "support", "of", "their", "use.", "<tag3>"], "wordsA": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "PTSD,", "and", "antidepressants,", "sedative-hypnotics", "and", "antipsychotics", "not", "approved", "for", "PTSD", "are", "commonly", "prescribed", "despite", "generally", "weak", "evidence", "in", "support", "of", "their", "use."], "wordsB": ["Antidepressants,", "sedative-hypnotics", "and", "antipsychotics", "not", "approved", "for", "PTSD", "are", "commonly", "prescribed", "despite", "generally", "weak", "evidence", "in", "support", "of", "their", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p28_s5", "idA": "1430306_15_item1_p29_s3", "sentA": "We believe that TNX-102 SL may be ideally suited to address the need for a treatment for PTSD that is effective, safe, and well-tolerated.", "sentB": "As of 2009, there were approximately 500,000 veterans receiving treatment for PTSD in the Veterans Health Administration, or VHA.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "TNX-102", "SL", "may", "be", "ideally", "suited", "to", "address", "the", "need", "for", "a", "treatment", "for", "PTSD", "that", "is", "effective,", "safe,", "and", "well-tolerated.", "<tag2>", "As", "of", "2009,", "there", "were", "approximately", "500,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA.", "<tag3>"], "wordsA": ["We", "believe", "that", "TNX-102", "SL", "may", "be", "ideally", "suited", "to", "address", "the", "need", "for", "a", "treatment", "for", "PTSD", "that", "is", "effective,", "safe,", "and", "well-tolerated."], "wordsB": ["As", "of", "2009,", "there", "were", "approximately", "500,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p15_s0", "idA": "1430306_15_item1_p30_s0", "sentA": "TNX-201 is an oral formulation of (R)-isometheptene mucate that we are developing for ETTH.", "sentB": "TNX-201 is an oral formulation of dexisometheptene mucate that we were developing for episodic tension-type headache, or ETTH.", "type": 2, "words": ["<tag1>", "TNX-201", "is", "an", "oral", "formulation", "of", "(R)-isometheptene", "mucate", "that", "we", "are", "developing", "for", "ETTH.", "<tag2>", "TNX-201", "is", "an", "oral", "formulation", "of", "dexisometheptene", "mucate", "that", "we", "were", "developing", "for", "episodic", "tension-type", "headache,", "or", "ETTH.", "<tag3>"], "wordsA": ["TNX-201", "is", "an", "oral", "formulation", "of", "(R)-isometheptene", "mucate", "that", "we", "are", "developing", "for", "ETTH."], "wordsB": ["TNX-201", "is", "an", "oral", "formulation", "of", "dexisometheptene", "mucate", "that", "we", "were", "developing", "for", "episodic", "tension-type", "headache,", "or", "ETTH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p29_s2", "idA": "1430306_15_item1_p31_s1", "sentA": "Although the approved prescription products for ETTH may have some therapeutic value in treating the primary headache condition, they are associated with significant safety liabilities and pose a risk of abuse and addiction.", "sentB": "Current PTSD treatments include off-label use of anxiolytics, sedative-hypnotics, and antipsychotics, many of which lack reliable evidence of efficacy, and have significant safety liabilities and dependence risk.", "type": 2, "words": ["<tag1>", "Although", "the", "approved", "prescription", "products", "for", "ETTH", "may", "have", "some", "therapeutic", "value", "in", "treating", "the", "primary", "headache", "condition,", "they", "are", "associated", "with", "significant", "safety", "liabilities", "and", "pose", "a", "risk", "of", "abuse", "and", "addiction.", "<tag2>", "Current", "PTSD", "treatments", "include", "off-label", "use", "of", "anxiolytics,", "sedative-hypnotics,", "and", "antipsychotics,", "many", "of", "which", "lack", "reliable", "evidence", "of", "efficacy,", "and", "have", "significant", "safety", "liabilities", "and", "dependence", "risk.", "<tag3>"], "wordsA": ["Although", "the", "approved", "prescription", "products", "for", "ETTH", "may", "have", "some", "therapeutic", "value", "in", "treating", "the", "primary", "headache", "condition,", "they", "are", "associated", "with", "significant", "safety", "liabilities", "and", "pose", "a", "risk", "of", "abuse", "and", "addiction."], "wordsB": ["Current", "PTSD", "treatments", "include", "off-label", "use", "of", "anxiolytics,", "sedative-hypnotics,", "and", "antipsychotics,", "many", "of", "which", "lack", "reliable", "evidence", "of", "efficacy,", "and", "have", "significant", "safety", "liabilities", "and", "dependence", "risk."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p7_s1", "idA": "1430306_15_item1_p32_s1", "sentA": "We complement our management team with a network of scientific, clinical, and regulatory advisors that includes recognized experts in the fields of FM, PTSD, ETTH and other central nervous system disorders.", "sentB": "We complement our management team with a network of scientific, clinical, and regulatory advisors that includes recognized experts in the fields of FM, PTSD and other central nervous system disorders.", "type": 2, "words": ["<tag1>", "We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "FM,", "PTSD,", "ETTH", "and", "other", "central", "nervous", "system", "disorders.", "<tag2>", "We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "FM,", "PTSD", "and", "other", "central", "nervous", "system", "disorders.", "<tag3>"], "wordsA": ["We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "FM,", "PTSD,", "ETTH", "and", "other", "central", "nervous", "system", "disorders."], "wordsB": ["We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "FM,", "PTSD", "and", "other", "central", "nervous", "system", "disorders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p16_s0", "idA": "1430306_15_item1_p33_s0", "sentA": "Our objective is to develop and commercialize our product candidates, including TNX-102 SL and TNX-201.", "sentB": "Our objective is to develop and commercialize our product candidates.", "type": 2, "words": ["<tag1>", "Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "including", "TNX-102", "SL", "and", "TNX-201.", "<tag2>", "Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "including", "TNX-102", "SL", "and", "TNX-201."], "wordsB": ["Our", "objective", "is", "to", "develop", "and", "commercialize", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p17_s0", "idA": "1430306_15_item1_p34_s0", "sentA": "Develop TNX-102 SL and TNX-201 for multiple central nervous system disorders .", "sentB": "Develop TNX-102 SL for multiple central nervous system disorders .", "type": 2, "words": ["<tag1>", "Develop", "TNX-102", "SL", "and", "TNX-201", "for", "multiple", "central", "nervous", "system", "disorders", ".", "<tag2>", "Develop", "TNX-102", "SL", "for", "multiple", "central", "nervous", "system", "disorders", ".", "<tag3>"], "wordsA": ["Develop", "TNX-102", "SL", "and", "TNX-201", "for", "multiple", "central", "nervous", "system", "disorders", "."], "wordsB": ["Develop", "TNX-102", "SL", "for", "multiple", "central", "nervous", "system", "disorders", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p17_s1", "idA": "1430306_15_item1_p34_s1", "sentA": "We currently are pursuing the development of TNX-102 SL for two separate indications, FM and PTSD, and we are developing TNX-201 for ETTH.", "sentB": "We currently are pursuing the development of TNX-102 SL for two separate indications, FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "currently", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications,", "FM", "and", "PTSD,", "and", "we", "are", "developing", "TNX-201", "for", "ETTH.", "<tag2>", "We", "currently", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications,", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "currently", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications,", "FM", "and", "PTSD,", "and", "we", "are", "developing", "TNX-201", "for", "ETTH."], "wordsB": ["We", "currently", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications,", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p18_s0", "idA": "1430306_15_item1_p35_s0", "sentA": "Maximize the commercial potential of TNX-102 SL and TNX-201 .", "sentB": "Maximize the commercial potential of TNX-102 SL .", "type": 2, "words": ["<tag1>", "Maximize", "the", "commercial", "potential", "of", "TNX-102", "SL", "and", "TNX-201", ".", "<tag2>", "Maximize", "the", "commercial", "potential", "of", "TNX-102", "SL", ".", "<tag3>"], "wordsA": ["Maximize", "the", "commercial", "potential", "of", "TNX-102", "SL", "and", "TNX-201", "."], "wordsB": ["Maximize", "the", "commercial", "potential", "of", "TNX-102", "SL", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p18_s1", "idA": "1430306_15_item1_p35_s1", "sentA": "We plan to commercialize TNX-102 SL and TNX-201 for their respective indications either on our own or through collaboration with partners.", "sentB": "We plan to commercialize TNX-102 SL for indications including FM and PTSD either on our own or through collaboration with partners.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "commercialize", "TNX-102", "SL", "and", "TNX-201", "for", "their", "respective", "indications", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners.", "<tag2>", "We", "plan", "to", "commercialize", "TNX-102", "SL", "for", "indications", "including", "FM", "and", "PTSD", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners.", "<tag3>"], "wordsA": ["We", "plan", "to", "commercialize", "TNX-102", "SL", "and", "TNX-201", "for", "their", "respective", "indications", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners."], "wordsB": ["We", "plan", "to", "commercialize", "TNX-102", "SL", "for", "indications", "including", "FM", "and", "PTSD", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p18_s2", "idA": "1430306_15_item1_p35_s2", "sentA": "We believe TNX-102 SL and TNX-201 can be marketed to U.S. physicians either by an internal sales force that we will build or by a contract sales organization, which we would engage.", "sentB": "We believe TNX-102 SL can be marketed to U.S. physicians either by an internal sales force that we will build or by a contract sales organization, which we would engage.", "type": 2, "words": ["<tag1>", "We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage.", "<tag2>", "We", "believe", "TNX-102", "SL", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage.", "<tag3>"], "wordsA": ["We", "believe", "TNX-102", "SL", "and", "TNX-201", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage."], "wordsB": ["We", "believe", "TNX-102", "SL", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p20_s2", "idA": "1430306_15_item1_p37_s2", "sentA": "In the cases of TNX-102 SL and TNX-201, we have been engaged in market research and commercial assessment activities, the results of which we may use to inform future commercial strategy.", "sentB": "In the case of TNX-102 SL, we have been engaged in market research and commercial assessment activities, the results of which we may use to inform future commercial strategy.", "type": 2, "words": ["<tag1>", "In", "the", "cases", "of", "TNX-102", "SL", "and", "TNX-201,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy.", "<tag2>", "In", "the", "case", "of", "TNX-102", "SL,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy.", "<tag3>"], "wordsA": ["In", "the", "cases", "of", "TNX-102", "SL", "and", "TNX-201,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy."], "wordsB": ["In", "the", "case", "of", "TNX-102", "SL,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p21_s1", "idA": "1430306_15_item1_p38_s1", "sentA": "We will seek to maximize the value of TNX-102 SL, TNX-201, and our other product candidates by pursuing other indications and commercial opportunities for such candidates.", "sentB": "We will seek to maximize the value of TNX-102 SL, and our other product candidates by pursuing other indications and commercial opportunities for such candidates.", "type": 2, "words": ["<tag1>", "We", "will", "seek", "to", "maximize", "the", "value", "of", "TNX-102", "SL,", "TNX-201,", "and", "our", "other", "product", "candidates", "by", "pursuing", "other", "indications", "and", "commercial", "opportunities", "for", "such", "candidates.", "<tag2>", "We", "will", "seek", "to", "maximize", "the", "value", "of", "TNX-102", "SL,", "and", "our", "other", "product", "candidates", "by", "pursuing", "other", "indications", "and", "commercial", "opportunities", "for", "such", "candidates.", "<tag3>"], "wordsA": ["We", "will", "seek", "to", "maximize", "the", "value", "of", "TNX-102", "SL,", "TNX-201,", "and", "our", "other", "product", "candidates", "by", "pursuing", "other", "indications", "and", "commercial", "opportunities", "for", "such", "candidates."], "wordsB": ["We", "will", "seek", "to", "maximize", "the", "value", "of", "TNX-102", "SL,", "and", "our", "other", "product", "candidates", "by", "pursuing", "other", "indications", "and", "commercial", "opportunities", "for", "such", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p78_s6", "idA": "1430306_15_item1_p38_s3", "sentA": "In the future, we may explore the development of TNX-201 for the treatment of migraine headaches.", "sentB": "Since TNX-201 failed to show any efficacy, we abandoned development of TNX-201.", "type": 2, "words": ["<tag1>", "In", "the", "future,", "we", "may", "explore", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "migraine", "headaches.", "<tag2>", "Since", "TNX-201", "failed", "to", "show", "any", "efficacy,", "we", "abandoned", "development", "of", "TNX-201.", "<tag3>"], "wordsA": ["In", "the", "future,", "we", "may", "explore", "the", "development", "of", "TNX-201", "for", "the", "treatment", "of", "migraine", "headaches."], "wordsB": ["Since", "TNX-201", "failed", "to", "show", "any", "efficacy,", "we", "abandoned", "development", "of", "TNX-201."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p22_s0", "idA": "1430306_15_item1_p39_s0", "sentA": "Our product candidates address diseases that are not well served by currently available therapies and represent large potential commercial market opportunities.", "sentB": "Our product candidates address disorders that are not well served by currently available therapies and represent large potential commercial market opportunities.", "type": 2, "words": ["<tag1>", "Our", "product", "candidates", "address", "diseases", "that", "are", "not", "well", "served", "by", "currently", "available", "therapies", "and", "represent", "large", "potential", "commercial", "market", "opportunities.", "<tag2>", "Our", "product", "candidates", "address", "disorders", "that", "are", "not", "well", "served", "by", "currently", "available", "therapies", "and", "represent", "large", "potential", "commercial", "market", "opportunities.", "<tag3>"], "wordsA": ["Our", "product", "candidates", "address", "diseases", "that", "are", "not", "well", "served", "by", "currently", "available", "therapies", "and", "represent", "large", "potential", "commercial", "market", "opportunities."], "wordsB": ["Our", "product", "candidates", "address", "disorders", "that", "are", "not", "well", "served", "by", "currently", "available", "therapies", "and", "represent", "large", "potential", "commercial", "market", "opportunities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p22_s1", "idA": "1430306_15_item1_p39_s1", "sentA": "Background information on the diseases and related commercial markets that may be addressed by our clinical-stage product candidates is set forth below.", "sentB": "Background information on the disorders and related commercial markets that may be addressed by our clinical-stage product candidates is set forth below.", "type": 2, "words": ["<tag1>", "Background", "information", "on", "the", "diseases", "and", "related", "commercial", "markets", "that", "may", "be", "addressed", "by", "our", "clinical-stage", "product", "candidates", "is", "set", "forth", "below.", "<tag2>", "Background", "information", "on", "the", "disorders", "and", "related", "commercial", "markets", "that", "may", "be", "addressed", "by", "our", "clinical-stage", "product", "candidates", "is", "set", "forth", "below.", "<tag3>"], "wordsA": ["Background", "information", "on", "the", "diseases", "and", "related", "commercial", "markets", "that", "may", "be", "addressed", "by", "our", "clinical-stage", "product", "candidates", "is", "set", "forth", "below."], "wordsB": ["Background", "information", "on", "the", "disorders", "and", "related", "commercial", "markets", "that", "may", "be", "addressed", "by", "our", "clinical-stage", "product", "candidates", "is", "set", "forth", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p28_s4", "idA": "1430306_15_item1_p40_s1", "sentA": "According to published estimates, there are approximately five to fifteen million people suffering from FM in the U.S.", "sentB": "According to the U.S. Department of Veterans Affairs, the prevalence rate of PTSD in the military population is higher than that among civilians.", "type": 2, "words": ["<tag1>", "According", "to", "published", "estimates,", "there", "are", "approximately", "five", "to", "fifteen", "million", "people", "suffering", "from", "FM", "in", "the", "U.S.", "<tag2>", "According", "to", "the", "U.S.", "Department", "of", "Veterans", "Affairs,", "the", "prevalence", "rate", "of", "PTSD", "in", "the", "military", "population", "is", "higher", "than", "that", "among", "civilians.", "<tag3>"], "wordsA": ["According", "to", "published", "estimates,", "there", "are", "approximately", "five", "to", "fifteen", "million", "people", "suffering", "from", "FM", "in", "the", "U.S."], "wordsB": ["According", "to", "the", "U.S.", "Department", "of", "Veterans", "Affairs,", "the", "prevalence", "rate", "of", "PTSD", "in", "the", "military", "population", "is", "higher", "than", "that", "among", "civilians."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p26_s0", "idA": "1430306_15_item1_p43_s2", "sentA": "Many patients fail to adequately respond to the approved medications, or discontinue therapy due to poor tolerability.", "sentB": "According to a report by Frost and Sullivan that we commissioned, despite the availability of approved medications, the majority of patients fail therapy due to either insufficient efficacy or poor tolerability, or both.", "type": 2, "words": ["<tag1>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "approved", "medications,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability.", "<tag2>", "According", "to", "a", "report", "by", "Frost", "and", "Sullivan", "that", "we", "commissioned,", "despite", "the", "availability", "of", "approved", "medications,", "the", "majority", "of", "patients", "fail", "therapy", "due", "to", "either", "insufficient", "efficacy", "or", "poor", "tolerability,", "or", "both.", "<tag3>"], "wordsA": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "approved", "medications,", "or", "discontinue", "therapy", "due", "to", "poor", "tolerability."], "wordsB": ["According", "to", "a", "report", "by", "Frost", "and", "Sullivan", "that", "we", "commissioned,", "despite", "the", "availability", "of", "approved", "medications,", "the", "majority", "of", "patients", "fail", "therapy", "due", "to", "either", "insufficient", "efficacy", "or", "poor", "tolerability,", "or", "both."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p27_s0", "idA": "1430306_15_item1_p43_s3", "sentA": "Prescription pain and sleep medications are widely used for symptomatic relief, despite the lack of evidence that such medications provide a meaningful or durable therapeutic effect.", "sentB": "Prescription pain and sleep medications are frequently prescribed off-label for symptomatic relief, despite the lack of evidence that such medications provide a meaningful or durable therapeutic benefit, and many of these medications carry significant safety risks and risk of dependence.", "type": 2, "words": ["<tag1>", "Prescription", "pain", "and", "sleep", "medications", "are", "widely", "used", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect.", "<tag2>", "Prescription", "pain", "and", "sleep", "medications", "are", "frequently", "prescribed", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "benefit,", "and", "many", "of", "these", "medications", "carry", "significant", "safety", "risks", "and", "risk", "of", "dependence.", "<tag3>"], "wordsA": ["Prescription", "pain", "and", "sleep", "medications", "are", "widely", "used", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "effect."], "wordsB": ["Prescription", "pain", "and", "sleep", "medications", "are", "frequently", "prescribed", "off-label", "for", "symptomatic", "relief,", "despite", "the", "lack", "of", "evidence", "that", "such", "medications", "provide", "a", "meaningful", "or", "durable", "therapeutic", "benefit,", "and", "many", "of", "these", "medications", "carry", "significant", "safety", "risks", "and", "risk", "of", "dependence."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p28_s2", "idA": "1430306_15_item1_p45_s2", "sentA": "People with PTSD suffer significant impairment in their daily functioning, including occupational activities and social relations, and are at elevated risk for impulsive, violent behaviors toward others and themselves, including suicide.", "sentB": "People with PTSD suffer significant impairment in their daily functioning, including occupational activities and social relations, and are at elevated risk for impulsive violent behaviors toward others and themselves, including suicide.", "type": 2, "words": ["<tag1>", "People", "with", "PTSD", "suffer", "significant", "impairment", "in", "their", "daily", "functioning,", "including", "occupational", "activities", "and", "social", "relations,", "and", "are", "at", "elevated", "risk", "for", "impulsive,", "violent", "behaviors", "toward", "others", "and", "themselves,", "including", "suicide.", "<tag2>", "People", "with", "PTSD", "suffer", "significant", "impairment", "in", "their", "daily", "functioning,", "including", "occupational", "activities", "and", "social", "relations,", "and", "are", "at", "elevated", "risk", "for", "impulsive", "violent", "behaviors", "toward", "others", "and", "themselves,", "including", "suicide.", "<tag3>"], "wordsA": ["People", "with", "PTSD", "suffer", "significant", "impairment", "in", "their", "daily", "functioning,", "including", "occupational", "activities", "and", "social", "relations,", "and", "are", "at", "elevated", "risk", "for", "impulsive,", "violent", "behaviors", "toward", "others", "and", "themselves,", "including", "suicide."], "wordsB": ["People", "with", "PTSD", "suffer", "significant", "impairment", "in", "their", "daily", "functioning,", "including", "occupational", "activities", "and", "social", "relations,", "and", "are", "at", "elevated", "risk", "for", "impulsive", "violent", "behaviors", "toward", "others", "and", "themselves,", "including", "suicide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p29_s1", "idA": "1430306_15_item1_p49_s0", "sentA": "Sleep disturbances play a central role in PTSD, and present a difficult therapeutic challenge.", "sentB": "Sleep disturbances are central features of PTSD and are predictive of disease severity, depression, substance abuse, and suicidal ideation, yet are resistant to the approved medications and present a difficult therapeutic challenge.", "type": 2, "words": ["<tag1>", "Sleep", "disturbances", "play", "a", "central", "role", "in", "PTSD,", "and", "present", "a", "difficult", "therapeutic", "challenge.", "<tag2>", "Sleep", "disturbances", "are", "central", "features", "of", "PTSD", "and", "are", "predictive", "of", "disease", "severity,", "depression,", "substance", "abuse,", "and", "suicidal", "ideation,", "yet", "are", "resistant", "to", "the", "approved", "medications", "and", "present", "a", "difficult", "therapeutic", "challenge.", "<tag3>"], "wordsA": ["Sleep", "disturbances", "play", "a", "central", "role", "in", "PTSD,", "and", "present", "a", "difficult", "therapeutic", "challenge."], "wordsB": ["Sleep", "disturbances", "are", "central", "features", "of", "PTSD", "and", "are", "predictive", "of", "disease", "severity,", "depression,", "substance", "abuse,", "and", "suicidal", "ideation,", "yet", "are", "resistant", "to", "the", "approved", "medications", "and", "present", "a", "difficult", "therapeutic", "challenge."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p3_s0", "idA": "1430306_15_item1_p4_s0", "sentA": "Tonix Pharmaceuticals and other trademarks and intellectual property of ours appearing in this report are our property.", "sentB": "Tonix Pharmaceuticals , Tonmya and other trademarks and intellectual property of ours appearing in this report are our property.", "type": 2, "words": ["<tag1>", "Tonix", "Pharmaceuticals", "and", "other", "trademarks", "and", "intellectual", "property", "of", "ours", "appearing", "in", "this", "report", "are", "our", "property.", "<tag2>", "Tonix", "Pharmaceuticals", ",", "Tonmya", "and", "other", "trademarks", "and", "intellectual", "property", "of", "ours", "appearing", "in", "this", "report", "are", "our", "property.", "<tag3>"], "wordsA": ["Tonix", "Pharmaceuticals", "and", "other", "trademarks", "and", "intellectual", "property", "of", "ours", "appearing", "in", "this", "report", "are", "our", "property."], "wordsB": ["Tonix", "Pharmaceuticals", ",", "Tonmya", "and", "other", "trademarks", "and", "intellectual", "property", "of", "ours", "appearing", "in", "this", "report", "are", "our", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p78_s0", "idA": "1430306_15_item1_p50_s0", "sentA": "ETTH is the most common type of headache, estimated to account for over 60% of headaches (Stovner et al, Cephalalgia 2007;27:193-210).", "sentB": "ETTH is the most common type of headache, estimated to account for over 60% of headaches.", "type": 2, "words": ["<tag1>", "ETTH", "is", "the", "most", "common", "type", "of", "headache,", "estimated", "to", "account", "for", "over", "60%", "of", "headaches", "(Stovner", "et", "al,", "Cephalalgia", "2007;27:193-210).", "<tag2>", "ETTH", "is", "the", "most", "common", "type", "of", "headache,", "estimated", "to", "account", "for", "over", "60%", "of", "headaches.", "<tag3>"], "wordsA": ["ETTH", "is", "the", "most", "common", "type", "of", "headache,", "estimated", "to", "account", "for", "over", "60%", "of", "headaches", "(Stovner", "et", "al,", "Cephalalgia", "2007;27:193-210)."], "wordsB": ["ETTH", "is", "the", "most", "common", "type", "of", "headache,", "estimated", "to", "account", "for", "over", "60%", "of", "headaches."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p30_s0", "idA": "1430306_15_item1_p54_s0", "sentA": "We currently are focused on developing a portfolio of product candidates, including two product candidates in clinical development for registration in three indications.", "sentB": "We currently are focused on developing a portfolio of product candidates, including one product candidate in clinical development for registration in two indications.", "type": 2, "words": ["<tag1>", "We", "currently", "are", "focused", "on", "developing", "a", "portfolio", "of", "product", "candidates,", "including", "two", "product", "candidates", "in", "clinical", "development", "for", "registration", "in", "three", "indications.", "<tag2>", "We", "currently", "are", "focused", "on", "developing", "a", "portfolio", "of", "product", "candidates,", "including", "one", "product", "candidate", "in", "clinical", "development", "for", "registration", "in", "two", "indications.", "<tag3>"], "wordsA": ["We", "currently", "are", "focused", "on", "developing", "a", "portfolio", "of", "product", "candidates,", "including", "two", "product", "candidates", "in", "clinical", "development", "for", "registration", "in", "three", "indications."], "wordsB": ["We", "currently", "are", "focused", "on", "developing", "a", "portfolio", "of", "product", "candidates,", "including", "one", "product", "candidate", "in", "clinical", "development", "for", "registration", "in", "two", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p10_s1", "idA": "1430306_15_item1_p55_s1", "sentA": "We are developing TNX-102 SL for fibromyalgia and post-traumatic stress disorder.", "sentB": "We are developing TNX-102 SL for two indications:", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "fibromyalgia", "and", "post-traumatic", "stress", "disorder.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "two", "indications:", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "fibromyalgia", "and", "post-traumatic", "stress", "disorder."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "two", "indications:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p32_s0", "idA": "1430306_15_item1_p56_s0", "sentA": "In addition to CBP, TNX-102 SL contains excipients, which are well-characterized, are listed in the Inactive Ingredient Guide and are approved for pharmaceutical use.", "sentB": "Excipients used in TNX-102 SL are approved for pharmaceutical use.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "CBP,", "TNX-102", "SL", "contains", "excipients,", "which", "are", "well-characterized,", "are", "listed", "in", "the", "Inactive", "Ingredient", "Guide", "and", "are", "approved", "for", "pharmaceutical", "use.", "<tag2>", "Excipients", "used", "in", "TNX-102", "SL", "are", "approved", "for", "pharmaceutical", "use.", "<tag3>"], "wordsA": ["In", "addition", "to", "CBP,", "TNX-102", "SL", "contains", "excipients,", "which", "are", "well-characterized,", "are", "listed", "in", "the", "Inactive", "Ingredient", "Guide", "and", "are", "approved", "for", "pharmaceutical", "use."], "wordsB": ["Excipients", "used", "in", "TNX-102", "SL", "are", "approved", "for", "pharmaceutical", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p32_s1", "idA": "1430306_15_item1_p56_s1", "sentA": "TNX-102 SL contains sublingual absorption-enabling ingredients that promote a local oral environment that facilitates mucosal absorption of CBP.", "sentB": "Some of the excipients were specially selected to promote a local oral environment that facilitates mucosal absorption of CBP.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "contains", "sublingual", "absorption-enabling", "ingredients", "that", "promote", "a", "local", "oral", "environment", "that", "facilitates", "mucosal", "absorption", "of", "CBP.", "<tag2>", "Some", "of", "the", "excipients", "were", "specially", "selected", "to", "promote", "a", "local", "oral", "environment", "that", "facilitates", "mucosal", "absorption", "of", "CBP.", "<tag3>"], "wordsA": ["TNX-102", "SL", "contains", "sublingual", "absorption-enabling", "ingredients", "that", "promote", "a", "local", "oral", "environment", "that", "facilitates", "mucosal", "absorption", "of", "CBP."], "wordsB": ["Some", "of", "the", "excipients", "were", "specially", "selected", "to", "promote", "a", "local", "oral", "environment", "that", "facilitates", "mucosal", "absorption", "of", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p50_s1", "idA": "1430306_15_item1_p57_s0", "sentA": "TNX-102 SL contains 2.8 mg of CBP.", "sentB": "The study demonstrated that the TNX-102 SL 2.8 mg tablets manufactured at the two different facilities are bioequivalent.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP.", "<tag2>", "The", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "the", "two", "different", "facilities", "are", "bioequivalent.", "<tag3>"], "wordsA": ["TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP."], "wordsB": ["The", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "the", "two", "different", "facilities", "are", "bioequivalent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p33_s1", "idA": "1430306_15_item1_p57_s1", "sentA": "We selected this dose with the goal of providing a balance of efficacy, safety, and tolerability that would be acceptable as a first-line therapy and for chronic use, and in patient populations characterized by burdensome symptoms and sensitivity to medications.", "sentB": "We selected this dose with the goal of providing a balance of efficacy, safety, and tolerability that would be acceptable as a first-line therapy and for long-term use, and in patient populations characterized by burdensome symptoms and sensitivity to medications.", "type": 2, "words": ["<tag1>", "We", "selected", "this", "dose", "with", "the", "goal", "of", "providing", "a", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "that", "would", "be", "acceptable", "as", "a", "first-line", "therapy", "and", "for", "chronic", "use,", "and", "in", "patient", "populations", "characterized", "by", "burdensome", "symptoms", "and", "sensitivity", "to", "medications.", "<tag2>", "We", "selected", "this", "dose", "with", "the", "goal", "of", "providing", "a", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "that", "would", "be", "acceptable", "as", "a", "first-line", "therapy", "and", "for", "long-term", "use,", "and", "in", "patient", "populations", "characterized", "by", "burdensome", "symptoms", "and", "sensitivity", "to", "medications.", "<tag3>"], "wordsA": ["We", "selected", "this", "dose", "with", "the", "goal", "of", "providing", "a", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "that", "would", "be", "acceptable", "as", "a", "first-line", "therapy", "and", "for", "chronic", "use,", "and", "in", "patient", "populations", "characterized", "by", "burdensome", "symptoms", "and", "sensitivity", "to", "medications."], "wordsB": ["We", "selected", "this", "dose", "with", "the", "goal", "of", "providing", "a", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "that", "would", "be", "acceptable", "as", "a", "first-line", "therapy", "and", "for", "long-term", "use,", "and", "in", "patient", "populations", "characterized", "by", "burdensome", "symptoms", "and", "sensitivity", "to", "medications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p34_s3", "idA": "1430306_15_item1_p58_s3", "sentA": "As such, TNX-102 SL acts upon cellular receptors that play important roles in the treatment of FM and PTSD, yet also acts upon other receptors in the central nervous system not targeted by products approved for these indications.", "sentB": "As such, TNX-102 SL acts upon cellular receptors that play important roles in the treatment of FM and PTSD, including the receptors that mediate serotonin and norepinephrine reuptake.", "type": 2, "words": ["<tag1>", "As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "yet", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications.", "<tag2>", "As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "including", "the", "receptors", "that", "mediate", "serotonin", "and", "norepinephrine", "reuptake.", "<tag3>"], "wordsA": ["As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "yet", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications."], "wordsB": ["As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "including", "the", "receptors", "that", "mediate", "serotonin", "and", "norepinephrine", "reuptake."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p34_s4", "idA": "1430306_15_item1_p58_s3", "sentA": "As such, TNX-102 SL acts upon cellular receptors that play important roles in the treatment of FM and PTSD, yet also acts upon other receptors in the central nervous system not targeted by products approved for these indications.", "sentB": "In addition, TNX-102 SL also acts upon other receptors in the central nervous system not targeted by products approved for these indications, including the serotonin 2A and alpha-1 adrenergic receptors.", "type": 2, "words": ["<tag1>", "As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "yet", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications.", "<tag2>", "In", "addition,", "TNX-102", "SL", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications,", "including", "the", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptors.", "<tag3>"], "wordsA": ["As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "yet", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications."], "wordsB": ["In", "addition,", "TNX-102", "SL", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications,", "including", "the", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p35_s0", "idA": "1430306_15_item1_p59_s0", "sentA": "CBP is the active ingredient of two products, or CBP products, that are approved in the U.S. for the treatment of muscle spasm: Flexeril (oral immediate-release tablet, 5 mg and 10 mg dosage forms) and Amrix (oral extended-release capsule, 15 mg and 30 mg dosage forms).", "sentB": "CBP is the active ingredient of two products that are approved in the U.S. for the treatment of muscle spasm: FLEXERIL (oral immediate-release tablet, 5 mg and 10 mg dosage forms) and AMRIX (oral extended-release capsule, 15 mg and 30 mg dosage forms).", "type": 2, "words": ["<tag1>", "CBP", "is", "the", "active", "ingredient", "of", "two", "products,", "or", "CBP", "products,", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "Flexeril", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "Amrix", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms).", "<tag2>", "CBP", "is", "the", "active", "ingredient", "of", "two", "products", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "FLEXERIL", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "AMRIX", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms).", "<tag3>"], "wordsA": ["CBP", "is", "the", "active", "ingredient", "of", "two", "products,", "or", "CBP", "products,", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "Flexeril", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "Amrix", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms)."], "wordsB": ["CBP", "is", "the", "active", "ingredient", "of", "two", "products", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "FLEXERIL", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "AMRIX", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p36_s1", "idA": "1430306_15_item1_p59_s1", "sentA": "CBP products are not indicated for the treatment of FM or PTSD, and are approved for acute use (two to three weeks) only.", "sentB": "CBP-containing products are not indicated for the treatment of FM or PTSD.", "type": 2, "words": ["<tag1>", "CBP", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD,", "and", "are", "approved", "for", "acute", "use", "(two", "to", "three", "weeks)", "only.", "<tag2>", "CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD.", "<tag3>"], "wordsA": ["CBP", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD,", "and", "are", "approved", "for", "acute", "use", "(two", "to", "three", "weeks)", "only."], "wordsB": ["CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p36_s2", "idA": "1430306_15_item1_p59_s1", "sentA": "CBP products are not indicated for the treatment of FM or PTSD, and are approved for acute use (two to three weeks) only.", "sentB": "CBP-containing products are approved for short term use (two to three weeks) only.", "type": 2, "words": ["<tag1>", "CBP", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD,", "and", "are", "approved", "for", "acute", "use", "(two", "to", "three", "weeks)", "only.", "<tag2>", "CBP-containing", "products", "are", "approved", "for", "short", "term", "use", "(two", "to", "three", "weeks)", "only.", "<tag3>"], "wordsA": ["CBP", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD,", "and", "are", "approved", "for", "acute", "use", "(two", "to", "three", "weeks)", "only."], "wordsB": ["CBP-containing", "products", "are", "approved", "for", "short", "term", "use", "(two", "to", "three", "weeks)", "only."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p36_s4", "idA": "1430306_15_item1_p59_s3", "sentA": "Extended-release CBP capsules mimic, and flatten, the pharmacokinetic profile of three times per day immediate-release CBP tablets.", "sentB": "Extended-release CBP capsules taken once a day mimic, and flatten, the pharmacokinetic profile of three times per day immediate-release CBP tablets.", "type": 2, "words": ["<tag1>", "Extended-release", "CBP", "capsules", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets.", "<tag2>", "Extended-release", "CBP", "capsules", "taken", "once", "a", "day", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets.", "<tag3>"], "wordsA": ["Extended-release", "CBP", "capsules", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets."], "wordsB": ["Extended-release", "CBP", "capsules", "taken", "once", "a", "day", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p37_s0", "idA": "1430306_15_item1_p60_s1", "sentA": "We designed TNX-102 SL to be administered once-daily at bedtime in a chronic dosing regimen.", "sentB": "We designed TNX-102 SL to be administered once-daily at bedtime and intended for long-term dosing regimen.", "type": 2, "words": ["<tag1>", "We", "designed", "TNX-102", "SL", "to", "be", "administered", "once-daily", "at", "bedtime", "in", "a", "chronic", "dosing", "regimen.", "<tag2>", "We", "designed", "TNX-102", "SL", "to", "be", "administered", "once-daily", "at", "bedtime", "and", "intended", "for", "long-term", "dosing", "regimen.", "<tag3>"], "wordsA": ["We", "designed", "TNX-102", "SL", "to", "be", "administered", "once-daily", "at", "bedtime", "in", "a", "chronic", "dosing", "regimen."], "wordsB": ["We", "designed", "TNX-102", "SL", "to", "be", "administered", "once-daily", "at", "bedtime", "and", "intended", "for", "long-term", "dosing", "regimen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p37_s1", "idA": "1430306_15_item1_p60_s2", "sentA": "We believe the dose and pharmacokinetic parameters of TNX-102 SL will enable it to achieve a desirable balance of efficacy, safety, and tolerability in FM and PTSD.", "sentB": "We believe the selected dose of TNX-102 SL and its pharmacokinetic profile will enable it to achieve a desirable balance of efficacy, safety, and tolerability in FM and PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "dose", "and", "pharmacokinetic", "parameters", "of", "TNX-102", "SL", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "FM", "and", "PTSD.", "<tag2>", "We", "believe", "the", "selected", "dose", "of", "TNX-102", "SL", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "FM", "and", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "the", "dose", "and", "pharmacokinetic", "parameters", "of", "TNX-102", "SL", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "FM", "and", "PTSD."], "wordsB": ["We", "believe", "the", "selected", "dose", "of", "TNX-102", "SL", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "FM", "and", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p38_s0", "idA": "1430306_15_item1_p61_s0", "sentA": "TNX-102 SL was generally well-tolerated, with no serious adverse events reported in these studies.", "sentB": "In clinical studies, TNX-102 SL, 2.8 mg was generally well-tolerated, with no serious adverse events reported in these studies.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag2>", "In", "clinical", "studies,", "TNX-102", "SL,", "2.8", "mg", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag3>"], "wordsA": ["TNX-102", "SL", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "wordsB": ["In", "clinical", "studies,", "TNX-102", "SL,", "2.8", "mg", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p38_s1", "idA": "1430306_15_item1_p61_s1", "sentA": "Some subjects experienced transient numbness on the tongue after TNX-102 SL administration, and other side-effects reported were similar to those reported with approved CBP products.", "sentB": "Some subjects experienced transient numbness of the tongue after TNX-102 SL administration.", "type": 2, "words": ["<tag1>", "Some", "subjects", "experienced", "transient", "numbness", "on", "the", "tongue", "after", "TNX-102", "SL", "administration,", "and", "other", "side-effects", "reported", "were", "similar", "to", "those", "reported", "with", "approved", "CBP", "products.", "<tag2>", "Some", "subjects", "experienced", "transient", "numbness", "of", "the", "tongue", "after", "TNX-102", "SL", "administration.", "<tag3>"], "wordsA": ["Some", "subjects", "experienced", "transient", "numbness", "on", "the", "tongue", "after", "TNX-102", "SL", "administration,", "and", "other", "side-effects", "reported", "were", "similar", "to", "those", "reported", "with", "approved", "CBP", "products."], "wordsB": ["Some", "subjects", "experienced", "transient", "numbness", "of", "the", "tongue", "after", "TNX-102", "SL", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p39_s0", "idA": "1430306_15_item1_p62_s0", "sentA": "We expect that any applications we submit to the Food and Drug Administration, or FDA, for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, which we believe will allow for a shorter timeline of clinical and non-clinical development as compared to that needed to fulfill the requirements of Section 505(b)(1), under which new chemical entities, or NCEs, that have never been approved in the United States, are generally developed to meet the FDA s new drug registration requirements.", "sentB": "We expect that any applications we submit to the Food and Drug Administration, or FDA, for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, for product candidates containing an active ingredient that is similar or identical to an already approved product.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "new", "drug", "registration", "requirements.", "<tag2>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product.", "<tag3>"], "wordsA": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "new", "drug", "registration", "requirements."], "wordsB": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p39_s1", "idA": "1430306_15_item1_p62_s0", "sentA": "We expect that any applications we submit to the Food and Drug Administration, or FDA, for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, which we believe will allow for a shorter timeline of clinical and non-clinical development as compared to that needed to fulfill the requirements of Section 505(b)(1), under which new chemical entities, or NCEs, that have never been approved in the United States, are generally developed to meet the FDA s new drug registration requirements.", "sentB": "In general, the development timeline for a 505(b)(2) New Drug Application, or NDA, is shorter and less expensive than an NDA developed under Section 505(b)(1), which is for new chemical entities, or NCEs, that have never been approved in the United States.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "new", "drug", "registration", "requirements.", "<tag2>", "In", "general,", "the", "development", "timeline", "for", "a", "505(b)(2)", "New", "Drug", "Application,", "or", "NDA,", "is", "shorter", "and", "less", "expensive", "than", "an", "NDA", "developed", "under", "Section", "505(b)(1),", "which", "is", "for", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "which", "we", "believe", "will", "allow", "for", "a", "shorter", "timeline", "of", "clinical", "and", "non-clinical", "development", "as", "compared", "to", "that", "needed", "to", "fulfill", "the", "requirements", "of", "Section", "505(b)(1),", "under", "which", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States,", "are", "generally", "developed", "to", "meet", "the", "FDA", "s", "new", "drug", "registration", "requirements."], "wordsB": ["In", "general,", "the", "development", "timeline", "for", "a", "505(b)(2)", "New", "Drug", "Application,", "or", "NDA,", "is", "shorter", "and", "less", "expensive", "than", "an", "NDA", "developed", "under", "Section", "505(b)(1),", "which", "is", "for", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p40_s1", "idA": "1430306_15_item1_p62_s2", "sentA": "These indications are fibromyalgia, for which TNX-102 SL is advancing into Phase 3 development, and post-traumatic stress disorder, for which TNX-102 SL is in Phase 2 development.", "sentB": "These indications are fibromyalgia, for which TNX-102 SL is in Phase 3 development, and post-traumatic stress disorder, for which TNX-102 SL is in Phase 2 development.", "type": 2, "words": ["<tag1>", "These", "indications", "are", "fibromyalgia,", "for", "which", "TNX-102", "SL", "is", "advancing", "into", "Phase", "3", "development,", "and", "post-traumatic", "stress", "disorder,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "2", "development.", "<tag2>", "These", "indications", "are", "fibromyalgia,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "3", "development,", "and", "post-traumatic", "stress", "disorder,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "2", "development.", "<tag3>"], "wordsA": ["These", "indications", "are", "fibromyalgia,", "for", "which", "TNX-102", "SL", "is", "advancing", "into", "Phase", "3", "development,", "and", "post-traumatic", "stress", "disorder,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "2", "development."], "wordsB": ["These", "indications", "are", "fibromyalgia,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "3", "development,", "and", "post-traumatic", "stress", "disorder,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "2", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p40_s2", "idA": "1430306_15_item1_p62_s3", "sentA": "We believe that TNX-102 SL has the potential to effectively treat these and possibly other CNS indications that are underserved by currently marketed products.", "sentB": "We believe that TNX-102 SL has the potential to provide clinical benefit to these and possibly other CNS indications that are underserved by currently marketed products.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "effectively", "treat", "these", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products.", "<tag2>", "We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "provide", "clinical", "benefit", "to", "these", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products.", "<tag3>"], "wordsA": ["We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "effectively", "treat", "these", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products."], "wordsB": ["We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "provide", "clinical", "benefit", "to", "these", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p41_s2", "idA": "1430306_15_item1_p63_s2", "sentA": "This study demonstrated significant decreases in pain and other symptoms in subjects treated with TNX-102 capsules daily between dinner and bedtime for eight weeks.", "sentB": "This study demonstrated significant decreases in pain and other symptoms in patients treated with TNX-102 capsules daily between dinner and bedtime for eight weeks.", "type": 2, "words": ["<tag1>", "This", "study", "demonstrated", "significant", "decreases", "in", "pain", "and", "other", "symptoms", "in", "subjects", "treated", "with", "TNX-102", "capsules", "daily", "between", "dinner", "and", "bedtime", "for", "eight", "weeks.", "<tag2>", "This", "study", "demonstrated", "significant", "decreases", "in", "pain", "and", "other", "symptoms", "in", "patients", "treated", "with", "TNX-102", "capsules", "daily", "between", "dinner", "and", "bedtime", "for", "eight", "weeks.", "<tag3>"], "wordsA": ["This", "study", "demonstrated", "significant", "decreases", "in", "pain", "and", "other", "symptoms", "in", "subjects", "treated", "with", "TNX-102", "capsules", "daily", "between", "dinner", "and", "bedtime", "for", "eight", "weeks."], "wordsB": ["This", "study", "demonstrated", "significant", "decreases", "in", "pain", "and", "other", "symptoms", "in", "patients", "treated", "with", "TNX-102", "capsules", "daily", "between", "dinner", "and", "bedtime", "for", "eight", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p66_s0", "idA": "1430306_15_item1_p63_s3", "sentA": "This study also demonstrated that treatment with TNX-102 capsules led to a significant improvement in objective measures of sleep quality, which we believe relates to the mechanism by which CBP leads to improvement of FM symptoms.", "sentB": "Results from our BESTFIT study, which showed that treatment with TNX-102 SL resulted in: 1) an observed statistically significant improvement of FM, a separate but related central nervous system disorder having significant overlap with PTSD (Chrousos, 2009); 2) an observed statistically significant improvement in sleep quality in FM, which is similarly impaired in PTSD and central to the neuropathology (Germain, 2013); and 3) statistically significant improvements in anxiety and sensory sensitivity, symptoms that are of particular relevance to PTSD.", "type": 2, "words": ["<tag1>", "This", "study", "also", "demonstrated", "that", "treatment", "with", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms.", "<tag2>", "Results", "from", "our", "BESTFIT", "study,", "which", "showed", "that", "treatment", "with", "TNX-102", "SL", "resulted", "in:", "1)", "an", "observed", "statistically", "significant", "improvement", "of", "FM,", "a", "separate", "but", "related", "central", "nervous", "system", "disorder", "having", "significant", "overlap", "with", "PTSD", "(Chrousos,", "2009);", "2)", "an", "observed", "statistically", "significant", "improvement", "in", "sleep", "quality", "in", "FM,", "which", "is", "similarly", "impaired", "in", "PTSD", "and", "central", "to", "the", "neuropathology", "(Germain,", "2013);", "and", "3)", "statistically", "significant", "improvements", "in", "anxiety", "and", "sensory", "sensitivity,", "symptoms", "that", "are", "of", "particular", "relevance", "to", "PTSD.", "<tag3>"], "wordsA": ["This", "study", "also", "demonstrated", "that", "treatment", "with", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms."], "wordsB": ["Results", "from", "our", "BESTFIT", "study,", "which", "showed", "that", "treatment", "with", "TNX-102", "SL", "resulted", "in:", "1)", "an", "observed", "statistically", "significant", "improvement", "of", "FM,", "a", "separate", "but", "related", "central", "nervous", "system", "disorder", "having", "significant", "overlap", "with", "PTSD", "(Chrousos,", "2009);", "2)", "an", "observed", "statistically", "significant", "improvement", "in", "sleep", "quality", "in", "FM,", "which", "is", "similarly", "impaired", "in", "PTSD", "and", "central", "to", "the", "neuropathology", "(Germain,", "2013);", "and", "3)", "statistically", "significant", "improvements", "in", "anxiety", "and", "sensory", "sensitivity,", "symptoms", "that", "are", "of", "particular", "relevance", "to", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p43_s1", "idA": "1430306_15_item1_p65_s1", "sentA": "We reported preliminary top-line results from the BESTFIT trial in September 2014.", "sentB": "We reported preliminary top line results from the BESTFIT trial in September 2014.", "type": 2, "words": ["<tag1>", "We", "reported", "preliminary", "top-line", "results", "from", "the", "BESTFIT", "trial", "in", "September", "2014.", "<tag2>", "We", "reported", "preliminary", "top", "line", "results", "from", "the", "BESTFIT", "trial", "in", "September", "2014.", "<tag3>"], "wordsA": ["We", "reported", "preliminary", "top-line", "results", "from", "the", "BESTFIT", "trial", "in", "September", "2014."], "wordsB": ["We", "reported", "preliminary", "top", "line", "results", "from", "the", "BESTFIT", "trial", "in", "September", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p45_s1", "idA": "1430306_15_item1_p67_s1", "sentA": "Among subjects randomized to the active and control arms, 86% and 83%, respectively, completed the 12-week dosing period.", "sentB": "Among patients randomized to the active and control arms, 86% and 83%, respectively, completed the 12-week dosing period.", "type": 2, "words": ["<tag1>", "Among", "subjects", "randomized", "to", "the", "active", "and", "control", "arms,", "86%", "and", "83%,", "respectively,", "completed", "the", "12-week", "dosing", "period.", "<tag2>", "Among", "patients", "randomized", "to", "the", "active", "and", "control", "arms,", "86%", "and", "83%,", "respectively,", "completed", "the", "12-week", "dosing", "period.", "<tag3>"], "wordsA": ["Among", "subjects", "randomized", "to", "the", "active", "and", "control", "arms,", "86%", "and", "83%,", "respectively,", "completed", "the", "12-week", "dosing", "period."], "wordsB": ["Among", "patients", "randomized", "to", "the", "active", "and", "control", "arms,", "86%", "and", "83%,", "respectively,", "completed", "the", "12-week", "dosing", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p47_s0", "idA": "1430306_15_item1_p69_s0", "sentA": "Following our report of the results of the BESTFIT trial, we requested guidance from the FDA on our proposed use of a 30% pain responder analysis as the primary efficacy endpoint in our prospective Phase 3 clinical trial.", "sentB": "Following our report of the results of the BESTFIT trial, we requested guidance from the FDA on our proposed use of a 30% pain responder analysis as the primary efficacy endpoint in a prospective Phase 3 registration program.", "type": 2, "words": ["<tag1>", "Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "prospective", "Phase", "3", "clinical", "trial.", "<tag2>", "Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "a", "prospective", "Phase", "3", "registration", "program.", "<tag3>"], "wordsA": ["Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "prospective", "Phase", "3", "clinical", "trial."], "wordsB": ["Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "a", "prospective", "Phase", "3", "registration", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p48_s1", "idA": "1430306_15_item1_p69_s0", "sentA": "Following our report of the results of the BESTFIT trial, we requested guidance from the FDA on our proposed use of a 30% pain responder analysis as the primary efficacy endpoint in our prospective Phase 3 clinical trial.", "sentB": "The primary endpoint of the AFFIRM trial is the FDA-agreed upon 30% pain responder analysis.", "type": 2, "words": ["<tag1>", "Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "prospective", "Phase", "3", "clinical", "trial.", "<tag2>", "The", "primary", "endpoint", "of", "the", "AFFIRM", "trial", "is", "the", "FDA-agreed", "upon", "30%", "pain", "responder", "analysis.", "<tag3>"], "wordsA": ["Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "prospective", "Phase", "3", "clinical", "trial."], "wordsB": ["The", "primary", "endpoint", "of", "the", "AFFIRM", "trial", "is", "the", "FDA-agreed", "upon", "30%", "pain", "responder", "analysis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p47_s1", "idA": "1430306_15_item1_p69_s1", "sentA": "In January 2015, we announced receipt of the written guidance, whereby the FDA accepted our proposal to use a 30% pain responder analysis as the primary efficacy endpoint in our Phase 3 trial to support the approval of TNX-102 SL for the management of FM.", "sentB": "In January 2015, we announced receipt of the written guidance, whereby the FDA accepted our proposal to use a 30% pain responder analysis as the primary efficacy endpoint to support the approval of TNX-102 SL for the management of FM.", "type": 2, "words": ["<tag1>", "In", "January", "2015,", "we", "announced", "receipt", "of", "the", "written", "guidance,", "whereby", "the", "FDA", "accepted", "our", "proposal", "to", "use", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "Phase", "3", "trial", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "In", "January", "2015,", "we", "announced", "receipt", "of", "the", "written", "guidance,", "whereby", "the", "FDA", "accepted", "our", "proposal", "to", "use", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag3>"], "wordsA": ["In", "January", "2015,", "we", "announced", "receipt", "of", "the", "written", "guidance,", "whereby", "the", "FDA", "accepted", "our", "proposal", "to", "use", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "our", "Phase", "3", "trial", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["In", "January", "2015,", "we", "announced", "receipt", "of", "the", "written", "guidance,", "whereby", "the", "FDA", "accepted", "our", "proposal", "to", "use", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p48_s2", "idA": "1430306_15_item1_p69_s3", "sentA": "We expect to report top line results from this trial in the second half of 2016.", "sentB": "We expect to report top line results from the AFFIRM trial in the third quarter of 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "top", "line", "results", "from", "this", "trial", "in", "the", "second", "half", "of", "2016.", "<tag2>", "We", "expect", "to", "report", "top", "line", "results", "from", "the", "AFFIRM", "trial", "in", "the", "third", "quarter", "of", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "top", "line", "results", "from", "this", "trial", "in", "the", "second", "half", "of", "2016."], "wordsB": ["We", "expect", "to", "report", "top", "line", "results", "from", "the", "AFFIRM", "trial", "in", "the", "third", "quarter", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p69_s2", "idA": "1430306_15_item1_p69_s3", "sentA": "We expect to report top line results from this trial in the second half of 2016.", "sentB": "We expect to report top line results from the AtEase study in the second quarter of 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "top", "line", "results", "from", "this", "trial", "in", "the", "second", "half", "of", "2016.", "<tag2>", "We", "expect", "to", "report", "top", "line", "results", "from", "the", "AtEase", "study", "in", "the", "second", "quarter", "of", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "top", "line", "results", "from", "this", "trial", "in", "the", "second", "half", "of", "2016."], "wordsB": ["We", "expect", "to", "report", "top", "line", "results", "from", "the", "AtEase", "study", "in", "the", "second", "quarter", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p78_s5", "idA": "1430306_15_item1_p69_s3", "sentA": "We expect to report top line results from this trial in the second half of 2016.", "sentB": "We reported top line results from this study on February 16, 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "top", "line", "results", "from", "this", "trial", "in", "the", "second", "half", "of", "2016.", "<tag2>", "We", "reported", "top", "line", "results", "from", "this", "study", "on", "February", "16,", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "top", "line", "results", "from", "this", "trial", "in", "the", "second", "half", "of", "2016."], "wordsB": ["We", "reported", "top", "line", "results", "from", "this", "study", "on", "February", "16,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p159_s0", "idA": "1430306_15_item1_p6_s0", "sentA": "We were incorporated on November 16, 2007 under the laws of the State of Nevada as Tamandare Explorations Inc. From inception through October 2011, we were involved in the acquisition, exploration and development of natural resource properties in the State of Nevada.", "sentB": "We were incorporated on November 16, 2007 under the laws of the State of Nevada as Tamandare Explorations Inc. On October 11, 2011, we changed our name to Tonix Pharmaceuticals Holding Corp.", "type": 2, "words": ["<tag1>", "We", "were", "incorporated", "on", "November", "16,", "2007", "under", "the", "laws", "of", "the", "State", "of", "Nevada", "as", "Tamandare", "Explorations", "Inc.", "From", "inception", "through", "October", "2011,", "we", "were", "involved", "in", "the", "acquisition,", "exploration", "and", "development", "of", "natural", "resource", "properties", "in", "the", "State", "of", "Nevada.", "<tag2>", "We", "were", "incorporated", "on", "November", "16,", "2007", "under", "the", "laws", "of", "the", "State", "of", "Nevada", "as", "Tamandare", "Explorations", "Inc.", "On", "October", "11,", "2011,", "we", "changed", "our", "name", "to", "Tonix", "Pharmaceuticals", "Holding", "Corp.", "<tag3>"], "wordsA": ["We", "were", "incorporated", "on", "November", "16,", "2007", "under", "the", "laws", "of", "the", "State", "of", "Nevada", "as", "Tamandare", "Explorations", "Inc.", "From", "inception", "through", "October", "2011,", "we", "were", "involved", "in", "the", "acquisition,", "exploration", "and", "development", "of", "natural", "resource", "properties", "in", "the", "State", "of", "Nevada."], "wordsB": ["We", "were", "incorporated", "on", "November", "16,", "2007", "under", "the", "laws", "of", "the", "State", "of", "Nevada", "as", "Tamandare", "Explorations", "Inc.", "On", "October", "11,", "2011,", "we", "changed", "our", "name", "to", "Tonix", "Pharmaceuticals", "Holding", "Corp."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p49_s0", "idA": "1430306_15_item1_p70_s0", "sentA": "In December 2013, we commenced Study F203, a 12-month open-label extension study of TNX-102 SL in patients who had completed the BESTFIT trial.", "sentB": "In August 2015, we completed Study F203, a 12-month open-label extension study of TNX-102 SL in patients who had completed the BESTFIT study.", "type": 2, "words": ["<tag1>", "In", "December", "2013,", "we", "commenced", "Study", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "in", "patients", "who", "had", "completed", "the", "BESTFIT", "trial.", "<tag2>", "In", "August", "2015,", "we", "completed", "Study", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "in", "patients", "who", "had", "completed", "the", "BESTFIT", "study.", "<tag3>"], "wordsA": ["In", "December", "2013,", "we", "commenced", "Study", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "in", "patients", "who", "had", "completed", "the", "BESTFIT", "trial."], "wordsB": ["In", "August", "2015,", "we", "completed", "Study", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "in", "patients", "who", "had", "completed", "the", "BESTFIT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p49_s1", "idA": "1430306_15_item1_p70_s1", "sentA": "The goal of Study F203 is to obtain the prerequisite six- and 12-month safety exposure data to support NDA filing for approval for the management of FM, a chronic indication.", "sentB": "The goal of Study F203 was to obtain the prerequisite long-term safety exposure data to support a New Drug Application, or NDA, filing for TNX-102 SL for the management of FM, a chronic medical condition.", "type": 2, "words": ["<tag1>", "The", "goal", "of", "Study", "F203", "is", "to", "obtain", "the", "prerequisite", "six-", "and", "12-month", "safety", "exposure", "data", "to", "support", "NDA", "filing", "for", "approval", "for", "the", "management", "of", "FM,", "a", "chronic", "indication.", "<tag2>", "The", "goal", "of", "Study", "F203", "was", "to", "obtain", "the", "prerequisite", "long-term", "safety", "exposure", "data", "to", "support", "a", "New", "Drug", "Application,", "or", "NDA,", "filing", "for", "TNX-102", "SL", "for", "the", "management", "of", "FM,", "a", "chronic", "medical", "condition.", "<tag3>"], "wordsA": ["The", "goal", "of", "Study", "F203", "is", "to", "obtain", "the", "prerequisite", "six-", "and", "12-month", "safety", "exposure", "data", "to", "support", "NDA", "filing", "for", "approval", "for", "the", "management", "of", "FM,", "a", "chronic", "indication."], "wordsB": ["The", "goal", "of", "Study", "F203", "was", "to", "obtain", "the", "prerequisite", "long-term", "safety", "exposure", "data", "to", "support", "a", "New", "Drug", "Application,", "or", "NDA,", "filing", "for", "TNX-102", "SL", "for", "the", "management", "of", "FM,", "a", "chronic", "medical", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p51_s0", "idA": "1430306_15_item1_p71_s0", "sentA": "We expect to conduct a second randomized, double-blind, placebo-controlled Phase 3 clinical trial of TNX-102 SL to support product registration.", "sentB": "In the second quarter of 2016, we plan to commence the REAFFIRM trial, a second randomized, double-blind Phase 3 clinical trial of TNX-102 SL, to support product registration.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "conduct", "a", "second", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "clinical", "trial", "of", "TNX-102", "SL", "to", "support", "product", "registration.", "<tag2>", "In", "the", "second", "quarter", "of", "2016,", "we", "plan", "to", "commence", "the", "REAFFIRM", "trial,", "a", "second", "randomized,", "double-blind", "Phase", "3", "clinical", "trial", "of", "TNX-102", "SL,", "to", "support", "product", "registration.", "<tag3>"], "wordsA": ["We", "expect", "to", "conduct", "a", "second", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "clinical", "trial", "of", "TNX-102", "SL", "to", "support", "product", "registration."], "wordsB": ["In", "the", "second", "quarter", "of", "2016,", "we", "plan", "to", "commence", "the", "REAFFIRM", "trial,", "a", "second", "randomized,", "double-blind", "Phase", "3", "clinical", "trial", "of", "TNX-102", "SL,", "to", "support", "product", "registration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p53_s0", "idA": "1430306_15_item1_p72_s0", "sentA": "Since CBP will be used chronically in TNX-102 SL, we plan to study TNX-102 SL in comparison to IR CBP in a multiple-day dosing (once daily) study.", "sentB": "Since TNX-102 SL will be submitted as a 505(b)(2) NDA using CBP 5 mg IR tablets as our reference product, we plan to study TNX-102 SL, 2.8 mg in comparison to CBP 5 mg IR tablets in a multiple-dose pharmacokinetic study.", "type": 2, "words": ["<tag1>", "Since", "CBP", "will", "be", "used", "chronically", "in", "TNX-102", "SL,", "we", "plan", "to", "study", "TNX-102", "SL", "in", "comparison", "to", "IR", "CBP", "in", "a", "multiple-day", "dosing", "(once", "daily)", "study.", "<tag2>", "Since", "TNX-102", "SL", "will", "be", "submitted", "as", "a", "505(b)(2)", "NDA", "using", "CBP", "5", "mg", "IR", "tablets", "as", "our", "reference", "product,", "we", "plan", "to", "study", "TNX-102", "SL,", "2.8", "mg", "in", "comparison", "to", "CBP", "5", "mg", "IR", "tablets", "in", "a", "multiple-dose", "pharmacokinetic", "study.", "<tag3>"], "wordsA": ["Since", "CBP", "will", "be", "used", "chronically", "in", "TNX-102", "SL,", "we", "plan", "to", "study", "TNX-102", "SL", "in", "comparison", "to", "IR", "CBP", "in", "a", "multiple-day", "dosing", "(once", "daily)", "study."], "wordsB": ["Since", "TNX-102", "SL", "will", "be", "submitted", "as", "a", "505(b)(2)", "NDA", "using", "CBP", "5", "mg", "IR", "tablets", "as", "our", "reference", "product,", "we", "plan", "to", "study", "TNX-102", "SL,", "2.8", "mg", "in", "comparison", "to", "CBP", "5", "mg", "IR", "tablets", "in", "a", "multiple-dose", "pharmacokinetic", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p53_s1", "idA": "1430306_15_item1_p72_s1", "sentA": "The results of this study will provide information regarding blood levels of CBP resulting from use of the marketed IR tablet and our sublingual TNX-102 SL tablet when taken in a multiple day regimen.", "sentB": "The results of this study will provide information regarding blood levels of CBP at steady state after repeated dosing of CBP 5 mg IR tablet and TNX-102 SL.", "type": 2, "words": ["<tag1>", "The", "results", "of", "this", "study", "will", "provide", "information", "regarding", "blood", "levels", "of", "CBP", "resulting", "from", "use", "of", "the", "marketed", "IR", "tablet", "and", "our", "sublingual", "TNX-102", "SL", "tablet", "when", "taken", "in", "a", "multiple", "day", "regimen.", "<tag2>", "The", "results", "of", "this", "study", "will", "provide", "information", "regarding", "blood", "levels", "of", "CBP", "at", "steady", "state", "after", "repeated", "dosing", "of", "CBP", "5", "mg", "IR", "tablet", "and", "TNX-102", "SL.", "<tag3>"], "wordsA": ["The", "results", "of", "this", "study", "will", "provide", "information", "regarding", "blood", "levels", "of", "CBP", "resulting", "from", "use", "of", "the", "marketed", "IR", "tablet", "and", "our", "sublingual", "TNX-102", "SL", "tablet", "when", "taken", "in", "a", "multiple", "day", "regimen."], "wordsB": ["The", "results", "of", "this", "study", "will", "provide", "information", "regarding", "blood", "levels", "of", "CBP", "at", "steady", "state", "after", "repeated", "dosing", "of", "CBP", "5", "mg", "IR", "tablet", "and", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p53_s2", "idA": "1430306_15_item1_p72_s2", "sentA": "We expect the data from this study to serve as a bridge , in that it will allow us to use the IR CBP tablet as the reference product in our submission of a Section 505(b)(2) NDA for TNX-102 SL.", "sentB": "We expect the data from this study to serve as a bridge to enable us to use the reference product labeling information to support the TNX-102 SL NDA.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", ",", "in", "that", "it", "will", "allow", "us", "to", "use", "the", "IR", "CBP", "tablet", "as", "the", "reference", "product", "in", "our", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "TNX-102", "SL.", "<tag2>", "We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", "to", "enable", "us", "to", "use", "the", "reference", "product", "labeling", "information", "to", "support", "the", "TNX-102", "SL", "NDA.", "<tag3>"], "wordsA": ["We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", ",", "in", "that", "it", "will", "allow", "us", "to", "use", "the", "IR", "CBP", "tablet", "as", "the", "reference", "product", "in", "our", "submission", "of", "a", "Section", "505(b)(2)", "NDA", "for", "TNX-102", "SL."], "wordsB": ["We", "expect", "the", "data", "from", "this", "study", "to", "serve", "as", "a", "bridge", "to", "enable", "us", "to", "use", "the", "reference", "product", "labeling", "information", "to", "support", "the", "TNX-102", "SL", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p54_s0", "idA": "1430306_15_item1_p74_s0", "sentA": "In addition to the clinical studies necessary to support the TNX-102 SL 505(b)(2) NDA filing for the fibromyalgia indication, the FDA has accepted our proposal on the nonclinical studies to support the NDA filing, since the information from the reference product is either unavailable for reference or failed to meet the current regulatory standard.", "sentB": "In addition to the clinical studies necessary to support the TNX-102 SL 505(b)(2) NDA filing for the management of fibromyalgia, we proposed, and the FDA has accepted, our nonclinical data package to support the NDA filing, as the NDA requires nonclinical information that is not completely available in the reference product labeling.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "clinical", "studies", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "fibromyalgia", "indication,", "the", "FDA", "has", "accepted", "our", "proposal", "on", "the", "nonclinical", "studies", "to", "support", "the", "NDA", "filing,", "since", "the", "information", "from", "the", "reference", "product", "is", "either", "unavailable", "for", "reference", "or", "failed", "to", "meet", "the", "current", "regulatory", "standard.", "<tag2>", "In", "addition", "to", "the", "clinical", "studies", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "management", "of", "fibromyalgia,", "we", "proposed,", "and", "the", "FDA", "has", "accepted,", "our", "nonclinical", "data", "package", "to", "support", "the", "NDA", "filing,", "as", "the", "NDA", "requires", "nonclinical", "information", "that", "is", "not", "completely", "available", "in", "the", "reference", "product", "labeling.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "clinical", "studies", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "fibromyalgia", "indication,", "the", "FDA", "has", "accepted", "our", "proposal", "on", "the", "nonclinical", "studies", "to", "support", "the", "NDA", "filing,", "since", "the", "information", "from", "the", "reference", "product", "is", "either", "unavailable", "for", "reference", "or", "failed", "to", "meet", "the", "current", "regulatory", "standard."], "wordsB": ["In", "addition", "to", "the", "clinical", "studies", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "management", "of", "fibromyalgia,", "we", "proposed,", "and", "the", "FDA", "has", "accepted,", "our", "nonclinical", "data", "package", "to", "support", "the", "NDA", "filing,", "as", "the", "NDA", "requires", "nonclinical", "information", "that", "is", "not", "completely", "available", "in", "the", "reference", "product", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p54_s1", "idA": "1430306_15_item1_p74_s1", "sentA": "In 2014, we completed dose-ranging studies to identify the doses requested by the FDA for the chronic toxicity studies to improve the existing CBP labeling.", "sentB": "In 2014, we completed dose-ranging studies to identify the doses for the chronic toxicity studies requested by the FDA to augment the nonclinical information in the CBP labeling which will be used to support the TNX-102 SL labeling for long-term use.", "type": 2, "words": ["<tag1>", "In", "2014,", "we", "completed", "dose-ranging", "studies", "to", "identify", "the", "doses", "requested", "by", "the", "FDA", "for", "the", "chronic", "toxicity", "studies", "to", "improve", "the", "existing", "CBP", "labeling.", "<tag2>", "In", "2014,", "we", "completed", "dose-ranging", "studies", "to", "identify", "the", "doses", "for", "the", "chronic", "toxicity", "studies", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "CBP", "labeling", "which", "will", "be", "used", "to", "support", "the", "TNX-102", "SL", "labeling", "for", "long-term", "use.", "<tag3>"], "wordsA": ["In", "2014,", "we", "completed", "dose-ranging", "studies", "to", "identify", "the", "doses", "requested", "by", "the", "FDA", "for", "the", "chronic", "toxicity", "studies", "to", "improve", "the", "existing", "CBP", "labeling."], "wordsB": ["In", "2014,", "we", "completed", "dose-ranging", "studies", "to", "identify", "the", "doses", "for", "the", "chronic", "toxicity", "studies", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "CBP", "labeling", "which", "will", "be", "used", "to", "support", "the", "TNX-102", "SL", "labeling", "for", "long-term", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p54_s2", "idA": "1430306_15_item1_p74_s2", "sentA": "In January 2015, we engaged an FDA-certified Good Laboratory Practices laboratory to conduct a six month repeated-dose toxicology study of TNX-102 SL in rats, a nine month repeated-dose toxicology study in dogs and a peri- and post-natal Segment II study required for the NDA filing.", "sentB": "In January 2015, we engaged an FDA-certified Good Laboratory Practices laboratory to conduct a six-month repeated-dose toxicology study of TNX-102 in rats and a nine-month repeated-dose toxicology study in dogs required for the NDA filing and to support Phase 3 clinical studies outside the U.S.", "type": 2, "words": ["<tag1>", "In", "January", "2015,", "we", "engaged", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six", "month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "SL", "in", "rats,", "a", "nine", "month", "repeated-dose", "toxicology", "study", "in", "dogs", "and", "a", "peri-", "and", "post-natal", "Segment", "II", "study", "required", "for", "the", "NDA", "filing.", "<tag2>", "In", "January", "2015,", "we", "engaged", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six-month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S.", "<tag3>"], "wordsA": ["In", "January", "2015,", "we", "engaged", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six", "month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "SL", "in", "rats,", "a", "nine", "month", "repeated-dose", "toxicology", "study", "in", "dogs", "and", "a", "peri-", "and", "post-natal", "Segment", "II", "study", "required", "for", "the", "NDA", "filing."], "wordsB": ["In", "January", "2015,", "we", "engaged", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six-month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p54_s4", "idA": "1430306_15_item1_p75_s0", "sentA": "Based on the Flexeril labeling and post-marketing surveillance information, there is no evidence of abuse for CBP.", "sentB": "Based on the prescribing information of AMRIX and FLEXERIL (discontinued since May 2013) and the post-marketing surveillance information, there is no evidence of abuse for CBP.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "Flexeril", "labeling", "and", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "CBP.", "<tag2>", "Based", "on", "the", "prescribing", "information", "of", "AMRIX", "and", "FLEXERIL", "(discontinued", "since", "May", "2013)", "and", "the", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "CBP.", "<tag3>"], "wordsA": ["Based", "on", "the", "Flexeril", "labeling", "and", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "CBP."], "wordsB": ["Based", "on", "the", "prescribing", "information", "of", "AMRIX", "and", "FLEXERIL", "(discontinued", "since", "May", "2013)", "and", "the", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p54_s5", "idA": "1430306_15_item1_p75_s1", "sentA": "As a result, the FDA has advised we will not have to assess the abuse potential of TNX-102 SL for the NDA submission.", "sentB": "As a result, the FDA has advised that we will not have to assess the abuse potential of TNX-102 SL for the TNX-102 SL 505(b)(2) NDA submission.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "the", "FDA", "has", "advised", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission.", "<tag2>", "As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission.", "<tag3>"], "wordsA": ["As", "a", "result,", "the", "FDA", "has", "advised", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "NDA", "submission."], "wordsB": ["As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p55_s0", "idA": "1430306_15_item1_p76_s0", "sentA": "The TNX-102 SL drug product manufactured for our BESTFIT study was manufactured in a small-scale current Good Manufacturing Practice, or cGMP, facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "sentB": "The TNX-102 SL drug product manufactured for our Phase 2b BESTFIT study was manufactured in a small-scale current Good Manufacturing Practice, or cGMP, facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "type": 2, "words": ["<tag1>", "The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag2>", "The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "Phase", "2b", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag3>"], "wordsA": ["The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "wordsB": ["The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "Phase", "2b", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p70_s0", "idA": "1430306_15_item1_p76_s0", "sentA": "The TNX-102 SL drug product manufactured for our BESTFIT study was manufactured in a small-scale current Good Manufacturing Practice, or cGMP, facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "sentB": "The TNX-102 SL drug product manufactured for our Phase 2 AtEase trial was manufactured in a small-scale cGMP facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "type": 2, "words": ["<tag1>", "The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag2>", "The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "Phase", "2", "AtEase", "trial", "was", "manufactured", "in", "a", "small-scale", "cGMP", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag3>"], "wordsA": ["The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "wordsB": ["The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "Phase", "2", "AtEase", "trial", "was", "manufactured", "in", "a", "small-scale", "cGMP", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p56_s0", "idA": "1430306_15_item1_p76_s2", "sentA": "The product s comparability will be supported by the bioequivalence results from the multiple-dose bridging study, if necessary.", "sentB": "The product s comparability is supported by the bioequivalence results of the single-dose pharmacokinetic study (F105).", "type": 2, "words": ["<tag1>", "The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "multiple-dose", "bridging", "study,", "if", "necessary.", "<tag2>", "The", "product", "s", "comparability", "is", "supported", "by", "the", "bioequivalence", "results", "of", "the", "single-dose", "pharmacokinetic", "study", "(F105).", "<tag3>"], "wordsA": ["The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "multiple-dose", "bridging", "study,", "if", "necessary."], "wordsB": ["The", "product", "s", "comparability", "is", "supported", "by", "the", "bioequivalence", "results", "of", "the", "single-dose", "pharmacokinetic", "study", "(F105)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p71_s0", "idA": "1430306_15_item1_p76_s2", "sentA": "The product s comparability will be supported by the bioequivalence results from the multiple-dose bridging study, if necessary.", "sentB": "The product s comparability is supported by the bioequivalence results of single-dose pharmacokinetic study (F105).", "type": 2, "words": ["<tag1>", "The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "multiple-dose", "bridging", "study,", "if", "necessary.", "<tag2>", "The", "product", "s", "comparability", "is", "supported", "by", "the", "bioequivalence", "results", "of", "single-dose", "pharmacokinetic", "study", "(F105).", "<tag3>"], "wordsA": ["The", "product", "s", "comparability", "will", "be", "supported", "by", "the", "bioequivalence", "results", "from", "the", "multiple-dose", "bridging", "study,", "if", "necessary."], "wordsB": ["The", "product", "s", "comparability", "is", "supported", "by", "the", "bioequivalence", "results", "of", "single-dose", "pharmacokinetic", "study", "(F105)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p57_s0", "idA": "1430306_15_item1_p77_s0", "sentA": "We have submitted a Pediatric Study Plan, or PSP, which contains a partial waiver of the requirement to submit pediatric assessments of TNX-102 SL per Section 505B(a)(4)(A)(i) of the FDCA.", "sentB": "We have an Agreed Initial Pediatric Study Plan, or iPSP, with the FDA.", "type": 2, "words": ["<tag1>", "We", "have", "submitted", "a", "Pediatric", "Study", "Plan,", "or", "PSP,", "which", "contains", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "of", "TNX-102", "SL", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA.", "<tag2>", "We", "have", "an", "Agreed", "Initial", "Pediatric", "Study", "Plan,", "or", "iPSP,", "with", "the", "FDA.", "<tag3>"], "wordsA": ["We", "have", "submitted", "a", "Pediatric", "Study", "Plan,", "or", "PSP,", "which", "contains", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "of", "TNX-102", "SL", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA."], "wordsB": ["We", "have", "an", "Agreed", "Initial", "Pediatric", "Study", "Plan,", "or", "iPSP,", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p57_s1", "idA": "1430306_15_item1_p77_s0", "sentA": "We have submitted a Pediatric Study Plan, or PSP, which contains a partial waiver of the requirement to submit pediatric assessments of TNX-102 SL per Section 505B(a)(4)(A)(i) of the FDCA.", "sentB": "The iPSP contains (i) an agreement whereby we will submit a protocol to conduct a single dose, open-label pharmacokinetic study in adolescent patients (13-17 years of age) with fibromyalgia before our NDA filing and (ii) a partial waiver of the requirement to submit pediatric assessments of TNX-102 SL per Section 505B(a)(4)(A)(i) of the FDCA.", "type": 2, "words": ["<tag1>", "We", "have", "submitted", "a", "Pediatric", "Study", "Plan,", "or", "PSP,", "which", "contains", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "of", "TNX-102", "SL", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA.", "<tag2>", "The", "iPSP", "contains", "(i)", "an", "agreement", "whereby", "we", "will", "submit", "a", "protocol", "to", "conduct", "a", "single", "dose,", "open-label", "pharmacokinetic", "study", "in", "adolescent", "patients", "(13-17", "years", "of", "age)", "with", "fibromyalgia", "before", "our", "NDA", "filing", "and", "(ii)", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "of", "TNX-102", "SL", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA.", "<tag3>"], "wordsA": ["We", "have", "submitted", "a", "Pediatric", "Study", "Plan,", "or", "PSP,", "which", "contains", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "of", "TNX-102", "SL", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA."], "wordsB": ["The", "iPSP", "contains", "(i)", "an", "agreement", "whereby", "we", "will", "submit", "a", "protocol", "to", "conduct", "a", "single", "dose,", "open-label", "pharmacokinetic", "study", "in", "adolescent", "patients", "(13-17", "years", "of", "age)", "with", "fibromyalgia", "before", "our", "NDA", "filing", "and", "(ii)", "a", "partial", "waiver", "of", "the", "requirement", "to", "submit", "pediatric", "assessments", "of", "TNX-102", "SL", "per", "Section", "505B(a)(4)(A)(i)", "of", "the", "FDCA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p57_s2", "idA": "1430306_15_item1_p77_s1", "sentA": "Final PSP requirement will be determined at the time of NDA approval.", "sentB": "A Final Pediatric Study Plan requirement will be determined at the time of the NDA approval.", "type": 2, "words": ["<tag1>", "Final", "PSP", "requirement", "will", "be", "determined", "at", "the", "time", "of", "NDA", "approval.", "<tag2>", "A", "Final", "Pediatric", "Study", "Plan", "requirement", "will", "be", "determined", "at", "the", "time", "of", "the", "NDA", "approval.", "<tag3>"], "wordsA": ["Final", "PSP", "requirement", "will", "be", "determined", "at", "the", "time", "of", "NDA", "approval."], "wordsB": ["A", "Final", "Pediatric", "Study", "Plan", "requirement", "will", "be", "determined", "at", "the", "time", "of", "the", "NDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p58_s0", "idA": "1430306_15_item1_p78_s0", "sentA": "Based our discussions with the FDA and the FDA formal meeting minutes, we will not have to conduct special populations (geriatric and renal/hepatic impaired), drug-drug interaction or a cardiovascular safety study to support the NDA filing.", "sentB": "Based our discussions with the FDA and the FDA official meeting minutes, we will not have to conduct special populations (geriatric and renal/hepatic impaired), drug-drug interaction or cardiovascular safety studies to support the NDA filing.", "type": 2, "words": ["<tag1>", "Based", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "formal", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "a", "cardiovascular", "safety", "study", "to", "support", "the", "NDA", "filing.", "<tag2>", "Based", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "cardiovascular", "safety", "studies", "to", "support", "the", "NDA", "filing.", "<tag3>"], "wordsA": ["Based", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "formal", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "a", "cardiovascular", "safety", "study", "to", "support", "the", "NDA", "filing."], "wordsB": ["Based", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "cardiovascular", "safety", "studies", "to", "support", "the", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p58_s1", "idA": "1430306_15_item1_p78_s1", "sentA": "Due to the well-established safety profile of CBP at much higher doses than we proposed for FM, the FDA requests no risk management plan or medication guide for this product.", "sentB": "Due to the well-established safety profile of CBP at much higher doses than we proposed for FM, the FDA has not requested a risk management plan or medication guide for this product.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "FM,", "the", "FDA", "requests", "no", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product.", "<tag2>", "Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "FM,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product.", "<tag3>"], "wordsA": ["Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "FM,", "the", "FDA", "requests", "no", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product."], "wordsB": ["Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "FM,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p72_s0", "idA": "1430306_15_item1_p79_s0", "sentA": "We expect to register TNX-102 SL with the FDA through the provisions of Section 505(b)(2).", "sentB": "We expect to register TNX-102 SL in PTSD with the FDA through the provisions of Section 505(b)(2).", "type": 2, "words": ["<tag1>", "We", "expect", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2).", "<tag2>", "We", "expect", "to", "register", "TNX-102", "SL", "in", "PTSD", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2).", "<tag3>"], "wordsA": ["We", "expect", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2)."], "wordsB": ["We", "expect", "to", "register", "TNX-102", "SL", "in", "PTSD", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p60_s2", "idA": "1430306_15_item1_p80_s2", "sentA": "We believe that the safety data package from these products and the CBP prescriptions utilization database analyzed by IMS Health Incorporated will provide adequate safety margin to support TNX-102 SL development.", "sentB": "We believe that the nonclinical safety data package from these products, together with their marketing experience, will provide an adequate safety margin to support TNX-102 SL development and marketing application for FM.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "safety", "data", "package", "from", "these", "products", "and", "the", "CBP", "prescriptions", "utilization", "database", "analyzed", "by", "IMS", "Health", "Incorporated", "will", "provide", "adequate", "safety", "margin", "to", "support", "TNX-102", "SL", "development.", "<tag2>", "We", "believe", "that", "the", "nonclinical", "safety", "data", "package", "from", "these", "products,", "together", "with", "their", "marketing", "experience,", "will", "provide", "an", "adequate", "safety", "margin", "to", "support", "TNX-102", "SL", "development", "and", "marketing", "application", "for", "FM.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "safety", "data", "package", "from", "these", "products", "and", "the", "CBP", "prescriptions", "utilization", "database", "analyzed", "by", "IMS", "Health", "Incorporated", "will", "provide", "adequate", "safety", "margin", "to", "support", "TNX-102", "SL", "development."], "wordsB": ["We", "believe", "that", "the", "nonclinical", "safety", "data", "package", "from", "these", "products,", "together", "with", "their", "marketing", "experience,", "will", "provide", "an", "adequate", "safety", "margin", "to", "support", "TNX-102", "SL", "development", "and", "marketing", "application", "for", "FM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p62_s0", "idA": "1430306_15_item1_p82_s0", "sentA": "We are developing TNX-102 SL for the management of PTSD under a separate IND allowed by the FDA in June 2014, and we are currently conducting our AtEase trial, a Phase 2 clinical trial of TNX-102 SL in military-related PTSD.", "sentB": "We are developing TNX-102 SL for the management of PTSD under a separate IND, cleared by the FDA in June 2014, and we are currently conducting our AtEase trial, a Phase 2 clinical trial of TNX-102 SL in military-related PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "a", "separate", "IND", "allowed", "by", "the", "FDA", "in", "June", "2014,", "and", "we", "are", "currently", "conducting", "our", "AtEase", "trial,", "a", "Phase", "2", "clinical", "trial", "of", "TNX-102", "SL", "in", "military-related", "PTSD.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "a", "separate", "IND,", "cleared", "by", "the", "FDA", "in", "June", "2014,", "and", "we", "are", "currently", "conducting", "our", "AtEase", "trial,", "a", "Phase", "2", "clinical", "trial", "of", "TNX-102", "SL", "in", "military-related", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "a", "separate", "IND", "allowed", "by", "the", "FDA", "in", "June", "2014,", "and", "we", "are", "currently", "conducting", "our", "AtEase", "trial,", "a", "Phase", "2", "clinical", "trial", "of", "TNX-102", "SL", "in", "military-related", "PTSD."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "a", "separate", "IND,", "cleared", "by", "the", "FDA", "in", "June", "2014,", "and", "we", "are", "currently", "conducting", "our", "AtEase", "trial,", "a", "Phase", "2", "clinical", "trial", "of", "TNX-102", "SL", "in", "military-related", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p65_s0", "idA": "1430306_15_item1_p85_s0", "sentA": "Our rationale for developing TNX-102 SL for treatment of PTSD derives from the following:", "sentB": "Our rationale for developing TNX-102 SL for treatment of PTSD is supported by the following:", "type": 2, "words": ["<tag1>", "Our", "rationale", "for", "developing", "TNX-102", "SL", "for", "treatment", "of", "PTSD", "derives", "from", "the", "following:", "<tag2>", "Our", "rationale", "for", "developing", "TNX-102", "SL", "for", "treatment", "of", "PTSD", "is", "supported", "by", "the", "following:", "<tag3>"], "wordsA": ["Our", "rationale", "for", "developing", "TNX-102", "SL", "for", "treatment", "of", "PTSD", "derives", "from", "the", "following:"], "wordsB": ["Our", "rationale", "for", "developing", "TNX-102", "SL", "for", "treatment", "of", "PTSD", "is", "supported", "by", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p68_s0", "idA": "1430306_15_item1_p87_s0", "sentA": "In January 2015, we commenced the AtEase trial, a 220-patient, randomized, double-blind, placebo-controlled, 12-week Phase 2 trial of TNX-102 SL in subjects with military-related PTSD.", "sentB": "In the first quarter of 2015, we commenced the AtEase trial, a randomized, double-blind, placebo-controlled, 12-week Phase 2 trial of TNX-102 SL in approximately 240 patients with military-related PTSD.", "type": 2, "words": ["<tag1>", "In", "January", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "220-patient,", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD.", "<tag2>", "In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "approximately", "240", "patients", "with", "military-related", "PTSD.", "<tag3>"], "wordsA": ["In", "January", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "220-patient,", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "subjects", "with", "military-related", "PTSD."], "wordsB": ["In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "approximately", "240", "patients", "with", "military-related", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p51_s1", "idA": "1430306_15_item1_p87_s1", "sentA": "This trial will be conducted at approximately 25 U.S. centers.", "sentB": "We currently expect that the size and design of the REAFFIRM trial will be similar to that of the AFFIRM trial.", "type": 2, "words": ["<tag1>", "This", "trial", "will", "be", "conducted", "at", "approximately", "25", "U.S.", "centers.", "<tag2>", "We", "currently", "expect", "that", "the", "size", "and", "design", "of", "the", "REAFFIRM", "trial", "will", "be", "similar", "to", "that", "of", "the", "AFFIRM", "trial.", "<tag3>"], "wordsA": ["This", "trial", "will", "be", "conducted", "at", "approximately", "25", "U.S.", "centers."], "wordsB": ["We", "currently", "expect", "that", "the", "size", "and", "design", "of", "the", "REAFFIRM", "trial", "will", "be", "similar", "to", "that", "of", "the", "AFFIRM", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p68_s2", "idA": "1430306_15_item1_p87_s1", "sentA": "This trial will be conducted at approximately 25 U.S. centers.", "sentB": "This trial is being conducted at approximately 25 U.S. centers.", "type": 2, "words": ["<tag1>", "This", "trial", "will", "be", "conducted", "at", "approximately", "25", "U.S.", "centers.", "<tag2>", "This", "trial", "is", "being", "conducted", "at", "approximately", "25", "U.S.", "centers.", "<tag3>"], "wordsA": ["This", "trial", "will", "be", "conducted", "at", "approximately", "25", "U.S.", "centers."], "wordsB": ["This", "trial", "is", "being", "conducted", "at", "approximately", "25", "U.S.", "centers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p68_s1", "idA": "1430306_15_item1_p88_s0", "sentA": "The AtEase trial is designed to study the efficacy and safety of two doses of TNX-102 SL (2.8 mg and 5.6 mg) administered once daily at bedtime.", "sentB": "In the AtEase study, patients are randomized in a 2:1:2 ratio to TNX-102 SL 2.8 mg, TNX-102 SL 5.6 mg, or placebo, respectively, sublingually once daily at bedtime.", "type": 2, "words": ["<tag1>", "The", "AtEase", "trial", "is", "designed", "to", "study", "the", "efficacy", "and", "safety", "of", "two", "doses", "of", "TNX-102", "SL", "(2.8", "mg", "and", "5.6", "mg)", "administered", "once", "daily", "at", "bedtime.", "<tag2>", "In", "the", "AtEase", "study,", "patients", "are", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo,", "respectively,", "sublingually", "once", "daily", "at", "bedtime.", "<tag3>"], "wordsA": ["The", "AtEase", "trial", "is", "designed", "to", "study", "the", "efficacy", "and", "safety", "of", "two", "doses", "of", "TNX-102", "SL", "(2.8", "mg", "and", "5.6", "mg)", "administered", "once", "daily", "at", "bedtime."], "wordsB": ["In", "the", "AtEase", "study,", "patients", "are", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo,", "respectively,", "sublingually", "once", "daily", "at", "bedtime."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p78_s4", "idA": "1430306_15_item1_p88_s0", "sentA": "The AtEase trial is designed to study the efficacy and safety of two doses of TNX-102 SL (2.8 mg and 5.6 mg) administered once daily at bedtime.", "sentB": "This study was designed to test the activity and tolerability of TNX-201 to support possible future efficacy and safety studies.", "type": 2, "words": ["<tag1>", "The", "AtEase", "trial", "is", "designed", "to", "study", "the", "efficacy", "and", "safety", "of", "two", "doses", "of", "TNX-102", "SL", "(2.8", "mg", "and", "5.6", "mg)", "administered", "once", "daily", "at", "bedtime.", "<tag2>", "This", "study", "was", "designed", "to", "test", "the", "activity", "and", "tolerability", "of", "TNX-201", "to", "support", "possible", "future", "efficacy", "and", "safety", "studies.", "<tag3>"], "wordsA": ["The", "AtEase", "trial", "is", "designed", "to", "study", "the", "efficacy", "and", "safety", "of", "two", "doses", "of", "TNX-102", "SL", "(2.8", "mg", "and", "5.6", "mg)", "administered", "once", "daily", "at", "bedtime."], "wordsB": ["This", "study", "was", "designed", "to", "test", "the", "activity", "and", "tolerability", "of", "TNX-201", "to", "support", "possible", "future", "efficacy", "and", "safety", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p69_s0", "idA": "1430306_15_item1_p88_s1", "sentA": "The primary objective of the AtEase trial is to evaluate the efficacy of TNX-102 SL 2.8 mg as compared to placebo sublingual tablet following eight weeks of treatment using the Clinician-Administered PTSD Scale.", "sentB": "The primary objective of the AtEase trial is to evaluate the efficacy of TNX-102 SL 2.8 mg as compared to placebo sublingual tablet following 12 weeks of treatment using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5).", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "eight", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale.", "<tag2>", "The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "12", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5", "(CAPS-5).", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "eight", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale."], "wordsB": ["The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "12", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5", "(CAPS-5)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p73_s1", "idA": "1430306_15_item1_p89_s1", "sentA": "Based on our communications with the FDA to date, we believe that positive results from two adequate, well-controlled efficacy and safety studies and long-term (six- and 12-month) safety exposure studies would support FDA approval of TNX-102 SL for the management of PTSD.", "sentB": "Based on our communications with the FDA to date, we believe that positive results from two adequate, well-controlled efficacy and safety studies and long-term (six- and 12-month) safety exposure studies (F203 and P202) would support FDA approval of TNX-102 SL for the management of PTSD.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "communications", "with", "the", "FDA", "to", "date,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "Based", "on", "our", "communications", "with", "the", "FDA", "to", "date,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "(F203", "and", "P202)", "would", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag3>"], "wordsA": ["Based", "on", "our", "communications", "with", "the", "FDA", "to", "date,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["Based", "on", "our", "communications", "with", "the", "FDA", "to", "date,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "(F203", "and", "P202)", "would", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p69_s1", "idA": "1430306_15_item1_p89_s2", "sentA": "If we achieve our primary outcome measure in the AtEase study, it could qualify as one of the two studies required to support the NDA.", "sentB": "If the AtEase study achieves success in its primary outcome measure, it could serve as one of the two pivotal studies required to establish sufficient evidence of efficacy and safety to support the approval of TNX-102 SL for PTSD.", "type": 2, "words": ["<tag1>", "If", "we", "achieve", "our", "primary", "outcome", "measure", "in", "the", "AtEase", "study,", "it", "could", "qualify", "as", "one", "of", "the", "two", "studies", "required", "to", "support", "the", "NDA.", "<tag2>", "If", "the", "AtEase", "study", "achieves", "success", "in", "its", "primary", "outcome", "measure,", "it", "could", "serve", "as", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "establish", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD.", "<tag3>"], "wordsA": ["If", "we", "achieve", "our", "primary", "outcome", "measure", "in", "the", "AtEase", "study,", "it", "could", "qualify", "as", "one", "of", "the", "two", "studies", "required", "to", "support", "the", "NDA."], "wordsB": ["If", "the", "AtEase", "study", "achieves", "success", "in", "its", "primary", "outcome", "measure,", "it", "could", "serve", "as", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "establish", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p74_s2", "idA": "1430306_15_item1_p89_s3", "sentA": "We expect that we can use the long-term safety exposure data generated by our clinical development of TNX-102 SL in FM to supplement the long-term safety exposure data required for the PTSD NDA.", "sentB": "We expect that we can use the long-term safety exposure data generated by our clinical development of TNX-102 SL in FM (F203) to supplement the long-term safety exposure data required for the PTSD NDA.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "we", "can", "use", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "to", "supplement", "the", "long-term", "safety", "exposure", "data", "required", "for", "the", "PTSD", "NDA.", "<tag2>", "We", "expect", "that", "we", "can", "use", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "(F203)", "to", "supplement", "the", "long-term", "safety", "exposure", "data", "required", "for", "the", "PTSD", "NDA.", "<tag3>"], "wordsA": ["We", "expect", "that", "we", "can", "use", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "to", "supplement", "the", "long-term", "safety", "exposure", "data", "required", "for", "the", "PTSD", "NDA."], "wordsB": ["We", "expect", "that", "we", "can", "use", "the", "long-term", "safety", "exposure", "data", "generated", "by", "our", "clinical", "development", "of", "TNX-102", "SL", "in", "FM", "(F203)", "to", "supplement", "the", "long-term", "safety", "exposure", "data", "required", "for", "the", "PTSD", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p73_s0", "idA": "1430306_15_item1_p90_s0", "sentA": "The approvals by the FDA of Paxil and Zoloft for treating PTSD established a regulatory approval pathway for symptom reduction in PTSD.", "sentB": "The FDA approvals of paroxetine and sertraline for treating PTSD established a regulatory approval pathway for symptom reduction in PTSD.", "type": 2, "words": ["<tag1>", "The", "approvals", "by", "the", "FDA", "of", "Paxil", "and", "Zoloft", "for", "treating", "PTSD", "established", "a", "regulatory", "approval", "pathway", "for", "symptom", "reduction", "in", "PTSD.", "<tag2>", "The", "FDA", "approvals", "of", "paroxetine", "and", "sertraline", "for", "treating", "PTSD", "established", "a", "regulatory", "approval", "pathway", "for", "symptom", "reduction", "in", "PTSD.", "<tag3>"], "wordsA": ["The", "approvals", "by", "the", "FDA", "of", "Paxil", "and", "Zoloft", "for", "treating", "PTSD", "established", "a", "regulatory", "approval", "pathway", "for", "symptom", "reduction", "in", "PTSD."], "wordsB": ["The", "FDA", "approvals", "of", "paroxetine", "and", "sertraline", "for", "treating", "PTSD", "established", "a", "regulatory", "approval", "pathway", "for", "symptom", "reduction", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p5_s0", "idA": "1430306_15_item1_p91_s0", "sentA": "We plan to meet with the FDA when we complete the AtEase study to further discuss our development plan for TNX-102 SL for PTSD, especially the proposed design of the pivotal studies.", "sentB": "Tonmya is the proposed trade name for TNX-102 SL for fibromyalgia, or FM, and has been conditionally accepted by the FDA.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "AtEase", "study", "to", "further", "discuss", "our", "development", "plan", "for", "TNX-102", "SL", "for", "PTSD,", "especially", "the", "proposed", "design", "of", "the", "pivotal", "studies.", "<tag2>", "Tonmya", "is", "the", "proposed", "trade", "name", "for", "TNX-102", "SL", "for", "fibromyalgia,", "or", "FM,", "and", "has", "been", "conditionally", "accepted", "by", "the", "FDA.", "<tag3>"], "wordsA": ["We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "AtEase", "study", "to", "further", "discuss", "our", "development", "plan", "for", "TNX-102", "SL", "for", "PTSD,", "especially", "the", "proposed", "design", "of", "the", "pivotal", "studies."], "wordsB": ["Tonmya", "is", "the", "proposed", "trade", "name", "for", "TNX-102", "SL", "for", "fibromyalgia,", "or", "FM,", "and", "has", "been", "conditionally", "accepted", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p74_s0", "idA": "1430306_15_item1_p91_s0", "sentA": "We plan to meet with the FDA when we complete the AtEase study to further discuss our development plan for TNX-102 SL for PTSD, especially the proposed design of the pivotal studies.", "sentB": "We plan to meet with the FDA after we complete the AtEase study to further discuss our development plan for TNX-102 SL for PTSD, including the proposed design of the registration program that would be required to support approval of an NDA for this indication.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "AtEase", "study", "to", "further", "discuss", "our", "development", "plan", "for", "TNX-102", "SL", "for", "PTSD,", "especially", "the", "proposed", "design", "of", "the", "pivotal", "studies.", "<tag2>", "We", "plan", "to", "meet", "with", "the", "FDA", "after", "we", "complete", "the", "AtEase", "study", "to", "further", "discuss", "our", "development", "plan", "for", "TNX-102", "SL", "for", "PTSD,", "including", "the", "proposed", "design", "of", "the", "registration", "program", "that", "would", "be", "required", "to", "support", "approval", "of", "an", "NDA", "for", "this", "indication.", "<tag3>"], "wordsA": ["We", "plan", "to", "meet", "with", "the", "FDA", "when", "we", "complete", "the", "AtEase", "study", "to", "further", "discuss", "our", "development", "plan", "for", "TNX-102", "SL", "for", "PTSD,", "especially", "the", "proposed", "design", "of", "the", "pivotal", "studies."], "wordsB": ["We", "plan", "to", "meet", "with", "the", "FDA", "after", "we", "complete", "the", "AtEase", "study", "to", "further", "discuss", "our", "development", "plan", "for", "TNX-102", "SL", "for", "PTSD,", "including", "the", "proposed", "design", "of", "the", "registration", "program", "that", "would", "be", "required", "to", "support", "approval", "of", "an", "NDA", "for", "this", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p62_s1", "idA": "1430306_15_item1_p91_s1", "sentA": "If the results from the AtEase study are positive, we plan to seek a Breakthrough Therapy designation for TNX-102 SL in PTSD.", "sentB": "Patients who successfully complete the AtEase study are eligible to enroll into a three-month open-label extension study (P202).", "type": 2, "words": ["<tag1>", "If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD.", "<tag2>", "Patients", "who", "successfully", "complete", "the", "AtEase", "study", "are", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "(P202).", "<tag3>"], "wordsA": ["If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD."], "wordsB": ["Patients", "who", "successfully", "complete", "the", "AtEase", "study", "are", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "(P202)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p75_s0", "idA": "1430306_15_item1_p91_s1", "sentA": "If the results from the AtEase study are positive, we plan to seek a Breakthrough Therapy designation for TNX-102 SL in PTSD.", "sentB": "If the results from the AtEase study are positive, we plan to seek Fast Track Development and/or Breakthrough Therapy designation for TNX-102 SL in PTSD.", "type": 2, "words": ["<tag1>", "If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD.", "<tag2>", "If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "Fast", "Track", "Development", "and/or", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD.", "<tag3>"], "wordsA": ["If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "a", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD."], "wordsB": ["If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "Fast", "Track", "Development", "and/or", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p76_s0", "idA": "1430306_15_item1_p91_s2", "sentA": "The Breakthrough Therapy designation process is a new and uncertain process, in which the majority of requests for designation have been denied.", "sentB": "The Breakthrough Therapy designation process is a relatively new and uncertain process for drugs intended alone or in combination with one or more other drugs to treat a serious or life threatening disease or condition, the preliminary clinical evidence of which indicates that the drug may demonstrate substantial improvement over existing therapies, in which the majority of requests for designation have been denied.", "type": 2, "words": ["<tag1>", "The", "Breakthrough", "Therapy", "designation", "process", "is", "a", "new", "and", "uncertain", "process,", "in", "which", "the", "majority", "of", "requests", "for", "designation", "have", "been", "denied.", "<tag2>", "The", "Breakthrough", "Therapy", "designation", "process", "is", "a", "relatively", "new", "and", "uncertain", "process", "for", "drugs", "intended", "alone", "or", "in", "combination", "with", "one", "or", "more", "other", "drugs", "to", "treat", "a", "serious", "or", "life", "threatening", "disease", "or", "condition,", "the", "preliminary", "clinical", "evidence", "of", "which", "indicates", "that", "the", "drug", "may", "demonstrate", "substantial", "improvement", "over", "existing", "therapies,", "in", "which", "the", "majority", "of", "requests", "for", "designation", "have", "been", "denied.", "<tag3>"], "wordsA": ["The", "Breakthrough", "Therapy", "designation", "process", "is", "a", "new", "and", "uncertain", "process,", "in", "which", "the", "majority", "of", "requests", "for", "designation", "have", "been", "denied."], "wordsB": ["The", "Breakthrough", "Therapy", "designation", "process", "is", "a", "relatively", "new", "and", "uncertain", "process", "for", "drugs", "intended", "alone", "or", "in", "combination", "with", "one", "or", "more", "other", "drugs", "to", "treat", "a", "serious", "or", "life", "threatening", "disease", "or", "condition,", "the", "preliminary", "clinical", "evidence", "of", "which", "indicates", "that", "the", "drug", "may", "demonstrate", "substantial", "improvement", "over", "existing", "therapies,", "in", "which", "the", "majority", "of", "requests", "for", "designation", "have", "been", "denied."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p29_s0", "idA": "1430306_15_item1_p93_s0", "sentA": "We are developing TNX-201 for the treatment of ETTH under an IND cleared by the FDA in October 2014.", "sentB": "The medications currently approved by the FDA for the treatment of PTSD show little evidence of a treatment effect in men, lack evidence of efficacy in those for whom the traumatic event was combat-related, and carry suicidality warnings.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-201", "for", "the", "treatment", "of", "ETTH", "under", "an", "IND", "cleared", "by", "the", "FDA", "in", "October", "2014.", "<tag2>", "The", "medications", "currently", "approved", "by", "the", "FDA", "for", "the", "treatment", "of", "PTSD", "show", "little", "evidence", "of", "a", "treatment", "effect", "in", "men,", "lack", "evidence", "of", "efficacy", "in", "those", "for", "whom", "the", "traumatic", "event", "was", "combat-related,", "and", "carry", "suicidality", "warnings.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-201", "for", "the", "treatment", "of", "ETTH", "under", "an", "IND", "cleared", "by", "the", "FDA", "in", "October", "2014."], "wordsB": ["The", "medications", "currently", "approved", "by", "the", "FDA", "for", "the", "treatment", "of", "PTSD", "show", "little", "evidence", "of", "a", "treatment", "effect", "in", "men,", "lack", "evidence", "of", "efficacy", "in", "those", "for", "whom", "the", "traumatic", "event", "was", "combat-related,", "and", "carry", "suicidality", "warnings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_16_item1_p77_s0", "idA": "1430306_15_item1_p93_s0", "sentA": "We are developing TNX-201 for the treatment of ETTH under an IND cleared by the FDA in October 2014.", "sentB": "We were developing TNX-201 for the treatment of episodic tension-type headache under an IND cleared by the FDA in October 2014.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-201", "for", "the", "treatment", "of", "ETTH", "under", "an", "IND", "cleared", "by", "the", "FDA", "in", "October", "2014.", "<tag2>", "We", "were", "developing", "TNX-201", "for", "the", "treatment", "of", "episodic", "tension-type", "headache", "under", "an", "IND", "cleared", "by", "the", "FDA", "in", "October", "2014.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-201", "for", "the", "treatment", "of", "ETTH", "under", "an", "IND", "cleared", "by", "the", "FDA", "in", "October", "2014."], "wordsB": ["We", "were", "developing", "TNX-201", "for", "the", "treatment", "of", "episodic", "tension-type", "headache", "under", "an", "IND", "cleared", "by", "the", "FDA", "in", "October", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p85_s1", "idA": "1430306_16_item1_p101_s3", "sentA": "The patent expiring last is expected to expire in 2024, excluding any patent term extensions.", "sentB": "No. 9,474,728 is expected to expire in 2031, excluding any patent term extensions.", "type": 2, "words": ["<tag1>", "The", "patent", "expiring", "last", "is", "expected", "to", "expire", "in", "2024,", "excluding", "any", "patent", "term", "extensions.", "<tag2>", "No.", "9,474,728", "is", "expected", "to", "expire", "in", "2031,", "excluding", "any", "patent", "term", "extensions.", "<tag3>"], "wordsA": ["The", "patent", "expiring", "last", "is", "expected", "to", "expire", "in", "2024,", "excluding", "any", "patent", "term", "extensions."], "wordsB": ["No.", "9,474,728", "is", "expected", "to", "expire", "in", "2031,", "excluding", "any", "patent", "term", "extensions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p106_s0", "idA": "1430306_16_item1_p102_s0", "sentA": "We own the rights to develop a potential biodefense technology, which is a new vaccine candidate against smallpox.", "sentB": "Our smallpox-preventing vaccine candidate is a biologic uses live form of HPXV.", "type": 2, "words": ["<tag1>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag2>", "Our", "smallpox-preventing", "vaccine", "candidate", "is", "a", "biologic", "uses", "live", "form", "of", "HPXV.", "<tag3>"], "wordsA": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox."], "wordsB": ["Our", "smallpox-preventing", "vaccine", "candidate", "is", "a", "biologic", "uses", "live", "form", "of", "HPXV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p68_s4", "idA": "1430306_16_item1_p102_s0", "sentA": "We own the rights to develop a potential biodefense technology, which is a new vaccine candidate against smallpox.", "sentB": "We are currently working to develop a vaccine that meets cGMP quality to support an IND.", "type": 2, "words": ["<tag1>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag2>", "We", "are", "currently", "working", "to", "develop", "a", "vaccine", "that", "meets", "cGMP", "quality", "to", "support", "an", "IND.", "<tag3>"], "wordsA": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox."], "wordsB": ["We", "are", "currently", "working", "to", "develop", "a", "vaccine", "that", "meets", "cGMP", "quality", "to", "support", "an", "IND."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p76_s0", "idA": "1430306_16_item1_p102_s0", "sentA": "We own the rights to develop a potential biodefense technology, which is a new vaccine candidate against smallpox.", "sentB": "Bavarian Nordic is developing Modified Virus Ankara, or MVA, which is a vaccine.", "type": 2, "words": ["<tag1>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag2>", "Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine.", "<tag3>"], "wordsA": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox."], "wordsB": ["Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p92_s0", "idA": "1430306_16_item1_p102_s0", "sentA": "We own the rights to develop a potential biodefense technology, which is a new vaccine candidate against smallpox.", "sentB": "We own the rights to develop a potential biodefense technology, TNX-801, a live HPXV that is a new vaccine candidate against smallpox.", "type": 2, "words": ["<tag1>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag2>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "TNX-801,", "a", "live", "HPXV", "that", "is", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag3>"], "wordsA": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox."], "wordsB": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "TNX-801,", "a", "live", "HPXV", "that", "is", "a", "new", "vaccine", "candidate", "against", "smallpox."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p93_s1", "idA": "1430306_16_item1_p102_s0", "sentA": "We own the rights to develop a potential biodefense technology, which is a new vaccine candidate against smallpox.", "sentB": "We also own the rights to develop some different vaccine candidates against smallpox.", "type": 2, "words": ["<tag1>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag2>", "We", "also", "own", "the", "rights", "to", "develop", "some", "different", "vaccine", "candidates", "against", "smallpox.", "<tag3>"], "wordsA": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox."], "wordsB": ["We", "also", "own", "the", "rights", "to", "develop", "some", "different", "vaccine", "candidates", "against", "smallpox."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p95_s0", "idA": "1430306_16_item1_p102_s0", "sentA": "We own the rights to develop a potential biodefense technology, which is a new vaccine candidate against smallpox.", "sentB": "We own the rights to develop a potential biodefense technology, which is a potential radioprotective therapy.", "type": 2, "words": ["<tag1>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox.", "<tag2>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "potential", "radioprotective", "therapy.", "<tag3>"], "wordsA": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "new", "vaccine", "candidate", "against", "smallpox."], "wordsB": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "which", "is", "a", "potential", "radioprotective", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p93_s2", "idA": "1430306_16_item1_p102_s1", "sentA": "With respect to the smallpox vaccine candidate, we own U.S. non-provisional Patent Application No. 14,207,727 and related intellectual property rights.", "sentB": "With respect to this smallpox vaccine candidate, we own U.S. non-provisional Patent Application No. 14,207,727 and related intellectual property rights.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "we", "own", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights.", "<tag2>", "With", "respect", "to", "this", "smallpox", "vaccine", "candidate,", "we", "own", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights.", "<tag3>"], "wordsA": ["With", "respect", "to", "the", "smallpox", "vaccine", "candidate,", "we", "own", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights."], "wordsB": ["With", "respect", "to", "this", "smallpox", "vaccine", "candidate,", "we", "own", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p93_s3", "idA": "1430306_16_item1_p102_s2", "sentA": "The smallpox vaccine technology relates to proprietary forms of live vaccinia vaccines which may be safer than ACAM2000, the only currently available replication competent, live vaccinia vaccine to protect against smallpox disease.", "sentB": "The smallpox vaccine technologies relate to proprietary forms of live HPXV and vaccinia vaccines which may be safer than ACAM2000, the only currently available replication competent, live vaccinia vaccine to protect against smallpox disease.", "type": 2, "words": ["<tag1>", "The", "smallpox", "vaccine", "technology", "relates", "to", "proprietary", "forms", "of", "live", "vaccinia", "vaccines", "which", "may", "be", "safer", "than", "ACAM2000,", "the", "only", "currently", "available", "replication", "competent,", "live", "vaccinia", "vaccine", "to", "protect", "against", "smallpox", "disease.", "<tag2>", "The", "smallpox", "vaccine", "technologies", "relate", "to", "proprietary", "forms", "of", "live", "HPXV", "and", "vaccinia", "vaccines", "which", "may", "be", "safer", "than", "ACAM2000,", "the", "only", "currently", "available", "replication", "competent,", "live", "vaccinia", "vaccine", "to", "protect", "against", "smallpox", "disease.", "<tag3>"], "wordsA": ["The", "smallpox", "vaccine", "technology", "relates", "to", "proprietary", "forms", "of", "live", "vaccinia", "vaccines", "which", "may", "be", "safer", "than", "ACAM2000,", "the", "only", "currently", "available", "replication", "competent,", "live", "vaccinia", "vaccine", "to", "protect", "against", "smallpox", "disease."], "wordsB": ["The", "smallpox", "vaccine", "technologies", "relate", "to", "proprietary", "forms", "of", "live", "HPXV", "and", "vaccinia", "vaccines", "which", "may", "be", "safer", "than", "ACAM2000,", "the", "only", "currently", "available", "replication", "competent,", "live", "vaccinia", "vaccine", "to", "protect", "against", "smallpox", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p101_s1", "idA": "1430306_16_item1_p109_s1", "sentA": "No. 4656463, issued 12/16/2015) and TONMYA (Reg.", "sentB": "No. 4656463, issued December 16, 2014) and TONMYA (Reg.", "type": 2, "words": ["<tag1>", "No.", "4656463,", "issued", "12/16/2015)", "and", "TONMYA", "(Reg.", "<tag2>", "No.", "4656463,", "issued", "December", "16,", "2014)", "and", "TONMYA", "(Reg.", "<tag3>"], "wordsA": ["No.", "4656463,", "issued", "12/16/2015)", "and", "TONMYA", "(Reg."], "wordsB": ["No.", "4656463,", "issued", "December", "16,", "2014)", "and", "TONMYA", "(Reg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p22_s1", "idA": "1430306_16_item1_p10_s1", "sentA": "We are developing TNX-102 SL for two indications:", "sentB": "We are developing TNX-102 SL for PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "two", "indications:", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "two", "indications:"], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p102_s0", "idA": "1430306_16_item1_p110_s0", "sentA": "We are the owner of the following marks for which applications for U.S. federal registration are currently pending: FYMRALIN (Serial No. 86/516046, filed 01/27/2015), MODALTIN (Serial No. 86/631228, filed 05/15/2015), RAPONTIS (Serial No. 86/631236, filed 05/15/2015), IMADAZIO (Serial No. 86/631242, filed 05/15/2015), PROTECTIC (Serial No. 86/636119, filed 05/20/2015) and TONIX PHARMACEUTICALS (Serial No. 86/400401, filed 09/19/2014).", "sentB": "We are the owner of the following marks for which applications for U.S. federal registration are currently pending: FYMRALIN (Serial No. 86/516046, filed January 27, 2015), MODALTIN (Serial No. 86/631228, filed May 15, 2015), RAPONTIS (Serial No. 86/631236, filed May 15, 2015), IMADAZIO (Serial No. 86/631242, filed May 15, 2015), PROTECTIC (Serial No. 86/636119, filed May 20, 2015), TONIX PHARMACEUTICALS (Serial No. 86/400401, filed September 19, 2014) and ANGSTRO-TECHNOLOGY (Serial No. 86/713402, filed August 3, 2015).", "type": 2, "words": ["<tag1>", "We", "are", "the", "owner", "of", "the", "following", "marks", "for", "which", "applications", "for", "U.S.", "federal", "registration", "are", "currently", "pending:", "FYMRALIN", "(Serial", "No.", "86/516046,", "filed", "01/27/2015),", "MODALTIN", "(Serial", "No.", "86/631228,", "filed", "05/15/2015),", "RAPONTIS", "(Serial", "No.", "86/631236,", "filed", "05/15/2015),", "IMADAZIO", "(Serial", "No.", "86/631242,", "filed", "05/15/2015),", "PROTECTIC", "(Serial", "No.", "86/636119,", "filed", "05/20/2015)", "and", "TONIX", "PHARMACEUTICALS", "(Serial", "No.", "86/400401,", "filed", "09/19/2014).", "<tag2>", "We", "are", "the", "owner", "of", "the", "following", "marks", "for", "which", "applications", "for", "U.S.", "federal", "registration", "are", "currently", "pending:", "FYMRALIN", "(Serial", "No.", "86/516046,", "filed", "January", "27,", "2015),", "MODALTIN", "(Serial", "No.", "86/631228,", "filed", "May", "15,", "2015),", "RAPONTIS", "(Serial", "No.", "86/631236,", "filed", "May", "15,", "2015),", "IMADAZIO", "(Serial", "No.", "86/631242,", "filed", "May", "15,", "2015),", "PROTECTIC", "(Serial", "No.", "86/636119,", "filed", "May", "20,", "2015),", "TONIX", "PHARMACEUTICALS", "(Serial", "No.", "86/400401,", "filed", "September", "19,", "2014)", "and", "ANGSTRO-TECHNOLOGY", "(Serial", "No.", "86/713402,", "filed", "August", "3,", "2015).", "<tag3>"], "wordsA": ["We", "are", "the", "owner", "of", "the", "following", "marks", "for", "which", "applications", "for", "U.S.", "federal", "registration", "are", "currently", "pending:", "FYMRALIN", "(Serial", "No.", "86/516046,", "filed", "01/27/2015),", "MODALTIN", "(Serial", "No.", "86/631228,", "filed", "05/15/2015),", "RAPONTIS", "(Serial", "No.", "86/631236,", "filed", "05/15/2015),", "IMADAZIO", "(Serial", "No.", "86/631242,", "filed", "05/15/2015),", "PROTECTIC", "(Serial", "No.", "86/636119,", "filed", "05/20/2015)", "and", "TONIX", "PHARMACEUTICALS", "(Serial", "No.", "86/400401,", "filed", "09/19/2014)."], "wordsB": ["We", "are", "the", "owner", "of", "the", "following", "marks", "for", "which", "applications", "for", "U.S.", "federal", "registration", "are", "currently", "pending:", "FYMRALIN", "(Serial", "No.", "86/516046,", "filed", "January", "27,", "2015),", "MODALTIN", "(Serial", "No.", "86/631228,", "filed", "May", "15,", "2015),", "RAPONTIS", "(Serial", "No.", "86/631236,", "filed", "May", "15,", "2015),", "IMADAZIO", "(Serial", "No.", "86/631242,", "filed", "May", "15,", "2015),", "PROTECTIC", "(Serial", "No.", "86/636119,", "filed", "May", "20,", "2015),", "TONIX", "PHARMACEUTICALS", "(Serial", "No.", "86/400401,", "filed", "September", "19,", "2014)", "and", "ANGSTRO-TECHNOLOGY", "(Serial", "No.", "86/713402,", "filed", "August", "3,", "2015)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p103_s0", "idA": "1430306_16_item1_p111_s0", "sentA": "We have approximately 15 employees dedicated to research and development.", "sentB": "We have approximately 10 employees dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "approximately", "15", "employees", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "approximately", "10", "employees", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "approximately", "15", "employees", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "approximately", "10", "employees", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p103_s1", "idA": "1430306_16_item1_p111_s1", "sentA": "We anticipate that our research and development expenditures will increase several fold as we continue our late-stage clinical development of TNX-102 SL and advance other candidates in our pipeline.", "sentB": "We anticipate that our research and development expenditures will decrease as we focus our efforts on our late-stage clinical development of TNX-102 SL for PTSD.", "type": 2, "words": ["<tag1>", "We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "continue", "our", "late-stage", "clinical", "development", "of", "TNX-102", "SL", "and", "advance", "other", "candidates", "in", "our", "pipeline.", "<tag2>", "We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "decrease", "as", "we", "focus", "our", "efforts", "on", "our", "late-stage", "clinical", "development", "of", "TNX-102", "SL", "for", "PTSD.", "<tag3>"], "wordsA": ["We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "increase", "several", "fold", "as", "we", "continue", "our", "late-stage", "clinical", "development", "of", "TNX-102", "SL", "and", "advance", "other", "candidates", "in", "our", "pipeline."], "wordsB": ["We", "anticipate", "that", "our", "research", "and", "development", "expenditures", "will", "decrease", "as", "we", "focus", "our", "efforts", "on", "our", "late-stage", "clinical", "development", "of", "TNX-102", "SL", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p103_s3", "idA": "1430306_16_item1_p111_s3", "sentA": "Our research and development operations are located in New York, NY, San Diego, CA, San Jose, CA, Dublin, Ireland and Montreal, Canada.", "sentB": "Our research and development operations are located in New York, NY, San Diego, CA, Dublin, Ireland and Montreal, Canada.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "San", "Jose,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada.", "<tag2>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "San", "Jose,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada."], "wordsB": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p154_s2", "idA": "1430306_16_item1_p111_s3", "sentA": "Our research and development operations are located in New York, NY, San Diego, CA, San Jose, CA, Dublin, Ireland and Montreal, Canada.", "sentB": "Our research and development operations are located in New York, NY, San Diego, CA, Dublin, Ireland and Montreal, Canada.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "San", "Jose,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada.", "<tag2>", "Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "San", "Jose,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada."], "wordsB": ["Our", "research", "and", "development", "operations", "are", "located", "in", "New", "York,", "NY,", "San", "Diego,", "CA,", "Dublin,", "Ireland", "and", "Montreal,", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p105_s0", "idA": "1430306_16_item1_p113_s0", "sentA": "All of our compounds are small molecules, synthesized using industry standard processes, and our drug products are formulated using commercially available pharmaceutical grade excipients.", "sentB": "All of our small molecules drug candidates are synthesized using industry standard processes, and our drug products are formulated using commercially available pharmaceutical grade excipients.", "type": 2, "words": ["<tag1>", "All", "of", "our", "compounds", "are", "small", "molecules,", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "pharmaceutical", "grade", "excipients.", "<tag2>", "All", "of", "our", "small", "molecules", "drug", "candidates", "are", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "pharmaceutical", "grade", "excipients.", "<tag3>"], "wordsA": ["All", "of", "our", "compounds", "are", "small", "molecules,", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "pharmaceutical", "grade", "excipients."], "wordsB": ["All", "of", "our", "small", "molecules", "drug", "candidates", "are", "synthesized", "using", "industry", "standard", "processes,", "and", "our", "drug", "products", "are", "formulated", "using", "commercially", "available", "pharmaceutical", "grade", "excipients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p108_s0", "idA": "1430306_16_item1_p115_s0", "sentA": "The FDA regulates, among other things, the research, manufacture, promotion and distribution of dr ugs in the United States under the FDCA and other statutes and implementing regulations.", "sentB": "The FDA regulates, among other things, the research, manufacture, promotion and distribution of drugs in the United States under the FDCA and other statutes and implementing regulations.", "type": 2, "words": ["<tag1>", "The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "dr", "ugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations.", "<tag2>", "The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations.", "<tag3>"], "wordsA": ["The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "dr", "ugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations."], "wordsB": ["The", "FDA", "regulates,", "among", "other", "things,", "the", "research,", "manufacture,", "promotion", "and", "distribution", "of", "drugs", "in", "the", "United", "States", "under", "the", "FDCA", "and", "other", "statutes", "and", "implementing", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p144_s1", "idA": "1430306_16_item1_p121_s1", "sentA": "Each protocol for a U.S. study is submitted to the FDA as part of the IND.", "sentB": "One part of the Act, Section 3086, is aimed at Encouraging Treatments for Agents that Present a National Security Threat.", "type": 2, "words": ["<tag1>", "Each", "protocol", "for", "a", "U.S.", "study", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND.", "<tag2>", "One", "part", "of", "the", "Act,", "Section", "3086,", "is", "aimed", "at", "Encouraging", "Treatments", "for", "Agents", "that", "Present", "a", "National", "Security", "Threat.", "<tag3>"], "wordsA": ["Each", "protocol", "for", "a", "U.S.", "study", "is", "submitted", "to", "the", "FDA", "as", "part", "of", "the", "IND."], "wordsB": ["One", "part", "of", "the", "Act,", "Section", "3086,", "is", "aimed", "at", "Encouraging", "Treatments", "for", "Agents", "that", "Present", "a", "National", "Security", "Threat."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p119_s1", "idA": "1430306_16_item1_p126_s1", "sentA": "The size of Phase 3 clinical trials depends upon clinical and statistical considerations for the product candidate and disease, but sometimes can include several thousand patients.", "sentB": "The size of Phase 3 clinical trials depends upon clinical and statistical considerations for the product candidate and disease.", "type": 2, "words": ["<tag1>", "The", "size", "of", "Phase", "3", "clinical", "trials", "depends", "upon", "clinical", "and", "statistical", "considerations", "for", "the", "product", "candidate", "and", "disease,", "but", "sometimes", "can", "include", "several", "thousand", "patients.", "<tag2>", "The", "size", "of", "Phase", "3", "clinical", "trials", "depends", "upon", "clinical", "and", "statistical", "considerations", "for", "the", "product", "candidate", "and", "disease.", "<tag3>"], "wordsA": ["The", "size", "of", "Phase", "3", "clinical", "trials", "depends", "upon", "clinical", "and", "statistical", "considerations", "for", "the", "product", "candidate", "and", "disease,", "but", "sometimes", "can", "include", "several", "thousand", "patients."], "wordsB": ["The", "size", "of", "Phase", "3", "clinical", "trials", "depends", "upon", "clinical", "and", "statistical", "considerations", "for", "the", "product", "candidate", "and", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p41_s6", "idA": "1430306_16_item1_p126_s2", "sentA": "Phase 3 clinical trials are intended to establish the overall risk-benefit ratio of the product candidate and provide an adequate basis for product labeling.", "sentB": "We received FDA acceptance of the Phase 3 HONOR study design in January of 2017.", "type": 2, "words": ["<tag1>", "Phase", "3", "clinical", "trials", "are", "intended", "to", "establish", "the", "overall", "risk-benefit", "ratio", "of", "the", "product", "candidate", "and", "provide", "an", "adequate", "basis", "for", "product", "labeling.", "<tag2>", "We", "received", "FDA", "acceptance", "of", "the", "Phase", "3", "HONOR", "study", "design", "in", "January", "of", "2017.", "<tag3>"], "wordsA": ["Phase", "3", "clinical", "trials", "are", "intended", "to", "establish", "the", "overall", "risk-benefit", "ratio", "of", "the", "product", "candidate", "and", "provide", "an", "adequate", "basis", "for", "product", "labeling."], "wordsB": ["We", "received", "FDA", "acceptance", "of", "the", "Phase", "3", "HONOR", "study", "design", "in", "January", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p152_s0", "idA": "1430306_16_item1_p130_s2", "sentA": "In this event, the NDA must be resubmitted with the additional information and is subject to review before the FDA accepts it for filing.", "sentB": "The FDCA is subject to routine legislative amendments with a broad range of downstream effects.", "type": 2, "words": ["<tag1>", "In", "this", "event,", "the", "NDA", "must", "be", "resubmitted", "with", "the", "additional", "information", "and", "is", "subject", "to", "review", "before", "the", "FDA", "accepts", "it", "for", "filing.", "<tag2>", "The", "FDCA", "is", "subject", "to", "routine", "legislative", "amendments", "with", "a", "broad", "range", "of", "downstream", "effects.", "<tag3>"], "wordsA": ["In", "this", "event,", "the", "NDA", "must", "be", "resubmitted", "with", "the", "additional", "information", "and", "is", "subject", "to", "review", "before", "the", "FDA", "accepts", "it", "for", "filing."], "wordsB": ["The", "FDCA", "is", "subject", "to", "routine", "legislative", "amendments", "with", "a", "broad", "range", "of", "downstream", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p126_s1", "idA": "1430306_16_item1_p132_s1", "sentA": "We intend to file Section 505(b)(2) NDAs for TNX-102 SL for FM and PTSD, and for certain other products, that might, if accepted by the FDA, save time and expense in the development and testing of our product candidates.", "sentB": "We intend to file Section 505(b)(2) NDAs for TNX-102 SL for PTSD, and for certain other products, that might, if accepted by the FDA, save time and expense in the development and testing of our product candidates.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates.", "<tag2>", "We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "TNX-102", "SL", "for", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates."], "wordsB": ["We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "TNX-102", "SL", "for", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p52_s2", "idA": "1430306_16_item1_p134_s1", "sentA": "In some cases, extensive, time-consuming, and costly clinical and nonclinical studies may still be required for approval of a Section 505(b)(2) NDA.", "sentB": "Similarly, no drug abuse and dependence study is required for this NDA.", "type": 2, "words": ["<tag1>", "In", "some", "cases,", "extensive,", "time-consuming,", "and", "costly", "clinical", "and", "nonclinical", "studies", "may", "still", "be", "required", "for", "approval", "of", "a", "Section", "505(b)(2)", "NDA.", "<tag2>", "Similarly,", "no", "drug", "abuse", "and", "dependence", "study", "is", "required", "for", "this", "NDA.", "<tag3>"], "wordsA": ["In", "some", "cases,", "extensive,", "time-consuming,", "and", "costly", "clinical", "and", "nonclinical", "studies", "may", "still", "be", "required", "for", "approval", "of", "a", "Section", "505(b)(2)", "NDA."], "wordsB": ["Similarly,", "no", "drug", "abuse", "and", "dependence", "study", "is", "required", "for", "this", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p129_s1", "idA": "1430306_16_item1_p135_s1", "sentA": "As such, we plan to submit NDAs under Section 505(b)(2) for TNX-102 SL for FM and PTSD.", "sentB": "As such, we plan to submit an NDA under Section 505(b)(2) for TNX-102 SL for PTSD.", "type": 2, "words": ["<tag1>", "As", "such,", "we", "plan", "to", "submit", "NDAs", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD.", "<tag2>", "As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "PTSD.", "<tag3>"], "wordsA": ["As", "such,", "we", "plan", "to", "submit", "NDAs", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD."], "wordsB": ["As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p70_s2", "idA": "1430306_16_item1_p135_s1", "sentA": "As such, we plan to submit NDAs under Section 505(b)(2) for TNX-102 SL for FM and PTSD.", "sentB": "Similar to the regulatory pathway intended for TNX-801, we plan to develop TNX-701 under 21 CFR 601 Subpart H, or the Animal Rule .", "type": 2, "words": ["<tag1>", "As", "such,", "we", "plan", "to", "submit", "NDAs", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD.", "<tag2>", "Similar", "to", "the", "regulatory", "pathway", "intended", "for", "TNX-801,", "we", "plan", "to", "develop", "TNX-701", "under", "21", "CFR", "601", "Subpart", "H,", "or", "the", "Animal", "Rule", ".", "<tag3>"], "wordsA": ["As", "such,", "we", "plan", "to", "submit", "NDAs", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "FM", "and", "PTSD."], "wordsB": ["Similar", "to", "the", "regulatory", "pathway", "intended", "for", "TNX-801,", "we", "plan", "to", "develop", "TNX-701", "under", "21", "CFR", "601", "Subpart", "H,", "or", "the", "Animal", "Rule", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p129_s2", "idA": "1430306_16_item1_p135_s2", "sentA": "The FDA may not agree that this product candidate is approvable for FM or PTSD as Section 505(b)(2) NDAs.", "sentB": "The FDA may not agree that this product candidate is approvable for PTSD as a Section 505(b)(2) NDA.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "not", "agree", "that", "this", "product", "candidate", "is", "approvable", "for", "FM", "or", "PTSD", "as", "Section", "505(b)(2)", "NDAs.", "<tag2>", "The", "FDA", "may", "not", "agree", "that", "this", "product", "candidate", "is", "approvable", "for", "PTSD", "as", "a", "Section", "505(b)(2)", "NDA.", "<tag3>"], "wordsA": ["The", "FDA", "may", "not", "agree", "that", "this", "product", "candidate", "is", "approvable", "for", "FM", "or", "PTSD", "as", "Section", "505(b)(2)", "NDAs."], "wordsB": ["The", "FDA", "may", "not", "agree", "that", "this", "product", "candidate", "is", "approvable", "for", "PTSD", "as", "a", "Section", "505(b)(2)", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p129_s3", "idA": "1430306_16_item1_p135_s3", "sentA": "If the FDA determines that Section 505(b)(2) NDAs are not appropriate and that full NDAs are required for TNX-102 SL, the time and financial resources required to obtain FDA approval for TNX-102 SL could substantially and materially increase, and TNX-102 SL might be less likely to be approved.", "sentB": "If the FDA determines that a Section 505(b)(2) NDA is not appropriate and that a full NDA is required for TNX-102 SL, the time and financial resources required to obtain FDA approval for TNX-102 SL could substantially and materially increase, and TNX-102 SL might be less likely to be approved.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "determines", "that", "Section", "505(b)(2)", "NDAs", "are", "not", "appropriate", "and", "that", "full", "NDAs", "are", "required", "for", "TNX-102", "SL,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "TNX-102", "SL", "could", "substantially", "and", "materially", "increase,", "and", "TNX-102", "SL", "might", "be", "less", "likely", "to", "be", "approved.", "<tag2>", "If", "the", "FDA", "determines", "that", "a", "Section", "505(b)(2)", "NDA", "is", "not", "appropriate", "and", "that", "a", "full", "NDA", "is", "required", "for", "TNX-102", "SL,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "TNX-102", "SL", "could", "substantially", "and", "materially", "increase,", "and", "TNX-102", "SL", "might", "be", "less", "likely", "to", "be", "approved.", "<tag3>"], "wordsA": ["If", "the", "FDA", "determines", "that", "Section", "505(b)(2)", "NDAs", "are", "not", "appropriate", "and", "that", "full", "NDAs", "are", "required", "for", "TNX-102", "SL,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "TNX-102", "SL", "could", "substantially", "and", "materially", "increase,", "and", "TNX-102", "SL", "might", "be", "less", "likely", "to", "be", "approved."], "wordsB": ["If", "the", "FDA", "determines", "that", "a", "Section", "505(b)(2)", "NDA", "is", "not", "appropriate", "and", "that", "a", "full", "NDA", "is", "required", "for", "TNX-102", "SL,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "TNX-102", "SL", "could", "substantially", "and", "materially", "increase,", "and", "TNX-102", "SL", "might", "be", "less", "likely", "to", "be", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p129_s4", "idA": "1430306_16_item1_p135_s4", "sentA": "If the FDA requires full NDAs for TNX-102 SL, or requires more extensive testing and development for some other reason, our ability to compete with alternative products that arrive on the market more quickly than our product candidates would be adversely impacted.", "sentB": "If the FDA requires a full NDA for TNX-102 SL, or requires more extensive testing and development for some other reason, our ability to compete with alternative products that arrive on the market more quickly than our product candidates would be adversely impacted.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "requires", "full", "NDAs", "for", "TNX-102", "SL,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted.", "<tag2>", "If", "the", "FDA", "requires", "a", "full", "NDA", "for", "TNX-102", "SL,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted.", "<tag3>"], "wordsA": ["If", "the", "FDA", "requires", "full", "NDAs", "for", "TNX-102", "SL,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted."], "wordsB": ["If", "the", "FDA", "requires", "a", "full", "NDA", "for", "TNX-102", "SL,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p11_s0", "idA": "1430306_16_item1_p13_s0", "sentA": "An estimated 8.4 million adults in the U.S. suffer from PTSD, a chronic disorder that is characterized by avoidance, emotional numbing, hyperarousal, and sleep disturbances.", "sentB": "An estimated 8.6 million adults in the U.S. suffer from PTSD, a chronic disorder that is characterized by hyperarousal, avoidance, emotional numbing, and sleep disturbances.", "type": 2, "words": ["<tag1>", "An", "estimated", "8.4", "million", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "sleep", "disturbances.", "<tag2>", "An", "estimated", "8.6", "million", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "hyperarousal,", "avoidance,", "emotional", "numbing,", "and", "sleep", "disturbances.", "<tag3>"], "wordsA": ["An", "estimated", "8.4", "million", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "avoidance,", "emotional", "numbing,", "hyperarousal,", "and", "sleep", "disturbances."], "wordsB": ["An", "estimated", "8.6", "million", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "hyperarousal,", "avoidance,", "emotional", "numbing,", "and", "sleep", "disturbances."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p144_s0", "idA": "1430306_16_item1_p146_s0", "sentA": "On July 9, 2012, the Food and Drug Administration Safety and Innovation Act, or FDASIA, was signed.", "sentB": "In 2016, the 21st Century Cures Act, or the Act, was signed into law to support ongoing biomedical innovation.", "type": 2, "words": ["<tag1>", "On", "July", "9,", "2012,", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act,", "or", "FDASIA,", "was", "signed.", "<tag2>", "In", "2016,", "the", "21st", "Century", "Cures", "Act,", "or", "the", "Act,", "was", "signed", "into", "law", "to", "support", "ongoing", "biomedical", "innovation.", "<tag3>"], "wordsA": ["On", "July", "9,", "2012,", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act,", "or", "FDASIA,", "was", "signed."], "wordsB": ["In", "2016,", "the", "21st", "Century", "Cures", "Act,", "or", "the", "Act,", "was", "signed", "into", "law", "to", "support", "ongoing", "biomedical", "innovation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p152_s1", "idA": "1430306_16_item1_p146_s0", "sentA": "On July 9, 2012, the Food and Drug Administration Safety and Innovation Act, or FDASIA, was signed.", "sentB": "In addition to new legislation, such as the 21st Century Cures Act in 2016, or the Food and Drug Administration Safety and Innovation Act in 2012, Congress introduces amendments to reauthorize drug user fees and address emerging concerns every five years.", "type": 2, "words": ["<tag1>", "On", "July", "9,", "2012,", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act,", "or", "FDASIA,", "was", "signed.", "<tag2>", "In", "addition", "to", "new", "legislation,", "such", "as", "the", "21st", "Century", "Cures", "Act", "in", "2016,", "or", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act", "in", "2012,", "Congress", "introduces", "amendments", "to", "reauthorize", "drug", "user", "fees", "and", "address", "emerging", "concerns", "every", "five", "years.", "<tag3>"], "wordsA": ["On", "July", "9,", "2012,", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act,", "or", "FDASIA,", "was", "signed."], "wordsB": ["In", "addition", "to", "new", "legislation,", "such", "as", "the", "21st", "Century", "Cures", "Act", "in", "2016,", "or", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act", "in", "2012,", "Congress", "introduces", "amendments", "to", "reauthorize", "drug", "user", "fees", "and", "address", "emerging", "concerns", "every", "five", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p146_s0", "idA": "1430306_16_item1_p146_s1", "sentA": "FDASIA Section 902 provides for a new drug designation Breakthrough Therapy.", "sentB": "A priority review voucher can be applied to any other product; it shortens the FDA review timeline for a new application from 10 months to 6 months.", "type": 2, "words": ["<tag1>", "FDASIA", "Section", "902", "provides", "for", "a", "new", "drug", "designation", "Breakthrough", "Therapy.", "<tag2>", "A", "priority", "review", "voucher", "can", "be", "applied", "to", "any", "other", "product;", "it", "shortens", "the", "FDA", "review", "timeline", "for", "a", "new", "application", "from", "10", "months", "to", "6", "months.", "<tag3>"], "wordsA": ["FDASIA", "Section", "902", "provides", "for", "a", "new", "drug", "designation", "Breakthrough", "Therapy."], "wordsB": ["A", "priority", "review", "voucher", "can", "be", "applied", "to", "any", "other", "product;", "it", "shortens", "the", "FDA", "review", "timeline", "for", "a", "new", "application", "from", "10", "months", "to", "6", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p143_s0", "idA": "1430306_16_item1_p148_s0", "sentA": "If a drug is designated as Breakthrough Therapy, the FDA will expedite the development and review of such drug.", "sentB": "Breakthrough Therapy designation is intended to expedite the development and review of drugs for serious or life-threatening conditions.", "type": 2, "words": ["<tag1>", "If", "a", "drug", "is", "designated", "as", "Breakthrough", "Therapy,", "the", "FDA", "will", "expedite", "the", "development", "and", "review", "of", "such", "drug.", "<tag2>", "Breakthrough", "Therapy", "designation", "is", "intended", "to", "expedite", "the", "development", "and", "review", "of", "drugs", "for", "serious", "or", "life-threatening", "conditions.", "<tag3>"], "wordsA": ["If", "a", "drug", "is", "designated", "as", "Breakthrough", "Therapy,", "the", "FDA", "will", "expedite", "the", "development", "and", "review", "of", "such", "drug."], "wordsB": ["Breakthrough", "Therapy", "designation", "is", "intended", "to", "expedite", "the", "development", "and", "review", "of", "drugs", "for", "serious", "or", "life-threatening", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p49_s0", "idA": "1430306_16_item1_p148_s0", "sentA": "If a drug is designated as Breakthrough Therapy, the FDA will expedite the development and review of such drug.", "sentB": "Breakthrough Therapy designation is intended to expedite the development and review of drugs for serious or life-threatening conditions.", "type": 2, "words": ["<tag1>", "If", "a", "drug", "is", "designated", "as", "Breakthrough", "Therapy,", "the", "FDA", "will", "expedite", "the", "development", "and", "review", "of", "such", "drug.", "<tag2>", "Breakthrough", "Therapy", "designation", "is", "intended", "to", "expedite", "the", "development", "and", "review", "of", "drugs", "for", "serious", "or", "life-threatening", "conditions.", "<tag3>"], "wordsA": ["If", "a", "drug", "is", "designated", "as", "Breakthrough", "Therapy,", "the", "FDA", "will", "expedite", "the", "development", "and", "review", "of", "such", "drug."], "wordsB": ["Breakthrough", "Therapy", "designation", "is", "intended", "to", "expedite", "the", "development", "and", "review", "of", "drugs", "for", "serious", "or", "life-threatening", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p43_s0", "idA": "1430306_16_item1_p148_s1", "sentA": "In the event that our AtEase study of TNX-102 SL in PTSD is successful, we will request Breakthrough Therapy designation for TNX-102 SL.", "sentB": "A second, randomized, double-blind placebo-controlled Phase 3 study of TNX-102 SL in approximately 550 predominantly civilian PTSD patients will follow.", "type": 2, "words": ["<tag1>", "In", "the", "event", "that", "our", "AtEase", "study", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "request", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL.", "<tag2>", "A", "second,", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "approximately", "550", "predominantly", "civilian", "PTSD", "patients", "will", "follow.", "<tag3>"], "wordsA": ["In", "the", "event", "that", "our", "AtEase", "study", "of", "TNX-102", "SL", "in", "PTSD", "is", "successful,", "we", "will", "request", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL."], "wordsB": ["A", "second,", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "approximately", "550", "predominantly", "civilian", "PTSD", "patients", "will", "follow."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p12_s2", "idA": "1430306_16_item1_p14_s1", "sentA": "Antidepressants, sedative-hypnotics and antipsychotics not approved for PTSD are commonly prescribed despite generally weak evidence in support of their use.", "sentB": "Antianxiety drugs, also called anxiolytics, are not approved for PTSD, but are commonly prescribed despite the recommendations against their use by many experts.", "type": 2, "words": ["<tag1>", "Antidepressants,", "sedative-hypnotics", "and", "antipsychotics", "not", "approved", "for", "PTSD", "are", "commonly", "prescribed", "despite", "generally", "weak", "evidence", "in", "support", "of", "their", "use.", "<tag2>", "Antianxiety", "drugs,", "also", "called", "anxiolytics,", "are", "not", "approved", "for", "PTSD,", "but", "are", "commonly", "prescribed", "despite", "the", "recommendations", "against", "their", "use", "by", "many", "experts.", "<tag3>"], "wordsA": ["Antidepressants,", "sedative-hypnotics", "and", "antipsychotics", "not", "approved", "for", "PTSD", "are", "commonly", "prescribed", "despite", "generally", "weak", "evidence", "in", "support", "of", "their", "use."], "wordsB": ["Antianxiety", "drugs,", "also", "called", "anxiolytics,", "are", "not", "approved", "for", "PTSD,", "but", "are", "commonly", "prescribed", "despite", "the", "recommendations", "against", "their", "use", "by", "many", "experts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p152_s2", "idA": "1430306_16_item1_p155_s0", "sentA": "The FDA has not yet implemented many of the provisions of the FDAAA, so we cannot predict the impact of the new legislation on the pharmaceutical industry or our business.", "sentB": "We cannot predict the impact of these new legislative acts and their implementing regulations on our business.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "not", "yet", "implemented", "many", "of", "the", "provisions", "of", "the", "FDAAA,", "so", "we", "cannot", "predict", "the", "impact", "of", "the", "new", "legislation", "on", "the", "pharmaceutical", "industry", "or", "our", "business.", "<tag2>", "We", "cannot", "predict", "the", "impact", "of", "these", "new", "legislative", "acts", "and", "their", "implementing", "regulations", "on", "our", "business.", "<tag3>"], "wordsA": ["The", "FDA", "has", "not", "yet", "implemented", "many", "of", "the", "provisions", "of", "the", "FDAAA,", "so", "we", "cannot", "predict", "the", "impact", "of", "the", "new", "legislation", "on", "the", "pharmaceutical", "industry", "or", "our", "business."], "wordsB": ["We", "cannot", "predict", "the", "impact", "of", "these", "new", "legislative", "acts", "and", "their", "implementing", "regulations", "on", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p32_s1", "idA": "1430306_16_item1_p155_s0", "sentA": "The FDA has not yet implemented many of the provisions of the FDAAA, so we cannot predict the impact of the new legislation on the pharmaceutical industry or our business.", "sentB": "The allowed claims will protect the pharmaceutical composition, since it is based on the eutectic.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "not", "yet", "implemented", "many", "of", "the", "provisions", "of", "the", "FDAAA,", "so", "we", "cannot", "predict", "the", "impact", "of", "the", "new", "legislation", "on", "the", "pharmaceutical", "industry", "or", "our", "business.", "<tag2>", "The", "allowed", "claims", "will", "protect", "the", "pharmaceutical", "composition,", "since", "it", "is", "based", "on", "the", "eutectic.", "<tag3>"], "wordsA": ["The", "FDA", "has", "not", "yet", "implemented", "many", "of", "the", "provisions", "of", "the", "FDAAA,", "so", "we", "cannot", "predict", "the", "impact", "of", "the", "new", "legislation", "on", "the", "pharmaceutical", "industry", "or", "our", "business."], "wordsB": ["The", "allowed", "claims", "will", "protect", "the", "pharmaceutical", "composition,", "since", "it", "is", "based", "on", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p87_s1", "idA": "1430306_16_item1_p155_s0", "sentA": "The FDA has not yet implemented many of the provisions of the FDAAA, so we cannot predict the impact of the new legislation on the pharmaceutical industry or our business.", "sentB": "The allowed claims will protect the pharmaceutical composition since it is based on the eutectic.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "not", "yet", "implemented", "many", "of", "the", "provisions", "of", "the", "FDAAA,", "so", "we", "cannot", "predict", "the", "impact", "of", "the", "new", "legislation", "on", "the", "pharmaceutical", "industry", "or", "our", "business.", "<tag2>", "The", "allowed", "claims", "will", "protect", "the", "pharmaceutical", "composition", "since", "it", "is", "based", "on", "the", "eutectic.", "<tag3>"], "wordsA": ["The", "FDA", "has", "not", "yet", "implemented", "many", "of", "the", "provisions", "of", "the", "FDAAA,", "so", "we", "cannot", "predict", "the", "impact", "of", "the", "new", "legislation", "on", "the", "pharmaceutical", "industry", "or", "our", "business."], "wordsB": ["The", "allowed", "claims", "will", "protect", "the", "pharmaceutical", "composition", "since", "it", "is", "based", "on", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p153_s0", "idA": "1430306_16_item1_p155_s1", "sentA": "However, the requirements and changes imposed by the FDAAA may make it more difficult, and more costly, to obtain and maintain approval for new pharmaceutical products, or to produce, market and distribute existing products.", "sentB": "The requirements and changes imposed by the legislation to reauthorize the act may make it more difficult, and more costly, to obtain and maintain approval for new pharmaceutical products, or to produce, market and distribute existing products.", "type": 2, "words": ["<tag1>", "However,", "the", "requirements", "and", "changes", "imposed", "by", "the", "FDAAA", "may", "make", "it", "more", "difficult,", "and", "more", "costly,", "to", "obtain", "and", "maintain", "approval", "for", "new", "pharmaceutical", "products,", "or", "to", "produce,", "market", "and", "distribute", "existing", "products.", "<tag2>", "The", "requirements", "and", "changes", "imposed", "by", "the", "legislation", "to", "reauthorize", "the", "act", "may", "make", "it", "more", "difficult,", "and", "more", "costly,", "to", "obtain", "and", "maintain", "approval", "for", "new", "pharmaceutical", "products,", "or", "to", "produce,", "market", "and", "distribute", "existing", "products.", "<tag3>"], "wordsA": ["However,", "the", "requirements", "and", "changes", "imposed", "by", "the", "FDAAA", "may", "make", "it", "more", "difficult,", "and", "more", "costly,", "to", "obtain", "and", "maintain", "approval", "for", "new", "pharmaceutical", "products,", "or", "to", "produce,", "market", "and", "distribute", "existing", "products."], "wordsB": ["The", "requirements", "and", "changes", "imposed", "by", "the", "legislation", "to", "reauthorize", "the", "act", "may", "make", "it", "more", "difficult,", "and", "more", "costly,", "to", "obtain", "and", "maintain", "approval", "for", "new", "pharmaceutical", "products,", "or", "to", "produce,", "market", "and", "distribute", "existing", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p153_s1", "idA": "1430306_16_item1_p155_s3", "sentA": "It is impossible to predict whether additional legislative changes will be enacted, or FDA regulations, guidance or interpretations changed, or what the impact of such changes, if any, may be.", "sentB": "It is impossible to predict whether additional legislative changes will be enacted, or FDA regulations, guidance or interpretations will change, or what the impact of such changes, if any, may be.", "type": 2, "words": ["<tag1>", "It", "is", "impossible", "to", "predict", "whether", "additional", "legislative", "changes", "will", "be", "enacted,", "or", "FDA", "regulations,", "guidance", "or", "interpretations", "changed,", "or", "what", "the", "impact", "of", "such", "changes,", "if", "any,", "may", "be.", "<tag2>", "It", "is", "impossible", "to", "predict", "whether", "additional", "legislative", "changes", "will", "be", "enacted,", "or", "FDA", "regulations,", "guidance", "or", "interpretations", "will", "change,", "or", "what", "the", "impact", "of", "such", "changes,", "if", "any,", "may", "be.", "<tag3>"], "wordsA": ["It", "is", "impossible", "to", "predict", "whether", "additional", "legislative", "changes", "will", "be", "enacted,", "or", "FDA", "regulations,", "guidance", "or", "interpretations", "changed,", "or", "what", "the", "impact", "of", "such", "changes,", "if", "any,", "may", "be."], "wordsB": ["It", "is", "impossible", "to", "predict", "whether", "additional", "legislative", "changes", "will", "be", "enacted,", "or", "FDA", "regulations,", "guidance", "or", "interpretations", "will", "change,", "or", "what", "the", "impact", "of", "such", "changes,", "if", "any,", "may", "be."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p154_s0", "idA": "1430306_16_item1_p156_s0", "sentA": "As of March 1, 2016, we had 28 full-time employees, of whom eight hold M.D. or Ph.D. degrees.", "sentB": "As of April 12, 2017, we had 18 full-time employees, of whom five hold M.D. or Ph.D. degrees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "1,", "2016,", "we", "had", "28", "full-time", "employees,", "of", "whom", "eight", "hold", "M.D.", "or", "Ph.D.", "degrees.", "<tag2>", "As", "of", "April", "12,", "2017,", "we", "had", "18", "full-time", "employees,", "of", "whom", "five", "hold", "M.D.", "or", "Ph.D.", "degrees.", "<tag3>"], "wordsA": ["As", "of", "March", "1,", "2016,", "we", "had", "28", "full-time", "employees,", "of", "whom", "eight", "hold", "M.D.", "or", "Ph.D.", "degrees."], "wordsB": ["As", "of", "April", "12,", "2017,", "we", "had", "18", "full-time", "employees,", "of", "whom", "five", "hold", "M.D.", "or", "Ph.D.", "degrees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p154_s1", "idA": "1430306_16_item1_p156_s1", "sentA": "We have 15 employees dedicated to research and development.", "sentB": "We have 10 employees dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "15", "employees", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "10", "employees", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "15", "employees", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "10", "employees", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p8_s2", "idA": "1430306_16_item1_p15_s1", "sentA": "On February 16, 2016, we announced that we discontinued development of TNX-20 1 because it lacked efficacy.", "sentB": "In September 2016, we discontinued our fibromyalgia program in order to fully focus our resources on our PTSD program.", "type": 2, "words": ["<tag1>", "On", "February", "16,", "2016,", "we", "announced", "that", "we", "discontinued", "development", "of", "TNX-20", "1", "because", "it", "lacked", "efficacy.", "<tag2>", "In", "September", "2016,", "we", "discontinued", "our", "fibromyalgia", "program", "in", "order", "to", "fully", "focus", "our", "resources", "on", "our", "PTSD", "program.", "<tag3>"], "wordsA": ["On", "February", "16,", "2016,", "we", "announced", "that", "we", "discontinued", "development", "of", "TNX-20", "1", "because", "it", "lacked", "efficacy."], "wordsB": ["In", "September", "2016,", "we", "discontinued", "our", "fibromyalgia", "program", "in", "order", "to", "fully", "focus", "our", "resources", "on", "our", "PTSD", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p14_s0", "idA": "1430306_16_item1_p17_s0", "sentA": "Develop TNX-102 SL for multiple central nervous system disorders .", "sentB": "Develop TNX-102 SL for PTSD .", "type": 2, "words": ["<tag1>", "Develop", "TNX-102", "SL", "for", "multiple", "central", "nervous", "system", "disorders", ".", "<tag2>", "Develop", "TNX-102", "SL", "for", "PTSD", ".", "<tag3>"], "wordsA": ["Develop", "TNX-102", "SL", "for", "multiple", "central", "nervous", "system", "disorders", "."], "wordsB": ["Develop", "TNX-102", "SL", "for", "PTSD", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p14_s1", "idA": "1430306_16_item1_p17_s1", "sentA": "We currently are pursuing the development of TNX-102 SL for two separate indications, FM and PTSD.", "sentB": "We currently are focusing on the development of TNX-102 SL for PTSD.", "type": 2, "words": ["<tag1>", "We", "currently", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications,", "FM", "and", "PTSD.", "<tag2>", "We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD.", "<tag3>"], "wordsA": ["We", "currently", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications,", "FM", "and", "PTSD."], "wordsB": ["We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p15_s1", "idA": "1430306_16_item1_p18_s1", "sentA": "We plan to commercialize TNX-102 SL for indications including FM and PTSD either on our own or through collaboration with partners.", "sentB": "We plan to commercialize TNX-102 SL for PTSD, either on our own or through collaboration with partners.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "commercialize", "TNX-102", "SL", "for", "indications", "including", "FM", "and", "PTSD", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners.", "<tag2>", "We", "plan", "to", "commercialize", "TNX-102", "SL", "for", "PTSD,", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners.", "<tag3>"], "wordsA": ["We", "plan", "to", "commercialize", "TNX-102", "SL", "for", "indications", "including", "FM", "and", "PTSD", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners."], "wordsB": ["We", "plan", "to", "commercialize", "TNX-102", "SL", "for", "PTSD,", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p18_s2", "idA": "1430306_16_item1_p21_s2", "sentA": "For example, we own rights related to the development and commercialization of CBP for generalized anxiety disorder, depression, and fatigue related to disordered sleep.", "sentB": "For example, we own rights related to the development and commercialization of CBP for fibromyalgia, generalized anxiety disorder, depression, and fatigue related to disordered sleep.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "own", "rights", "related", "to", "the", "development", "and", "commercialization", "of", "CBP", "for", "generalized", "anxiety", "disorder,", "depression,", "and", "fatigue", "related", "to", "disordered", "sleep.", "<tag2>", "For", "example,", "we", "own", "rights", "related", "to", "the", "development", "and", "commercialization", "of", "CBP", "for", "fibromyalgia,", "generalized", "anxiety", "disorder,", "depression,", "and", "fatigue", "related", "to", "disordered", "sleep.", "<tag3>"], "wordsA": ["For", "example,", "we", "own", "rights", "related", "to", "the", "development", "and", "commercialization", "of", "CBP", "for", "generalized", "anxiety", "disorder,", "depression,", "and", "fatigue", "related", "to", "disordered", "sleep."], "wordsB": ["For", "example,", "we", "own", "rights", "related", "to", "the", "development", "and", "commercialization", "of", "CBP", "for", "fibromyalgia,", "generalized", "anxiety", "disorder,", "depression,", "and", "fatigue", "related", "to", "disordered", "sleep."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p20_s5", "idA": "1430306_16_item1_p28_s5", "sentA": "As of 2009, there were approximately 500,000 veterans receiving treatment for PTSD in the Veterans Health Administration, or VHA.", "sentB": "As of 2015, there were approximately 638,000 veterans receiving treatment for PTSD in the Veterans Health Administration, or VHA.", "type": 2, "words": ["<tag1>", "As", "of", "2009,", "there", "were", "approximately", "500,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA.", "<tag2>", "As", "of", "2015,", "there", "were", "approximately", "638,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA.", "<tag3>"], "wordsA": ["As", "of", "2009,", "there", "were", "approximately", "500,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA."], "wordsB": ["As", "of", "2015,", "there", "were", "approximately", "638,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p74_s3", "idA": "1430306_16_item1_p28_s5", "sentA": "As of 2009, there were approximately 500,000 veterans receiving treatment for PTSD in the Veterans Health Administration, or VHA.", "sentB": "MDMA is Phase 3 ready for PTSD and is a Drug Enforcement Administration, or DEA, schedule 1 hallucinogen that is being studied for drug-assisted psychotherapy.", "type": 2, "words": ["<tag1>", "As", "of", "2009,", "there", "were", "approximately", "500,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA.", "<tag2>", "MDMA", "is", "Phase", "3", "ready", "for", "PTSD", "and", "is", "a", "Drug", "Enforcement", "Administration,", "or", "DEA,", "schedule", "1", "hallucinogen", "that", "is", "being", "studied", "for", "drug-assisted", "psychotherapy.", "<tag3>"], "wordsA": ["As", "of", "2009,", "there", "were", "approximately", "500,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA."], "wordsB": ["MDMA", "is", "Phase", "3", "ready", "for", "PTSD", "and", "is", "a", "Drug", "Enforcement", "Administration,", "or", "DEA,", "schedule", "1", "hallucinogen", "that", "is", "being", "studied", "for", "drug-assisted", "psychotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p20_s6", "idA": "1430306_16_item1_p28_s6", "sentA": "Based on March 2014 VHA data, approximately 20% of military personnel involved in recent conflicts were seen at VHA facilities for potential or provisional PTSD.", "sentB": "Based on March 2015 VHA data, more than 19% of military veterans involved in recent conflicts were seen at VHA facilities for potential or provisional PTSD.", "type": 2, "words": ["<tag1>", "Based", "on", "March", "2014", "VHA", "data,", "approximately", "20%", "of", "military", "personnel", "involved", "in", "recent", "conflicts", "were", "seen", "at", "VHA", "facilities", "for", "potential", "or", "provisional", "PTSD.", "<tag2>", "Based", "on", "March", "2015", "VHA", "data,", "more", "than", "19%", "of", "military", "veterans", "involved", "in", "recent", "conflicts", "were", "seen", "at", "VHA", "facilities", "for", "potential", "or", "provisional", "PTSD.", "<tag3>"], "wordsA": ["Based", "on", "March", "2014", "VHA", "data,", "approximately", "20%", "of", "military", "personnel", "involved", "in", "recent", "conflicts", "were", "seen", "at", "VHA", "facilities", "for", "potential", "or", "provisional", "PTSD."], "wordsB": ["Based", "on", "March", "2015", "VHA", "data,", "more", "than", "19%", "of", "military", "veterans", "involved", "in", "recent", "conflicts", "were", "seen", "at", "VHA", "facilities", "for", "potential", "or", "provisional", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p22_s0", "idA": "1430306_16_item1_p31_s0", "sentA": "TNX-102 SL is a sublingual tablet formulation of CBP that efficiently delivers CBP across the oral mucosal membrane into the systemic circulation.", "sentB": "TNX-102 SL is a proprietary sublingual tablet formulation of CBP that efficiently delivers CBP across the oral mucosal membrane into the systemic circulation.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation.", "<tag2>", "TNX-102", "SL", "is", "a", "proprietary", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation."], "wordsB": ["TNX-102", "SL", "is", "a", "proprietary", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p24_s0", "idA": "1430306_16_item1_p33_s0", "sentA": "TNX-102 SL contains 2.8 mg of CBP.", "sentB": "The current TNX-102 SL sublingual tablets contain 2.8 mg of CBP.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP.", "<tag2>", "The", "current", "TNX-102", "SL", "sublingual", "tablets", "contain", "2.8", "mg", "of", "CBP.", "<tag3>"], "wordsA": ["TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP."], "wordsB": ["The", "current", "TNX-102", "SL", "sublingual", "tablets", "contain", "2.8", "mg", "of", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p24_s1", "idA": "1430306_16_item1_p33_s0", "sentA": "TNX-102 SL contains 2.8 mg of CBP.", "sentB": "For the treatment of PTSD, 5.6 mg of TNX-102 SL, comprised of two TNX-102 SL 2.8 mg tablets administered simultaneously at bedtime, is in Phase 3 development.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP.", "<tag2>", "For", "the", "treatment", "of", "PTSD,", "5.6", "mg", "of", "TNX-102", "SL,", "comprised", "of", "two", "TNX-102", "SL", "2.8", "mg", "tablets", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development.", "<tag3>"], "wordsA": ["TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP."], "wordsB": ["For", "the", "treatment", "of", "PTSD,", "5.6", "mg", "of", "TNX-102", "SL,", "comprised", "of", "two", "TNX-102", "SL", "2.8", "mg", "tablets", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p39_s4", "idA": "1430306_16_item1_p33_s0", "sentA": "TNX-102 SL contains 2.8 mg of CBP.", "sentB": "Glossodynia, or a burning or stinging sensation in the mouth, occurred in 3% of patients treated with the 2.8 mg dose and 6% of patients treated with the 5.6 mg dose, compared to 1% of patients receiving placebo.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP.", "<tag2>", "Glossodynia,", "or", "a", "burning", "or", "stinging", "sensation", "in", "the", "mouth,", "occurred", "in", "3%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "6%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "1%", "of", "patients", "receiving", "placebo.", "<tag3>"], "wordsA": ["TNX-102", "SL", "contains", "2.8", "mg", "of", "CBP."], "wordsB": ["Glossodynia,", "or", "a", "burning", "or", "stinging", "sensation", "in", "the", "mouth,", "occurred", "in", "3%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "6%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "1%", "of", "patients", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p26_s1", "idA": "1430306_16_item1_p34_s3", "sentA": "As such, TNX-102 SL acts upon cellular receptors that play important roles in the treatment of FM and PTSD, including the receptors that mediate serotonin and norepinephrine reuptake.", "sentB": "As such, TNX-102 SL acts upon cellular receptors that play important roles in the treatment of PTSD, including the transporters that mediate serotonin and norepinephrine reuptake.", "type": 2, "words": ["<tag1>", "As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "including", "the", "receptors", "that", "mediate", "serotonin", "and", "norepinephrine", "reuptake.", "<tag2>", "As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "PTSD,", "including", "the", "transporters", "that", "mediate", "serotonin", "and", "norepinephrine", "reuptake.", "<tag3>"], "wordsA": ["As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "FM", "and", "PTSD,", "including", "the", "receptors", "that", "mediate", "serotonin", "and", "norepinephrine", "reuptake."], "wordsB": ["As", "such,", "TNX-102", "SL", "acts", "upon", "cellular", "receptors", "that", "play", "important", "roles", "in", "the", "treatment", "of", "PTSD,", "including", "the", "transporters", "that", "mediate", "serotonin", "and", "norepinephrine", "reuptake."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p26_s2", "idA": "1430306_16_item1_p34_s4", "sentA": "In addition, TNX-102 SL also acts upon other receptors in the central nervous system not targeted by products approved for these indications, including the serotonin 2A and alpha-1 adrenergic receptors.", "sentB": "In addition, TNX-102 SL also acts upon other receptors in the central nervous system not targeted by products approved for PTSD, including the serotonin 2A, alpha-1 adrenergic and histamine H-1 receptors.", "type": 2, "words": ["<tag1>", "In", "addition,", "TNX-102", "SL", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications,", "including", "the", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptors.", "<tag2>", "In", "addition,", "TNX-102", "SL", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "PTSD,", "including", "the", "serotonin", "2A,", "alpha-1", "adrenergic", "and", "histamine", "H-1", "receptors.", "<tag3>"], "wordsA": ["In", "addition,", "TNX-102", "SL", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "these", "indications,", "including", "the", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptors."], "wordsB": ["In", "addition,", "TNX-102", "SL", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "PTSD,", "including", "the", "serotonin", "2A,", "alpha-1", "adrenergic", "and", "histamine", "H-1", "receptors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p60_s0", "idA": "1430306_16_item1_p35_s0", "sentA": "CBP is the active ingredient of two products that are approved in the U.S. for the treatment of muscle spasm: FLEXERIL (oral immediate-release tablet, 5 mg and 10 mg dosage forms) and AMRIX (oral extended-release capsule, 15 mg and 30 mg dosage forms).", "sentB": "Currently there is no tianeptine-containing product approved in the U.S., but tianeptine sodium (amorphous) has been marketed in Europe, Asia, and Latin America for the treatment of depression since 1987.", "type": 2, "words": ["<tag1>", "CBP", "is", "the", "active", "ingredient", "of", "two", "products", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "FLEXERIL", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "AMRIX", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms).", "<tag2>", "Currently", "there", "is", "no", "tianeptine-containing", "product", "approved", "in", "the", "U.S.,", "but", "tianeptine", "sodium", "(amorphous)", "has", "been", "marketed", "in", "Europe,", "Asia,", "and", "Latin", "America", "for", "the", "treatment", "of", "depression", "since", "1987.", "<tag3>"], "wordsA": ["CBP", "is", "the", "active", "ingredient", "of", "two", "products", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "FLEXERIL", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "AMRIX", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms)."], "wordsB": ["Currently", "there", "is", "no", "tianeptine-containing", "product", "approved", "in", "the", "U.S.,", "but", "tianeptine", "sodium", "(amorphous)", "has", "been", "marketed", "in", "Europe,", "Asia,", "and", "Latin", "America", "for", "the", "treatment", "of", "depression", "since", "1987."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p67_s1", "idA": "1430306_16_item1_p35_s1", "sentA": "FLEXERIL brand of cyclobenzaprine immediate-release tablet has been discontinued since May 2013.", "sentB": "This approval pathway has been described as the Animal Rule .", "type": 2, "words": ["<tag1>", "FLEXERIL", "brand", "of", "cyclobenzaprine", "immediate-release", "tablet", "has", "been", "discontinued", "since", "May", "2013.", "<tag2>", "This", "approval", "pathway", "has", "been", "described", "as", "the", "Animal", "Rule", ".", "<tag3>"], "wordsA": ["FLEXERIL", "brand", "of", "cyclobenzaprine", "immediate-release", "tablet", "has", "been", "discontinued", "since", "May", "2013."], "wordsB": ["This", "approval", "pathway", "has", "been", "described", "as", "the", "Animal", "Rule", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p68_s1", "idA": "1430306_16_item1_p36_s0", "sentA": "There are numerous generic versions of cyclobenzaprine immediate-release tablets on the market.", "sentB": "We recently filed a patent on the novel virus vaccine.", "type": 2, "words": ["<tag1>", "There", "are", "numerous", "generic", "versions", "of", "cyclobenzaprine", "immediate-release", "tablets", "on", "the", "market.", "<tag2>", "We", "recently", "filed", "a", "patent", "on", "the", "novel", "virus", "vaccine.", "<tag3>"], "wordsA": ["There", "are", "numerous", "generic", "versions", "of", "cyclobenzaprine", "immediate-release", "tablets", "on", "the", "market."], "wordsB": ["We", "recently", "filed", "a", "patent", "on", "the", "novel", "virus", "vaccine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p28_s1", "idA": "1430306_16_item1_p36_s1", "sentA": "CBP-containing products are not indicated for the treatment of FM or PTSD.", "sentB": "CBP-containing products are not indicated for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD.", "<tag2>", "CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD."], "wordsB": ["CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p59_s0", "idA": "1430306_16_item1_p36_s1", "sentA": "CBP-containing products are not indicated for the treatment of FM or PTSD.", "sentB": "TNX-601 is a novel oral formulation of tianeptine oxalate in the pre-IND stage of development for the treatment for PTSD.", "type": 2, "words": ["<tag1>", "CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD.", "<tag2>", "TNX-601", "is", "a", "novel", "oral", "formulation", "of", "tianeptine", "oxalate", "in", "the", "pre-IND", "stage", "of", "development", "for", "the", "treatment", "for", "PTSD.", "<tag3>"], "wordsA": ["CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "FM", "or", "PTSD."], "wordsB": ["TNX-601", "is", "a", "novel", "oral", "formulation", "of", "tianeptine", "oxalate", "in", "the", "pre-IND", "stage", "of", "development", "for", "the", "treatment", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p28_s2", "idA": "1430306_16_item1_p36_s2", "sentA": "CBP-containing products are approved for short term use (two to three weeks) only.", "sentB": "CBP-containing products are approved for short term use (two to three weeks) only as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.", "type": 2, "words": ["<tag1>", "CBP-containing", "products", "are", "approved", "for", "short", "term", "use", "(two", "to", "three", "weeks)", "only.", "<tag2>", "CBP-containing", "products", "are", "approved", "for", "short", "term", "use", "(two", "to", "three", "weeks)", "only", "as", "an", "adjunct", "to", "rest", "and", "physical", "therapy", "for", "relief", "of", "muscle", "spasm", "associated", "with", "acute,", "painful", "musculoskeletal", "conditions.", "<tag3>"], "wordsA": ["CBP-containing", "products", "are", "approved", "for", "short", "term", "use", "(two", "to", "three", "weeks)", "only."], "wordsB": ["CBP-containing", "products", "are", "approved", "for", "short", "term", "use", "(two", "to", "three", "weeks)", "only", "as", "an", "adjunct", "to", "rest", "and", "physical", "therapy", "for", "relief", "of", "muscle", "spasm", "associated", "with", "acute,", "painful", "musculoskeletal", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p29_s1", "idA": "1430306_16_item1_p37_s1", "sentA": "We believe the selected dose of TNX-102 SL and its pharmacokinetic profile will enable it to achieve a desirable balance of efficacy, safety, and tolerability in FM and PTSD.", "sentB": "We believe the selected dose of TNX-102 SL and its pharmacokinetic profile will enable it to achieve a desirable balance of efficacy, safety, and tolerability in PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "selected", "dose", "of", "TNX-102", "SL", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "FM", "and", "PTSD.", "<tag2>", "We", "believe", "the", "selected", "dose", "of", "TNX-102", "SL", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "the", "selected", "dose", "of", "TNX-102", "SL", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "FM", "and", "PTSD."], "wordsB": ["We", "believe", "the", "selected", "dose", "of", "TNX-102", "SL", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p30_s0", "idA": "1430306_16_item1_p38_s0", "sentA": "In clinical studies, TNX-102 SL, 2.8 mg was generally well-tolerated, with no serious adverse events reported in these studies.", "sentB": "In clinical studies, TNX-102 SL 2.8 mg and TNX-102 SL 5.6 mg were generally well-tolerated, with no serious adverse events reported in these studies.", "type": 2, "words": ["<tag1>", "In", "clinical", "studies,", "TNX-102", "SL,", "2.8", "mg", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag2>", "In", "clinical", "studies,", "TNX-102", "SL", "2.8", "mg", "and", "TNX-102", "SL", "5.6", "mg", "were", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag3>"], "wordsA": ["In", "clinical", "studies,", "TNX-102", "SL,", "2.8", "mg", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "wordsB": ["In", "clinical", "studies,", "TNX-102", "SL", "2.8", "mg", "and", "TNX-102", "SL", "5.6", "mg", "were", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p39_s6", "idA": "1430306_16_item1_p38_s0", "sentA": "In clinical studies, TNX-102 SL, 2.8 mg was generally well-tolerated, with no serious adverse events reported in these studies.", "sentB": "For the patients treated with the 2.8 mg dose, the incidence of the most common systemic adverse events reported above were less frequent than patients treated with the 5.6 mg dose with the exception of insomnia, which was 8%.", "type": 2, "words": ["<tag1>", "In", "clinical", "studies,", "TNX-102", "SL,", "2.8", "mg", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag2>", "For", "the", "patients", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "patients", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%.", "<tag3>"], "wordsA": ["In", "clinical", "studies,", "TNX-102", "SL,", "2.8", "mg", "was", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "wordsB": ["For", "the", "patients", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "patients", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p31_s0", "idA": "1430306_16_item1_p39_s0", "sentA": "We expect that any applications we submit to the Food and Drug Administration, or FDA, for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, for product candidates containing an active ingredient that is similar or identical to an already approved product.", "sentB": "We expect that any applications we submit to the FDA for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, for product candidates containing an active ingredient that is similar or identical to an already approved product.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product.", "<tag2>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "FDA", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product.", "<tag3>"], "wordsA": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "Food", "and", "Drug", "Administration,", "or", "FDA,", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product."], "wordsB": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "FDA", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p3_s0", "idA": "1430306_16_item1_p3_s0", "sentA": "Tonix Pharmaceuticals , Tonmya and other trademarks and intellectual property of ours appearing in this report are our property.", "sentB": "Tonix Pharmaceuticals , TONMYA , Protectic , Angstro-Technology and other trademarks and intellectual property of ours appearing in this report are our property.", "type": 2, "words": ["<tag1>", "Tonix", "Pharmaceuticals", ",", "Tonmya", "and", "other", "trademarks", "and", "intellectual", "property", "of", "ours", "appearing", "in", "this", "report", "are", "our", "property.", "<tag2>", "Tonix", "Pharmaceuticals", ",", "TONMYA", ",", "Protectic", ",", "Angstro-Technology", "and", "other", "trademarks", "and", "intellectual", "property", "of", "ours", "appearing", "in", "this", "report", "are", "our", "property.", "<tag3>"], "wordsA": ["Tonix", "Pharmaceuticals", ",", "Tonmya", "and", "other", "trademarks", "and", "intellectual", "property", "of", "ours", "appearing", "in", "this", "report", "are", "our", "property."], "wordsB": ["Tonix", "Pharmaceuticals", ",", "TONMYA", ",", "Protectic", ",", "Angstro-Technology", "and", "other", "trademarks", "and", "intellectual", "property", "of", "ours", "appearing", "in", "this", "report", "are", "our", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p31_s2", "idA": "1430306_16_item1_p40_s0", "sentA": "Currently, we are pursuing the development of TNX-102 SL for two separate indications.", "sentB": "Currently, we are pursuing the development of TNX-102 SL for PTSD, for which TNX-102 SL is in Phase 3 development.", "type": 2, "words": ["<tag1>", "Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications.", "<tag2>", "Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "PTSD,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "3", "development.", "<tag3>"], "wordsA": ["Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "two", "separate", "indications."], "wordsB": ["Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "PTSD,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "3", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p31_s3", "idA": "1430306_16_item1_p40_s2", "sentA": "We believe that TNX-102 SL has the potential to provide clinical benefit to these and possibly other CNS indications that are underserved by currently marketed products.", "sentB": "We believe that TNX-102 SL has the potential to provide clinical benefit to this and possibly other CNS indications that are underserved by currently marketed products.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "provide", "clinical", "benefit", "to", "these", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products.", "<tag2>", "We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "provide", "clinical", "benefit", "to", "this", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products.", "<tag3>"], "wordsA": ["We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "provide", "clinical", "benefit", "to", "these", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products."], "wordsB": ["We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "provide", "clinical", "benefit", "to", "this", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p142_s0", "idA": "1430306_16_item1_p41_s0", "sentA": "We are developing TNX-102 SL for the treatment of FM under an effective investigational new drug, or IND, application.", "sentB": "In December 2016, the FDA granted Breakthrough Therapy designation to TNX-102 SL for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application.", "<tag2>", "In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application."], "wordsB": ["In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p35_s0", "idA": "1430306_16_item1_p41_s0", "sentA": "We are developing TNX-102 SL for the treatment of FM under an effective investigational new drug, or IND, application.", "sentB": "We are developing TNX-102 SL for the treatment of PTSD under an effective IND application.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p48_s0", "idA": "1430306_16_item1_p41_s0", "sentA": "We are developing TNX-102 SL for the treatment of FM under an effective investigational new drug, or IND, application.", "sentB": "In December 2016, the FDA granted Breakthrough Therapy designation to TNX-102 SL for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application.", "<tag2>", "In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application."], "wordsB": ["In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p66_s2", "idA": "1430306_16_item1_p41_s0", "sentA": "We are developing TNX-102 SL for the treatment of FM under an effective investigational new drug, or IND, application.", "sentB": "We are developing TNX-801 as a potential smallpox-preventing vaccine for widespread immunization and for the U.S. strategic national stockpile.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application.", "<tag2>", "We", "are", "developing", "TNX-801", "as", "a", "potential", "smallpox-preventing", "vaccine", "for", "widespread", "immunization", "and", "for", "the", "U.S.", "strategic", "national", "stockpile.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "FM", "under", "an", "effective", "investigational", "new", "drug,", "or", "IND,", "application."], "wordsB": ["We", "are", "developing", "TNX-801", "as", "a", "potential", "smallpox-preventing", "vaccine", "for", "widespread", "immunization", "and", "for", "the", "U.S.", "strategic", "national", "stockpile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p61_s0", "idA": "1430306_16_item1_p41_s3", "sentA": "This study also demonstrated that treatment with TNX-102 capsules led to a significant improvement in objective measures of sleep quality, which we believe relates to the mechanism by which CBP leads to improvement of FM symptoms.", "sentB": "We have discovered a novel oxalate salt and polymorph, which we believe may provide improved stability, consistency, and manufacturability relative to the known forms of tianeptine.", "type": 2, "words": ["<tag1>", "This", "study", "also", "demonstrated", "that", "treatment", "with", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms.", "<tag2>", "We", "have", "discovered", "a", "novel", "oxalate", "salt", "and", "polymorph,", "which", "we", "believe", "may", "provide", "improved", "stability,", "consistency,", "and", "manufacturability", "relative", "to", "the", "known", "forms", "of", "tianeptine.", "<tag3>"], "wordsA": ["This", "study", "also", "demonstrated", "that", "treatment", "with", "TNX-102", "capsules", "led", "to", "a", "significant", "improvement", "in", "objective", "measures", "of", "sleep", "quality,", "which", "we", "believe", "relates", "to", "the", "mechanism", "by", "which", "CBP", "leads", "to", "improvement", "of", "FM", "symptoms."], "wordsB": ["We", "have", "discovered", "a", "novel", "oxalate", "salt", "and", "polymorph,", "which", "we", "believe", "may", "provide", "improved", "stability,", "consistency,", "and", "manufacturability", "relative", "to", "the", "known", "forms", "of", "tianeptine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p46_s0", "idA": "1430306_16_item1_p42_s0", "sentA": "At an End-of-Phase 2/Pre-Phase 3 meeting with the FDA in February 2013, we discussed the design of our clinical program, including the acceptability of the pivotal study design and the proposed registration plan, to support the approval of TNX-102 SL for the management of FM.", "sentB": "Subsequent to reporting the Phase 2 AtEase study topline result, we held an End-of-Phase 2/Pre-Phase 3 meeting with the FDA in early August 2016 to discuss the Phase 3 program required to support the registration of TNX-102 SL 5.6 mg for the treatment of PTSD and the remaining data package for the NDA filing.", "type": 2, "words": ["<tag1>", "At", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "Subsequent", "to", "reporting", "the", "Phase", "2", "AtEase", "study", "topline", "result,", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "early", "August", "2016", "to", "discuss", "the", "Phase", "3", "program", "required", "to", "support", "the", "registration", "of", "TNX-102", "SL", "5.6", "mg", "for", "the", "treatment", "of", "PTSD", "and", "the", "remaining", "data", "package", "for", "the", "NDA", "filing.", "<tag3>"], "wordsA": ["At", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "February", "2013,", "we", "discussed", "the", "design", "of", "our", "clinical", "program,", "including", "the", "acceptability", "of", "the", "pivotal", "study", "design", "and", "the", "proposed", "registration", "plan,", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["Subsequent", "to", "reporting", "the", "Phase", "2", "AtEase", "study", "topline", "result,", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "early", "August", "2016", "to", "discuss", "the", "Phase", "3", "program", "required", "to", "support", "the", "registration", "of", "TNX-102", "SL", "5.6", "mg", "for", "the", "treatment", "of", "PTSD", "and", "the", "remaining", "data", "package", "for", "the", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p46_s1", "idA": "1430306_16_item1_p42_s1", "sentA": "On the basis of our discussions with the FDA, we believe that positive results from two adequate, well-controlled efficacy and safety studies and long-term (six- and 12-month) safety exposure studies would provide sufficient evidence of efficacy and safety to support FDA approval of TNX-102 SL for the management of FM.", "sentB": "Based on this meeting discussion and the official FDA meeting minutes, we expect that positive results from two adequate, well-controlled Phase 3 efficacy and safety studies and long-term (six- and 12-month) safety exposure studies would provide sufficient evidence of efficacy and safety to support the clinical approval of TNX-102 SL 5.6 mg for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "On", "the", "basis", "of", "our", "discussions", "with", "the", "FDA,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "provide", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM.", "<tag2>", "Based", "on", "this", "meeting", "discussion", "and", "the", "official", "FDA", "meeting", "minutes,", "we", "expect", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "Phase", "3", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "provide", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "clinical", "approval", "of", "TNX-102", "SL", "5.6", "mg", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["On", "the", "basis", "of", "our", "discussions", "with", "the", "FDA,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "provide", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "FM."], "wordsB": ["Based", "on", "this", "meeting", "discussion", "and", "the", "official", "FDA", "meeting", "minutes,", "we", "expect", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "Phase", "3", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "would", "provide", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "clinical", "approval", "of", "TNX-102", "SL", "5.6", "mg", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p38_s1", "idA": "1430306_16_item1_p44_s2", "sentA": "In the BESTFIT trial, TNX-102 SL did not achieve statistical significance in the primary outcome measure (p=0.172).", "sentB": "Although the 2.8 mg dose trended in the direction of a therapeutic effect, it did not reach statistical significance on the primary endpoint.", "type": 2, "words": ["<tag1>", "In", "the", "BESTFIT", "trial,", "TNX-102", "SL", "did", "not", "achieve", "statistical", "significance", "in", "the", "primary", "outcome", "measure", "(p=0.172).", "<tag2>", "Although", "the", "2.8", "mg", "dose", "trended", "in", "the", "direction", "of", "a", "therapeutic", "effect,", "it", "did", "not", "reach", "statistical", "significance", "on", "the", "primary", "endpoint.", "<tag3>"], "wordsA": ["In", "the", "BESTFIT", "trial,", "TNX-102", "SL", "did", "not", "achieve", "statistical", "significance", "in", "the", "primary", "outcome", "measure", "(p=0.172)."], "wordsB": ["Although", "the", "2.8", "mg", "dose", "trended", "in", "the", "direction", "of", "a", "therapeutic", "effect,", "it", "did", "not", "reach", "statistical", "significance", "on", "the", "primary", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p63_s3", "idA": "1430306_16_item1_p44_s7", "sentA": "In addition, statistically significant improvements with TNX-102 SL were observed on several FIQ-R items (pain, sleep quality, anxiety, stiffness, and sensitivity) as well as on the overall symptom subdomain.", "sentB": "Tianeptine s reported pro-cognitive and anxiolytic effects as well as its ability to attenuate the neuropathological effects of excessive stress responses suggest that it may be used to treat PTSD by a different mechanism of action than TNX-102 SL.", "type": 2, "words": ["<tag1>", "In", "addition,", "statistically", "significant", "improvements", "with", "TNX-102", "SL", "were", "observed", "on", "several", "FIQ-R", "items", "(pain,", "sleep", "quality,", "anxiety,", "stiffness,", "and", "sensitivity)", "as", "well", "as", "on", "the", "overall", "symptom", "subdomain.", "<tag2>", "Tianeptine", "s", "reported", "pro-cognitive", "and", "anxiolytic", "effects", "as", "well", "as", "its", "ability", "to", "attenuate", "the", "neuropathological", "effects", "of", "excessive", "stress", "responses", "suggest", "that", "it", "may", "be", "used", "to", "treat", "PTSD", "by", "a", "different", "mechanism", "of", "action", "than", "TNX-102", "SL.", "<tag3>"], "wordsA": ["In", "addition,", "statistically", "significant", "improvements", "with", "TNX-102", "SL", "were", "observed", "on", "several", "FIQ-R", "items", "(pain,", "sleep", "quality,", "anxiety,", "stiffness,", "and", "sensitivity)", "as", "well", "as", "on", "the", "overall", "symptom", "subdomain."], "wordsB": ["Tianeptine", "s", "reported", "pro-cognitive", "and", "anxiolytic", "effects", "as", "well", "as", "its", "ability", "to", "attenuate", "the", "neuropathological", "effects", "of", "excessive", "stress", "responses", "suggest", "that", "it", "may", "be", "used", "to", "treat", "PTSD", "by", "a", "different", "mechanism", "of", "action", "than", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p39_s2", "idA": "1430306_16_item1_p46_s0", "sentA": "The most common adverse events were local in nature, with transient tongue or mouth numbness occurring in 44% of participants on TNX-102 SL vs. 2% on placebo, and bitter taste in 8% on TNX-102 SL compared to none on placebo.", "sentB": "The most common non-dose related adverse events were mild and transient local administration site conditions and of these oral hypoaesthesia, or numbness, was the most frequent and occurred in 39% of patients treated with the 2.8 mg dose and 36% of the patients treated with the 5.6 mg dose, compared to 2% of the patients receiving placebo.", "type": 2, "words": ["<tag1>", "The", "most", "common", "adverse", "events", "were", "local", "in", "nature,", "with", "transient", "tongue", "or", "mouth", "numbness", "occurring", "in", "44%", "of", "participants", "on", "TNX-102", "SL", "vs.", "2%", "on", "placebo,", "and", "bitter", "taste", "in", "8%", "on", "TNX-102", "SL", "compared", "to", "none", "on", "placebo.", "<tag2>", "The", "most", "common", "non-dose", "related", "adverse", "events", "were", "mild", "and", "transient", "local", "administration", "site", "conditions", "and", "of", "these", "oral", "hypoaesthesia,", "or", "numbness,", "was", "the", "most", "frequent", "and", "occurred", "in", "39%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "36%", "of", "the", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "2%", "of", "the", "patients", "receiving", "placebo.", "<tag3>"], "wordsA": ["The", "most", "common", "adverse", "events", "were", "local", "in", "nature,", "with", "transient", "tongue", "or", "mouth", "numbness", "occurring", "in", "44%", "of", "participants", "on", "TNX-102", "SL", "vs.", "2%", "on", "placebo,", "and", "bitter", "taste", "in", "8%", "on", "TNX-102", "SL", "compared", "to", "none", "on", "placebo."], "wordsB": ["The", "most", "common", "non-dose", "related", "adverse", "events", "were", "mild", "and", "transient", "local", "administration", "site", "conditions", "and", "of", "these", "oral", "hypoaesthesia,", "or", "numbness,", "was", "the", "most", "frequent", "and", "occurred", "in", "39%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "36%", "of", "the", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "2%", "of", "the", "patients", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p39_s1", "idA": "1430306_16_item1_p46_s3", "sentA": "No serious adverse events were reported.", "sentB": "Four distinct serious adverse events, or SAEs, were reported in the study; three were in the placebo group, and one (proctitis/peri-rectal abscess) in the TNX-102 SL arm, which was determined to be unrelated to TNX-102 SL.", "type": 2, "words": ["<tag1>", "No", "serious", "adverse", "events", "were", "reported.", "<tag2>", "Four", "distinct", "serious", "adverse", "events,", "or", "SAEs,", "were", "reported", "in", "the", "study;", "three", "were", "in", "the", "placebo", "group,", "and", "one", "(proctitis/peri-rectal", "abscess)", "in", "the", "TNX-102", "SL", "arm,", "which", "was", "determined", "to", "be", "unrelated", "to", "TNX-102", "SL.", "<tag3>"], "wordsA": ["No", "serious", "adverse", "events", "were", "reported."], "wordsB": ["Four", "distinct", "serious", "adverse", "events,", "or", "SAEs,", "were", "reported", "in", "the", "study;", "three", "were", "in", "the", "placebo", "group,", "and", "one", "(proctitis/peri-rectal", "abscess)", "in", "the", "TNX-102", "SL", "arm,", "which", "was", "determined", "to", "be", "unrelated", "to", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p41_s1", "idA": "1430306_16_item1_p47_s0", "sentA": "Following our report of the results of the BESTFIT trial, we requested guidance from the FDA on our proposed use of a 30% pain responder analysis as the primary efficacy endpoint in a prospective Phase 3 registration program.", "sentB": "This first Phase 3 study, the HONOR study, is an adaptive design study based on the results of the Phase 2 AtEase study.", "type": 2, "words": ["<tag1>", "Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "a", "prospective", "Phase", "3", "registration", "program.", "<tag2>", "This", "first", "Phase", "3", "study,", "the", "HONOR", "study,", "is", "an", "adaptive", "design", "study", "based", "on", "the", "results", "of", "the", "Phase", "2", "AtEase", "study.", "<tag3>"], "wordsA": ["Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "a", "prospective", "Phase", "3", "registration", "program."], "wordsB": ["This", "first", "Phase", "3", "study,", "the", "HONOR", "study,", "is", "an", "adaptive", "design", "study", "based", "on", "the", "results", "of", "the", "Phase", "2", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p43_s2", "idA": "1430306_16_item1_p47_s0", "sentA": "Following our report of the results of the BESTFIT trial, we requested guidance from the FDA on our proposed use of a 30% pain responder analysis as the primary efficacy endpoint in a prospective Phase 3 registration program.", "sentB": "As in the case of the HONOR and AtEase studies, the primary efficacy endpoint of this second Phase 3 study will be the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the CAPS-5 scale between those treated with TNX-102 SL 5.6 mg and those receiving placebo.", "type": 2, "words": ["<tag1>", "Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "a", "prospective", "Phase", "3", "registration", "program.", "<tag2>", "As", "in", "the", "case", "of", "the", "HONOR", "and", "AtEase", "studies,", "the", "primary", "efficacy", "endpoint", "of", "this", "second", "Phase", "3", "study", "will", "be", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo.", "<tag3>"], "wordsA": ["Following", "our", "report", "of", "the", "results", "of", "the", "BESTFIT", "trial,", "we", "requested", "guidance", "from", "the", "FDA", "on", "our", "proposed", "use", "of", "a", "30%", "pain", "responder", "analysis", "as", "the", "primary", "efficacy", "endpoint", "in", "a", "prospective", "Phase", "3", "registration", "program."], "wordsB": ["As", "in", "the", "case", "of", "the", "HONOR", "and", "AtEase", "studies,", "the", "primary", "efficacy", "endpoint", "of", "this", "second", "Phase", "3", "study", "will", "be", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p51_s1", "idA": "1430306_16_item1_p48_s2", "sentA": "We expect to report top line results from the AFFIRM trial in the third quarter of 2016.", "sentB": "We submitted an Agreed iPSP in the first quarter of 2017, which incorporated the FDA comments received on our Initial Pediatric Study Plan submitted in the third quarter of 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "top", "line", "results", "from", "the", "AFFIRM", "trial", "in", "the", "third", "quarter", "of", "2016.", "<tag2>", "We", "submitted", "an", "Agreed", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "Initial", "Pediatric", "Study", "Plan", "submitted", "in", "the", "third", "quarter", "of", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "top", "line", "results", "from", "the", "AFFIRM", "trial", "in", "the", "third", "quarter", "of", "2016."], "wordsB": ["We", "submitted", "an", "Agreed", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "Initial", "Pediatric", "Study", "Plan", "submitted", "in", "the", "third", "quarter", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p44_s0", "idA": "1430306_16_item1_p49_s0", "sentA": "In August 2015, we completed Study F203, a 12-month open-label extension study of TNX-102 SL in patients who had completed the BESTFIT study.", "sentB": "We plan to conduct the registration-required open-label extension studies of TNX-102 SL 5.6 mg in patients who complete either the HONOR study or the predominantly civilian PTSD Phase 3 study.", "type": 2, "words": ["<tag1>", "In", "August", "2015,", "we", "completed", "Study", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "in", "patients", "who", "had", "completed", "the", "BESTFIT", "study.", "<tag2>", "We", "plan", "to", "conduct", "the", "registration-required", "open-label", "extension", "studies", "of", "TNX-102", "SL", "5.6", "mg", "in", "patients", "who", "complete", "either", "the", "HONOR", "study", "or", "the", "predominantly", "civilian", "PTSD", "Phase", "3", "study.", "<tag3>"], "wordsA": ["In", "August", "2015,", "we", "completed", "Study", "F203,", "a", "12-month", "open-label", "extension", "study", "of", "TNX-102", "SL", "in", "patients", "who", "had", "completed", "the", "BESTFIT", "study."], "wordsB": ["We", "plan", "to", "conduct", "the", "registration-required", "open-label", "extension", "studies", "of", "TNX-102", "SL", "5.6", "mg", "in", "patients", "who", "complete", "either", "the", "HONOR", "study", "or", "the", "predominantly", "civilian", "PTSD", "Phase", "3", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p45_s0", "idA": "1430306_16_item1_p49_s1", "sentA": "The goal of Study F203 was to obtain the prerequisite long-term safety exposure data to support a New Drug Application, or NDA, filing for TNX-102 SL for the management of FM, a chronic medical condition.", "sentB": "6- and 12-month safety exposure data from the maximum therapeutic dose to support the registration of TNX-102 SL for the treatment of PTSD, a chronic psychiatric condition.", "type": 2, "words": ["<tag1>", "The", "goal", "of", "Study", "F203", "was", "to", "obtain", "the", "prerequisite", "long-term", "safety", "exposure", "data", "to", "support", "a", "New", "Drug", "Application,", "or", "NDA,", "filing", "for", "TNX-102", "SL", "for", "the", "management", "of", "FM,", "a", "chronic", "medical", "condition.", "<tag2>", "6-", "and", "12-month", "safety", "exposure", "data", "from", "the", "maximum", "therapeutic", "dose", "to", "support", "the", "registration", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD,", "a", "chronic", "psychiatric", "condition.", "<tag3>"], "wordsA": ["The", "goal", "of", "Study", "F203", "was", "to", "obtain", "the", "prerequisite", "long-term", "safety", "exposure", "data", "to", "support", "a", "New", "Drug", "Application,", "or", "NDA,", "filing", "for", "TNX-102", "SL", "for", "the", "management", "of", "FM,", "a", "chronic", "medical", "condition."], "wordsB": ["6-", "and", "12-month", "safety", "exposure", "data", "from", "the", "maximum", "therapeutic", "dose", "to", "support", "the", "registration", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD,", "a", "chronic", "psychiatric", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p53_s0", "idA": "1430306_16_item1_p50_s0", "sentA": "We have completed the clinical phase of a Phase 1 bioequivalence pharmacokinetic study (F105) that compared the pharmacokinetic profiles of single-doses of TNX-102 SL, 2.8 mg tablets manufactured at two facilities: the facility used to produce study medication for our Phase 2b BESTFIT study and the facility used to produce study medication for our ongoing Phase 3 AFFIRM study and the to-be-marketed product.", "sentB": "We completed a Phase 1 bioequivalence study that compared the pharmacokinetic profiles of single-dose of TNX-102 SL 2.8 mg tablets manufactured at two facilities: (i) the facility used to produce TNX-102 SL 2.8 mg tablets for the Phase 2 AtEase study; and (ii) the facility used to produce TNX-102 SL 2.8.mg tablets for our clinical studies required to support the PTSD NDA submission and the to-be-marketed product.", "type": 2, "words": ["<tag1>", "We", "have", "completed", "the", "clinical", "phase", "of", "a", "Phase", "1", "bioequivalence", "pharmacokinetic", "study", "(F105)", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "single-doses", "of", "TNX-102", "SL,", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "the", "facility", "used", "to", "produce", "study", "medication", "for", "our", "Phase", "2b", "BESTFIT", "study", "and", "the", "facility", "used", "to", "produce", "study", "medication", "for", "our", "ongoing", "Phase", "3", "AFFIRM", "study", "and", "the", "to-be-marketed", "product.", "<tag2>", "We", "completed", "a", "Phase", "1", "bioequivalence", "study", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "single-dose", "of", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "(i)", "the", "facility", "used", "to", "produce", "TNX-102", "SL", "2.8", "mg", "tablets", "for", "the", "Phase", "2", "AtEase", "study;", "and", "(ii)", "the", "facility", "used", "to", "produce", "TNX-102", "SL", "2.8.mg", "tablets", "for", "our", "clinical", "studies", "required", "to", "support", "the", "PTSD", "NDA", "submission", "and", "the", "to-be-marketed", "product.", "<tag3>"], "wordsA": ["We", "have", "completed", "the", "clinical", "phase", "of", "a", "Phase", "1", "bioequivalence", "pharmacokinetic", "study", "(F105)", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "single-doses", "of", "TNX-102", "SL,", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "the", "facility", "used", "to", "produce", "study", "medication", "for", "our", "Phase", "2b", "BESTFIT", "study", "and", "the", "facility", "used", "to", "produce", "study", "medication", "for", "our", "ongoing", "Phase", "3", "AFFIRM", "study", "and", "the", "to-be-marketed", "product."], "wordsB": ["We", "completed", "a", "Phase", "1", "bioequivalence", "study", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "single-dose", "of", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "(i)", "the", "facility", "used", "to", "produce", "TNX-102", "SL", "2.8", "mg", "tablets", "for", "the", "Phase", "2", "AtEase", "study;", "and", "(ii)", "the", "facility", "used", "to", "produce", "TNX-102", "SL", "2.8.mg", "tablets", "for", "our", "clinical", "studies", "required", "to", "support", "the", "PTSD", "NDA", "submission", "and", "the", "to-be-marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p40_s3", "idA": "1430306_16_item1_p50_s1", "sentA": "The study demonstrated that the TNX-102 SL 2.8 mg tablets manufactured at the two different facilities are bioequivalent.", "sentB": "TNX-102 SL 2.8 mg was well tolerated for up to six months of treatment and no new safety signals were revealed in this open-label extension study.", "type": 2, "words": ["<tag1>", "The", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "the", "two", "different", "facilities", "are", "bioequivalent.", "<tag2>", "TNX-102", "SL", "2.8", "mg", "was", "well", "tolerated", "for", "up", "to", "six", "months", "of", "treatment", "and", "no", "new", "safety", "signals", "were", "revealed", "in", "this", "open-label", "extension", "study.", "<tag3>"], "wordsA": ["The", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "the", "two", "different", "facilities", "are", "bioequivalent."], "wordsB": ["TNX-102", "SL", "2.8", "mg", "was", "well", "tolerated", "for", "up", "to", "six", "months", "of", "treatment", "and", "no", "new", "safety", "signals", "were", "revealed", "in", "this", "open-label", "extension", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p53_s1", "idA": "1430306_16_item1_p50_s1", "sentA": "The study demonstrated that the TNX-102 SL 2.8 mg tablets manufactured at the two different facilities are bioequivalent.", "sentB": "This bioequivalence study demonstrated that the TNX-102 SL 2.8 mg tablets manufactured at these two facilities were bioequivalent, supporting the use of the AtEase study to support the Phase 3 studies.", "type": 2, "words": ["<tag1>", "The", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "the", "two", "different", "facilities", "are", "bioequivalent.", "<tag2>", "This", "bioequivalence", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "these", "two", "facilities", "were", "bioequivalent,", "supporting", "the", "use", "of", "the", "AtEase", "study", "to", "support", "the", "Phase", "3", "studies.", "<tag3>"], "wordsA": ["The", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "the", "two", "different", "facilities", "are", "bioequivalent."], "wordsB": ["This", "bioequivalence", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "these", "two", "facilities", "were", "bioequivalent,", "supporting", "the", "use", "of", "the", "AtEase", "study", "to", "support", "the", "Phase", "3", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p41_s4", "idA": "1430306_16_item1_p53_s0", "sentA": "Since TNX-102 SL will be submitted as a 505(b)(2) NDA using CBP 5 mg IR tablets as our reference product, we plan to study TNX-102 SL, 2.8 mg in comparison to CBP 5 mg IR tablets in a multiple-dose pharmacokinetic study.", "sentB": "In addition, there will be one active dose (5.6 mg administered as 2 x 2.8 mg tablets) and the entrance criterion is CAPS-5 33 in this Phase 3 study.", "type": 2, "words": ["<tag1>", "Since", "TNX-102", "SL", "will", "be", "submitted", "as", "a", "505(b)(2)", "NDA", "using", "CBP", "5", "mg", "IR", "tablets", "as", "our", "reference", "product,", "we", "plan", "to", "study", "TNX-102", "SL,", "2.8", "mg", "in", "comparison", "to", "CBP", "5", "mg", "IR", "tablets", "in", "a", "multiple-dose", "pharmacokinetic", "study.", "<tag2>", "In", "addition,", "there", "will", "be", "one", "active", "dose", "(5.6", "mg", "administered", "as", "2", "x", "2.8", "mg", "tablets)", "and", "the", "entrance", "criterion", "is", "CAPS-5", "33", "in", "this", "Phase", "3", "study.", "<tag3>"], "wordsA": ["Since", "TNX-102", "SL", "will", "be", "submitted", "as", "a", "505(b)(2)", "NDA", "using", "CBP", "5", "mg", "IR", "tablets", "as", "our", "reference", "product,", "we", "plan", "to", "study", "TNX-102", "SL,", "2.8", "mg", "in", "comparison", "to", "CBP", "5", "mg", "IR", "tablets", "in", "a", "multiple-dose", "pharmacokinetic", "study."], "wordsB": ["In", "addition,", "there", "will", "be", "one", "active", "dose", "(5.6", "mg", "administered", "as", "2", "x", "2.8", "mg", "tablets)", "and", "the", "entrance", "criterion", "is", "CAPS-5", "33", "in", "this", "Phase", "3", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p54_s1", "idA": "1430306_16_item1_p53_s0", "sentA": "Since TNX-102 SL will be submitted as a 505(b)(2) NDA using CBP 5 mg IR tablets as our reference product, we plan to study TNX-102 SL, 2.8 mg in comparison to CBP 5 mg IR tablets in a multiple-dose pharmacokinetic study.", "sentB": "As agreed upon by the FDA, we plan to study TNX-102 SL 5.6 mg (two 2.8 mg tablets) in comparison to AMRIX 30 mg extended-release capsules in a multiple-dose bridging PK study to provide a systemic exposure bridge.", "type": 2, "words": ["<tag1>", "Since", "TNX-102", "SL", "will", "be", "submitted", "as", "a", "505(b)(2)", "NDA", "using", "CBP", "5", "mg", "IR", "tablets", "as", "our", "reference", "product,", "we", "plan", "to", "study", "TNX-102", "SL,", "2.8", "mg", "in", "comparison", "to", "CBP", "5", "mg", "IR", "tablets", "in", "a", "multiple-dose", "pharmacokinetic", "study.", "<tag2>", "As", "agreed", "upon", "by", "the", "FDA,", "we", "plan", "to", "study", "TNX-102", "SL", "5.6", "mg", "(two", "2.8", "mg", "tablets)", "in", "comparison", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "in", "a", "multiple-dose", "bridging", "PK", "study", "to", "provide", "a", "systemic", "exposure", "bridge.", "<tag3>"], "wordsA": ["Since", "TNX-102", "SL", "will", "be", "submitted", "as", "a", "505(b)(2)", "NDA", "using", "CBP", "5", "mg", "IR", "tablets", "as", "our", "reference", "product,", "we", "plan", "to", "study", "TNX-102", "SL,", "2.8", "mg", "in", "comparison", "to", "CBP", "5", "mg", "IR", "tablets", "in", "a", "multiple-dose", "pharmacokinetic", "study."], "wordsB": ["As", "agreed", "upon", "by", "the", "FDA,", "we", "plan", "to", "study", "TNX-102", "SL", "5.6", "mg", "(two", "2.8", "mg", "tablets)", "in", "comparison", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "in", "a", "multiple-dose", "bridging", "PK", "study", "to", "provide", "a", "systemic", "exposure", "bridge."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p56_s0", "idA": "1430306_16_item1_p54_s0", "sentA": "In addition to the clinical studies necessary to support the TNX-102 SL 505(b)(2) NDA filing for the management of fibromyalgia, we proposed, and the FDA has accepted, our nonclinical data package to support the NDA filing, as the NDA requires nonclinical information that is not completely available in the reference product labeling.", "sentB": "The FDA has accepted our proposed nonclinical data package to support our PTSD NDA filing.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "clinical", "studies", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "management", "of", "fibromyalgia,", "we", "proposed,", "and", "the", "FDA", "has", "accepted,", "our", "nonclinical", "data", "package", "to", "support", "the", "NDA", "filing,", "as", "the", "NDA", "requires", "nonclinical", "information", "that", "is", "not", "completely", "available", "in", "the", "reference", "product", "labeling.", "<tag2>", "The", "FDA", "has", "accepted", "our", "proposed", "nonclinical", "data", "package", "to", "support", "our", "PTSD", "NDA", "filing.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "clinical", "studies", "necessary", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "filing", "for", "the", "management", "of", "fibromyalgia,", "we", "proposed,", "and", "the", "FDA", "has", "accepted,", "our", "nonclinical", "data", "package", "to", "support", "the", "NDA", "filing,", "as", "the", "NDA", "requires", "nonclinical", "information", "that", "is", "not", "completely", "available", "in", "the", "reference", "product", "labeling."], "wordsB": ["The", "FDA", "has", "accepted", "our", "proposed", "nonclinical", "data", "package", "to", "support", "our", "PTSD", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p56_s2", "idA": "1430306_16_item1_p54_s1", "sentA": "In 2014, we completed dose-ranging studies to identify the doses for the chronic toxicity studies requested by the FDA to augment the nonclinical information in the CBP labeling which will be used to support the TNX-102 SL labeling for long-term use.", "sentB": "These chronic toxicity studies were requested by the FDA to augment the nonclinical information in the AMRIX approved prescribing information, or labeling, which is necessary to support the TNX-102 SL labeling for long-term use.", "type": 2, "words": ["<tag1>", "In", "2014,", "we", "completed", "dose-ranging", "studies", "to", "identify", "the", "doses", "for", "the", "chronic", "toxicity", "studies", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "CBP", "labeling", "which", "will", "be", "used", "to", "support", "the", "TNX-102", "SL", "labeling", "for", "long-term", "use.", "<tag2>", "These", "chronic", "toxicity", "studies", "were", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "AMRIX", "approved", "prescribing", "information,", "or", "labeling,", "which", "is", "necessary", "to", "support", "the", "TNX-102", "SL", "labeling", "for", "long-term", "use.", "<tag3>"], "wordsA": ["In", "2014,", "we", "completed", "dose-ranging", "studies", "to", "identify", "the", "doses", "for", "the", "chronic", "toxicity", "studies", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "CBP", "labeling", "which", "will", "be", "used", "to", "support", "the", "TNX-102", "SL", "labeling", "for", "long-term", "use."], "wordsB": ["These", "chronic", "toxicity", "studies", "were", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "AMRIX", "approved", "prescribing", "information,", "or", "labeling,", "which", "is", "necessary", "to", "support", "the", "TNX-102", "SL", "labeling", "for", "long-term", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p56_s1", "idA": "1430306_16_item1_p54_s2", "sentA": "In January 2015, we engaged an FDA-certified Good Laboratory Practices laboratory to conduct a six-month repeated-dose toxicology study of TNX-102 in rats and a nine-month repeated-dose toxicology study in dogs required for the NDA filing and to support Phase 3 clinical studies outside the U.S.", "sentB": "In October 2016, we completed the six-month repeated-dose toxicology study of TNX-102 in rats and a nine-month repeated-dose toxicology study in dogs required for the NDA filing and to support Phase 3 clinical studies outside the U.S., if necessary.", "type": 2, "words": ["<tag1>", "In", "January", "2015,", "we", "engaged", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six-month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S.", "<tag2>", "In", "October", "2016,", "we", "completed", "the", "six-month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S.,", "if", "necessary.", "<tag3>"], "wordsA": ["In", "January", "2015,", "we", "engaged", "an", "FDA-certified", "Good", "Laboratory", "Practices", "laboratory", "to", "conduct", "a", "six-month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S."], "wordsB": ["In", "October", "2016,", "we", "completed", "the", "six-month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S.,", "if", "necessary."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p56_s3", "idA": "1430306_16_item1_p54_s4", "sentA": "Based on the prescribing information of AMRIX and FLEXERIL (discontinued since May 2013) and the post-marketing surveillance information, there is no evidence of abuse for CBP.", "sentB": "Based on the prescribing information of AMRIX and the post-marketing surveillance information, there is no evidence of abuse for cyclobenzaprine.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "prescribing", "information", "of", "AMRIX", "and", "FLEXERIL", "(discontinued", "since", "May", "2013)", "and", "the", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "CBP.", "<tag2>", "Based", "on", "the", "prescribing", "information", "of", "AMRIX", "and", "the", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "cyclobenzaprine.", "<tag3>"], "wordsA": ["Based", "on", "the", "prescribing", "information", "of", "AMRIX", "and", "FLEXERIL", "(discontinued", "since", "May", "2013)", "and", "the", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "CBP."], "wordsB": ["Based", "on", "the", "prescribing", "information", "of", "AMRIX", "and", "the", "post-marketing", "surveillance", "information,", "there", "is", "no", "evidence", "of", "abuse", "for", "cyclobenzaprine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p50_s2", "idA": "1430306_16_item1_p54_s5", "sentA": "As a result, the FDA has advised that we will not have to assess the abuse potential of TNX-102 SL for the TNX-102 SL 505(b)(2) NDA submission.", "sentB": "Additionally, due to the lack of evidence of potential abuse in clinical studies of TNX-102 SL, the FDA agreed that studies in assessing abuse potential of TNX-102 SL are not required to support the TNX-102 SL NDA.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission.", "<tag2>", "Additionally,", "due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "TNX-102", "SL,", "the", "FDA", "agreed", "that", "studies", "in", "assessing", "abuse", "potential", "of", "TNX-102", "SL", "are", "not", "required", "to", "support", "the", "TNX-102", "SL", "NDA.", "<tag3>"], "wordsA": ["As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission."], "wordsB": ["Additionally,", "due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "TNX-102", "SL,", "the", "FDA", "agreed", "that", "studies", "in", "assessing", "abuse", "potential", "of", "TNX-102", "SL", "are", "not", "required", "to", "support", "the", "TNX-102", "SL", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p55_s0", "idA": "1430306_16_item1_p54_s5", "sentA": "As a result, the FDA has advised that we will not have to assess the abuse potential of TNX-102 SL for the TNX-102 SL 505(b)(2) NDA submission.", "sentB": "To support the TNX-102 SL product registration, a randomized, open-label, 2-way crossover, food-effect, comparative bioavailability study of TNX-102 SL following a single dose in healthy subjects under fasting and fed conditions and a randomized, open-label, 2-way crossover, dose-proportionality, comparative bioavailability study of TNX-102 SL following a single dose in healthy subjects under fasting conditions will be completed for the TNX-102 SL NDA submission.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission.", "<tag2>", "To", "support", "the", "TNX-102", "SL", "product", "registration,", "a", "randomized,", "open-label,", "2-way", "crossover,", "food-effect,", "comparative", "bioavailability", "study", "of", "TNX-102", "SL", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "and", "fed", "conditions", "and", "a", "randomized,", "open-label,", "2-way", "crossover,", "dose-proportionality,", "comparative", "bioavailability", "study", "of", "TNX-102", "SL", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "conditions", "will", "be", "completed", "for", "the", "TNX-102", "SL", "NDA", "submission.", "<tag3>"], "wordsA": ["As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission."], "wordsB": ["To", "support", "the", "TNX-102", "SL", "product", "registration,", "a", "randomized,", "open-label,", "2-way", "crossover,", "food-effect,", "comparative", "bioavailability", "study", "of", "TNX-102", "SL", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "and", "fed", "conditions", "and", "a", "randomized,", "open-label,", "2-way", "crossover,", "dose-proportionality,", "comparative", "bioavailability", "study", "of", "TNX-102", "SL", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "conditions", "will", "be", "completed", "for", "the", "TNX-102", "SL", "NDA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p56_s4", "idA": "1430306_16_item1_p54_s5", "sentA": "As a result, the FDA has advised that we will not have to assess the abuse potential of TNX-102 SL for the TNX-102 SL 505(b)(2) NDA submission.", "sentB": "As a result, the FDA has advised that we will not have to assess the abuse potential of TNX-102 SL to support the TNX-102 SL 505(b)(2) NDA submission for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission.", "<tag2>", "As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "for", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission."], "wordsB": ["As", "a", "result,", "the", "FDA", "has", "advised", "that", "we", "will", "not", "have", "to", "assess", "the", "abuse", "potential", "of", "TNX-102", "SL", "to", "support", "the", "TNX-102", "SL", "505(b)(2)", "NDA", "submission", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p57_s0", "idA": "1430306_16_item1_p55_s0", "sentA": "The TNX-102 SL drug product manufactured for our Phase 2b BESTFIT study was manufactured in a small-scale current Good Manufacturing Practice, or cGMP, facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "sentB": "The TNX-102 SL drug product was manufactured in a small-scale current Good Manufacturing Practice, or cGMP, facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "type": 2, "words": ["<tag1>", "The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "Phase", "2b", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag2>", "The", "TNX-102", "SL", "drug", "product", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag3>"], "wordsA": ["The", "TNX-102", "SL", "drug", "product", "manufactured", "for", "our", "Phase", "2b", "BESTFIT", "study", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "wordsB": ["The", "TNX-102", "SL", "drug", "product", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p32_s0", "idA": "1430306_16_item1_p55_s1", "sentA": "For Phase 3 trials and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "sentB": "On March 10, 2017, we received a notice of allowance for the US patent application No. 14/214,433 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride , which includes compositions of cyclobenzaprine HCl and methods of manufacturing the eutectic.", "type": 2, "words": ["<tag1>", "For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag2>", "On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "for", "the", "US", "patent", "application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic.", "<tag3>"], "wordsA": ["For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "wordsB": ["On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "for", "the", "US", "patent", "application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p32_s2", "idA": "1430306_16_item1_p55_s1", "sentA": "For Phase 3 trials and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "sentB": "The allowed claims will also protect the method of manufacturing the eutectic.", "type": 2, "words": ["<tag1>", "For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag2>", "The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic.", "<tag3>"], "wordsA": ["For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "wordsB": ["The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p87_s2", "idA": "1430306_16_item1_p55_s1", "sentA": "For Phase 3 trials and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "sentB": "The allowed claims will also protect the method of manufacturing the eutectic.", "type": 2, "words": ["<tag1>", "For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag2>", "The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic.", "<tag3>"], "wordsA": ["For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "wordsB": ["The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p57_s2", "idA": "1430306_16_item1_p56_s0", "sentA": "The product s comparability is supported by the bioequivalence results of the single-dose pharmacokinetic study (F105).", "sentB": "The product s comparability is supported by the bioequivalence results of the single-dose pharmacokinetic study.", "type": 2, "words": ["<tag1>", "The", "product", "s", "comparability", "is", "supported", "by", "the", "bioequivalence", "results", "of", "the", "single-dose", "pharmacokinetic", "study", "(F105).", "<tag2>", "The", "product", "s", "comparability", "is", "supported", "by", "the", "bioequivalence", "results", "of", "the", "single-dose", "pharmacokinetic", "study.", "<tag3>"], "wordsA": ["The", "product", "s", "comparability", "is", "supported", "by", "the", "bioequivalence", "results", "of", "the", "single-dose", "pharmacokinetic", "study", "(F105)."], "wordsB": ["The", "product", "s", "comparability", "is", "supported", "by", "the", "bioequivalence", "results", "of", "the", "single-dose", "pharmacokinetic", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p51_s0", "idA": "1430306_16_item1_p57_s0", "sentA": "We have an Agreed Initial Pediatric Study Plan, or iPSP, with the FDA.", "sentB": "An Agreed Initial Pediatric Study Plan, or Agreed iPSP, is required for the initial NDA submission.", "type": 2, "words": ["<tag1>", "We", "have", "an", "Agreed", "Initial", "Pediatric", "Study", "Plan,", "or", "iPSP,", "with", "the", "FDA.", "<tag2>", "An", "Agreed", "Initial", "Pediatric", "Study", "Plan,", "or", "Agreed", "iPSP,", "is", "required", "for", "the", "initial", "NDA", "submission.", "<tag3>"], "wordsA": ["We", "have", "an", "Agreed", "Initial", "Pediatric", "Study", "Plan,", "or", "iPSP,", "with", "the", "FDA."], "wordsB": ["An", "Agreed", "Initial", "Pediatric", "Study", "Plan,", "or", "Agreed", "iPSP,", "is", "required", "for", "the", "initial", "NDA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p41_s5", "idA": "1430306_16_item1_p57_s2", "sentA": "A Final Pediatric Study Plan requirement will be determined at the time of the NDA approval.", "sentB": "The interim analysis will be conducted when approximately 50% (approximately 250 300 patients) of the initially planned patient enrollment is evaluable for efficacy.", "type": 2, "words": ["<tag1>", "A", "Final", "Pediatric", "Study", "Plan", "requirement", "will", "be", "determined", "at", "the", "time", "of", "the", "NDA", "approval.", "<tag2>", "The", "interim", "analysis", "will", "be", "conducted", "when", "approximately", "50%", "(approximately", "250", "300", "patients)", "of", "the", "initially", "planned", "patient", "enrollment", "is", "evaluable", "for", "efficacy.", "<tag3>"], "wordsA": ["A", "Final", "Pediatric", "Study", "Plan", "requirement", "will", "be", "determined", "at", "the", "time", "of", "the", "NDA", "approval."], "wordsB": ["The", "interim", "analysis", "will", "be", "conducted", "when", "approximately", "50%", "(approximately", "250", "300", "patients)", "of", "the", "initially", "planned", "patient", "enrollment", "is", "evaluable", "for", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p50_s1", "idA": "1430306_16_item1_p58_s0", "sentA": "Based our discussions with the FDA and the FDA official meeting minutes, we will not have to conduct special populations (geriatric and renal/hepatic impaired), drug-drug interaction or cardiovascular safety studies to support the NDA filing.", "sentB": "Based on our discussions with the FDA and the FDA official meeting minutes, a single-study NDA approval could be possible based on topline data from the ongoing HONOR study.", "type": 2, "words": ["<tag1>", "Based", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "cardiovascular", "safety", "studies", "to", "support", "the", "NDA", "filing.", "<tag2>", "Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "a", "single-study", "NDA", "approval", "could", "be", "possible", "based", "on", "topline", "data", "from", "the", "ongoing", "HONOR", "study.", "<tag3>"], "wordsA": ["Based", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "cardiovascular", "safety", "studies", "to", "support", "the", "NDA", "filing."], "wordsB": ["Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "a", "single-study", "NDA", "approval", "could", "be", "possible", "based", "on", "topline", "data", "from", "the", "ongoing", "HONOR", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p52_s1", "idA": "1430306_16_item1_p58_s1", "sentA": "Due to the well-established safety profile of CBP at much higher doses than we proposed for FM, the FDA has not requested a risk management plan or medication guide for this product.", "sentB": "Due to the well-established safety profile of CBP at much higher doses than we proposed for PTSD and the long-term safety data (up to 15 months) on TNX-102 SL 2.8 mg in a prior fibromyalgia program, the FDA has not requested a risk management plan or medication guide for this product.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "FM,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product.", "<tag2>", "Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "PTSD", "and", "the", "long-term", "safety", "data", "(up", "to", "15", "months)", "on", "TNX-102", "SL", "2.8", "mg", "in", "a", "prior", "fibromyalgia", "program,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product.", "<tag3>"], "wordsA": ["Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "FM,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product."], "wordsB": ["Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "PTSD", "and", "the", "long-term", "safety", "data", "(up", "to", "15", "months)", "on", "TNX-102", "SL", "2.8", "mg", "in", "a", "prior", "fibromyalgia", "program,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p10_s1", "idA": "1430306_16_item1_p59_s0", "sentA": "We expect to register TNX-102 SL with the FDA through the provisions of Section 505(b)(2).", "sentB": "TNX-102 SL has a proprietary, Protectic protective eutectic formulation of cyclobenzaprine that allows for rapid systemic exposure and increased bioavailability through the transmucosal delivery.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2).", "<tag2>", "TNX-102", "SL", "has", "a", "proprietary,", "Protectic", "protective", "eutectic", "formulation", "of", "cyclobenzaprine", "that", "allows", "for", "rapid", "systemic", "exposure", "and", "increased", "bioavailability", "through", "the", "transmucosal", "delivery.", "<tag3>"], "wordsA": ["We", "expect", "to", "register", "TNX-102", "SL", "with", "the", "FDA", "through", "the", "provisions", "of", "Section", "505(b)(2)."], "wordsB": ["TNX-102", "SL", "has", "a", "proprietary,", "Protectic", "protective", "eutectic", "formulation", "of", "cyclobenzaprine", "that", "allows", "for", "rapid", "systemic", "exposure", "and", "increased", "bioavailability", "through", "the", "transmucosal", "delivery."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p5_s0", "idA": "1430306_16_item1_p5_s1", "sentA": "TNX-102 SL for FM and PTSD is an investigational new drug and has not been approved for any indication.", "sentB": "TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for posttraumatic stress disorder, or PTSD, is an investigational new drug and has not been approved for any indication.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "for", "FM", "and", "PTSD", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication.", "<tag2>", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "for", "posttraumatic", "stress", "disorder,", "or", "PTSD,", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication.", "<tag3>"], "wordsA": ["TNX-102", "SL", "for", "FM", "and", "PTSD", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication."], "wordsB": ["TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "for", "posttraumatic", "stress", "disorder,", "or", "PTSD,", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p47_s1", "idA": "1430306_16_item1_p60_s0", "sentA": "The 505(b)(2)-based product development plan for TNX-102 SL is designed to leverage the safety data that have been generated by other manufacturers for CBP-containing products and accepted by the FDA in support of their product registrations, in addition to the safety data we generate.", "sentB": "In general, our proposed NDA CMC plan for TNX-102 SL was acceptable to the FDA and can be applied to the PTSD NDA.", "type": 2, "words": ["<tag1>", "The", "505(b)(2)-based", "product", "development", "plan", "for", "TNX-102", "SL", "is", "designed", "to", "leverage", "the", "safety", "data", "that", "have", "been", "generated", "by", "other", "manufacturers", "for", "CBP-containing", "products", "and", "accepted", "by", "the", "FDA", "in", "support", "of", "their", "product", "registrations,", "in", "addition", "to", "the", "safety", "data", "we", "generate.", "<tag2>", "In", "general,", "our", "proposed", "NDA", "CMC", "plan", "for", "TNX-102", "SL", "was", "acceptable", "to", "the", "FDA", "and", "can", "be", "applied", "to", "the", "PTSD", "NDA.", "<tag3>"], "wordsA": ["The", "505(b)(2)-based", "product", "development", "plan", "for", "TNX-102", "SL", "is", "designed", "to", "leverage", "the", "safety", "data", "that", "have", "been", "generated", "by", "other", "manufacturers", "for", "CBP-containing", "products", "and", "accepted", "by", "the", "FDA", "in", "support", "of", "their", "product", "registrations,", "in", "addition", "to", "the", "safety", "data", "we", "generate."], "wordsB": ["In", "general,", "our", "proposed", "NDA", "CMC", "plan", "for", "TNX-102", "SL", "was", "acceptable", "to", "the", "FDA", "and", "can", "be", "applied", "to", "the", "PTSD", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p10_s2", "idA": "1430306_16_item1_p62_s0", "sentA": "We are developing TNX-102 SL for the management of PTSD under a separate IND, cleared by the FDA in June 2014, and we are currently conducting our AtEase trial, a Phase 2 clinical trial of TNX-102 SL in military-related PTSD.", "sentB": "We are developing TNX-102 SL for the management of PTSD under an IND cleared by the U.S. Food and Drug Administration, or FDA, in June 2014.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "a", "separate", "IND,", "cleared", "by", "the", "FDA", "in", "June", "2014,", "and", "we", "are", "currently", "conducting", "our", "AtEase", "trial,", "a", "Phase", "2", "clinical", "trial", "of", "TNX-102", "SL", "in", "military-related", "PTSD.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "an", "IND", "cleared", "by", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "in", "June", "2014.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "a", "separate", "IND,", "cleared", "by", "the", "FDA", "in", "June", "2014,", "and", "we", "are", "currently", "conducting", "our", "AtEase", "trial,", "a", "Phase", "2", "clinical", "trial", "of", "TNX-102", "SL", "in", "military-related", "PTSD."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "an", "IND", "cleared", "by", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "in", "June", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p40_s0", "idA": "1430306_16_item1_p62_s1", "sentA": "Patients who successfully complete the AtEase study are eligible to enroll into a three-month open-label extension study (P202).", "sentB": "Patients who completed the AtEase study were eligible to enroll into a three-month open-label extension study with TNX-102 SL 2.8 mg.", "type": 2, "words": ["<tag1>", "Patients", "who", "successfully", "complete", "the", "AtEase", "study", "are", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "(P202).", "<tag2>", "Patients", "who", "completed", "the", "AtEase", "study", "were", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "with", "TNX-102", "SL", "2.8", "mg.", "<tag3>"], "wordsA": ["Patients", "who", "successfully", "complete", "the", "AtEase", "study", "are", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "(P202)."], "wordsB": ["Patients", "who", "completed", "the", "AtEase", "study", "were", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "with", "TNX-102", "SL", "2.8", "mg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p40_s1", "idA": "1430306_16_item1_p62_s1", "sentA": "Patients who successfully complete the AtEase study are eligible to enroll into a three-month open-label extension study (P202).", "sentB": "We conducted this open-label extension study to obtain additional safety information from patients in the AtEase Study.", "type": 2, "words": ["<tag1>", "Patients", "who", "successfully", "complete", "the", "AtEase", "study", "are", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "(P202).", "<tag2>", "We", "conducted", "this", "open-label", "extension", "study", "to", "obtain", "additional", "safety", "information", "from", "patients", "in", "the", "AtEase", "Study.", "<tag3>"], "wordsA": ["Patients", "who", "successfully", "complete", "the", "AtEase", "study", "are", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "(P202)."], "wordsB": ["We", "conducted", "this", "open-label", "extension", "study", "to", "obtain", "additional", "safety", "information", "from", "patients", "in", "the", "AtEase", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p40_s2", "idA": "1430306_16_item1_p62_s1", "sentA": "Patients who successfully complete the AtEase study are eligible to enroll into a three-month open-label extension study (P202).", "sentB": "The clinical phase of this open-label extension study is complete.", "type": 2, "words": ["<tag1>", "Patients", "who", "successfully", "complete", "the", "AtEase", "study", "are", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "(P202).", "<tag2>", "The", "clinical", "phase", "of", "this", "open-label", "extension", "study", "is", "complete.", "<tag3>"], "wordsA": ["Patients", "who", "successfully", "complete", "the", "AtEase", "study", "are", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "(P202)."], "wordsB": ["The", "clinical", "phase", "of", "this", "open-label", "extension", "study", "is", "complete."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p74_s2", "idA": "1430306_16_item1_p63_s2", "sentA": "Conversely, in a different survey of FM patients, 57% of the patients had symptoms associated with PTSD (Cohen et al, Semin Arthritis Rheum 2002;32:38-50).", "sentB": "Riluzole is in a Phase 2 trial for active duty military members and veterans with PTSD and is a blocker of certain sodium channels and a modulator of the glutamatergic system.", "type": 2, "words": ["<tag1>", "Conversely,", "in", "a", "different", "survey", "of", "FM", "patients,", "57%", "of", "the", "patients", "had", "symptoms", "associated", "with", "PTSD", "(Cohen", "et", "al,", "Semin", "Arthritis", "Rheum", "2002;32:38-50).", "<tag2>", "Riluzole", "is", "in", "a", "Phase", "2", "trial", "for", "active", "duty", "military", "members", "and", "veterans", "with", "PTSD", "and", "is", "a", "blocker", "of", "certain", "sodium", "channels", "and", "a", "modulator", "of", "the", "glutamatergic", "system.", "<tag3>"], "wordsA": ["Conversely,", "in", "a", "different", "survey", "of", "FM", "patients,", "57%", "of", "the", "patients", "had", "symptoms", "associated", "with", "PTSD", "(Cohen", "et", "al,", "Semin", "Arthritis", "Rheum", "2002;32:38-50)."], "wordsB": ["Riluzole", "is", "in", "a", "Phase", "2", "trial", "for", "active", "duty", "military", "members", "and", "veterans", "with", "PTSD", "and", "is", "a", "blocker", "of", "certain", "sodium", "channels", "and", "a", "modulator", "of", "the", "glutamatergic", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p36_s0", "idA": "1430306_16_item1_p68_s0", "sentA": "In the first quarter of 2015, we commenced the AtEase trial, a randomized, double-blind, placebo-controlled, 12-week Phase 2 trial of TNX-102 SL in approximately 240 patients with military-related PTSD.", "sentB": "In the first quarter of 2015, we commenced a randomized, double-blind, placebo-controlled, 12-week Phase 2 study of TNX-102 SL in patients with military-related PTSD, which we refer to as the AtEase study.", "type": 2, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "approximately", "240", "patients", "with", "military-related", "PTSD.", "<tag2>", "In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "study", "of", "TNX-102", "SL", "in", "patients", "with", "military-related", "PTSD,", "which", "we", "refer", "to", "as", "the", "AtEase", "study.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "approximately", "240", "patients", "with", "military-related", "PTSD."], "wordsB": ["In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "study", "of", "TNX-102", "SL", "in", "patients", "with", "military-related", "PTSD,", "which", "we", "refer", "to", "as", "the", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p41_s0", "idA": "1430306_16_item1_p68_s0", "sentA": "In the first quarter of 2015, we commenced the AtEase trial, a randomized, double-blind, placebo-controlled, 12-week Phase 2 trial of TNX-102 SL in approximately 240 patients with military-related PTSD.", "sentB": "We have commenced a randomized, double-blind placebo-controlled Phase 3 study of TNX-102 SL in approximately 550 patients with military-related PTSD in the first quarter of 2017.", "type": 2, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "approximately", "240", "patients", "with", "military-related", "PTSD.", "<tag2>", "We", "have", "commenced", "a", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "approximately", "550", "patients", "with", "military-related", "PTSD", "in", "the", "first", "quarter", "of", "2017.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "approximately", "240", "patients", "with", "military-related", "PTSD."], "wordsB": ["We", "have", "commenced", "a", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "approximately", "550", "patients", "with", "military-related", "PTSD", "in", "the", "first", "quarter", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p46_s2", "idA": "1430306_16_item1_p68_s0", "sentA": "In the first quarter of 2015, we commenced the AtEase trial, a randomized, double-blind, placebo-controlled, 12-week Phase 2 trial of TNX-102 SL in approximately 240 patients with military-related PTSD.", "sentB": "As described below, the first Phase 3 study will be in patients with military-related PTSD and the second Phase 3 study will study predominately civilian PTSD patients.", "type": 2, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "approximately", "240", "patients", "with", "military-related", "PTSD.", "<tag2>", "As", "described", "below,", "the", "first", "Phase", "3", "study", "will", "be", "in", "patients", "with", "military-related", "PTSD", "and", "the", "second", "Phase", "3", "study", "will", "study", "predominately", "civilian", "PTSD", "patients.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "the", "AtEase", "trial,", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "trial", "of", "TNX-102", "SL", "in", "approximately", "240", "patients", "with", "military-related", "PTSD."], "wordsB": ["As", "described", "below,", "the", "first", "Phase", "3", "study", "will", "be", "in", "patients", "with", "military-related", "PTSD", "and", "the", "second", "Phase", "3", "study", "will", "study", "predominately", "civilian", "PTSD", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p37_s0", "idA": "1430306_16_item1_p68_s1", "sentA": "In the AtEase study, patients are randomized in a 2:1:2 ratio to TNX-102 SL 2.8 mg, TNX-102 SL 5.6 mg, or placebo, respectively, sublingually once daily at bedtime.", "sentB": "In the AtEase study, patients were randomized in a 2:1:2 ratio to TNX-102 SL 2.8 mg, TNX-102 SL 5.6 mg, or placebo sublingual tablets at bedtime daily for 12 weeks.", "type": 2, "words": ["<tag1>", "In", "the", "AtEase", "study,", "patients", "are", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo,", "respectively,", "sublingually", "once", "daily", "at", "bedtime.", "<tag2>", "In", "the", "AtEase", "study,", "patients", "were", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo", "sublingual", "tablets", "at", "bedtime", "daily", "for", "12", "weeks.", "<tag3>"], "wordsA": ["In", "the", "AtEase", "study,", "patients", "are", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo,", "respectively,", "sublingually", "once", "daily", "at", "bedtime."], "wordsB": ["In", "the", "AtEase", "study,", "patients", "were", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo", "sublingual", "tablets", "at", "bedtime", "daily", "for", "12", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p39_s0", "idA": "1430306_16_item1_p68_s1", "sentA": "In the AtEase study, patients are randomized in a 2:1:2 ratio to TNX-102 SL 2.8 mg, TNX-102 SL 5.6 mg, or placebo, respectively, sublingually once daily at bedtime.", "sentB": "In the AtEase study, TNX-102 SL was well tolerated and the patient retention rate was 73% on placebo, 79% on TNX-102 SL 2.8 mg and 84% on TNX-102 SL 5.6 mg.", "type": 2, "words": ["<tag1>", "In", "the", "AtEase", "study,", "patients", "are", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo,", "respectively,", "sublingually", "once", "daily", "at", "bedtime.", "<tag2>", "In", "the", "AtEase", "study,", "TNX-102", "SL", "was", "well", "tolerated", "and", "the", "patient", "retention", "rate", "was", "73%", "on", "placebo,", "79%", "on", "TNX-102", "SL", "2.8", "mg", "and", "84%", "on", "TNX-102", "SL", "5.6", "mg.", "<tag3>"], "wordsA": ["In", "the", "AtEase", "study,", "patients", "are", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo,", "respectively,", "sublingually", "once", "daily", "at", "bedtime."], "wordsB": ["In", "the", "AtEase", "study,", "TNX-102", "SL", "was", "well", "tolerated", "and", "the", "patient", "retention", "rate", "was", "73%", "on", "placebo,", "79%", "on", "TNX-102", "SL", "2.8", "mg", "and", "84%", "on", "TNX-102", "SL", "5.6", "mg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p42_s0", "idA": "1430306_16_item1_p68_s1", "sentA": "In the AtEase study, patients are randomized in a 2:1:2 ratio to TNX-102 SL 2.8 mg, TNX-102 SL 5.6 mg, or placebo, respectively, sublingually once daily at bedtime.", "sentB": "As in the case of the AtEase study, the primary efficacy endpoint of the HONOR study is the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the CAPS-5 scale between those treated with TNX-102 SL 5.6 mg and those receiving placebo.", "type": 2, "words": ["<tag1>", "In", "the", "AtEase", "study,", "patients", "are", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo,", "respectively,", "sublingually", "once", "daily", "at", "bedtime.", "<tag2>", "As", "in", "the", "case", "of", "the", "AtEase", "study,", "the", "primary", "efficacy", "endpoint", "of", "the", "HONOR", "study", "is", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo.", "<tag3>"], "wordsA": ["In", "the", "AtEase", "study,", "patients", "are", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo,", "respectively,", "sublingually", "once", "daily", "at", "bedtime."], "wordsB": ["As", "in", "the", "case", "of", "the", "AtEase", "study,", "the", "primary", "efficacy", "endpoint", "of", "the", "HONOR", "study", "is", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p41_s7", "idA": "1430306_16_item1_p68_s2", "sentA": "This trial is being conducted at approximately 25 U.S. centers.", "sentB": "The HONOR study involves approximately 35 U.S. centers.", "type": 2, "words": ["<tag1>", "This", "trial", "is", "being", "conducted", "at", "approximately", "25", "U.S.", "centers.", "<tag2>", "The", "HONOR", "study", "involves", "approximately", "35", "U.S.", "centers.", "<tag3>"], "wordsA": ["This", "trial", "is", "being", "conducted", "at", "approximately", "25", "U.S.", "centers."], "wordsB": ["The", "HONOR", "study", "involves", "approximately", "35", "U.S.", "centers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p43_s1", "idA": "1430306_16_item1_p68_s2", "sentA": "This trial is being conducted at approximately 25 U.S. centers.", "sentB": "We expect this study to be conducted at approximately 35 U.S. centers.", "type": 2, "words": ["<tag1>", "This", "trial", "is", "being", "conducted", "at", "approximately", "25", "U.S.", "centers.", "<tag2>", "We", "expect", "this", "study", "to", "be", "conducted", "at", "approximately", "35", "U.S.", "centers.", "<tag3>"], "wordsA": ["This", "trial", "is", "being", "conducted", "at", "approximately", "25", "U.S.", "centers."], "wordsB": ["We", "expect", "this", "study", "to", "be", "conducted", "at", "approximately", "35", "U.S.", "centers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p37_s2", "idA": "1430306_16_item1_p69_s0", "sentA": "The primary objective of the AtEase trial is to evaluate the efficacy of TNX-102 SL 2.8 mg as compared to placebo sublingual tablet following 12 weeks of treatment using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5).", "sentB": "The primary objective of the AtEase study was to evaluate the potential clinical benefit of using TNX-102 SL to treat military-related PTSD at a dose of 2.8 mg or 5.6 mg.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "12", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5", "(CAPS-5).", "<tag2>", "The", "primary", "objective", "of", "the", "AtEase", "study", "was", "to", "evaluate", "the", "potential", "clinical", "benefit", "of", "using", "TNX-102", "SL", "to", "treat", "military-related", "PTSD", "at", "a", "dose", "of", "2.8", "mg", "or", "5.6", "mg.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "12", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5", "(CAPS-5)."], "wordsB": ["The", "primary", "objective", "of", "the", "AtEase", "study", "was", "to", "evaluate", "the", "potential", "clinical", "benefit", "of", "using", "TNX-102", "SL", "to", "treat", "military-related", "PTSD", "at", "a", "dose", "of", "2.8", "mg", "or", "5.6", "mg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p37_s3", "idA": "1430306_16_item1_p69_s0", "sentA": "The primary objective of the AtEase trial is to evaluate the efficacy of TNX-102 SL 2.8 mg as compared to placebo sublingual tablet following 12 weeks of treatment using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5).", "sentB": "The primary efficacy endpoint was the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the Clinician-Administered PTSD Scale for the Diagnostic and Statistical Manual-5, or CAPS-5, between those treated with TNX-102 SL and those receiving placebo.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "12", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5", "(CAPS-5).", "<tag2>", "The", "primary", "efficacy", "endpoint", "was", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "Clinician-Administered", "PTSD", "Scale", "for", "the", "Diagnostic", "and", "Statistical", "Manual-5,", "or", "CAPS-5,", "between", "those", "treated", "with", "TNX-102", "SL", "and", "those", "receiving", "placebo.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "12", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5", "(CAPS-5)."], "wordsB": ["The", "primary", "efficacy", "endpoint", "was", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "Clinician-Administered", "PTSD", "Scale", "for", "the", "Diagnostic", "and", "Statistical", "Manual-5,", "or", "CAPS-5,", "between", "those", "treated", "with", "TNX-102", "SL", "and", "those", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p39_s3", "idA": "1430306_16_item1_p69_s0", "sentA": "The primary objective of the AtEase trial is to evaluate the efficacy of TNX-102 SL 2.8 mg as compared to placebo sublingual tablet following 12 weeks of treatment using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5).", "sentB": "Oral paresthesia, or tingling, occurred in 16% of patients treated with the 2.8 mg dose and 4% of patients treated with the 5.6 mg dose, compared to 3% of the patients receiving placebo.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "12", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5", "(CAPS-5).", "<tag2>", "Oral", "paresthesia,", "or", "tingling,", "occurred", "in", "16%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "4%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "3%", "of", "the", "patients", "receiving", "placebo.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "AtEase", "trial", "is", "to", "evaluate", "the", "efficacy", "of", "TNX-102", "SL", "2.8", "mg", "as", "compared", "to", "placebo", "sublingual", "tablet", "following", "12", "weeks", "of", "treatment", "using", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5", "(CAPS-5)."], "wordsB": ["Oral", "paresthesia,", "or", "tingling,", "occurred", "in", "16%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "4%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "3%", "of", "the", "patients", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p38_s0", "idA": "1430306_16_item1_p69_s1", "sentA": "If the AtEase study achieves success in its primary outcome measure, it could serve as one of the two pivotal studies required to establish sufficient evidence of efficacy and safety to support the approval of TNX-102 SL for PTSD.", "sentB": "AtEase was adequately designed to evaluate whether a 2.8 mg dose would be efficacious, which would have provided an opportunity for this study to be used as one of the two pivotal efficacy studies required to support approval of TNX-102 SL for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "If", "the", "AtEase", "study", "achieves", "success", "in", "its", "primary", "outcome", "measure,", "it", "could", "serve", "as", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "establish", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "AtEase", "was", "adequately", "designed", "to", "evaluate", "whether", "a", "2.8", "mg", "dose", "would", "be", "efficacious,", "which", "would", "have", "provided", "an", "opportunity", "for", "this", "study", "to", "be", "used", "as", "one", "of", "the", "two", "pivotal", "efficacy", "studies", "required", "to", "support", "approval", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["If", "the", "AtEase", "study", "achieves", "success", "in", "its", "primary", "outcome", "measure,", "it", "could", "serve", "as", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "establish", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["AtEase", "was", "adequately", "designed", "to", "evaluate", "whether", "a", "2.8", "mg", "dose", "would", "be", "efficacious,", "which", "would", "have", "provided", "an", "opportunity", "for", "this", "study", "to", "be", "used", "as", "one", "of", "the", "two", "pivotal", "efficacy", "studies", "required", "to", "support", "approval", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p38_s3", "idA": "1430306_16_item1_p69_s1", "sentA": "If the AtEase study achieves success in its primary outcome measure, it could serve as one of the two pivotal studies required to establish sufficient evidence of efficacy and safety to support the approval of TNX-102 SL for PTSD.", "sentB": "TNX-102 SL 5.6 mg demonstrated a dose-effect on multiple efficacy and safety measurements in the AtEase study.", "type": 2, "words": ["<tag1>", "If", "the", "AtEase", "study", "achieves", "success", "in", "its", "primary", "outcome", "measure,", "it", "could", "serve", "as", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "establish", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "TNX-102", "SL", "5.6", "mg", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study.", "<tag3>"], "wordsA": ["If", "the", "AtEase", "study", "achieves", "success", "in", "its", "primary", "outcome", "measure,", "it", "could", "serve", "as", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "establish", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["TNX-102", "SL", "5.6", "mg", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p54_s2", "idA": "1430306_16_item1_p69_s1", "sentA": "If the AtEase study achieves success in its primary outcome measure, it could serve as one of the two pivotal studies required to establish sufficient evidence of efficacy and safety to support the approval of TNX-102 SL for PTSD.", "sentB": "If the exposures of TNX-102 SL (2 x 2.8 mg tablets) are less than the RLD maximum approved dose (30 mg) for the initial dose and at steady state, the results of this study will provide the necessary systemic exposure bridge of TNX-102 SL 5.6.mg to AMRIX 30 mg extended-release capsules and the approval of TNX-102 SL for PTSD can rely on the safety findings (clinical and nonclinical) of the currently approved cyclobenzaprine drug products.", "type": 2, "words": ["<tag1>", "If", "the", "AtEase", "study", "achieves", "success", "in", "its", "primary", "outcome", "measure,", "it", "could", "serve", "as", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "establish", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "If", "the", "exposures", "of", "TNX-102", "SL", "(2", "x", "2.8", "mg", "tablets)", "are", "less", "than", "the", "RLD", "maximum", "approved", "dose", "(30", "mg)", "for", "the", "initial", "dose", "and", "at", "steady", "state,", "the", "results", "of", "this", "study", "will", "provide", "the", "necessary", "systemic", "exposure", "bridge", "of", "TNX-102", "SL", "5.6.mg", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "and", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD", "can", "rely", "on", "the", "safety", "findings", "(clinical", "and", "nonclinical)", "of", "the", "currently", "approved", "cyclobenzaprine", "drug", "products.", "<tag3>"], "wordsA": ["If", "the", "AtEase", "study", "achieves", "success", "in", "its", "primary", "outcome", "measure,", "it", "could", "serve", "as", "one", "of", "the", "two", "pivotal", "studies", "required", "to", "establish", "sufficient", "evidence", "of", "efficacy", "and", "safety", "to", "support", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["If", "the", "exposures", "of", "TNX-102", "SL", "(2", "x", "2.8", "mg", "tablets)", "are", "less", "than", "the", "RLD", "maximum", "approved", "dose", "(30", "mg)", "for", "the", "initial", "dose", "and", "at", "steady", "state,", "the", "results", "of", "this", "study", "will", "provide", "the", "necessary", "systemic", "exposure", "bridge", "of", "TNX-102", "SL", "5.6.mg", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "and", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD", "can", "rely", "on", "the", "safety", "findings", "(clinical", "and", "nonclinical)", "of", "the", "currently", "approved", "cyclobenzaprine", "drug", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p36_s1", "idA": "1430306_16_item1_p69_s2", "sentA": "We expect to report top line results from the AtEase study in the second quarter of 2016.", "sentB": "We reported topline results from the AtEase study in May 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "top", "line", "results", "from", "the", "AtEase", "study", "in", "the", "second", "quarter", "of", "2016.", "<tag2>", "We", "reported", "topline", "results", "from", "the", "AtEase", "study", "in", "May", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "top", "line", "results", "from", "the", "AtEase", "study", "in", "the", "second", "quarter", "of", "2016."], "wordsB": ["We", "reported", "topline", "results", "from", "the", "AtEase", "study", "in", "May", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p6_s0", "idA": "1430306_16_item1_p6_s0", "sentA": "Tonix Pharmaceuticals Holding Corp., together with its subsidiaries (collectively we, our, us, Tonix or the Company ), is a clinical-stage pharmaceutical company dedicated to the invention and development of next-generation medicines.", "sentB": "Tonix Pharmaceuticals Holding Corp., together with its subsidiaries (collectively we, our, us, Tonix or the Company ), is a clinical-stage pharmaceutical company dedicated to the development of innovative pharmaceutical products to address public health challenges.", "type": 2, "words": ["<tag1>", "Tonix", "Pharmaceuticals", "Holding", "Corp.,", "together", "with", "its", "subsidiaries", "(collectively", "we,", "our,", "us,", "Tonix", "or", "the", "Company", "),", "is", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "invention", "and", "development", "of", "next-generation", "medicines.", "<tag2>", "Tonix", "Pharmaceuticals", "Holding", "Corp.,", "together", "with", "its", "subsidiaries", "(collectively", "we,", "our,", "us,", "Tonix", "or", "the", "Company", "),", "is", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "innovative", "pharmaceutical", "products", "to", "address", "public", "health", "challenges.", "<tag3>"], "wordsA": ["Tonix", "Pharmaceuticals", "Holding", "Corp.,", "together", "with", "its", "subsidiaries", "(collectively", "we,", "our,", "us,", "Tonix", "or", "the", "Company", "),", "is", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "invention", "and", "development", "of", "next-generation", "medicines."], "wordsB": ["Tonix", "Pharmaceuticals", "Holding", "Corp.,", "together", "with", "its", "subsidiaries", "(collectively", "we,", "our,", "us,", "Tonix", "or", "the", "Company", "),", "is", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "innovative", "pharmaceutical", "products", "to", "address", "public", "health", "challenges."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p6_s1", "idA": "1430306_16_item1_p6_s1", "sentA": "Our most advanced drug development programs are directed toward disorders affecting the central nervous system, or CNS, and include FM and post-traumatic stress disorder, or PTSD.", "sentB": "Our most advanced drug development program is focused on delivering an efficacious and safe long-term treatment for PTSD.", "type": 2, "words": ["<tag1>", "Our", "most", "advanced", "drug", "development", "programs", "are", "directed", "toward", "disorders", "affecting", "the", "central", "nervous", "system,", "or", "CNS,", "and", "include", "FM", "and", "post-traumatic", "stress", "disorder,", "or", "PTSD.", "<tag2>", "Our", "most", "advanced", "drug", "development", "program", "is", "focused", "on", "delivering", "an", "efficacious", "and", "safe", "long-term", "treatment", "for", "PTSD.", "<tag3>"], "wordsA": ["Our", "most", "advanced", "drug", "development", "programs", "are", "directed", "toward", "disorders", "affecting", "the", "central", "nervous", "system,", "or", "CNS,", "and", "include", "FM", "and", "post-traumatic", "stress", "disorder,", "or", "PTSD."], "wordsB": ["Our", "most", "advanced", "drug", "development", "program", "is", "focused", "on", "delivering", "an", "efficacious", "and", "safe", "long-term", "treatment", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p7_s0", "idA": "1430306_16_item1_p6_s2", "sentA": "These disorders are characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and significant economic burden.", "sentB": "PTSD is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and significant economic burden.", "type": 2, "words": ["<tag1>", "These", "disorders", "are", "characterized", "by", "chronic", "disability,", "inadequate", "treatment", "options,", "high", "utilization", "of", "healthcare", "services,", "and", "significant", "economic", "burden.", "<tag2>", "PTSD", "is", "characterized", "by", "chronic", "disability,", "inadequate", "treatment", "options,", "high", "utilization", "of", "healthcare", "services,", "and", "significant", "economic", "burden.", "<tag3>"], "wordsA": ["These", "disorders", "are", "characterized", "by", "chronic", "disability,", "inadequate", "treatment", "options,", "high", "utilization", "of", "healthcare", "services,", "and", "significant", "economic", "burden."], "wordsB": ["PTSD", "is", "characterized", "by", "chronic", "disability,", "inadequate", "treatment", "options,", "high", "utilization", "of", "healthcare", "services,", "and", "significant", "economic", "burden."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p57_s1", "idA": "1430306_16_item1_p70_s1", "sentA": "For Phase 3 trials and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "sentB": "For the HONOR study, the predominantly civilian PTSD Phase 3 study and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "type": 2, "words": ["<tag1>", "For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag2>", "For", "the", "HONOR", "study,", "the", "predominantly", "civilian", "PTSD", "Phase", "3", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag3>"], "wordsA": ["For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "wordsB": ["For", "the", "HONOR", "study,", "the", "predominantly", "civilian", "PTSD", "Phase", "3", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p87_s0", "idA": "1430306_16_item1_p70_s1", "sentA": "For Phase 3 trials and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "sentB": "On March 10, 2017, we received a notice of allowance from the PTO for the US patent No. 14/214,433 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride, which includes compositions of cyclobenzaprine HCl and methods of manufacturing the eutectic.", "type": 2, "words": ["<tag1>", "For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag2>", "On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "from", "the", "PTO", "for", "the", "US", "patent", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride,", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic.", "<tag3>"], "wordsA": ["For", "Phase", "3", "trials", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "wordsB": ["On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "from", "the", "PTO", "for", "the", "US", "patent", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride,", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p47_s0", "idA": "1430306_16_item1_p71_s1", "sentA": "An End-of-Phase 2 Chemistry, Manufacturing and Controls Meeting has been held in February 2016 to discuss the quality data requirement for the NDA filing.", "sentB": "We held an End-of-Phase 2 Chemistry, Manufacturing and Controls, or CMC, meeting with the FDA in February 2016 to discuss the quality data requirement for an NDA submission for TNX-102 SL.", "type": 2, "words": ["<tag1>", "An", "End-of-Phase", "2", "Chemistry,", "Manufacturing", "and", "Controls", "Meeting", "has", "been", "held", "in", "February", "2016", "to", "discuss", "the", "quality", "data", "requirement", "for", "the", "NDA", "filing.", "<tag2>", "We", "held", "an", "End-of-Phase", "2", "Chemistry,", "Manufacturing", "and", "Controls,", "or", "CMC,", "meeting", "with", "the", "FDA", "in", "February", "2016", "to", "discuss", "the", "quality", "data", "requirement", "for", "an", "NDA", "submission", "for", "TNX-102", "SL.", "<tag3>"], "wordsA": ["An", "End-of-Phase", "2", "Chemistry,", "Manufacturing", "and", "Controls", "Meeting", "has", "been", "held", "in", "February", "2016", "to", "discuss", "the", "quality", "data", "requirement", "for", "the", "NDA", "filing."], "wordsB": ["We", "held", "an", "End-of-Phase", "2", "Chemistry,", "Manufacturing", "and", "Controls,", "or", "CMC,", "meeting", "with", "the", "FDA", "in", "February", "2016", "to", "discuss", "the", "quality", "data", "requirement", "for", "an", "NDA", "submission", "for", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p50_s0", "idA": "1430306_16_item1_p73_s1", "sentA": "Based on our communications with the FDA to date, we believe that positive results from two adequate, well-controlled efficacy and safety studies and long-term (six- and 12-month) safety exposure studies (F203 and P202) would support FDA approval of TNX-102 SL for the management of PTSD.", "sentB": "In March 2017, we held the Initial Cross-Disciplinary Breakthrough Therapy Type B meeting with the FDA to discuss the opportunity to accelerate the development and submission of the TNX-102 SL NDA for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "communications", "with", "the", "FDA", "to", "date,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "(F203", "and", "P202)", "would", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "PTSD.", "<tag2>", "In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "TNX-102", "SL", "NDA", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["Based", "on", "our", "communications", "with", "the", "FDA", "to", "date,", "we", "believe", "that", "positive", "results", "from", "two", "adequate,", "well-controlled", "efficacy", "and", "safety", "studies", "and", "long-term", "(six-", "and", "12-month)", "safety", "exposure", "studies", "(F203", "and", "P202)", "would", "support", "FDA", "approval", "of", "TNX-102", "SL", "for", "the", "management", "of", "PTSD."], "wordsB": ["In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "TNX-102", "SL", "NDA", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p69_s3", "idA": "1430306_16_item1_p74_s1", "sentA": "If we achieve our primary outcome measure in the AtEase study, it could qualify as one of the two studies required to support the NDA.", "sentB": "At that meeting, the FDA advised us of the nonclinical studies required for this CDP IND application to support the initiation of the first-in-man study with TNX-301.", "type": 2, "words": ["<tag1>", "If", "we", "achieve", "our", "primary", "outcome", "measure", "in", "the", "AtEase", "study,", "it", "could", "qualify", "as", "one", "of", "the", "two", "studies", "required", "to", "support", "the", "NDA.", "<tag2>", "At", "that", "meeting,", "the", "FDA", "advised", "us", "of", "the", "nonclinical", "studies", "required", "for", "this", "CDP", "IND", "application", "to", "support", "the", "initiation", "of", "the", "first-in-man", "study", "with", "TNX-301.", "<tag3>"], "wordsA": ["If", "we", "achieve", "our", "primary", "outcome", "measure", "in", "the", "AtEase", "study,", "it", "could", "qualify", "as", "one", "of", "the", "two", "studies", "required", "to", "support", "the", "NDA."], "wordsB": ["At", "that", "meeting,", "the", "FDA", "advised", "us", "of", "the", "nonclinical", "studies", "required", "for", "this", "CDP", "IND", "application", "to", "support", "the", "initiation", "of", "the", "first-in-man", "study", "with", "TNX-301."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p142_s1", "idA": "1430306_16_item1_p75_s0", "sentA": "If the results from the AtEase study are positive, we plan to seek Fast Track Development and/or Breakthrough Therapy designation for TNX-102 SL in PTSD.", "sentB": "The Breakthrough Therapy designation request was submitted based on the preliminary clinical evidence of TNX 102-SL on military-related PTSD in the AtEase study.", "type": 2, "words": ["<tag1>", "If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "Fast", "Track", "Development", "and/or", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD.", "<tag2>", "The", "Breakthrough", "Therapy", "designation", "request", "was", "submitted", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study.", "<tag3>"], "wordsA": ["If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "Fast", "Track", "Development", "and/or", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD."], "wordsB": ["The", "Breakthrough", "Therapy", "designation", "request", "was", "submitted", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p48_s1", "idA": "1430306_16_item1_p75_s0", "sentA": "If the results from the AtEase study are positive, we plan to seek Fast Track Development and/or Breakthrough Therapy designation for TNX-102 SL in PTSD.", "sentB": "The Breakthrough Therapy designation request was based on the preliminary clinical evidence of TNX 102-SL on military-related PTSD in the AtEase study.", "type": 2, "words": ["<tag1>", "If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "Fast", "Track", "Development", "and/or", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD.", "<tag2>", "The", "Breakthrough", "Therapy", "designation", "request", "was", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study.", "<tag3>"], "wordsA": ["If", "the", "results", "from", "the", "AtEase", "study", "are", "positive,", "we", "plan", "to", "seek", "Fast", "Track", "Development", "and/or", "Breakthrough", "Therapy", "designation", "for", "TNX-102", "SL", "in", "PTSD."], "wordsB": ["The", "Breakthrough", "Therapy", "designation", "request", "was", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p37_s1", "idA": "1430306_16_item1_p78_s2", "sentA": "This trial was conducted at approximately 10 U.S. centers and randomized approximately 150 patients to receive TNX-201 140 mg or placebo capsules.", "sentB": "This study was conducted at 24 U.S. centers and enrolled 231 patients in the modified intent-to-treat population.", "type": 2, "words": ["<tag1>", "This", "trial", "was", "conducted", "at", "approximately", "10", "U.S.", "centers", "and", "randomized", "approximately", "150", "patients", "to", "receive", "TNX-201", "140", "mg", "or", "placebo", "capsules.", "<tag2>", "This", "study", "was", "conducted", "at", "24", "U.S.", "centers", "and", "enrolled", "231", "patients", "in", "the", "modified", "intent-to-treat", "population.", "<tag3>"], "wordsA": ["This", "trial", "was", "conducted", "at", "approximately", "10", "U.S.", "centers", "and", "randomized", "approximately", "150", "patients", "to", "receive", "TNX-201", "140", "mg", "or", "placebo", "capsules."], "wordsB": ["This", "study", "was", "conducted", "at", "24", "U.S.", "centers", "and", "enrolled", "231", "patients", "in", "the", "modified", "intent-to-treat", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p58_s0", "idA": "1430306_16_item1_p79_s0", "sentA": "We also have a pipeline of other product candidates, including TNX-301.", "sentB": "We also have a pipeline of other drug and biologic candidates, including two pre-IND candidates, TNX-601 for PTSD and TNX-801, a biologic vaccine product for the prevention of smallpox, as well as an IND candidate, TNX-301, a potential treatment for AUD.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-301.", "<tag2>", "We", "also", "have", "a", "pipeline", "of", "other", "drug", "and", "biologic", "candidates,", "including", "two", "pre-IND", "candidates,", "TNX-601", "for", "PTSD", "and", "TNX-801,", "a", "biologic", "vaccine", "product", "for", "the", "prevention", "of", "smallpox,", "as", "well", "as", "an", "IND", "candidate,", "TNX-301,", "a", "potential", "treatment", "for", "AUD.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "pipeline", "of", "other", "product", "candidates,", "including", "TNX-301."], "wordsB": ["We", "also", "have", "a", "pipeline", "of", "other", "drug", "and", "biologic", "candidates,", "including", "two", "pre-IND", "candidates,", "TNX-601", "for", "PTSD", "and", "TNX-801,", "a", "biologic", "vaccine", "product", "for", "the", "prevention", "of", "smallpox,", "as", "well", "as", "an", "IND", "candidate,", "TNX-301,", "a", "potential", "treatment", "for", "AUD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p8_s1", "idA": "1430306_16_item1_p7_s1", "sentA": "We complement our management team with a network of scientific, clinical, and regulatory advisors that includes recognized experts in the fields of FM, PTSD and other central nervous system disorders.", "sentB": "We complement our management team with a network of scientific, clinical, and regulatory advisors that includes recognized experts in the fields of PTSD and other central nervous system disorders.", "type": 2, "words": ["<tag1>", "We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "FM,", "PTSD", "and", "other", "central", "nervous", "system", "disorders.", "<tag2>", "We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "PTSD", "and", "other", "central", "nervous", "system", "disorders.", "<tag3>"], "wordsA": ["We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "FM,", "PTSD", "and", "other", "central", "nervous", "system", "disorders."], "wordsB": ["We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "PTSD", "and", "other", "central", "nervous", "system", "disorders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p146_s2", "idA": "1430306_16_item1_p80_s1", "sentA": "We intend to develop TNX-301 CDP under Section 505(b)(2) of the FDCA as a potential treatment for AUD, and we have commenced development work on TNX-301 formulations.", "sentB": "We intend to seek a priority voucher for TNX-801 as a material threat medical countermeasure.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations.", "<tag2>", "We", "intend", "to", "seek", "a", "priority", "voucher", "for", "TNX-801", "as", "a", "material", "threat", "medical", "countermeasure.", "<tag3>"], "wordsA": ["We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations."], "wordsB": ["We", "intend", "to", "seek", "a", "priority", "voucher", "for", "TNX-801", "as", "a", "material", "threat", "medical", "countermeasure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p54_s0", "idA": "1430306_16_item1_p80_s1", "sentA": "We intend to develop TNX-301 CDP under Section 505(b)(2) of the FDCA as a potential treatment for AUD, and we have commenced development work on TNX-301 formulations.", "sentB": "We intend to seek FDA marketing approval for TNX-102 SL pursuant to Section 505(b)(2) of the FDCA using AMRIX extended-release capsules (30 mg) as our reference listed drug, or RLD.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations.", "<tag2>", "We", "intend", "to", "seek", "FDA", "marketing", "approval", "for", "TNX-102", "SL", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "FDCA", "using", "AMRIX", "extended-release", "capsules", "(30", "mg)", "as", "our", "reference", "listed", "drug,", "or", "RLD.", "<tag3>"], "wordsA": ["We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations."], "wordsB": ["We", "intend", "to", "seek", "FDA", "marketing", "approval", "for", "TNX-102", "SL", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "FDCA", "using", "AMRIX", "extended-release", "capsules", "(30", "mg)", "as", "our", "reference", "listed", "drug,", "or", "RLD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p64_s1", "idA": "1430306_16_item1_p80_s1", "sentA": "We intend to develop TNX-301 CDP under Section 505(b)(2) of the FDCA as a potential treatment for AUD, and we have commenced development work on TNX-301 formulations.", "sentB": "We intend to develop TNX-601 under Section 505(b)(1) of the FDCA as a potential treatment for PTSD and cognitive dysfunction associated with corticosteroid use.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations.", "<tag2>", "We", "intend", "to", "develop", "TNX-601", "under", "Section", "505(b)(1)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "PTSD", "and", "cognitive", "dysfunction", "associated", "with", "corticosteroid", "use.", "<tag3>"], "wordsA": ["We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations."], "wordsB": ["We", "intend", "to", "develop", "TNX-601", "under", "Section", "505(b)(1)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "PTSD", "and", "cognitive", "dysfunction", "associated", "with", "corticosteroid", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p64_s2", "idA": "1430306_16_item1_p80_s1", "sentA": "We intend to develop TNX-301 CDP under Section 505(b)(2) of the FDCA as a potential treatment for AUD, and we have commenced development work on TNX-301 formulations.", "sentB": "Pharmaceutical development work on TNX-601 has been initiated.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations.", "<tag2>", "Pharmaceutical", "development", "work", "on", "TNX-601", "has", "been", "initiated.", "<tag3>"], "wordsA": ["We", "intend", "to", "develop", "TNX-301", "CDP", "under", "Section", "505(b)(2)", "of", "the", "FDCA", "as", "a", "potential", "treatment", "for", "AUD,", "and", "we", "have", "commenced", "development", "work", "on", "TNX-301", "formulations."], "wordsB": ["Pharmaceutical", "development", "work", "on", "TNX-601", "has", "been", "initiated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p69_s2", "idA": "1430306_16_item1_p80_s2", "sentA": "We held a Pre-IND Meeting with the FDA in February 2016 to discuss the clinical development of TNX-301 for AUD.", "sentB": "A pre-IND meeting was held in February 2016 to discuss the clinical development program of TNX-301 for AUD.", "type": 2, "words": ["<tag1>", "We", "held", "a", "Pre-IND", "Meeting", "with", "the", "FDA", "in", "February", "2016", "to", "discuss", "the", "clinical", "development", "of", "TNX-301", "for", "AUD.", "<tag2>", "A", "pre-IND", "meeting", "was", "held", "in", "February", "2016", "to", "discuss", "the", "clinical", "development", "program", "of", "TNX-301", "for", "AUD.", "<tag3>"], "wordsA": ["We", "held", "a", "Pre-IND", "Meeting", "with", "the", "FDA", "in", "February", "2016", "to", "discuss", "the", "clinical", "development", "of", "TNX-301", "for", "AUD."], "wordsB": ["A", "pre-IND", "meeting", "was", "held", "in", "February", "2016", "to", "discuss", "the", "clinical", "development", "program", "of", "TNX-301", "for", "AUD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p95_s1", "idA": "1430306_16_item1_p80_s3", "sentA": "As of the date of this filing, we have not received the FDA official minutes from the meeting.", "sentB": "For protection of intellectual property, we have not disclosed the identity of the new development candidate.", "type": 2, "words": ["<tag1>", "As", "of", "the", "date", "of", "this", "filing,", "we", "have", "not", "received", "the", "FDA", "official", "minutes", "from", "the", "meeting.", "<tag2>", "For", "protection", "of", "intellectual", "property,", "we", "have", "not", "disclosed", "the", "identity", "of", "the", "new", "development", "candidate.", "<tag3>"], "wordsA": ["As", "of", "the", "date", "of", "this", "filing,", "we", "have", "not", "received", "the", "FDA", "official", "minutes", "from", "the", "meeting."], "wordsB": ["For", "protection", "of", "intellectual", "property,", "we", "have", "not", "disclosed", "the", "identity", "of", "the", "new", "development", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p70_s0", "idA": "1430306_16_item1_p81_s0", "sentA": "In addition, we own rights to intellectual property on two biodefense technologies: one relating to the development of novel smallpox vaccines; and the other to the development of protective agents against radiation exposure.", "sentB": "In addition, we own rights to intellectual property on a biodefense technology relating to the development of protective agents against radiation exposure, which we refer to as TNX-701.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "own", "rights", "to", "intellectual", "property", "on", "two", "biodefense", "technologies:", "one", "relating", "to", "the", "development", "of", "novel", "smallpox", "vaccines;", "and", "the", "other", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure.", "<tag2>", "In", "addition,", "we", "own", "rights", "to", "intellectual", "property", "on", "a", "biodefense", "technology", "relating", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure,", "which", "we", "refer", "to", "as", "TNX-701.", "<tag3>"], "wordsA": ["In", "addition,", "we", "own", "rights", "to", "intellectual", "property", "on", "two", "biodefense", "technologies:", "one", "relating", "to", "the", "development", "of", "novel", "smallpox", "vaccines;", "and", "the", "other", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure."], "wordsB": ["In", "addition,", "we", "own", "rights", "to", "intellectual", "property", "on", "a", "biodefense", "technology", "relating", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure,", "which", "we", "refer", "to", "as", "TNX-701."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p70_s1", "idA": "1430306_16_item1_p81_s1", "sentA": "We have begun non-clinical research and development on these programs.", "sentB": "We have begun nonclinical research and development on TNX-701.", "type": 2, "words": ["<tag1>", "We", "have", "begun", "non-clinical", "research", "and", "development", "on", "these", "programs.", "<tag2>", "We", "have", "begun", "nonclinical", "research", "and", "development", "on", "TNX-701.", "<tag3>"], "wordsA": ["We", "have", "begun", "non-clinical", "research", "and", "development", "on", "these", "programs."], "wordsB": ["We", "have", "begun", "nonclinical", "research", "and", "development", "on", "TNX-701."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p70_s3", "idA": "1430306_16_item1_p82_s1", "sentA": "As a result, the licensure of these biodefense products in the U.S. may not require human efficacy studies, which we believe will reduce our development costs and risks compared to the development of other NCEs or new biologic candidates.", "sentB": "We expect significant reduction in development costs and risks compared to the development of other NCEs or new biologic candidates.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "the", "licensure", "of", "these", "biodefense", "products", "in", "the", "U.S.", "may", "not", "require", "human", "efficacy", "studies,", "which", "we", "believe", "will", "reduce", "our", "development", "costs", "and", "risks", "compared", "to", "the", "development", "of", "other", "NCEs", "or", "new", "biologic", "candidates.", "<tag2>", "We", "expect", "significant", "reduction", "in", "development", "costs", "and", "risks", "compared", "to", "the", "development", "of", "other", "NCEs", "or", "new", "biologic", "candidates.", "<tag3>"], "wordsA": ["As", "a", "result,", "the", "licensure", "of", "these", "biodefense", "products", "in", "the", "U.S.", "may", "not", "require", "human", "efficacy", "studies,", "which", "we", "believe", "will", "reduce", "our", "development", "costs", "and", "risks", "compared", "to", "the", "development", "of", "other", "NCEs", "or", "new", "biologic", "candidates."], "wordsB": ["We", "expect", "significant", "reduction", "in", "development", "costs", "and", "risks", "compared", "to", "the", "development", "of", "other", "NCEs", "or", "new", "biologic", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p72_s0", "idA": "1430306_16_item1_p84_s0", "sentA": "The markets for medicines to treat FM, PTSD and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "sentB": "The markets for medicines to treat PTSD and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "type": 2, "words": ["<tag1>", "The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag2>", "The", "markets", "for", "medicines", "to", "treat", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag3>"], "wordsA": ["The", "markets", "for", "medicines", "to", "treat", "FM,", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "wordsB": ["The", "markets", "for", "medicines", "to", "treat", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p75_s1", "idA": "1430306_16_item1_p86_s0", "sentA": "A number of companies are developing prescription medications for FM, including Allergan, Daiichi Sankyo, Meda, Merck, Pfizer, RiboCor and Theravance.", "sentB": "Additionally, a number of companies are working on vaccines/treatments for smallpox, including Bavarian Nordic, SIGA and Chimerix.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "FM,", "including", "Allergan,", "Daiichi", "Sankyo,", "Meda,", "Merck,", "Pfizer,", "RiboCor", "and", "Theravance.", "<tag2>", "Additionally,", "a", "number", "of", "companies", "are", "working", "on", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "and", "Chimerix.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "FM,", "including", "Allergan,", "Daiichi", "Sankyo,", "Meda,", "Merck,", "Pfizer,", "RiboCor", "and", "Theravance."], "wordsB": ["Additionally,", "a", "number", "of", "companies", "are", "working", "on", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "and", "Chimerix."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p68_s0", "idA": "1430306_16_item1_p86_s1", "sentA": "Clinical trials in the U.S. are registered with the FDA and reported on the website www.clinicaltrials.gov.", "sentB": "In the 1970s, vaccination against smallpox was discontinued in the U.S.; however, smallpox remains a material threat to national security.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov.", "<tag2>", "In", "the", "1970s,", "vaccination", "against", "smallpox", "was", "discontinued", "in", "the", "U.S.;", "however,", "smallpox", "remains", "a", "material", "threat", "to", "national", "security.", "<tag3>"], "wordsA": ["Clinical", "trials", "in", "the", "U.S.", "are", "registered", "with", "the", "FDA", "and", "reported", "on", "the", "website", "www.clinicaltrials.gov."], "wordsB": ["In", "the", "1970s,", "vaccination", "against", "smallpox", "was", "discontinued", "in", "the", "U.S.;", "however,", "smallpox", "remains", "a", "material", "threat", "to", "national", "security."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p73_s0", "idA": "1430306_16_item1_p88_s0", "sentA": "A number of companies are developing prescription medications for PTSD, including Actavis, Bionomics, Johnson and Johnson, Lundbeck, Marinus Pharmaceuticals, Merck, Otsuka, and Pfizer.", "sentB": "Certain other companies and institutions are known to be developing prescription medications for PTSD, including Bionomics (BNC-201), Otsuka/Lundbeck (Rexulti [brexpiprazole]), Uniformed Services University of the Health Sciences (riluzole) and the Multidisciplinary Association of Psychedelic Studies ( methylenedioxymethamphetamine [MDMA]).", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Bionomics,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer.", "<tag2>", "Certain", "other", "companies", "and", "institutions", "are", "known", "to", "be", "developing", "prescription", "medications", "for", "PTSD,", "including", "Bionomics", "(BNC-201),", "Otsuka/Lundbeck", "(Rexulti", "[brexpiprazole]),", "Uniformed", "Services", "University", "of", "the", "Health", "Sciences", "(riluzole)", "and", "the", "Multidisciplinary", "Association", "of", "Psychedelic", "Studies", "(", "methylenedioxymethamphetamine", "[MDMA]).", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Bionomics,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer."], "wordsB": ["Certain", "other", "companies", "and", "institutions", "are", "known", "to", "be", "developing", "prescription", "medications", "for", "PTSD,", "including", "Bionomics", "(BNC-201),", "Otsuka/Lundbeck", "(Rexulti", "[brexpiprazole]),", "Uniformed", "Services", "University", "of", "the", "Health", "Sciences", "(riluzole)", "and", "the", "Multidisciplinary", "Association", "of", "Psychedelic", "Studies", "(", "methylenedioxymethamphetamine", "[MDMA])."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p74_s5", "idA": "1430306_16_item1_p88_s0", "sentA": "A number of companies are developing prescription medications for PTSD, including Actavis, Bionomics, Johnson and Johnson, Lundbeck, Marinus Pharmaceuticals, Merck, Otsuka, and Pfizer.", "sentB": "A number of other companies have or may be developing prescription medications for PTSD, including Actavis, Johnson and Johnson, Marinus Pharmaceuticals, Merck, and Pfizer.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Bionomics,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer.", "<tag2>", "A", "number", "of", "other", "companies", "have", "or", "may", "be", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Johnson", "and", "Johnson,", "Marinus", "Pharmaceuticals,", "Merck,", "and", "Pfizer.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "are", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Bionomics,", "Johnson", "and", "Johnson,", "Lundbeck,", "Marinus", "Pharmaceuticals,", "Merck,", "Otsuka,", "and", "Pfizer."], "wordsB": ["A", "number", "of", "other", "companies", "have", "or", "may", "be", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Johnson", "and", "Johnson,", "Marinus", "Pharmaceuticals,", "Merck,", "and", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p91_s1", "idA": "1430306_16_item1_p89_s1", "sentA": "Our patent portfolio, described more fully below, includes claims directed to TNX-102 SL compositions and methods of use.", "sentB": "It includes claims directed to composition, including pharmaceutical compositions, and methods of use.", "type": 2, "words": ["<tag1>", "Our", "patent", "portfolio,", "described", "more", "fully", "below,", "includes", "claims", "directed", "to", "TNX-102", "SL", "compositions", "and", "methods", "of", "use.", "<tag2>", "It", "includes", "claims", "directed", "to", "composition,", "including", "pharmaceutical", "compositions,", "and", "methods", "of", "use.", "<tag3>"], "wordsA": ["Our", "patent", "portfolio,", "described", "more", "fully", "below,", "includes", "claims", "directed", "to", "TNX-102", "SL", "compositions", "and", "methods", "of", "use."], "wordsB": ["It", "includes", "claims", "directed", "to", "composition,", "including", "pharmaceutical", "compositions,", "and", "methods", "of", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p77_s2", "idA": "1430306_16_item1_p89_s2", "sentA": "As of March 1, 2016, we are either the owner of record of or own the contractual right to five issued U.S. patents and 26 issued non-U.S. patents.", "sentB": "As of March 31, 2017, the patents we are either the owner of record of or own the contractual right to include three issued U.S. patents and 16 issued non-U.S. patents.", "type": 2, "words": ["<tag1>", "As", "of", "March", "1,", "2016,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "26", "issued", "non-U.S.", "patents.", "<tag2>", "As", "of", "March", "31,", "2017,", "the", "patents", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "include", "three", "issued", "U.S.", "patents", "and", "16", "issued", "non-U.S.", "patents.", "<tag3>"], "wordsA": ["As", "of", "March", "1,", "2016,", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "five", "issued", "U.S.", "patents", "and", "26", "issued", "non-U.S.", "patents."], "wordsB": ["As", "of", "March", "31,", "2017,", "the", "patents", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "include", "three", "issued", "U.S.", "patents", "and", "16", "issued", "non-U.S.", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p77_s3", "idA": "1430306_16_item1_p89_s3", "sentA": "We are actively pursuing an additional 17 U.S. patent applications, of which six are provisional and 11 are non-provisional, five international patent applications, and 70 non-U.S./non-international patent applications.", "sentB": "We are actively pursuing an additional 15 U.S. patent applications, of which four are provisional and 11 are non-provisional, one international patent application, and 71 non-U.S./non-international patent applications.", "type": 2, "words": ["<tag1>", "We", "are", "actively", "pursuing", "an", "additional", "17", "U.S.", "patent", "applications,", "of", "which", "six", "are", "provisional", "and", "11", "are", "non-provisional,", "five", "international", "patent", "applications,", "and", "70", "non-U.S./non-international", "patent", "applications.", "<tag2>", "We", "are", "actively", "pursuing", "an", "additional", "15", "U.S.", "patent", "applications,", "of", "which", "four", "are", "provisional", "and", "11", "are", "non-provisional,", "one", "international", "patent", "application,", "and", "71", "non-U.S./non-international", "patent", "applications.", "<tag3>"], "wordsA": ["We", "are", "actively", "pursuing", "an", "additional", "17", "U.S.", "patent", "applications,", "of", "which", "six", "are", "provisional", "and", "11", "are", "non-provisional,", "five", "international", "patent", "applications,", "and", "70", "non-U.S./non-international", "patent", "applications."], "wordsB": ["We", "are", "actively", "pursuing", "an", "additional", "15", "U.S.", "patent", "applications,", "of", "which", "four", "are", "provisional", "and", "11", "are", "non-provisional,", "one", "international", "patent", "application,", "and", "71", "non-U.S./non-international", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p9_s0", "idA": "1430306_16_item1_p8_s0", "sentA": "Our lead product candidate, TNX-102 SL (cyclobenzaprine HCl sublingual tablets) is in Phase 3 clinical development as a potential treatment for FM.", "sentB": "Our lead product candidate, TNX-102 SL, a proprietary low-dose cyclobenzaprine sublingual tablet, designed for bedtime administration, is in Phase 3 development as a potential treatment for PTSD.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate,", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "is", "in", "Phase", "3", "clinical", "development", "as", "a", "potential", "treatment", "for", "FM.", "<tag2>", "Our", "lead", "product", "candidate,", "TNX-102", "SL,", "a", "proprietary", "low-dose", "cyclobenzaprine", "sublingual", "tablet,", "designed", "for", "bedtime", "administration,", "is", "in", "Phase", "3", "development", "as", "a", "potential", "treatment", "for", "PTSD.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate,", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "is", "in", "Phase", "3", "clinical", "development", "as", "a", "potential", "treatment", "for", "FM."], "wordsB": ["Our", "lead", "product", "candidate,", "TNX-102", "SL,", "a", "proprietary", "low-dose", "cyclobenzaprine", "sublingual", "tablet,", "designed", "for", "bedtime", "administration,", "is", "in", "Phase", "3", "development", "as", "a", "potential", "treatment", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p63_s1", "idA": "1430306_16_item1_p8_s1", "sentA": "In addition, TNX-102 SL is in Phase 2 clinical development as a potential treatment for PTSD.", "sentB": "In addition to being used to treat depression, several published studies support the potential of tianeptine as a potentially effective and safe therapy for patients with PTSD.", "type": 2, "words": ["<tag1>", "In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD.", "<tag2>", "In", "addition", "to", "being", "used", "to", "treat", "depression,", "several", "published", "studies", "support", "the", "potential", "of", "tianeptine", "as", "a", "potentially", "effective", "and", "safe", "therapy", "for", "patients", "with", "PTSD.", "<tag3>"], "wordsA": ["In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD."], "wordsB": ["In", "addition", "to", "being", "used", "to", "treat", "depression,", "several", "published", "studies", "support", "the", "potential", "of", "tianeptine", "as", "a", "potentially", "effective", "and", "safe", "therapy", "for", "patients", "with", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p63_s2", "idA": "1430306_16_item1_p8_s1", "sentA": "In addition, TNX-102 SL is in Phase 2 clinical development as a potential treatment for PTSD.", "sentB": "Leveraging our development expertise in PTSD, TNX-601 is being developed for daytime usage as a first-line monotherapy for PTSD.", "type": 2, "words": ["<tag1>", "In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD.", "<tag2>", "Leveraging", "our", "development", "expertise", "in", "PTSD,", "TNX-601", "is", "being", "developed", "for", "daytime", "usage", "as", "a", "first-line", "monotherapy", "for", "PTSD.", "<tag3>"], "wordsA": ["In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD."], "wordsB": ["Leveraging", "our", "development", "expertise", "in", "PTSD,", "TNX-601", "is", "being", "developed", "for", "daytime", "usage", "as", "a", "first-line", "monotherapy", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p74_s0", "idA": "1430306_16_item1_p8_s1", "sentA": "In addition, TNX-102 SL is in Phase 2 clinical development as a potential treatment for PTSD.", "sentB": "BNC-201 is in Phase 2 for civilian PTSD and is an allosteric modulator of the alpha 7 nicotinic acetylcholine receptor.", "type": 2, "words": ["<tag1>", "In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD.", "<tag2>", "BNC-201", "is", "in", "Phase", "2", "for", "civilian", "PTSD", "and", "is", "an", "allosteric", "modulator", "of", "the", "alpha", "7", "nicotinic", "acetylcholine", "receptor.", "<tag3>"], "wordsA": ["In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD."], "wordsB": ["BNC-201", "is", "in", "Phase", "2", "for", "civilian", "PTSD", "and", "is", "an", "allosteric", "modulator", "of", "the", "alpha", "7", "nicotinic", "acetylcholine", "receptor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p74_s1", "idA": "1430306_16_item1_p8_s1", "sentA": "In addition, TNX-102 SL is in Phase 2 clinical development as a potential treatment for PTSD.", "sentB": "Rexulti is in Phase 2 for PTSD and is an atypical antipsychotic.", "type": 2, "words": ["<tag1>", "In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD.", "<tag2>", "Rexulti", "is", "in", "Phase", "2", "for", "PTSD", "and", "is", "an", "atypical", "antipsychotic.", "<tag3>"], "wordsA": ["In", "addition,", "TNX-102", "SL", "is", "in", "Phase", "2", "clinical", "development", "as", "a", "potential", "treatment", "for", "PTSD."], "wordsB": ["Rexulti", "is", "in", "Phase", "2", "for", "PTSD", "and", "is", "an", "atypical", "antipsychotic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p9_s1", "idA": "1430306_16_item1_p8_s2", "sentA": "Our nonclinical pipeline includes a development program for the treatment of alcohol use disorders, or AUD, as well as two biodefense development programs for protection from smallpox virus and from radiation injury.", "sentB": "Our development pipeline includes: TNX-601 (tianeptine oxalate), a separate pre-IND (Investigational New Drug) candidate designed for daytime administration for the treatment of PTSD and cognitive dysfunction associated with steroid use; TNX-801, a potential smallpox-preventing vaccine based on a live synthetic version of horsepox virus, or HPXV; TNX-301 an IND candidate for the treatment of alcohol use disorders, or AUD; and TNX-701, a biodefense development program for protection from radiation injury.", "type": 2, "words": ["<tag1>", "Our", "nonclinical", "pipeline", "includes", "a", "development", "program", "for", "the", "treatment", "of", "alcohol", "use", "disorders,", "or", "AUD,", "as", "well", "as", "two", "biodefense", "development", "programs", "for", "protection", "from", "smallpox", "virus", "and", "from", "radiation", "injury.", "<tag2>", "Our", "development", "pipeline", "includes:", "TNX-601", "(tianeptine", "oxalate),", "a", "separate", "pre-IND", "(Investigational", "New", "Drug)", "candidate", "designed", "for", "daytime", "administration", "for", "the", "treatment", "of", "PTSD", "and", "cognitive", "dysfunction", "associated", "with", "steroid", "use;", "TNX-801,", "a", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "horsepox", "virus,", "or", "HPXV;", "TNX-301", "an", "IND", "candidate", "for", "the", "treatment", "of", "alcohol", "use", "disorders,", "or", "AUD;", "and", "TNX-701,", "a", "biodefense", "development", "program", "for", "protection", "from", "radiation", "injury.", "<tag3>"], "wordsA": ["Our", "nonclinical", "pipeline", "includes", "a", "development", "program", "for", "the", "treatment", "of", "alcohol", "use", "disorders,", "or", "AUD,", "as", "well", "as", "two", "biodefense", "development", "programs", "for", "protection", "from", "smallpox", "virus", "and", "from", "radiation", "injury."], "wordsB": ["Our", "development", "pipeline", "includes:", "TNX-601", "(tianeptine", "oxalate),", "a", "separate", "pre-IND", "(Investigational", "New", "Drug)", "candidate", "designed", "for", "daytime", "administration", "for", "the", "treatment", "of", "PTSD", "and", "cognitive", "dysfunction", "associated", "with", "steroid", "use;", "TNX-801,", "a", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "horsepox", "virus,", "or", "HPXV;", "TNX-301", "an", "IND", "candidate", "for", "the", "treatment", "of", "alcohol", "use", "disorders,", "or", "AUD;", "and", "TNX-701,", "a", "biodefense", "development", "program", "for", "protection", "from", "radiation", "injury."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p143_s2", "idA": "1430306_16_item1_p90_s2", "sentA": "We also rely on trade secrets that may be important to the development of our business.", "sentB": "The FDA is committing to provide us timely advice and interactive communications related to the design and efficient execution of our drug development program.", "type": 2, "words": ["<tag1>", "We", "also", "rely", "on", "trade", "secrets", "that", "may", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag2>", "The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "drug", "development", "program.", "<tag3>"], "wordsA": ["We", "also", "rely", "on", "trade", "secrets", "that", "may", "be", "important", "to", "the", "development", "of", "our", "business."], "wordsB": ["The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "drug", "development", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p49_s2", "idA": "1430306_16_item1_p90_s2", "sentA": "We also rely on trade secrets that may be important to the development of our business.", "sentB": "The FDA is committing to provide us timely advice and interactive communications related to the design and efficient execution of our drug development program.", "type": 2, "words": ["<tag1>", "We", "also", "rely", "on", "trade", "secrets", "that", "may", "be", "important", "to", "the", "development", "of", "our", "business.", "<tag2>", "The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "drug", "development", "program.", "<tag3>"], "wordsA": ["We", "also", "rely", "on", "trade", "secrets", "that", "may", "be", "important", "to", "the", "development", "of", "our", "business."], "wordsB": ["The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "drug", "development", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p16_s3", "idA": "1430306_16_item1_p94_s0", "sentA": "In the United States, a patent s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office, or PTO, in granting a patent, or may be shortened if a patent is terminally disclaimed over another patent.", "sentB": "We recently received a Notice of Allowance from the U.S. Patent and Trademark Office, or PTO, for patent claims the will protect the pharmaceutical eutectic composition of TNX-102 SL until 2034.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "a", "patent", "s", "term", "may", "be", "lengthened", "by", "patent", "term", "adjustment,", "which", "compensates", "a", "patentee", "for", "administrative", "delays", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "in", "granting", "a", "patent,", "or", "may", "be", "shortened", "if", "a", "patent", "is", "terminally", "disclaimed", "over", "another", "patent.", "<tag2>", "We", "recently", "received", "a", "Notice", "of", "Allowance", "from", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "for", "patent", "claims", "the", "will", "protect", "the", "pharmaceutical", "eutectic", "composition", "of", "TNX-102", "SL", "until", "2034.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "a", "patent", "s", "term", "may", "be", "lengthened", "by", "patent", "term", "adjustment,", "which", "compensates", "a", "patentee", "for", "administrative", "delays", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "in", "granting", "a", "patent,", "or", "may", "be", "shortened", "if", "a", "patent", "is", "terminally", "disclaimed", "over", "another", "patent."], "wordsB": ["We", "recently", "received", "a", "Notice", "of", "Allowance", "from", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "for", "patent", "claims", "the", "will", "protect", "the", "pharmaceutical", "eutectic", "composition", "of", "TNX-102", "SL", "until", "2034."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p82_s0", "idA": "1430306_16_item1_p94_s0", "sentA": "In the United States, a patent s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office, or PTO, in granting a patent, or may be shortened if a patent is terminally disclaimed over another patent.", "sentB": "In the United States, a patent s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the PTO in granting a patent, or may be shortened if a patent is terminally disclaimed over another patent.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "a", "patent", "s", "term", "may", "be", "lengthened", "by", "patent", "term", "adjustment,", "which", "compensates", "a", "patentee", "for", "administrative", "delays", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "in", "granting", "a", "patent,", "or", "may", "be", "shortened", "if", "a", "patent", "is", "terminally", "disclaimed", "over", "another", "patent.", "<tag2>", "In", "the", "United", "States,", "a", "patent", "s", "term", "may", "be", "lengthened", "by", "patent", "term", "adjustment,", "which", "compensates", "a", "patentee", "for", "administrative", "delays", "by", "the", "PTO", "in", "granting", "a", "patent,", "or", "may", "be", "shortened", "if", "a", "patent", "is", "terminally", "disclaimed", "over", "another", "patent.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "a", "patent", "s", "term", "may", "be", "lengthened", "by", "patent", "term", "adjustment,", "which", "compensates", "a", "patentee", "for", "administrative", "delays", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "in", "granting", "a", "patent,", "or", "may", "be", "shortened", "if", "a", "patent", "is", "terminally", "disclaimed", "over", "another", "patent."], "wordsB": ["In", "the", "United", "States,", "a", "patent", "s", "term", "may", "be", "lengthened", "by", "patent", "term", "adjustment,", "which", "compensates", "a", "patentee", "for", "administrative", "delays", "by", "the", "PTO", "in", "granting", "a", "patent,", "or", "may", "be", "shortened", "if", "a", "patent", "is", "terminally", "disclaimed", "over", "another", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p34_s2", "idA": "1430306_16_item1_p95_s1", "sentA": "The Hatch-Waxman Amendments permit a patent term extension of up to five years beyond the statutory 20-year term of the patent for the approved product if the active ingredient has not been previously approved in the U.S.", "sentB": "A Notice of Allowance signifies that we will be entitled to receive patent protection until 2034 in the U.S. for the allowed claims when the patent is issued.", "type": 2, "words": ["<tag1>", "The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20-year", "term", "of", "the", "patent", "for", "the", "approved", "product", "if", "the", "active", "ingredient", "has", "not", "been", "previously", "approved", "in", "the", "U.S.", "<tag2>", "A", "Notice", "of", "Allowance", "signifies", "that", "we", "will", "be", "entitled", "to", "receive", "patent", "protection", "until", "2034", "in", "the", "U.S.", "for", "the", "allowed", "claims", "when", "the", "patent", "is", "issued.", "<tag3>"], "wordsA": ["The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20-year", "term", "of", "the", "patent", "for", "the", "approved", "product", "if", "the", "active", "ingredient", "has", "not", "been", "previously", "approved", "in", "the", "U.S."], "wordsB": ["A", "Notice", "of", "Allowance", "signifies", "that", "we", "will", "be", "entitled", "to", "receive", "patent", "protection", "until", "2034", "in", "the", "U.S.", "for", "the", "allowed", "claims", "when", "the", "patent", "is", "issued."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p84_s0", "idA": "1430306_16_item1_p96_s0", "sentA": "The patent portfolios for our proprietary technology platform and our three most advanced product candidates as of March 1, 2016 are summarized below.", "sentB": "The patent portfolios for our proprietary technology platform and our three most advanced product candidates as of March 31, 2017 are summarized below.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "1,", "2016", "are", "summarized", "below.", "<tag2>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "31,", "2017", "are", "summarized", "below.", "<tag3>"], "wordsA": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "1,", "2016", "are", "summarized", "below."], "wordsB": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "31,", "2017", "are", "summarized", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p85_s0", "idA": "1430306_16_item1_p97_s0", "sentA": "Our patent portfolio for TNX-102 SL includes patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating FM and other CNS conditions utilizing these compositions and formulations.", "sentB": "Our patent portfolio for TNX-102 SL includes patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating CNS conditions utilizing these compositions and formulations.", "type": 2, "words": ["<tag1>", "Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag2>", "Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag3>"], "wordsA": ["Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "wordsB": ["Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p90_s1", "idA": "1430306_16_item1_p98_s1", "sentA": "The patent portfolio for TNX-102 SL relating to the PK Technology includes patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating FM and other CNS conditions utilizing these compositions and formulations.", "sentB": "The patent portfolio for TNX-102 SL relating to the PK Technology includes patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating PTSD and other CNS conditions utilizing these compositions and formulations.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag2>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "wordsB": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p91_s0", "idA": "1430306_16_item1_p98_s2", "sentA": "The PK Technology patent portfolio includes U.S. Patent Application No. 13/918,692.", "sentB": "Our patent portfolio for tianeptine oxalate includes U.S. provisional Patent Application No. 62/439,533.", "type": 2, "words": ["<tag1>", "The", "PK", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "13/918,692.", "<tag2>", "Our", "patent", "portfolio", "for", "tianeptine", "oxalate", "includes", "U.S.", "provisional", "Patent", "Application", "No.", "62/439,533.", "<tag3>"], "wordsA": ["The", "PK", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "13/918,692."], "wordsB": ["Our", "patent", "portfolio", "for", "tianeptine", "oxalate", "includes", "U.S.", "provisional", "Patent", "Application", "No.", "62/439,533."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p93_s0", "idA": "1430306_16_item1_p98_s2", "sentA": "The PK Technology patent portfolio includes U.S. Patent Application No. 13/918,692.", "sentB": "These applications include U.S. provisional Patent Application Nos.", "type": 2, "words": ["<tag1>", "The", "PK", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "13/918,692.", "<tag2>", "These", "applications", "include", "U.S.", "provisional", "Patent", "Application", "Nos.", "<tag3>"], "wordsA": ["The", "PK", "Technology", "patent", "portfolio", "includes", "U.S.", "Patent", "Application", "No.", "13/918,692."], "wordsB": ["These", "applications", "include", "U.S.", "provisional", "Patent", "Application", "Nos."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p86_s1", "idA": "1430306_16_item1_p99_s1", "sentA": "The patent portfolio for TNX-102 SL relating to the Eutectic Technology includes patent applications directed to eutectic compositions containing CBP, eutectic CBP formulations, methods for treating FM and other CNS conditions utilizing eutectic CBP compositions and formulations, and methods of manufacturing eutectic CBP compositions.", "sentB": "The patent portfolio for TNX-102 SL relating to the Eutectic Technology includes patent applications directed to eutectic compositions containing CBP, eutectic CBP formulations, methods for treating PTSD and other CNS conditions utilizing eutectic CBP compositions and formulations, and methods of manufacturing eutectic CBP compositions.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions.", "<tag2>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions."], "wordsB": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_17_item1_p92_s1", "idA": "1430306_16_item1_p99_s1", "sentA": "The patent portfolio for TNX-102 SL relating to the Eutectic Technology includes patent applications directed to eutectic compositions containing CBP, eutectic CBP formulations, methods for treating FM and other CNS conditions utilizing eutectic CBP compositions and formulations, and methods of manufacturing eutectic CBP compositions.", "sentB": "We have patent applications directed to synthetic chimeric poxviruses and methods of using these poxviruses to protect individuals against smallpox.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions.", "<tag2>", "We", "have", "patent", "applications", "directed", "to", "synthetic", "chimeric", "poxviruses", "and", "methods", "of", "using", "these", "poxviruses", "to", "protect", "individuals", "against", "smallpox.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "FM", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions."], "wordsB": ["We", "have", "patent", "applications", "directed", "to", "synthetic", "chimeric", "poxviruses", "and", "methods", "of", "using", "these", "poxviruses", "to", "protect", "individuals", "against", "smallpox."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p28_s4", "idA": "1430306_17_item1_p100_s0", "sentA": "We seek trademark and service mark protection in the United States and outside of the United States where available and when appropriate.", "sentB": "The presence of agitation nearly doubles the cost of caring for patients with Alzheimer s disease, and agitation is estimated to account for more than 12 percent of the $256 billion in healthcare and societal cost of associated with Alzheimer s disease for the year 2017 in the United States.", "type": 2, "words": ["<tag1>", "We", "seek", "trademark", "and", "service", "mark", "protection", "in", "the", "United", "States", "and", "outside", "of", "the", "United", "States", "where", "available", "and", "when", "appropriate.", "<tag2>", "The", "presence", "of", "agitation", "nearly", "doubles", "the", "cost", "of", "caring", "for", "patients", "with", "Alzheimer", "s", "disease,", "and", "agitation", "is", "estimated", "to", "account", "for", "more", "than", "12", "percent", "of", "the", "$256", "billion", "in", "healthcare", "and", "societal", "cost", "of", "associated", "with", "Alzheimer", "s", "disease", "for", "the", "year", "2017", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["We", "seek", "trademark", "and", "service", "mark", "protection", "in", "the", "United", "States", "and", "outside", "of", "the", "United", "States", "where", "available", "and", "when", "appropriate."], "wordsB": ["The", "presence", "of", "agitation", "nearly", "doubles", "the", "cost", "of", "caring", "for", "patients", "with", "Alzheimer", "s", "disease,", "and", "agitation", "is", "estimated", "to", "account", "for", "more", "than", "12", "percent", "of", "the", "$256", "billion", "in", "healthcare", "and", "societal", "cost", "of", "associated", "with", "Alzheimer", "s", "disease", "for", "the", "year", "2017", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p132_s0", "idA": "1430306_17_item1_p103_s0", "sentA": "We have approximately 10 employees dedicated to research and development.", "sentB": "We have approximately 9 employees dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "approximately", "10", "employees", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "approximately", "9", "employees", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "approximately", "10", "employees", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "approximately", "9", "employees", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p133_s0", "idA": "1430306_17_item1_p104_s0", "sentA": "We have contracted with third-party cGMP-compliant contract manufacturing organizations, or CMOs, for the manufacture of TNX-102 SL drug substances and drug products for investigational purposes, including nonclinical and clinical testing.", "sentB": "We have contracted with third-party cGMP-compliant contract manufacturer organization, or CMOs, for the manufacture of Tonmya and TNX-102 SL drug substances and drug products for investigational purposes, including nonclinical and clinical testing.", "type": 2, "words": ["<tag1>", "We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing.", "<tag2>", "We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturer", "organization,", "or", "CMOs,", "for", "the", "manufacture", "of", "Tonmya", "and", "TNX-102", "SL", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing.", "<tag3>"], "wordsA": ["We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturing", "organizations,", "or", "CMOs,", "for", "the", "manufacture", "of", "TNX-102", "SL", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing."], "wordsB": ["We", "have", "contracted", "with", "third-party", "cGMP-compliant", "contract", "manufacturer", "organization,", "or", "CMOs,", "for", "the", "manufacture", "of", "Tonmya", "and", "TNX-102", "SL", "drug", "substances", "and", "drug", "products", "for", "investigational", "purposes,", "including", "nonclinical", "and", "clinical", "testing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p133_s1", "idA": "1430306_17_item1_p104_s1", "sentA": "For TNX-102 SL, we have engaged a cGMP facility for manufacturing of to-be-marketed product for Phase 3 clinical and commercial.", "sentB": "For Tonmya and TNX-102 SL, we have engaged a cGMP facility for manufacturing of to-be-marketed product for Phase 3 clinical and commercial.", "type": 2, "words": ["<tag1>", "For", "TNX-102", "SL,", "we", "have", "engaged", "a", "cGMP", "facility", "for", "manufacturing", "of", "to-be-marketed", "product", "for", "Phase", "3", "clinical", "and", "commercial.", "<tag2>", "For", "Tonmya", "and", "TNX-102", "SL,", "we", "have", "engaged", "a", "cGMP", "facility", "for", "manufacturing", "of", "to-be-marketed", "product", "for", "Phase", "3", "clinical", "and", "commercial.", "<tag3>"], "wordsA": ["For", "TNX-102", "SL,", "we", "have", "engaged", "a", "cGMP", "facility", "for", "manufacturing", "of", "to-be-marketed", "product", "for", "Phase", "3", "clinical", "and", "commercial."], "wordsB": ["For", "Tonmya", "and", "TNX-102", "SL,", "we", "have", "engaged", "a", "cGMP", "facility", "for", "manufacturing", "of", "to-be-marketed", "product", "for", "Phase", "3", "clinical", "and", "commercial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p135_s0", "idA": "1430306_17_item1_p106_s0", "sentA": "Our smallpox-preventing vaccine candidate is a biologic uses live form of HPXV.", "sentB": "Our smallpox-preventing vaccine candidate is a biologic and uses live form of HPXV.", "type": 2, "words": ["<tag1>", "Our", "smallpox-preventing", "vaccine", "candidate", "is", "a", "biologic", "uses", "live", "form", "of", "HPXV.", "<tag2>", "Our", "smallpox-preventing", "vaccine", "candidate", "is", "a", "biologic", "and", "uses", "live", "form", "of", "HPXV.", "<tag3>"], "wordsA": ["Our", "smallpox-preventing", "vaccine", "candidate", "is", "a", "biologic", "uses", "live", "form", "of", "HPXV."], "wordsB": ["Our", "smallpox-preventing", "vaccine", "candidate", "is", "a", "biologic", "and", "uses", "live", "form", "of", "HPXV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p135_s1", "idA": "1430306_17_item1_p106_s1", "sentA": "Both the drug substance (horsepox virus and the cell bank) and the drug product (vaccine) will be manufactured by contract cGMP-compliant facilities capable of manufacturing for nonclinical/clinical testing and licensed product.", "sentB": "Both the drug substance (HPVX and the cell bank) and the drug product (vaccine) will be manufactured by contract cGMP-compliant facilities capable of manufacturing for nonclinical/clinical testing and licensed product.", "type": 2, "words": ["<tag1>", "Both", "the", "drug", "substance", "(horsepox", "virus", "and", "the", "cell", "bank)", "and", "the", "drug", "product", "(vaccine)", "will", "be", "manufactured", "by", "contract", "cGMP-compliant", "facilities", "capable", "of", "manufacturing", "for", "nonclinical/clinical", "testing", "and", "licensed", "product.", "<tag2>", "Both", "the", "drug", "substance", "(HPVX", "and", "the", "cell", "bank)", "and", "the", "drug", "product", "(vaccine)", "will", "be", "manufactured", "by", "contract", "cGMP-compliant", "facilities", "capable", "of", "manufacturing", "for", "nonclinical/clinical", "testing", "and", "licensed", "product.", "<tag3>"], "wordsA": ["Both", "the", "drug", "substance", "(horsepox", "virus", "and", "the", "cell", "bank)", "and", "the", "drug", "product", "(vaccine)", "will", "be", "manufactured", "by", "contract", "cGMP-compliant", "facilities", "capable", "of", "manufacturing", "for", "nonclinical/clinical", "testing", "and", "licensed", "product."], "wordsB": ["Both", "the", "drug", "substance", "(HPVX", "and", "the", "cell", "bank)", "and", "the", "drug", "product", "(vaccine)", "will", "be", "manufactured", "by", "contract", "cGMP-compliant", "facilities", "capable", "of", "manufacturing", "for", "nonclinical/clinical", "testing", "and", "licensed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p183_s1", "idA": "1430306_17_item1_p107_s3", "sentA": "Moreover, failure to comply with applicable FDA or other requirements may result in civil or criminal penalties, recall or seizure of products, injunctive relief including partial or total suspension of production, or withdrawal of a product from the market.", "sentB": "Failure to comply with these laws, where applicable, can result in the imposition of significant civil penalties, criminal penalties, or both.", "type": 2, "words": ["<tag1>", "Moreover,", "failure", "to", "comply", "with", "applicable", "FDA", "or", "other", "requirements", "may", "result", "in", "civil", "or", "criminal", "penalties,", "recall", "or", "seizure", "of", "products,", "injunctive", "relief", "including", "partial", "or", "total", "suspension", "of", "production,", "or", "withdrawal", "of", "a", "product", "from", "the", "market.", "<tag2>", "Failure", "to", "comply", "with", "these", "laws,", "where", "applicable,", "can", "result", "in", "the", "imposition", "of", "significant", "civil", "penalties,", "criminal", "penalties,", "or", "both.", "<tag3>"], "wordsA": ["Moreover,", "failure", "to", "comply", "with", "applicable", "FDA", "or", "other", "requirements", "may", "result", "in", "civil", "or", "criminal", "penalties,", "recall", "or", "seizure", "of", "products,", "injunctive", "relief", "including", "partial", "or", "total", "suspension", "of", "production,", "or", "withdrawal", "of", "a", "product", "from", "the", "market."], "wordsB": ["Failure", "to", "comply", "with", "these", "laws,", "where", "applicable,", "can", "result", "in", "the", "imposition", "of", "significant", "civil", "penalties,", "criminal", "penalties,", "or", "both."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p11_s1", "idA": "1430306_17_item1_p10_s0", "sentA": "TNX-102 SL is a small, rapidly disintegrating tablet containing cyclobenzaprine, or CBP, for sublingual administration and transmucosal absorption.", "sentB": "TNX-102 SL is also being developed as a treatment for agitation in Alzheimer s disease, or AAD.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine,", "or", "CBP,", "for", "sublingual", "administration", "and", "transmucosal", "absorption.", "<tag2>", "TNX-102", "SL", "is", "also", "being", "developed", "as", "a", "treatment", "for", "agitation", "in", "Alzheimer", "s", "disease,", "or", "AAD.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine,", "or", "CBP,", "for", "sublingual", "administration", "and", "transmucosal", "absorption."], "wordsB": ["TNX-102", "SL", "is", "also", "being", "developed", "as", "a", "treatment", "for", "agitation", "in", "Alzheimer", "s", "disease,", "or", "AAD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p12_s0", "idA": "1430306_17_item1_p10_s0", "sentA": "TNX-102 SL is a small, rapidly disintegrating tablet containing cyclobenzaprine, or CBP, for sublingual administration and transmucosal absorption.", "sentB": "Tonmya is a small, rapidly disintegrating tablet containing CBP for sublingual administration.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine,", "or", "CBP,", "for", "sublingual", "administration", "and", "transmucosal", "absorption.", "<tag2>", "Tonmya", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "cyclobenzaprine,", "or", "CBP,", "for", "sublingual", "administration", "and", "transmucosal", "absorption."], "wordsB": ["Tonmya", "is", "a", "small,", "rapidly", "disintegrating", "tablet", "containing", "CBP", "for", "sublingual", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p12_s1", "idA": "1430306_17_item1_p10_s1", "sentA": "TNX-102 SL has a proprietary, Protectic protective eutectic formulation of cyclobenzaprine that allows for rapid systemic exposure and increased bioavailability through the transmucosal delivery.", "sentB": "Tonmya employs a proprietary, Protectic protective eutectic formulation of CBP which enables rapid systemic exposure and increased bioavailability through transmucosal absorption.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "has", "a", "proprietary,", "Protectic", "protective", "eutectic", "formulation", "of", "cyclobenzaprine", "that", "allows", "for", "rapid", "systemic", "exposure", "and", "increased", "bioavailability", "through", "the", "transmucosal", "delivery.", "<tag2>", "Tonmya", "employs", "a", "proprietary,", "Protectic", "protective", "eutectic", "formulation", "of", "CBP", "which", "enables", "rapid", "systemic", "exposure", "and", "increased", "bioavailability", "through", "transmucosal", "absorption.", "<tag3>"], "wordsA": ["TNX-102", "SL", "has", "a", "proprietary,", "Protectic", "protective", "eutectic", "formulation", "of", "cyclobenzaprine", "that", "allows", "for", "rapid", "systemic", "exposure", "and", "increased", "bioavailability", "through", "the", "transmucosal", "delivery."], "wordsB": ["Tonmya", "employs", "a", "proprietary,", "Protectic", "protective", "eutectic", "formulation", "of", "CBP", "which", "enables", "rapid", "systemic", "exposure", "and", "increased", "bioavailability", "through", "transmucosal", "absorption."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p41_s1", "idA": "1430306_17_item1_p10_s1", "sentA": "TNX-102 SL has a proprietary, Protectic protective eutectic formulation of cyclobenzaprine that allows for rapid systemic exposure and increased bioavailability through the transmucosal delivery.", "sentB": "The Protectic protective eutectic and Angstro-Technology formulation claimed in the patent are important elements of our proprietary Tonmya or TNX-102 SL composition.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "has", "a", "proprietary,", "Protectic", "protective", "eutectic", "formulation", "of", "cyclobenzaprine", "that", "allows", "for", "rapid", "systemic", "exposure", "and", "increased", "bioavailability", "through", "the", "transmucosal", "delivery.", "<tag2>", "The", "Protectic", "protective", "eutectic", "and", "Angstro-Technology", "formulation", "claimed", "in", "the", "patent", "are", "important", "elements", "of", "our", "proprietary", "Tonmya", "or", "TNX-102", "SL", "composition.", "<tag3>"], "wordsA": ["TNX-102", "SL", "has", "a", "proprietary,", "Protectic", "protective", "eutectic", "formulation", "of", "cyclobenzaprine", "that", "allows", "for", "rapid", "systemic", "exposure", "and", "increased", "bioavailability", "through", "the", "transmucosal", "delivery."], "wordsB": ["The", "Protectic", "protective", "eutectic", "and", "Angstro-Technology", "formulation", "claimed", "in", "the", "patent", "are", "important", "elements", "of", "our", "proprietary", "Tonmya", "or", "TNX-102", "SL", "composition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p9_s0", "idA": "1430306_17_item1_p10_s2", "sentA": "We are developing TNX-102 SL for the management of PTSD under an IND cleared by the U.S. Food and Drug Administration, or FDA, in June 2014.", "sentB": "In June 2017, the U.S. Food and Drug Administration, or FDA, conditionally accepted the proposed trade name Tonmya for TNX-102 SL, for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "an", "IND", "cleared", "by", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "in", "June", "2014.", "<tag2>", "In", "June", "2017,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "conditionally", "accepted", "the", "proposed", "trade", "name", "Tonmya", "for", "TNX-102", "SL,", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "an", "IND", "cleared", "by", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "in", "June", "2014."], "wordsB": ["In", "June", "2017,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "conditionally", "accepted", "the", "proposed", "trade", "name", "Tonmya", "for", "TNX-102", "SL,", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p9_s2", "idA": "1430306_17_item1_p10_s2", "sentA": "We are developing TNX-102 SL for the management of PTSD under an IND cleared by the U.S. Food and Drug Administration, or FDA, in June 2014.", "sentB": "A request for review of Tonmya as the proposed name for TNX-102 SL for the management of fibromyalgia has been withdrawn at the FDA.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "an", "IND", "cleared", "by", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "in", "June", "2014.", "<tag2>", "A", "request", "for", "review", "of", "Tonmya", "as", "the", "proposed", "name", "for", "TNX-102", "SL", "for", "the", "management", "of", "fibromyalgia", "has", "been", "withdrawn", "at", "the", "FDA.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "management", "of", "PTSD", "under", "an", "IND", "cleared", "by", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "FDA,", "in", "June", "2014."], "wordsB": ["A", "request", "for", "review", "of", "Tonmya", "as", "the", "proposed", "name", "for", "TNX-102", "SL", "for", "the", "management", "of", "fibromyalgia", "has", "been", "withdrawn", "at", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p16_s0", "idA": "1430306_17_item1_p11_s0", "sentA": "An estimated 8.6 million adults in the U.S. suffer from PTSD, a chronic disorder that is characterized by hyperarousal, avoidance, emotional numbing, and sleep disturbances.", "sentB": "An estimated 5.3 million people in the U.S suffer from Alzheimer s disease, with more than half that number expected to be affected by agitation.", "type": 2, "words": ["<tag1>", "An", "estimated", "8.6", "million", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "hyperarousal,", "avoidance,", "emotional", "numbing,", "and", "sleep", "disturbances.", "<tag2>", "An", "estimated", "5.3", "million", "people", "in", "the", "U.S", "suffer", "from", "Alzheimer", "s", "disease,", "with", "more", "than", "half", "that", "number", "expected", "to", "be", "affected", "by", "agitation.", "<tag3>"], "wordsA": ["An", "estimated", "8.6", "million", "adults", "in", "the", "U.S.", "suffer", "from", "PTSD,", "a", "chronic", "disorder", "that", "is", "characterized", "by", "hyperarousal,", "avoidance,", "emotional", "numbing,", "and", "sleep", "disturbances."], "wordsB": ["An", "estimated", "5.3", "million", "people", "in", "the", "U.S", "suffer", "from", "Alzheimer", "s", "disease,", "with", "more", "than", "half", "that", "number", "expected", "to", "be", "affected", "by", "agitation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p17_s2", "idA": "1430306_17_item1_p123_s1", "sentA": "An NDA also must contain extensive manufacturing information, as well as proposed labeling for the finished product.", "sentB": "Agitation in Alzheimer s disease is associated with significant negative consequences for both patients as well as their caregivers.", "type": 2, "words": ["<tag1>", "An", "NDA", "also", "must", "contain", "extensive", "manufacturing", "information,", "as", "well", "as", "proposed", "labeling", "for", "the", "finished", "product.", "<tag2>", "Agitation", "in", "Alzheimer", "s", "disease", "is", "associated", "with", "significant", "negative", "consequences", "for", "both", "patients", "as", "well", "as", "their", "caregivers.", "<tag3>"], "wordsA": ["An", "NDA", "also", "must", "contain", "extensive", "manufacturing", "information,", "as", "well", "as", "proposed", "labeling", "for", "the", "finished", "product."], "wordsB": ["Agitation", "in", "Alzheimer", "s", "disease", "is", "associated", "with", "significant", "negative", "consequences", "for", "both", "patients", "as", "well", "as", "their", "caregivers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p29_s0", "idA": "1430306_17_item1_p123_s1", "sentA": "An NDA also must contain extensive manufacturing information, as well as proposed labeling for the finished product.", "sentB": "Agitation in Alzheimer s disease is associated with significant negative consequences for both patients as well as their caregivers.", "type": 2, "words": ["<tag1>", "An", "NDA", "also", "must", "contain", "extensive", "manufacturing", "information,", "as", "well", "as", "proposed", "labeling", "for", "the", "finished", "product.", "<tag2>", "Agitation", "in", "Alzheimer", "s", "disease", "is", "associated", "with", "significant", "negative", "consequences", "for", "both", "patients", "as", "well", "as", "their", "caregivers.", "<tag3>"], "wordsA": ["An", "NDA", "also", "must", "contain", "extensive", "manufacturing", "information,", "as", "well", "as", "proposed", "labeling", "for", "the", "finished", "product."], "wordsB": ["Agitation", "in", "Alzheimer", "s", "disease", "is", "associated", "with", "significant", "negative", "consequences", "for", "both", "patients", "as", "well", "as", "their", "caregivers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p12_s3", "idA": "1430306_17_item1_p123_s3", "sentA": "The manufacturing process must be capable of consistently producing quality product within specifications approved by the FDA.", "sentB": "Tonmya for PTSD was designated Breakthrough Therapy by the FDA in December 2016.", "type": 2, "words": ["<tag1>", "The", "manufacturing", "process", "must", "be", "capable", "of", "consistently", "producing", "quality", "product", "within", "specifications", "approved", "by", "the", "FDA.", "<tag2>", "Tonmya", "for", "PTSD", "was", "designated", "Breakthrough", "Therapy", "by", "the", "FDA", "in", "December", "2016.", "<tag3>"], "wordsA": ["The", "manufacturing", "process", "must", "be", "capable", "of", "consistently", "producing", "quality", "product", "within", "specifications", "approved", "by", "the", "FDA."], "wordsB": ["Tonmya", "for", "PTSD", "was", "designated", "Breakthrough", "Therapy", "by", "the", "FDA", "in", "December", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p49_s1", "idA": "1430306_17_item1_p123_s3", "sentA": "The manufacturing process must be capable of consistently producing quality product within specifications approved by the FDA.", "sentB": "Tonmya for PTSD has been designated as Breakthrough Therapy by the FDA.", "type": 2, "words": ["<tag1>", "The", "manufacturing", "process", "must", "be", "capable", "of", "consistently", "producing", "quality", "product", "within", "specifications", "approved", "by", "the", "FDA.", "<tag2>", "Tonmya", "for", "PTSD", "has", "been", "designated", "as", "Breakthrough", "Therapy", "by", "the", "FDA.", "<tag3>"], "wordsA": ["The", "manufacturing", "process", "must", "be", "capable", "of", "consistently", "producing", "quality", "product", "within", "specifications", "approved", "by", "the", "FDA."], "wordsB": ["Tonmya", "for", "PTSD", "has", "been", "designated", "as", "Breakthrough", "Therapy", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p152_s5", "idA": "1430306_17_item1_p123_s5", "sentA": "In addition, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product does not undergo unacceptable deterioration over its shelf life.", "sentB": "In addition, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product does not undergo unacceptable deterioration over its shelf life.", "type": 2, "words": ["<tag1>", "In", "addition,", "appropriate", "packaging", "must", "be", "selected", "and", "tested", "and", "stability", "studies", "must", "be", "conducted", "to", "demonstrate", "that", "the", "product", "does", "not", "undergo", "unacceptable", "deterioration", "over", "its", "shelf", "life.", "<tag2>", "In", "addition,", "appropriate", "packaging", "must", "be", "selected", "and", "tested,", "and", "stability", "studies", "must", "be", "conducted", "to", "demonstrate", "that", "the", "product", "does", "not", "undergo", "unacceptable", "deterioration", "over", "its", "shelf", "life.", "<tag3>"], "wordsA": ["In", "addition,", "appropriate", "packaging", "must", "be", "selected", "and", "tested", "and", "stability", "studies", "must", "be", "conducted", "to", "demonstrate", "that", "the", "product", "does", "not", "undergo", "unacceptable", "deterioration", "over", "its", "shelf", "life."], "wordsB": ["In", "addition,", "appropriate", "packaging", "must", "be", "selected", "and", "tested,", "and", "stability", "studies", "must", "be", "conducted", "to", "demonstrate", "that", "the", "product", "does", "not", "undergo", "unacceptable", "deterioration", "over", "its", "shelf", "life."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p155_s1", "idA": "1430306_17_item1_p126_s1", "sentA": "We intend to file Section 505(b)(2) NDAs for TNX-102 SL for PTSD, and for certain other products, that might, if accepted by the FDA, save time and expense in the development and testing of our product candidates.", "sentB": "We intend to file Section 505(b)(2) NDAs for Tonmya for PTSD, and for certain other products, that might, if accepted by the FDA, save time and expense in the development and testing of our product candidates.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "TNX-102", "SL", "for", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates.", "<tag2>", "We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "Tonmya", "for", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "TNX-102", "SL", "for", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates."], "wordsB": ["We", "intend", "to", "file", "Section", "505(b)(2)", "NDAs", "for", "Tonmya", "for", "PTSD,", "and", "for", "certain", "other", "products,", "that", "might,", "if", "accepted", "by", "the", "FDA,", "save", "time", "and", "expense", "in", "the", "development", "and", "testing", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p158_s1", "idA": "1430306_17_item1_p129_s1", "sentA": "As such, we plan to submit an NDA under Section 505(b)(2) for TNX-102 SL for PTSD.", "sentB": "As such, we plan to submit an NDA under Section 505(b)(2) for Tonmya for PTSD.", "type": 2, "words": ["<tag1>", "As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "Tonmya", "for", "PTSD.", "<tag3>"], "wordsA": ["As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "Tonmya", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p31_s2", "idA": "1430306_17_item1_p129_s1", "sentA": "As such, we plan to submit an NDA under Section 505(b)(2) for TNX-102 SL for PTSD.", "sentB": "The following table summarizes our most advanced product candidates, for which we plan to complete the required clinical studies to support their NDA filings:", "type": 2, "words": ["<tag1>", "As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "The", "following", "table", "summarizes", "our", "most", "advanced", "product", "candidates,", "for", "which", "we", "plan", "to", "complete", "the", "required", "clinical", "studies", "to", "support", "their", "NDA", "filings:", "<tag3>"], "wordsA": ["As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["The", "following", "table", "summarizes", "our", "most", "advanced", "product", "candidates,", "for", "which", "we", "plan", "to", "complete", "the", "required", "clinical", "studies", "to", "support", "their", "NDA", "filings:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p78_s2", "idA": "1430306_17_item1_p129_s1", "sentA": "As such, we plan to submit an NDA under Section 505(b)(2) for TNX-102 SL for PTSD.", "sentB": "We plan to submit the TNX-102 SL IND for agitation in Alzheimer s disease in March 2018.", "type": 2, "words": ["<tag1>", "As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "We", "plan", "to", "submit", "the", "TNX-102", "SL", "IND", "for", "agitation", "in", "Alzheimer", "s", "disease", "in", "March", "2018.", "<tag3>"], "wordsA": ["As", "such,", "we", "plan", "to", "submit", "an", "NDA", "under", "Section", "505(b)(2)", "for", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["We", "plan", "to", "submit", "the", "TNX-102", "SL", "IND", "for", "agitation", "in", "Alzheimer", "s", "disease", "in", "March", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p158_s3", "idA": "1430306_17_item1_p129_s3", "sentA": "If the FDA determines that a Section 505(b)(2) NDA is not appropriate and that a full NDA is required for TNX-102 SL, the time and financial resources required to obtain FDA approval for TNX-102 SL could substantially and materially increase, and TNX-102 SL might be less likely to be approved.", "sentB": "If the FDA determines that a Section 505(b)(2) NDA is not appropriate and that a full NDA is required for Tonmya, the time and financial resources required to obtain FDA approval for Tonmya could substantially and materially increase, and Tonmya might be less likely to be approved.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "determines", "that", "a", "Section", "505(b)(2)", "NDA", "is", "not", "appropriate", "and", "that", "a", "full", "NDA", "is", "required", "for", "TNX-102", "SL,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "TNX-102", "SL", "could", "substantially", "and", "materially", "increase,", "and", "TNX-102", "SL", "might", "be", "less", "likely", "to", "be", "approved.", "<tag2>", "If", "the", "FDA", "determines", "that", "a", "Section", "505(b)(2)", "NDA", "is", "not", "appropriate", "and", "that", "a", "full", "NDA", "is", "required", "for", "Tonmya,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "Tonmya", "could", "substantially", "and", "materially", "increase,", "and", "Tonmya", "might", "be", "less", "likely", "to", "be", "approved.", "<tag3>"], "wordsA": ["If", "the", "FDA", "determines", "that", "a", "Section", "505(b)(2)", "NDA", "is", "not", "appropriate", "and", "that", "a", "full", "NDA", "is", "required", "for", "TNX-102", "SL,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "TNX-102", "SL", "could", "substantially", "and", "materially", "increase,", "and", "TNX-102", "SL", "might", "be", "less", "likely", "to", "be", "approved."], "wordsB": ["If", "the", "FDA", "determines", "that", "a", "Section", "505(b)(2)", "NDA", "is", "not", "appropriate", "and", "that", "a", "full", "NDA", "is", "required", "for", "Tonmya,", "the", "time", "and", "financial", "resources", "required", "to", "obtain", "FDA", "approval", "for", "Tonmya", "could", "substantially", "and", "materially", "increase,", "and", "Tonmya", "might", "be", "less", "likely", "to", "be", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p158_s4", "idA": "1430306_17_item1_p129_s4", "sentA": "If the FDA requires a full NDA for TNX-102 SL, or requires more extensive testing and development for some other reason, our ability to compete with alternative products that arrive on the market more quickly than our product candidates would be adversely impacted.", "sentB": "If the FDA requires a full NDA for Tonmya, or requires more extensive testing and development for some other reason, our ability to compete with alternative products that arrive on the market more quickly than our product candidates would be adversely impacted.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "requires", "a", "full", "NDA", "for", "TNX-102", "SL,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted.", "<tag2>", "If", "the", "FDA", "requires", "a", "full", "NDA", "for", "Tonmya,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted.", "<tag3>"], "wordsA": ["If", "the", "FDA", "requires", "a", "full", "NDA", "for", "TNX-102", "SL,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted."], "wordsB": ["If", "the", "FDA", "requires", "a", "full", "NDA", "for", "Tonmya,", "or", "requires", "more", "extensive", "testing", "and", "development", "for", "some", "other", "reason,", "our", "ability", "to", "compete", "with", "alternative", "products", "that", "arrive", "on", "the", "market", "more", "quickly", "than", "our", "product", "candidates", "would", "be", "adversely", "impacted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p158_s5", "idA": "1430306_17_item1_p129_s5", "sentA": "If CBP-containing products are withdrawn from the market by the FDA for any reason, we may not be able to reference such products to support our anticipated TNX-102 SL 505(b)(2) NDA, and we may be required to follow the requirements of Section 505(b)(1).", "sentB": "If CBP-containing products are withdrawn from the market by the FDA for a safety reason, we may not be able to reference such products to support our anticipated Tonmya 505(b)(2) NDA, and we may be required to follow the requirements of Section 505(b)(1).", "type": 2, "words": ["<tag1>", "If", "CBP-containing", "products", "are", "withdrawn", "from", "the", "market", "by", "the", "FDA", "for", "any", "reason,", "we", "may", "not", "be", "able", "to", "reference", "such", "products", "to", "support", "our", "anticipated", "TNX-102", "SL", "505(b)(2)", "NDA,", "and", "we", "may", "be", "required", "to", "follow", "the", "requirements", "of", "Section", "505(b)(1).", "<tag2>", "If", "CBP-containing", "products", "are", "withdrawn", "from", "the", "market", "by", "the", "FDA", "for", "a", "safety", "reason,", "we", "may", "not", "be", "able", "to", "reference", "such", "products", "to", "support", "our", "anticipated", "Tonmya", "505(b)(2)", "NDA,", "and", "we", "may", "be", "required", "to", "follow", "the", "requirements", "of", "Section", "505(b)(1).", "<tag3>"], "wordsA": ["If", "CBP-containing", "products", "are", "withdrawn", "from", "the", "market", "by", "the", "FDA", "for", "any", "reason,", "we", "may", "not", "be", "able", "to", "reference", "such", "products", "to", "support", "our", "anticipated", "TNX-102", "SL", "505(b)(2)", "NDA,", "and", "we", "may", "be", "required", "to", "follow", "the", "requirements", "of", "Section", "505(b)(1)."], "wordsB": ["If", "CBP-containing", "products", "are", "withdrawn", "from", "the", "market", "by", "the", "FDA", "for", "a", "safety", "reason,", "we", "may", "not", "be", "able", "to", "reference", "such", "products", "to", "support", "our", "anticipated", "Tonmya", "505(b)(2)", "NDA,", "and", "we", "may", "be", "required", "to", "follow", "the", "requirements", "of", "Section", "505(b)(1)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p69_s2", "idA": "1430306_17_item1_p12_s0", "sentA": "Many patients fail to adequately respond to the medications approved for PTSD.", "sentB": "This is critical to the successful launch of a potentially improved treatment option for PTSD patients, especially those with military-related PTSD.", "type": 2, "words": ["<tag1>", "Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "PTSD.", "<tag2>", "This", "is", "critical", "to", "the", "successful", "launch", "of", "a", "potentially", "improved", "treatment", "option", "for", "PTSD", "patients,", "especially", "those", "with", "military-related", "PTSD.", "<tag3>"], "wordsA": ["Many", "patients", "fail", "to", "adequately", "respond", "to", "the", "medications", "approved", "for", "PTSD."], "wordsB": ["This", "is", "critical", "to", "the", "successful", "launch", "of", "a", "potentially", "improved", "treatment", "option", "for", "PTSD", "patients,", "especially", "those", "with", "military-related", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p14_s3", "idA": "1430306_17_item1_p12_s3", "sentA": "Anxiolytics are comprised of benzodiazepine and non-benzodiazepine drugs, which carry risks of tolerance and addiction and are also associated with potential serious side-effects, such as retrograde amnesia.", "sentB": "Anxiolytics and sedative-hypnotics are comprised of benzodiazepine and non-benzodiazepine drugs, which carry risks of tolerance and addiction and are also associated with potential serious side-effects, such as retrograde amnesia.", "type": 2, "words": ["<tag1>", "Anxiolytics", "are", "comprised", "of", "benzodiazepine", "and", "non-benzodiazepine", "drugs,", "which", "carry", "risks", "of", "tolerance", "and", "addiction", "and", "are", "also", "associated", "with", "potential", "serious", "side-effects,", "such", "as", "retrograde", "amnesia.", "<tag2>", "Anxiolytics", "and", "sedative-hypnotics", "are", "comprised", "of", "benzodiazepine", "and", "non-benzodiazepine", "drugs,", "which", "carry", "risks", "of", "tolerance", "and", "addiction", "and", "are", "also", "associated", "with", "potential", "serious", "side-effects,", "such", "as", "retrograde", "amnesia.", "<tag3>"], "wordsA": ["Anxiolytics", "are", "comprised", "of", "benzodiazepine", "and", "non-benzodiazepine", "drugs,", "which", "carry", "risks", "of", "tolerance", "and", "addiction", "and", "are", "also", "associated", "with", "potential", "serious", "side-effects,", "such", "as", "retrograde", "amnesia."], "wordsB": ["Anxiolytics", "and", "sedative-hypnotics", "are", "comprised", "of", "benzodiazepine", "and", "non-benzodiazepine", "drugs,", "which", "carry", "risks", "of", "tolerance", "and", "addiction", "and", "are", "also", "associated", "with", "potential", "serious", "side-effects,", "such", "as", "retrograde", "amnesia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p28_s0", "idA": "1430306_17_item1_p140_s2", "sentA": "A Breakthrough Therapy is a drug:", "sentB": "Alzheimer s is a chronic neurodegenerative disease in which behavioral symptoms are a major clinical complication.", "type": 2, "words": ["<tag1>", "A", "Breakthrough", "Therapy", "is", "a", "drug:", "<tag2>", "Alzheimer", "s", "is", "a", "chronic", "neurodegenerative", "disease", "in", "which", "behavioral", "symptoms", "are", "a", "major", "clinical", "complication.", "<tag3>"], "wordsA": ["A", "Breakthrough", "Therapy", "is", "a", "drug:"], "wordsB": ["Alzheimer", "s", "is", "a", "chronic", "neurodegenerative", "disease", "in", "which", "behavioral", "symptoms", "are", "a", "major", "clinical", "complication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p171_s0", "idA": "1430306_17_item1_p142_s0", "sentA": "In December 2016, the FDA granted Breakthrough Therapy designation to TNX-102 SL for the treatment of PTSD.", "sentB": "In December 2016, the FDA granted Breakthrough Therapy designation to Tonmya for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "Tonmya", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "Tonmya", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p65_s0", "idA": "1430306_17_item1_p142_s0", "sentA": "In December 2016, the FDA granted Breakthrough Therapy designation to TNX-102 SL for the treatment of PTSD.", "sentB": "In December 2016, the FDA granted Breakthrough Therapy designation to Tonmya for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "Tonmya", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "Tonmya", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p68_s0", "idA": "1430306_17_item1_p142_s0", "sentA": "In December 2016, the FDA granted Breakthrough Therapy designation to TNX-102 SL for the treatment of PTSD.", "sentB": "In June 2017, the FDA conditionally accepted the proposed trade name Tonmya for TNX-102 SL for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "In", "June", "2017,", "the", "FDA", "conditionally", "accepted", "the", "proposed", "trade", "name", "Tonmya", "for", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["In", "June", "2017,", "the", "FDA", "conditionally", "accepted", "the", "proposed", "trade", "name", "Tonmya", "for", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p95_s4", "idA": "1430306_17_item1_p142_s0", "sentA": "In December 2016, the FDA granted Breakthrough Therapy designation to TNX-102 SL for the treatment of PTSD.", "sentB": "MDMA was awarded Breakthrough Therapy designation by the FDA in August 2017.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "MDMA", "was", "awarded", "Breakthrough", "Therapy", "designation", "by", "the", "FDA", "in", "August", "2017.", "<tag3>"], "wordsA": ["In", "December", "2016,", "the", "FDA", "granted", "Breakthrough", "Therapy", "designation", "to", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["MDMA", "was", "awarded", "Breakthrough", "Therapy", "designation", "by", "the", "FDA", "in", "August", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p171_s1", "idA": "1430306_17_item1_p142_s1", "sentA": "The Breakthrough Therapy designation request was submitted based on the preliminary clinical evidence of TNX 102-SL on military-related PTSD in the AtEase study.", "sentB": "The Breakthrough Therapy designation request was submitted based on the preliminary clinical evidence of Tonmya on military-related PTSD in the AtEase study.", "type": 2, "words": ["<tag1>", "The", "Breakthrough", "Therapy", "designation", "request", "was", "submitted", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study.", "<tag2>", "The", "Breakthrough", "Therapy", "designation", "request", "was", "submitted", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "Tonmya", "on", "military-related", "PTSD", "in", "the", "AtEase", "study.", "<tag3>"], "wordsA": ["The", "Breakthrough", "Therapy", "designation", "request", "was", "submitted", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study."], "wordsB": ["The", "Breakthrough", "Therapy", "designation", "request", "was", "submitted", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "Tonmya", "on", "military-related", "PTSD", "in", "the", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p69_s1", "idA": "1430306_17_item1_p142_s1", "sentA": "The Breakthrough Therapy designation request was submitted based on the preliminary clinical evidence of TNX 102-SL on military-related PTSD in the AtEase study.", "sentB": "We received the FDA formal minutes from that meeting in October 2017 that reflect our readiness to manufacture Tonmya commercial product at production scale if an NDA can be submitted based on the HONOR study.", "type": 2, "words": ["<tag1>", "The", "Breakthrough", "Therapy", "designation", "request", "was", "submitted", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study.", "<tag2>", "We", "received", "the", "FDA", "formal", "minutes", "from", "that", "meeting", "in", "October", "2017", "that", "reflect", "our", "readiness", "to", "manufacture", "Tonmya", "commercial", "product", "at", "production", "scale", "if", "an", "NDA", "can", "be", "submitted", "based", "on", "the", "HONOR", "study.", "<tag3>"], "wordsA": ["The", "Breakthrough", "Therapy", "designation", "request", "was", "submitted", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study."], "wordsB": ["We", "received", "the", "FDA", "formal", "minutes", "from", "that", "meeting", "in", "October", "2017", "that", "reflect", "our", "readiness", "to", "manufacture", "Tonmya", "commercial", "product", "at", "production", "scale", "if", "an", "NDA", "can", "be", "submitted", "based", "on", "the", "HONOR", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p172_s1", "idA": "1430306_17_item1_p143_s1", "sentA": "The benefits of Breakthrough Therapy designation include the eligibility for priority review of the NDA within six months instead of 10 months and rolling submission of portions of the NDA, in addition to an organizational commitment involving FDA's senior managers contributing significant guidance.", "sentB": "The benefits of Breakthrough Therapy designation include the eligibility for priority review of the NDA in about six months instead of 10 months after submission and rolling submission of completed portions of the NDA, in addition to an organizational commitment involving FDA s senior managers contributing significant guidance.", "type": 2, "words": ["<tag1>", "The", "benefits", "of", "Breakthrough", "Therapy", "designation", "include", "the", "eligibility", "for", "priority", "review", "of", "the", "NDA", "within", "six", "months", "instead", "of", "10", "months", "and", "rolling", "submission", "of", "portions", "of", "the", "NDA,", "in", "addition", "to", "an", "organizational", "commitment", "involving", "FDA's", "senior", "managers", "contributing", "significant", "guidance.", "<tag2>", "The", "benefits", "of", "Breakthrough", "Therapy", "designation", "include", "the", "eligibility", "for", "priority", "review", "of", "the", "NDA", "in", "about", "six", "months", "instead", "of", "10", "months", "after", "submission", "and", "rolling", "submission", "of", "completed", "portions", "of", "the", "NDA,", "in", "addition", "to", "an", "organizational", "commitment", "involving", "FDA", "s", "senior", "managers", "contributing", "significant", "guidance.", "<tag3>"], "wordsA": ["The", "benefits", "of", "Breakthrough", "Therapy", "designation", "include", "the", "eligibility", "for", "priority", "review", "of", "the", "NDA", "within", "six", "months", "instead", "of", "10", "months", "and", "rolling", "submission", "of", "portions", "of", "the", "NDA,", "in", "addition", "to", "an", "organizational", "commitment", "involving", "FDA's", "senior", "managers", "contributing", "significant", "guidance."], "wordsB": ["The", "benefits", "of", "Breakthrough", "Therapy", "designation", "include", "the", "eligibility", "for", "priority", "review", "of", "the", "NDA", "in", "about", "six", "months", "instead", "of", "10", "months", "after", "submission", "and", "rolling", "submission", "of", "completed", "portions", "of", "the", "NDA,", "in", "addition", "to", "an", "organizational", "commitment", "involving", "FDA", "s", "senior", "managers", "contributing", "significant", "guidance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p66_s1", "idA": "1430306_17_item1_p143_s1", "sentA": "The benefits of Breakthrough Therapy designation include the eligibility for priority review of the NDA within six months instead of 10 months and rolling submission of portions of the NDA, in addition to an organizational commitment involving FDA's senior managers contributing significant guidance.", "sentB": "The benefits of Breakthrough Therapy designation include the eligibility for priority review of the NDA in about six months instead of 10 months after submission and rolling submission of completed portions of the NDA, in addition to an organizational commitment involving FDA s senior managers contributing significant guidance.", "type": 2, "words": ["<tag1>", "The", "benefits", "of", "Breakthrough", "Therapy", "designation", "include", "the", "eligibility", "for", "priority", "review", "of", "the", "NDA", "within", "six", "months", "instead", "of", "10", "months", "and", "rolling", "submission", "of", "portions", "of", "the", "NDA,", "in", "addition", "to", "an", "organizational", "commitment", "involving", "FDA's", "senior", "managers", "contributing", "significant", "guidance.", "<tag2>", "The", "benefits", "of", "Breakthrough", "Therapy", "designation", "include", "the", "eligibility", "for", "priority", "review", "of", "the", "NDA", "in", "about", "six", "months", "instead", "of", "10", "months", "after", "submission", "and", "rolling", "submission", "of", "completed", "portions", "of", "the", "NDA,", "in", "addition", "to", "an", "organizational", "commitment", "involving", "FDA", "s", "senior", "managers", "contributing", "significant", "guidance.", "<tag3>"], "wordsA": ["The", "benefits", "of", "Breakthrough", "Therapy", "designation", "include", "the", "eligibility", "for", "priority", "review", "of", "the", "NDA", "within", "six", "months", "instead", "of", "10", "months", "and", "rolling", "submission", "of", "portions", "of", "the", "NDA,", "in", "addition", "to", "an", "organizational", "commitment", "involving", "FDA's", "senior", "managers", "contributing", "significant", "guidance."], "wordsB": ["The", "benefits", "of", "Breakthrough", "Therapy", "designation", "include", "the", "eligibility", "for", "priority", "review", "of", "the", "NDA", "in", "about", "six", "months", "instead", "of", "10", "months", "after", "submission", "and", "rolling", "submission", "of", "completed", "portions", "of", "the", "NDA,", "in", "addition", "to", "an", "organizational", "commitment", "involving", "FDA", "s", "senior", "managers", "contributing", "significant", "guidance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p172_s2", "idA": "1430306_17_item1_p143_s2", "sentA": "The FDA is committing to provide us timely advice and interactive communications related to the design and efficient execution of our drug development program.", "sentB": "The FDA is committing to provide us timely advice and interactive communications related to the design and efficient execution of our Breakthrough Therapy development program.", "type": 2, "words": ["<tag1>", "The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "drug", "development", "program.", "<tag2>", "The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "Breakthrough", "Therapy", "development", "program.", "<tag3>"], "wordsA": ["The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "drug", "development", "program."], "wordsB": ["The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "Breakthrough", "Therapy", "development", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p66_s2", "idA": "1430306_17_item1_p143_s2", "sentA": "The FDA is committing to provide us timely advice and interactive communications related to the design and efficient execution of our drug development program.", "sentB": "The FDA is committing to provide us timely advice and interactive communications related to the design and efficient execution of our Breakthrough Therapy development program.", "type": 2, "words": ["<tag1>", "The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "drug", "development", "program.", "<tag2>", "The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "Breakthrough", "Therapy", "development", "program.", "<tag3>"], "wordsA": ["The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "drug", "development", "program."], "wordsB": ["The", "FDA", "is", "committing", "to", "provide", "us", "timely", "advice", "and", "interactive", "communications", "related", "to", "the", "design", "and", "efficient", "execution", "of", "our", "Breakthrough", "Therapy", "development", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p173_s0", "idA": "1430306_17_item1_p144_s0", "sentA": "In 2016, the 21st Century Cures Act, or the Act, was signed into law to support ongoing biomedical innovation.", "sentB": "In 2016, the 21 st Century Cures Act, or Act, was signed into law to support ongoing biomedical innovation.", "type": 2, "words": ["<tag1>", "In", "2016,", "the", "21st", "Century", "Cures", "Act,", "or", "the", "Act,", "was", "signed", "into", "law", "to", "support", "ongoing", "biomedical", "innovation.", "<tag2>", "In", "2016,", "the", "21", "st", "Century", "Cures", "Act,", "or", "Act,", "was", "signed", "into", "law", "to", "support", "ongoing", "biomedical", "innovation.", "<tag3>"], "wordsA": ["In", "2016,", "the", "21st", "Century", "Cures", "Act,", "or", "the", "Act,", "was", "signed", "into", "law", "to", "support", "ongoing", "biomedical", "innovation."], "wordsB": ["In", "2016,", "the", "21", "st", "Century", "Cures", "Act,", "or", "Act,", "was", "signed", "into", "law", "to", "support", "ongoing", "biomedical", "innovation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p175_s0", "idA": "1430306_17_item1_p146_s0", "sentA": "A priority review voucher can be applied to any other product; it shortens the FDA review timeline for a new application from 10 months to 6 months.", "sentB": "A priority review voucher can be applied to any other product application; it shortens the FDA review timeline for a new application from 10-12 months to 6 months.", "type": 2, "words": ["<tag1>", "A", "priority", "review", "voucher", "can", "be", "applied", "to", "any", "other", "product;", "it", "shortens", "the", "FDA", "review", "timeline", "for", "a", "new", "application", "from", "10", "months", "to", "6", "months.", "<tag2>", "A", "priority", "review", "voucher", "can", "be", "applied", "to", "any", "other", "product", "application;", "it", "shortens", "the", "FDA", "review", "timeline", "for", "a", "new", "application", "from", "10-12", "months", "to", "6", "months.", "<tag3>"], "wordsA": ["A", "priority", "review", "voucher", "can", "be", "applied", "to", "any", "other", "product;", "it", "shortens", "the", "FDA", "review", "timeline", "for", "a", "new", "application", "from", "10", "months", "to", "6", "months."], "wordsB": ["A", "priority", "review", "voucher", "can", "be", "applied", "to", "any", "other", "product", "application;", "it", "shortens", "the", "FDA", "review", "timeline", "for", "a", "new", "application", "from", "10-12", "months", "to", "6", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p175_s2", "idA": "1430306_17_item1_p146_s2", "sentA": "We intend to seek a priority voucher for TNX-801 as a material threat medical countermeasure.", "sentB": "We intend to seek a priority review voucher for TNX-801 licensure as a material threat medical countermeasure.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "seek", "a", "priority", "voucher", "for", "TNX-801", "as", "a", "material", "threat", "medical", "countermeasure.", "<tag2>", "We", "intend", "to", "seek", "a", "priority", "review", "voucher", "for", "TNX-801", "licensure", "as", "a", "material", "threat", "medical", "countermeasure.", "<tag3>"], "wordsA": ["We", "intend", "to", "seek", "a", "priority", "voucher", "for", "TNX-801", "as", "a", "material", "threat", "medical", "countermeasure."], "wordsB": ["We", "intend", "to", "seek", "a", "priority", "review", "voucher", "for", "TNX-801", "licensure", "as", "a", "material", "threat", "medical", "countermeasure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p20_s0", "idA": "1430306_17_item1_p14_s0", "sentA": "Develop TNX-102 SL for PTSD .", "sentB": "Develop Tonmya for PTSD and TNX-102 SL for Other Indications .", "type": 2, "words": ["<tag1>", "Develop", "TNX-102", "SL", "for", "PTSD", ".", "<tag2>", "Develop", "Tonmya", "for", "PTSD", "and", "TNX-102", "SL", "for", "Other", "Indications", ".", "<tag3>"], "wordsA": ["Develop", "TNX-102", "SL", "for", "PTSD", "."], "wordsB": ["Develop", "Tonmya", "for", "PTSD", "and", "TNX-102", "SL", "for", "Other", "Indications", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p117_s2", "idA": "1430306_17_item1_p14_s1", "sentA": "We currently are focusing on the development of TNX-102 SL for PTSD.", "sentB": "The patent is expected to provide Tonmya with European market exclusivity until 2030 and may be extended based on the timing of the European marketing authorization of Tonmya for PTSD.", "type": 2, "words": ["<tag1>", "We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "The", "patent", "is", "expected", "to", "provide", "Tonmya", "with", "European", "market", "exclusivity", "until", "2030", "and", "may", "be", "extended", "based", "on", "the", "timing", "of", "the", "European", "marketing", "authorization", "of", "Tonmya", "for", "PTSD.", "<tag3>"], "wordsA": ["We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["The", "patent", "is", "expected", "to", "provide", "Tonmya", "with", "European", "market", "exclusivity", "until", "2030", "and", "may", "be", "extended", "based", "on", "the", "timing", "of", "the", "European", "marketing", "authorization", "of", "Tonmya", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p20_s1", "idA": "1430306_17_item1_p14_s1", "sentA": "We currently are focusing on the development of TNX-102 SL for PTSD.", "sentB": "We currently are focusing on the development of Tonmya for PTSD.", "type": 2, "words": ["<tag1>", "We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "We", "currently", "are", "focusing", "on", "the", "development", "of", "Tonmya", "for", "PTSD.", "<tag3>"], "wordsA": ["We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["We", "currently", "are", "focusing", "on", "the", "development", "of", "Tonmya", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p31_s0", "idA": "1430306_17_item1_p14_s1", "sentA": "We currently are focusing on the development of TNX-102 SL for PTSD.", "sentB": "We currently are focused on developing a portfolio of product candidates, including one product candidate in clinical development for registration in two indications.", "type": 2, "words": ["<tag1>", "We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "We", "currently", "are", "focused", "on", "developing", "a", "portfolio", "of", "product", "candidates,", "including", "one", "product", "candidate", "in", "clinical", "development", "for", "registration", "in", "two", "indications.", "<tag3>"], "wordsA": ["We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["We", "currently", "are", "focused", "on", "developing", "a", "portfolio", "of", "product", "candidates,", "including", "one", "product", "candidate", "in", "clinical", "development", "for", "registration", "in", "two", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p44_s2", "idA": "1430306_17_item1_p14_s1", "sentA": "We currently are focusing on the development of TNX-102 SL for PTSD.", "sentB": "The patent is expected to provide Tonmya with European market exclusivity until 2030 and may be extended based on the timing of the European marketing authorization of Tonmya for PTSD.", "type": 2, "words": ["<tag1>", "We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "The", "patent", "is", "expected", "to", "provide", "Tonmya", "with", "European", "market", "exclusivity", "until", "2030", "and", "may", "be", "extended", "based", "on", "the", "timing", "of", "the", "European", "marketing", "authorization", "of", "Tonmya", "for", "PTSD.", "<tag3>"], "wordsA": ["We", "currently", "are", "focusing", "on", "the", "development", "of", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["The", "patent", "is", "expected", "to", "provide", "Tonmya", "with", "European", "market", "exclusivity", "until", "2030", "and", "may", "be", "extended", "based", "on", "the", "timing", "of", "the", "European", "marketing", "authorization", "of", "Tonmya", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p185_s1", "idA": "1430306_17_item1_p152_s1", "sentA": "In addition to new legislation, such as the 21st Century Cures Act in 2016, or the Food and Drug Administration Safety and Innovation Act in 2012, Congress introduces amendments to reauthorize drug user fees and address emerging concerns every five years.", "sentB": "In addition to new legislation, such as the FDA Reauthorization Act of 2017 or the FDASIA in 2012, Congress introduces amendments to reauthorize drug user fees and address emerging concerns every five years.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "new", "legislation,", "such", "as", "the", "21st", "Century", "Cures", "Act", "in", "2016,", "or", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act", "in", "2012,", "Congress", "introduces", "amendments", "to", "reauthorize", "drug", "user", "fees", "and", "address", "emerging", "concerns", "every", "five", "years.", "<tag2>", "In", "addition", "to", "new", "legislation,", "such", "as", "the", "FDA", "Reauthorization", "Act", "of", "2017", "or", "the", "FDASIA", "in", "2012,", "Congress", "introduces", "amendments", "to", "reauthorize", "drug", "user", "fees", "and", "address", "emerging", "concerns", "every", "five", "years.", "<tag3>"], "wordsA": ["In", "addition", "to", "new", "legislation,", "such", "as", "the", "21st", "Century", "Cures", "Act", "in", "2016,", "or", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act", "in", "2012,", "Congress", "introduces", "amendments", "to", "reauthorize", "drug", "user", "fees", "and", "address", "emerging", "concerns", "every", "five", "years."], "wordsB": ["In", "addition", "to", "new", "legislation,", "such", "as", "the", "FDA", "Reauthorization", "Act", "of", "2017", "or", "the", "FDASIA", "in", "2012,", "Congress", "introduces", "amendments", "to", "reauthorize", "drug", "user", "fees", "and", "address", "emerging", "concerns", "every", "five", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p181_s2", "idA": "1430306_17_item1_p152_s5", "sentA": "In addition, the FDA s regulations, policies and guidance are often revised or reinterpreted by the agency or the courts in ways that may significantly affect our business and our products.", "sentB": "In addition, the U.S. government, state legislatures and foreign governments have continued implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "FDA", "s", "regulations,", "policies", "and", "guidance", "are", "often", "revised", "or", "reinterpreted", "by", "the", "agency", "or", "the", "courts", "in", "ways", "that", "may", "significantly", "affect", "our", "business", "and", "our", "products.", "<tag2>", "In", "addition,", "the", "U.S.", "government,", "state", "legislatures", "and", "foreign", "governments", "have", "continued", "implementing", "cost-containment", "programs,", "including", "price", "controls,", "restrictions", "on", "reimbursement", "and", "requirements", "for", "substitution", "of", "generic", "products.", "<tag3>"], "wordsA": ["In", "addition,", "the", "FDA", "s", "regulations,", "policies", "and", "guidance", "are", "often", "revised", "or", "reinterpreted", "by", "the", "agency", "or", "the", "courts", "in", "ways", "that", "may", "significantly", "affect", "our", "business", "and", "our", "products."], "wordsB": ["In", "addition,", "the", "U.S.", "government,", "state", "legislatures", "and", "foreign", "governments", "have", "continued", "implementing", "cost-containment", "programs,", "including", "price", "controls,", "restrictions", "on", "reimbursement", "and", "requirements", "for", "substitution", "of", "generic", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p185_s6", "idA": "1430306_17_item1_p152_s7", "sentA": "Additionally, the current legislative authority for the Prescription Drug User Fee Act expires in September 2017.", "sentB": "Additionally, the current legislative authority for the Prescription Drug User Fee Act expired in September 2017.", "type": 2, "words": ["<tag1>", "Additionally,", "the", "current", "legislative", "authority", "for", "the", "Prescription", "Drug", "User", "Fee", "Act", "expires", "in", "September", "2017.", "<tag2>", "Additionally,", "the", "current", "legislative", "authority", "for", "the", "Prescription", "Drug", "User", "Fee", "Act", "expired", "in", "September", "2017.", "<tag3>"], "wordsA": ["Additionally,", "the", "current", "legislative", "authority", "for", "the", "Prescription", "Drug", "User", "Fee", "Act", "expires", "in", "September", "2017."], "wordsB": ["Additionally,", "the", "current", "legislative", "authority", "for", "the", "Prescription", "Drug", "User", "Fee", "Act", "expired", "in", "September", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p188_s0", "idA": "1430306_17_item1_p154_s0", "sentA": "As of April 12, 2017, we had 18 full-time employees, of whom five hold M.D. or Ph.D. degrees.", "sentB": "As of March 1, 2018, we had 14 full-time employees, of whom five hold M.D. or Ph.D. degrees.", "type": 2, "words": ["<tag1>", "As", "of", "April", "12,", "2017,", "we", "had", "18", "full-time", "employees,", "of", "whom", "five", "hold", "M.D.", "or", "Ph.D.", "degrees.", "<tag2>", "As", "of", "March", "1,", "2018,", "we", "had", "14", "full-time", "employees,", "of", "whom", "five", "hold", "M.D.", "or", "Ph.D.", "degrees.", "<tag3>"], "wordsA": ["As", "of", "April", "12,", "2017,", "we", "had", "18", "full-time", "employees,", "of", "whom", "five", "hold", "M.D.", "or", "Ph.D.", "degrees."], "wordsB": ["As", "of", "March", "1,", "2018,", "we", "had", "14", "full-time", "employees,", "of", "whom", "five", "hold", "M.D.", "or", "Ph.D.", "degrees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p188_s1", "idA": "1430306_17_item1_p154_s1", "sentA": "We have 10 employees dedicated to research and development.", "sentB": "We have nine employees dedicated to research and development.", "type": 2, "words": ["<tag1>", "We", "have", "10", "employees", "dedicated", "to", "research", "and", "development.", "<tag2>", "We", "have", "nine", "employees", "dedicated", "to", "research", "and", "development.", "<tag3>"], "wordsA": ["We", "have", "10", "employees", "dedicated", "to", "research", "and", "development."], "wordsB": ["We", "have", "nine", "employees", "dedicated", "to", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p190_s0", "idA": "1430306_17_item1_p156_s0", "sentA": "Our principal executive offices are located at 509 Madison Avenue, Suite 306, New York, New York 10022, and our telephone number is (212) 980-9155.", "sentB": "We lease the space for our principal executive offices, which are located at 509 Madison Avenue, Suite 306, New York, New York 10022, and our telephone number is (212) 980-9155.", "type": 2, "words": ["<tag1>", "Our", "principal", "executive", "offices", "are", "located", "at", "509", "Madison", "Avenue,", "Suite", "306,", "New", "York,", "New", "York", "10022,", "and", "our", "telephone", "number", "is", "(212)", "980-9155.", "<tag2>", "We", "lease", "the", "space", "for", "our", "principal", "executive", "offices,", "which", "are", "located", "at", "509", "Madison", "Avenue,", "Suite", "306,", "New", "York,", "New", "York", "10022,", "and", "our", "telephone", "number", "is", "(212)", "980-9155.", "<tag3>"], "wordsA": ["Our", "principal", "executive", "offices", "are", "located", "at", "509", "Madison", "Avenue,", "Suite", "306,", "New", "York,", "New", "York", "10022,", "and", "our", "telephone", "number", "is", "(212)", "980-9155."], "wordsB": ["We", "lease", "the", "space", "for", "our", "principal", "executive", "offices,", "which", "are", "located", "at", "509", "Madison", "Avenue,", "Suite", "306,", "New", "York,", "New", "York", "10022,", "and", "our", "telephone", "number", "is", "(212)", "980-9155."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p21_s0", "idA": "1430306_17_item1_p15_s0", "sentA": "Maximize the commercial potential of TNX-102 SL .", "sentB": "Maximize the commercial potential of Tonmya .", "type": 2, "words": ["<tag1>", "Maximize", "the", "commercial", "potential", "of", "TNX-102", "SL", ".", "<tag2>", "Maximize", "the", "commercial", "potential", "of", "Tonmya", ".", "<tag3>"], "wordsA": ["Maximize", "the", "commercial", "potential", "of", "TNX-102", "SL", "."], "wordsB": ["Maximize", "the", "commercial", "potential", "of", "Tonmya", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p21_s1", "idA": "1430306_17_item1_p15_s1", "sentA": "We plan to commercialize TNX-102 SL for PTSD, either on our own or through collaboration with partners.", "sentB": "We plan to commercialize Tonmya for PTSD, either on our own or through collaboration with partners.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "commercialize", "TNX-102", "SL", "for", "PTSD,", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners.", "<tag2>", "We", "plan", "to", "commercialize", "Tonmya", "for", "PTSD,", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners.", "<tag3>"], "wordsA": ["We", "plan", "to", "commercialize", "TNX-102", "SL", "for", "PTSD,", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners."], "wordsB": ["We", "plan", "to", "commercialize", "Tonmya", "for", "PTSD,", "either", "on", "our", "own", "or", "through", "collaboration", "with", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p21_s2", "idA": "1430306_17_item1_p15_s2", "sentA": "We believe TNX-102 SL can be marketed to U.S. physicians either by an internal sales force that we will build or by a contract sales organization, which we would engage.", "sentB": "We believe Tonmya can be marketed to U.S. physicians either by an internal sales force that we will build or by a contract sales organization, which we would engage.", "type": 2, "words": ["<tag1>", "We", "believe", "TNX-102", "SL", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage.", "<tag2>", "We", "believe", "Tonmya", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage.", "<tag3>"], "wordsA": ["We", "believe", "TNX-102", "SL", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage."], "wordsB": ["We", "believe", "Tonmya", "can", "be", "marketed", "to", "U.S.", "physicians", "either", "by", "an", "internal", "sales", "force", "that", "we", "will", "build", "or", "by", "a", "contract", "sales", "organization,", "which", "we", "would", "engage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p22_s2", "idA": "1430306_17_item1_p16_s2", "sentA": "In the case of TNX-102 SL, we own patents and patent applications protecting its composition-of-matter, certain methods of its use, its formulation, and its pharmacokinetic properties.", "sentB": "In the cases of Tonmya and TNX-102 SL, we own patents and patent applications protecting its composition-of-matter, certain methods of its use, its formulation, and its pharmacokinetic properties.", "type": 2, "words": ["<tag1>", "In", "the", "case", "of", "TNX-102", "SL,", "we", "own", "patents", "and", "patent", "applications", "protecting", "its", "composition-of-matter,", "certain", "methods", "of", "its", "use,", "its", "formulation,", "and", "its", "pharmacokinetic", "properties.", "<tag2>", "In", "the", "cases", "of", "Tonmya", "and", "TNX-102", "SL,", "we", "own", "patents", "and", "patent", "applications", "protecting", "its", "composition-of-matter,", "certain", "methods", "of", "its", "use,", "its", "formulation,", "and", "its", "pharmacokinetic", "properties.", "<tag3>"], "wordsA": ["In", "the", "case", "of", "TNX-102", "SL,", "we", "own", "patents", "and", "patent", "applications", "protecting", "its", "composition-of-matter,", "certain", "methods", "of", "its", "use,", "its", "formulation,", "and", "its", "pharmacokinetic", "properties."], "wordsB": ["In", "the", "cases", "of", "Tonmya", "and", "TNX-102", "SL,", "we", "own", "patents", "and", "patent", "applications", "protecting", "its", "composition-of-matter,", "certain", "methods", "of", "its", "use,", "its", "formulation,", "and", "its", "pharmacokinetic", "properties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p10_s0", "idA": "1430306_17_item1_p16_s3", "sentA": "We recently received a Notice of Allowance from the U.S. Patent and Trademark Office, or PTO, for patent claims the will protect the pharmaceutical eutectic composition of TNX-102 SL until 2034.", "sentB": "The U.S. Patent and Trademark Office, or PTO, has granted the federal registration of the Tonmya mark.", "type": 2, "words": ["<tag1>", "We", "recently", "received", "a", "Notice", "of", "Allowance", "from", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "for", "patent", "claims", "the", "will", "protect", "the", "pharmaceutical", "eutectic", "composition", "of", "TNX-102", "SL", "until", "2034.", "<tag2>", "The", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "has", "granted", "the", "federal", "registration", "of", "the", "Tonmya", "mark.", "<tag3>"], "wordsA": ["We", "recently", "received", "a", "Notice", "of", "Allowance", "from", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "for", "patent", "claims", "the", "will", "protect", "the", "pharmaceutical", "eutectic", "composition", "of", "TNX-102", "SL", "until", "2034."], "wordsB": ["The", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "has", "granted", "the", "federal", "registration", "of", "the", "Tonmya", "mark."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p119_s0", "idA": "1430306_17_item1_p16_s3", "sentA": "We recently received a Notice of Allowance from the U.S. Patent and Trademark Office, or PTO, for patent claims the will protect the pharmaceutical eutectic composition of TNX-102 SL until 2034.", "sentB": "On January 17, 2018, we received a Notice of Allowance from the USPTO for the U.S. Patent Application No. 12/948,828 Methods and Compositions for Treating Symptoms Associated with PTSD Using Cyclobenzaprine .", "type": 2, "words": ["<tag1>", "We", "recently", "received", "a", "Notice", "of", "Allowance", "from", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "for", "patent", "claims", "the", "will", "protect", "the", "pharmaceutical", "eutectic", "composition", "of", "TNX-102", "SL", "until", "2034.", "<tag2>", "On", "January", "17,", "2018,", "we", "received", "a", "Notice", "of", "Allowance", "from", "the", "USPTO", "for", "the", "U.S.", "Patent", "Application", "No.", "12/948,828", "Methods", "and", "Compositions", "for", "Treating", "Symptoms", "Associated", "with", "PTSD", "Using", "Cyclobenzaprine", ".", "<tag3>"], "wordsA": ["We", "recently", "received", "a", "Notice", "of", "Allowance", "from", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "for", "patent", "claims", "the", "will", "protect", "the", "pharmaceutical", "eutectic", "composition", "of", "TNX-102", "SL", "until", "2034."], "wordsB": ["On", "January", "17,", "2018,", "we", "received", "a", "Notice", "of", "Allowance", "from", "the", "USPTO", "for", "the", "U.S.", "Patent", "Application", "No.", "12/948,828", "Methods", "and", "Compositions", "for", "Treating", "Symptoms", "Associated", "with", "PTSD", "Using", "Cyclobenzaprine", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p46_s0", "idA": "1430306_17_item1_p16_s3", "sentA": "We recently received a Notice of Allowance from the U.S. Patent and Trademark Office, or PTO, for patent claims the will protect the pharmaceutical eutectic composition of TNX-102 SL until 2034.", "sentB": "On January 23, 2018, we were issued a Notice of Allowance from PTO for U.S. Patent Application 12/948,828, Methods and compositions for treating symptoms associated with PTSD using Cyclobenzaprine .", "type": 2, "words": ["<tag1>", "We", "recently", "received", "a", "Notice", "of", "Allowance", "from", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "for", "patent", "claims", "the", "will", "protect", "the", "pharmaceutical", "eutectic", "composition", "of", "TNX-102", "SL", "until", "2034.", "<tag2>", "On", "January", "23,", "2018,", "we", "were", "issued", "a", "Notice", "of", "Allowance", "from", "PTO", "for", "U.S.", "Patent", "Application", "12/948,828,", "Methods", "and", "compositions", "for", "treating", "symptoms", "associated", "with", "PTSD", "using", "Cyclobenzaprine", ".", "<tag3>"], "wordsA": ["We", "recently", "received", "a", "Notice", "of", "Allowance", "from", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "or", "PTO,", "for", "patent", "claims", "the", "will", "protect", "the", "pharmaceutical", "eutectic", "composition", "of", "TNX-102", "SL", "until", "2034."], "wordsB": ["On", "January", "23,", "2018,", "we", "were", "issued", "a", "Notice", "of", "Allowance", "from", "PTO", "for", "U.S.", "Patent", "Application", "12/948,828,", "Methods", "and", "compositions", "for", "treating", "symptoms", "associated", "with", "PTSD", "using", "Cyclobenzaprine", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p182_s6", "idA": "1430306_17_item1_p17_s0", "sentA": "Provide value propositions to merit market demand and reimbursement for our product candidates .", "sentB": "Decreases in third-party reimbursement for our product candidates or a decision by a third-party payor to not cover our product candidates could reduce physician usage of our product candidates, once approved, and have a material adverse effect on our sales, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Provide", "value", "propositions", "to", "merit", "market", "demand", "and", "reimbursement", "for", "our", "product", "candidates", ".", "<tag2>", "Decreases", "in", "third-party", "reimbursement", "for", "our", "product", "candidates", "or", "a", "decision", "by", "a", "third-party", "payor", "to", "not", "cover", "our", "product", "candidates", "could", "reduce", "physician", "usage", "of", "our", "product", "candidates,", "once", "approved,", "and", "have", "a", "material", "adverse", "effect", "on", "our", "sales,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Provide", "value", "propositions", "to", "merit", "market", "demand", "and", "reimbursement", "for", "our", "product", "candidates", "."], "wordsB": ["Decreases", "in", "third-party", "reimbursement", "for", "our", "product", "candidates", "or", "a", "decision", "by", "a", "third-party", "payor", "to", "not", "cover", "our", "product", "candidates", "could", "reduce", "physician", "usage", "of", "our", "product", "candidates,", "once", "approved,", "and", "have", "a", "material", "adverse", "effect", "on", "our", "sales,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p23_s2", "idA": "1430306_17_item1_p17_s2", "sentA": "In the case of TNX-102 SL, we have been engaged in market research and commercial assessment activities, the results of which we may use to inform future commercial strategy.", "sentB": "In the case of Tonmya, we have been engaged in market research and commercial assessment activities, the results of which we may use to inform future commercial strategy.", "type": 2, "words": ["<tag1>", "In", "the", "case", "of", "TNX-102", "SL,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy.", "<tag2>", "In", "the", "case", "of", "Tonmya,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy.", "<tag3>"], "wordsA": ["In", "the", "case", "of", "TNX-102", "SL,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy."], "wordsB": ["In", "the", "case", "of", "Tonmya,", "we", "have", "been", "engaged", "in", "market", "research", "and", "commercial", "assessment", "activities,", "the", "results", "of", "which", "we", "may", "use", "to", "inform", "future", "commercial", "strategy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p25_s0", "idA": "1430306_17_item1_p19_s0", "sentA": "Our product candidates address disorders that are not well served by currently available therapies and represent large potential commercial market opportunities.", "sentB": "Our product candidates address disorders that are not well served by currently available therapies or have no approved treatment which represent large potential commercial market opportunities.", "type": 2, "words": ["<tag1>", "Our", "product", "candidates", "address", "disorders", "that", "are", "not", "well", "served", "by", "currently", "available", "therapies", "and", "represent", "large", "potential", "commercial", "market", "opportunities.", "<tag2>", "Our", "product", "candidates", "address", "disorders", "that", "are", "not", "well", "served", "by", "currently", "available", "therapies", "or", "have", "no", "approved", "treatment", "which", "represent", "large", "potential", "commercial", "market", "opportunities.", "<tag3>"], "wordsA": ["Our", "product", "candidates", "address", "disorders", "that", "are", "not", "well", "served", "by", "currently", "available", "therapies", "and", "represent", "large", "potential", "commercial", "market", "opportunities."], "wordsB": ["Our", "product", "candidates", "address", "disorders", "that", "are", "not", "well", "served", "by", "currently", "available", "therapies", "or", "have", "no", "approved", "treatment", "which", "represent", "large", "potential", "commercial", "market", "opportunities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p1_s3", "idA": "1430306_17_item1_p1_s3", "sentA": "You can read and copy any materials we file with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Washington, DC 20549.", "sentB": "You can read and copy any materials we file with the SEC at the SEC s Public Reference Room at 100 F Street, NE, Washington, DC 20549.", "type": 2, "words": ["<tag1>", "You", "can", "read", "and", "copy", "any", "materials", "we", "file", "with", "the", "SEC", "at", "the", "SEC's", "Public", "Reference", "Room", "at", "100", "F", "Street,", "NE,", "Washington,", "DC", "20549.", "<tag2>", "You", "can", "read", "and", "copy", "any", "materials", "we", "file", "with", "the", "SEC", "at", "the", "SEC", "s", "Public", "Reference", "Room", "at", "100", "F", "Street,", "NE,", "Washington,", "DC", "20549.", "<tag3>"], "wordsA": ["You", "can", "read", "and", "copy", "any", "materials", "we", "file", "with", "the", "SEC", "at", "the", "SEC's", "Public", "Reference", "Room", "at", "100", "F", "Street,", "NE,", "Washington,", "DC", "20549."], "wordsB": ["You", "can", "read", "and", "copy", "any", "materials", "we", "file", "with", "the", "SEC", "at", "the", "SEC", "s", "Public", "Reference", "Room", "at", "100", "F", "Street,", "NE,", "Washington,", "DC", "20549."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p26_s0", "idA": "1430306_17_item1_p20_s0", "sentA": "PTSD is a chronic syndrome that may develop after a person is exposed to one or more traumatic events, such as warfare, sexual assault, serious injury, or threat of imminent death.", "sentB": "PTSD is a chronic condition that may develop after a person is exposed to one or more traumatic events, such as warfare, sexual assault, serious injury, or threat of imminent death.", "type": 2, "words": ["<tag1>", "PTSD", "is", "a", "chronic", "syndrome", "that", "may", "develop", "after", "a", "person", "is", "exposed", "to", "one", "or", "more", "traumatic", "events,", "such", "as", "warfare,", "sexual", "assault,", "serious", "injury,", "or", "threat", "of", "imminent", "death.", "<tag2>", "PTSD", "is", "a", "chronic", "condition", "that", "may", "develop", "after", "a", "person", "is", "exposed", "to", "one", "or", "more", "traumatic", "events,", "such", "as", "warfare,", "sexual", "assault,", "serious", "injury,", "or", "threat", "of", "imminent", "death.", "<tag3>"], "wordsA": ["PTSD", "is", "a", "chronic", "syndrome", "that", "may", "develop", "after", "a", "person", "is", "exposed", "to", "one", "or", "more", "traumatic", "events,", "such", "as", "warfare,", "sexual", "assault,", "serious", "injury,", "or", "threat", "of", "imminent", "death."], "wordsB": ["PTSD", "is", "a", "chronic", "condition", "that", "may", "develop", "after", "a", "person", "is", "exposed", "to", "one", "or", "more", "traumatic", "events,", "such", "as", "warfare,", "sexual", "assault,", "serious", "injury,", "or", "threat", "of", "imminent", "death."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p26_s5", "idA": "1430306_17_item1_p20_s5", "sentA": "As of 2015, there were approximately 638,000 veterans receiving treatment for PTSD in the Veterans Health Administration, or VHA.", "sentB": "As of 2012, there were approximately 638,000 veterans receiving treatment for PTSD in the Veterans Health Administration, or VHA.", "type": 2, "words": ["<tag1>", "As", "of", "2015,", "there", "were", "approximately", "638,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA.", "<tag2>", "As", "of", "2012,", "there", "were", "approximately", "638,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA.", "<tag3>"], "wordsA": ["As", "of", "2015,", "there", "were", "approximately", "638,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA."], "wordsB": ["As", "of", "2012,", "there", "were", "approximately", "638,000", "veterans", "receiving", "treatment", "for", "PTSD", "in", "the", "Veterans", "Health", "Administration,", "or", "VHA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p17_s1", "idA": "1430306_17_item1_p21_s1", "sentA": "Sleep disturbances are central features of PTSD and are predictive of disease severity, depression, substance abuse, and suicidal ideation, yet are resistant to the approved medications and present a difficult therapeutic challenge.", "sentB": "Sleep disturbances and agitation are common and co-morbid features of Alzheimer s disease.", "type": 2, "words": ["<tag1>", "Sleep", "disturbances", "are", "central", "features", "of", "PTSD", "and", "are", "predictive", "of", "disease", "severity,", "depression,", "substance", "abuse,", "and", "suicidal", "ideation,", "yet", "are", "resistant", "to", "the", "approved", "medications", "and", "present", "a", "difficult", "therapeutic", "challenge.", "<tag2>", "Sleep", "disturbances", "and", "agitation", "are", "common", "and", "co-morbid", "features", "of", "Alzheimer", "s", "disease.", "<tag3>"], "wordsA": ["Sleep", "disturbances", "are", "central", "features", "of", "PTSD", "and", "are", "predictive", "of", "disease", "severity,", "depression,", "substance", "abuse,", "and", "suicidal", "ideation,", "yet", "are", "resistant", "to", "the", "approved", "medications", "and", "present", "a", "difficult", "therapeutic", "challenge."], "wordsB": ["Sleep", "disturbances", "and", "agitation", "are", "common", "and", "co-morbid", "features", "of", "Alzheimer", "s", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p28_s1", "idA": "1430306_17_item1_p21_s1", "sentA": "Sleep disturbances are central features of PTSD and are predictive of disease severity, depression, substance abuse, and suicidal ideation, yet are resistant to the approved medications and present a difficult therapeutic challenge.", "sentB": "Sleep disturbances and agitation are common and co-morbid features of Alzheimer s disease.", "type": 2, "words": ["<tag1>", "Sleep", "disturbances", "are", "central", "features", "of", "PTSD", "and", "are", "predictive", "of", "disease", "severity,", "depression,", "substance", "abuse,", "and", "suicidal", "ideation,", "yet", "are", "resistant", "to", "the", "approved", "medications", "and", "present", "a", "difficult", "therapeutic", "challenge.", "<tag2>", "Sleep", "disturbances", "and", "agitation", "are", "common", "and", "co-morbid", "features", "of", "Alzheimer", "s", "disease.", "<tag3>"], "wordsA": ["Sleep", "disturbances", "are", "central", "features", "of", "PTSD", "and", "are", "predictive", "of", "disease", "severity,", "depression,", "substance", "abuse,", "and", "suicidal", "ideation,", "yet", "are", "resistant", "to", "the", "approved", "medications", "and", "present", "a", "difficult", "therapeutic", "challenge."], "wordsB": ["Sleep", "disturbances", "and", "agitation", "are", "common", "and", "co-morbid", "features", "of", "Alzheimer", "s", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p32_s0", "idA": "1430306_17_item1_p22_s0", "sentA": "TNX-102 SL is a proprietary sublingual tablet formulation of CBP that efficiently delivers CBP across the oral mucosal membrane into the systemic circulation.", "sentB": "Tonmya or TNX-102 SL is a proprietary sublingual tablet formulation of CBP that efficiently delivers CBP across the oral mucosal membrane into the systemic circulation.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "proprietary", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation.", "<tag2>", "Tonmya", "or", "TNX-102", "SL", "is", "a", "proprietary", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "proprietary", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation."], "wordsB": ["Tonmya", "or", "TNX-102", "SL", "is", "a", "proprietary", "sublingual", "tablet", "formulation", "of", "CBP", "that", "efficiently", "delivers", "CBP", "across", "the", "oral", "mucosal", "membrane", "into", "the", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p32_s1", "idA": "1430306_17_item1_p22_s1", "sentA": "We are developing TNX-102 SL for PTSD.", "sentB": "We are developing Tonmya for PTSD.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "PTSD.", "<tag2>", "We", "are", "developing", "Tonmya", "for", "PTSD.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "PTSD."], "wordsB": ["We", "are", "developing", "Tonmya", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p32_s2", "idA": "1430306_17_item1_p22_s2", "sentA": "We own all rights to TNX-102 SL in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "sentB": "We own all rights to Tonmya in all geographies, and we bear no obligations to third-parties for any future development or commercialization.", "type": 2, "words": ["<tag1>", "We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag2>", "We", "own", "all", "rights", "to", "Tonmya", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization.", "<tag3>"], "wordsA": ["We", "own", "all", "rights", "to", "TNX-102", "SL", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "wordsB": ["We", "own", "all", "rights", "to", "Tonmya", "in", "all", "geographies,", "and", "we", "bear", "no", "obligations", "to", "third-parties", "for", "any", "future", "development", "or", "commercialization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p33_s0", "idA": "1430306_17_item1_p23_s0", "sentA": "Excipients used in TNX-102 SL are approved for pharmaceutical use.", "sentB": "Excipients used in Tonmya are approved for pharmaceutical use.", "type": 2, "words": ["<tag1>", "Excipients", "used", "in", "TNX-102", "SL", "are", "approved", "for", "pharmaceutical", "use.", "<tag2>", "Excipients", "used", "in", "Tonmya", "are", "approved", "for", "pharmaceutical", "use.", "<tag3>"], "wordsA": ["Excipients", "used", "in", "TNX-102", "SL", "are", "approved", "for", "pharmaceutical", "use."], "wordsB": ["Excipients", "used", "in", "Tonmya", "are", "approved", "for", "pharmaceutical", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p34_s0", "idA": "1430306_17_item1_p24_s0", "sentA": "The current TNX-102 SL sublingual tablets contain 2.8 mg of CBP.", "sentB": "The current Tonmya sublingual tablets contain 2.8 mg of CBP.", "type": 2, "words": ["<tag1>", "The", "current", "TNX-102", "SL", "sublingual", "tablets", "contain", "2.8", "mg", "of", "CBP.", "<tag2>", "The", "current", "Tonmya", "sublingual", "tablets", "contain", "2.8", "mg", "of", "CBP.", "<tag3>"], "wordsA": ["The", "current", "TNX-102", "SL", "sublingual", "tablets", "contain", "2.8", "mg", "of", "CBP."], "wordsB": ["The", "current", "Tonmya", "sublingual", "tablets", "contain", "2.8", "mg", "of", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p34_s1", "idA": "1430306_17_item1_p24_s1", "sentA": "For the treatment of PTSD, 5.6 mg of TNX-102 SL, comprised of two TNX-102 SL 2.8 mg tablets administered simultaneously at bedtime, is in Phase 3 development.", "sentB": "For the treatment of PTSD, Tonmya, 5.6 mg (two 2.8 mg tablets) administered simultaneously at bedtime, is in Phase 3 development.", "type": 2, "words": ["<tag1>", "For", "the", "treatment", "of", "PTSD,", "5.6", "mg", "of", "TNX-102", "SL,", "comprised", "of", "two", "TNX-102", "SL", "2.8", "mg", "tablets", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development.", "<tag2>", "For", "the", "treatment", "of", "PTSD,", "Tonmya,", "5.6", "mg", "(two", "2.8", "mg", "tablets)", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development.", "<tag3>"], "wordsA": ["For", "the", "treatment", "of", "PTSD,", "5.6", "mg", "of", "TNX-102", "SL,", "comprised", "of", "two", "TNX-102", "SL", "2.8", "mg", "tablets", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development."], "wordsB": ["For", "the", "treatment", "of", "PTSD,", "Tonmya,", "5.6", "mg", "(two", "2.8", "mg", "tablets)", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p99_s1", "idA": "1430306_17_item1_p24_s1", "sentA": "For the treatment of PTSD, 5.6 mg of TNX-102 SL, comprised of two TNX-102 SL 2.8 mg tablets administered simultaneously at bedtime, is in Phase 3 development.", "sentB": "Deudextromethorphan is in Phase 3 for the treatment of agitation in patients with dementia of the Alzheimer s type.", "type": 2, "words": ["<tag1>", "For", "the", "treatment", "of", "PTSD,", "5.6", "mg", "of", "TNX-102", "SL,", "comprised", "of", "two", "TNX-102", "SL", "2.8", "mg", "tablets", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development.", "<tag2>", "Deudextromethorphan", "is", "in", "Phase", "3", "for", "the", "treatment", "of", "agitation", "in", "patients", "with", "dementia", "of", "the", "Alzheimer", "s", "type.", "<tag3>"], "wordsA": ["For", "the", "treatment", "of", "PTSD,", "5.6", "mg", "of", "TNX-102", "SL,", "comprised", "of", "two", "TNX-102", "SL", "2.8", "mg", "tablets", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development."], "wordsB": ["Deudextromethorphan", "is", "in", "Phase", "3", "for", "the", "treatment", "of", "agitation", "in", "patients", "with", "dementia", "of", "the", "Alzheimer", "s", "type."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p99_s2", "idA": "1430306_17_item1_p24_s1", "sentA": "For the treatment of PTSD, 5.6 mg of TNX-102 SL, comprised of two TNX-102 SL 2.8 mg tablets administered simultaneously at bedtime, is in Phase 3 development.", "sentB": "Dextromethorphan/buproprion is in Phase 3 for the treatment of resistant depression and agitation in patients with Alzheimer s disease.", "type": 2, "words": ["<tag1>", "For", "the", "treatment", "of", "PTSD,", "5.6", "mg", "of", "TNX-102", "SL,", "comprised", "of", "two", "TNX-102", "SL", "2.8", "mg", "tablets", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development.", "<tag2>", "Dextromethorphan/buproprion", "is", "in", "Phase", "3", "for", "the", "treatment", "of", "resistant", "depression", "and", "agitation", "in", "patients", "with", "Alzheimer", "s", "disease.", "<tag3>"], "wordsA": ["For", "the", "treatment", "of", "PTSD,", "5.6", "mg", "of", "TNX-102", "SL,", "comprised", "of", "two", "TNX-102", "SL", "2.8", "mg", "tablets", "administered", "simultaneously", "at", "bedtime,", "is", "in", "Phase", "3", "development."], "wordsB": ["Dextromethorphan/buproprion", "is", "in", "Phase", "3", "for", "the", "treatment", "of", "resistant", "depression", "and", "agitation", "in", "patients", "with", "Alzheimer", "s", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p35_s0", "idA": "1430306_17_item1_p25_s0", "sentA": "TNX-102 SL is a serotonin 2A and alpha-1 adrenergic receptor antagonist as well as an inhibitor of serotonin and norepinephrine reuptake, and we refer to it as a Serotonin and Norepinephrine receptor Antagonist and Reuptake Inhibitor, or SNARI.", "sentB": "The active ingredient in Tonmya, is CBP, a serotonin-2A and alpha-1 adrenergic receptor antagonist as well as an inhibitor of serotonin and norepinephrine reuptake.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "is", "a", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptor", "antagonist", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake,", "and", "we", "refer", "to", "it", "as", "a", "Serotonin", "and", "Norepinephrine", "receptor", "Antagonist", "and", "Reuptake", "Inhibitor,", "or", "SNARI.", "<tag2>", "The", "active", "ingredient", "in", "Tonmya,", "is", "CBP,", "a", "serotonin-2A", "and", "alpha-1", "adrenergic", "receptor", "antagonist", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake.", "<tag3>"], "wordsA": ["TNX-102", "SL", "is", "a", "serotonin", "2A", "and", "alpha-1", "adrenergic", "receptor", "antagonist", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake,", "and", "we", "refer", "to", "it", "as", "a", "Serotonin", "and", "Norepinephrine", "receptor", "Antagonist", "and", "Reuptake", "Inhibitor,", "or", "SNARI."], "wordsB": ["The", "active", "ingredient", "in", "Tonmya,", "is", "CBP,", "a", "serotonin-2A", "and", "alpha-1", "adrenergic", "receptor", "antagonist", "as", "well", "as", "an", "inhibitor", "of", "serotonin", "and", "norepinephrine", "reuptake."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p35_s1", "idA": "1430306_17_item1_p26_s2", "sentA": "In addition, TNX-102 SL also acts upon other receptors in the central nervous system not targeted by products approved for PTSD, including the serotonin 2A, alpha-1 adrenergic and histamine H-1 receptors.", "sentB": "In addition, Tonmya acts upon other receptors in the central nervous system not targeted by products approved for PTSD, including the serotonin 2A, alpha-1 adrenergic and histamine H-1 receptors.", "type": 2, "words": ["<tag1>", "In", "addition,", "TNX-102", "SL", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "PTSD,", "including", "the", "serotonin", "2A,", "alpha-1", "adrenergic", "and", "histamine", "H-1", "receptors.", "<tag2>", "In", "addition,", "Tonmya", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "PTSD,", "including", "the", "serotonin", "2A,", "alpha-1", "adrenergic", "and", "histamine", "H-1", "receptors.", "<tag3>"], "wordsA": ["In", "addition,", "TNX-102", "SL", "also", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "PTSD,", "including", "the", "serotonin", "2A,", "alpha-1", "adrenergic", "and", "histamine", "H-1", "receptors."], "wordsB": ["In", "addition,", "Tonmya", "acts", "upon", "other", "receptors", "in", "the", "central", "nervous", "system", "not", "targeted", "by", "products", "approved", "for", "PTSD,", "including", "the", "serotonin", "2A,", "alpha-1", "adrenergic", "and", "histamine", "H-1", "receptors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p36_s0", "idA": "1430306_17_item1_p27_s0", "sentA": "CBP is the active ingredient of two products that are approved in the U.S. for the treatment of muscle spasm: FLEXERIL (oral immediate-release tablet, 5 mg and 10 mg dosage forms) and AMRIX (oral extended-release capsule, 15 mg and 30 mg dosage forms).", "sentB": "CBP is the active ingredient of two products that are approved in the U.S. for the treatment of muscle spasm: FLEXERIL (5 mg and 10 mg oral immediate-release, or IR, tablet) and AMRIX (15 mg and 30 mg oral extended-release capsule).", "type": 2, "words": ["<tag1>", "CBP", "is", "the", "active", "ingredient", "of", "two", "products", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "FLEXERIL", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "AMRIX", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms).", "<tag2>", "CBP", "is", "the", "active", "ingredient", "of", "two", "products", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "FLEXERIL", "(5", "mg", "and", "10", "mg", "oral", "immediate-release,", "or", "IR,", "tablet)", "and", "AMRIX", "(15", "mg", "and", "30", "mg", "oral", "extended-release", "capsule).", "<tag3>"], "wordsA": ["CBP", "is", "the", "active", "ingredient", "of", "two", "products", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "FLEXERIL", "(oral", "immediate-release", "tablet,", "5", "mg", "and", "10", "mg", "dosage", "forms)", "and", "AMRIX", "(oral", "extended-release", "capsule,", "15", "mg", "and", "30", "mg", "dosage", "forms)."], "wordsB": ["CBP", "is", "the", "active", "ingredient", "of", "two", "products", "that", "are", "approved", "in", "the", "U.S.", "for", "the", "treatment", "of", "muscle", "spasm:", "FLEXERIL", "(5", "mg", "and", "10", "mg", "oral", "immediate-release,", "or", "IR,", "tablet)", "and", "AMRIX", "(15", "mg", "and", "30", "mg", "oral", "extended-release", "capsule)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p36_s1", "idA": "1430306_17_item1_p27_s1", "sentA": "The FLEXERIL brand of cyclobenzaprine immediate-release tablet has been discontinued since May 2013.", "sentB": "The FLEXERIL brand of CBP IR tablet has been discontinued since May 2013.", "type": 2, "words": ["<tag1>", "The", "FLEXERIL", "brand", "of", "cyclobenzaprine", "immediate-release", "tablet", "has", "been", "discontinued", "since", "May", "2013.", "<tag2>", "The", "FLEXERIL", "brand", "of", "CBP", "IR", "tablet", "has", "been", "discontinued", "since", "May", "2013.", "<tag3>"], "wordsA": ["The", "FLEXERIL", "brand", "of", "cyclobenzaprine", "immediate-release", "tablet", "has", "been", "discontinued", "since", "May", "2013."], "wordsB": ["The", "FLEXERIL", "brand", "of", "CBP", "IR", "tablet", "has", "been", "discontinued", "since", "May", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p37_s0", "idA": "1430306_17_item1_p28_s0", "sentA": "There are numerous generic versions of cyclobenzaprine immediate-release tablets on the market.", "sentB": "There are numerous generic versions of CBP IR tablets on the market.", "type": 2, "words": ["<tag1>", "There", "are", "numerous", "generic", "versions", "of", "cyclobenzaprine", "immediate-release", "tablets", "on", "the", "market.", "<tag2>", "There", "are", "numerous", "generic", "versions", "of", "CBP", "IR", "tablets", "on", "the", "market.", "<tag3>"], "wordsA": ["There", "are", "numerous", "generic", "versions", "of", "cyclobenzaprine", "immediate-release", "tablets", "on", "the", "market."], "wordsB": ["There", "are", "numerous", "generic", "versions", "of", "CBP", "IR", "tablets", "on", "the", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p117_s1", "idA": "1430306_17_item1_p28_s1", "sentA": "CBP-containing products are not indicated for the treatment of PTSD.", "sentB": "This patent recites the use of CBP for the treatment of PTSD, which covers the use of Tonmya for the treatment of PTSD, since the active ingredient in Tonmya is CBP.", "type": 2, "words": ["<tag1>", "CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "This", "patent", "recites", "the", "use", "of", "CBP", "for", "the", "treatment", "of", "PTSD,", "which", "covers", "the", "use", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD,", "since", "the", "active", "ingredient", "in", "Tonmya", "is", "CBP.", "<tag3>"], "wordsA": ["CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["This", "patent", "recites", "the", "use", "of", "CBP", "for", "the", "treatment", "of", "PTSD,", "which", "covers", "the", "use", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD,", "since", "the", "active", "ingredient", "in", "Tonmya", "is", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p44_s1", "idA": "1430306_17_item1_p28_s1", "sentA": "CBP-containing products are not indicated for the treatment of PTSD.", "sentB": "This patent recites the use of CBP for the treatment of PTSD, which covers the use of Tonmya for the treatment of PTSD, since the active ingredient in Tonmya is CBP.", "type": 2, "words": ["<tag1>", "CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "This", "patent", "recites", "the", "use", "of", "CBP", "for", "the", "treatment", "of", "PTSD,", "which", "covers", "the", "use", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD,", "since", "the", "active", "ingredient", "in", "Tonmya", "is", "CBP.", "<tag3>"], "wordsA": ["CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["This", "patent", "recites", "the", "use", "of", "CBP", "for", "the", "treatment", "of", "PTSD,", "which", "covers", "the", "use", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD,", "since", "the", "active", "ingredient", "in", "Tonmya", "is", "CBP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p46_s1", "idA": "1430306_17_item1_p28_s1", "sentA": "CBP-containing products are not indicated for the treatment of PTSD.", "sentB": "This patent protects the use of Tonmya for the treatment of PTSD as well as its active ingredient CBP for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "This", "patent", "protects", "the", "use", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD", "as", "well", "as", "its", "active", "ingredient", "CBP", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["CBP-containing", "products", "are", "not", "indicated", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["This", "patent", "protects", "the", "use", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD", "as", "well", "as", "its", "active", "ingredient", "CBP", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p37_s2", "idA": "1430306_17_item1_p28_s3", "sentA": "Immediate-release, or IR, CBP tablets are recommended for three times per day dosing, which results in relatively stable blood levels of CBP after several days of treatment.", "sentB": "IR CBP tablets are recommended for three times per day dosing, which results in relatively stable blood levels of CBP after several days of treatment.", "type": 2, "words": ["<tag1>", "Immediate-release,", "or", "IR,", "CBP", "tablets", "are", "recommended", "for", "three", "times", "per", "day", "dosing,", "which", "results", "in", "relatively", "stable", "blood", "levels", "of", "CBP", "after", "several", "days", "of", "treatment.", "<tag2>", "IR", "CBP", "tablets", "are", "recommended", "for", "three", "times", "per", "day", "dosing,", "which", "results", "in", "relatively", "stable", "blood", "levels", "of", "CBP", "after", "several", "days", "of", "treatment.", "<tag3>"], "wordsA": ["Immediate-release,", "or", "IR,", "CBP", "tablets", "are", "recommended", "for", "three", "times", "per", "day", "dosing,", "which", "results", "in", "relatively", "stable", "blood", "levels", "of", "CBP", "after", "several", "days", "of", "treatment."], "wordsB": ["IR", "CBP", "tablets", "are", "recommended", "for", "three", "times", "per", "day", "dosing,", "which", "results", "in", "relatively", "stable", "blood", "levels", "of", "CBP", "after", "several", "days", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p118_s0", "idA": "1430306_17_item1_p28_s4", "sentA": "Extended-release CBP capsules taken once a day mimic, and flatten, the pharmacokinetic profile of three times per day immediate-release CBP tablets.", "sentB": "On December 15, 2017 we were issued Japanese Patent No. 6259452, Compositions and Methods for Transmucosal Absorption, by the JPO relating to the pharmacokinetic profile of Tonmya or TNX-102 SL.", "type": 2, "words": ["<tag1>", "Extended-release", "CBP", "capsules", "taken", "once", "a", "day", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets.", "<tag2>", "On", "December", "15,", "2017", "we", "were", "issued", "Japanese", "Patent", "No.", "6259452,", "Compositions", "and", "Methods", "for", "Transmucosal", "Absorption,", "by", "the", "JPO", "relating", "to", "the", "pharmacokinetic", "profile", "of", "Tonmya", "or", "TNX-102", "SL.", "<tag3>"], "wordsA": ["Extended-release", "CBP", "capsules", "taken", "once", "a", "day", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets."], "wordsB": ["On", "December", "15,", "2017", "we", "were", "issued", "Japanese", "Patent", "No.", "6259452,", "Compositions", "and", "Methods", "for", "Transmucosal", "Absorption,", "by", "the", "JPO", "relating", "to", "the", "pharmacokinetic", "profile", "of", "Tonmya", "or", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p37_s3", "idA": "1430306_17_item1_p28_s4", "sentA": "Extended-release CBP capsules taken once a day mimic, and flatten, the pharmacokinetic profile of three times per day immediate-release CBP tablets.", "sentB": "Extended-release CBP capsules taken once a day mimic, and flatten, the pharmacokinetic profile of three times per day IR CBP tablets.", "type": 2, "words": ["<tag1>", "Extended-release", "CBP", "capsules", "taken", "once", "a", "day", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets.", "<tag2>", "Extended-release", "CBP", "capsules", "taken", "once", "a", "day", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "IR", "CBP", "tablets.", "<tag3>"], "wordsA": ["Extended-release", "CBP", "capsules", "taken", "once", "a", "day", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "immediate-release", "CBP", "tablets."], "wordsB": ["Extended-release", "CBP", "capsules", "taken", "once", "a", "day", "mimic,", "and", "flatten,", "the", "pharmacokinetic", "profile", "of", "three", "times", "per", "day", "IR", "CBP", "tablets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p38_s0", "idA": "1430306_17_item1_p29_s0", "sentA": "We designed TNX-102 SL to be administered once-daily at bedtime and intended for long-term dosing regimen.", "sentB": "We designed Tonmya to be administered once-daily at bedtime and intended for long-term use.", "type": 2, "words": ["<tag1>", "We", "designed", "TNX-102", "SL", "to", "be", "administered", "once-daily", "at", "bedtime", "and", "intended", "for", "long-term", "dosing", "regimen.", "<tag2>", "We", "designed", "Tonmya", "to", "be", "administered", "once-daily", "at", "bedtime", "and", "intended", "for", "long-term", "use.", "<tag3>"], "wordsA": ["We", "designed", "TNX-102", "SL", "to", "be", "administered", "once-daily", "at", "bedtime", "and", "intended", "for", "long-term", "dosing", "regimen."], "wordsB": ["We", "designed", "Tonmya", "to", "be", "administered", "once-daily", "at", "bedtime", "and", "intended", "for", "long-term", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p38_s1", "idA": "1430306_17_item1_p29_s1", "sentA": "We believe the selected dose of TNX-102 SL and its pharmacokinetic profile will enable it to achieve a desirable balance of efficacy, safety, and tolerability in PTSD.", "sentB": "We believe the selected dose of Tonmya and its pharmacokinetic profile will enable it to achieve a desirable balance of efficacy, safety, and tolerability in PTSD.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "selected", "dose", "of", "TNX-102", "SL", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "PTSD.", "<tag2>", "We", "believe", "the", "selected", "dose", "of", "Tonmya", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "PTSD.", "<tag3>"], "wordsA": ["We", "believe", "the", "selected", "dose", "of", "TNX-102", "SL", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "PTSD."], "wordsB": ["We", "believe", "the", "selected", "dose", "of", "Tonmya", "and", "its", "pharmacokinetic", "profile", "will", "enable", "it", "to", "achieve", "a", "desirable", "balance", "of", "efficacy,", "safety,", "and", "tolerability", "in", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p38_s2", "idA": "1430306_17_item1_p29_s2", "sentA": "Our Phase 1 comparative trials showed that, on a dose-adjusted basis, TNX-102 SL results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following sublingual administration relative to oral immediate-release CBP tablets.", "sentB": "Our Phase 1 comparative trials showed that, on a dose-adjusted basis, Tonmya results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following sublingual administration relative to oral IR CBP tablets.", "type": 2, "words": ["<tag1>", "Our", "Phase", "1", "comparative", "trials", "showed", "that,", "on", "a", "dose-adjusted", "basis,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "sublingual", "administration", "relative", "to", "oral", "immediate-release", "CBP", "tablets.", "<tag2>", "Our", "Phase", "1", "comparative", "trials", "showed", "that,", "on", "a", "dose-adjusted", "basis,", "Tonmya", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "sublingual", "administration", "relative", "to", "oral", "IR", "CBP", "tablets.", "<tag3>"], "wordsA": ["Our", "Phase", "1", "comparative", "trials", "showed", "that,", "on", "a", "dose-adjusted", "basis,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "sublingual", "administration", "relative", "to", "oral", "immediate-release", "CBP", "tablets."], "wordsB": ["Our", "Phase", "1", "comparative", "trials", "showed", "that,", "on", "a", "dose-adjusted", "basis,", "Tonmya", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "sublingual", "administration", "relative", "to", "oral", "IR", "CBP", "tablets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p38_s3", "idA": "1430306_17_item1_p29_s2", "sentA": "Our Phase 1 comparative trials showed that, on a dose-adjusted basis, TNX-102 SL results in faster systemic absorption and significantly higher plasma levels of CBP in the first hour following sublingual administration relative to oral immediate-release CBP tablets.", "sentB": "It also showed that the sublingual route of administration, which largely bypasses the first pass metabolism that swallowed medications undergo, results in a higher plasma ratio of CBP to its main active metabolite, norcyclobenzaprine.", "type": 2, "words": ["<tag1>", "Our", "Phase", "1", "comparative", "trials", "showed", "that,", "on", "a", "dose-adjusted", "basis,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "sublingual", "administration", "relative", "to", "oral", "immediate-release", "CBP", "tablets.", "<tag2>", "It", "also", "showed", "that", "the", "sublingual", "route", "of", "administration,", "which", "largely", "bypasses", "the", "first", "pass", "metabolism", "that", "swallowed", "medications", "undergo,", "results", "in", "a", "higher", "plasma", "ratio", "of", "CBP", "to", "its", "main", "active", "metabolite,", "norcyclobenzaprine.", "<tag3>"], "wordsA": ["Our", "Phase", "1", "comparative", "trials", "showed", "that,", "on", "a", "dose-adjusted", "basis,", "TNX-102", "SL", "results", "in", "faster", "systemic", "absorption", "and", "significantly", "higher", "plasma", "levels", "of", "CBP", "in", "the", "first", "hour", "following", "sublingual", "administration", "relative", "to", "oral", "immediate-release", "CBP", "tablets."], "wordsB": ["It", "also", "showed", "that", "the", "sublingual", "route", "of", "administration,", "which", "largely", "bypasses", "the", "first", "pass", "metabolism", "that", "swallowed", "medications", "undergo,", "results", "in", "a", "higher", "plasma", "ratio", "of", "CBP", "to", "its", "main", "active", "metabolite,", "norcyclobenzaprine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p39_s0", "idA": "1430306_17_item1_p30_s0", "sentA": "In clinical studies, TNX-102 SL 2.8 mg and TNX-102 SL 5.6 mg were generally well-tolerated, with no serious adverse events reported in these studies.", "sentB": "In clinical studies, Tonmya 2.8 mg and Tonmya 5.6 mg were generally well-tolerated, with no drug-related serious adverse events, or SAEs, reported in these studies.", "type": 2, "words": ["<tag1>", "In", "clinical", "studies,", "TNX-102", "SL", "2.8", "mg", "and", "TNX-102", "SL", "5.6", "mg", "were", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies.", "<tag2>", "In", "clinical", "studies,", "Tonmya", "2.8", "mg", "and", "Tonmya", "5.6", "mg", "were", "generally", "well-tolerated,", "with", "no", "drug-related", "serious", "adverse", "events,", "or", "SAEs,", "reported", "in", "these", "studies.", "<tag3>"], "wordsA": ["In", "clinical", "studies,", "TNX-102", "SL", "2.8", "mg", "and", "TNX-102", "SL", "5.6", "mg", "were", "generally", "well-tolerated,", "with", "no", "serious", "adverse", "events", "reported", "in", "these", "studies."], "wordsB": ["In", "clinical", "studies,", "Tonmya", "2.8", "mg", "and", "Tonmya", "5.6", "mg", "were", "generally", "well-tolerated,", "with", "no", "drug-related", "serious", "adverse", "events,", "or", "SAEs,", "reported", "in", "these", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p39_s1", "idA": "1430306_17_item1_p30_s1", "sentA": "Some subjects experienced transient numbness of the tongue after TNX-102 SL administration.", "sentB": "Some subjects experienced transient numbness of the tongue after Tonmya administration.", "type": 2, "words": ["<tag1>", "Some", "subjects", "experienced", "transient", "numbness", "of", "the", "tongue", "after", "TNX-102", "SL", "administration.", "<tag2>", "Some", "subjects", "experienced", "transient", "numbness", "of", "the", "tongue", "after", "Tonmya", "administration.", "<tag3>"], "wordsA": ["Some", "subjects", "experienced", "transient", "numbness", "of", "the", "tongue", "after", "TNX-102", "SL", "administration."], "wordsB": ["Some", "subjects", "experienced", "transient", "numbness", "of", "the", "tongue", "after", "Tonmya", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p40_s0", "idA": "1430306_17_item1_p31_s0", "sentA": "We expect that any applications we submit to the FDA for approval of TNX-102 SL will be submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, or FDCA, for product candidates containing an active ingredient that is similar or identical to an already approved product.", "sentB": "We expect that any applications we submit to the FDA for approval of Tonmya for the treatment of PTSD will be submitted under Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act, or FDCA, for product candidates containing an active ingredient that is similar or identical to an already approved product.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "FDA", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product.", "<tag2>", "We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "FDA", "for", "approval", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product.", "<tag3>"], "wordsA": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "FDA", "for", "approval", "of", "TNX-102", "SL", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product."], "wordsB": ["We", "expect", "that", "any", "applications", "we", "submit", "to", "the", "FDA", "for", "approval", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD", "will", "be", "submitted", "under", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act,", "or", "FDCA,", "for", "product", "candidates", "containing", "an", "active", "ingredient", "that", "is", "similar", "or", "identical", "to", "an", "already", "approved", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p40_s1", "idA": "1430306_17_item1_p31_s1", "sentA": "In general, the development timeline for a 505(b)(2) New Drug Application, or NDA, is shorter and less expensive than an NDA developed under Section 505(b)(1), which is for new chemical entities, or NCEs, that have never been approved in the United States.", "sentB": "In general, the development timeline for a 505(b)(2) NDA is shorter and less expensive than an NDA developed under Section 505(b)(1), which is for new chemical entities, or NCEs, that have never been approved in the United States.", "type": 2, "words": ["<tag1>", "In", "general,", "the", "development", "timeline", "for", "a", "505(b)(2)", "New", "Drug", "Application,", "or", "NDA,", "is", "shorter", "and", "less", "expensive", "than", "an", "NDA", "developed", "under", "Section", "505(b)(1),", "which", "is", "for", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States.", "<tag2>", "In", "general,", "the", "development", "timeline", "for", "a", "505(b)(2)", "NDA", "is", "shorter", "and", "less", "expensive", "than", "an", "NDA", "developed", "under", "Section", "505(b)(1),", "which", "is", "for", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["In", "general,", "the", "development", "timeline", "for", "a", "505(b)(2)", "New", "Drug", "Application,", "or", "NDA,", "is", "shorter", "and", "less", "expensive", "than", "an", "NDA", "developed", "under", "Section", "505(b)(1),", "which", "is", "for", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States."], "wordsB": ["In", "general,", "the", "development", "timeline", "for", "a", "505(b)(2)", "NDA", "is", "shorter", "and", "less", "expensive", "than", "an", "NDA", "developed", "under", "Section", "505(b)(1),", "which", "is", "for", "new", "chemical", "entities,", "or", "NCEs,", "that", "have", "never", "been", "approved", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p40_s2", "idA": "1430306_17_item1_p31_s2", "sentA": "Currently, we are pursuing the development of TNX-102 SL for PTSD, for which TNX-102 SL is in Phase 3 development.", "sentB": "Currently, we are pursuing the development of Tonmya for PTSD, for which Tonmya is in Phase 3 development.", "type": 2, "words": ["<tag1>", "Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "PTSD,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "3", "development.", "<tag2>", "Currently,", "we", "are", "pursuing", "the", "development", "of", "Tonmya", "for", "PTSD,", "for", "which", "Tonmya", "is", "in", "Phase", "3", "development.", "<tag3>"], "wordsA": ["Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "PTSD,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "3", "development."], "wordsB": ["Currently,", "we", "are", "pursuing", "the", "development", "of", "Tonmya", "for", "PTSD,", "for", "which", "Tonmya", "is", "in", "Phase", "3", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p99_s3", "idA": "1430306_17_item1_p31_s2", "sentA": "Currently, we are pursuing the development of TNX-102 SL for PTSD, for which TNX-102 SL is in Phase 3 development.", "sentB": "Lumateperone is in Phase 3 for treating behavioral disturbances associated with dementia.", "type": 2, "words": ["<tag1>", "Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "PTSD,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "3", "development.", "<tag2>", "Lumateperone", "is", "in", "Phase", "3", "for", "treating", "behavioral", "disturbances", "associated", "with", "dementia.", "<tag3>"], "wordsA": ["Currently,", "we", "are", "pursuing", "the", "development", "of", "TNX-102", "SL", "for", "PTSD,", "for", "which", "TNX-102", "SL", "is", "in", "Phase", "3", "development."], "wordsB": ["Lumateperone", "is", "in", "Phase", "3", "for", "treating", "behavioral", "disturbances", "associated", "with", "dementia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p40_s3", "idA": "1430306_17_item1_p31_s3", "sentA": "We believe that TNX-102 SL has the potential to provide clinical benefit to this and possibly other CNS indications that are underserved by currently marketed products.", "sentB": "We believe that Tonmya and TNX-102 SL have the potential to provide clinical benefit to this and possibly other CNS (central nervous system) indications that are underserved by currently marketed products or have no approved treatment.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "provide", "clinical", "benefit", "to", "this", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products.", "<tag2>", "We", "believe", "that", "Tonmya", "and", "TNX-102", "SL", "have", "the", "potential", "to", "provide", "clinical", "benefit", "to", "this", "and", "possibly", "other", "CNS", "(central", "nervous", "system)", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products", "or", "have", "no", "approved", "treatment.", "<tag3>"], "wordsA": ["We", "believe", "that", "TNX-102", "SL", "has", "the", "potential", "to", "provide", "clinical", "benefit", "to", "this", "and", "possibly", "other", "CNS", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products."], "wordsB": ["We", "believe", "that", "Tonmya", "and", "TNX-102", "SL", "have", "the", "potential", "to", "provide", "clinical", "benefit", "to", "this", "and", "possibly", "other", "CNS", "(central", "nervous", "system)", "indications", "that", "are", "underserved", "by", "currently", "marketed", "products", "or", "have", "no", "approved", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p120_s0", "idA": "1430306_17_item1_p32_s0", "sentA": "On March 10, 2017, we received a notice of allowance for the US patent application No. 14/214,433 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride , which includes compositions of cyclobenzaprine HCl and methods of manufacturing the eutectic.", "sentB": "On March 1, 2018, we received a Notice of Allowance from the JPO for Japanese Patent Application No. 2016-503239 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride The allowed claims recite pharmaceutical compositions comprising the eutectics and methods of manufacturing these eutectic formulations.", "type": 2, "words": ["<tag1>", "On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "for", "the", "US", "patent", "application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic.", "<tag2>", "On", "March", "1,", "2018,", "we", "received", "a", "Notice", "of", "Allowance", "from", "the", "JPO", "for", "Japanese", "Patent", "Application", "No.", "2016-503239", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", "The", "allowed", "claims", "recite", "pharmaceutical", "compositions", "comprising", "the", "eutectics", "and", "methods", "of", "manufacturing", "these", "eutectic", "formulations.", "<tag3>"], "wordsA": ["On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "for", "the", "US", "patent", "application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic."], "wordsB": ["On", "March", "1,", "2018,", "we", "received", "a", "Notice", "of", "Allowance", "from", "the", "JPO", "for", "Japanese", "Patent", "Application", "No.", "2016-503239", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", "The", "allowed", "claims", "recite", "pharmaceutical", "compositions", "comprising", "the", "eutectics", "and", "methods", "of", "manufacturing", "these", "eutectic", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p41_s0", "idA": "1430306_17_item1_p32_s0", "sentA": "On March 10, 2017, we received a notice of allowance for the US patent application No. 14/214,433 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride , which includes compositions of cyclobenzaprine HCl and methods of manufacturing the eutectic.", "sentB": "On May 2, 2017, we were issued U.S. patent 9,636,408 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride , which includes compositions of CBP and methods of manufacturing the eutectic.", "type": 2, "words": ["<tag1>", "On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "for", "the", "US", "patent", "application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic.", "<tag2>", "On", "May", "2,", "2017,", "we", "were", "issued", "U.S.", "patent", "9,636,408", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "CBP", "and", "methods", "of", "manufacturing", "the", "eutectic.", "<tag3>"], "wordsA": ["On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "for", "the", "US", "patent", "application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic."], "wordsB": ["On", "May", "2,", "2017,", "we", "were", "issued", "U.S.", "patent", "9,636,408", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "CBP", "and", "methods", "of", "manufacturing", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p48_s0", "idA": "1430306_17_item1_p32_s0", "sentA": "On March 10, 2017, we received a notice of allowance for the US patent application No. 14/214,433 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride , which includes compositions of cyclobenzaprine HCl and methods of manufacturing the eutectic.", "sentB": "On March 1, 2018, we received a Notice of Allowance from the JPO for Japanese Patent Application No. 2016-503239 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride The allowed claims recite pharmaceutical compositions comprising the eutectics and methods of manufacturing these eutectic formulations.", "type": 2, "words": ["<tag1>", "On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "for", "the", "US", "patent", "application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic.", "<tag2>", "On", "March", "1,", "2018,", "we", "received", "a", "Notice", "of", "Allowance", "from", "the", "JPO", "for", "Japanese", "Patent", "Application", "No.", "2016-503239", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", "The", "allowed", "claims", "recite", "pharmaceutical", "compositions", "comprising", "the", "eutectics", "and", "methods", "of", "manufacturing", "these", "eutectic", "formulations.", "<tag3>"], "wordsA": ["On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "for", "the", "US", "patent", "application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", ",", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic."], "wordsB": ["On", "March", "1,", "2018,", "we", "received", "a", "Notice", "of", "Allowance", "from", "the", "JPO", "for", "Japanese", "Patent", "Application", "No.", "2016-503239", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride", "The", "allowed", "claims", "recite", "pharmaceutical", "compositions", "comprising", "the", "eutectics", "and", "methods", "of", "manufacturing", "these", "eutectic", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p113_s2", "idA": "1430306_17_item1_p32_s2", "sentA": "The allowed claims will also protect the method of manufacturing the eutectic.", "sentB": "The patent claims recite pharmaceutical compositions comprising the eutectic.", "type": 2, "words": ["<tag1>", "The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic.", "<tag2>", "The", "patent", "claims", "recite", "pharmaceutical", "compositions", "comprising", "the", "eutectic.", "<tag3>"], "wordsA": ["The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic."], "wordsB": ["The", "patent", "claims", "recite", "pharmaceutical", "compositions", "comprising", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p119_s1", "idA": "1430306_17_item1_p32_s2", "sentA": "The allowed claims will also protect the method of manufacturing the eutectic.", "sentB": "The allowed claims recite a method of using Tonmya s active ingredient cyclobenzaprine to treat PTSD.", "type": 2, "words": ["<tag1>", "The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic.", "<tag2>", "The", "allowed", "claims", "recite", "a", "method", "of", "using", "Tonmya", "s", "active", "ingredient", "cyclobenzaprine", "to", "treat", "PTSD.", "<tag3>"], "wordsA": ["The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic."], "wordsB": ["The", "allowed", "claims", "recite", "a", "method", "of", "using", "Tonmya", "s", "active", "ingredient", "cyclobenzaprine", "to", "treat", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p114_s0", "idA": "1430306_17_item1_p33_s0", "sentA": "Eutectic tablets containing cyclobenzaprine HCl and mannitol eutectic have good pharmaceutical stability and manufacturability.", "sentB": "Tablets containing CBP and mannitol eutectic have good pharmaceutical stability and manufacturability.", "type": 2, "words": ["<tag1>", "Eutectic", "tablets", "containing", "cyclobenzaprine", "HCl", "and", "mannitol", "eutectic", "have", "good", "pharmaceutical", "stability", "and", "manufacturability.", "<tag2>", "Tablets", "containing", "CBP", "and", "mannitol", "eutectic", "have", "good", "pharmaceutical", "stability", "and", "manufacturability.", "<tag3>"], "wordsA": ["Eutectic", "tablets", "containing", "cyclobenzaprine", "HCl", "and", "mannitol", "eutectic", "have", "good", "pharmaceutical", "stability", "and", "manufacturability."], "wordsB": ["Tablets", "containing", "CBP", "and", "mannitol", "eutectic", "have", "good", "pharmaceutical", "stability", "and", "manufacturability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p42_s0", "idA": "1430306_17_item1_p33_s0", "sentA": "Eutectic tablets containing cyclobenzaprine HCl and mannitol eutectic have good pharmaceutical stability and manufacturability.", "sentB": "Eutectic tablets containing CBP and mannitol eutectic have good pharmaceutical stability and manufacturability.", "type": 2, "words": ["<tag1>", "Eutectic", "tablets", "containing", "cyclobenzaprine", "HCl", "and", "mannitol", "eutectic", "have", "good", "pharmaceutical", "stability", "and", "manufacturability.", "<tag2>", "Eutectic", "tablets", "containing", "CBP", "and", "mannitol", "eutectic", "have", "good", "pharmaceutical", "stability", "and", "manufacturability.", "<tag3>"], "wordsA": ["Eutectic", "tablets", "containing", "cyclobenzaprine", "HCl", "and", "mannitol", "eutectic", "have", "good", "pharmaceutical", "stability", "and", "manufacturability."], "wordsB": ["Eutectic", "tablets", "containing", "CBP", "and", "mannitol", "eutectic", "have", "good", "pharmaceutical", "stability", "and", "manufacturability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p46_s2", "idA": "1430306_17_item1_p34_s2", "sentA": "A Notice of Allowance signifies that we will be entitled to receive patent protection until 2034 in the U.S. for the allowed claims when the patent is issued.", "sentB": "A Notice of Allowance signifies that we will be entitled to receive patent protection until 2030 in the U.S. for the allowed claims when the patent is issued.", "type": 2, "words": ["<tag1>", "A", "Notice", "of", "Allowance", "signifies", "that", "we", "will", "be", "entitled", "to", "receive", "patent", "protection", "until", "2034", "in", "the", "U.S.", "for", "the", "allowed", "claims", "when", "the", "patent", "is", "issued.", "<tag2>", "A", "Notice", "of", "Allowance", "signifies", "that", "we", "will", "be", "entitled", "to", "receive", "patent", "protection", "until", "2030", "in", "the", "U.S.", "for", "the", "allowed", "claims", "when", "the", "patent", "is", "issued.", "<tag3>"], "wordsA": ["A", "Notice", "of", "Allowance", "signifies", "that", "we", "will", "be", "entitled", "to", "receive", "patent", "protection", "until", "2034", "in", "the", "U.S.", "for", "the", "allowed", "claims", "when", "the", "patent", "is", "issued."], "wordsB": ["A", "Notice", "of", "Allowance", "signifies", "that", "we", "will", "be", "entitled", "to", "receive", "patent", "protection", "until", "2030", "in", "the", "U.S.", "for", "the", "allowed", "claims", "when", "the", "patent", "is", "issued."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p12_s2", "idA": "1430306_17_item1_p35_s0", "sentA": "We are developing TNX-102 SL for the treatment of PTSD under an effective IND application.", "sentB": "We are developing Tonmya for the treatment of PTSD under an effective Investigational New Drug application, or IND, cleared by the FDA in June 2014.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application.", "<tag2>", "We", "are", "developing", "Tonmya", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "Investigational", "New", "Drug", "application,", "or", "IND,", "cleared", "by", "the", "FDA", "in", "June", "2014.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application."], "wordsB": ["We", "are", "developing", "Tonmya", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "Investigational", "New", "Drug", "application,", "or", "IND,", "cleared", "by", "the", "FDA", "in", "June", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p15_s0", "idA": "1430306_17_item1_p35_s0", "sentA": "We are developing TNX-102 SL for the treatment of PTSD under an effective IND application.", "sentB": "We are developing TNX-102 SL for the treatment of agitation in Alzheimer s disease and held a pre-IND meeting with the FDA in November 2017.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application.", "<tag2>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "agitation", "in", "Alzheimer", "s", "disease", "and", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "November", "2017.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application."], "wordsB": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "agitation", "in", "Alzheimer", "s", "disease", "and", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "November", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p49_s0", "idA": "1430306_17_item1_p35_s0", "sentA": "We are developing TNX-102 SL for the treatment of PTSD under an effective IND application.", "sentB": "We are developing Tonmya for the treatment of PTSD under an effective IND application.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application.", "<tag2>", "We", "are", "developing", "Tonmya", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application."], "wordsB": ["We", "are", "developing", "Tonmya", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p9_s1", "idA": "1430306_17_item1_p35_s0", "sentA": "We are developing TNX-102 SL for the treatment of PTSD under an effective IND application.", "sentB": "The FDA s final approval of Tonmya as a name for TNX-102 SL for the treatment of PTSD is subject to a, New Drug Application, or NDA, approval.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application.", "<tag2>", "The", "FDA", "s", "final", "approval", "of", "Tonmya", "as", "a", "name", "for", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "is", "subject", "to", "a,", "New", "Drug", "Application,", "or", "NDA,", "approval.", "<tag3>"], "wordsA": ["We", "are", "developing", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "under", "an", "effective", "IND", "application."], "wordsB": ["The", "FDA", "s", "final", "approval", "of", "Tonmya", "as", "a", "name", "for", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD", "is", "subject", "to", "a,", "New", "Drug", "Application,", "or", "NDA,", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p50_s0", "idA": "1430306_17_item1_p36_s0", "sentA": "In the first quarter of 2015, we commenced a randomized, double-blind, placebo-controlled, 12-week Phase 2 study of TNX-102 SL in patients with military-related PTSD, which we refer to as the AtEase study.", "sentB": "In the first quarter of 2015, we commenced a randomized, double-blind, placebo-controlled, 12-week Phase 2 study of Tonmya in participants with military-related PTSD, which we refer to as the AtEase study.", "type": 2, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "study", "of", "TNX-102", "SL", "in", "patients", "with", "military-related", "PTSD,", "which", "we", "refer", "to", "as", "the", "AtEase", "study.", "<tag2>", "In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "study", "of", "Tonmya", "in", "participants", "with", "military-related", "PTSD,", "which", "we", "refer", "to", "as", "the", "AtEase", "study.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "study", "of", "TNX-102", "SL", "in", "patients", "with", "military-related", "PTSD,", "which", "we", "refer", "to", "as", "the", "AtEase", "study."], "wordsB": ["In", "the", "first", "quarter", "of", "2015,", "we", "commenced", "a", "randomized,", "double-blind,", "placebo-controlled,", "12-week", "Phase", "2", "study", "of", "Tonmya", "in", "participants", "with", "military-related", "PTSD,", "which", "we", "refer", "to", "as", "the", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p51_s0", "idA": "1430306_17_item1_p37_s0", "sentA": "In the AtEase study, patients were randomized in a 2:1:2 ratio to TNX-102 SL 2.8 mg, TNX-102 SL 5.6 mg, or placebo sublingual tablets at bedtime daily for 12 weeks.", "sentB": "In the AtEase study, participants experienced their index trauma during military service in 2001 or later and had a baseline CAPS-5 score of 29 or higher, and were randomized in a 2:1:2 ratio to bedtime daily Tonmya 2.8 mg, Tonmya 5.6 mg, or placebo sublingual tablets for 12 weeks, respectively.", "type": 2, "words": ["<tag1>", "In", "the", "AtEase", "study,", "patients", "were", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo", "sublingual", "tablets", "at", "bedtime", "daily", "for", "12", "weeks.", "<tag2>", "In", "the", "AtEase", "study,", "participants", "experienced", "their", "index", "trauma", "during", "military", "service", "in", "2001", "or", "later", "and", "had", "a", "baseline", "CAPS-5", "score", "of", "29", "or", "higher,", "and", "were", "randomized", "in", "a", "2:1:2", "ratio", "to", "bedtime", "daily", "Tonmya", "2.8", "mg,", "Tonmya", "5.6", "mg,", "or", "placebo", "sublingual", "tablets", "for", "12", "weeks,", "respectively.", "<tag3>"], "wordsA": ["In", "the", "AtEase", "study,", "patients", "were", "randomized", "in", "a", "2:1:2", "ratio", "to", "TNX-102", "SL", "2.8", "mg,", "TNX-102", "SL", "5.6", "mg,", "or", "placebo", "sublingual", "tablets", "at", "bedtime", "daily", "for", "12", "weeks."], "wordsB": ["In", "the", "AtEase", "study,", "participants", "experienced", "their", "index", "trauma", "during", "military", "service", "in", "2001", "or", "later", "and", "had", "a", "baseline", "CAPS-5", "score", "of", "29", "or", "higher,", "and", "were", "randomized", "in", "a", "2:1:2", "ratio", "to", "bedtime", "daily", "Tonmya", "2.8", "mg,", "Tonmya", "5.6", "mg,", "or", "placebo", "sublingual", "tablets", "for", "12", "weeks,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p51_s1", "idA": "1430306_17_item1_p37_s1", "sentA": "This study was conducted at 24 U.S. centers and enrolled 231 patients in the modified intent-to-treat population.", "sentB": "The AtEase study was conducted at 24 U.S. centers and enrolled 231 participants in the modified intent-to-treat population.", "type": 2, "words": ["<tag1>", "This", "study", "was", "conducted", "at", "24", "U.S.", "centers", "and", "enrolled", "231", "patients", "in", "the", "modified", "intent-to-treat", "population.", "<tag2>", "The", "AtEase", "study", "was", "conducted", "at", "24", "U.S.", "centers", "and", "enrolled", "231", "participants", "in", "the", "modified", "intent-to-treat", "population.", "<tag3>"], "wordsA": ["This", "study", "was", "conducted", "at", "24", "U.S.", "centers", "and", "enrolled", "231", "patients", "in", "the", "modified", "intent-to-treat", "population."], "wordsB": ["The", "AtEase", "study", "was", "conducted", "at", "24", "U.S.", "centers", "and", "enrolled", "231", "participants", "in", "the", "modified", "intent-to-treat", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p50_s1", "idA": "1430306_17_item1_p37_s2", "sentA": "The primary objective of the AtEase study was to evaluate the potential clinical benefit of using TNX-102 SL to treat military-related PTSD at a dose of 2.8 mg or 5.6 mg.", "sentB": "The primary objective of this study was to evaluate the potential clinical benefit of using Tonmya to treat military-related PTSD at a dose of 2.8 mg or 5.6 mg (2 x 2.8 mg tablets).", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "AtEase", "study", "was", "to", "evaluate", "the", "potential", "clinical", "benefit", "of", "using", "TNX-102", "SL", "to", "treat", "military-related", "PTSD", "at", "a", "dose", "of", "2.8", "mg", "or", "5.6", "mg.", "<tag2>", "The", "primary", "objective", "of", "this", "study", "was", "to", "evaluate", "the", "potential", "clinical", "benefit", "of", "using", "Tonmya", "to", "treat", "military-related", "PTSD", "at", "a", "dose", "of", "2.8", "mg", "or", "5.6", "mg", "(2", "x", "2.8", "mg", "tablets).", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "AtEase", "study", "was", "to", "evaluate", "the", "potential", "clinical", "benefit", "of", "using", "TNX-102", "SL", "to", "treat", "military-related", "PTSD", "at", "a", "dose", "of", "2.8", "mg", "or", "5.6", "mg."], "wordsB": ["The", "primary", "objective", "of", "this", "study", "was", "to", "evaluate", "the", "potential", "clinical", "benefit", "of", "using", "Tonmya", "to", "treat", "military-related", "PTSD", "at", "a", "dose", "of", "2.8", "mg", "or", "5.6", "mg", "(2", "x", "2.8", "mg", "tablets)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p50_s2", "idA": "1430306_17_item1_p37_s3", "sentA": "The primary efficacy endpoint was the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the Clinician-Administered PTSD Scale for the Diagnostic and Statistical Manual-5, or CAPS-5, between those treated with TNX-102 SL and those receiving placebo.", "sentB": "The primary efficacy endpoint was the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the Clinician-Administered PTSD Scale for DSM-5, or CAPS-5, between those treated with Tonmya and those receiving placebo.", "type": 2, "words": ["<tag1>", "The", "primary", "efficacy", "endpoint", "was", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "Clinician-Administered", "PTSD", "Scale", "for", "the", "Diagnostic", "and", "Statistical", "Manual-5,", "or", "CAPS-5,", "between", "those", "treated", "with", "TNX-102", "SL", "and", "those", "receiving", "placebo.", "<tag2>", "The", "primary", "efficacy", "endpoint", "was", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5,", "or", "CAPS-5,", "between", "those", "treated", "with", "Tonmya", "and", "those", "receiving", "placebo.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "endpoint", "was", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "Clinician-Administered", "PTSD", "Scale", "for", "the", "Diagnostic", "and", "Statistical", "Manual-5,", "or", "CAPS-5,", "between", "those", "treated", "with", "TNX-102", "SL", "and", "those", "receiving", "placebo."], "wordsB": ["The", "primary", "efficacy", "endpoint", "was", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "Clinician-Administered", "PTSD", "Scale", "for", "DSM-5,", "or", "CAPS-5,", "between", "those", "treated", "with", "Tonmya", "and", "those", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p52_s0", "idA": "1430306_17_item1_p38_s0", "sentA": "AtEase was adequately designed to evaluate whether a 2.8 mg dose would be efficacious, which would have provided an opportunity for this study to be used as one of the two pivotal efficacy studies required to support approval of TNX-102 SL for the treatment of PTSD.", "sentB": "AtEase was adequately designed to evaluate whether a 2.8 mg dose would be efficacious, which would have provided an opportunity for this study to be used as one of the two pivotal efficacy studies required to support approval of Tonmya for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "AtEase", "was", "adequately", "designed", "to", "evaluate", "whether", "a", "2.8", "mg", "dose", "would", "be", "efficacious,", "which", "would", "have", "provided", "an", "opportunity", "for", "this", "study", "to", "be", "used", "as", "one", "of", "the", "two", "pivotal", "efficacy", "studies", "required", "to", "support", "approval", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "AtEase", "was", "adequately", "designed", "to", "evaluate", "whether", "a", "2.8", "mg", "dose", "would", "be", "efficacious,", "which", "would", "have", "provided", "an", "opportunity", "for", "this", "study", "to", "be", "used", "as", "one", "of", "the", "two", "pivotal", "efficacy", "studies", "required", "to", "support", "approval", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["AtEase", "was", "adequately", "designed", "to", "evaluate", "whether", "a", "2.8", "mg", "dose", "would", "be", "efficacious,", "which", "would", "have", "provided", "an", "opportunity", "for", "this", "study", "to", "be", "used", "as", "one", "of", "the", "two", "pivotal", "efficacy", "studies", "required", "to", "support", "approval", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["AtEase", "was", "adequately", "designed", "to", "evaluate", "whether", "a", "2.8", "mg", "dose", "would", "be", "efficacious,", "which", "would", "have", "provided", "an", "opportunity", "for", "this", "study", "to", "be", "used", "as", "one", "of", "the", "two", "pivotal", "efficacy", "studies", "required", "to", "support", "approval", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p78_s1", "idA": "1430306_17_item1_p38_s0", "sentA": "AtEase was adequately designed to evaluate whether a 2.8 mg dose would be efficacious, which would have provided an opportunity for this study to be used as one of the two pivotal efficacy studies required to support approval of TNX-102 SL for the treatment of PTSD.", "sentB": "We received the formal minutes from that meeting in December 2017 that reflect that Tonix has the data needed to file an IND to support a Phase 2 study which can potentially be one of the pivotal efficacy studies.", "type": 2, "words": ["<tag1>", "AtEase", "was", "adequately", "designed", "to", "evaluate", "whether", "a", "2.8", "mg", "dose", "would", "be", "efficacious,", "which", "would", "have", "provided", "an", "opportunity", "for", "this", "study", "to", "be", "used", "as", "one", "of", "the", "two", "pivotal", "efficacy", "studies", "required", "to", "support", "approval", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "We", "received", "the", "formal", "minutes", "from", "that", "meeting", "in", "December", "2017", "that", "reflect", "that", "Tonix", "has", "the", "data", "needed", "to", "file", "an", "IND", "to", "support", "a", "Phase", "2", "study", "which", "can", "potentially", "be", "one", "of", "the", "pivotal", "efficacy", "studies.", "<tag3>"], "wordsA": ["AtEase", "was", "adequately", "designed", "to", "evaluate", "whether", "a", "2.8", "mg", "dose", "would", "be", "efficacious,", "which", "would", "have", "provided", "an", "opportunity", "for", "this", "study", "to", "be", "used", "as", "one", "of", "the", "two", "pivotal", "efficacy", "studies", "required", "to", "support", "approval", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["We", "received", "the", "formal", "minutes", "from", "that", "meeting", "in", "December", "2017", "that", "reflect", "that", "Tonix", "has", "the", "data", "needed", "to", "file", "an", "IND", "to", "support", "a", "Phase", "2", "study", "which", "can", "potentially", "be", "one", "of", "the", "pivotal", "efficacy", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p52_s2", "idA": "1430306_17_item1_p38_s2", "sentA": "The 5.6 mg dose had a therapeutic effect as assessed by the CAPS-5 scale, which was statistically significant by Mixed-effect Model Repeated Measures, or MMRM, with Multiple Imputation, or MI, analysis (p-value = 0.031), even though this arm of the study, by design, included only approximately half the number of patients of the 2.8 mg and placebo arms.", "sentB": "The 5.6 mg dose had a therapeutic effect as assessed by the CAPS-5 scale, which was statistically significant by MMRM with MI analysis (p-value = 0.031), even though this arm of the study, by design, included only approximately half the number of participants of the 2.8 mg and placebo arms.", "type": 2, "words": ["<tag1>", "The", "5.6", "mg", "dose", "had", "a", "therapeutic", "effect", "as", "assessed", "by", "the", "CAPS-5", "scale,", "which", "was", "statistically", "significant", "by", "Mixed-effect", "Model", "Repeated", "Measures,", "or", "MMRM,", "with", "Multiple", "Imputation,", "or", "MI,", "analysis", "(p-value", "=", "0.031),", "even", "though", "this", "arm", "of", "the", "study,", "by", "design,", "included", "only", "approximately", "half", "the", "number", "of", "patients", "of", "the", "2.8", "mg", "and", "placebo", "arms.", "<tag2>", "The", "5.6", "mg", "dose", "had", "a", "therapeutic", "effect", "as", "assessed", "by", "the", "CAPS-5", "scale,", "which", "was", "statistically", "significant", "by", "MMRM", "with", "MI", "analysis", "(p-value", "=", "0.031),", "even", "though", "this", "arm", "of", "the", "study,", "by", "design,", "included", "only", "approximately", "half", "the", "number", "of", "participants", "of", "the", "2.8", "mg", "and", "placebo", "arms.", "<tag3>"], "wordsA": ["The", "5.6", "mg", "dose", "had", "a", "therapeutic", "effect", "as", "assessed", "by", "the", "CAPS-5", "scale,", "which", "was", "statistically", "significant", "by", "Mixed-effect", "Model", "Repeated", "Measures,", "or", "MMRM,", "with", "Multiple", "Imputation,", "or", "MI,", "analysis", "(p-value", "=", "0.031),", "even", "though", "this", "arm", "of", "the", "study,", "by", "design,", "included", "only", "approximately", "half", "the", "number", "of", "patients", "of", "the", "2.8", "mg", "and", "placebo", "arms."], "wordsB": ["The", "5.6", "mg", "dose", "had", "a", "therapeutic", "effect", "as", "assessed", "by", "the", "CAPS-5", "scale,", "which", "was", "statistically", "significant", "by", "MMRM", "with", "MI", "analysis", "(p-value", "=", "0.031),", "even", "though", "this", "arm", "of", "the", "study,", "by", "design,", "included", "only", "approximately", "half", "the", "number", "of", "participants", "of", "the", "2.8", "mg", "and", "placebo", "arms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p53_s0", "idA": "1430306_17_item1_p38_s3", "sentA": "TNX-102 SL 5.6 mg demonstrated a dose-effect on multiple efficacy and safety measurements in the AtEase study.", "sentB": "Tonmya demonstrated a dose-effect on multiple efficacy and safety measurements in the AtEase study.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "5.6", "mg", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study.", "<tag2>", "Tonmya", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study.", "<tag3>"], "wordsA": ["TNX-102", "SL", "5.6", "mg", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study."], "wordsB": ["Tonmya", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p55_s1", "idA": "1430306_17_item1_p38_s3", "sentA": "TNX-102 SL 5.6 mg demonstrated a dose-effect on multiple efficacy and safety measurements in the AtEase study.", "sentB": "The effect size (Cohen s d ) of the PTSD symptom improvement by CAPS-5 in this subset, comparing Tonmya 5.6 mg with placebo, was larger at 0.53 than the effect size in the full set with CAPS-5 score of 29 or higher at baseline at 0.36.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "5.6", "mg", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study.", "<tag2>", "The", "effect", "size", "(Cohen", "s", "d", ")", "of", "the", "PTSD", "symptom", "improvement", "by", "CAPS-5", "in", "this", "subset,", "comparing", "Tonmya", "5.6", "mg", "with", "placebo,", "was", "larger", "at", "0.53", "than", "the", "effect", "size", "in", "the", "full", "set", "with", "CAPS-5", "score", "of", "29", "or", "higher", "at", "baseline", "at", "0.36.", "<tag3>"], "wordsA": ["TNX-102", "SL", "5.6", "mg", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study."], "wordsB": ["The", "effect", "size", "(Cohen", "s", "d", ")", "of", "the", "PTSD", "symptom", "improvement", "by", "CAPS-5", "in", "this", "subset,", "comparing", "Tonmya", "5.6", "mg", "with", "placebo,", "was", "larger", "at", "0.53", "than", "the", "effect", "size", "in", "the", "full", "set", "with", "CAPS-5", "score", "of", "29", "or", "higher", "at", "baseline", "at", "0.36."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p56_s0", "idA": "1430306_17_item1_p38_s3", "sentA": "TNX-102 SL 5.6 mg demonstrated a dose-effect on multiple efficacy and safety measurements in the AtEase study.", "sentB": "The beneficial effects of Tonmya 5.6 mg were preserved in the subgroup with PTSD from combat traumas (85% of AtEase population).", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "5.6", "mg", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study.", "<tag2>", "The", "beneficial", "effects", "of", "Tonmya", "5.6", "mg", "were", "preserved", "in", "the", "subgroup", "with", "PTSD", "from", "combat", "traumas", "(85%", "of", "AtEase", "population).", "<tag3>"], "wordsA": ["TNX-102", "SL", "5.6", "mg", "demonstrated", "a", "dose-effect", "on", "multiple", "efficacy", "and", "safety", "measurements", "in", "the", "AtEase", "study."], "wordsB": ["The", "beneficial", "effects", "of", "Tonmya", "5.6", "mg", "were", "preserved", "in", "the", "subgroup", "with", "PTSD", "from", "combat", "traumas", "(85%", "of", "AtEase", "population)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p54_s0", "idA": "1430306_17_item1_p39_s0", "sentA": "In the AtEase study, TNX-102 SL was well tolerated and the patient retention rate was 73% on placebo, 79% on TNX-102 SL 2.8 mg and 84% on TNX-102 SL 5.6 mg.", "sentB": "In the AtEase study, Tonmya was well tolerated and the participant retention rate was 73% on placebo, 79% on Tonmya 2.8 mg and 84% on Tonmya 5.6 mg.", "type": 2, "words": ["<tag1>", "In", "the", "AtEase", "study,", "TNX-102", "SL", "was", "well", "tolerated", "and", "the", "patient", "retention", "rate", "was", "73%", "on", "placebo,", "79%", "on", "TNX-102", "SL", "2.8", "mg", "and", "84%", "on", "TNX-102", "SL", "5.6", "mg.", "<tag2>", "In", "the", "AtEase", "study,", "Tonmya", "was", "well", "tolerated", "and", "the", "participant", "retention", "rate", "was", "73%", "on", "placebo,", "79%", "on", "Tonmya", "2.8", "mg", "and", "84%", "on", "Tonmya", "5.6", "mg.", "<tag3>"], "wordsA": ["In", "the", "AtEase", "study,", "TNX-102", "SL", "was", "well", "tolerated", "and", "the", "patient", "retention", "rate", "was", "73%", "on", "placebo,", "79%", "on", "TNX-102", "SL", "2.8", "mg", "and", "84%", "on", "TNX-102", "SL", "5.6", "mg."], "wordsB": ["In", "the", "AtEase", "study,", "Tonmya", "was", "well", "tolerated", "and", "the", "participant", "retention", "rate", "was", "73%", "on", "placebo,", "79%", "on", "Tonmya", "2.8", "mg", "and", "84%", "on", "Tonmya", "5.6", "mg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p54_s1", "idA": "1430306_17_item1_p39_s1", "sentA": "Four distinct serious adverse events, or SAEs, were reported in the study; three were in the placebo group, and one (proctitis/peri-rectal abscess) in the TNX-102 SL arm, which was determined to be unrelated to TNX-102 SL.", "sentB": "Four distinct SAEs were reported in the study; three were in the placebo group, and one (proctitis/peri-rectal abscess) in the Tonmya arm, which was determined to be unrelated to Tonmya.", "type": 2, "words": ["<tag1>", "Four", "distinct", "serious", "adverse", "events,", "or", "SAEs,", "were", "reported", "in", "the", "study;", "three", "were", "in", "the", "placebo", "group,", "and", "one", "(proctitis/peri-rectal", "abscess)", "in", "the", "TNX-102", "SL", "arm,", "which", "was", "determined", "to", "be", "unrelated", "to", "TNX-102", "SL.", "<tag2>", "Four", "distinct", "SAEs", "were", "reported", "in", "the", "study;", "three", "were", "in", "the", "placebo", "group,", "and", "one", "(proctitis/peri-rectal", "abscess)", "in", "the", "Tonmya", "arm,", "which", "was", "determined", "to", "be", "unrelated", "to", "Tonmya.", "<tag3>"], "wordsA": ["Four", "distinct", "serious", "adverse", "events,", "or", "SAEs,", "were", "reported", "in", "the", "study;", "three", "were", "in", "the", "placebo", "group,", "and", "one", "(proctitis/peri-rectal", "abscess)", "in", "the", "TNX-102", "SL", "arm,", "which", "was", "determined", "to", "be", "unrelated", "to", "TNX-102", "SL."], "wordsB": ["Four", "distinct", "SAEs", "were", "reported", "in", "the", "study;", "three", "were", "in", "the", "placebo", "group,", "and", "one", "(proctitis/peri-rectal", "abscess)", "in", "the", "Tonmya", "arm,", "which", "was", "determined", "to", "be", "unrelated", "to", "Tonmya."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p54_s2", "idA": "1430306_17_item1_p39_s2", "sentA": "The most common non-dose related adverse events were mild and transient local administration site conditions and of these oral hypoaesthesia, or numbness, was the most frequent and occurred in 39% of patients treated with the 2.8 mg dose and 36% of the patients treated with the 5.6 mg dose, compared to 2% of the patients receiving placebo.", "sentB": "The most common not dose-related adverse events were mild and transient local administration site conditions and of these oral hypoaesthesia, or numbness, was the most frequent and occurred in 39% of participants treated with the 2.8 mg dose and 36% of the participants treated with the 5.6 mg dose, compared to 2% of the participants receiving placebo.", "type": 2, "words": ["<tag1>", "The", "most", "common", "non-dose", "related", "adverse", "events", "were", "mild", "and", "transient", "local", "administration", "site", "conditions", "and", "of", "these", "oral", "hypoaesthesia,", "or", "numbness,", "was", "the", "most", "frequent", "and", "occurred", "in", "39%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "36%", "of", "the", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "2%", "of", "the", "patients", "receiving", "placebo.", "<tag2>", "The", "most", "common", "not", "dose-related", "adverse", "events", "were", "mild", "and", "transient", "local", "administration", "site", "conditions", "and", "of", "these", "oral", "hypoaesthesia,", "or", "numbness,", "was", "the", "most", "frequent", "and", "occurred", "in", "39%", "of", "participants", "treated", "with", "the", "2.8", "mg", "dose", "and", "36%", "of", "the", "participants", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "2%", "of", "the", "participants", "receiving", "placebo.", "<tag3>"], "wordsA": ["The", "most", "common", "non-dose", "related", "adverse", "events", "were", "mild", "and", "transient", "local", "administration", "site", "conditions", "and", "of", "these", "oral", "hypoaesthesia,", "or", "numbness,", "was", "the", "most", "frequent", "and", "occurred", "in", "39%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "36%", "of", "the", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "2%", "of", "the", "patients", "receiving", "placebo."], "wordsB": ["The", "most", "common", "not", "dose-related", "adverse", "events", "were", "mild", "and", "transient", "local", "administration", "site", "conditions", "and", "of", "these", "oral", "hypoaesthesia,", "or", "numbness,", "was", "the", "most", "frequent", "and", "occurred", "in", "39%", "of", "participants", "treated", "with", "the", "2.8", "mg", "dose", "and", "36%", "of", "the", "participants", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "2%", "of", "the", "participants", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p54_s3", "idA": "1430306_17_item1_p39_s3", "sentA": "Oral paresthesia, or tingling, occurred in 16% of patients treated with the 2.8 mg dose and 4% of patients treated with the 5.6 mg dose, compared to 3% of the patients receiving placebo.", "sentB": "Oral paresthesia, or tingling, occurred in 16% of participants treated with the 2.8 mg dose and 4% of participants treated with the 5.6 mg dose, compared to 3% of the participants receiving placebo.", "type": 2, "words": ["<tag1>", "Oral", "paresthesia,", "or", "tingling,", "occurred", "in", "16%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "4%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "3%", "of", "the", "patients", "receiving", "placebo.", "<tag2>", "Oral", "paresthesia,", "or", "tingling,", "occurred", "in", "16%", "of", "participants", "treated", "with", "the", "2.8", "mg", "dose", "and", "4%", "of", "participants", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "3%", "of", "the", "participants", "receiving", "placebo.", "<tag3>"], "wordsA": ["Oral", "paresthesia,", "or", "tingling,", "occurred", "in", "16%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "4%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "3%", "of", "the", "patients", "receiving", "placebo."], "wordsB": ["Oral", "paresthesia,", "or", "tingling,", "occurred", "in", "16%", "of", "participants", "treated", "with", "the", "2.8", "mg", "dose", "and", "4%", "of", "participants", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "3%", "of", "the", "participants", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p54_s4", "idA": "1430306_17_item1_p39_s4", "sentA": "Glossodynia, or a burning or stinging sensation in the mouth, occurred in 3% of patients treated with the 2.8 mg dose and 6% of patients treated with the 5.6 mg dose, compared to 1% of patients receiving placebo.", "sentB": "Glossodynia, or a burning or stinging sensation in the mouth, occurred in 3% of participants treated with the 2.8 mg dose and 6% of participants treated with the 5.6 mg dose, compared to 1% of participants receiving placebo.", "type": 2, "words": ["<tag1>", "Glossodynia,", "or", "a", "burning", "or", "stinging", "sensation", "in", "the", "mouth,", "occurred", "in", "3%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "6%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "1%", "of", "patients", "receiving", "placebo.", "<tag2>", "Glossodynia,", "or", "a", "burning", "or", "stinging", "sensation", "in", "the", "mouth,", "occurred", "in", "3%", "of", "participants", "treated", "with", "the", "2.8", "mg", "dose", "and", "6%", "of", "participants", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "1%", "of", "participants", "receiving", "placebo.", "<tag3>"], "wordsA": ["Glossodynia,", "or", "a", "burning", "or", "stinging", "sensation", "in", "the", "mouth,", "occurred", "in", "3%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "6%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "1%", "of", "patients", "receiving", "placebo."], "wordsB": ["Glossodynia,", "or", "a", "burning", "or", "stinging", "sensation", "in", "the", "mouth,", "occurred", "in", "3%", "of", "participants", "treated", "with", "the", "2.8", "mg", "dose", "and", "6%", "of", "participants", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "1%", "of", "participants", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p56_s1", "idA": "1430306_17_item1_p39_s4", "sentA": "Glossodynia, or a burning or stinging sensation in the mouth, occurred in 3% of patients treated with the 2.8 mg dose and 6% of patients treated with the 5.6 mg dose, compared to 1% of patients receiving placebo.", "sentB": "Also, continuing remission (i.e. satisfying remission criterion of CAPS-5 score less than 11 at both week 8 and week 12) was observed in 21% of participants receiving a 5.6 mg dose of Tonmya as compared to 5% of participants in the placebo group (p = 0.02, logistic regression).", "type": 2, "words": ["<tag1>", "Glossodynia,", "or", "a", "burning", "or", "stinging", "sensation", "in", "the", "mouth,", "occurred", "in", "3%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "6%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "1%", "of", "patients", "receiving", "placebo.", "<tag2>", "Also,", "continuing", "remission", "(i.e.", "satisfying", "remission", "criterion", "of", "CAPS-5", "score", "less", "than", "11", "at", "both", "week", "8", "and", "week", "12)", "was", "observed", "in", "21%", "of", "participants", "receiving", "a", "5.6", "mg", "dose", "of", "Tonmya", "as", "compared", "to", "5%", "of", "participants", "in", "the", "placebo", "group", "(p", "=", "0.02,", "logistic", "regression).", "<tag3>"], "wordsA": ["Glossodynia,", "or", "a", "burning", "or", "stinging", "sensation", "in", "the", "mouth,", "occurred", "in", "3%", "of", "patients", "treated", "with", "the", "2.8", "mg", "dose", "and", "6%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose,", "compared", "to", "1%", "of", "patients", "receiving", "placebo."], "wordsB": ["Also,", "continuing", "remission", "(i.e.", "satisfying", "remission", "criterion", "of", "CAPS-5", "score", "less", "than", "11", "at", "both", "week", "8", "and", "week", "12)", "was", "observed", "in", "21%", "of", "participants", "receiving", "a", "5.6", "mg", "dose", "of", "Tonmya", "as", "compared", "to", "5%", "of", "participants", "in", "the", "placebo", "group", "(p", "=", "0.02,", "logistic", "regression)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p54_s5", "idA": "1430306_17_item1_p39_s5", "sentA": "Systemic adverse events that were potentially dose-related and occurred in greater than or equal to 5% of patients treated with the 5.6 mg dose or placebo included: somnolence in 16% versus 6% of the patients receiving placebo; dry mouth in 16% versus 11% of the patients receiving placebo; headache in 12% versus 4% of the patients receiving placebo; insomnia in 6% versus 9% of the patients receiving placebo; sedation in 12% versus 1% of the patients receiving placebo; upper respiratory tract infection in 4% versus 5% of the patients receiving placebo; abnormal dreams in 2% versus 5% of the patients receiving placebo; and weight increase in 2% versus 5% of the patients receiving placebo.", "sentB": "Systemic adverse events that were potentially dose-related and occurred in greater than or equal to 5% of participants treated with the 5.6 mg dose or placebo included: somnolence in 16% versus 6% of the participants receiving placebo; dry mouth in 16% versus 11% of the participants receiving placebo; headache in 12% versus 4% of the participants receiving placebo; insomnia in 6% versus 9% of the participants receiving placebo; sedation in 12% versus 1% of the participants receiving placebo; upper respiratory tract infection in 4% versus 5% of the participants receiving placebo; abnormal dreams in 2% versus 5% of the participants receiving placebo; and weight increase in 2% versus 5% of the participants receiving placebo.", "type": 2, "words": ["<tag1>", "Systemic", "adverse", "events", "that", "were", "potentially", "dose-related", "and", "occurred", "in", "greater", "than", "or", "equal", "to", "5%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose", "or", "placebo", "included:", "somnolence", "in", "16%", "versus", "6%", "of", "the", "patients", "receiving", "placebo;", "dry", "mouth", "in", "16%", "versus", "11%", "of", "the", "patients", "receiving", "placebo;", "headache", "in", "12%", "versus", "4%", "of", "the", "patients", "receiving", "placebo;", "insomnia", "in", "6%", "versus", "9%", "of", "the", "patients", "receiving", "placebo;", "sedation", "in", "12%", "versus", "1%", "of", "the", "patients", "receiving", "placebo;", "upper", "respiratory", "tract", "infection", "in", "4%", "versus", "5%", "of", "the", "patients", "receiving", "placebo;", "abnormal", "dreams", "in", "2%", "versus", "5%", "of", "the", "patients", "receiving", "placebo;", "and", "weight", "increase", "in", "2%", "versus", "5%", "of", "the", "patients", "receiving", "placebo.", "<tag2>", "Systemic", "adverse", "events", "that", "were", "potentially", "dose-related", "and", "occurred", "in", "greater", "than", "or", "equal", "to", "5%", "of", "participants", "treated", "with", "the", "5.6", "mg", "dose", "or", "placebo", "included:", "somnolence", "in", "16%", "versus", "6%", "of", "the", "participants", "receiving", "placebo;", "dry", "mouth", "in", "16%", "versus", "11%", "of", "the", "participants", "receiving", "placebo;", "headache", "in", "12%", "versus", "4%", "of", "the", "participants", "receiving", "placebo;", "insomnia", "in", "6%", "versus", "9%", "of", "the", "participants", "receiving", "placebo;", "sedation", "in", "12%", "versus", "1%", "of", "the", "participants", "receiving", "placebo;", "upper", "respiratory", "tract", "infection", "in", "4%", "versus", "5%", "of", "the", "participants", "receiving", "placebo;", "abnormal", "dreams", "in", "2%", "versus", "5%", "of", "the", "participants", "receiving", "placebo;", "and", "weight", "increase", "in", "2%", "versus", "5%", "of", "the", "participants", "receiving", "placebo.", "<tag3>"], "wordsA": ["Systemic", "adverse", "events", "that", "were", "potentially", "dose-related", "and", "occurred", "in", "greater", "than", "or", "equal", "to", "5%", "of", "patients", "treated", "with", "the", "5.6", "mg", "dose", "or", "placebo", "included:", "somnolence", "in", "16%", "versus", "6%", "of", "the", "patients", "receiving", "placebo;", "dry", "mouth", "in", "16%", "versus", "11%", "of", "the", "patients", "receiving", "placebo;", "headache", "in", "12%", "versus", "4%", "of", "the", "patients", "receiving", "placebo;", "insomnia", "in", "6%", "versus", "9%", "of", "the", "patients", "receiving", "placebo;", "sedation", "in", "12%", "versus", "1%", "of", "the", "patients", "receiving", "placebo;", "upper", "respiratory", "tract", "infection", "in", "4%", "versus", "5%", "of", "the", "patients", "receiving", "placebo;", "abnormal", "dreams", "in", "2%", "versus", "5%", "of", "the", "patients", "receiving", "placebo;", "and", "weight", "increase", "in", "2%", "versus", "5%", "of", "the", "patients", "receiving", "placebo."], "wordsB": ["Systemic", "adverse", "events", "that", "were", "potentially", "dose-related", "and", "occurred", "in", "greater", "than", "or", "equal", "to", "5%", "of", "participants", "treated", "with", "the", "5.6", "mg", "dose", "or", "placebo", "included:", "somnolence", "in", "16%", "versus", "6%", "of", "the", "participants", "receiving", "placebo;", "dry", "mouth", "in", "16%", "versus", "11%", "of", "the", "participants", "receiving", "placebo;", "headache", "in", "12%", "versus", "4%", "of", "the", "participants", "receiving", "placebo;", "insomnia", "in", "6%", "versus", "9%", "of", "the", "participants", "receiving", "placebo;", "sedation", "in", "12%", "versus", "1%", "of", "the", "participants", "receiving", "placebo;", "upper", "respiratory", "tract", "infection", "in", "4%", "versus", "5%", "of", "the", "participants", "receiving", "placebo;", "abnormal", "dreams", "in", "2%", "versus", "5%", "of", "the", "participants", "receiving", "placebo;", "and", "weight", "increase", "in", "2%", "versus", "5%", "of", "the", "participants", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p17_s3", "idA": "1430306_17_item1_p39_s6", "sentA": "For the patients treated with the 2.8 mg dose, the incidence of the most common systemic adverse events reported above were less frequent than patients treated with the 5.6 mg dose with the exception of insomnia, which was 8%.", "sentB": "Development of agitation, or its worsening, is one of the most common reasons for patients having to transition to nursing homes and other long-term care settings.", "type": 2, "words": ["<tag1>", "For", "the", "patients", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "patients", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%.", "<tag2>", "Development", "of", "agitation,", "or", "its", "worsening,", "is", "one", "of", "the", "most", "common", "reasons", "for", "patients", "having", "to", "transition", "to", "nursing", "homes", "and", "other", "long-term", "care", "settings.", "<tag3>"], "wordsA": ["For", "the", "patients", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "patients", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%."], "wordsB": ["Development", "of", "agitation,", "or", "its", "worsening,", "is", "one", "of", "the", "most", "common", "reasons", "for", "patients", "having", "to", "transition", "to", "nursing", "homes", "and", "other", "long-term", "care", "settings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p29_s1", "idA": "1430306_17_item1_p39_s6", "sentA": "For the patients treated with the 2.8 mg dose, the incidence of the most common systemic adverse events reported above were less frequent than patients treated with the 5.6 mg dose with the exception of insomnia, which was 8%.", "sentB": "Development of agitation, or its worsening, is one of the most common reasons for patients having to transition to nursing homes and other long-term care settings.", "type": 2, "words": ["<tag1>", "For", "the", "patients", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "patients", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%.", "<tag2>", "Development", "of", "agitation,", "or", "its", "worsening,", "is", "one", "of", "the", "most", "common", "reasons", "for", "patients", "having", "to", "transition", "to", "nursing", "homes", "and", "other", "long-term", "care", "settings.", "<tag3>"], "wordsA": ["For", "the", "patients", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "patients", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%."], "wordsB": ["Development", "of", "agitation,", "or", "its", "worsening,", "is", "one", "of", "the", "most", "common", "reasons", "for", "patients", "having", "to", "transition", "to", "nursing", "homes", "and", "other", "long-term", "care", "settings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p54_s6", "idA": "1430306_17_item1_p39_s6", "sentA": "For the patients treated with the 2.8 mg dose, the incidence of the most common systemic adverse events reported above were less frequent than patients treated with the 5.6 mg dose with the exception of insomnia, which was 8%.", "sentB": "For the participants treated with the 2.8 mg dose, the incidence of the most common systemic adverse events reported above were less frequent than participants treated with the 5.6 mg dose with the exception of insomnia, which was 8%.", "type": 2, "words": ["<tag1>", "For", "the", "patients", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "patients", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%.", "<tag2>", "For", "the", "participants", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "participants", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%.", "<tag3>"], "wordsA": ["For", "the", "patients", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "patients", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%."], "wordsB": ["For", "the", "participants", "treated", "with", "the", "2.8", "mg", "dose,", "the", "incidence", "of", "the", "most", "common", "systemic", "adverse", "events", "reported", "above", "were", "less", "frequent", "than", "participants", "treated", "with", "the", "5.6", "mg", "dose", "with", "the", "exception", "of", "insomnia,", "which", "was", "8%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p57_s0", "idA": "1430306_17_item1_p40_s0", "sentA": "Patients who completed the AtEase study were eligible to enroll into a three-month open-label extension study with TNX-102 SL 2.8 mg.", "sentB": "Participants who completed the AtEase study were eligible to enroll into a 12-week open-label extension study with Tonmya 2.8 mg.", "type": 2, "words": ["<tag1>", "Patients", "who", "completed", "the", "AtEase", "study", "were", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "with", "TNX-102", "SL", "2.8", "mg.", "<tag2>", "Participants", "who", "completed", "the", "AtEase", "study", "were", "eligible", "to", "enroll", "into", "a", "12-week", "open-label", "extension", "study", "with", "Tonmya", "2.8", "mg.", "<tag3>"], "wordsA": ["Patients", "who", "completed", "the", "AtEase", "study", "were", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "with", "TNX-102", "SL", "2.8", "mg."], "wordsB": ["Participants", "who", "completed", "the", "AtEase", "study", "were", "eligible", "to", "enroll", "into", "a", "12-week", "open-label", "extension", "study", "with", "Tonmya", "2.8", "mg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p60_s0", "idA": "1430306_17_item1_p40_s0", "sentA": "Patients who completed the AtEase study were eligible to enroll into a three-month open-label extension study with TNX-102 SL 2.8 mg.", "sentB": "To obtain additional safety information from participants in the HONOR study, participants who completed the HONOR study are eligible to enroll into a 12-week open-label extension study with Tonmya 5.6 mg.", "type": 2, "words": ["<tag1>", "Patients", "who", "completed", "the", "AtEase", "study", "were", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "with", "TNX-102", "SL", "2.8", "mg.", "<tag2>", "To", "obtain", "additional", "safety", "information", "from", "participants", "in", "the", "HONOR", "study,", "participants", "who", "completed", "the", "HONOR", "study", "are", "eligible", "to", "enroll", "into", "a", "12-week", "open-label", "extension", "study", "with", "Tonmya", "5.6", "mg.", "<tag3>"], "wordsA": ["Patients", "who", "completed", "the", "AtEase", "study", "were", "eligible", "to", "enroll", "into", "a", "three-month", "open-label", "extension", "study", "with", "TNX-102", "SL", "2.8", "mg."], "wordsB": ["To", "obtain", "additional", "safety", "information", "from", "participants", "in", "the", "HONOR", "study,", "participants", "who", "completed", "the", "HONOR", "study", "are", "eligible", "to", "enroll", "into", "a", "12-week", "open-label", "extension", "study", "with", "Tonmya", "5.6", "mg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p57_s1", "idA": "1430306_17_item1_p40_s1", "sentA": "We conducted this open-label extension study to obtain additional safety information from patients in the AtEase Study.", "sentB": "We conducted this open-label extension study to obtain additional safety information from participants in the AtEase Study.", "type": 2, "words": ["<tag1>", "We", "conducted", "this", "open-label", "extension", "study", "to", "obtain", "additional", "safety", "information", "from", "patients", "in", "the", "AtEase", "Study.", "<tag2>", "We", "conducted", "this", "open-label", "extension", "study", "to", "obtain", "additional", "safety", "information", "from", "participants", "in", "the", "AtEase", "Study.", "<tag3>"], "wordsA": ["We", "conducted", "this", "open-label", "extension", "study", "to", "obtain", "additional", "safety", "information", "from", "patients", "in", "the", "AtEase", "Study."], "wordsB": ["We", "conducted", "this", "open-label", "extension", "study", "to", "obtain", "additional", "safety", "information", "from", "participants", "in", "the", "AtEase", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p60_s1", "idA": "1430306_17_item1_p40_s2", "sentA": "The clinical phase of this open-label extension study is complete.", "sentB": "This open-label extension study is ongoing.", "type": 2, "words": ["<tag1>", "The", "clinical", "phase", "of", "this", "open-label", "extension", "study", "is", "complete.", "<tag2>", "This", "open-label", "extension", "study", "is", "ongoing.", "<tag3>"], "wordsA": ["The", "clinical", "phase", "of", "this", "open-label", "extension", "study", "is", "complete."], "wordsB": ["This", "open-label", "extension", "study", "is", "ongoing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p57_s3", "idA": "1430306_17_item1_p40_s3", "sentA": "TNX-102 SL 2.8 mg was well tolerated for up to six months of treatment and no new safety signals were revealed in this open-label extension study.", "sentB": "Tonmya 2.8 mg was well tolerated for up to six months of treatment and no new safety signals were revealed in this open-label extension study.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "2.8", "mg", "was", "well", "tolerated", "for", "up", "to", "six", "months", "of", "treatment", "and", "no", "new", "safety", "signals", "were", "revealed", "in", "this", "open-label", "extension", "study.", "<tag2>", "Tonmya", "2.8", "mg", "was", "well", "tolerated", "for", "up", "to", "six", "months", "of", "treatment", "and", "no", "new", "safety", "signals", "were", "revealed", "in", "this", "open-label", "extension", "study.", "<tag3>"], "wordsA": ["TNX-102", "SL", "2.8", "mg", "was", "well", "tolerated", "for", "up", "to", "six", "months", "of", "treatment", "and", "no", "new", "safety", "signals", "were", "revealed", "in", "this", "open-label", "extension", "study."], "wordsB": ["Tonmya", "2.8", "mg", "was", "well", "tolerated", "for", "up", "to", "six", "months", "of", "treatment", "and", "no", "new", "safety", "signals", "were", "revealed", "in", "this", "open-label", "extension", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p58_s0", "idA": "1430306_17_item1_p41_s0", "sentA": "We have commenced a randomized, double-blind placebo-controlled Phase 3 study of TNX-102 SL in approximately 550 patients with military-related PTSD in the first quarter of 2017.", "sentB": "We have commenced the HONOR study, a randomized, double-blind, placebo-controlled Phase 3 study of Tonmya in approximately 550 participants with military-related PTSD in the first quarter of 2017.", "type": 2, "words": ["<tag1>", "We", "have", "commenced", "a", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "approximately", "550", "patients", "with", "military-related", "PTSD", "in", "the", "first", "quarter", "of", "2017.", "<tag2>", "We", "have", "commenced", "the", "HONOR", "study,", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "of", "Tonmya", "in", "approximately", "550", "participants", "with", "military-related", "PTSD", "in", "the", "first", "quarter", "of", "2017.", "<tag3>"], "wordsA": ["We", "have", "commenced", "a", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "approximately", "550", "patients", "with", "military-related", "PTSD", "in", "the", "first", "quarter", "of", "2017."], "wordsB": ["We", "have", "commenced", "the", "HONOR", "study,", "a", "randomized,", "double-blind,", "placebo-controlled", "Phase", "3", "study", "of", "Tonmya", "in", "approximately", "550", "participants", "with", "military-related", "PTSD", "in", "the", "first", "quarter", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p58_s1", "idA": "1430306_17_item1_p41_s1", "sentA": "This first Phase 3 study, the HONOR study, is an adaptive design study based on the results of the Phase 2 AtEase study.", "sentB": "This study is an adaptive design study based on the results of the Phase 2 AtEase study.", "type": 2, "words": ["<tag1>", "This", "first", "Phase", "3", "study,", "the", "HONOR", "study,", "is", "an", "adaptive", "design", "study", "based", "on", "the", "results", "of", "the", "Phase", "2", "AtEase", "study.", "<tag2>", "This", "study", "is", "an", "adaptive", "design", "study", "based", "on", "the", "results", "of", "the", "Phase", "2", "AtEase", "study.", "<tag3>"], "wordsA": ["This", "first", "Phase", "3", "study,", "the", "HONOR", "study,", "is", "an", "adaptive", "design", "study", "based", "on", "the", "results", "of", "the", "Phase", "2", "AtEase", "study."], "wordsB": ["This", "study", "is", "an", "adaptive", "design", "study", "based", "on", "the", "results", "of", "the", "Phase", "2", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p58_s2", "idA": "1430306_17_item1_p41_s2", "sentA": "The study design is very similar to the Phase 2 AtEase study , except there will be one planned interim analysis and the involvement of an independent data monitoring committee, or IDMC, to review unblinded interim analysis results.", "sentB": "The study design is very similar to the Phase 2 AtEase study, except there will be one planned interim analysis, or IA, and the involvement of the independent data monitoring committee, or IDMC, to review unblinded IA results.", "type": 2, "words": ["<tag1>", "The", "study", "design", "is", "very", "similar", "to", "the", "Phase", "2", "AtEase", "study", ",", "except", "there", "will", "be", "one", "planned", "interim", "analysis", "and", "the", "involvement", "of", "an", "independent", "data", "monitoring", "committee,", "or", "IDMC,", "to", "review", "unblinded", "interim", "analysis", "results.", "<tag2>", "The", "study", "design", "is", "very", "similar", "to", "the", "Phase", "2", "AtEase", "study,", "except", "there", "will", "be", "one", "planned", "interim", "analysis,", "or", "IA,", "and", "the", "involvement", "of", "the", "independent", "data", "monitoring", "committee,", "or", "IDMC,", "to", "review", "unblinded", "IA", "results.", "<tag3>"], "wordsA": ["The", "study", "design", "is", "very", "similar", "to", "the", "Phase", "2", "AtEase", "study", ",", "except", "there", "will", "be", "one", "planned", "interim", "analysis", "and", "the", "involvement", "of", "an", "independent", "data", "monitoring", "committee,", "or", "IDMC,", "to", "review", "unblinded", "interim", "analysis", "results."], "wordsB": ["The", "study", "design", "is", "very", "similar", "to", "the", "Phase", "2", "AtEase", "study,", "except", "there", "will", "be", "one", "planned", "interim", "analysis,", "or", "IA,", "and", "the", "involvement", "of", "the", "independent", "data", "monitoring", "committee,", "or", "IDMC,", "to", "review", "unblinded", "IA", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p58_s3", "idA": "1430306_17_item1_p41_s3", "sentA": "The IDMC will make a recommendation to continue as planned, to continue but increase the number of recruited patients or to stop for success.", "sentB": "The IDMC will make a recommendation to continue as planned, to continue but increase the number of recruited participants or to stop for success.", "type": 2, "words": ["<tag1>", "The", "IDMC", "will", "make", "a", "recommendation", "to", "continue", "as", "planned,", "to", "continue", "but", "increase", "the", "number", "of", "recruited", "patients", "or", "to", "stop", "for", "success.", "<tag2>", "The", "IDMC", "will", "make", "a", "recommendation", "to", "continue", "as", "planned,", "to", "continue", "but", "increase", "the", "number", "of", "recruited", "participants", "or", "to", "stop", "for", "success.", "<tag3>"], "wordsA": ["The", "IDMC", "will", "make", "a", "recommendation", "to", "continue", "as", "planned,", "to", "continue", "but", "increase", "the", "number", "of", "recruited", "patients", "or", "to", "stop", "for", "success."], "wordsB": ["The", "IDMC", "will", "make", "a", "recommendation", "to", "continue", "as", "planned,", "to", "continue", "but", "increase", "the", "number", "of", "recruited", "participants", "or", "to", "stop", "for", "success."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p58_s4", "idA": "1430306_17_item1_p41_s4", "sentA": "In addition, there will be one active dose (5.6 mg administered as 2 x 2.8 mg tablets) and the entrance criterion is CAPS-5 33 in this Phase 3 study.", "sentB": "In addition, only one active dose (5.6 mg administered as 2 x 2.8 mg tablets) is being investigated and the entrance criterion is CAPS-5 33 in this Phase 3 study.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "will", "be", "one", "active", "dose", "(5.6", "mg", "administered", "as", "2", "x", "2.8", "mg", "tablets)", "and", "the", "entrance", "criterion", "is", "CAPS-5", "33", "in", "this", "Phase", "3", "study.", "<tag2>", "In", "addition,", "only", "one", "active", "dose", "(5.6", "mg", "administered", "as", "2", "x", "2.8", "mg", "tablets)", "is", "being", "investigated", "and", "the", "entrance", "criterion", "is", "CAPS-5", "33", "in", "this", "Phase", "3", "study.", "<tag3>"], "wordsA": ["In", "addition,", "there", "will", "be", "one", "active", "dose", "(5.6", "mg", "administered", "as", "2", "x", "2.8", "mg", "tablets)", "and", "the", "entrance", "criterion", "is", "CAPS-5", "33", "in", "this", "Phase", "3", "study."], "wordsB": ["In", "addition,", "only", "one", "active", "dose", "(5.6", "mg", "administered", "as", "2", "x", "2.8", "mg", "tablets)", "is", "being", "investigated", "and", "the", "entrance", "criterion", "is", "CAPS-5", "33", "in", "this", "Phase", "3", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p59_s0", "idA": "1430306_17_item1_p41_s5", "sentA": "The interim analysis will be conducted when approximately 50% (approximately 250 300 patients) of the initially planned patient enrollment is evaluable for efficacy.", "sentB": "The IA will be conducted when approximately 50% (approximately 250 300 participants) of the initially planned participant enrollment is evaluable for efficacy.", "type": 2, "words": ["<tag1>", "The", "interim", "analysis", "will", "be", "conducted", "when", "approximately", "50%", "(approximately", "250", "300", "patients)", "of", "the", "initially", "planned", "patient", "enrollment", "is", "evaluable", "for", "efficacy.", "<tag2>", "The", "IA", "will", "be", "conducted", "when", "approximately", "50%", "(approximately", "250", "300", "participants)", "of", "the", "initially", "planned", "participant", "enrollment", "is", "evaluable", "for", "efficacy.", "<tag3>"], "wordsA": ["The", "interim", "analysis", "will", "be", "conducted", "when", "approximately", "50%", "(approximately", "250", "300", "patients)", "of", "the", "initially", "planned", "patient", "enrollment", "is", "evaluable", "for", "efficacy."], "wordsB": ["The", "IA", "will", "be", "conducted", "when", "approximately", "50%", "(approximately", "250", "300", "participants)", "of", "the", "initially", "planned", "participant", "enrollment", "is", "evaluable", "for", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p59_s2", "idA": "1430306_17_item1_p41_s7", "sentA": "The HONOR study involves approximately 35 U.S. centers.", "sentB": "The HONOR study is being conducted at approximately 40 U.S. sites.", "type": 2, "words": ["<tag1>", "The", "HONOR", "study", "involves", "approximately", "35", "U.S.", "centers.", "<tag2>", "The", "HONOR", "study", "is", "being", "conducted", "at", "approximately", "40", "U.S.", "sites.", "<tag3>"], "wordsA": ["The", "HONOR", "study", "involves", "approximately", "35", "U.S.", "centers."], "wordsB": ["The", "HONOR", "study", "is", "being", "conducted", "at", "approximately", "40", "U.S.", "sites."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p56_s2", "idA": "1430306_17_item1_p42_s0", "sentA": "As in the case of the AtEase study, the primary efficacy endpoint of the HONOR study is the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the CAPS-5 scale between those treated with TNX-102 SL 5.6 mg and those receiving placebo.", "sentB": "The AtEase study supported the hypothesized mechanism of sleep quality improvement, since additional retrospective analyses showed that in the CAPS-5 score of 33 or higher subset of participants, sleep improvement at week 4, measured by the PROMIS Sleep Disturbance instrument, predicted treatment response (by improvement in total CAPS-5 score without the sleep item) at week 12 in the Tonmya 5.6 mg group (p = 0.01, linear regression), whereas these measures were not related in placebo.", "type": 2, "words": ["<tag1>", "As", "in", "the", "case", "of", "the", "AtEase", "study,", "the", "primary", "efficacy", "endpoint", "of", "the", "HONOR", "study", "is", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo.", "<tag2>", "The", "AtEase", "study", "supported", "the", "hypothesized", "mechanism", "of", "sleep", "quality", "improvement,", "since", "additional", "retrospective", "analyses", "showed", "that", "in", "the", "CAPS-5", "score", "of", "33", "or", "higher", "subset", "of", "participants,", "sleep", "improvement", "at", "week", "4,", "measured", "by", "the", "PROMIS", "Sleep", "Disturbance", "instrument,", "predicted", "treatment", "response", "(by", "improvement", "in", "total", "CAPS-5", "score", "without", "the", "sleep", "item)", "at", "week", "12", "in", "the", "Tonmya", "5.6", "mg", "group", "(p", "=", "0.01,", "linear", "regression),", "whereas", "these", "measures", "were", "not", "related", "in", "placebo.", "<tag3>"], "wordsA": ["As", "in", "the", "case", "of", "the", "AtEase", "study,", "the", "primary", "efficacy", "endpoint", "of", "the", "HONOR", "study", "is", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo."], "wordsB": ["The", "AtEase", "study", "supported", "the", "hypothesized", "mechanism", "of", "sleep", "quality", "improvement,", "since", "additional", "retrospective", "analyses", "showed", "that", "in", "the", "CAPS-5", "score", "of", "33", "or", "higher", "subset", "of", "participants,", "sleep", "improvement", "at", "week", "4,", "measured", "by", "the", "PROMIS", "Sleep", "Disturbance", "instrument,", "predicted", "treatment", "response", "(by", "improvement", "in", "total", "CAPS-5", "score", "without", "the", "sleep", "item)", "at", "week", "12", "in", "the", "Tonmya", "5.6", "mg", "group", "(p", "=", "0.01,", "linear", "regression),", "whereas", "these", "measures", "were", "not", "related", "in", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p59_s3", "idA": "1430306_17_item1_p42_s0", "sentA": "As in the case of the AtEase study, the primary efficacy endpoint of the HONOR study is the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the CAPS-5 scale between those treated with TNX-102 SL 5.6 mg and those receiving placebo.", "sentB": "As in the case of the AtEase study, the primary efficacy endpoint of the HONOR study is the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the CAPS-5 scale between those treated with Tonmya and those receiving placebo.", "type": 2, "words": ["<tag1>", "As", "in", "the", "case", "of", "the", "AtEase", "study,", "the", "primary", "efficacy", "endpoint", "of", "the", "HONOR", "study", "is", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo.", "<tag2>", "As", "in", "the", "case", "of", "the", "AtEase", "study,", "the", "primary", "efficacy", "endpoint", "of", "the", "HONOR", "study", "is", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "Tonmya", "and", "those", "receiving", "placebo.", "<tag3>"], "wordsA": ["As", "in", "the", "case", "of", "the", "AtEase", "study,", "the", "primary", "efficacy", "endpoint", "of", "the", "HONOR", "study", "is", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo."], "wordsB": ["As", "in", "the", "case", "of", "the", "AtEase", "study,", "the", "primary", "efficacy", "endpoint", "of", "the", "HONOR", "study", "is", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "Tonmya", "and", "those", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p61_s0", "idA": "1430306_17_item1_p43_s0", "sentA": "A second, randomized, double-blind placebo-controlled Phase 3 study of TNX-102 SL in approximately 550 predominantly civilian PTSD patients will follow.", "sentB": "A second, randomized, double-blind placebo-controlled Phase 3 study of Tonmya 5.6 mg (2 x 2.8 mg tablets) in approximately 550 PTSD participants may follow, if necessary.", "type": 2, "words": ["<tag1>", "A", "second,", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "approximately", "550", "predominantly", "civilian", "PTSD", "patients", "will", "follow.", "<tag2>", "A", "second,", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "Tonmya", "5.6", "mg", "(2", "x", "2.8", "mg", "tablets)", "in", "approximately", "550", "PTSD", "participants", "may", "follow,", "if", "necessary.", "<tag3>"], "wordsA": ["A", "second,", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "TNX-102", "SL", "in", "approximately", "550", "predominantly", "civilian", "PTSD", "patients", "will", "follow."], "wordsB": ["A", "second,", "randomized,", "double-blind", "placebo-controlled", "Phase", "3", "study", "of", "Tonmya", "5.6", "mg", "(2", "x", "2.8", "mg", "tablets)", "in", "approximately", "550", "PTSD", "participants", "may", "follow,", "if", "necessary."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p61_s1", "idA": "1430306_17_item1_p43_s1", "sentA": "We expect this study to be conducted at approximately 35 U.S. centers.", "sentB": "We expect this study to be conducted at approximately 40 U.S. sites.", "type": 2, "words": ["<tag1>", "We", "expect", "this", "study", "to", "be", "conducted", "at", "approximately", "35", "U.S.", "centers.", "<tag2>", "We", "expect", "this", "study", "to", "be", "conducted", "at", "approximately", "40", "U.S.", "sites.", "<tag3>"], "wordsA": ["We", "expect", "this", "study", "to", "be", "conducted", "at", "approximately", "35", "U.S.", "centers."], "wordsB": ["We", "expect", "this", "study", "to", "be", "conducted", "at", "approximately", "40", "U.S.", "sites."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p61_s2", "idA": "1430306_17_item1_p43_s2", "sentA": "As in the case of the HONOR and AtEase studies, the primary efficacy endpoint of this second Phase 3 study will be the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the CAPS-5 scale between those treated with TNX-102 SL 5.6 mg and those receiving placebo.", "sentB": "As in the case of the HONOR and AtEase studies, the primary efficacy endpoint of this second Phase 3 study will be the 12-week mean change from baseline in the severity of PTSD symptoms as measured by the CAPS-5 scale between those treated with Tonmya and those receiving placebo.", "type": 2, "words": ["<tag1>", "As", "in", "the", "case", "of", "the", "HONOR", "and", "AtEase", "studies,", "the", "primary", "efficacy", "endpoint", "of", "this", "second", "Phase", "3", "study", "will", "be", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo.", "<tag2>", "As", "in", "the", "case", "of", "the", "HONOR", "and", "AtEase", "studies,", "the", "primary", "efficacy", "endpoint", "of", "this", "second", "Phase", "3", "study", "will", "be", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "Tonmya", "and", "those", "receiving", "placebo.", "<tag3>"], "wordsA": ["As", "in", "the", "case", "of", "the", "HONOR", "and", "AtEase", "studies,", "the", "primary", "efficacy", "endpoint", "of", "this", "second", "Phase", "3", "study", "will", "be", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "TNX-102", "SL", "5.6", "mg", "and", "those", "receiving", "placebo."], "wordsB": ["As", "in", "the", "case", "of", "the", "HONOR", "and", "AtEase", "studies,", "the", "primary", "efficacy", "endpoint", "of", "this", "second", "Phase", "3", "study", "will", "be", "the", "12-week", "mean", "change", "from", "baseline", "in", "the", "severity", "of", "PTSD", "symptoms", "as", "measured", "by", "the", "CAPS-5", "scale", "between", "those", "treated", "with", "Tonmya", "and", "those", "receiving", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p62_s0", "idA": "1430306_17_item1_p44_s0", "sentA": "We plan to conduct the registration-required open-label extension studies of TNX-102 SL 5.6 mg in patients who complete either the HONOR study or the predominantly civilian PTSD Phase 3 study.", "sentB": "In addition to the ongoing 12-week open-label extension study for HONOR, we plan to conduct the registration-required open-label extension studies of Tonmya in participants who complete either the 12-week open-label extension study of HONOR study or the second PTSD Phase 3 study.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "conduct", "the", "registration-required", "open-label", "extension", "studies", "of", "TNX-102", "SL", "5.6", "mg", "in", "patients", "who", "complete", "either", "the", "HONOR", "study", "or", "the", "predominantly", "civilian", "PTSD", "Phase", "3", "study.", "<tag2>", "In", "addition", "to", "the", "ongoing", "12-week", "open-label", "extension", "study", "for", "HONOR,", "we", "plan", "to", "conduct", "the", "registration-required", "open-label", "extension", "studies", "of", "Tonmya", "in", "participants", "who", "complete", "either", "the", "12-week", "open-label", "extension", "study", "of", "HONOR", "study", "or", "the", "second", "PTSD", "Phase", "3", "study.", "<tag3>"], "wordsA": ["We", "plan", "to", "conduct", "the", "registration-required", "open-label", "extension", "studies", "of", "TNX-102", "SL", "5.6", "mg", "in", "patients", "who", "complete", "either", "the", "HONOR", "study", "or", "the", "predominantly", "civilian", "PTSD", "Phase", "3", "study."], "wordsB": ["In", "addition", "to", "the", "ongoing", "12-week", "open-label", "extension", "study", "for", "HONOR,", "we", "plan", "to", "conduct", "the", "registration-required", "open-label", "extension", "studies", "of", "Tonmya", "in", "participants", "who", "complete", "either", "the", "12-week", "open-label", "extension", "study", "of", "HONOR", "study", "or", "the", "second", "PTSD", "Phase", "3", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p63_s0", "idA": "1430306_17_item1_p45_s0", "sentA": "6- and 12-month safety exposure data from the maximum therapeutic dose to support the registration of TNX-102 SL for the treatment of PTSD, a chronic psychiatric condition.", "sentB": "6- and 12-month safety exposure data from Tonmya 5.6 mg to support its registration for the treatment of PTSD as it is a chronic psychiatric condition.", "type": 2, "words": ["<tag1>", "6-", "and", "12-month", "safety", "exposure", "data", "from", "the", "maximum", "therapeutic", "dose", "to", "support", "the", "registration", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD,", "a", "chronic", "psychiatric", "condition.", "<tag2>", "6-", "and", "12-month", "safety", "exposure", "data", "from", "Tonmya", "5.6", "mg", "to", "support", "its", "registration", "for", "the", "treatment", "of", "PTSD", "as", "it", "is", "a", "chronic", "psychiatric", "condition.", "<tag3>"], "wordsA": ["6-", "and", "12-month", "safety", "exposure", "data", "from", "the", "maximum", "therapeutic", "dose", "to", "support", "the", "registration", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "PTSD,", "a", "chronic", "psychiatric", "condition."], "wordsB": ["6-", "and", "12-month", "safety", "exposure", "data", "from", "Tonmya", "5.6", "mg", "to", "support", "its", "registration", "for", "the", "treatment", "of", "PTSD", "as", "it", "is", "a", "chronic", "psychiatric", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p64_s0", "idA": "1430306_17_item1_p46_s0", "sentA": "Subsequent to reporting the Phase 2 AtEase study topline result, we held an End-of-Phase 2/Pre-Phase 3 meeting with the FDA in early August 2016 to discuss the Phase 3 program required to support the registration of TNX-102 SL 5.6 mg for the treatment of PTSD and the remaining data package for the NDA filing.", "sentB": "Subsequent to reporting the Phase 2 AtEase study topline result, we held an End-of-Phase 2/Pre-Phase 3 meeting with the FDA in August 2016 to discuss the Phase 3 program required to support the registration of Tonmya for the treatment of PTSD and the remaining data package for the NDA filing.", "type": 2, "words": ["<tag1>", "Subsequent", "to", "reporting", "the", "Phase", "2", "AtEase", "study", "topline", "result,", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "early", "August", "2016", "to", "discuss", "the", "Phase", "3", "program", "required", "to", "support", "the", "registration", "of", "TNX-102", "SL", "5.6", "mg", "for", "the", "treatment", "of", "PTSD", "and", "the", "remaining", "data", "package", "for", "the", "NDA", "filing.", "<tag2>", "Subsequent", "to", "reporting", "the", "Phase", "2", "AtEase", "study", "topline", "result,", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "August", "2016", "to", "discuss", "the", "Phase", "3", "program", "required", "to", "support", "the", "registration", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD", "and", "the", "remaining", "data", "package", "for", "the", "NDA", "filing.", "<tag3>"], "wordsA": ["Subsequent", "to", "reporting", "the", "Phase", "2", "AtEase", "study", "topline", "result,", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "early", "August", "2016", "to", "discuss", "the", "Phase", "3", "program", "required", "to", "support", "the", "registration", "of", "TNX-102", "SL", "5.6", "mg", "for", "the", "treatment", "of", "PTSD", "and", "the", "remaining", "data", "package", "for", "the", "NDA", "filing."], "wordsB": ["Subsequent", "to", "reporting", "the", "Phase", "2", "AtEase", "study", "topline", "result,", "we", "held", "an", "End-of-Phase", "2/Pre-Phase", "3", "meeting", "with", "the", "FDA", "in", "August", "2016", "to", "discuss", "the", "Phase", "3", "program", "required", "to", "support", "the", "registration", "of", "Tonmya", "for", "the", "treatment", "of", "PTSD", "and", "the", "remaining", "data", "package", "for", "the", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p64_s1", "idA": "1430306_17_item1_p46_s2", "sentA": "As described below, the first Phase 3 study will be in patients with military-related PTSD and the second Phase 3 study will study predominately civilian PTSD patients.", "sentB": "As described below, the first Phase 3 stud, currently ongoing, is in participants with military-related PTSD and the second Phase 3 study, if needed, will be performed in participants suffering from PTSD.", "type": 2, "words": ["<tag1>", "As", "described", "below,", "the", "first", "Phase", "3", "study", "will", "be", "in", "patients", "with", "military-related", "PTSD", "and", "the", "second", "Phase", "3", "study", "will", "study", "predominately", "civilian", "PTSD", "patients.", "<tag2>", "As", "described", "below,", "the", "first", "Phase", "3", "stud,", "currently", "ongoing,", "is", "in", "participants", "with", "military-related", "PTSD", "and", "the", "second", "Phase", "3", "study,", "if", "needed,", "will", "be", "performed", "in", "participants", "suffering", "from", "PTSD.", "<tag3>"], "wordsA": ["As", "described", "below,", "the", "first", "Phase", "3", "study", "will", "be", "in", "patients", "with", "military-related", "PTSD", "and", "the", "second", "Phase", "3", "study", "will", "study", "predominately", "civilian", "PTSD", "patients."], "wordsB": ["As", "described", "below,", "the", "first", "Phase", "3", "stud,", "currently", "ongoing,", "is", "in", "participants", "with", "military-related", "PTSD", "and", "the", "second", "Phase", "3", "study,", "if", "needed,", "will", "be", "performed", "in", "participants", "suffering", "from", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p69_s0", "idA": "1430306_17_item1_p47_s0", "sentA": "We held an End-of-Phase 2 Chemistry, Manufacturing and Controls, or CMC, meeting with the FDA in February 2016 to discuss the quality data requirement for an NDA submission for TNX-102 SL.", "sentB": "On September 7, 2017, we had a Breakthrough Therapy Chemistry, Manufacturing and Controls ( CMC ) guidance meeting with the FDA regarding the CMC data required to support the Tonmya NDA and commercial product.", "type": 2, "words": ["<tag1>", "We", "held", "an", "End-of-Phase", "2", "Chemistry,", "Manufacturing", "and", "Controls,", "or", "CMC,", "meeting", "with", "the", "FDA", "in", "February", "2016", "to", "discuss", "the", "quality", "data", "requirement", "for", "an", "NDA", "submission", "for", "TNX-102", "SL.", "<tag2>", "On", "September", "7,", "2017,", "we", "had", "a", "Breakthrough", "Therapy", "Chemistry,", "Manufacturing", "and", "Controls", "(", "CMC", ")", "guidance", "meeting", "with", "the", "FDA", "regarding", "the", "CMC", "data", "required", "to", "support", "the", "Tonmya", "NDA", "and", "commercial", "product.", "<tag3>"], "wordsA": ["We", "held", "an", "End-of-Phase", "2", "Chemistry,", "Manufacturing", "and", "Controls,", "or", "CMC,", "meeting", "with", "the", "FDA", "in", "February", "2016", "to", "discuss", "the", "quality", "data", "requirement", "for", "an", "NDA", "submission", "for", "TNX-102", "SL."], "wordsB": ["On", "September", "7,", "2017,", "we", "had", "a", "Breakthrough", "Therapy", "Chemistry,", "Manufacturing", "and", "Controls", "(", "CMC", ")", "guidance", "meeting", "with", "the", "FDA", "regarding", "the", "CMC", "data", "required", "to", "support", "the", "Tonmya", "NDA", "and", "commercial", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p70_s0", "idA": "1430306_17_item1_p47_s1", "sentA": "In general, our proposed NDA CMC plan for TNX-102 SL was acceptable to the FDA and can be applied to the PTSD NDA.", "sentB": "In principle, our proposed CMC data package to support Tonmya s NDA approval and commercial manufacturing plans was acceptable to the FDA.", "type": 2, "words": ["<tag1>", "In", "general,", "our", "proposed", "NDA", "CMC", "plan", "for", "TNX-102", "SL", "was", "acceptable", "to", "the", "FDA", "and", "can", "be", "applied", "to", "the", "PTSD", "NDA.", "<tag2>", "In", "principle,", "our", "proposed", "CMC", "data", "package", "to", "support", "Tonmya", "s", "NDA", "approval", "and", "commercial", "manufacturing", "plans", "was", "acceptable", "to", "the", "FDA.", "<tag3>"], "wordsA": ["In", "general,", "our", "proposed", "NDA", "CMC", "plan", "for", "TNX-102", "SL", "was", "acceptable", "to", "the", "FDA", "and", "can", "be", "applied", "to", "the", "PTSD", "NDA."], "wordsB": ["In", "principle,", "our", "proposed", "CMC", "data", "package", "to", "support", "Tonmya", "s", "NDA", "approval", "and", "commercial", "manufacturing", "plans", "was", "acceptable", "to", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p65_s1", "idA": "1430306_17_item1_p48_s1", "sentA": "The Breakthrough Therapy designation request was based on the preliminary clinical evidence of TNX 102-SL on military-related PTSD in the AtEase study.", "sentB": "The Breakthrough Therapy designation request was based on the preliminary clinical evidence of Tonmya 5.6 mg on military-related PTSD in the AtEase study.", "type": 2, "words": ["<tag1>", "The", "Breakthrough", "Therapy", "designation", "request", "was", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study.", "<tag2>", "The", "Breakthrough", "Therapy", "designation", "request", "was", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "Tonmya", "5.6", "mg", "on", "military-related", "PTSD", "in", "the", "AtEase", "study.", "<tag3>"], "wordsA": ["The", "Breakthrough", "Therapy", "designation", "request", "was", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "TNX", "102-SL", "on", "military-related", "PTSD", "in", "the", "AtEase", "study."], "wordsB": ["The", "Breakthrough", "Therapy", "designation", "request", "was", "based", "on", "the", "preliminary", "clinical", "evidence", "of", "Tonmya", "5.6", "mg", "on", "military-related", "PTSD", "in", "the", "AtEase", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p67_s0", "idA": "1430306_17_item1_p50_s0", "sentA": "In March 2017, we held the Initial Cross-Disciplinary Breakthrough Therapy Type B meeting with the FDA to discuss the opportunity to accelerate the development and submission of the TNX-102 SL NDA for the treatment of PTSD.", "sentB": "In March 2017, we held the Initial Cross-Disciplinary Breakthrough Therapy Type B meeting with the FDA to discuss the opportunity to accelerate the development and submission of the Tonmya NDA for the treatment of PTSD.", "type": 2, "words": ["<tag1>", "In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "TNX-102", "SL", "NDA", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "Tonmya", "NDA", "for", "the", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "TNX-102", "SL", "NDA", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "Tonmya", "NDA", "for", "the", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p78_s0", "idA": "1430306_17_item1_p50_s0", "sentA": "In March 2017, we held the Initial Cross-Disciplinary Breakthrough Therapy Type B meeting with the FDA to discuss the opportunity to accelerate the development and submission of the TNX-102 SL NDA for the treatment of PTSD.", "sentB": "On November 6, 2017, we held a pre-IND meeting with the FDA to discuss our proposed development of TNX-102 SL for the treatment of agitation in Alzheimer s disease.", "type": 2, "words": ["<tag1>", "In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "TNX-102", "SL", "NDA", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "On", "November", "6,", "2017,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "to", "discuss", "our", "proposed", "development", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "agitation", "in", "Alzheimer", "s", "disease.", "<tag3>"], "wordsA": ["In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "TNX-102", "SL", "NDA", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["On", "November", "6,", "2017,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "to", "discuss", "our", "proposed", "development", "of", "TNX-102", "SL", "for", "the", "treatment", "of", "agitation", "in", "Alzheimer", "s", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p88_s0", "idA": "1430306_17_item1_p50_s0", "sentA": "In March 2017, we held the Initial Cross-Disciplinary Breakthrough Therapy Type B meeting with the FDA to discuss the opportunity to accelerate the development and submission of the TNX-102 SL NDA for the treatment of PTSD.", "sentB": "We intend to meet with the FDA to discuss the most efficient and appropriate investigational plan, e.g., the application of the FDA Animal Efficacy Rule, or Animal Rule, or conducting active comparator studies using ACAM2000, the current licensed live vaccinia virus vaccine, to establish the safety and effectiveness evidence to support the licensure TNX-801.", "type": 2, "words": ["<tag1>", "In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "TNX-102", "SL", "NDA", "for", "the", "treatment", "of", "PTSD.", "<tag2>", "We", "intend", "to", "meet", "with", "the", "FDA", "to", "discuss", "the", "most", "efficient", "and", "appropriate", "investigational", "plan,", "e.g.,", "the", "application", "of", "the", "FDA", "Animal", "Efficacy", "Rule,", "or", "Animal", "Rule,", "or", "conducting", "active", "comparator", "studies", "using", "ACAM2000,", "the", "current", "licensed", "live", "vaccinia", "virus", "vaccine,", "to", "establish", "the", "safety", "and", "effectiveness", "evidence", "to", "support", "the", "licensure", "TNX-801.", "<tag3>"], "wordsA": ["In", "March", "2017,", "we", "held", "the", "Initial", "Cross-Disciplinary", "Breakthrough", "Therapy", "Type", "B", "meeting", "with", "the", "FDA", "to", "discuss", "the", "opportunity", "to", "accelerate", "the", "development", "and", "submission", "of", "the", "TNX-102", "SL", "NDA", "for", "the", "treatment", "of", "PTSD."], "wordsB": ["We", "intend", "to", "meet", "with", "the", "FDA", "to", "discuss", "the", "most", "efficient", "and", "appropriate", "investigational", "plan,", "e.g.,", "the", "application", "of", "the", "FDA", "Animal", "Efficacy", "Rule,", "or", "Animal", "Rule,", "or", "conducting", "active", "comparator", "studies", "using", "ACAM2000,", "the", "current", "licensed", "live", "vaccinia", "virus", "vaccine,", "to", "establish", "the", "safety", "and", "effectiveness", "evidence", "to", "support", "the", "licensure", "TNX-801."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p67_s1", "idA": "1430306_17_item1_p50_s1", "sentA": "Based on our discussions with the FDA and the FDA official meeting minutes, a single-study NDA approval could be possible based on topline data from the ongoing HONOR study.", "sentB": "Based on our discussions with the FDA and the FDA official meeting minutes, a single-study NDA approval could be possible based on statistically persuasive topline data from the ongoing HONOR study.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "a", "single-study", "NDA", "approval", "could", "be", "possible", "based", "on", "topline", "data", "from", "the", "ongoing", "HONOR", "study.", "<tag2>", "Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "a", "single-study", "NDA", "approval", "could", "be", "possible", "based", "on", "statistically", "persuasive", "topline", "data", "from", "the", "ongoing", "HONOR", "study.", "<tag3>"], "wordsA": ["Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "a", "single-study", "NDA", "approval", "could", "be", "possible", "based", "on", "topline", "data", "from", "the", "ongoing", "HONOR", "study."], "wordsB": ["Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "a", "single-study", "NDA", "approval", "could", "be", "possible", "based", "on", "statistically", "persuasive", "topline", "data", "from", "the", "ongoing", "HONOR", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p67_s2", "idA": "1430306_17_item1_p50_s2", "sentA": "Additionally, due to the lack of evidence of potential abuse in clinical studies of TNX-102 SL, the FDA agreed that studies in assessing abuse potential of TNX-102 SL are not required to support the TNX-102 SL NDA.", "sentB": "Additionally, due to the lack of evidence of potential abuse in clinical studies of Tonmya, the FDA agreed that studies in assessing abuse and dependency potential of Tonmya are not required to support the Tonmya NDA filing.", "type": 2, "words": ["<tag1>", "Additionally,", "due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "TNX-102", "SL,", "the", "FDA", "agreed", "that", "studies", "in", "assessing", "abuse", "potential", "of", "TNX-102", "SL", "are", "not", "required", "to", "support", "the", "TNX-102", "SL", "NDA.", "<tag2>", "Additionally,", "due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "Tonmya,", "the", "FDA", "agreed", "that", "studies", "in", "assessing", "abuse", "and", "dependency", "potential", "of", "Tonmya", "are", "not", "required", "to", "support", "the", "Tonmya", "NDA", "filing.", "<tag3>"], "wordsA": ["Additionally,", "due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "TNX-102", "SL,", "the", "FDA", "agreed", "that", "studies", "in", "assessing", "abuse", "potential", "of", "TNX-102", "SL", "are", "not", "required", "to", "support", "the", "TNX-102", "SL", "NDA."], "wordsB": ["Additionally,", "due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "Tonmya,", "the", "FDA", "agreed", "that", "studies", "in", "assessing", "abuse", "and", "dependency", "potential", "of", "Tonmya", "are", "not", "required", "to", "support", "the", "Tonmya", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p76_s3", "idA": "1430306_17_item1_p50_s2", "sentA": "Additionally, due to the lack of evidence of potential abuse in clinical studies of TNX-102 SL, the FDA agreed that studies in assessing abuse potential of TNX-102 SL are not required to support the TNX-102 SL NDA.", "sentB": "Due to the lack of evidence of potential abuse in clinical studies of Tonmya, the FDA agreed that nonclinical study to assess CBP abuse and dependency potential is not required to support the Tonmya NDA filing.", "type": 2, "words": ["<tag1>", "Additionally,", "due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "TNX-102", "SL,", "the", "FDA", "agreed", "that", "studies", "in", "assessing", "abuse", "potential", "of", "TNX-102", "SL", "are", "not", "required", "to", "support", "the", "TNX-102", "SL", "NDA.", "<tag2>", "Due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "Tonmya,", "the", "FDA", "agreed", "that", "nonclinical", "study", "to", "assess", "CBP", "abuse", "and", "dependency", "potential", "is", "not", "required", "to", "support", "the", "Tonmya", "NDA", "filing.", "<tag3>"], "wordsA": ["Additionally,", "due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "TNX-102", "SL,", "the", "FDA", "agreed", "that", "studies", "in", "assessing", "abuse", "potential", "of", "TNX-102", "SL", "are", "not", "required", "to", "support", "the", "TNX-102", "SL", "NDA."], "wordsB": ["Due", "to", "the", "lack", "of", "evidence", "of", "potential", "abuse", "in", "clinical", "studies", "of", "Tonmya,", "the", "FDA", "agreed", "that", "nonclinical", "study", "to", "assess", "CBP", "abuse", "and", "dependency", "potential", "is", "not", "required", "to", "support", "the", "Tonmya", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p71_s1", "idA": "1430306_17_item1_p51_s1", "sentA": "We submitted an Agreed iPSP in the first quarter of 2017, which incorporated the FDA comments received on our Initial Pediatric Study Plan submitted in the third quarter of 2016.", "sentB": "We submitted a revised iPSP in the first quarter of 2017, which incorporated the FDA comments received on our iPSP submitted in the third quarter of 2016.", "type": 2, "words": ["<tag1>", "We", "submitted", "an", "Agreed", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "Initial", "Pediatric", "Study", "Plan", "submitted", "in", "the", "third", "quarter", "of", "2016.", "<tag2>", "We", "submitted", "a", "revised", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "iPSP", "submitted", "in", "the", "third", "quarter", "of", "2016.", "<tag3>"], "wordsA": ["We", "submitted", "an", "Agreed", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "Initial", "Pediatric", "Study", "Plan", "submitted", "in", "the", "third", "quarter", "of", "2016."], "wordsB": ["We", "submitted", "a", "revised", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "iPSP", "submitted", "in", "the", "third", "quarter", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p71_s2", "idA": "1430306_17_item1_p51_s1", "sentA": "We submitted an Agreed iPSP in the first quarter of 2017, which incorporated the FDA comments received on our Initial Pediatric Study Plan submitted in the third quarter of 2016.", "sentB": "Additional comments from the FDA were received in second quarter of 2017 on our revised iPSP.", "type": 2, "words": ["<tag1>", "We", "submitted", "an", "Agreed", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "Initial", "Pediatric", "Study", "Plan", "submitted", "in", "the", "third", "quarter", "of", "2016.", "<tag2>", "Additional", "comments", "from", "the", "FDA", "were", "received", "in", "second", "quarter", "of", "2017", "on", "our", "revised", "iPSP.", "<tag3>"], "wordsA": ["We", "submitted", "an", "Agreed", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "Initial", "Pediatric", "Study", "Plan", "submitted", "in", "the", "third", "quarter", "of", "2016."], "wordsB": ["Additional", "comments", "from", "the", "FDA", "were", "received", "in", "second", "quarter", "of", "2017", "on", "our", "revised", "iPSP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p71_s3", "idA": "1430306_17_item1_p51_s1", "sentA": "We submitted an Agreed iPSP in the first quarter of 2017, which incorporated the FDA comments received on our Initial Pediatric Study Plan submitted in the third quarter of 2016.", "sentB": "We plan to submit an Agreed iPSP in the third quarter of 2018.", "type": 2, "words": ["<tag1>", "We", "submitted", "an", "Agreed", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "Initial", "Pediatric", "Study", "Plan", "submitted", "in", "the", "third", "quarter", "of", "2016.", "<tag2>", "We", "plan", "to", "submit", "an", "Agreed", "iPSP", "in", "the", "third", "quarter", "of", "2018.", "<tag3>"], "wordsA": ["We", "submitted", "an", "Agreed", "iPSP", "in", "the", "first", "quarter", "of", "2017,", "which", "incorporated", "the", "FDA", "comments", "received", "on", "our", "Initial", "Pediatric", "Study", "Plan", "submitted", "in", "the", "third", "quarter", "of", "2016."], "wordsB": ["We", "plan", "to", "submit", "an", "Agreed", "iPSP", "in", "the", "third", "quarter", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p72_s0", "idA": "1430306_17_item1_p52_s0", "sentA": "Based on our discussions with the FDA and the FDA official meeting minutes, we will not have to conduct special populations (geriatric and renal/hepatic impaired), drug-drug interaction or cardiovascular safety studies to support the NDA filing.", "sentB": "Based on our discussions with the FDA and the FDA official meeting minutes, we will not have to conduct special populations (geriatric and renal/hepatic impaired), drug-drug interaction or cardiovascular safety studies to support the Tonmya NDA filing.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "cardiovascular", "safety", "studies", "to", "support", "the", "NDA", "filing.", "<tag2>", "Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "cardiovascular", "safety", "studies", "to", "support", "the", "Tonmya", "NDA", "filing.", "<tag3>"], "wordsA": ["Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "cardiovascular", "safety", "studies", "to", "support", "the", "NDA", "filing."], "wordsB": ["Based", "on", "our", "discussions", "with", "the", "FDA", "and", "the", "FDA", "official", "meeting", "minutes,", "we", "will", "not", "have", "to", "conduct", "special", "populations", "(geriatric", "and", "renal/hepatic", "impaired),", "drug-drug", "interaction", "or", "cardiovascular", "safety", "studies", "to", "support", "the", "Tonmya", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p72_s1", "idA": "1430306_17_item1_p52_s1", "sentA": "Due to the well-established safety profile of CBP at much higher doses than we proposed for PTSD and the long-term safety data (up to 15 months) on TNX-102 SL 2.8 mg in a prior fibromyalgia program, the FDA has not requested a risk management plan or medication guide for this product.", "sentB": "Due to the well-established safety profile of CBP at much higher doses than we proposed for PTSD and the long-term safety data (up to 15 months) on Tonmya 2.8 mg in a prior fibromyalgia program, the FDA has not requested a risk management plan or medication guide for this product.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "PTSD", "and", "the", "long-term", "safety", "data", "(up", "to", "15", "months)", "on", "TNX-102", "SL", "2.8", "mg", "in", "a", "prior", "fibromyalgia", "program,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product.", "<tag2>", "Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "PTSD", "and", "the", "long-term", "safety", "data", "(up", "to", "15", "months)", "on", "Tonmya", "2.8", "mg", "in", "a", "prior", "fibromyalgia", "program,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product.", "<tag3>"], "wordsA": ["Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "PTSD", "and", "the", "long-term", "safety", "data", "(up", "to", "15", "months)", "on", "TNX-102", "SL", "2.8", "mg", "in", "a", "prior", "fibromyalgia", "program,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product."], "wordsB": ["Due", "to", "the", "well-established", "safety", "profile", "of", "CBP", "at", "much", "higher", "doses", "than", "we", "proposed", "for", "PTSD", "and", "the", "long-term", "safety", "data", "(up", "to", "15", "months)", "on", "Tonmya", "2.8", "mg", "in", "a", "prior", "fibromyalgia", "program,", "the", "FDA", "has", "not", "requested", "a", "risk", "management", "plan", "or", "medication", "guide", "for", "this", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p73_s0", "idA": "1430306_17_item1_p53_s0", "sentA": "We completed a Phase 1 bioequivalence study that compared the pharmacokinetic profiles of single-dose of TNX-102 SL 2.8 mg tablets manufactured at two facilities: (i) the facility used to produce TNX-102 SL 2.8 mg tablets for the Phase 2 AtEase study; and (ii) the facility used to produce TNX-102 SL 2.8.mg tablets for our clinical studies required to support the PTSD NDA submission and the to-be-marketed product.", "sentB": "We completed a Phase 1 bioequivalence study that compared the pharmacokinetic profiles of a single-dose of Tonmya 2.8 mg tablets manufactured at two facilities: (i) the facility used to produce Tonmya 2.8 mg tablets for the Phase 2 AtEase study; and (ii) the facility used to produce Tonmya 2.8.mg tablets for our clinical studies required to support the PTSD NDA submission and the to-be-marketed product.", "type": 2, "words": ["<tag1>", "We", "completed", "a", "Phase", "1", "bioequivalence", "study", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "single-dose", "of", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "(i)", "the", "facility", "used", "to", "produce", "TNX-102", "SL", "2.8", "mg", "tablets", "for", "the", "Phase", "2", "AtEase", "study;", "and", "(ii)", "the", "facility", "used", "to", "produce", "TNX-102", "SL", "2.8.mg", "tablets", "for", "our", "clinical", "studies", "required", "to", "support", "the", "PTSD", "NDA", "submission", "and", "the", "to-be-marketed", "product.", "<tag2>", "We", "completed", "a", "Phase", "1", "bioequivalence", "study", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "a", "single-dose", "of", "Tonmya", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "(i)", "the", "facility", "used", "to", "produce", "Tonmya", "2.8", "mg", "tablets", "for", "the", "Phase", "2", "AtEase", "study;", "and", "(ii)", "the", "facility", "used", "to", "produce", "Tonmya", "2.8.mg", "tablets", "for", "our", "clinical", "studies", "required", "to", "support", "the", "PTSD", "NDA", "submission", "and", "the", "to-be-marketed", "product.", "<tag3>"], "wordsA": ["We", "completed", "a", "Phase", "1", "bioequivalence", "study", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "single-dose", "of", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "(i)", "the", "facility", "used", "to", "produce", "TNX-102", "SL", "2.8", "mg", "tablets", "for", "the", "Phase", "2", "AtEase", "study;", "and", "(ii)", "the", "facility", "used", "to", "produce", "TNX-102", "SL", "2.8.mg", "tablets", "for", "our", "clinical", "studies", "required", "to", "support", "the", "PTSD", "NDA", "submission", "and", "the", "to-be-marketed", "product."], "wordsB": ["We", "completed", "a", "Phase", "1", "bioequivalence", "study", "that", "compared", "the", "pharmacokinetic", "profiles", "of", "a", "single-dose", "of", "Tonmya", "2.8", "mg", "tablets", "manufactured", "at", "two", "facilities:", "(i)", "the", "facility", "used", "to", "produce", "Tonmya", "2.8", "mg", "tablets", "for", "the", "Phase", "2", "AtEase", "study;", "and", "(ii)", "the", "facility", "used", "to", "produce", "Tonmya", "2.8.mg", "tablets", "for", "our", "clinical", "studies", "required", "to", "support", "the", "PTSD", "NDA", "submission", "and", "the", "to-be-marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p55_s0", "idA": "1430306_17_item1_p53_s1", "sentA": "This bioequivalence study demonstrated that the TNX-102 SL 2.8 mg tablets manufactured at these two facilities were bioequivalent, supporting the use of the AtEase study to support the Phase 3 studies.", "sentB": "Retrospective analysis of the AtEase study suggested that the subset of participants with CAPS-5 score of 33 or higher at baseline (80% of AtEase population) was equivalent to the population of PTSD subjects studied in prior FDA registration studies of paroxetine and sertraline using older versions of the CAPS.", "type": 2, "words": ["<tag1>", "This", "bioequivalence", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "these", "two", "facilities", "were", "bioequivalent,", "supporting", "the", "use", "of", "the", "AtEase", "study", "to", "support", "the", "Phase", "3", "studies.", "<tag2>", "Retrospective", "analysis", "of", "the", "AtEase", "study", "suggested", "that", "the", "subset", "of", "participants", "with", "CAPS-5", "score", "of", "33", "or", "higher", "at", "baseline", "(80%", "of", "AtEase", "population)", "was", "equivalent", "to", "the", "population", "of", "PTSD", "subjects", "studied", "in", "prior", "FDA", "registration", "studies", "of", "paroxetine", "and", "sertraline", "using", "older", "versions", "of", "the", "CAPS.", "<tag3>"], "wordsA": ["This", "bioequivalence", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "these", "two", "facilities", "were", "bioequivalent,", "supporting", "the", "use", "of", "the", "AtEase", "study", "to", "support", "the", "Phase", "3", "studies."], "wordsB": ["Retrospective", "analysis", "of", "the", "AtEase", "study", "suggested", "that", "the", "subset", "of", "participants", "with", "CAPS-5", "score", "of", "33", "or", "higher", "at", "baseline", "(80%", "of", "AtEase", "population)", "was", "equivalent", "to", "the", "population", "of", "PTSD", "subjects", "studied", "in", "prior", "FDA", "registration", "studies", "of", "paroxetine", "and", "sertraline", "using", "older", "versions", "of", "the", "CAPS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p73_s1", "idA": "1430306_17_item1_p53_s1", "sentA": "This bioequivalence study demonstrated that the TNX-102 SL 2.8 mg tablets manufactured at these two facilities were bioequivalent, supporting the use of the AtEase study to support the Phase 3 studies.", "sentB": "This bioequivalence study demonstrated that the Tonmya 2.8 mg tablets manufactured at these two facilities were bioequivalent, supporting the use of the AtEase study to support the Phase 3 studies.", "type": 2, "words": ["<tag1>", "This", "bioequivalence", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "these", "two", "facilities", "were", "bioequivalent,", "supporting", "the", "use", "of", "the", "AtEase", "study", "to", "support", "the", "Phase", "3", "studies.", "<tag2>", "This", "bioequivalence", "study", "demonstrated", "that", "the", "Tonmya", "2.8", "mg", "tablets", "manufactured", "at", "these", "two", "facilities", "were", "bioequivalent,", "supporting", "the", "use", "of", "the", "AtEase", "study", "to", "support", "the", "Phase", "3", "studies.", "<tag3>"], "wordsA": ["This", "bioequivalence", "study", "demonstrated", "that", "the", "TNX-102", "SL", "2.8", "mg", "tablets", "manufactured", "at", "these", "two", "facilities", "were", "bioequivalent,", "supporting", "the", "use", "of", "the", "AtEase", "study", "to", "support", "the", "Phase", "3", "studies."], "wordsB": ["This", "bioequivalence", "study", "demonstrated", "that", "the", "Tonmya", "2.8", "mg", "tablets", "manufactured", "at", "these", "two", "facilities", "were", "bioequivalent,", "supporting", "the", "use", "of", "the", "AtEase", "study", "to", "support", "the", "Phase", "3", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p74_s0", "idA": "1430306_17_item1_p54_s0", "sentA": "We intend to seek FDA marketing approval for TNX-102 SL pursuant to Section 505(b)(2) of the FDCA using AMRIX extended-release capsules (30 mg) as our reference listed drug, or RLD.", "sentB": "We intend to seek FDA marketing approval for Tonmya or TNX-102 SL pursuant to Section 505(b)(2) of the FDCA using AMRIX extended-release or ER capsules (30 mg) as our reference listed drug, or RLD.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "seek", "FDA", "marketing", "approval", "for", "TNX-102", "SL", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "FDCA", "using", "AMRIX", "extended-release", "capsules", "(30", "mg)", "as", "our", "reference", "listed", "drug,", "or", "RLD.", "<tag2>", "We", "intend", "to", "seek", "FDA", "marketing", "approval", "for", "Tonmya", "or", "TNX-102", "SL", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "FDCA", "using", "AMRIX", "extended-release", "or", "ER", "capsules", "(30", "mg)", "as", "our", "reference", "listed", "drug,", "or", "RLD.", "<tag3>"], "wordsA": ["We", "intend", "to", "seek", "FDA", "marketing", "approval", "for", "TNX-102", "SL", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "FDCA", "using", "AMRIX", "extended-release", "capsules", "(30", "mg)", "as", "our", "reference", "listed", "drug,", "or", "RLD."], "wordsB": ["We", "intend", "to", "seek", "FDA", "marketing", "approval", "for", "Tonmya", "or", "TNX-102", "SL", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "FDCA", "using", "AMRIX", "extended-release", "or", "ER", "capsules", "(30", "mg)", "as", "our", "reference", "listed", "drug,", "or", "RLD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p74_s1", "idA": "1430306_17_item1_p54_s1", "sentA": "As agreed upon by the FDA, we plan to study TNX-102 SL 5.6 mg (two 2.8 mg tablets) in comparison to AMRIX 30 mg extended-release capsules in a multiple-dose bridging PK study to provide a systemic exposure bridge.", "sentB": "As agreed upon by the FDA, we have started to study Tonmya 5.6 mg (2 x 2.8 mg tablets) in comparison to AMRIX 30 mg ER capsules in a randomized, open-label, parallel, multiple-dose bridging PK study to provide a systemic exposure bridge.", "type": 2, "words": ["<tag1>", "As", "agreed", "upon", "by", "the", "FDA,", "we", "plan", "to", "study", "TNX-102", "SL", "5.6", "mg", "(two", "2.8", "mg", "tablets)", "in", "comparison", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "in", "a", "multiple-dose", "bridging", "PK", "study", "to", "provide", "a", "systemic", "exposure", "bridge.", "<tag2>", "As", "agreed", "upon", "by", "the", "FDA,", "we", "have", "started", "to", "study", "Tonmya", "5.6", "mg", "(2", "x", "2.8", "mg", "tablets)", "in", "comparison", "to", "AMRIX", "30", "mg", "ER", "capsules", "in", "a", "randomized,", "open-label,", "parallel,", "multiple-dose", "bridging", "PK", "study", "to", "provide", "a", "systemic", "exposure", "bridge.", "<tag3>"], "wordsA": ["As", "agreed", "upon", "by", "the", "FDA,", "we", "plan", "to", "study", "TNX-102", "SL", "5.6", "mg", "(two", "2.8", "mg", "tablets)", "in", "comparison", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "in", "a", "multiple-dose", "bridging", "PK", "study", "to", "provide", "a", "systemic", "exposure", "bridge."], "wordsB": ["As", "agreed", "upon", "by", "the", "FDA,", "we", "have", "started", "to", "study", "Tonmya", "5.6", "mg", "(2", "x", "2.8", "mg", "tablets)", "in", "comparison", "to", "AMRIX", "30", "mg", "ER", "capsules", "in", "a", "randomized,", "open-label,", "parallel,", "multiple-dose", "bridging", "PK", "study", "to", "provide", "a", "systemic", "exposure", "bridge."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p74_s2", "idA": "1430306_17_item1_p54_s2", "sentA": "If the exposures of TNX-102 SL (2 x 2.8 mg tablets) are less than the RLD maximum approved dose (30 mg) for the initial dose and at steady state, the results of this study will provide the necessary systemic exposure bridge of TNX-102 SL 5.6.mg to AMRIX 30 mg extended-release capsules and the approval of TNX-102 SL for PTSD can rely on the safety findings (clinical and nonclinical) of the currently approved cyclobenzaprine drug products.", "sentB": "If the Tonmya initial dose and at steady state exposures are less than or comparable to the RLD maximum approved dose (30 mg) and the metabolic profile is similar to AMRIX, the results of this study will provide the necessary systemic exposure bridge of Tonmya to AMRIX.", "type": 2, "words": ["<tag1>", "If", "the", "exposures", "of", "TNX-102", "SL", "(2", "x", "2.8", "mg", "tablets)", "are", "less", "than", "the", "RLD", "maximum", "approved", "dose", "(30", "mg)", "for", "the", "initial", "dose", "and", "at", "steady", "state,", "the", "results", "of", "this", "study", "will", "provide", "the", "necessary", "systemic", "exposure", "bridge", "of", "TNX-102", "SL", "5.6.mg", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "and", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD", "can", "rely", "on", "the", "safety", "findings", "(clinical", "and", "nonclinical)", "of", "the", "currently", "approved", "cyclobenzaprine", "drug", "products.", "<tag2>", "If", "the", "Tonmya", "initial", "dose", "and", "at", "steady", "state", "exposures", "are", "less", "than", "or", "comparable", "to", "the", "RLD", "maximum", "approved", "dose", "(30", "mg)", "and", "the", "metabolic", "profile", "is", "similar", "to", "AMRIX,", "the", "results", "of", "this", "study", "will", "provide", "the", "necessary", "systemic", "exposure", "bridge", "of", "Tonmya", "to", "AMRIX.", "<tag3>"], "wordsA": ["If", "the", "exposures", "of", "TNX-102", "SL", "(2", "x", "2.8", "mg", "tablets)", "are", "less", "than", "the", "RLD", "maximum", "approved", "dose", "(30", "mg)", "for", "the", "initial", "dose", "and", "at", "steady", "state,", "the", "results", "of", "this", "study", "will", "provide", "the", "necessary", "systemic", "exposure", "bridge", "of", "TNX-102", "SL", "5.6.mg", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "and", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD", "can", "rely", "on", "the", "safety", "findings", "(clinical", "and", "nonclinical)", "of", "the", "currently", "approved", "cyclobenzaprine", "drug", "products."], "wordsB": ["If", "the", "Tonmya", "initial", "dose", "and", "at", "steady", "state", "exposures", "are", "less", "than", "or", "comparable", "to", "the", "RLD", "maximum", "approved", "dose", "(30", "mg)", "and", "the", "metabolic", "profile", "is", "similar", "to", "AMRIX,", "the", "results", "of", "this", "study", "will", "provide", "the", "necessary", "systemic", "exposure", "bridge", "of", "Tonmya", "to", "AMRIX."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p74_s3", "idA": "1430306_17_item1_p54_s2", "sentA": "If the exposures of TNX-102 SL (2 x 2.8 mg tablets) are less than the RLD maximum approved dose (30 mg) for the initial dose and at steady state, the results of this study will provide the necessary systemic exposure bridge of TNX-102 SL 5.6.mg to AMRIX 30 mg extended-release capsules and the approval of TNX-102 SL for PTSD can rely on the safety findings (clinical and nonclinical) of the currently approved cyclobenzaprine drug products.", "sentB": "The approval of Tonmya for PTSD NDA can thus rely on the safety findings (clinical and nonclinical) of the currently approved CBP drug products.", "type": 2, "words": ["<tag1>", "If", "the", "exposures", "of", "TNX-102", "SL", "(2", "x", "2.8", "mg", "tablets)", "are", "less", "than", "the", "RLD", "maximum", "approved", "dose", "(30", "mg)", "for", "the", "initial", "dose", "and", "at", "steady", "state,", "the", "results", "of", "this", "study", "will", "provide", "the", "necessary", "systemic", "exposure", "bridge", "of", "TNX-102", "SL", "5.6.mg", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "and", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD", "can", "rely", "on", "the", "safety", "findings", "(clinical", "and", "nonclinical)", "of", "the", "currently", "approved", "cyclobenzaprine", "drug", "products.", "<tag2>", "The", "approval", "of", "Tonmya", "for", "PTSD", "NDA", "can", "thus", "rely", "on", "the", "safety", "findings", "(clinical", "and", "nonclinical)", "of", "the", "currently", "approved", "CBP", "drug", "products.", "<tag3>"], "wordsA": ["If", "the", "exposures", "of", "TNX-102", "SL", "(2", "x", "2.8", "mg", "tablets)", "are", "less", "than", "the", "RLD", "maximum", "approved", "dose", "(30", "mg)", "for", "the", "initial", "dose", "and", "at", "steady", "state,", "the", "results", "of", "this", "study", "will", "provide", "the", "necessary", "systemic", "exposure", "bridge", "of", "TNX-102", "SL", "5.6.mg", "to", "AMRIX", "30", "mg", "extended-release", "capsules", "and", "the", "approval", "of", "TNX-102", "SL", "for", "PTSD", "can", "rely", "on", "the", "safety", "findings", "(clinical", "and", "nonclinical)", "of", "the", "currently", "approved", "cyclobenzaprine", "drug", "products."], "wordsB": ["The", "approval", "of", "Tonmya", "for", "PTSD", "NDA", "can", "thus", "rely", "on", "the", "safety", "findings", "(clinical", "and", "nonclinical)", "of", "the", "currently", "approved", "CBP", "drug", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p75_s0", "idA": "1430306_17_item1_p55_s0", "sentA": "To support the TNX-102 SL product registration, a randomized, open-label, 2-way crossover, food-effect, comparative bioavailability study of TNX-102 SL following a single dose in healthy subjects under fasting and fed conditions and a randomized, open-label, 2-way crossover, dose-proportionality, comparative bioavailability study of TNX-102 SL following a single dose in healthy subjects under fasting conditions will be completed for the TNX-102 SL NDA submission.", "sentB": "To support the Tonmya product registration, a randomized, open-label, 2-way crossover, food-effect, comparative bioavailability study of Tonmya following a single dose in healthy subjects under fasting and fed conditions and a randomized, open-label, 2-way crossover, dose-proportionality, comparative bioavailability study of a single dose Tonmya 2.8 mg vs 5.6 mg in healthy subjects under fasting conditions will be completed for the Tonmya NDA submission.", "type": 2, "words": ["<tag1>", "To", "support", "the", "TNX-102", "SL", "product", "registration,", "a", "randomized,", "open-label,", "2-way", "crossover,", "food-effect,", "comparative", "bioavailability", "study", "of", "TNX-102", "SL", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "and", "fed", "conditions", "and", "a", "randomized,", "open-label,", "2-way", "crossover,", "dose-proportionality,", "comparative", "bioavailability", "study", "of", "TNX-102", "SL", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "conditions", "will", "be", "completed", "for", "the", "TNX-102", "SL", "NDA", "submission.", "<tag2>", "To", "support", "the", "Tonmya", "product", "registration,", "a", "randomized,", "open-label,", "2-way", "crossover,", "food-effect,", "comparative", "bioavailability", "study", "of", "Tonmya", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "and", "fed", "conditions", "and", "a", "randomized,", "open-label,", "2-way", "crossover,", "dose-proportionality,", "comparative", "bioavailability", "study", "of", "a", "single", "dose", "Tonmya", "2.8", "mg", "vs", "5.6", "mg", "in", "healthy", "subjects", "under", "fasting", "conditions", "will", "be", "completed", "for", "the", "Tonmya", "NDA", "submission.", "<tag3>"], "wordsA": ["To", "support", "the", "TNX-102", "SL", "product", "registration,", "a", "randomized,", "open-label,", "2-way", "crossover,", "food-effect,", "comparative", "bioavailability", "study", "of", "TNX-102", "SL", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "and", "fed", "conditions", "and", "a", "randomized,", "open-label,", "2-way", "crossover,", "dose-proportionality,", "comparative", "bioavailability", "study", "of", "TNX-102", "SL", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "conditions", "will", "be", "completed", "for", "the", "TNX-102", "SL", "NDA", "submission."], "wordsB": ["To", "support", "the", "Tonmya", "product", "registration,", "a", "randomized,", "open-label,", "2-way", "crossover,", "food-effect,", "comparative", "bioavailability", "study", "of", "Tonmya", "following", "a", "single", "dose", "in", "healthy", "subjects", "under", "fasting", "and", "fed", "conditions", "and", "a", "randomized,", "open-label,", "2-way", "crossover,", "dose-proportionality,", "comparative", "bioavailability", "study", "of", "a", "single", "dose", "Tonmya", "2.8", "mg", "vs", "5.6", "mg", "in", "healthy", "subjects", "under", "fasting", "conditions", "will", "be", "completed", "for", "the", "Tonmya", "NDA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p77_s3", "idA": "1430306_17_item1_p56_s0", "sentA": "The FDA has accepted our proposed nonclinical data package to support our PTSD NDA filing.", "sentB": "FDA has accepted our proposed CMC data package to support Tonmya s NDA approval and commercial manufacturing plans, reflecting our readiness to manufacture Tonmya commercial product at production scale.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "accepted", "our", "proposed", "nonclinical", "data", "package", "to", "support", "our", "PTSD", "NDA", "filing.", "<tag2>", "FDA", "has", "accepted", "our", "proposed", "CMC", "data", "package", "to", "support", "Tonmya", "s", "NDA", "approval", "and", "commercial", "manufacturing", "plans,", "reflecting", "our", "readiness", "to", "manufacture", "Tonmya", "commercial", "product", "at", "production", "scale.", "<tag3>"], "wordsA": ["The", "FDA", "has", "accepted", "our", "proposed", "nonclinical", "data", "package", "to", "support", "our", "PTSD", "NDA", "filing."], "wordsB": ["FDA", "has", "accepted", "our", "proposed", "CMC", "data", "package", "to", "support", "Tonmya", "s", "NDA", "approval", "and", "commercial", "manufacturing", "plans,", "reflecting", "our", "readiness", "to", "manufacture", "Tonmya", "commercial", "product", "at", "production", "scale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p76_s1", "idA": "1430306_17_item1_p56_s1", "sentA": "In October 2016, we completed the six-month repeated-dose toxicology study of TNX-102 in rats and a nine-month repeated-dose toxicology study in dogs required for the NDA filing and to support Phase 3 clinical studies outside the U.S., if necessary.", "sentB": "In October 2016, we completed the six-month repeated-dose toxicology study of the active ingredient, CBP, in rats and a nine-month repeated-dose toxicology study in dogs required for the NDA filing and to support Phase 3 clinical studies outside the U.S., if necessary.", "type": 2, "words": ["<tag1>", "In", "October", "2016,", "we", "completed", "the", "six-month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S.,", "if", "necessary.", "<tag2>", "In", "October", "2016,", "we", "completed", "the", "six-month", "repeated-dose", "toxicology", "study", "of", "the", "active", "ingredient,", "CBP,", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S.,", "if", "necessary.", "<tag3>"], "wordsA": ["In", "October", "2016,", "we", "completed", "the", "six-month", "repeated-dose", "toxicology", "study", "of", "TNX-102", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S.,", "if", "necessary."], "wordsB": ["In", "October", "2016,", "we", "completed", "the", "six-month", "repeated-dose", "toxicology", "study", "of", "the", "active", "ingredient,", "CBP,", "in", "rats", "and", "a", "nine-month", "repeated-dose", "toxicology", "study", "in", "dogs", "required", "for", "the", "NDA", "filing", "and", "to", "support", "Phase", "3", "clinical", "studies", "outside", "the", "U.S.,", "if", "necessary."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p76_s2", "idA": "1430306_17_item1_p56_s2", "sentA": "These chronic toxicity studies were requested by the FDA to augment the nonclinical information in the AMRIX approved prescribing information, or labeling, which is necessary to support the TNX-102 SL labeling for long-term use.", "sentB": "These chronic toxicity studies were requested by the FDA to augment the nonclinical information in the AMRIX approved prescribing information, or labeling, which is necessary to support the Tonmya or TNX-102 SL labeling for long-term use.", "type": 2, "words": ["<tag1>", "These", "chronic", "toxicity", "studies", "were", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "AMRIX", "approved", "prescribing", "information,", "or", "labeling,", "which", "is", "necessary", "to", "support", "the", "TNX-102", "SL", "labeling", "for", "long-term", "use.", "<tag2>", "These", "chronic", "toxicity", "studies", "were", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "AMRIX", "approved", "prescribing", "information,", "or", "labeling,", "which", "is", "necessary", "to", "support", "the", "Tonmya", "or", "TNX-102", "SL", "labeling", "for", "long-term", "use.", "<tag3>"], "wordsA": ["These", "chronic", "toxicity", "studies", "were", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "AMRIX", "approved", "prescribing", "information,", "or", "labeling,", "which", "is", "necessary", "to", "support", "the", "TNX-102", "SL", "labeling", "for", "long-term", "use."], "wordsB": ["These", "chronic", "toxicity", "studies", "were", "requested", "by", "the", "FDA", "to", "augment", "the", "nonclinical", "information", "in", "the", "AMRIX", "approved", "prescribing", "information,", "or", "labeling,", "which", "is", "necessary", "to", "support", "the", "Tonmya", "or", "TNX-102", "SL", "labeling", "for", "long-term", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p77_s0", "idA": "1430306_17_item1_p57_s0", "sentA": "The TNX-102 SL drug product was manufactured in a small-scale current Good Manufacturing Practice, or cGMP, facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "sentB": "TNX-102 SL drug product for Phase 2 was manufactured in a small-scale cGMP facility that is licensed to manufacture clinical trial materials, but not equipped for large-scale commercial production.", "type": 2, "words": ["<tag1>", "The", "TNX-102", "SL", "drug", "product", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag2>", "TNX-102", "SL", "drug", "product", "for", "Phase", "2", "was", "manufactured", "in", "a", "small-scale", "cGMP", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production.", "<tag3>"], "wordsA": ["The", "TNX-102", "SL", "drug", "product", "was", "manufactured", "in", "a", "small-scale", "current", "Good", "Manufacturing", "Practice,", "or", "cGMP,", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "wordsB": ["TNX-102", "SL", "drug", "product", "for", "Phase", "2", "was", "manufactured", "in", "a", "small-scale", "cGMP", "facility", "that", "is", "licensed", "to", "manufacture", "clinical", "trial", "materials,", "but", "not", "equipped", "for", "large-scale", "commercial", "production."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p77_s1", "idA": "1430306_17_item1_p57_s1", "sentA": "For the HONOR study, the predominantly civilian PTSD Phase 3 study and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "sentB": "For the clinical trial materials for Phase 3 clinical and NDA required Phase 1 studies, and for the commercial product, we have engaged a commercial cGMP facility that is capable of manufacturing the registration batches to support the NDA.", "type": 2, "words": ["<tag1>", "For", "the", "HONOR", "study,", "the", "predominantly", "civilian", "PTSD", "Phase", "3", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag2>", "For", "the", "clinical", "trial", "materials", "for", "Phase", "3", "clinical", "and", "NDA", "required", "Phase", "1", "studies,", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA.", "<tag3>"], "wordsA": ["For", "the", "HONOR", "study,", "the", "predominantly", "civilian", "PTSD", "Phase", "3", "study", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "wordsB": ["For", "the", "clinical", "trial", "materials", "for", "Phase", "3", "clinical", "and", "NDA", "required", "Phase", "1", "studies,", "and", "for", "the", "commercial", "product,", "we", "have", "engaged", "a", "commercial", "cGMP", "facility", "that", "is", "capable", "of", "manufacturing", "the", "registration", "batches", "to", "support", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p79_s0", "idA": "1430306_17_item1_p58_s0", "sentA": "We also have a pipeline of other drug and biologic candidates, including two pre-IND candidates, TNX-601 for PTSD and TNX-801, a biologic vaccine product for the prevention of smallpox, as well as an IND candidate, TNX-301, a potential treatment for AUD.", "sentB": "We also have a pipeline of other drug and biologic candidates, including two pre-IND candidates, TNX-601, a daytime treatment for PTSD and TNX-801, a biologic vaccine product for the prevention of smallpox, as well as an IND candidate, TNX-301, a potential treatment for AUD.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "pipeline", "of", "other", "drug", "and", "biologic", "candidates,", "including", "two", "pre-IND", "candidates,", "TNX-601", "for", "PTSD", "and", "TNX-801,", "a", "biologic", "vaccine", "product", "for", "the", "prevention", "of", "smallpox,", "as", "well", "as", "an", "IND", "candidate,", "TNX-301,", "a", "potential", "treatment", "for", "AUD.", "<tag2>", "We", "also", "have", "a", "pipeline", "of", "other", "drug", "and", "biologic", "candidates,", "including", "two", "pre-IND", "candidates,", "TNX-601,", "a", "daytime", "treatment", "for", "PTSD", "and", "TNX-801,", "a", "biologic", "vaccine", "product", "for", "the", "prevention", "of", "smallpox,", "as", "well", "as", "an", "IND", "candidate,", "TNX-301,", "a", "potential", "treatment", "for", "AUD.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "pipeline", "of", "other", "drug", "and", "biologic", "candidates,", "including", "two", "pre-IND", "candidates,", "TNX-601", "for", "PTSD", "and", "TNX-801,", "a", "biologic", "vaccine", "product", "for", "the", "prevention", "of", "smallpox,", "as", "well", "as", "an", "IND", "candidate,", "TNX-301,", "a", "potential", "treatment", "for", "AUD."], "wordsB": ["We", "also", "have", "a", "pipeline", "of", "other", "drug", "and", "biologic", "candidates,", "including", "two", "pre-IND", "candidates,", "TNX-601,", "a", "daytime", "treatment", "for", "PTSD", "and", "TNX-801,", "a", "biologic", "vaccine", "product", "for", "the", "prevention", "of", "smallpox,", "as", "well", "as", "an", "IND", "candidate,", "TNX-301,", "a", "potential", "treatment", "for", "AUD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p5_s0", "idA": "1430306_17_item1_p5_s0", "sentA": "TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for posttraumatic stress disorder, or PTSD, is an investigational new drug and has not been approved for any indication.", "sentB": "*Tonmya has been conditionally accepted by the U.S. Food and Drug Administration (FDA) as the proposed trade name for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for posttraumatic stress disorder, or PTSD.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "for", "posttraumatic", "stress", "disorder,", "or", "PTSD,", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication.", "<tag2>", "*Tonmya", "has", "been", "conditionally", "accepted", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "as", "the", "proposed", "trade", "name", "for", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "for", "posttraumatic", "stress", "disorder,", "or", "PTSD.", "<tag3>"], "wordsA": ["TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "for", "posttraumatic", "stress", "disorder,", "or", "PTSD,", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication."], "wordsB": ["*Tonmya", "has", "been", "conditionally", "accepted", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "as", "the", "proposed", "trade", "name", "for", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "for", "posttraumatic", "stress", "disorder,", "or", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p5_s1", "idA": "1430306_17_item1_p5_s0", "sentA": "TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for posttraumatic stress disorder, or PTSD, is an investigational new drug and has not been approved for any indication.", "sentB": "TNX-102 SL is an investigational new drug and has not been approved for any indication.", "type": 2, "words": ["<tag1>", "TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "for", "posttraumatic", "stress", "disorder,", "or", "PTSD,", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication.", "<tag2>", "TNX-102", "SL", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication.", "<tag3>"], "wordsA": ["TNX-102", "SL", "(cyclobenzaprine", "HCl", "sublingual", "tablets)", "for", "posttraumatic", "stress", "disorder,", "or", "PTSD,", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication."], "wordsB": ["TNX-102", "SL", "is", "an", "investigational", "new", "drug", "and", "has", "not", "been", "approved", "for", "any", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p83_s0", "idA": "1430306_17_item1_p62_s0", "sentA": "Like cyclobenzaprine, tianeptine shares structural similarities with classic tricyclic antidepressants, but it has unique pharmacological and neurochemical properties.", "sentB": "Like CBP, tianeptine shares structural similarities with classic tricyclic antidepressants, but it has unique pharmacological and neurochemical properties.", "type": 2, "words": ["<tag1>", "Like", "cyclobenzaprine,", "tianeptine", "shares", "structural", "similarities", "with", "classic", "tricyclic", "antidepressants,", "but", "it", "has", "unique", "pharmacological", "and", "neurochemical", "properties.", "<tag2>", "Like", "CBP,", "tianeptine", "shares", "structural", "similarities", "with", "classic", "tricyclic", "antidepressants,", "but", "it", "has", "unique", "pharmacological", "and", "neurochemical", "properties.", "<tag3>"], "wordsA": ["Like", "cyclobenzaprine,", "tianeptine", "shares", "structural", "similarities", "with", "classic", "tricyclic", "antidepressants,", "but", "it", "has", "unique", "pharmacological", "and", "neurochemical", "properties."], "wordsB": ["Like", "CBP,", "tianeptine", "shares", "structural", "similarities", "with", "classic", "tricyclic", "antidepressants,", "but", "it", "has", "unique", "pharmacological", "and", "neurochemical", "properties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p84_s0", "idA": "1430306_17_item1_p63_s0", "sentA": "Due to its use in Europe, Asia, and Latin America for several decades, tianeptine has an established safety profile.", "sentB": "Due to its decades of use in Europe, Asia, and Latin America, tianeptine has an established safety profile.", "type": 2, "words": ["<tag1>", "Due", "to", "its", "use", "in", "Europe,", "Asia,", "and", "Latin", "America", "for", "several", "decades,", "tianeptine", "has", "an", "established", "safety", "profile.", "<tag2>", "Due", "to", "its", "decades", "of", "use", "in", "Europe,", "Asia,", "and", "Latin", "America,", "tianeptine", "has", "an", "established", "safety", "profile.", "<tag3>"], "wordsA": ["Due", "to", "its", "use", "in", "Europe,", "Asia,", "and", "Latin", "America", "for", "several", "decades,", "tianeptine", "has", "an", "established", "safety", "profile."], "wordsB": ["Due", "to", "its", "decades", "of", "use", "in", "Europe,", "Asia,", "and", "Latin", "America,", "tianeptine", "has", "an", "established", "safety", "profile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p96_s0", "idA": "1430306_17_item1_p63_s2", "sentA": "Leveraging our development expertise in PTSD, TNX-601 is being developed for daytime usage as a first-line monotherapy for PTSD.", "sentB": "Several companies have clinical candidates for which PTSD is being considered as a secondary indication.", "type": 2, "words": ["<tag1>", "Leveraging", "our", "development", "expertise", "in", "PTSD,", "TNX-601", "is", "being", "developed", "for", "daytime", "usage", "as", "a", "first-line", "monotherapy", "for", "PTSD.", "<tag2>", "Several", "companies", "have", "clinical", "candidates", "for", "which", "PTSD", "is", "being", "considered", "as", "a", "secondary", "indication.", "<tag3>"], "wordsA": ["Leveraging", "our", "development", "expertise", "in", "PTSD,", "TNX-601", "is", "being", "developed", "for", "daytime", "usage", "as", "a", "first-line", "monotherapy", "for", "PTSD."], "wordsB": ["Several", "companies", "have", "clinical", "candidates", "for", "which", "PTSD", "is", "being", "considered", "as", "a", "secondary", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p84_s3", "idA": "1430306_17_item1_p63_s3", "sentA": "Tianeptine s reported pro-cognitive and anxiolytic effects as well as its ability to attenuate the neuropathological effects of excessive stress responses suggest that it may be used to treat PTSD by a different mechanism of action than TNX-102 SL.", "sentB": "Tianeptine s reported pro-cognitive and anxiolytic effects as well as its ability to attenuate the neuropathological effects of excessive stress responses suggest that it may be used to treat PTSD by a different mechanism of action than Tonmya.", "type": 2, "words": ["<tag1>", "Tianeptine", "s", "reported", "pro-cognitive", "and", "anxiolytic", "effects", "as", "well", "as", "its", "ability", "to", "attenuate", "the", "neuropathological", "effects", "of", "excessive", "stress", "responses", "suggest", "that", "it", "may", "be", "used", "to", "treat", "PTSD", "by", "a", "different", "mechanism", "of", "action", "than", "TNX-102", "SL.", "<tag2>", "Tianeptine", "s", "reported", "pro-cognitive", "and", "anxiolytic", "effects", "as", "well", "as", "its", "ability", "to", "attenuate", "the", "neuropathological", "effects", "of", "excessive", "stress", "responses", "suggest", "that", "it", "may", "be", "used", "to", "treat", "PTSD", "by", "a", "different", "mechanism", "of", "action", "than", "Tonmya.", "<tag3>"], "wordsA": ["Tianeptine", "s", "reported", "pro-cognitive", "and", "anxiolytic", "effects", "as", "well", "as", "its", "ability", "to", "attenuate", "the", "neuropathological", "effects", "of", "excessive", "stress", "responses", "suggest", "that", "it", "may", "be", "used", "to", "treat", "PTSD", "by", "a", "different", "mechanism", "of", "action", "than", "TNX-102", "SL."], "wordsB": ["Tianeptine", "s", "reported", "pro-cognitive", "and", "anxiolytic", "effects", "as", "well", "as", "its", "ability", "to", "attenuate", "the", "neuropathological", "effects", "of", "excessive", "stress", "responses", "suggest", "that", "it", "may", "be", "used", "to", "treat", "PTSD", "by", "a", "different", "mechanism", "of", "action", "than", "Tonmya."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p86_s0", "idA": "1430306_17_item1_p65_s0", "sentA": "TNX-801 is a novel potential smallpox-preventing vaccine based on a live synthetic version of HPXV grown in cell culture.", "sentB": "TNX-801 is a novel potential smallpox-preventing vaccine based on a live synthetic version of horsepox virus, or HPXV, grown in cell culture.", "type": 2, "words": ["<tag1>", "TNX-801", "is", "a", "novel", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "HPXV", "grown", "in", "cell", "culture.", "<tag2>", "TNX-801", "is", "a", "novel", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "horsepox", "virus,", "or", "HPXV,", "grown", "in", "cell", "culture.", "<tag3>"], "wordsA": ["TNX-801", "is", "a", "novel", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "HPXV", "grown", "in", "cell", "culture."], "wordsB": ["TNX-801", "is", "a", "novel", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "horsepox", "virus,", "or", "HPXV,", "grown", "in", "cell", "culture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p87_s2", "idA": "1430306_17_item1_p66_s1", "sentA": "Vaccine manufacturing activities have been initiated to support further nonclinical testing of TNX-801.", "sentB": "Discussions regarding vaccine manufacturing activities have been initiated to support further nonclinical testing of TNX-801.", "type": 2, "words": ["<tag1>", "Vaccine", "manufacturing", "activities", "have", "been", "initiated", "to", "support", "further", "nonclinical", "testing", "of", "TNX-801.", "<tag2>", "Discussions", "regarding", "vaccine", "manufacturing", "activities", "have", "been", "initiated", "to", "support", "further", "nonclinical", "testing", "of", "TNX-801.", "<tag3>"], "wordsA": ["Vaccine", "manufacturing", "activities", "have", "been", "initiated", "to", "support", "further", "nonclinical", "testing", "of", "TNX-801."], "wordsB": ["Discussions", "regarding", "vaccine", "manufacturing", "activities", "have", "been", "initiated", "to", "support", "further", "nonclinical", "testing", "of", "TNX-801."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p87_s0", "idA": "1430306_17_item1_p68_s1", "sentA": "We recently filed a patent on the novel virus vaccine.", "sentB": "Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.", "type": 2, "words": ["<tag1>", "We", "recently", "filed", "a", "patent", "on", "the", "novel", "virus", "vaccine.", "<tag2>", "Construction", "of", "an", "infectious", "horsepox", "virus", "vaccine", "from", "chemically", "synthesized", "DNA", "fragments.", "<tag3>"], "wordsA": ["We", "recently", "filed", "a", "patent", "on", "the", "novel", "virus", "vaccine."], "wordsB": ["Construction", "of", "an", "infectious", "horsepox", "virus", "vaccine", "from", "chemically", "synthesized", "DNA", "fragments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p89_s2", "idA": "1430306_17_item1_p68_s2", "sentA": "In addition, 12 years of non-patent based exclusivity is expected under the Patient Protection and Affordable Care Act.", "sentB": "In addition, 12 years of non-patent-based exclusivity is expected under the Patient Protection and Affordable Care Act, or PPACA.", "type": 2, "words": ["<tag1>", "In", "addition,", "12", "years", "of", "non-patent", "based", "exclusivity", "is", "expected", "under", "the", "Patient", "Protection", "and", "Affordable", "Care", "Act.", "<tag2>", "In", "addition,", "12", "years", "of", "non-patent-based", "exclusivity", "is", "expected", "under", "the", "Patient", "Protection", "and", "Affordable", "Care", "Act,", "or", "PPACA.", "<tag3>"], "wordsA": ["In", "addition,", "12", "years", "of", "non-patent", "based", "exclusivity", "is", "expected", "under", "the", "Patient", "Protection", "and", "Affordable", "Care", "Act."], "wordsB": ["In", "addition,", "12", "years", "of", "non-patent-based", "exclusivity", "is", "expected", "under", "the", "Patient", "Protection", "and", "Affordable", "Care", "Act,", "or", "PPACA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p175_s3", "idA": "1430306_17_item1_p68_s3", "sentA": "Following the recent passage of the 21st Century Cures Act, we believe TNX-801 qualifies as a medical countermeasure, and therefore should be eligible for a Priority Review Voucher upon FDA approval.", "sentB": "However, the Priority Review Voucher program provision of the 21st Century Cures Act is set to expire in 2023.", "type": 2, "words": ["<tag1>", "Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval.", "<tag2>", "However,", "the", "Priority", "Review", "Voucher", "program", "provision", "of", "the", "21st", "Century", "Cures", "Act", "is", "set", "to", "expire", "in", "2023.", "<tag3>"], "wordsA": ["Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval."], "wordsB": ["However,", "the", "Priority", "Review", "Voucher", "program", "provision", "of", "the", "21st", "Century", "Cures", "Act", "is", "set", "to", "expire", "in", "2023."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p175_s4", "idA": "1430306_17_item1_p68_s3", "sentA": "Following the recent passage of the 21st Century Cures Act, we believe TNX-801 qualifies as a medical countermeasure, and therefore should be eligible for a Priority Review Voucher upon FDA approval.", "sentB": "If TNX-801 does not receive FDA licensure by 2023, we may not be able to capitalize on the incentives contained in the 21st Century Cures Act unless the provision allowing for the Priority Review Voucher Program is extended until such time as TNX-801 is licensed.", "type": 2, "words": ["<tag1>", "Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval.", "<tag2>", "If", "TNX-801", "does", "not", "receive", "FDA", "licensure", "by", "2023,", "we", "may", "not", "be", "able", "to", "capitalize", "on", "the", "incentives", "contained", "in", "the", "21st", "Century", "Cures", "Act", "unless", "the", "provision", "allowing", "for", "the", "Priority", "Review", "Voucher", "Program", "is", "extended", "until", "such", "time", "as", "TNX-801", "is", "licensed.", "<tag3>"], "wordsA": ["Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval."], "wordsB": ["If", "TNX-801", "does", "not", "receive", "FDA", "licensure", "by", "2023,", "we", "may", "not", "be", "able", "to", "capitalize", "on", "the", "incentives", "contained", "in", "the", "21st", "Century", "Cures", "Act", "unless", "the", "provision", "allowing", "for", "the", "Priority", "Review", "Voucher", "Program", "is", "extended", "until", "such", "time", "as", "TNX-801", "is", "licensed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p89_s3", "idA": "1430306_17_item1_p68_s3", "sentA": "Following the recent passage of the 21st Century Cures Act, we believe TNX-801 qualifies as a medical countermeasure, and therefore should be eligible for a Priority Review Voucher upon FDA approval.", "sentB": "Following the recent passage of the 21st Century Cures Act, we believe TNX-801 qualifies as a medical countermeasure, and therefore should be eligible for a Priority Review Voucher upon receiving FDA licensure.", "type": 2, "words": ["<tag1>", "Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval.", "<tag2>", "Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "receiving", "FDA", "licensure.", "<tag3>"], "wordsA": ["Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval."], "wordsB": ["Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "receiving", "FDA", "licensure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p89_s4", "idA": "1430306_17_item1_p68_s3", "sentA": "Following the recent passage of the 21st Century Cures Act, we believe TNX-801 qualifies as a medical countermeasure, and therefore should be eligible for a Priority Review Voucher upon FDA approval.", "sentB": "However, the Priority Review Voucher program provision of the 21st Century Cures Act is set to expire in 2023.", "type": 2, "words": ["<tag1>", "Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval.", "<tag2>", "However,", "the", "Priority", "Review", "Voucher", "program", "provision", "of", "the", "21st", "Century", "Cures", "Act", "is", "set", "to", "expire", "in", "2023.", "<tag3>"], "wordsA": ["Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval."], "wordsB": ["However,", "the", "Priority", "Review", "Voucher", "program", "provision", "of", "the", "21st", "Century", "Cures", "Act", "is", "set", "to", "expire", "in", "2023."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p89_s5", "idA": "1430306_17_item1_p68_s3", "sentA": "Following the recent passage of the 21st Century Cures Act, we believe TNX-801 qualifies as a medical countermeasure, and therefore should be eligible for a Priority Review Voucher upon FDA approval.", "sentB": "If TNX-801 does not receive FDA licensure by 2023, we may not be able to capitalize on the incentives contained in the 21st Century Cures Act unless the provision allowing for the Priority Review Voucher Program is extended until such time as TNX-801 is licensed.", "type": 2, "words": ["<tag1>", "Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval.", "<tag2>", "If", "TNX-801", "does", "not", "receive", "FDA", "licensure", "by", "2023,", "we", "may", "not", "be", "able", "to", "capitalize", "on", "the", "incentives", "contained", "in", "the", "21st", "Century", "Cures", "Act", "unless", "the", "provision", "allowing", "for", "the", "Priority", "Review", "Voucher", "Program", "is", "extended", "until", "such", "time", "as", "TNX-801", "is", "licensed.", "<tag3>"], "wordsA": ["Following", "the", "recent", "passage", "of", "the", "21st", "Century", "Cures", "Act,", "we", "believe", "TNX-801", "qualifies", "as", "a", "medical", "countermeasure,", "and", "therefore", "should", "be", "eligible", "for", "a", "Priority", "Review", "Voucher", "upon", "FDA", "approval."], "wordsB": ["If", "TNX-801", "does", "not", "receive", "FDA", "licensure", "by", "2023,", "we", "may", "not", "be", "able", "to", "capitalize", "on", "the", "incentives", "contained", "in", "the", "21st", "Century", "Cures", "Act", "unless", "the", "provision", "allowing", "for", "the", "Priority", "Review", "Voucher", "Program", "is", "extended", "until", "such", "time", "as", "TNX-801", "is", "licensed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p15_s1", "idA": "1430306_17_item1_p68_s4", "sentA": "We are currently working to develop a vaccine that meets cGMP quality to support an IND.", "sentB": "We expect to file an IND to support a Phase 2 efficacy study in March 2018.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "working", "to", "develop", "a", "vaccine", "that", "meets", "cGMP", "quality", "to", "support", "an", "IND.", "<tag2>", "We", "expect", "to", "file", "an", "IND", "to", "support", "a", "Phase", "2", "efficacy", "study", "in", "March", "2018.", "<tag3>"], "wordsA": ["We", "are", "currently", "working", "to", "develop", "a", "vaccine", "that", "meets", "cGMP", "quality", "to", "support", "an", "IND."], "wordsB": ["We", "expect", "to", "file", "an", "IND", "to", "support", "a", "Phase", "2", "efficacy", "study", "in", "March", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p89_s6", "idA": "1430306_17_item1_p68_s4", "sentA": "We are currently working to develop a vaccine that meets cGMP quality to support an IND.", "sentB": "We are currently working to develop a vaccine that meets cGMP quality to support an IND study.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "working", "to", "develop", "a", "vaccine", "that", "meets", "cGMP", "quality", "to", "support", "an", "IND.", "<tag2>", "We", "are", "currently", "working", "to", "develop", "a", "vaccine", "that", "meets", "cGMP", "quality", "to", "support", "an", "IND", "study.", "<tag3>"], "wordsA": ["We", "are", "currently", "working", "to", "develop", "a", "vaccine", "that", "meets", "cGMP", "quality", "to", "support", "an", "IND."], "wordsB": ["We", "are", "currently", "working", "to", "develop", "a", "vaccine", "that", "meets", "cGMP", "quality", "to", "support", "an", "IND", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p6_s0", "idA": "1430306_17_item1_p6_s0", "sentA": "Tonix Pharmaceuticals Holding Corp., together with its subsidiaries (collectively we, our, us, Tonix or the Company ), is a clinical-stage pharmaceutical company dedicated to the development of innovative pharmaceutical products to address public health challenges.", "sentB": "Tonix is a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and to improve biodefense through the development of potential medical counter-measures.", "type": 2, "words": ["<tag1>", "Tonix", "Pharmaceuticals", "Holding", "Corp.,", "together", "with", "its", "subsidiaries", "(collectively", "we,", "our,", "us,", "Tonix", "or", "the", "Company", "),", "is", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "innovative", "pharmaceutical", "products", "to", "address", "public", "health", "challenges.", "<tag2>", "Tonix", "is", "a", "clinical-stage", "biopharmaceutical", "company", "focused", "on", "discovering", "and", "developing", "pharmaceutical", "products", "to", "treat", "serious", "neuropsychiatric", "conditions", "and", "to", "improve", "biodefense", "through", "the", "development", "of", "potential", "medical", "counter-measures.", "<tag3>"], "wordsA": ["Tonix", "Pharmaceuticals", "Holding", "Corp.,", "together", "with", "its", "subsidiaries", "(collectively", "we,", "our,", "us,", "Tonix", "or", "the", "Company", "),", "is", "a", "clinical-stage", "pharmaceutical", "company", "dedicated", "to", "the", "development", "of", "innovative", "pharmaceutical", "products", "to", "address", "public", "health", "challenges."], "wordsB": ["Tonix", "is", "a", "clinical-stage", "biopharmaceutical", "company", "focused", "on", "discovering", "and", "developing", "pharmaceutical", "products", "to", "treat", "serious", "neuropsychiatric", "conditions", "and", "to", "improve", "biodefense", "through", "the", "development", "of", "potential", "medical", "counter-measures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p6_s1", "idA": "1430306_17_item1_p6_s1", "sentA": "Our most advanced drug development program is focused on delivering an efficacious and safe long-term treatment for PTSD.", "sentB": "Our most advanced drug development program is focused on delivering a safe and effective long-term treatment for PTSD.", "type": 2, "words": ["<tag1>", "Our", "most", "advanced", "drug", "development", "program", "is", "focused", "on", "delivering", "an", "efficacious", "and", "safe", "long-term", "treatment", "for", "PTSD.", "<tag2>", "Our", "most", "advanced", "drug", "development", "program", "is", "focused", "on", "delivering", "a", "safe", "and", "effective", "long-term", "treatment", "for", "PTSD.", "<tag3>"], "wordsA": ["Our", "most", "advanced", "drug", "development", "program", "is", "focused", "on", "delivering", "an", "efficacious", "and", "safe", "long-term", "treatment", "for", "PTSD."], "wordsB": ["Our", "most", "advanced", "drug", "development", "program", "is", "focused", "on", "delivering", "a", "safe", "and", "effective", "long-term", "treatment", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p91_s0", "idA": "1430306_17_item1_p70_s0", "sentA": "In addition, we own rights to intellectual property on a biodefense technology relating to the development of protective agents against radiation exposure, which we refer to as TNX-701.", "sentB": "We own rights to intellectual property on a biodefense technology relating to the development of protective agents against radiation exposure, which we refer to as TNX-701.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "own", "rights", "to", "intellectual", "property", "on", "a", "biodefense", "technology", "relating", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure,", "which", "we", "refer", "to", "as", "TNX-701.", "<tag2>", "We", "own", "rights", "to", "intellectual", "property", "on", "a", "biodefense", "technology", "relating", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure,", "which", "we", "refer", "to", "as", "TNX-701.", "<tag3>"], "wordsA": ["In", "addition,", "we", "own", "rights", "to", "intellectual", "property", "on", "a", "biodefense", "technology", "relating", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure,", "which", "we", "refer", "to", "as", "TNX-701."], "wordsB": ["We", "own", "rights", "to", "intellectual", "property", "on", "a", "biodefense", "technology", "relating", "to", "the", "development", "of", "protective", "agents", "against", "radiation", "exposure,", "which", "we", "refer", "to", "as", "TNX-701."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p91_s2", "idA": "1430306_17_item1_p70_s2", "sentA": "Similar to the regulatory pathway intended for TNX-801, we plan to develop TNX-701 under 21 CFR 601 Subpart H, or the Animal Rule .", "sentB": "We plan to develop TNX-701 under the Animal Rule, which is applicable when human efficacy studies are not ethical or feasible.", "type": 2, "words": ["<tag1>", "Similar", "to", "the", "regulatory", "pathway", "intended", "for", "TNX-801,", "we", "plan", "to", "develop", "TNX-701", "under", "21", "CFR", "601", "Subpart", "H,", "or", "the", "Animal", "Rule", ".", "<tag2>", "We", "plan", "to", "develop", "TNX-701", "under", "the", "Animal", "Rule,", "which", "is", "applicable", "when", "human", "efficacy", "studies", "are", "not", "ethical", "or", "feasible.", "<tag3>"], "wordsA": ["Similar", "to", "the", "regulatory", "pathway", "intended", "for", "TNX-801,", "we", "plan", "to", "develop", "TNX-701", "under", "21", "CFR", "601", "Subpart", "H,", "or", "the", "Animal", "Rule", "."], "wordsB": ["We", "plan", "to", "develop", "TNX-701", "under", "the", "Animal", "Rule,", "which", "is", "applicable", "when", "human", "efficacy", "studies", "are", "not", "ethical", "or", "feasible."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p31_s1", "idA": "1430306_17_item1_p71_s2", "sentA": "We believe that key competitive factors that will affect the development and commercial success of our product candidates are efficacy, safety, tolerability, reliability, price and reimbursement level.", "sentB": "We believe that our product candidates offer innovative therapeutic approaches and may provide significant advantages relative to current therapies.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "key", "competitive", "factors", "that", "will", "affect", "the", "development", "and", "commercial", "success", "of", "our", "product", "candidates", "are", "efficacy,", "safety,", "tolerability,", "reliability,", "price", "and", "reimbursement", "level.", "<tag2>", "We", "believe", "that", "our", "product", "candidates", "offer", "innovative", "therapeutic", "approaches", "and", "may", "provide", "significant", "advantages", "relative", "to", "current", "therapies.", "<tag3>"], "wordsA": ["We", "believe", "that", "key", "competitive", "factors", "that", "will", "affect", "the", "development", "and", "commercial", "success", "of", "our", "product", "candidates", "are", "efficacy,", "safety,", "tolerability,", "reliability,", "price", "and", "reimbursement", "level."], "wordsB": ["We", "believe", "that", "our", "product", "candidates", "offer", "innovative", "therapeutic", "approaches", "and", "may", "provide", "significant", "advantages", "relative", "to", "current", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p93_s0", "idA": "1430306_17_item1_p72_s0", "sentA": "The markets for medicines to treat PTSD and other CNS conditions are well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "sentB": "The market for therapies to treat PTSD and other CNS conditions is well developed and populated with established drugs marketed by large and small pharmaceutical, biotechnology and generic drug companies.", "type": 2, "words": ["<tag1>", "The", "markets", "for", "medicines", "to", "treat", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag2>", "The", "market", "for", "therapies", "to", "treat", "PTSD", "and", "other", "CNS", "conditions", "is", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies.", "<tag3>"], "wordsA": ["The", "markets", "for", "medicines", "to", "treat", "PTSD", "and", "other", "CNS", "conditions", "are", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "wordsB": ["The", "market", "for", "therapies", "to", "treat", "PTSD", "and", "other", "CNS", "conditions", "is", "well", "developed", "and", "populated", "with", "established", "drugs", "marketed", "by", "large", "and", "small", "pharmaceutical,", "biotechnology", "and", "generic", "drug", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p95_s0", "idA": "1430306_17_item1_p74_s0", "sentA": "BNC-201 is in Phase 2 for civilian PTSD and is an allosteric modulator of the alpha 7 nicotinic acetylcholine receptor.", "sentB": "BNC-201 is in Phase 2 for PTSD and is an allosteric modulator of the alpha 7 nicotinic acetylcholine receptor.", "type": 2, "words": ["<tag1>", "BNC-201", "is", "in", "Phase", "2", "for", "civilian", "PTSD", "and", "is", "an", "allosteric", "modulator", "of", "the", "alpha", "7", "nicotinic", "acetylcholine", "receptor.", "<tag2>", "BNC-201", "is", "in", "Phase", "2", "for", "PTSD", "and", "is", "an", "allosteric", "modulator", "of", "the", "alpha", "7", "nicotinic", "acetylcholine", "receptor.", "<tag3>"], "wordsA": ["BNC-201", "is", "in", "Phase", "2", "for", "civilian", "PTSD", "and", "is", "an", "allosteric", "modulator", "of", "the", "alpha", "7", "nicotinic", "acetylcholine", "receptor."], "wordsB": ["BNC-201", "is", "in", "Phase", "2", "for", "PTSD", "and", "is", "an", "allosteric", "modulator", "of", "the", "alpha", "7", "nicotinic", "acetylcholine", "receptor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p96_s1", "idA": "1430306_17_item1_p74_s1", "sentA": "Rexulti is in Phase 2 for PTSD and is an atypical antipsychotic.", "sentB": "Johnson and Johnson is developing CERC-501 which is in Phase 2 for depression, targeting the kappa opioid receptor, NeuroRx is developing NRX-101 which is in Phase 2 for bipolar depression and is a combination of ketamine, lurasidone, and d -cycloserine, Roche is developing RG7314 which is in Phase 2 for Autism, Rodin Therapeutics has a preclinical candidate for Alzheimer s disease that targets histone deacetylase 2 (HDAC2 gene product), SpringWorks Therapeutics is developing PF-04457845 which is in Phase 2 for osteoarthritis and targets fatty acid amide hydrolase (FAAH).", "type": 2, "words": ["<tag1>", "Rexulti", "is", "in", "Phase", "2", "for", "PTSD", "and", "is", "an", "atypical", "antipsychotic.", "<tag2>", "Johnson", "and", "Johnson", "is", "developing", "CERC-501", "which", "is", "in", "Phase", "2", "for", "depression,", "targeting", "the", "kappa", "opioid", "receptor,", "NeuroRx", "is", "developing", "NRX-101", "which", "is", "in", "Phase", "2", "for", "bipolar", "depression", "and", "is", "a", "combination", "of", "ketamine,", "lurasidone,", "and", "d", "-cycloserine,", "Roche", "is", "developing", "RG7314", "which", "is", "in", "Phase", "2", "for", "Autism,", "Rodin", "Therapeutics", "has", "a", "preclinical", "candidate", "for", "Alzheimer", "s", "disease", "that", "targets", "histone", "deacetylase", "2", "(HDAC2", "gene", "product),", "SpringWorks", "Therapeutics", "is", "developing", "PF-04457845", "which", "is", "in", "Phase", "2", "for", "osteoarthritis", "and", "targets", "fatty", "acid", "amide", "hydrolase", "(FAAH).", "<tag3>"], "wordsA": ["Rexulti", "is", "in", "Phase", "2", "for", "PTSD", "and", "is", "an", "atypical", "antipsychotic."], "wordsB": ["Johnson", "and", "Johnson", "is", "developing", "CERC-501", "which", "is", "in", "Phase", "2", "for", "depression,", "targeting", "the", "kappa", "opioid", "receptor,", "NeuroRx", "is", "developing", "NRX-101", "which", "is", "in", "Phase", "2", "for", "bipolar", "depression", "and", "is", "a", "combination", "of", "ketamine,", "lurasidone,", "and", "d", "-cycloserine,", "Roche", "is", "developing", "RG7314", "which", "is", "in", "Phase", "2", "for", "Autism,", "Rodin", "Therapeutics", "has", "a", "preclinical", "candidate", "for", "Alzheimer", "s", "disease", "that", "targets", "histone", "deacetylase", "2", "(HDAC2", "gene", "product),", "SpringWorks", "Therapeutics", "is", "developing", "PF-04457845", "which", "is", "in", "Phase", "2", "for", "osteoarthritis", "and", "targets", "fatty", "acid", "amide", "hydrolase", "(FAAH)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p95_s3", "idA": "1430306_17_item1_p74_s3", "sentA": "MDMA is Phase 3 ready for PTSD and is a Drug Enforcement Administration, or DEA, schedule 1 hallucinogen that is being studied for drug-assisted psychotherapy.", "sentB": "MDMA is Phase 3 ready for PTSD and is a DEA schedule 1 hallucinogen that is being studied for drug-assisted psychotherapy.", "type": 2, "words": ["<tag1>", "MDMA", "is", "Phase", "3", "ready", "for", "PTSD", "and", "is", "a", "Drug", "Enforcement", "Administration,", "or", "DEA,", "schedule", "1", "hallucinogen", "that", "is", "being", "studied", "for", "drug-assisted", "psychotherapy.", "<tag2>", "MDMA", "is", "Phase", "3", "ready", "for", "PTSD", "and", "is", "a", "DEA", "schedule", "1", "hallucinogen", "that", "is", "being", "studied", "for", "drug-assisted", "psychotherapy.", "<tag3>"], "wordsA": ["MDMA", "is", "Phase", "3", "ready", "for", "PTSD", "and", "is", "a", "Drug", "Enforcement", "Administration,", "or", "DEA,", "schedule", "1", "hallucinogen", "that", "is", "being", "studied", "for", "drug-assisted", "psychotherapy."], "wordsB": ["MDMA", "is", "Phase", "3", "ready", "for", "PTSD", "and", "is", "a", "DEA", "schedule", "1", "hallucinogen", "that", "is", "being", "studied", "for", "drug-assisted", "psychotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p95_s5", "idA": "1430306_17_item1_p74_s4", "sentA": "Brainsway Ltd., a medical device company, is currently recruiting patients for a pivotal Phase 3 trial using a deep transcranial magnetic stimulation device.", "sentB": "Brainsway Ltd., a medical device company, is currently recruiting patients for a pivotal Phase 3 trial using a deep transcranial magnetic stimulation device for treatment of PTSD.", "type": 2, "words": ["<tag1>", "Brainsway", "Ltd.,", "a", "medical", "device", "company,", "is", "currently", "recruiting", "patients", "for", "a", "pivotal", "Phase", "3", "trial", "using", "a", "deep", "transcranial", "magnetic", "stimulation", "device.", "<tag2>", "Brainsway", "Ltd.,", "a", "medical", "device", "company,", "is", "currently", "recruiting", "patients", "for", "a", "pivotal", "Phase", "3", "trial", "using", "a", "deep", "transcranial", "magnetic", "stimulation", "device", "for", "treatment", "of", "PTSD.", "<tag3>"], "wordsA": ["Brainsway", "Ltd.,", "a", "medical", "device", "company,", "is", "currently", "recruiting", "patients", "for", "a", "pivotal", "Phase", "3", "trial", "using", "a", "deep", "transcranial", "magnetic", "stimulation", "device."], "wordsB": ["Brainsway", "Ltd.,", "a", "medical", "device", "company,", "is", "currently", "recruiting", "patients", "for", "a", "pivotal", "Phase", "3", "trial", "using", "a", "deep", "transcranial", "magnetic", "stimulation", "device", "for", "treatment", "of", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p95_s6", "idA": "1430306_17_item1_p74_s5", "sentA": "A number of other companies have or may be developing prescription medications for PTSD, including Actavis, Johnson and Johnson, Marinus Pharmaceuticals, Merck, and Pfizer.", "sentB": "A number of other companies and institutions have or may be developing prescription medications for PTSD, including: Aptinyx is developing NYX-783 which is in Phase I and targets the NMDA receptor, Mt. Sinai Hospital and Medical School in New York City is developing ketamine which is in Phase 2 and targets the NMDA receptor, Azevan Pharmaceuticals is developing SRX246 which is in Phase 2 and targets the vasopressin V1A receptor, University of California, San Diego (UCSD) is developing losartan which is in Phase 2 and is an angiotensin receptor blocker (ARB), and Massachusetts General Hospital (MGH) and University of California, San Francisco (UCSF) are developing oxytocin which is in Phase 2 and targets the oxytocin receptor.", "type": 2, "words": ["<tag1>", "A", "number", "of", "other", "companies", "have", "or", "may", "be", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Johnson", "and", "Johnson,", "Marinus", "Pharmaceuticals,", "Merck,", "and", "Pfizer.", "<tag2>", "A", "number", "of", "other", "companies", "and", "institutions", "have", "or", "may", "be", "developing", "prescription", "medications", "for", "PTSD,", "including:", "Aptinyx", "is", "developing", "NYX-783", "which", "is", "in", "Phase", "I", "and", "targets", "the", "NMDA", "receptor,", "Mt.", "Sinai", "Hospital", "and", "Medical", "School", "in", "New", "York", "City", "is", "developing", "ketamine", "which", "is", "in", "Phase", "2", "and", "targets", "the", "NMDA", "receptor,", "Azevan", "Pharmaceuticals", "is", "developing", "SRX246", "which", "is", "in", "Phase", "2", "and", "targets", "the", "vasopressin", "V1A", "receptor,", "University", "of", "California,", "San", "Diego", "(UCSD)", "is", "developing", "losartan", "which", "is", "in", "Phase", "2", "and", "is", "an", "angiotensin", "receptor", "blocker", "(ARB),", "and", "Massachusetts", "General", "Hospital", "(MGH)", "and", "University", "of", "California,", "San", "Francisco", "(UCSF)", "are", "developing", "oxytocin", "which", "is", "in", "Phase", "2", "and", "targets", "the", "oxytocin", "receptor.", "<tag3>"], "wordsA": ["A", "number", "of", "other", "companies", "have", "or", "may", "be", "developing", "prescription", "medications", "for", "PTSD,", "including", "Actavis,", "Johnson", "and", "Johnson,", "Marinus", "Pharmaceuticals,", "Merck,", "and", "Pfizer."], "wordsB": ["A", "number", "of", "other", "companies", "and", "institutions", "have", "or", "may", "be", "developing", "prescription", "medications", "for", "PTSD,", "including:", "Aptinyx", "is", "developing", "NYX-783", "which", "is", "in", "Phase", "I", "and", "targets", "the", "NMDA", "receptor,", "Mt.", "Sinai", "Hospital", "and", "Medical", "School", "in", "New", "York", "City", "is", "developing", "ketamine", "which", "is", "in", "Phase", "2", "and", "targets", "the", "NMDA", "receptor,", "Azevan", "Pharmaceuticals", "is", "developing", "SRX246", "which", "is", "in", "Phase", "2", "and", "targets", "the", "vasopressin", "V1A", "receptor,", "University", "of", "California,", "San", "Diego", "(UCSD)", "is", "developing", "losartan", "which", "is", "in", "Phase", "2", "and", "is", "an", "angiotensin", "receptor", "blocker", "(ARB),", "and", "Massachusetts", "General", "Hospital", "(MGH)", "and", "University", "of", "California,", "San", "Francisco", "(UCSF)", "are", "developing", "oxytocin", "which", "is", "in", "Phase", "2", "and", "targets", "the", "oxytocin", "receptor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p97_s0", "idA": "1430306_17_item1_p75_s0", "sentA": "Medications that are used off-label for the treatment of PTSD include: anti-depressants, such as nefazodone and trazodone; the antihistamine cyproheptadine; and certain atypical antipsychotics, such as olanzapine and risperidone.", "sentB": "In addition, approved medications that are used off-label for the treatment of PTSD include: anti-depressants, such as nefazodone and trazodone; the antihistamine cyproheptadine; and certain atypical antipsychotics, such as olanzapine and risperidone.", "type": 2, "words": ["<tag1>", "Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include:", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone.", "<tag2>", "In", "addition,", "approved", "medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include:", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone.", "<tag3>"], "wordsA": ["Medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include:", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone."], "wordsB": ["In", "addition,", "approved", "medications", "that", "are", "used", "off-label", "for", "the", "treatment", "of", "PTSD", "include:", "anti-depressants,", "such", "as", "nefazodone", "and", "trazodone;", "the", "antihistamine", "cyproheptadine;", "and", "certain", "atypical", "antipsychotics,", "such", "as", "olanzapine", "and", "risperidone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p100_s0", "idA": "1430306_17_item1_p75_s1", "sentA": "Additionally, a number of companies are working on vaccines/treatments for smallpox, including Bavarian Nordic, SIGA and Chimerix.", "sentB": "Although a number of companies are marketing or developing prescription medicines for sleep disorders, including Merck Co, Purdue Pharma, Eisai, GlaxoSmithKline, Johnson Johnson and Sage Therapeutics, none of these sleep disorders drugs are approved for PTSD or AAD.", "type": 2, "words": ["<tag1>", "Additionally,", "a", "number", "of", "companies", "are", "working", "on", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "and", "Chimerix.", "<tag2>", "Although", "a", "number", "of", "companies", "are", "marketing", "or", "developing", "prescription", "medicines", "for", "sleep", "disorders,", "including", "Merck", "Co,", "Purdue", "Pharma,", "Eisai,", "GlaxoSmithKline,", "Johnson", "Johnson", "and", "Sage", "Therapeutics,", "none", "of", "these", "sleep", "disorders", "drugs", "are", "approved", "for", "PTSD", "or", "AAD.", "<tag3>"], "wordsA": ["Additionally,", "a", "number", "of", "companies", "are", "working", "on", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "and", "Chimerix."], "wordsB": ["Although", "a", "number", "of", "companies", "are", "marketing", "or", "developing", "prescription", "medicines", "for", "sleep", "disorders,", "including", "Merck", "Co,", "Purdue", "Pharma,", "Eisai,", "GlaxoSmithKline,", "Johnson", "Johnson", "and", "Sage", "Therapeutics,", "none", "of", "these", "sleep", "disorders", "drugs", "are", "approved", "for", "PTSD", "or", "AAD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p101_s0", "idA": "1430306_17_item1_p75_s1", "sentA": "Additionally, a number of companies are working on vaccines/treatments for smallpox, including Bavarian Nordic, SIGA and Chimerix.", "sentB": "Additionally, a number of companies are working on potential vaccines/treatments for smallpox, including Bavarian Nordic, SIGA Technologies and Chimerix.", "type": 2, "words": ["<tag1>", "Additionally,", "a", "number", "of", "companies", "are", "working", "on", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "and", "Chimerix.", "<tag2>", "Additionally,", "a", "number", "of", "companies", "are", "working", "on", "potential", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "Technologies", "and", "Chimerix.", "<tag3>"], "wordsA": ["Additionally,", "a", "number", "of", "companies", "are", "working", "on", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "and", "Chimerix."], "wordsB": ["Additionally,", "a", "number", "of", "companies", "are", "working", "on", "potential", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "Technologies", "and", "Chimerix."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p98_s0", "idA": "1430306_17_item1_p75_s1", "sentA": "Additionally, a number of companies are working on vaccines/treatments for smallpox, including Bavarian Nordic, SIGA and Chimerix.", "sentB": "Additionally, a number of companies are developing prescription medicines for agitation in Alzheimer s, including Otsuka/Lundbeck (Rexulti or brexpiprazole), Avanir/Otsuka (deudextromethorphan), Axsome (dextromethorphan/buproprion) and InterCellular (lumateperone).", "type": 2, "words": ["<tag1>", "Additionally,", "a", "number", "of", "companies", "are", "working", "on", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "and", "Chimerix.", "<tag2>", "Additionally,", "a", "number", "of", "companies", "are", "developing", "prescription", "medicines", "for", "agitation", "in", "Alzheimer", "s,", "including", "Otsuka/Lundbeck", "(Rexulti", "or", "brexpiprazole),", "Avanir/Otsuka", "(deudextromethorphan),", "Axsome", "(dextromethorphan/buproprion)", "and", "InterCellular", "(lumateperone).", "<tag3>"], "wordsA": ["Additionally,", "a", "number", "of", "companies", "are", "working", "on", "vaccines/treatments", "for", "smallpox,", "including", "Bavarian", "Nordic,", "SIGA", "and", "Chimerix."], "wordsB": ["Additionally,", "a", "number", "of", "companies", "are", "developing", "prescription", "medicines", "for", "agitation", "in", "Alzheimer", "s,", "including", "Otsuka/Lundbeck", "(Rexulti", "or", "brexpiprazole),", "Avanir/Otsuka", "(deudextromethorphan),", "Axsome", "(dextromethorphan/buproprion)", "and", "InterCellular", "(lumateperone)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p100_s1", "idA": "1430306_17_item1_p76_s0", "sentA": "Bavarian Nordic is developing Modified Virus Ankara, or MVA, which is a vaccine.", "sentB": "Merck is marketing Belsomra (suvorexant), which is a dual orexin receptor anatomist indicated for insomnia.", "type": 2, "words": ["<tag1>", "Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine.", "<tag2>", "Merck", "is", "marketing", "Belsomra", "(suvorexant),", "which", "is", "a", "dual", "orexin", "receptor", "anatomist", "indicated", "for", "insomnia.", "<tag3>"], "wordsA": ["Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine."], "wordsB": ["Merck", "is", "marketing", "Belsomra", "(suvorexant),", "which", "is", "a", "dual", "orexin", "receptor", "anatomist", "indicated", "for", "insomnia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p100_s3", "idA": "1430306_17_item1_p76_s0", "sentA": "Bavarian Nordic is developing Modified Virus Ankara, or MVA, which is a vaccine.", "sentB": "Johnson Johnson and Minerva Neurosciences are developing seltorexant which is a selective orexin-2 antagonist.", "type": 2, "words": ["<tag1>", "Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine.", "<tag2>", "Johnson", "Johnson", "and", "Minerva", "Neurosciences", "are", "developing", "seltorexant", "which", "is", "a", "selective", "orexin-2", "antagonist.", "<tag3>"], "wordsA": ["Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine."], "wordsB": ["Johnson", "Johnson", "and", "Minerva", "Neurosciences", "are", "developing", "seltorexant", "which", "is", "a", "selective", "orexin-2", "antagonist."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p100_s4", "idA": "1430306_17_item1_p76_s0", "sentA": "Bavarian Nordic is developing Modified Virus Ankara, or MVA, which is a vaccine.", "sentB": "Sage Therapeutics is developing SAGE-217 which is a neurosteroid derivative that acts as a positive allosteric modulator of synaptic and extrasynaptic GABA receptors and was recently shown to increase sleep efficiency in a 5-hour phase advance model of insomnia.", "type": 2, "words": ["<tag1>", "Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine.", "<tag2>", "Sage", "Therapeutics", "is", "developing", "SAGE-217", "which", "is", "a", "neurosteroid", "derivative", "that", "acts", "as", "a", "positive", "allosteric", "modulator", "of", "synaptic", "and", "extrasynaptic", "GABA", "receptors", "and", "was", "recently", "shown", "to", "increase", "sleep", "efficiency", "in", "a", "5-hour", "phase", "advance", "model", "of", "insomnia.", "<tag3>"], "wordsA": ["Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine."], "wordsB": ["Sage", "Therapeutics", "is", "developing", "SAGE-217", "which", "is", "a", "neurosteroid", "derivative", "that", "acts", "as", "a", "positive", "allosteric", "modulator", "of", "synaptic", "and", "extrasynaptic", "GABA", "receptors", "and", "was", "recently", "shown", "to", "increase", "sleep", "efficiency", "in", "a", "5-hour", "phase", "advance", "model", "of", "insomnia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p101_s1", "idA": "1430306_17_item1_p76_s0", "sentA": "Bavarian Nordic is developing Modified Virus Ankara, or MVA, which is a vaccine.", "sentB": "Bavarian Nordic is developing and has submitted an NDA for Imvamune (or Modified Virus Ankara or MVA), which is a non-replicating vaccinia virus vaccine, which has been approved in other countries.", "type": 2, "words": ["<tag1>", "Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine.", "<tag2>", "Bavarian", "Nordic", "is", "developing", "and", "has", "submitted", "an", "NDA", "for", "Imvamune", "(or", "Modified", "Virus", "Ankara", "or", "MVA),", "which", "is", "a", "non-replicating", "vaccinia", "virus", "vaccine,", "which", "has", "been", "approved", "in", "other", "countries.", "<tag3>"], "wordsA": ["Bavarian", "Nordic", "is", "developing", "Modified", "Virus", "Ankara,", "or", "MVA,", "which", "is", "a", "vaccine."], "wordsB": ["Bavarian", "Nordic", "is", "developing", "and", "has", "submitted", "an", "NDA", "for", "Imvamune", "(or", "Modified", "Virus", "Ankara", "or", "MVA),", "which", "is", "a", "non-replicating", "vaccinia", "virus", "vaccine,", "which", "has", "been", "approved", "in", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p102_s0", "idA": "1430306_17_item1_p77_s0", "sentA": "We believe that we have an extensive patent portfolio and substantial know-how relating to TNX-102 SL and our other product candidates.", "sentB": "We believe that we have an extensive patent portfolio and substantial know-how relating to Tonmya or TNX-102 SL and our other product candidates.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates.", "<tag2>", "We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "Tonmya", "or", "TNX-102", "SL", "and", "our", "other", "product", "candidates.", "<tag3>"], "wordsA": ["We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "TNX-102", "SL", "and", "our", "other", "product", "candidates."], "wordsB": ["We", "believe", "that", "we", "have", "an", "extensive", "patent", "portfolio", "and", "substantial", "know-how", "relating", "to", "Tonmya", "or", "TNX-102", "SL", "and", "our", "other", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p102_s1", "idA": "1430306_17_item1_p77_s1", "sentA": "Our patent portfolio, described more fully below, includes claims directed to TNX-102 SL compositions and methods of use.", "sentB": "Our patent portfolio, described more fully below, includes claims directed to Tonmya or TNX-102 SL compositions and methods of use.", "type": 2, "words": ["<tag1>", "Our", "patent", "portfolio,", "described", "more", "fully", "below,", "includes", "claims", "directed", "to", "TNX-102", "SL", "compositions", "and", "methods", "of", "use.", "<tag2>", "Our", "patent", "portfolio,", "described", "more", "fully", "below,", "includes", "claims", "directed", "to", "Tonmya", "or", "TNX-102", "SL", "compositions", "and", "methods", "of", "use.", "<tag3>"], "wordsA": ["Our", "patent", "portfolio,", "described", "more", "fully", "below,", "includes", "claims", "directed", "to", "TNX-102", "SL", "compositions", "and", "methods", "of", "use."], "wordsB": ["Our", "patent", "portfolio,", "described", "more", "fully", "below,", "includes", "claims", "directed", "to", "Tonmya", "or", "TNX-102", "SL", "compositions", "and", "methods", "of", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p102_s2", "idA": "1430306_17_item1_p77_s2", "sentA": "As of March 31, 2017, the patents we are either the owner of record of or own the contractual right to include three issued U.S. patents and 16 issued non-U.S. patents.", "sentB": "As of February 1, 2018, the patents we are either the owner of record of or own the contractual right to include eight issued U.S. patents and 87 issued non-U.S. patents.", "type": 2, "words": ["<tag1>", "As", "of", "March", "31,", "2017,", "the", "patents", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "include", "three", "issued", "U.S.", "patents", "and", "16", "issued", "non-U.S.", "patents.", "<tag2>", "As", "of", "February", "1,", "2018,", "the", "patents", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "include", "eight", "issued", "U.S.", "patents", "and", "87", "issued", "non-U.S.", "patents.", "<tag3>"], "wordsA": ["As", "of", "March", "31,", "2017,", "the", "patents", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "include", "three", "issued", "U.S.", "patents", "and", "16", "issued", "non-U.S.", "patents."], "wordsB": ["As", "of", "February", "1,", "2018,", "the", "patents", "we", "are", "either", "the", "owner", "of", "record", "of", "or", "own", "the", "contractual", "right", "to", "include", "eight", "issued", "U.S.", "patents", "and", "87", "issued", "non-U.S.", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p102_s3", "idA": "1430306_17_item1_p77_s3", "sentA": "We are actively pursuing an additional 15 U.S. patent applications, of which four are provisional and 11 are non-provisional, one international patent application, and 71 non-U.S./non-international patent applications.", "sentB": "We are actively pursuing an additional 16 U.S. patent applications, of which three are provisional and 13 are non-provisional, three international patent applications, and 72 non-U.S./non-international patent applications.", "type": 2, "words": ["<tag1>", "We", "are", "actively", "pursuing", "an", "additional", "15", "U.S.", "patent", "applications,", "of", "which", "four", "are", "provisional", "and", "11", "are", "non-provisional,", "one", "international", "patent", "application,", "and", "71", "non-U.S./non-international", "patent", "applications.", "<tag2>", "We", "are", "actively", "pursuing", "an", "additional", "16", "U.S.", "patent", "applications,", "of", "which", "three", "are", "provisional", "and", "13", "are", "non-provisional,", "three", "international", "patent", "applications,", "and", "72", "non-U.S./non-international", "patent", "applications.", "<tag3>"], "wordsA": ["We", "are", "actively", "pursuing", "an", "additional", "15", "U.S.", "patent", "applications,", "of", "which", "four", "are", "provisional", "and", "11", "are", "non-provisional,", "one", "international", "patent", "application,", "and", "71", "non-U.S./non-international", "patent", "applications."], "wordsB": ["We", "are", "actively", "pursuing", "an", "additional", "16", "U.S.", "patent", "applications,", "of", "which", "three", "are", "provisional", "and", "13", "are", "non-provisional,", "three", "international", "patent", "applications,", "and", "72", "non-U.S./non-international", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p187_s0", "idA": "1430306_17_item1_p80_s0", "sentA": "We cannot be certain that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications we may own or license in the future, nor can we be certain that any of our existing patents or any patents we may own or license in the future will be useful in protecting our technology.", "sentB": "We expect that additional federal and state, as well as foreign, healthcare reform measures will be adopted in the future, any of which could result in reduced demand for our products or additional pricing pressure.", "type": 2, "words": ["<tag1>", "We", "cannot", "be", "certain", "that", "patents", "will", "be", "granted", "with", "respect", "to", "any", "of", "our", "pending", "patent", "applications", "or", "with", "respect", "to", "any", "patent", "applications", "we", "may", "own", "or", "license", "in", "the", "future,", "nor", "can", "we", "be", "certain", "that", "any", "of", "our", "existing", "patents", "or", "any", "patents", "we", "may", "own", "or", "license", "in", "the", "future", "will", "be", "useful", "in", "protecting", "our", "technology.", "<tag2>", "We", "expect", "that", "additional", "federal", "and", "state,", "as", "well", "as", "foreign,", "healthcare", "reform", "measures", "will", "be", "adopted", "in", "the", "future,", "any", "of", "which", "could", "result", "in", "reduced", "demand", "for", "our", "products", "or", "additional", "pricing", "pressure.", "<tag3>"], "wordsA": ["We", "cannot", "be", "certain", "that", "patents", "will", "be", "granted", "with", "respect", "to", "any", "of", "our", "pending", "patent", "applications", "or", "with", "respect", "to", "any", "patent", "applications", "we", "may", "own", "or", "license", "in", "the", "future,", "nor", "can", "we", "be", "certain", "that", "any", "of", "our", "existing", "patents", "or", "any", "patents", "we", "may", "own", "or", "license", "in", "the", "future", "will", "be", "useful", "in", "protecting", "our", "technology."], "wordsB": ["We", "expect", "that", "additional", "federal", "and", "state,", "as", "well", "as", "foreign,", "healthcare", "reform", "measures", "will", "be", "adopted", "in", "the", "future,", "any", "of", "which", "could", "result", "in", "reduced", "demand", "for", "our", "products", "or", "additional", "pricing", "pressure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p108_s0", "idA": "1430306_17_item1_p83_s0", "sentA": "The term of a U.S. patent that covers an FDA-approved drug may also be eligible for patent term extension, which permits patent term restoration as compensation for the patent term lost during the FDA regulatory review process.", "sentB": "The term of a U.S. patent that covers an FDA-approved drug or methods of making or using that drug may also be eligible for patent term extension, which permits patent term restoration as compensation for the patent term lost during the FDA regulatory review process.", "type": 2, "words": ["<tag1>", "The", "term", "of", "a", "U.S.", "patent", "that", "covers", "an", "FDA-approved", "drug", "may", "also", "be", "eligible", "for", "patent", "term", "extension,", "which", "permits", "patent", "term", "restoration", "as", "compensation", "for", "the", "patent", "term", "lost", "during", "the", "FDA", "regulatory", "review", "process.", "<tag2>", "The", "term", "of", "a", "U.S.", "patent", "that", "covers", "an", "FDA-approved", "drug", "or", "methods", "of", "making", "or", "using", "that", "drug", "may", "also", "be", "eligible", "for", "patent", "term", "extension,", "which", "permits", "patent", "term", "restoration", "as", "compensation", "for", "the", "patent", "term", "lost", "during", "the", "FDA", "regulatory", "review", "process.", "<tag3>"], "wordsA": ["The", "term", "of", "a", "U.S.", "patent", "that", "covers", "an", "FDA-approved", "drug", "may", "also", "be", "eligible", "for", "patent", "term", "extension,", "which", "permits", "patent", "term", "restoration", "as", "compensation", "for", "the", "patent", "term", "lost", "during", "the", "FDA", "regulatory", "review", "process."], "wordsB": ["The", "term", "of", "a", "U.S.", "patent", "that", "covers", "an", "FDA-approved", "drug", "or", "methods", "of", "making", "or", "using", "that", "drug", "may", "also", "be", "eligible", "for", "patent", "term", "extension,", "which", "permits", "patent", "term", "restoration", "as", "compensation", "for", "the", "patent", "term", "lost", "during", "the", "FDA", "regulatory", "review", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p109_s0", "idA": "1430306_17_item1_p83_s1", "sentA": "The Hatch-Waxman Amendments permit a patent term extension of up to five years beyond the statutory 20-year term of the patent for the approved product if the active ingredient has not been previously approved in the U.S.", "sentB": "The Drug Price Competition and Patent Term Restoration Act, also known as the Hatch-Waxman Act, is a federal law that encourages new drug research by restoring patent term lost to regulatory delays by permitting a patent term extension of up to five years beyond the statutory 20-year term of the patent for the approved product or its methods of manufacture or use if the active ingredient has not been previously approved in the U.S.", "type": 2, "words": ["<tag1>", "The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20-year", "term", "of", "the", "patent", "for", "the", "approved", "product", "if", "the", "active", "ingredient", "has", "not", "been", "previously", "approved", "in", "the", "U.S.", "<tag2>", "The", "Drug", "Price", "Competition", "and", "Patent", "Term", "Restoration", "Act,", "also", "known", "as", "the", "Hatch-Waxman", "Act,", "is", "a", "federal", "law", "that", "encourages", "new", "drug", "research", "by", "restoring", "patent", "term", "lost", "to", "regulatory", "delays", "by", "permitting", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20-year", "term", "of", "the", "patent", "for", "the", "approved", "product", "or", "its", "methods", "of", "manufacture", "or", "use", "if", "the", "active", "ingredient", "has", "not", "been", "previously", "approved", "in", "the", "U.S.", "<tag3>"], "wordsA": ["The", "Hatch-Waxman", "Amendments", "permit", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20-year", "term", "of", "the", "patent", "for", "the", "approved", "product", "if", "the", "active", "ingredient", "has", "not", "been", "previously", "approved", "in", "the", "U.S."], "wordsB": ["The", "Drug", "Price", "Competition", "and", "Patent", "Term", "Restoration", "Act,", "also", "known", "as", "the", "Hatch-Waxman", "Act,", "is", "a", "federal", "law", "that", "encourages", "new", "drug", "research", "by", "restoring", "patent", "term", "lost", "to", "regulatory", "delays", "by", "permitting", "a", "patent", "term", "extension", "of", "up", "to", "five", "years", "beyond", "the", "statutory", "20-year", "term", "of", "the", "patent", "for", "the", "approved", "product", "or", "its", "methods", "of", "manufacture", "or", "use", "if", "the", "active", "ingredient", "has", "not", "been", "previously", "approved", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p109_s4", "idA": "1430306_17_item1_p83_s5", "sentA": "When possible, depending upon the length of clinical trials and other factors involved in the filing of a new drug application, or NDA, we expect to apply for patent term extensions for patents covering our product candidates and their methods of use.", "sentB": "When possible, depending upon the length of clinical trials and other factors involved in the filing of an NDA, we expect to apply for patent term extensions for patents covering our product candidates and their methods of use.", "type": 2, "words": ["<tag1>", "When", "possible,", "depending", "upon", "the", "length", "of", "clinical", "trials", "and", "other", "factors", "involved", "in", "the", "filing", "of", "a", "new", "drug", "application,", "or", "NDA,", "we", "expect", "to", "apply", "for", "patent", "term", "extensions", "for", "patents", "covering", "our", "product", "candidates", "and", "their", "methods", "of", "use.", "<tag2>", "When", "possible,", "depending", "upon", "the", "length", "of", "clinical", "trials", "and", "other", "factors", "involved", "in", "the", "filing", "of", "an", "NDA,", "we", "expect", "to", "apply", "for", "patent", "term", "extensions", "for", "patents", "covering", "our", "product", "candidates", "and", "their", "methods", "of", "use.", "<tag3>"], "wordsA": ["When", "possible,", "depending", "upon", "the", "length", "of", "clinical", "trials", "and", "other", "factors", "involved", "in", "the", "filing", "of", "a", "new", "drug", "application,", "or", "NDA,", "we", "expect", "to", "apply", "for", "patent", "term", "extensions", "for", "patents", "covering", "our", "product", "candidates", "and", "their", "methods", "of", "use."], "wordsB": ["When", "possible,", "depending", "upon", "the", "length", "of", "clinical", "trials", "and", "other", "factors", "involved", "in", "the", "filing", "of", "an", "NDA,", "we", "expect", "to", "apply", "for", "patent", "term", "extensions", "for", "patents", "covering", "our", "product", "candidates", "and", "their", "methods", "of", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p110_s0", "idA": "1430306_17_item1_p84_s0", "sentA": "The patent portfolios for our proprietary technology platform and our three most advanced product candidates as of March 31, 2017 are summarized below.", "sentB": "The patent portfolios for our proprietary technology platform and our five most advanced product candidates as of March 1, 2018 are summarized below.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "31,", "2017", "are", "summarized", "below.", "<tag2>", "The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "five", "most", "advanced", "product", "candidates", "as", "of", "March", "1,", "2018", "are", "summarized", "below.", "<tag3>"], "wordsA": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "three", "most", "advanced", "product", "candidates", "as", "of", "March", "31,", "2017", "are", "summarized", "below."], "wordsB": ["The", "patent", "portfolios", "for", "our", "proprietary", "technology", "platform", "and", "our", "five", "most", "advanced", "product", "candidates", "as", "of", "March", "1,", "2018", "are", "summarized", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p111_s0", "idA": "1430306_17_item1_p85_s0", "sentA": "Our patent portfolio for TNX-102 SL includes patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating CNS conditions utilizing these compositions and formulations.", "sentB": "Our patent portfolio for TNX-102 SL include patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating CNS conditions, such as Tonmya for PTSD, and TNX-102 SL for agitation in neurodegenerative conditions, e.g. agitation in Alzheimer s disease, utilizing these compositions and formulations.", "type": 2, "words": ["<tag1>", "Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag2>", "Our", "patent", "portfolio", "for", "TNX-102", "SL", "include", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "CNS", "conditions,", "such", "as", "Tonmya", "for", "PTSD,", "and", "TNX-102", "SL", "for", "agitation", "in", "neurodegenerative", "conditions,", "e.g.", "agitation", "in", "Alzheimer", "s", "disease,", "utilizing", "these", "compositions", "and", "formulations.", "<tag3>"], "wordsA": ["Our", "patent", "portfolio", "for", "TNX-102", "SL", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "wordsB": ["Our", "patent", "portfolio", "for", "TNX-102", "SL", "include", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "CNS", "conditions,", "such", "as", "Tonmya", "for", "PTSD,", "and", "TNX-102", "SL", "for", "agitation", "in", "neurodegenerative", "conditions,", "e.g.", "agitation", "in", "Alzheimer", "s", "disease,", "utilizing", "these", "compositions", "and", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p119_s2", "idA": "1430306_17_item1_p85_s1", "sentA": "No. 9,474,728 is expected to expire in 2031, excluding any patent term extensions.", "sentB": "The patent, when it issues is expected to provide Tonmya with US market exclusivity until 2030.", "type": 2, "words": ["<tag1>", "No.", "9,474,728", "is", "expected", "to", "expire", "in", "2031,", "excluding", "any", "patent", "term", "extensions.", "<tag2>", "The", "patent,", "when", "it", "issues", "is", "expected", "to", "provide", "Tonmya", "with", "US", "market", "exclusivity", "until", "2030.", "<tag3>"], "wordsA": ["No.", "9,474,728", "is", "expected", "to", "expire", "in", "2031,", "excluding", "any", "patent", "term", "extensions."], "wordsB": ["The", "patent,", "when", "it", "issues", "is", "expected", "to", "provide", "Tonmya", "with", "US", "market", "exclusivity", "until", "2030."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p28_s3", "idA": "1430306_17_item1_p85_s1", "sentA": "No. 9,474,728 is expected to expire in 2031, excluding any patent term extensions.", "sentB": "Agitation is likely to affect more than half of the 5.3 million Americans who currently suffer from Alzheimer s disease, and this number is expected to nearly triple by 2050.", "type": 2, "words": ["<tag1>", "No.", "9,474,728", "is", "expected", "to", "expire", "in", "2031,", "excluding", "any", "patent", "term", "extensions.", "<tag2>", "Agitation", "is", "likely", "to", "affect", "more", "than", "half", "of", "the", "5.3", "million", "Americans", "who", "currently", "suffer", "from", "Alzheimer", "s", "disease,", "and", "this", "number", "is", "expected", "to", "nearly", "triple", "by", "2050.", "<tag3>"], "wordsA": ["No.", "9,474,728", "is", "expected", "to", "expire", "in", "2031,", "excluding", "any", "patent", "term", "extensions."], "wordsB": ["Agitation", "is", "likely", "to", "affect", "more", "than", "half", "of", "the", "5.3", "million", "Americans", "who", "currently", "suffer", "from", "Alzheimer", "s", "disease,", "and", "this", "number", "is", "expected", "to", "nearly", "triple", "by", "2050."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p112_s1", "idA": "1430306_17_item1_p86_s1", "sentA": "The patent portfolio for TNX-102 SL relating to the Eutectic Technology includes patent applications directed to eutectic compositions containing CBP, eutectic CBP formulations, methods for treating PTSD and other CNS conditions utilizing eutectic CBP compositions and formulations, and methods of manufacturing eutectic CBP compositions.", "sentB": "The patent portfolio for Tonmya and TNX-102 SL relating to the Eutectic Technology includes patent applications directed to eutectic compositions containing CBP, eutectic CBP formulations, methods for treating PTSD and other CNS conditions utilizing eutectic CBP compositions and formulations, and methods of manufacturing eutectic CBP compositions.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions.", "<tag2>", "The", "patent", "portfolio", "for", "Tonmya", "and", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions."], "wordsB": ["The", "patent", "portfolio", "for", "Tonmya", "and", "TNX-102", "SL", "relating", "to", "the", "Eutectic", "Technology", "includes", "patent", "applications", "directed", "to", "eutectic", "compositions", "containing", "CBP,", "eutectic", "CBP", "formulations,", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "eutectic", "CBP", "compositions", "and", "formulations,", "and", "methods", "of", "manufacturing", "eutectic", "CBP", "compositions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p113_s1", "idA": "1430306_17_item1_p86_s2", "sentA": "The Eutectic Technology patent portfolio includes U.S. patent applications, such as U.S. Patent Application No. 14/214,433.", "sentB": "The U.S. eutectic patent was issued on May 2, 2017 as U.S. Patent No. 9,636,408.", "type": 2, "words": ["<tag1>", "The", "Eutectic", "Technology", "patent", "portfolio", "includes", "U.S.", "patent", "applications,", "such", "as", "U.S.", "Patent", "Application", "No.", "14/214,433.", "<tag2>", "The", "U.S.", "eutectic", "patent", "was", "issued", "on", "May", "2,", "2017", "as", "U.S.", "Patent", "No.", "9,636,408.", "<tag3>"], "wordsA": ["The", "Eutectic", "Technology", "patent", "portfolio", "includes", "U.S.", "patent", "applications,", "such", "as", "U.S.", "Patent", "Application", "No.", "14/214,433."], "wordsB": ["The", "U.S.", "eutectic", "patent", "was", "issued", "on", "May", "2,", "2017", "as", "U.S.", "Patent", "No.", "9,636,408."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p113_s0", "idA": "1430306_17_item1_p87_s0", "sentA": "On March 10, 2017, we received a notice of allowance from the PTO for the US patent No. 14/214,433 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride, which includes compositions of cyclobenzaprine HCl and methods of manufacturing the eutectic.", "sentB": "On March 10, 2017, we received a Notice of Allowance from the USPTO for the U.S. Patent Application No. 14/214,433 Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride, which includes compositions of CBP and methods of manufacturing the eutectic.", "type": 2, "words": ["<tag1>", "On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "from", "the", "PTO", "for", "the", "US", "patent", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride,", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic.", "<tag2>", "On", "March", "10,", "2017,", "we", "received", "a", "Notice", "of", "Allowance", "from", "the", "USPTO", "for", "the", "U.S.", "Patent", "Application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride,", "which", "includes", "compositions", "of", "CBP", "and", "methods", "of", "manufacturing", "the", "eutectic.", "<tag3>"], "wordsA": ["On", "March", "10,", "2017,", "we", "received", "a", "notice", "of", "allowance", "from", "the", "PTO", "for", "the", "US", "patent", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride,", "which", "includes", "compositions", "of", "cyclobenzaprine", "HCl", "and", "methods", "of", "manufacturing", "the", "eutectic."], "wordsB": ["On", "March", "10,", "2017,", "we", "received", "a", "Notice", "of", "Allowance", "from", "the", "USPTO", "for", "the", "U.S.", "Patent", "Application", "No.", "14/214,433", "Eutectic", "Formulations", "of", "Cyclobenzaprine", "Hydrochloride", "and", "Amitriptyline", "Hydrochloride,", "which", "includes", "compositions", "of", "CBP", "and", "methods", "of", "manufacturing", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p113_s3", "idA": "1430306_17_item1_p87_s2", "sentA": "The allowed claims will also protect the method of manufacturing the eutectic.", "sentB": "The patent claims also recite methods of manufacturing the eutectic.", "type": 2, "words": ["<tag1>", "The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic.", "<tag2>", "The", "patent", "claims", "also", "recite", "methods", "of", "manufacturing", "the", "eutectic.", "<tag3>"], "wordsA": ["The", "allowed", "claims", "will", "also", "protect", "the", "method", "of", "manufacturing", "the", "eutectic."], "wordsB": ["The", "patent", "claims", "also", "recite", "methods", "of", "manufacturing", "the", "eutectic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p8_s1", "idA": "1430306_17_item1_p8_s1", "sentA": "We complement our management team with a network of scientific, clinical, and regulatory advisors that includes recognized experts in the fields of PTSD and other central nervous system disorders.", "sentB": "We complement our management team with a network of scientific, clinical, and regulatory advisors that includes recognized experts in the fields of PTSD, other central nervous system disorders and biodefense.", "type": 2, "words": ["<tag1>", "We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "PTSD", "and", "other", "central", "nervous", "system", "disorders.", "<tag2>", "We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "PTSD,", "other", "central", "nervous", "system", "disorders", "and", "biodefense.", "<tag3>"], "wordsA": ["We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "PTSD", "and", "other", "central", "nervous", "system", "disorders."], "wordsB": ["We", "complement", "our", "management", "team", "with", "a", "network", "of", "scientific,", "clinical,", "and", "regulatory", "advisors", "that", "includes", "recognized", "experts", "in", "the", "fields", "of", "PTSD,", "other", "central", "nervous", "system", "disorders", "and", "biodefense."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p116_s0", "idA": "1430306_17_item1_p90_s0", "sentA": "The unique pharmacokinetic profile of TNX-102 SL was discovered by Tonix and its development partners and is termed the PK Technology.", "sentB": "The unique pharmacokinetic profile of Tonmya and TNX-102 SL, or the PK Technology, was discovered by Tonix and its development partners.", "type": 2, "words": ["<tag1>", "The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "SL", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology.", "<tag2>", "The", "unique", "pharmacokinetic", "profile", "of", "Tonmya", "and", "TNX-102", "SL,", "or", "the", "PK", "Technology,", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners.", "<tag3>"], "wordsA": ["The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "SL", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology."], "wordsB": ["The", "unique", "pharmacokinetic", "profile", "of", "Tonmya", "and", "TNX-102", "SL,", "or", "the", "PK", "Technology,", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p45_s0", "idA": "1430306_17_item1_p90_s0", "sentA": "The unique pharmacokinetic profile of TNX-102 SL was discovered by Tonix and its development partners and is termed the PK Technology.", "sentB": "On December 15, 2017 we were issued Japanese Patent No. 6259452, Compositions and Methods for Transmucosal Absorption, by the Japanese Patent Office (JPO) relating to the pharmacokinetic profile of Tonmya, or TNX-102 SL.", "type": 2, "words": ["<tag1>", "The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "SL", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology.", "<tag2>", "On", "December", "15,", "2017", "we", "were", "issued", "Japanese", "Patent", "No.", "6259452,", "Compositions", "and", "Methods", "for", "Transmucosal", "Absorption,", "by", "the", "Japanese", "Patent", "Office", "(JPO)", "relating", "to", "the", "pharmacokinetic", "profile", "of", "Tonmya,", "or", "TNX-102", "SL.", "<tag3>"], "wordsA": ["The", "unique", "pharmacokinetic", "profile", "of", "TNX-102", "SL", "was", "discovered", "by", "Tonix", "and", "its", "development", "partners", "and", "is", "termed", "the", "PK", "Technology."], "wordsB": ["On", "December", "15,", "2017", "we", "were", "issued", "Japanese", "Patent", "No.", "6259452,", "Compositions", "and", "Methods", "for", "Transmucosal", "Absorption,", "by", "the", "Japanese", "Patent", "Office", "(JPO)", "relating", "to", "the", "pharmacokinetic", "profile", "of", "Tonmya,", "or", "TNX-102", "SL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p116_s1", "idA": "1430306_17_item1_p90_s1", "sentA": "The patent portfolio for TNX-102 SL relating to the PK Technology includes patent applications directed to compositions of matter of CBP, formulations containing CBP, and methods for treating PTSD and other CNS conditions utilizing these compositions and formulations.", "sentB": "The patent portfolio for Tonmya and TNX-102 SL relating to the PK Technology includes patent applications directed to compositions of matter of CBP, formulations containing CBP, methods for treating PTSD, agitation in neurodegenerative conditions, and other CNS conditions utilizing these compositions and formulations.", "type": 2, "words": ["<tag1>", "The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag2>", "The", "patent", "portfolio", "for", "Tonmya", "and", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "methods", "for", "treating", "PTSD,", "agitation", "in", "neurodegenerative", "conditions,", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations.", "<tag3>"], "wordsA": ["The", "patent", "portfolio", "for", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "and", "methods", "for", "treating", "PTSD", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "wordsB": ["The", "patent", "portfolio", "for", "Tonmya", "and", "TNX-102", "SL", "relating", "to", "the", "PK", "Technology", "includes", "patent", "applications", "directed", "to", "compositions", "of", "matter", "of", "CBP,", "formulations", "containing", "CBP,", "methods", "for", "treating", "PTSD,", "agitation", "in", "neurodegenerative", "conditions,", "and", "other", "CNS", "conditions", "utilizing", "these", "compositions", "and", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p121_s0", "idA": "1430306_17_item1_p91_s0", "sentA": "Our patent portfolio for tianeptine oxalate includes U.S. provisional Patent Application No. 62/439,533.", "sentB": "Our patent portfolio for tianeptine oxalate includes U.S. Patent Application No. 15/856,818 and International Patent application PCT/IB2017/001709.", "type": 2, "words": ["<tag1>", "Our", "patent", "portfolio", "for", "tianeptine", "oxalate", "includes", "U.S.", "provisional", "Patent", "Application", "No.", "62/439,533.", "<tag2>", "Our", "patent", "portfolio", "for", "tianeptine", "oxalate", "includes", "U.S.", "Patent", "Application", "No.", "15/856,818", "and", "International", "Patent", "application", "PCT/IB2017/001709.", "<tag3>"], "wordsA": ["Our", "patent", "portfolio", "for", "tianeptine", "oxalate", "includes", "U.S.", "provisional", "Patent", "Application", "No.", "62/439,533."], "wordsB": ["Our", "patent", "portfolio", "for", "tianeptine", "oxalate", "includes", "U.S.", "Patent", "Application", "No.", "15/856,818", "and", "International", "Patent", "application", "PCT/IB2017/001709."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p122_s0", "idA": "1430306_17_item1_p92_s1", "sentA": "We have patent applications directed to synthetic chimeric poxviruses and methods of using these poxviruses to protect individuals against smallpox.", "sentB": "We own the rights to develop a potential biodefense technology, TNX-801, a live HPXV that is being developed as a new smallpox preventing vaccine, we have patent applications directed to synthetic chimeric poxviruses and methods of using these poxviruses to protect individuals against smallpox.", "type": 2, "words": ["<tag1>", "We", "have", "patent", "applications", "directed", "to", "synthetic", "chimeric", "poxviruses", "and", "methods", "of", "using", "these", "poxviruses", "to", "protect", "individuals", "against", "smallpox.", "<tag2>", "We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "TNX-801,", "a", "live", "HPXV", "that", "is", "being", "developed", "as", "a", "new", "smallpox", "preventing", "vaccine,", "we", "have", "patent", "applications", "directed", "to", "synthetic", "chimeric", "poxviruses", "and", "methods", "of", "using", "these", "poxviruses", "to", "protect", "individuals", "against", "smallpox.", "<tag3>"], "wordsA": ["We", "have", "patent", "applications", "directed", "to", "synthetic", "chimeric", "poxviruses", "and", "methods", "of", "using", "these", "poxviruses", "to", "protect", "individuals", "against", "smallpox."], "wordsB": ["We", "own", "the", "rights", "to", "develop", "a", "potential", "biodefense", "technology,", "TNX-801,", "a", "live", "HPXV", "that", "is", "being", "developed", "as", "a", "new", "smallpox", "preventing", "vaccine,", "we", "have", "patent", "applications", "directed", "to", "synthetic", "chimeric", "poxviruses", "and", "methods", "of", "using", "these", "poxviruses", "to", "protect", "individuals", "against", "smallpox."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p122_s1", "idA": "1430306_17_item1_p93_s0", "sentA": "These applications include U.S. provisional Patent Application Nos.", "sentB": "These applications include U.S. non-provisional Patent Application No. 15/802,189 and International Patent Application No. PCT/US2017/059782.", "type": 2, "words": ["<tag1>", "These", "applications", "include", "U.S.", "provisional", "Patent", "Application", "Nos.", "<tag2>", "These", "applications", "include", "U.S.", "non-provisional", "Patent", "Application", "No.", "15/802,189", "and", "International", "Patent", "Application", "No.", "PCT/US2017/059782.", "<tag3>"], "wordsA": ["These", "applications", "include", "U.S.", "provisional", "Patent", "Application", "Nos."], "wordsB": ["These", "applications", "include", "U.S.", "non-provisional", "Patent", "Application", "No.", "15/802,189", "and", "International", "Patent", "Application", "No.", "PCT/US2017/059782."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p122_s2", "idA": "1430306_17_item1_p93_s1", "sentA": "We also own the rights to develop some different vaccine candidates against smallpox.", "sentB": "We also own the rights to develop other vaccine candidates against smallpox.", "type": 2, "words": ["<tag1>", "We", "also", "own", "the", "rights", "to", "develop", "some", "different", "vaccine", "candidates", "against", "smallpox.", "<tag2>", "We", "also", "own", "the", "rights", "to", "develop", "other", "vaccine", "candidates", "against", "smallpox.", "<tag3>"], "wordsA": ["We", "also", "own", "the", "rights", "to", "develop", "some", "different", "vaccine", "candidates", "against", "smallpox."], "wordsB": ["We", "also", "own", "the", "rights", "to", "develop", "other", "vaccine", "candidates", "against", "smallpox."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p122_s3", "idA": "1430306_17_item1_p93_s2", "sentA": "With respect to this smallpox vaccine candidate, we own U.S. non-provisional Patent Application No. 14,207,727 and related intellectual property rights.", "sentB": "With respect to these vaccine candidates, we own U.S. Patent Application No. 14/207,727 and related intellectual property rights.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "this", "smallpox", "vaccine", "candidate,", "we", "own", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights.", "<tag2>", "With", "respect", "to", "these", "vaccine", "candidates,", "we", "own", "U.S.", "Patent", "Application", "No.", "14/207,727", "and", "related", "intellectual", "property", "rights.", "<tag3>"], "wordsA": ["With", "respect", "to", "this", "smallpox", "vaccine", "candidate,", "we", "own", "U.S.", "non-provisional", "Patent", "Application", "No.", "14,207,727", "and", "related", "intellectual", "property", "rights."], "wordsB": ["With", "respect", "to", "these", "vaccine", "candidates,", "we", "own", "U.S.", "Patent", "Application", "No.", "14/207,727", "and", "related", "intellectual", "property", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p41_s2", "idA": "1430306_17_item1_p94_s3", "sentA": "The patent expiring last is expected to expire in 2024, excluding any patent term extensions.", "sentB": "The patent is expected to provide Tonmya or TNX-102 SL with U.S. market exclusivity until 2034.", "type": 2, "words": ["<tag1>", "The", "patent", "expiring", "last", "is", "expected", "to", "expire", "in", "2024,", "excluding", "any", "patent", "term", "extensions.", "<tag2>", "The", "patent", "is", "expected", "to", "provide", "Tonmya", "or", "TNX-102", "SL", "with", "U.S.", "market", "exclusivity", "until", "2034.", "<tag3>"], "wordsA": ["The", "patent", "expiring", "last", "is", "expected", "to", "expire", "in", "2024,", "excluding", "any", "patent", "term", "extensions."], "wordsB": ["The", "patent", "is", "expected", "to", "provide", "Tonmya", "or", "TNX-102", "SL", "with", "U.S.", "market", "exclusivity", "until", "2034."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p124_s1", "idA": "1430306_17_item1_p95_s1", "sentA": "For protection of intellectual property, we have not disclosed the identity of the new development candidate.", "sentB": "For protection of our intellectual property, we have not disclosed the identity of the new development candidate.", "type": 2, "words": ["<tag1>", "For", "protection", "of", "intellectual", "property,", "we", "have", "not", "disclosed", "the", "identity", "of", "the", "new", "development", "candidate.", "<tag2>", "For", "protection", "of", "our", "intellectual", "property,", "we", "have", "not", "disclosed", "the", "identity", "of", "the", "new", "development", "candidate.", "<tag3>"], "wordsA": ["For", "protection", "of", "intellectual", "property,", "we", "have", "not", "disclosed", "the", "identity", "of", "the", "new", "development", "candidate."], "wordsB": ["For", "protection", "of", "our", "intellectual", "property,", "we", "have", "not", "disclosed", "the", "identity", "of", "the", "new", "development", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p184_s1", "idA": "1430306_17_item1_p97_s6", "sentA": "To the extent that our contractors use intellectual property owned by others in their work for us, disputes may arise as to rights in related or resulting inventions and know-how.", "sentB": "Additionally, to the extent that our product is sold in a foreign country, we may be subject to similar foreign laws.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "our", "contractors", "use", "intellectual", "property", "owned", "by", "others", "in", "their", "work", "for", "us,", "disputes", "may", "arise", "as", "to", "rights", "in", "related", "or", "resulting", "inventions", "and", "know-how.", "<tag2>", "Additionally,", "to", "the", "extent", "that", "our", "product", "is", "sold", "in", "a", "foreign", "country,", "we", "may", "be", "subject", "to", "similar", "foreign", "laws.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "our", "contractors", "use", "intellectual", "property", "owned", "by", "others", "in", "their", "work", "for", "us,", "disputes", "may", "arise", "as", "to", "rights", "in", "related", "or", "resulting", "inventions", "and", "know-how."], "wordsB": ["Additionally,", "to", "the", "extent", "that", "our", "product", "is", "sold", "in", "a", "foreign", "country,", "we", "may", "be", "subject", "to", "similar", "foreign", "laws."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p11_s0", "idA": "1430306_17_item1_p9_s0", "sentA": "Our lead product candidate, TNX-102 SL, a proprietary low-dose cyclobenzaprine sublingual tablet, designed for bedtime administration, is in Phase 3 development as a potential treatment for PTSD.", "sentB": "Our lead product candidate, Tonmya, or TNX-102 SL, a proprietary low-dose cyclobenzaprine, or CBP, sublingual tablet, designed for bedtime administration, is in Phase 3 development as a potential treatment for PTSD.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate,", "TNX-102", "SL,", "a", "proprietary", "low-dose", "cyclobenzaprine", "sublingual", "tablet,", "designed", "for", "bedtime", "administration,", "is", "in", "Phase", "3", "development", "as", "a", "potential", "treatment", "for", "PTSD.", "<tag2>", "Our", "lead", "product", "candidate,", "Tonmya,", "or", "TNX-102", "SL,", "a", "proprietary", "low-dose", "cyclobenzaprine,", "or", "CBP,", "sublingual", "tablet,", "designed", "for", "bedtime", "administration,", "is", "in", "Phase", "3", "development", "as", "a", "potential", "treatment", "for", "PTSD.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate,", "TNX-102", "SL,", "a", "proprietary", "low-dose", "cyclobenzaprine", "sublingual", "tablet,", "designed", "for", "bedtime", "administration,", "is", "in", "Phase", "3", "development", "as", "a", "potential", "treatment", "for", "PTSD."], "wordsB": ["Our", "lead", "product", "candidate,", "Tonmya,", "or", "TNX-102", "SL,", "a", "proprietary", "low-dose", "cyclobenzaprine,", "or", "CBP,", "sublingual", "tablet,", "designed", "for", "bedtime", "administration,", "is", "in", "Phase", "3", "development", "as", "a", "potential", "treatment", "for", "PTSD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1430306_18_item1_p11_s2", "idA": "1430306_17_item1_p9_s1", "sentA": "Our development pipeline includes: TNX-601 (tianeptine oxalate), a separate pre-IND (Investigational New Drug) candidate designed for daytime administration for the treatment of PTSD and cognitive dysfunction associated with steroid use; TNX-801, a potential smallpox-preventing vaccine based on a live synthetic version of horsepox virus, or HPXV; TNX-301 an IND candidate for the treatment of alcohol use disorders, or AUD; and TNX-701, a biodefense development program for protection from radiation injury.", "sentB": "Our development pipeline includes: TNX-601 (tianeptine oxalate), a separate pre-Investigational New Drug, or pre-IND, candidate designed for daytime administration as a potential treatment of PTSD and for cognitive dysfunction associated with steroid use; TNX-801, a potential smallpox-preventing vaccine based on a live synthetic version of horsepox virus, or HPXV; TNX-301, an IND candidate for the treatment of alcohol use disorder, or AUD; and TNX-701, a biodefense development program for protection from radiation injury.", "type": 2, "words": ["<tag1>", "Our", "development", "pipeline", "includes:", "TNX-601", "(tianeptine", "oxalate),", "a", "separate", "pre-IND", "(Investigational", "New", "Drug)", "candidate", "designed", "for", "daytime", "administration", "for", "the", "treatment", "of", "PTSD", "and", "cognitive", "dysfunction", "associated", "with", "steroid", "use;", "TNX-801,", "a", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "horsepox", "virus,", "or", "HPXV;", "TNX-301", "an", "IND", "candidate", "for", "the", "treatment", "of", "alcohol", "use", "disorders,", "or", "AUD;", "and", "TNX-701,", "a", "biodefense", "development", "program", "for", "protection", "from", "radiation", "injury.", "<tag2>", "Our", "development", "pipeline", "includes:", "TNX-601", "(tianeptine", "oxalate),", "a", "separate", "pre-Investigational", "New", "Drug,", "or", "pre-IND,", "candidate", "designed", "for", "daytime", "administration", "as", "a", "potential", "treatment", "of", "PTSD", "and", "for", "cognitive", "dysfunction", "associated", "with", "steroid", "use;", "TNX-801,", "a", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "horsepox", "virus,", "or", "HPXV;", "TNX-301,", "an", "IND", "candidate", "for", "the", "treatment", "of", "alcohol", "use", "disorder,", "or", "AUD;", "and", "TNX-701,", "a", "biodefense", "development", "program", "for", "protection", "from", "radiation", "injury.", "<tag3>"], "wordsA": ["Our", "development", "pipeline", "includes:", "TNX-601", "(tianeptine", "oxalate),", "a", "separate", "pre-IND", "(Investigational", "New", "Drug)", "candidate", "designed", "for", "daytime", "administration", "for", "the", "treatment", "of", "PTSD", "and", "cognitive", "dysfunction", "associated", "with", "steroid", "use;", "TNX-801,", "a", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "horsepox", "virus,", "or", "HPXV;", "TNX-301", "an", "IND", "candidate", "for", "the", "treatment", "of", "alcohol", "use", "disorders,", "or", "AUD;", "and", "TNX-701,", "a", "biodefense", "development", "program", "for", "protection", "from", "radiation", "injury."], "wordsB": ["Our", "development", "pipeline", "includes:", "TNX-601", "(tianeptine", "oxalate),", "a", "separate", "pre-Investigational", "New", "Drug,", "or", "pre-IND,", "candidate", "designed", "for", "daytime", "administration", "as", "a", "potential", "treatment", "of", "PTSD", "and", "for", "cognitive", "dysfunction", "associated", "with", "steroid", "use;", "TNX-801,", "a", "potential", "smallpox-preventing", "vaccine", "based", "on", "a", "live", "synthetic", "version", "of", "horsepox", "virus,", "or", "HPXV;", "TNX-301,", "an", "IND", "candidate", "for", "the", "treatment", "of", "alcohol", "use", "disorder,", "or", "AUD;", "and", "TNX-701,", "a", "biodefense", "development", "program", "for", "protection", "from", "radiation", "injury."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
